<<

SCIENTIFIC CONGRESS INSIDE this program OPENING CEREMONY...... 2 ASRM WELCOME...... 3 HOTEL INFORMATION...... 5 ASRM SCIENTIFIC CONGRESS PLANNING COMMITTEES . . . . .7-9 ASRM OFFICERS AND BOARD OF DIRECTORS ...... 7 2016 AWARDS ...... 10-23 ASRM SCIENTIFIC CONGRESS POLICIES AND DISCLAIMERS . . . 24 MEMBERS' MEETINGS...... 26 CME/CE SECTION ...... 27 EDUCATIONAL SUPPORT . . . . .28 CONTINUING CONTINUING EDUCATION. . . . . 30, 31 PRE-CONGRESS PROGRAM . . 32-50 JOIN US FOR OUR NON-CME ACTIVITIES...... 51 ASRM 5K RUN INFORMATION. . . 51 NEEDS ASSESSMENT AND Opening Ceremony LEARNING OBJECTIVES...... 52 ASRM 2016 CONGRESS GRID. . . 53 SCIENTIFIC CONGRESS Monday, October 17th, 8:00 am – 9:00 am DAILY SCHEDULE...... 54-62 in the Salt Palace Convention Center Ballroom 2016 NICHD-ASRM WORKSHOP . .63 TRACKS GRID ...... 64-66 Come hear ASRM President, Dr. Owen Davis, discuss CONTRACEPTION TRACK . . . . .67 the Society's accomplishments this year and plans for TRACK...... 68 TRACK...... 69,70 "Scaling New Heights in Reproductive ." ART TRACK...... 71,72 FIBROIDS TRACK ...... 73 Plenary 1 will immediately follow in the same room. ENDOMETRIOSIS TRACK . . . . .74 GENETICS TRACK ...... 75 A continental breakfast will be available RESIDENT REPORTER TRACK. . . . . 76 7:00 am – 8:00 am PLENARY SESSIONS...... 77-81 LECTURES...... 82 Ballroom – North Foyer SYMPOSIA...... 83-98 INTERACTIVE SESSIONS. . . 99-110 ADDITIONAL SESSIONS. . . 111-114 NON-CME SECTION ...... 115 VIDEO SESSIONS...... 116-124 ROUNDTABLES ...... 125-130 ASRM IS PAPERLESS...... 130 FUTURE MEETINGS ...... 130 ABSTRACT REVIEW COMMITTEES...... 131,132 ORAL PRESENTATIONS. . . 133-164 POSTER PRESENTATIONS. . 165-235 ABSTRACT TOPIC INDEX. . .236-238 ABSTRACT AUTHOR INDEX. .239-266 SPEAKERS INDEX ...... 267-269 DISCLOSURES...... 270-288 ASRM 2O16 SCIENTIFIC CONGRESS

Welcome practice and laboratory managers, as well as scientific abstract presentations, representing specialists in mental health, law, and ethics, cutting-edge research in reproductive in order to advance the highest standards of medicine and biology. Dr. Schattman and medical care and to disseminate the latest the Pre-Congress Program Committee have developments in clinical and basic research. collaborated with our affiliated societies Dr. Clarisa Gracia, Chair of the Scientific and professional and special interest Congress Committee, Dr. Glenn Schattman, groups to present a stimulating array of Chair of the Pre-Congress Program Pre-Congress courses that will meet the Committee, and members of their organizing needs of our clinicians, scientists, laboratory It gives me great pleasure to teams have designed an outstanding and technologists, nurses, and other health-care welcome you to the beautiful provocative program for all of our members. and allied professionals. setting of Salt Lake City, Utah, for the 2016 American Society for The Continuing Medical Education (CME)/ We welcome our members and trainees Scientific Continuing Education (CE) portion of the as well as our colleagues from around nd Congress & Expo, our 72 Scientific Congress will include an exciting the world to attend and engage in the Scientific Congress & Expo. This array of plenary lectures, symposia, and ASRM Scientific Congress & Expo. As year’s Congress theme is “Scaling interactive sessions, all interweaving the always, we value the participation of New Heights in Reproductive theme of the Congress. Topics range from the our global community, including the Medicine,” and will encompass impact of environmental factors and stress on symposia organized and presented by our all aspects of reproductive reproductive health, to reproductive genetics international sister societies. The meeting medicine, technology, and and epigenetics, , global access will offer extensive opportunities for our health. The program will be a to reproductive care, reproductive and fetal attendees to network and interact, including comprehensive and stimulating surgery, optimization of assisted reproductive an enjoyable social program. I look forward balance between an exploration technology outcomes, preservation, to seeing you in stunning Salt Lake City of the latest molecular and and contraceptive technology. The where together we will be “Scaling New genetic techniques and how interactive sessions focus on a wide range Heights in Reproductive Medicine.” reproduction affects public of controversial topics and are designed health on a global scale. This to energize and stimulate discussion and live program is intended to serve interaction among the participants. The Sincerely, the needs of , nurses, CME program will be complemented by and embryology non-CME activities, including intimate, in- laboratory personnel, genetic depth roundtable luncheons with recognized Owen K. Davis, M.D. counselors, social workers, experts, in addition to oral and poster-format ASRM President, 2015-2016

nd 72 ASRM Scientific Congress & Expo 3 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

Salt LakeWELCOME TO City

Salt Lake is a city of unexpected surprises and brims with history, art, culture, entertainment, and recreation—all in a beautiful location at the foot of Utah's Wasatch Mountains. Salt Lake combines the amenities of a large metro area with the opportunity to take advantage of year-round outdoor recreation within minutes in every direction. An attractive, safe, and growing city, Salt Lake offers unequaled views, a thriving economy, exciting nightlife, remarkable history, the warm hospitality of a small western town, and "The Greatest Snow on Earth™". Salt Lake is an incredible destination for patrons of the performing arts with: Ballet West, Utah Opera Company, Ririe- Woodbury Dance Company, Repertory Dance Theatre, Mormon Tabernacle Choir, and The Utah Symphony. Numerous theater groups and over 20 art galleries are within minutes of Salt Lake's downtown hotels.

nd 72 ASRM Scientific Congress & Expo 4 Salt Lake City, Utah slctravel.com of courtesy Information l

t C a p i t o

a s

E

Pioneer UTAH STATE 300 North Memorial CAPITOL Museum . A St . B St . C St .

a n y o n R d Memory Grove Council C ASRM 2O16 SCIENTIFIC CONGRESS Hall 500 West 400 West 300 West 200 West

4th Ave. 200 North

p Conference North Temple Center 3rd Ave. Bridge/Salt Lake City Hotel Information Main St. Guadalupe State St. SALTTRAX LAKE DOWNTOWN ACCOMMODATIONSCity Creek Station West Temple Park 2nd Ave. North Templele to airport — 7 miles TEMPLE SQUARE Brigham Young Museum of Church Historic Park 8 History & Art Tabernacle Joseph Smith Memorial Beehive Building House Family History 1st Ave. First Library Lion Mormon Pioneer Presbyterian THE LDS Temple House Church Arena Temple Square Memorial GATEWAY Monument Union TRAX Station South Temple TRAX Station 4 Olympic Pacific 1 South Temple Legacy Depot Plaza Utah Cathedral 3 Museum of of the Contemporary City Center (100 S) Madeleine EnergySolutions Maurice Cathedral EnergySolutions Abravanel Art TRAX Station Arenaa Church of Hall Harmons Grocery St. Mark Discovery 1 Salt Lake To Go CITY CREEK CITY CREEK Gateway CENTER CENTER Visitor Information 1 1000 SSoSouthuthth Center 2 100 South Clark Planetarium

Planetarium SALT PALACE 2 TRAX Station N CONVENTION Capitol Theatre CENTER 200 ShSouth 3 200 South Old Greektown Gallivan TRAX Station 9 11 Center 5 Rio Grande Depot & Utah State Pierpont Ave. Pierpont Ave. Gallivan Plaza Historical Museum 2 TRAX Station TRAX / UTA Free Fare Zone 3 KUTV2 Main Street News Studio

300 South 4 300 South

PIONEER PARK 400 West to Foothill Cultural District 300 West 200 West

est Templ e 4 500 West 200 Eas t and University of Utah State St. W 1 Main St. Library 10 TRAX Light Rail — Red Line TRAX Station 400 South 400 South 5 Salt Lake City & LIBRARY 7 County Building SQUARE 1 Light Rail — RED, GREEN , & BLUE LINE S Court House TRAX Station

5TRAX 2 W ASHINGTON TRAX / UTA Free Fare Zone 15 SQUARE 500 South 6 500 South 1 1210 2 14

6 400 Eas t 31 6 10 300 Eas t 600 South 600 South 2 13 117 31 10 42American Society for Reproductive117 Medicine 1 8 700 South 32016 Annual Meeting | Salt Lake City,1012 Utah | October 15-19, 2016 42 11 3151 Salt Lake Marriott Downtown at City Creek 1012 88 Hyatt Place Salt Lake City Downtown 422 Hilton Salt Lake City Center 1311 99 Holiday Inn Express 353 Radisson Hotel Salt Lake City Downtown 1012 10 Fairfield Inn Salt Lake City Downtown (formerly Courtyard) 4624 The Salt Lake Plaza Hotel at Temple Square 1311 119 Hotel Monaco 355 Marriott Salt Lake City Center 1412 12 Little America Hotel & Towers 466 DoubleTree Suites by Hilton 1311 Red Lion Hotel Salt Lake Downtown 3 757 Hampton Inn Salt Lake City Downtown 1412 14 The Grand America Hotel 4 6 1513 15 Sheraton Salt Lake City Hotel 75 1412 468 1513 75 14 68 1513 975 14 nd 72 ASRM Scientific Congress & Expo 5 Salt Lake City, Utah 68 15 97 14 68 15 97 8 15 97 8 9 8 9

9 ASRM 2O16 SCIENTIFIC CONGRESS

OCTOBER 17-19, 2016 | SALT LAKE CITY, UT

Committees and Awards • ASRM Scientific Congress Program Planning Committee 7 • Society Awards 10-21 • ASRM Star Awards 22, 23 • ASRM Milestone Awards 23

SPONSORED BY THE AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE ASRM 2O16 SCIENTIFIC CONGRESS

ASRM 2016 Scientific Congress ASRM Officers and Program Planning Committee Board of Directors Owen K. Davis, M.D., President 2015­ — 2016 Clarisa R. Gracia, M.D., M.S.C.E., Scientific Congress Program Chair ASRM OFFICERS Owen K. Davis, M.D. Interactive Sessions Chair Anne Z. Steiner, M.D., M.P.H., President Anuja Dokras, M.D., Ph.D., Roundtables Chair Richard J. Paulson, M.D. Michael I. Eisenberg, M.D., Ad Hoc Committee Member President-Elect Sharon Covington, M.S.W., L.C.S.W.-C., Ad Hoc Committee Member Christos Coutifaris, M.D., Ph.D. Amy E. T. Sparks, Ph.D., H.C.L.D., Ad Hoc Committee Member Vice President Kevin J. Doody, M.D., H.C.L.D., Society for Assisted Reproductive Rebecca Z. Sokol, M.D., M.P.H. Technology Program Chair Immediate Past President Thomas M. Price, M.D., Society for Reproductive Endocrinology Catherine Racowsky, Ph.D., H.C.L.D. and Program Chair Secretary Daniel H. Williams, M.D., Society for Male Reproduction and George A. Hill, M.D. Program Chair Treasurer Ceana H. Nezhat, M.D., Society of Reproductive Surgeons Program Chair ASRM BOARD OF DIRECTORS Andrew D. Dorfmann, M.S., E.L.D. (A.B.B.), Society of Reproductive AND THEIR MEMBER SOCIETIES Biologists and Technologists Program Chair Robert D. Oates, M.D. Erica J. Mindes, Ph.D., Mental Health Professional Group Program Chair Julia V. Johnson, M.D. Lauren Nervi, M.S.N, R.N., Nurses’ Professional Group Program Chair Mark Sigman, M.D. Stephanie Caballero, J.D., Legal Professional Group Program Chair Maria Bustillo, M.D. Brad J. T. Senstra, M.H.A., Association of Reproductive Managers Paula Amato, M.D. Program Chair David A. Grainger, M.D., M.P.H. Richard H. Reindollar, M.D., ASRM Chief Executive Officer Valerie L. Baker, M.D. (SREI) Andrew R. La Barbera, Ph.D., H.C.L.D., ASRM Chief Scientific Officer Bradley J. Van Voorhis, M.D. (SART) Meredith Sauls, M.A., ASRM Education & Research Program Administrator Peter Chan, M.D. (SRS) Nancy Bowers, B.S.N., R.N., M.P.H., ASRM Manager, Continuing William E. Roudebush, Ph.D. (SRBT) Education Douglas T. Carrell, M.D. (SMRU)

ASRM CHIEF EXECUTIVE OFFICER Richard H. Reindollar, M.D.

ASRM 2016 Pre-Congress ASRM CHIEF SCIENTIFIC OFFICER Program Committee Andrew R. La Barbera, Ph.D., H.C.L.D. Glenn L. Schattman, M.D., Chair Karine Chung, M.D., M.S.C.E., Co-Chair Irene Su, M.D., M.S.C.E., Coordinating Chair

Richard H. Reindollar, M.D., ASRM Chief Executive Officer Andrew R. La Barbera, Ph.D., H.C.L.D., ASRM Chief Scientific Officer Meredith Sauls, M.A., ASRM Education & Research Program Administrator

nd 72 ASRM Scientific Congress & Expo 7 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

ASRM Committees 2015–2016

AMA Liaison Committee Continuing Medical Education Fund Development Committee Albert Hsu, M.D. Committee David B. Seifer, M.D., Co-Chair Julia V. Johnson, M.D. Edward Kim, M.D., Chair Jacqueline N. Gutmann, M.D., Co-Chair Eric D. Levens, M.D. Joseph Alukal, M.D. G. David Adamson, M.D. Barry S. Verkauf, M.D. Jennifer Dietrich, M.D. G. Wright Bates, M.D. Sue Gitlin, Ph.D. Marian D. Damewood, M.D. James Goldfarb, M.D. Owen K. Davis, M.D. Audit Committee Paul R. Shin, M.D. William E. Gibbons, M.D. Michael Alper, M.D., Chair Irene Su, M.D., M.S.C.E. Linda C. Giudice, M.D., Ph.D. Marc Fritz, M.D. Richard H. Reindollar, M.D., ex officio Emily S. Jungheim, M.D. Hugh Taylor, M.D. Andrew R. La Barbera, Ph.D., H.C.L.D. Mehryar K. Kavoussi, J.D., LL.M. Dan Carre, C.P.A., ex officio ex officio Roger D. Kempers, M.D. Dolores J. Lamb, Ph.D. Roger A. Lobo, M.D. Coding Committee Ethics Committee Kenneth K. Moghadam, M.D. Beth Rackow, M.D., Chair Judith F. Daar, J.D., Chair Kamran S. Moghissi, M.D. Silvina Bocca, M.D., Ph.D. Jean M. Benward, M.S.W. Suheil J. Muasher, M.D. Trey Brugh, M.D. Lee Collins, J.D. Robert Oates, M.D. Carli Chapman, M.S. Joseph Davis, D.O. Steven J. Ory, M.D. Miguel Damien, M.D. Leslie Francis, Ph.D., J.D. Edwin P. Peterson, M.D. Bryan Hecht, M.D. Elena Gates, M.D. Ginny L. Ryan, M.D. George A. Hill, M.D. Elizabeth Ginsburg, M.D. Rebecca Z. Sokol, M.D., M.P.H. Elizabeth Puscheck, M.D. Sigal Klipstein, M.D. Richard H. Reindollar, M.D., ex officio John Queenan, M.D. Barbara Koenig, Ph.D. Andrew R. La Barbera, Ph.D., H.C.L.D., Steven Spandorfer, M.D. Laurence McCullough, Ph.D. ex officio Richard H. Reindollar, M.D., ex officio Mark Sauer, M.D. Sean Tipton, M.A., ex officio Andrew R. La Barbera, Ph.D., H.C.L.D. Rebecca Z. Sokol, M.D., M.P.H. Vickie Gamble, M.P.P.M., ex officio ex officio Lynn Westphal, M.D. Dan Carre, C.P.A., ex officio Richard H. Reindollar, M.D., ex officio Suzan Henderson, M.P.A., ex officio Content Review Committee Andrew R. La Barbera, Ph.D., H.C.L.D., Bruce R. Carr, M.D., Chair ex officio William Catherino, M.D., Ph.D. Sean Tipton, M.A., ex officio Joao De Pinho, M.D. Rui Ferriani, M.D., Ph.D. Gary N. Frishman, M.D. Membership Committee Elizabeth A. Grill, Psy.D. Erma Z. Drobnis, Ph.D., Chair Shalini Gunawardena, R.N. Lisa Rinehart, J.D., R.N., Vice Chair Sangita K. Jindal, Ph.D. Margot P. Weinshel, R.N., L.C.S.W., Enrique Soto, M.D. Immediate Past Chair Cigdem Tanrikut, M.D. Rachel Bennett, M.D. James P. Toner, M.D., Ph.D. Mark Dow, Ph.D. Richard H. Reindollar, M.D., ex officio Lisa Marcus, R.N. Andrew R. La Barbera, Ph.D., H.C.L.D. Sheldon Marks, M.D. ex officio Laurie McKenzie, M.D. Ceana Nezhat, M.D. Jeanette Rodriguez, R.N.C. Steven Spandorfer, M.D. Julianne Zweifel, Ph.D. Richard H. Reindollar, M.D., ex officio Vickie Gamble, M.P.P.M., ex officio

nd 72 ASRM Scientific Congress & Expo 8 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

International Advisory Practice Committee Sessions Management Committee Committee Samantha Pfeifer, M.D., Chair Edward E. Moore, M.D., Chair Owen K. Davis, M.D., Chair Samantha Butts, M.D., M.S.C.E. Lee Lee Doyle, Ph.D., Co-Chair, Emeritus Michel Abou-Abdallah, M.D. Gregory Fossum, M.D. Pickens Gantt, M.D., Co-Chair David Albertini, Ph.D. Clarisa Gracia, M.D., M.S.C.E. Marguerite K. Shepard, M.D., Co-Chair Manish R. Banker, M.D. Jennifer Mersereau, M.D. Romaine B. Bayless, M.D., Associate Mark C. Bowman, M.D. Randall Odem, M.D. Chair Claudio F. Chillik, M.D., Ph.D. Richard Paulson, M.D. Paul R. Clisham, M.D., Associate Chair Christos Coutifaris, M.D. Alan Penzias, M.D. Fereshteh Fahimi, M.D., Associate Chair Luca Gianaroli, M.D. Margareta Pisarska, M.D. Joseph G. Gianfortoni, M.D., Associate Bunpei Ishizuka, M.D. Robert W. Rebar, M.D. Chair Roger D. Kempers, M.D. Mitchell Rosen, M.D. Gita P. Gidwani, M.D., Associate Chair Kersti Lundin, Ph.D. Jay Sandlow, M.D. Young S. Moon, Ph.D., Associate Chair Ragaa T. Mansour, M.D. Michael Vernon, M.D. Mohammad Mohsenian, M.D., Associate Kamran S. Moghissi, M.D. Richard H. Reindollar, M.D., ex officio Chair Yoshi Morimoto, M.D. Andrew R. La Barbera, Ph.D., H.C.L.D. Jay S. Schinfeld, M.D., Associate Chair Craig S. Niederberger, M.D. ex officio Sherry L. Singer, M.S., Associate Chair Robert J. Norman, M.D. Anne Z. Steiner, M.D., M.P.H., Associate Guido Parra, M.D. Chair Richard Paulson, M.D. Research Committee Edward Younglai, Ph.D., Associate Chair Antonio Pellicer, M.D. Robert W. Brannigan, M.D., Chair Joseph Baumgart, M.D. Anthony J. Rutherford, M.D. Ayman Al-Hendy, M.D., Ph.D. Grace Centola, Ph.D. Humberto Scoccia, M.D. Marlene Goldman, Ph.D. C. James Chuong, M.D. Carlos A. Simon, M.D., Ph.D. James Hotaling, M.D. Susannah C. Copland, M.D. Rebecca Z. Sokol, M.D., M.P.H. Alex Polotsky, M.D. Celia E. Dominguez, M.D. Basil C. Tarlatzis, M.D., Ph.D. Danny J. Schust, M.D. Esther Eisenberg, M.D. Gurkan Uncu, M.D. Emre Seli, M.D. Lisa Farah-Eways, M.D. Fernando Zegers-Hochschild, M.D. Yolanda Smith, M.D. Hugh C. Hensleigh, Ph.D. Richard H. Reindollar, M.D., ex officio Nathan Treff, Ph.D. Endrika L. Hinton, M.D. Andrew R. La Barbera, Ph.D., H.C.L.D., Richard H. Reindollar, M.D., ex officio David I. Hoffman, M.D. ex officio Andrew R. La Barbera, Ph.D., H.C.L.D., Satty Gill Keswani, M.D. Vickie Gamble, M.P.P.M., ex officio ex officio Hovey Lambert, Ph.D. Samuel P. Marynick, M.D., P.A. Olufemi A. Olatunbosun, M.D, F.R.C.S.C. Joint ASRM/CAP Laboratory Undergraduate, Graduate, Medical, Alice Rhoton-Vlasak, M.D. Accreditation Special Commission and Postgraduate Education Nanette Rollene, M.D. G. David Ball, Ph.D., H.C.L.D. Committee Jan L. Silverman, M.A. Erica Behnke, Ph.D., H.C.L.D. Ann J. Davis, M.D., Chair Lauri Thommason, M.S.N., R.N., R.N.C. Natan bar Chama, M.D. Yulian Zhao, M.D., Ph.D., H.C.L.D., M.B.A. Alexander Kotlyar, M.D. Richard H. Reindollar, M.D., ex officio Patient Education Committee Ertug Kovanci, M.D. Vickie Gamble, M.P.P.M., ex officio Margareta Pisarska, M.D., Chair Steven Lindheim, M.D. Kristen Bendikson, M.D. Staci Pollack, M.D. Catherine Bergh, M.S.N., R.N. Ranjith Ramasamy, M.D. Technology Committee Janet Choi, M.D. Carla Roberts, M.D., Ph.D. Kenan R. Omurtag, M.D., Chair Elaine Gordon, Ph.D. Melvin Thornton, M.D. Mark H. Amols, M.D. Deborah Jaffe, B.S.N. Rebecca Usadi, M.D. Arthur Chang, Ph.D. Howard Kim, M.D. Carol Wheeler, M.D. Serena H. Chen, M.D. Peter Kolettis, M.D. Abdelmoneim Younis, D.V.M., Ph.D. Michelle J. Cho, M.D. Lowell Ku, M.D. Richard H. Reindollar, M.D., ex officio Amanda N. Kallen, M.D. Lubna Pal, M.D. Andrew R. La Barbera, Ph.D., H.C.L.D., Brian A. Levine, M.D. Jared Robins, M.D. ex officio Daniel C. Martin, M.D. John Storment, M.D. Steven F. Palter, M.D. Aaron Styer, M.D. Jason S. Yeh, M.D. Richard H. Reindollar, M.D., ex officio Richard H. Reindollar, M.D., ex officio Andrew R. La Barbera, Ph.D., H.C.L.D., Rusty Howell, M.A., ex officio ex officio

nd 72 ASRM Scientific Congress & Expo 9 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

2016 Awards

AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE 2016 SOCIETY AWARDS DISTINGUISHED RESEARCHER AWARD The 2016 recipient of the ASRM Distinguished Professor Carlos Simón is the author of 408 Researcher Award is Carlos Simón peer-reviewed articles. He is a well-trained, Vallés, M.D., Ph.D. Professor Simón’s creative scientist, who is energetic, accomplishments as a clinical scientist, adventurous in thought, and blends basic leader, inventor, mentor, and citizen to the research with translational applications. scientific community have been outstanding, He consistently pushes the envelope, and moving beyond basic endometrial biology his studies have been recognized nationally to molecular genetics and more recently and internationally. His research has been stem cell research and clinical application of funded as principal investigator through 34 the novel tools that he has invented, while competitive governmental grants from the generously mentoring trainees and helping National Institutes of Health, the European other groups to advance science in our field. Union, the Spanish Government, and the Professor Simón’s work has focused on Valencian Government, and his research three main areas: embryonic implantation; governmental funding portfolio in 2016 totals endometrial receptivity; and stem cells in more than $1.29M direct costs. Furthermore, reproductive medicine. In all three, he is the he is a superb and dedicated mentor who first or last author of landmark papers that Carlos Simón Vallés, M.D., Ph.D. has supervised 33 PhD students, many of have attracted the attention and respect of whom have earned special recognition and many colleagues worldwide. prestigious international awards. Carlos is generous in spirit and collaborates widely, sharing resources In embryonic implantation, he made a breakthrough regarding with other laboratories and offering services to the clinical and mechanisms underlying the interleukin-1 system during the scientific communities at large. Carlos Simón is an outstanding phase of embryonic implantation, as well as the researcher, teacher, innovator, and colleague. His expertise cross-communication between the maternal and allows him to integrate clinical data and basic techniques as he the . He also worked on the molecular characterization teaches students and fellows, and his vast fund of knowledge of endometrial receptivity in humans, publishing more and experience underlie his excellence in teaching. than 20 papers as first or last author. He pioneered the first derivation of embryonic stem cell lines in Spain, participating Also, he is a careful experimentalist and a team player. In in a collaborative study demonstrating the lack of genetic summary, Professor Carlos Simón is one of the true visionaries diversity in the most commonly used cell lines worldwide. His in our field, and his innovative research contributions to lab demonstrated the existence and the functional proof of reproductive medicine and science are unparalleled. He concept of human endometrial stem cells that now are ready is an outstanding researcher, teacher, mentor, innovator, for clinical translation with the promise to restore endometria collaborator, and individual. in women with Asherman’s syndrome or “thin” endometria. Recently, he reported the generation of artificial using direct reprogramming with six germ line–related factors in human somatic cells. The promise of his most recent discovery would be transformative to patients with gonadal compromise.

nd 72 ASRM Scientific Congress & Expo 10 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

2016 Awards

IRA AND ESTER ROSENWAKS NEW INVESTIGATOR AWARD (supported by an endowment from Zev Rosenwaks, M.D.)

Marla E. Lujan, Ph.D., has been selected as the 2016 recipient of Her approach to the study of female reproductive function is the Ira and Ester Rosenwaks New Investigator Award. This award unique in that it combines state-of-the-art ultrasound imaging recognizes a member of ASRM who has made technology with serial endocrine and metabolic outstanding contributions to clinical or basic assessments in women. Dr. Lujan is a remarkably research in reproductive sciences published creative and productive research scientist whose within 10 years after completing research or publications are well cited and are having major clinical training and initiating an independent impact on improving the diagnosis and treatment career as an investigator. Dr. Lujan is an Assistant of polycystic ovary syndrome. Dr. Lujan has Professor in the Division of Nutritional Sciences received several awards for her outstanding at Cornell University. She earned her Bachelor performance and exceptional contributions to of Sciences degree from Queen’s University women's health research as a new investigator. in 1998 and was subsequently granted a PhD Her extraordinary research skills and exceptional in Physiology in 2005. She conducted her professional experience set her apart as one of post-doctoral studies within the Reproductive the top scientists investigating the link between Endocrinology Division of the Department nutrition, metabolism, and reproductive of , Gynecology, and Reproductive disorders in women. She has positioned herself Sciences at the University of Saskatchewan to address key, high impact questions related to from 2005 to 2008. She joined the Division Marla E. Lujan, Ph.D. the field of reproductive medicine. The results of Nutritional Sciences at Cornell University, of her continuing studies will form the basis for where her research encompasses the areas of maternal and child establishing nutritional, lifestyle, and pharmaceutical regimens that nutrition and obesity and chronic disease. Her work focuses on promote and preserve reproductive health in women. the nutritional and metabolic regulation of in women. SUHEIL J. MUASHER, M.D., DISTINGUISHED SERVICE AWARD (supported by an endowment from Suheil J. Muasher, M.D.)

Each year ASRM honors individuals or organizations that Committee. He has been an active member in the Mental Health have provided distinguished service to ASRM. Recipients are Professional Group rising to Chair in 1982-1983. He was a member of selected based on their scientific, leadership, the Society for Assisted Reproductive Technology organizational, political, or societal service and the Board of Directors from (2001-2004). contributions to ASRM, reproductive medicine, From 2002-2003 he was the chair of the Finance and/or reproductive medicine patients. In 2016 Committee and was president of ASRM in 2005- the Society recognizes G. David Adamson, M.D., 2006. He was on the Ethics Committee from for his contributions to the field of reproductive 2008-2009. Most importantly he co-chaired the medicine through his service as ASRM’s ASRM Fund Development Committee, in which ambassador to the international community. a large part was due to his initiative. He has had Dr. Adamson received his undergraduate and leadership roles in the World Health Organization, medical degrees from the University of Toronto. the International Committee Monitoring Assisted He is Board certified in obstetrics and gynecology Reproductive Technologies, and the International and in reproductive endocrinology and infertility. Federation of Fertility Societies. He has served as Not only is he an excellent scientist, clinician, and president of the World Endometriosis Research teacher, he also is a pioneer in entrepreneurial Foundation, the American Association of aspects of the specialty. This took a great deal Gynecological Laparoscopists, the Society of of courage because in the early days this was G. David Adamson, M.D. Reproductive Surgeons, and the Pacific Coast perceived as being not in the mainstream. He is the Reproductive Society. He served on the Board of founder and president of Fertility Physicians of Northern California, Directors of RESOLVE and recently received their prestigious Resolve founder and chairman of Advanced Reproductive Care. Dr. Adamson Eck Founders Award. Dr. Adamson has been a productive researcher, has been an outstanding member of ASRM. He has participated in having published 140 articles in peer-reviewed journals. G. David every meeting from 1977 to the present. He started his career in the Adamson, M.D., is a true physician-scientist and a wonderful teacher, Society as a member and then chair of the Society Development but most importantly he has been a paragon at ASRM.

nd 72 ASRM Scientific Congress & Expo 11 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

2016 Awards

KAVOUSSI FAMILY OUTSTANDING TEACHER AWARD (supported by an endowment from K.M. Kavoussi, M.D., Shahryar Kavoussi, M.D., Parviz Kavoussi, M.D. and Mehryar Kavoussi, J.D. with Austin Fertility & Reproductive Medicine/Westlake IVF)

This award honors an ASRM member who is recognized ACGME milestones for training in the . Training and as an outstanding educator in undergraduate, graduate, acquisition of skills in assisted reproductive technologies have postgraduate, professional, or patient been a focus of his research. education in the area of basic and/or clinical reproductive biology and medicine. Few Dr. Segars has been a strong proponent educators have had such a direct impact of simulation in fellowship training and on the practice of assisted reproductive acquisition of skills and by technologies as James H. Segars, M.D. trainees, and has authored several publications on the method, including description of the As the Howard W. and Georgeanna Seegar “afterload” method of embryo transfer. As Jones Professor in the Department of REI Division Director at ABOG, Dr. Segars Gynecology and Obstetrics at Johns has strongly supported implementation of Hopkins, and as former Head of the Unit of the ASRM embryo transfer simulator into Reproductive Endocrinology and Infertility the training curriculum for the specialty. at the National Institute of Child Health and Additionally, he has championed the Human Development (NICHD), Dr. Segars development of online training modules for has been passionate about understanding trainees in the field. the mechanisms of reproduction and he James H. Segars, M.D. imparts this passion to his fellows. He has Nationally, Dr. Segars has been a leader in served as Fellowship Program Director for reproductive medicine. He served as the the NICHD-sponsored Clinical Reproductive Endocrinology President of the Society for Reproductive Endocrinology and Training Program for 19 years, participating in the training of Infertility (SREI) and in that role helped support the SREI-Society 47 fellows in Reproductive Endocrinology and Infertility (REI), of Reproductive Surgeons (SRS) surgical training retreat and both programmatically and in his laboratory. Additionally, he transition of REI fellowship applications to Electronic Residency established a visiting research rotation for residents across Application Service® (ERAS). He served as council member of the United States and has served as a teacher and mentor the Society for Gynecologic Investigation (SGI), and as the SREI of over 40 residents in obstetrics and gynecology who have Representative to the American Congress of Obstetricians and participated in the rotation at the National Institutes of Health Gynecologists (ACOG) and ASRM Boards of Directors. (NIH) or Johns Hopkins. At the bench, Dr. Segars has helped train Howard Hughes Medical Institute–supported medical A prolific author, Dr. Segars has published more than 150 students, Clinical Research Training Program–supported medical manuscripts. Dr. Segars has chaired NIH review panels and students, postdoctoral students, predoctoral graduate students, has served as a standing member of an NIH Study Section, master’s students, college and high school students. He is keenly Chaired Ad Hoc panels, and served on the NICHD Institutional interested in graduate medical education and the training of Review Board. He currently serves as an associate editor the next generation of clinician-scientists and has served on the for Molecular and serves on several selection committee of the Reproductive Scientist Development editorial boards including Seminars in Reproductive Medicine, Program (RSDP) since 2006 and coordinated the national REI Reproductive Sciences, and Fertility and Sterility. As a senior fellowship retreat in 2007. investigator, Dr. Segars has been a leader and innovator in the areas of leiomyoma research, the role of BRX (aka, AKAP13), and Dr. Segars was elected to the Division of Reproductive reproductive health disparities. Dr. Segars is internationally Endocrinology and Infertility at the American Board of Obstetrics known for his expertise in multiple areas of research in the field and Gynecology (ABOG) in 2007. In 2012 he was elected to of reproductive endocrinology. He is considered a subject matter Director of the Division of Reproductive Endocrinology and expert in the identification of factors that promote leiomyoma Infertility and Chair of the Committee at ABOG, growth estrogen action in reproductive tissue. Dr. Segars is the helping to coordinate the transition of fellowship program epitome of the physician-scientist, and he is wholly dedicated to certification from ABOG to the Accreditation Council for Graduate creating and training the next generation of physician-scientists. Medical Education (ACGME). In that role he has impacted fellow His contributions to the field make him a worthy recipient of the education nationally by his leadership in establishing the 2016 Kavoussi Family Outstanding Teacher Award. ACGME program requirements for training in REI and the REI

nd 72 ASRM Scientific Congress & Expo 12 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

2016 Awards

ARNOLD P. GOLD FOUNDATION HUMANISM IN MEDICINE AWARD FOR PRACTICING PHYSICIANS (supported by a gift from the Arnold P. Gold Foundation)

The Arnold P. Gold Foundation Humanism in Medicine communication, support Award for Practicing Physicians honors an ASRM member of patient needs, and who as a practicing physician has best demonstrated the empathetic care, thereby ideals of compassionate and respectful care for a patient’s earning the trust and physical and emotional well-being. The recipient of the confidence of both patients award should have demonstrated compassion, empathy, and colleagues. He has also competence, respect, sensitivity, effective communication, spent his career integrating and trustworthiness. The Society has selected Selwyn pursuits in academic Oskowitz, M.D. for this award in 2016 because he is beloved endeavors to promote by his countless patients and admired by his colleagues. Dr. and enhance patient care. Oskowitz delivered compassion and empathetic care to all of He continues to promote Selwyn Oskowitz, M.D. his patients and encouraged those around him to value the respect, honor, and same aspects of patient well-being. He has promoted clear dedication to providing the best in fertility care.

KY CHA AWARD IN STEM CELL TECHNOLOGY (supported by an endowment from the Asia-Pacific Biomedical Research Foundation)

This award, which carries a $20,000 research grant, is that support the awarded competitively by ASRM to provide start-up funds development of the to initiate an innovative research project in regenerative in a mouse model. medicine and stem cell technology. A research project in They identified three genes which the applicant is the primary investigator is the essential that, when introduced into core of the grant. Selection is based primarily on the scientific skin cells, initiate a cell-fate merit of proposal and the qualifications of the applicant. The program that completely recipient of the KY Cha Award in Stem Cell Technology for converts the skin cells into 2016 is Yossi Buganim, Ph.D., Principal Investigator in the stable and fully functional Department of Developmental Biology and Cancer Research placenta-generating at the Hebrew University-Hadassah in cells. The skin-derived Jerusalem. The subject of his award research is “Development stem cells of a functional in vivo assay for assessing the capability resemble native trophoblast Yossi Buganim, Ph.D. of induced trophoblast stem cells to rescue placental stem cells and function and dysfunction diseases.” The main goal of the recipient’s contribute to placental development. When applied to human laboratory is to identify and investigate the components that cells, this approach should grant women who suffer from regulate cell plasticity and epigenome resetting. Dr. Buganim recurrent and placental dysfunction diseases an and his colleagues screened for genes opportunity to carry and deliver healthy babies.

nd 72 ASRM Scientific Congress & Expo 13 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

2016 Awards

ASRM RESEARCH GRANTS The ASRM 2016 Research Grants provide funds in amounts of of reproductive endocrinology and infertility. The RSDP $10,000 to $50,000 to foster the development of innovative provides career development support for obstetricians and research, to facilitate the research endeavors of new gynecologists who are committed to a basic science career investigators, and to provide bridge funding for projects in academic medicine and research. The areas of interests that advance the Society’s mission. Proposals from junior covered by the program are broadly defined, with emphasis faculty, particularly those in their first three years of faculty on cell and as applied to problems in appointment, receive priority in the competitive review by the reproductive endocrinology, genetics, maternal-fetal medicine, ASRM Research Committee. Following are the projects funded , infectious disease, or other aspects of reproduction. by the 2016 ASRM Research Grants: The 2016 RSDP Scholar is Aleksandar Stanic-Kostic, M.D., • Dieter Egli, Ph.D., Columbia University, “Mitochondrial Ph.D., Assistant Professor of Obstetrics and Gynecology at the replacement in human ,” $40,000 University of Wisconsin School of Medicine and . • Albert L. Hsu, M.D., Dartmouth-Hitchcock Medical Center, “Impact of endometriosis on mitochondrial function,” $40,000 SOCIETY FOR REPRODUCTIVE • Daylon James, Ph.D., Weill Cornell Medical College, “Cell-assisted preservation and mobilization of follicles in ENDOCRINOLOGY AND INFERTILITY, transplanted ovarian tissues,” $40,000 NATIONAL RESEARCH SERVICE • Patricia T. Jimenez, M.D., University of Texas Southwestern Medical Center, “Understanding the effects INSTITUTIONAL TRAINING AWARD (T32) of superovulation on uterine receptivity and implantation,” The Society for Reproductive Endocrinology and Infertility (REI) $40,000 was awarded a competitive training grant from the National • Werner Neuhausser, M.D., Ph.D., Harvard Medical School, Institute of Child Health and Human Development to provide REI “Reconstitution of the human and non-human primate fellows with specialized training in reproductive medicine and germ line from pluripotent stem cells,” $40,000 biology. Ten Board-approved REI fellowship programs currently participate in the program, which is administered through the University of Pennsylvania. Each year, REI fellows are awarded SOCIETY FOR REPRODUCTIVE 1- or 2-year National Institutes of Health (NIH) traineeships to ENDOCRINOLOGY AND INFERTILITY (SREI) conduct cutting-edge research in the laboratories of NIH-funded RESEARCH GRANT investigators. For 2016, the trainee is Alexis D. Greene, M.D., University of Cincinnati. The title of her project is “Curcumin The SREI 2016 Research Grant provides funds of $40,000 to suppression of di-(2-ethylhexyl) phthalate (DEHP)-induced foster the development of innovative research, to facilitate endometriosis,” and her mentor is Katherine A. Burns, Ph.D. the research endeavors of new investigators, and to provide bridge funding for projects that advance the Society’s mission. Proposals from junior faculty, particularly those in their first ASRM/NICHD/DUKE CLINICAL RESEARCH/ three years of faculty appointment, receive priority in the REPRODUCTIVE SCIENTIST TRAINING competitive review by the ASRM Research Committee. The 2016 SREI Research Grant was awarded to Suneeta Senapati, M.D., (CREST) PROGRAM University of Pennsylvania, for her project “The role of the peri- The CREST training program is offered by the NICHD, the implantation environment in DNA methylation and placental Clinical Research Training Program (CRTP) at Duke University, vasculogenesis.” and ASRM. This 2-year program meets an existing need for physicians in private or academic clinical practice to obtain formalized academic training in the quantitative and REPRODUCTIVE SCIENTIST DEVELOPMENT methodological principles of clinical research in reproductive PROGRAM (RSDP) medicine. ASRM welcomes the class of 2015-2016: Leslie This program was established in 1988 to train obstetrician- Appiah, M.D., University of Kentucky College of Medicine; gynecologists committed to academic investigative careers in Jennifer Eaton, M.D., M.Sc., Duke University; Rebecca Flyckt, fundamental biomedical science. The program is supported M.D., Cleveland ; Jennifer Kawwass, M.D., Emory by the Eunice Kennedy Shriver National Institute of Child University; Laura Londra, M.D., Ohio Reproductive Medicine; Health and Human Development (NICHD) in collaboration Michael Mersol-Barg, M.D., Michigan Reproductive Medicine. with private agencies, professional societies, foundations, and private industry. The American Society for Reproductive Medicine supports one clinician-scientist in the subspecialty

nd 72 ASRM Scientific Congress & Expo 14 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

2016 Awards

SCIENTIFIC CONGRESS PRIZE PAPERS MANHATTAN CRYOBANK ENDOWED Candidates for two Scientific Congress Prizes are selected by the TRAVELING SCHOLAR AWARD Research Committee from all abstracts submitted to the Congress This award allows a junior physician or basic science researcher regardless of designation of group for initial review. These oral to explore a career in male reproduction and urology. The primary presentations will be judged at the Congress and selection will be purpose of the award is to stimulate the scientific interests of determined by the Research Committee. The presenters of the two students, residents, and fellows in the study of male reproduction. Scientific Congress Prize papers will be awarded: The recipient for 2016 is Lorenzo DiGiorgio, M.D., Ph.D., who will present abstract O-20 titled “IMPACT OF CLOMIPHINE CITRATE ON • $1,000 PROSTATE SPECIFIC ANTIGEN VALUES FOR MEN BEING TREATED • One-year free ASRM membership FOR INFERTILITY” in the SMRU Traveling Scholars oral abstract • Free registration for ASRM 2017 in San Antonio, Texas session on Monday, October 17, 2016.

SCIENTIFIC CONGRESS PRIZE POSTERS SOCIETY FOR MALE REPRODUCTION AND Posters must be put up on the appropriate boards on Sunday, October 16, between 1:00 p.m. and 5:00 p.m. or on Monday, UROLOGY TRAVELING SCHOLARS PROGRAM October 17, between 8:00 a.m. and 12:00 noon, and must The annual SMRU Traveling Scholars Program allows a diverse remain in place for the entire Congress. Posters must be group of young clinical physicians and basic science researchers removed by 2:00 p.m. on Wednesday, October 19. Posters will the opportunity to explore a career in male reproductive be judged by the Prize Poster Committee beginning at 12:00 medicine. The primary purpose of the program is to stimulate noon Monday. The awardees will receive: the scientific interests of residents and fellows in the study of male reproduction. Scholars are selected by the SMRU Research • First Prize: $500 Committee based on the scores of their abstracts submitted for • Second Prize: $300 the Scientific Congress. The SMRU Traveling Scholars oral abstract • Third Prize: $200 session will take place on Monday, October 17, 2016. The following Traveling Scholars will present their research during the session: Lidia Minguez-Alarcon, Ph.D., O-21 “PERIPUBERTAL BLOOD CAPPY ROTHMAN, M.D., CHUCK SIMS, LEAD LEVELS AND SEMEN QUALITY IN A PROSPECTIVE COHORT M.D., AND THE CALIFORNIA CRYOBANK STUDY OF RUSSIAN MEN”; Ganesh Lakshmanan, B.H.M.S, M.Sc, TRAVELING SCHOLAR AWARD O-22“ALLEVIATING EFFECTS OF VARIOUS CONCENTRATIONS OF ETHANOLIC EXTRACT OF LYCOPODIUM CLAVATUM ON AGING This award allows a junior physician or basic science INDUCED TESTICULAR IN WISTAR ALBINO RATS”; and researcher to explore a career in male reproduction and Liina Nagirnaja, Ph.D. O-23, MAPPING GENETIC HETEROGENEITY urology. The primary purpose of the award is to stimulate OF VIABLE AND NON-VIABLE . the scientific interests of students, residents, and fellows in the study of male reproduction. The recipient for 2016 is Enrica Bianchi, Ph.D., who will present abstract O-24 titled ASRM CORPORATE MEMBER COUNCIL “MOLECULAR MECHANISMS BEHIND GHRELIN-MEDIATED IN-TRAINING TRAVEL AWARDS PREVENTION OF POST-SURGICAL ADHESIONS” in the Society Fifteen awards to trainee abstract presenters from the United for Male Reproduction and Urology (SMRU) Traveling Scholars States and five awards to trainee abstract presenters from oral abstract session on Monday, October 17, 2016. countries outside the United States are made possible through the generous support of the ASRM Corporate Member Council. SMRU LIPSHULTZ/LAMB TRAVELING Recipients of this award are undergraduate, graduate, medical SCHOLAR AWARD or allied health professions students, postdoctoral trainees, or clinical residents or fellows. Candidates are the first and This award allows a junior physician or basic science researcher presenting author of an abstract that has been selected for oral to explore a career in male reproduction and urology. The or poster presentation in the ASRM 2016 Scientific Congress. primary purpose of the award is to stimulate the scientific Selection is based on the scientific merit of the abstract and interests of students, residents, and fellows in the study of male the qualifications of the author. The awardees receive: reproduction. The recipient for 2016 is Amin Herati, M.D., who will present abstract O-19 titled “MORE THAN A FLAGELLAR • $1,000 (US presenters) PROTEIN: IFT140 IS A CANDIDATE GENE • $2,000 (Non-US presenters) THAT MAY MODULATE CELL SIGNALING” in the SMRU Traveling Scholars oral abstract session on Monday, October 17, 2016.

nd 72 ASRM Scientific Congress & Expo 15 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

2016 Awards

O-6, Monday, October 17, 2016, 12:30 PM V. Libby,1 B. G. Reed,1 S. Babayev,1 K. Doody2; 1UT Southwestern RANDOMIZED CONTROLLED TRIAL OF LOW (5%) VS. ULTRALOW Medical Center, Dallas, TX, 2Center for Assisted Reproduction, (2%) OXYGEN TENSION FOR IN VITRO DEVELOPMENT OF Bedford, TX HUMAN D. J. Kaser,1 B. Bogale,1 V. Sarda,2 L. V. Farland,1, 3 C. Racowsky1; O-67, Monday, October 17, 2016, 11:15 AM 1Dept of Obstetrics & Gynecology, Brigham & Women’s , FRUIT AND VEGETABLE INTAKE AND THEIR PESTICIDE RESIDUES Harvard Medical School, Boston, MA, 2Boston Children’s IN RELATION TO OUTCOMES OF ASSISTED REPRODUCTIVE Hospital, Boston, MA, 3Dept of Epidemiology, Harvard Chan TECHNOLOGY School, Boston, MA Y. Chiu,1 A. J. Gaskins,1 P. Williams,2 M. W. Gillman,3 L. Minguez- Alarcon,4 T. L. Toth,5 R. Hauser,4 J. E. Chavarro1; 1Department of O-31, Monday, October 17, 2016, 11:15 AM Nutrition, Harvard T.H. Chan School of Public Health, Boston, HUMAN ADHESION FIBROBLASTS ARE CHARACTERIZED BY A MA, 2Biostatistics and Epidemiology, Harvard T. H. Chan School REDUCTION IN THE LEVEL OF PLURIPOTENCY MARKERS AS of Public Health, Boston, MA, 3Obesity Prevention Program, COMPARED OT NORMAL PERITONEAL FIBROBLASTS Department of Population Medicine, Harvard Medical School and N. M. Fletcher,1 A. Juhani,1 M. S. Abusamaan,2 M. P. Diamond,3 Harvard Pilgrim Institute, Boston, MA, 4Environmental G. M. Saed1; 1Obstetrics and Gynecology, Wayne State Health, Harvard T.H. Chan School of Public Health, Boston, MA, University School of Medicine, Detroit, MI, 2Wayne State 5OB/GYN, Massachusetts General Hospital, Boston, MA University, Detroit, MI, 3Augusta University, Augusta, GA O-68, Monday, October 17, 2016, 11:30 AM O-36, Monday, October 17, 2016, 12:30 PM THE EFFECT OF THE ENDOCRINE DISRUPTING CHEMICAL DEHP THE INCIDENCE OF RENAL ANOMALIES IN PATIENTS WITH ON THE OVARIAN AND ADIPOSE TRANSCRIPTOME SEPTATE UTERI N. M. Grindler,1 I. Yang,2 K. Rajendiran,3 K. Kannan,3 A. J. Polotsky,1 D. E. Broughton,1 K. Anderson,1 E. Jungheim,1 C. Siegel2; D. Schwartz,2 T. Powell,4, 5 T. Jansson4; 1OBGYN, Division of REI, 1Obstetrics and Gynecology, Washington University, St. Louis, University of Colorado, Aurora, CO, 2Department of Medicine and MO, 2Radiology, Washington University, St. Louis, MO Integrated Center for Genes, Environment, and Health, University of Colorado Denver, Aurora, CO, 3Wadsworth Center, New York O-54, Monday, October 17, 2016, 12:30 PM State Dept of Health and School of Public Health, SUNY at Albany, HYPERESTROGENIC MILIEU DURING FRESH IN VITRO NY, Albany, NY, 4OBGYN, Division of Reproductive Sciences, FERTILIZATION CYCLES AND LOW BIRTH WEIGHT: DOES A University of Colorado Denver, Aurora, CO, 5Pediatrics, Section of SUPRAPHYSIOLOGIC THRESHOLD EXIST? , University of Colorado Denver, Aurora, CO N. Pereira, R. Elias, K. Hancock, J. P. Lekovich, Z. Rosenwaks; The Ronald O. Perelman and Claudia Cohen Center for O-71, Monday, October 17, 2016, 12:15 PM Reproductive Medicine, Weill Cornell Medicine, New York, NY BISPHENOL A (BPA) EXPOSURE IS NOT ASSOCIATED WITH LONGITUDINAL CHANGE IN OVARIAN RESERVE PARAMETERS O-56, Monday, October 17, 2016, 11:30 AM M. Quinn, R. R. Gerona, M. Cedars; Department of Obstetrics, MITOCHONDRIAL DNA CONTENT IS INCREASED IN THE Gynecology and Reproductive Sciences, University of ANEUPLOID MOUSE California, San Francisco, San Francisco, CA X. Tao,1 J. N. Landis,1 R. T. Scott III,1 N. Treff,2 A. Lonczak1; 1Foundation for Embryonic Competence, Basking Ridge, NJ, O-79, Monday, October 17, 2016, 11:15 AM 2RMANJ, Rutgers-RWJ, Basking Ridge, NJ HYPERANDROGENISM IS ASSOCIATED WITH PREFERENTIAL FAT DEPOSITION OF VISCERAL VERSUS SUBCUTANEOUS (SC) O-61, Monday, October 17, 2016, 11:15 AM ABDOMINAL FAT IN LEAN POLYCYSTIC OVARY SYNDROME (PCOS) EMBRYO SPECIFIC GRAVITY CAN DETECT CRYODAMAGE, WOMEN GENETIC INFORMATION AND ESTABLISH A. L. Akopians,1 V. Madrigal,1 S. Fisch,1 E. Ramirez,2 D. Margolis,3 C. E. Wessels,1 L. Penrose,2 S. Prien3; 1Animal Science, Texas M. K. Sarma,3 M. A. Thomas,3 T. Grogan,4 D. H. Abbott,5 R. Tech University, Lubbock, TX, 2Department of Obstetrics and Haykal,1 G. D. Chazenbalk,1 D. A. Dumesic1; 1OB/GYN, UCLA, Los Gynecology, Texas Tech University Health Sciences Center, Angeles, CA, 2Medicine, UCLA, Los Angeles, CA, 3Radiological Lubbock, TX, 3Ob/Gyn, Texas Tech University Health Sciences Science, UCLA, Los Angeles, CA, 4Medicine Statistics Core, Center, Lubbock, TX UCLA, Los Angeles, CA, 5OB/GYN, Wisconsin National Primate Research Center, Madison, WI O-65, Monday, October 17, 2016, 12:15 PM STRATEGIC IMPLEMENTATION OF EXTENDED CULTURE RESULTS O-101, Tuesday, October 18, 2016, 12:15 PM IN DIFFERENT CLINICAL OUTCOMES COMPARED TO ROUTINE LIMITATIONS ON THE COMPENSATION OF DONORS: A BLASTOCYST CULTURE SURVEY OF PUBLIC SUPPORT AND OPINION

nd 72 ASRM Scientific Congress & Expo 16 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

2016 Awards

M. S. Lee,1 L. V. Farland,2 S. A. Missmer,2 E. S. Ginsburg1; 1Dept P-75, Tuesday, October 18, 2016 of Obstetrics & Gynecology, Brigham & Women’s Hospital and EFFECT OF COLONY-STIMULATING GROWTH FACTOR ON Harvard Medical School, Boston, MA, 2Dept of Epidemiology, OUTCOME OF FROZEN-THAWED EMBRYO TRANSFER IN Harvard Chan School, Boston, MA, Boston, MA PATIENTS WITH REPEATED IMPLANTATION FAILURE D. Obidniak,1 A. Gzgzyan,2 L. Dzhemlikhanova,1 A. Feoktistov3; O-118, Tuesday, October 18, 2016, 12:00 PM 1Medical faculty, Saint-Petersburg State University, Saint- FSH PROMOTES PREMATURE PROGESTERONE OUTPUT IN Petersburg, Russian Federation, 2Saint-Petersburg State HUMAN GRANULOSA CELLS WITHOUT LUTEINIZATION BY University, Saint-Petersburg, Russian Federation, 3Medical UP-REGULATING THE EXPRESSION OF 3β-HSD AND INDUCING Faculty, Medical Group Mother and Child DISPROPORTIONAL INCREASES BETWEEN 17α-OH AND OTHER STEROIDOGENIC ENZYMES P-491, Wednesday, October 19, 2016 N. Akin,1 G. Bildik,1 A. Seyhan,2 B. Urman,3, 2 O. Oktem3, 2; 1School MAGNETIC ACTIVATED CELL SORTING PERFORMED BEFORE of Medicine and the Graduate School of Health Sciences, Koc DOUBLE GRADIENT CENTRIFUGATION IMPROVE THE RECOVERY University, Istanbul, Turkey, 2Women’s Health Center Assisted OF GOOD QUALITY SPERMATOZOA Reproduction Unit, American Hospital, Istanbul, Turkey, T. S. Bertelli,1 M. G. Da Broi,2 P. A. Navarro,3 W. Martins,4 R. Ferriani5; 3Obstetrics and Gynecology, Koc University School of Medicine, 1Human Reproduction Department, Ribeirao Preto Medical School Istanbul, Turkey ( FMRP ) - USP, Ribeirao Preto, Brazil, 2University of Sao Paulo, Ribeirao Preto, Brazil, 3Department of Obstetrics and Gynecology, O-123, Tuesday, October 18, 2016, 11:45 AM Faculty, Ribeirao Preto, Brazil, 4Ribeirao Preto Medical School, UTILIZATION OF ADIPOSE DERIVED STEM CELLS FOR THE IN University of Sao Paulo, Ribeirào Preto, Brazil, 5Obstetrics and VITRO MATURATION OF PRIMARY AND EARLY SECONDARY Gynecology, University of Sao Paulo, Ribeirao Preto, Brazil OVARIAN FOLLICLES L. J. Green,1 H. Zhou,1 A. Shikanov2; 1OBGYN, University of P-505, Wednesday, October 19, 2016 Michigan, Ann Arbor, MI, 2University of Michigan, Ann Arbor, MI TRIPEPTIDYL PEPTIDASE I (TPP1) IS A POSITIVE OUTCOME MARKER FOR VARICOCELECTOMY IN ADULTS O-223, Wednesday, October 19, 2016, 11:15 AM M. Camargo,1 P. Intasqui,1 L. Berloffa Belardin,1 M. P. Antoniassi,1 TROPHECTODERM BIOPSIES WITH HIGHER ESTIMATED K. Cardozo,2 V. Melechco Carvalho,2 A. Cedenho,1 R. Bertolla3; CELLULARITY INCREASE RISK OF PREGNANCY LOSS AND 1Sao Paulo Federal University, Sao Paulo, Brazil, 2Fleury Group, MONOZYGOTIC TWINNING Sao Paulo, Brazil, 3Deparment of Surgery, Division of Urology, S. J. Morin,1 J. M. Franasiak,1 C. R. Juneau,1 X. Tao,2 R. T. Scott1; Human R, Sao Paulo Federal University, Sao Paulo, Brazil 1Reproductive Medicine Associates of New Jersey, Basking Ridge, 2 NJ, Foundation for Embryonic Competence, Basking Ridge, NJ RESIDENT-IN-TRAINING AWARD O-247, Wednesday, October 19, 2016, 11:15 AM This award recognizes the presenter of an exceptional abstract MATERNAL FAT INTAKE DURING PREGNANCY IN RELATION TO who is currently a resident in training in the field of obstetrics IGF2 AND H19 METHYLATION IN NEWBORNS and gynecology or urology. Recipients of these awards A. J. Gaskins,1 H. Laue,2 K. Moley,3 A. Baccarelli,4, 2 M. W. specified that they would like to be eligible for the “Resident In- Gillman,1, 5 J. E. Chavarro1; 1Department of Nutrition, Harvard Training Award” during the online abstract submission process. T.H. Chan School of Public Health, Boston, MA, 2Department The awardee receives: of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, 3OB/GYN, Washington University in St. • $500 Louis, St. Louis, MO, 4Environmental Health Sciences, Columbia • One-year free ASRM membership Mailman School of Public Health, New York, NY, 5Department • Free registration to ASRM 2016 in Salt Lake City, UT of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA O-116, Tuesday, October 18, 2016, 11:30 AM DIMINISHED BUT NOT DECLINING: LONGITUDINAL ANDROGEN P-51, Tuesday, October 18, 2016 PRODUCTION AND FOLLICULAR MEASURES OF OVARIAN RESERVE POLYMORPHISM IN MTHFR 677 C>T AND 1298 A>C IN PATERNAL IN CANCER SURVIVORS COMPARED TO HEALTHY CONTROLS 1 2 3 4 SPERM DNA IS ASSOCIATED WITH INCREASED RISK OF K. Cameron, M. D. Sammel, M. M. Prewitt, M. E. Lynch, C. 1 1 2 RETINOBLASTOMA IN INDIAN CHILDREN Gracia ; University of Pennsylvania, Philadelphia, PA, Biostatistics S. Bisht,1 B. Chawla,2 R. Dada3; 1Laboratory for Molecular and Epidemiology, University of Pennsylvania, Perelman School of 3 Reproduction and Genetics, All India Institute of Medical Medicine, Philadelphia, PA, Obstetrics and Gynecology, University 4 Sciences, New Delhi, India, 2AIIMS, New Delhi, India, 3Anatomy, of Pennsylvania School of Medicine, Philadelphia, PA, University Lab For Molecular Reproduction and Genetics, N Delhi, India of Pennsylvania School of Medicine, Ardmore, PA

nd 72 ASRM Scientific Congress & Expo 17 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

2016 Awards

IN-TRAINING AWARDS FOR RESEARCH SRS IN-TRAINING AWARDS FOR RESEARCH Five In-Training Awards for Research are granted in recognition of Three (3) SRS In-Training Awards for research are granted. The outstanding research conducted by individuals who are in training. purpose of these awards is to recognize outstanding research Recipients of these awards specified that they would like to be conducted by individuals in training. Recipients of these awards eligible for the “In-Training Award for Research” during the online specified that they would like to be eligible for the “SRS In-Training abstract submission process. He/she is the presenting author (first) Award for Research” during the online abstract submission and a medical student, resident, fellow, or undergraduate, graduate, process and submitted their abstract to the “Reproductive or postdoctoral student. The awardees receive: Surgery” category. He/she is a presenting author (first), and a medical student, resident, fellow, or undergraduate, graduate, or • $250 postdoctoral student. The awardees receive: • One-year free ASRM membership • Free registration to ASRM 2016 in Salt Lake City, UT • $250 • One-year free ASRM and SRS memberships • Free registration to ASRM 2016 in Salt Lake City, UT O-37, Monday, October 17, 2016, 11:15 AM EXPERIENCE IN TRANSABDOMINAL RETREIVALS: A O-32, Monday, October 17, 2016, 11:30 AM CASE SERIES DEMOGRAPHIC CHARACTERISTICS OF WOMEN WITH UTERINE C. C. Shenoy, C. Coddington, Z. Khan, T. L. Jones, J. Jensen; FACTOR INFERTILITY SEEKING INFORMATION ON UTERINE Reproductive Endocrinology & Infertility, Mayo Clinic, TRANSPLANTATION Rochester, MN S. Arian,1 R. Flyckt,1 A. G. Tzakis,2 T. Falcone1; 1Obstetrics, Gynecology, and Women’s Health Institute, Cleveland Clinic, O-133, Tuesday, October 18, 2016, 11:15 AM Cleveland, OH, 2Transplant Surgery, Cleveland Clinic Florida, MITOCHONDRIAL STRESS RESPONSE IS REQUIRED FOR FEMALE Weston, FL FERTILITY Reproductive Biology: Animal and Experimental Models T. Wang, E. Babayev, K. Lowther, E. Seli; Department of O-33, Monday, October 17, 2016, 11:45 AM Obstetrics, Gynecology, and Reproductive Sciences, Yale School UTERINE AND OVARIAN VIABILITY IN THE BABOON WITH of Medicine, New Haven, CT BILATERAL UTERO-OVARIAN MICROVASCULAR ANASTOMOSES ALONE O-202, Wednesday, October 19, 2016, 12:00 PM B. D. Beran,1 K. S. Arnolds,1 M. E. Shockley,1 K. Rivas,2 M. L. HIGH FOLLICLE-STIMULATING (FSH) PROMOTES Sprague,1 M. Medina III,3 P. Escobar,4 A. G. Tzakis,5 T. Falcone,6 TUMOR ANGIOGENESIS OF CARCINOMA OF S. Zimberg1; 1Division of Minimally Invasive Gynecology, MENOPAUSAL WOMEN Cleveland Clinic Florida, Weston, FL, 2Mannheimer Foundation, S. Shi; Zhejiang Normal University, Jinhua, China Homestead, FL, 3Plastic Surgery, Cleveland Clinic Florida, Weston, FL, 4Gynecologic Oncology and Reproductive Medicine, O-210, Wednesday, October 19, 2016, 12:30 PM The University of Texas MD Anderson Cancer Center, Houston, MYELOPEROXIDASE AND ACTIVATED MACROPHAGES ALTER TX, 5Transplant Surgery, Cleveland Clinic Florida, Weston, FL, METAPHASE II MOUSE OOCYTE QUALITY BY DISASSEMBLY OF 6Obstetrics & Gynecology, Cleveland Clinic, Cleveland, OH ORGANIZING CENTER S. Khan,1 F. Shaeib,2 R. Jeelani,3 M. Thakur,4 H. Abu-Soud1; O-104, Tuesday, October 18, 2016, 11:30 AM 1Wayne State University, Detroit, MI, 2Ob/Gyn-Physiology, UTERINE VIABILITY FOLLOWING INTERRUPTION OF THE Wayne State University/Medical School, Detroit, MI, 3REI, Wayne UTERINE VEIN- A PILOT STUDY TO ASSESS ALTERNATIVE State University, Royal Oak, MI, 4Division of Reproductive VENOUS RETURN FOR UTERINE TRANSPLANT Endocrinology, Department, Wayne State University/ Detroit K. Arnolds,1 B. Beran,1 M. Shockley,1 K. Rivas,2 M. L. Sprague,1 A. Medical Center, Detroit, MI Tzakis,3 T. Falcone,4 S. Zimberg1; 1Gynecology, Cleveland Clinic Florida, Weston, FL, 2Mannheimer Foundation, Homestead, O-213, Wednesday, October 19, 2016, 11:45 AM FL, 3Transplant, Cleveland Clinic Florida, Weston, FL, 4Ob Gyn, THE ROLE OF THE GENETIC COUNSELOR IN THE Cleveland Clinic, Cleveland, OH PREIMPLANTATION GENETIC SCREENING DECISION J. Isaac,1 E. Mounts,2 L. Williamson Dean1 T. Von Wald,3 E. Barbieri,2 Q. Stein,4 J. Flanagan3; 1University of Arkansas for Medical Sciences, Little Rock, AR, 2Oregon Reproductive Medicine, Portland, OR, 3Sanford Health, Sioux Falls, SD, 4Augustana University, Sioux Falls, SD

nd 72 ASRM Scientific Congress & Expo 18 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

2016 Awards

AFFILIATED SOCIETY PRIZE PAPERS The Society for Assisted Reproductive Technology, The Society for Reproductive Endocrinology and Infertility, The Society of Reproductive Surgeons, and The Society for Male Reproduction and Urology have selected prize papers for an award of $500 each.

1 2 3 2 4 SART Prize Paper S. Mittal, A. Mielnik, A. Bolyakov, P. N. Schlegel, D. Paduch ; 1Urology, New York Presbyterian/Weill Cornell Medicine, New O-145, Tuesday, October 18, 2016, 11:15 AM York, NY, 2Urology, Weill Cornell Medical College, New York, NY, TRANSFER FRESH OR VITRIFY AFTER BLASTOCYST BIOPSY? 3Weill Cornell Medicine, New York, NY, 4Dept of Urology, Weill RESULTS OF AN RCT Cornell Medical College, New York, NY A. Coates,1 A. Kung,2 E. Mounts,3 J. S. Hesla,3 B. J. Bankowski,3 E. Barbieri,3 B. Ata,4 J. Cohen,5 S. Munne6; 1Oregon Reproductive Medicine, Portland, OR, 2Reprogenetics, Portland, OR, 3Oregon SRBT BASIC SCIENCE AWARD Reproductive Medicine, Portland, OR, 4Koc University School A prize of $500, made possible by a donation from Cryoport, of Medicine, Istanbul, Turkey, 5ART Institute of Washington, Inc., is awarded to a basic reproductive science abstract Livingston, NJ, 6Reprogenetics, Livingston, NJ submitted in either a Reproductive Biology or Reproductive Technology category for the ASRM 2016 Scientific Congress. SREI Prize Paper The abstract was selected for either oral or poster presentation. Abstracts were evaluated by the corresponding abstract O-115, Tuesday, October 18, 2016, 11:15 AM grading committee based on originality, experimental design, PROSPECTIVE, RANDOMIZED STUDY OF THE ENDOMETRIAL quality, and significance. RECEPTIVITY ANALYSIS (ERA) TEST IN THE INFERTILITY WORK- UP TO GUIDE PERSONALIZED EMBRYO TRANSFER VERSUS O-55, Monday, October 17, 2016, 11:15 AM FRESH TRANSFER OR DEFERRED EMBRYO TRANSFER COMPREHENSIVE CHROMOSOME SCREENING AND GENE 1 2 3 4 C. Simon, I. K. Vladimirov, G. Castillon Cortes, I. Ortega, EXPRESSION ANALYSIS FROM THE SAME BIOPSY 5 6 6 7 8 S. Cabanillas, C. VIDAL, J. Giles, A. Izquierdo, S. Portela, N. R. Treff,1 Y. Wang,1 X. Tao,2 R. T. Scott1; 1RMANJ, Rutgers- 9 10 11 12 I. Fernandez, M. Ferrando, S. Mackens, S. Barrera, RWJ, Basking Ridge, NJ, 2The Foundation for Embryonic 13 1 A. Pellicer ; Parque Cientifico Universidad de Valencia, Competence, Basking Ridge, NJ Paterna, Spain, 2Dept. IVF unit, SBALAGRM-Sofia, Bulgaria, Sofia, Bulgaria, 3IVI Barcelona, Barcelona, Spain, 4Medicina Reproductiva, IVI Madrid, Madrid, Spain, 5IVI Valencia - SRBT CLINICAL SCIENCE AWARD Medicina Reproductiva, Valencia, Spain, 6Unidad de Medicina A prize of $500, made possible by a donation from Irvine Reproductiva, IVI Valencia, Valencia, Spain, 7Medicina Scientific, Inc., is awarded to a clinical reproductive science Reproductiva, Madrid, Spain, 8Gynecologist, Vigo, Spain, 9IVI abstract submitted in either a Reproductive Biology or Vigo, Vigo, Spain, 10IVI Bilbao, LEIOA, Spain, 11Centrum Voor Reproductive Technology category for the ASRM 2016 Scientific Reproductieve Geneeskunde, Brussel, Belgium, 12IVI Panama, Congress. The abstract was selected for either oral or poster Panama, Panama, 13Hospital Universitari i Politecnic La Fe, presentation. Abstracts were evaluated by the corresponding Valencia, Spain abstract grading committee based on originality, experimental design, quality, and significance. SRS Prize Paper O-169, Tuesday, October 18, 2016, 11:15 AM O-105, Tuesday, October 18, 2016, 11:45 AM TARGETED NGS PROVIDES ACCURATE PREDICTIONS OF UNEXPLAINED INFERTILITY: LAPAROSCOPY FIRST OR ART SEGMENTAL (SEG) ANEUPLOIDY AND PROGNOSTICATES DIRECTLY REDUCED REPRODUCTIVE POTENTIAL OF THE HUMAN 1 1 1 1 A. Algergawy, A. Alhalwagy, A. Shehata, H. Salem, A. Abd BLASTOCYST 2 1 Alnaby ; Obstetrics and Gynecology Department, Faculty M. D. Werner,1 D. Goodrich,2 X. Tao,3 Y. Zhan,3 J. M. Franasiak,4 2 of Medicine, Tanta University, Tanta, Egypt, Obstetrics and C. R. Juneau,5 R. T. Scott,6 N. R. Treff7; 1REI, RMANJ, Rutgers- Gynecology Department, Clinical Pharmcist, Tanta, Egypt RWJ, Basking Ridge, NJ, 2Rutgers-RWJMS, Basking Ridge, NJ, 3FAEEC, Basking Ridge, NJ, 4RMANJ, NJ, NJ, 5Reproductive SMRU Prize Paper Medicine Associates of New Jersey, Basking Ridge, NJ, 6REI, RMANJ,Rutgers-RWJ, Basking Ridge, NJ, 7RMANJ, Rutgers-RWJ, O-228, Wednesday, October 19, 2016, 12:30 PM Basking Ridge, NJ INITIAL EXPERIENCE WITH FLUORESCENCE ACTIVATED CELL SORTING OF SPERMATOZOA FROM TESTIS TISSUE: A NOVEL METHOD FOR SPERM ISOLATION AFTER TESE S

nd 72 ASRM Scientific Congress & Expo 19 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

2016 Awards

PROFESSIONAL AND SPECIAL INTEREST GROUPS Several groups have selected prize papers for cash awards. Early Pregnancy SIG Prize Paper Health Disparaties SIG Prize Paper O-258, Wednesday, October 19, 2016, 12:30 PM O-2, Monday, October 17, 2016, 11:30 AM IS BLASTOCYST TRANSFER ASSOCIATED WITH A SIGNIFICANTLY EARLY LIFE DEVELOPMENTAL EXPOSURE TO ENDOCRINE LOWER INCIDENCE OF ECTOPIC PREGNANCY? A STRICTLY DISRUPTING CHEMICALS INCREASES THE RISK OF ADULT ONSET CONTROLLED RETROSPECTIVE COHORT STUDY BASED ON OF UTERINE FIBROIDS BY PERMANENTLY REPROGRAMMING MORE THAN 30,000 FROZEN EMBRYO TRANSFER CYCLES. THE EPIGENOME OF MYOMETRIAL STEM CELLS TOWARDS A T. Du, Q. Chen, Q. Lyu, Y. Kuang; Department of Assisted PRO-FIBROID LANDSCAPE Reproduction, Shanghai Ninth People’s Hospital, Shanghai, Q. Yang,1 L. Trevino,2 A. Mas,1 A. Laknaur,1 M. P. Diamond,1 C. L. China Walker,2 A. Al-Hendy1; 1OB/GYN, Augusta University, Augusta, GA, 2Texas A&M Health Science Center, Houston, TX Endometriosis SIG Prize Paper (Best Overall Oral) Mental Health Professional Group Prize O-229, Wednesday, October 19, 2016, 11:15 AM Paper THE IMPACT OF ON QUALITY OF LIFE IN WOMEN O-151, Tuesday, October 18, 2016, 11:15 AM WITH ENDOMETRIOSIS-ASSOCIATED PAIN: RESULTS FROM TWO DOES STRESS AFFECT IN VITRO FERTILIZATION (IVF) RANDOMIZED, PLACEBO-CONTROLLED STUDIES USING THE OUTCOME? ENDOMETRIOSIS HEALTH PROFILE QUESTIONNAIRE M. F. Costantini-Ferrando,1, 2 M. Joseph-Sohan,2 E. Grill,2 E. H. S. Taylor,1 E. Surrey,2 A. M. Soliman,3 J. Castelli-Haley,3 Rauch,1 S. D. Spandorfer2; 1Reproductive Medicine Associates of J. P. Rowan,3 K. Chwalisz,3 J. W. Thomas,3 B. Schwefel,3 L. A. New Jersey, Basking Ridge, NJ, 2Weill Cornell Medical College, Williams,3 R. I. Jain3; 1Yale School of Medicine, New Haven, CT, New York, NY 2Colorado Center for Reproductive Medicine, Lone Tree, CO, 3 AbbVie Inc., North Chicago, IL Reproductive SIG Prize Paper O-253, Wednesday, October 19, 2016, 11:15 AM Endometriosis SIG Prize Paper (Best Basic ENDOMETRIAL GENE EXPRESSION OF WOMEN WITH Science Poster In-Training) RECURRENT PREGNANCY LOSSES AND INFERTILITY 1, 2 3 1 1 P-430, Wednesday, October 19, 2016 L. Wu, D. Katukurundage, N. Sung, M. D. Salazar Garcia, A. M. Skariah,1 S. V. Dambaeva,3 A. Gilman-Sachs,3 K. Beaman,3 A NON-INVASIVE TEST FOR ENDOMETRIOSIS BASED ON A PANEL 1, 3 1 OF PLASMA J. Kwak-Kim ; Rosalind Franklin University of Medicine and Science, Vernon Hills, IL, 2Reproductive Medicine Center, Anhui A. Vanhie, Y. El-Aalamat, D. O, D. P., Peterse, C. Meuleman, A. Provincial Hospital Affiliated to Anhui Medical University, Fassbender, T. D’Hooghe; Development and Regeneration, KU 3 Leuven, Leuven, Belgium Hefei, Anhui, China, Clinical Immunology Laboratory Rosalind Franklin University, North Chicago, IL Fertility Preservation SIG Prize Paper Nutrition SIG Prize Paper A prize of $500 made possible by a donation from Ferring Pharmaceuticals, Inc., is awarded to an abstract submitted in A prize of $250 made possible by a donation from Theralogix, is the Fertility Preservation category. awarded to an abstract submitted in the Nutrition category.

O-3, Monday, October 17, 2016, 11:45 AM O-165, Tuesday, October 18, 2016, 11:45 AM MTOR INHIBITORS PRESERVE FERTILITY IN A MURINE ELEVATED SERUM LEVELS OF BIOLOGICALLY ACTIVE OMEGA-3 MODEL: A NOVEL PHARMACOLOGIC APPROACH TO FERTILITY FATTY ACIDS ARE ASSOCIATED WITH BETTER OVARIAN RESERVE PRESERVATION DURING GONADOTOXIC CHEMOTHERAPY 1 2 1 1 2 1 1 M. E. Skaznik-Wikiel, M. C. Rudolph, D. C. Swindle, A. J. K. N. Goldman, D. Chenette, D. L. Keefe, J. Grifo, R. J. 1 1 2 1 2 Polotsky ; Obstetrics and Gynecology, University of Colorado Schneider ; New York University, NY, NY, Cancer Institute, NYU 2 School of Medicine, NY, NY School of Medicine, Aurora, CO, Endocrinology, Diabetes, and Metabolism, University of Colorado School of Medicine, Aurora, CO

nd 72 ASRM Scientific Congress & Expo 20 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

2016 Awards

VIDEO PRESENTATION AWARDS The Video Committee selects an overall first prize award video and honorable mention awards in several categories. First Prize for Technical Achievement in Honorable Mention for Surgery Videos Video V-1, Monday, October 17, 2016, 4:00 PM V-6, Monday October 17, 2016, 4:35 PM ROBOTIC PARTIAL CYSTECTOMY FOR DEEPLY INFILTRATING ENDOMETRIOSIS OF THE BLADDER WALL. OF MICE AND WOMEN: A LAPAROSCOPIC MOUSE MODEL FOR 1 2 1 ENDOMETRIOSIS. F. Nezhat, N. Lakhi ; Weill Cornell Medicine, New York, NY, 2Department of Obstetrics and Gynecology, Richmond D. P. Peterse,1 M. Binda,1 K. De Clercq,1 D. O,1 A. Vanhie,2 A. Fassbender,1 J. Vriens,1 T. D’Hooghe1; 1Development and University Medical Center, Staten Island, NY. Regeneration, KU Leuven, Leuven, Belgium, 2Obstetrics and , University Hospital Leuven, Leuven, Belgium. V-7, Monday, October 17, 2016, 4:51 PM DECEASED DONOR UTERINE TRANSPLANTATION. R. Flyckt,1 A. Kotlyar,2 S. Arian,3 A. G. Tzakis,4 T. Falcone5; Honorable Mention for Urology Video 1Cleveland Clinic, Beachwood, OH, 2Ob/Gyn and Women’s V-17, Tuesday, October 18, 2016, 4:38 PM Health Institute, The Cleveland Clinic Foundation, Cleveland, IMPORTANCE OF MALE INFERTILITY MICROSURGERY TRAINING. OH, 3Cleveland Clinic, Cleveland, OH, 4Transplant Surgery, 5 F. Neto,1 B. V. Stone,1 B. B. Najari,1 P. V. Bach,2 M. Feliciano,1 P. N. Cleveland Clinic Florida, Weston, FL, Ob Gyn, Cleveland Clinic, Schlegel,1 M. Goldstein,3 P. S. Li1; 1Urology, Weill Cornell Medical Cleveland, OH. College, New York, NY, 2Weill Cornell Medical College, New York, NY, 3Male Reproductive Medicine, and Urology, Weill Cornell Medical College, New York Presbyterian, New York, NY.

Honorable Mention for ART Video V-12, Tuesday, October 18, 2016, 4:00 PM SPATIOTEMPORAL DYNAMICS OF THE CHROMOSOME SEGREGATION APPARATUS DURING FIRST CLEAVAGE IN HUMAN TRIPRONUCLEAR IN VITRO. Y. Kai,1 A. Kurimasa,2 Y. Mio3,1; 1Fertility Research Centre, Mio , Yonago, Japan, 2Department of Radiation Biology and Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan, 3Reproductive Centre, Mio Fertility Clinic, Yonago, Japan.

nd 72 ASRM Scientific Congress & Expo 21 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

2016 Awards

2016 ASRM STAR AWARD

The ASRM Star Award recognizes members who have presented during at least nine of the ASRM Annual Meetings from 2006-2015. Presentations may include postgraduate courses/seminars, Scientific Program symposia, posters, and/or oral abstracts.

2016 ASRM Star Award Recipients Mohamed Aboulghar, M.D. Tommaso Falcone, M.D. Roger Lobo, M.D. Alexis Adler, B.A. Rui Alberto Ferriani, M.D., Ph.D. Barbara Luke, D.Sc., M.P.H. Ashok Agarwal, Ph.D. Jill Fischer, M.S. Martha Luna, M.D. Michael Alper, M.D. Victor Fujimoto, M.D. Erica Marsh, M.D. David Archer, M.D. Aisaku Fukuda, M.D., Ph.D. Caroline McCaffrey, D.Phil.,Ph.D. Awoniyi Awonuga, M.B.B.S. Juan Garcia-Velasco, M.D. Blair McCallie, B.Sc. Valerie Baker, M.D. David Gardner, D.Phil.,Ph.D. Stacey Missmer, D.Sc. G. David Ball, Ph.D. Antonio Gargiulo, M.D. Kelle Moley, M.D. David Barad, M.D., M.S., M.A. Forest Garner, M.S. Dean Morbeck, Ph.D. Kurt Barnhart, M.D. William Gibbons, M.D. Yoshiharu Morimoto, M.D., Ph.D. Jason Barritt, Ph.D. Elizabeth Ginsburg, M.D. Eduardo Motta, M.D. Mohamed Bedaiwy, M.D., Ph.D. Linda Giudice, M.D., Ph.D., M.Sc. Suheil Muasher, M.D. Angeline Beltsos, M.D. Norbert Gleicher, M.D. Tanmoy Mukherjee, M.D. Claudio Benadiva, M.D. Jeffrey Goldberg, M.D. Santiago Munne, Ph.D. Paul Bergh, M.D. James Goldfarb, M.D., M.B.A. Zsolt Nagy, M.D., Ph.D. Alan Berkeley, M.D. Marc Goldstein, M.D. Genevieve Neal-Perry, M.D., Ph.D. Ricardo Bertolla, D.V.M., Ph.D., M.B.A. Frank González, M.D. Ceana Nezhat, M.D. Silvina Bocca, M.D., Ph.D. Clarisa Gracia, M.D. Nicole Noyes, M.D. Nancy Brackett, Ph.D. Jamie Grifo, M.D., Ph.D. John Nulsen, M.D. Serdar Bulun, M.D. Lawrence Grunfeld, M.D. Randall Odem, M.D. Samantha Butts, M.D. Karen Hammond, D.N.P. Sergio Oehninger, M.D., Ph.D. Douglas Carrell, Ph.D. Ahmad Hammoud, M.D., M.P.H. Kutluk Oktay, M.D., Ph.D. Peter Casson, M.D. Shu Hashimoto, D.Phil.,Ph.D. Lubna Pal, M.D., M.B.B.S., M.Sc. Nicholas Cataldo, M.D., M.P.H. Jon Hennebold, Ph.D. Gianpiero Palermo, M.D., Ph.D. William Catherino, M.D., Ph.D. David Hill, Ph.D. Angela Palumbo, M.D., Ph.D. R. Jeffrey Chang, M.D. Micah Hill, D.O. Sergio Papier, M.D. Jorge Chavarro, M.D., D.Sc. Hananel Holzer, B.S., M.D. Pasquale Patrizio, M.D. Jerome Check, M.D. Mark Hornstein, M.D. Richard Paulson, M.D. Shiling Chen, M.D. Heather Huddleston, M.D. Antonio Pellicer, M.D. Young Min Choi, M.D., Ph.D. Keith Isaacson, M.D. Alan Penzias, M.D. Alicia Christy, M.D. Jeffrey Jensen, M.D., M.P.H. William Petok, Ph.D. Karine Chung, M.D. Emily Jungheim, M.D. John Petrozza, M.D. Charles Coddington, M.D. Mandy Katz-Jaffe, Ph.D. Margareta Pisarska, M.D. Pere Colls-Comas, Ph.D. William Kearns, Ph.D. Alex Polotsky, M.D. Edmond Confino, M.D. David Keefe, M.D. Samuel Prien, Ph.D. Alan Copperman, M.D. Jaime Knopman, M.D. Elizabeth Puscheck, M.D. Christos Coutifaris, M.D., Ph.D. George Kovalevsky, M.D. Jie Qiao, M.D., Ph.D. Said Daneshmand, M.D. Ertug Kovanci, M.D. Catherine Racowsky, Ph.D. Hal Danzer, M.D. William Kutteh, M.D., Ph.D. Kevin Richter, Ph.D. Owen Davis, M.D. Dolores Lamb, Ph.D. Paolo Rinaudo, M.D., Ph.D. Alan DeCherney, M.D. Ruth Lathi, M.D. Mitchell Rosen, M.D. Nina Desai, Ph.D. Richard Legro, M.D. Zev Rosenwaks, M.D. Laura Detti, M.D. Bruce Lessey, M.D., Ph.D. Ginny Ryan, M.D., M.A. Michael Diamond, M.D. Eric Levens, M.D. Edmund Sabanegh, M.D. Antoni Duleba, M.D. Frederick Licciardi, M.D. Ghassan Saed, Ph.D. Daniel Dumesic, M.D. Juergen Liebermann, M.Sc.,Ph.D. Denny Sakkas, Ph.D. Lawrence Engmann, M.D. Harry Lieman, M.D. Mary Sammel, Sc.D.

nd 72 ASRM Scientific Congress & Expo 22 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

2016 Awards

Benjamin Sandler, M.D. Rakesh Sharma, Ph.D. Michael Tucker, Ph.D., B.Sc., Nanette Santoro, M.D. Mark Sigman, M.D. Meike Uhler, M.D. Mark Sauer, M.D. Carlos Simon, M.D., Ph.D. Bradley Van Vorhis, M.D. Glenn Schattman, M.D. Cynthia Sites, M.D. Amy Vance, M.S. Robert Schenken, M.D. Barbara Stegmann, M.D.,M.P.H.,Ph.D. Weidong Wang, Ph.D. Mitchel Schiewe, Ph.D., M.Sc. Judy Stern, Ph.D. Lawrence Werlin, M.D. Peter Schlegel, M.D. John Stevens, B.S. Eric Widra, M.D. William Schoolcraft, M.D. Richard Stouffer, Ph.D. Daniel Williams, M.D. Danny Schust, M.D. Pamela Stratton, M.D. Diane Wright, Ph.D. Richard Scott, M.D. Mark Surrey, M.D. Tae Ki Yoon, M.D., Ph.D. James Segars, M.D. Irene Su, M.D. Atsumi Yoshida, M.D. David Seifer, M.D. Carlos Sueldo, M.D. Steven Young, M.D., Ph.D. Emre Seli, M.D. Takumi Takeuchi, M.D., Ph.D. Armand Zini, M.D. Paulo Serafini, M.D., Ph.D. Hugh Taylor, M.D. Bruce Shapiro, M.D., Ph.D. Tyl Taylor, M.S., M.Sc. Daniel Shapiro, M.D. Michael Thomas, M.D. Fady Sharara, M.D. Nathan Treff, Ph.D.

2016 ASRM Service Milestone Award The ASRM Service Milestone Award recognizes 10-, 15-, and 20-year milestones for service on boards and/or committees of ASRM or its affiliated societies, professional groups, or special interest groups.

20-Year ASRM Service Milestone 15-Year ASRM Service Milestone 10-Year ASRM Service Milestone Award Recipients Award Recipients Award Recipients Marian Damewood, M.D. Christos Coutifaris, M.D., Ph.D. Ruben Alvero, M.D. Erma Drobnis, Ph.D., H.C.L.D. Samantha Pfeifer, M.D. Robert Brannigan, M.D. David Seifer, M.D. Jennifer Dietrich, M.D. Kevin Doody, M.D., H.C.L.D. Arlene Morales, M.D. Laurel Stadtmauer, M.D., Ph.D.

nd 72 ASRM Scientific Congress & Expo 23 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

ASRM Scientific Congress Policies and Disclaimers

CANCELLATION POLICY American Society for Reproductive to the letter and spirit of all laws and The American Society for Reproductive Medicine, 1209 Montgomery Highway, regulations pertaining to equal opportunity Medicine reserves the right to cancel Birmingham, Alabama, USA 35216, and nondiscrimination in employment, this activity due to unforeseen telephone 1-205-978-5000, a minimum of appointments, and elections to office. circumstances. In the event of such 10 working days in advance of the event cancellation, the full enrollment fee will if a reasonable accommodation for a DISCLAIMER STATEMENT be returned to the registrant. disability is needed. The content and views presented in this educational activity are those of the REFUND/NON-ATTENDANCE POLICY EQUAL OPPORTUNITY STATEMENT faculty/authors and do not necessarily Cancellations received before or The American Society for Reproductive reflect those of the American Society for by September 1st will receive a full Medicine values and promotes diversity Reproductive Medicine. This material refund minus a $150 processing fee. among its members, officers, and staff. The is prepared based on a review of Cancellations received after September Society prohibits discrimination toward any multiple sources of information, but it 12th will not be eligible for a refund. member or employee due to race, color, is not exhaustive of the subject matter. religion, age, gender, sexual orientation, Therefore, health-care professionals ADA STATEMENT national origin, citizenship, disability, and other individuals should review and The American Society for Reproductive military status, or other basis prohibited by consider other publications and materials Medicine fully complies with the legal law. ASRM strives to achieve gender, racial, on the subject matter before relying solely requirements of the Americans with and ethnic balance in hiring and governance. upon the information contained within Disabilities Act (ADA) and the rules and ASRM maintains policies, procedures, this educational activity to make clinical regulations thereof. Please notify the and personnel actions that conform decisions about individual patients.

Be Sure to Visit the Expo Hall Monday, October 17 ...... 9:00 am – 5:00 pm Tuesday, October 18 ...... 9:00 am – 5:00 pm Wednesday, October 19 ...... 9:00 am – 3:00 pm

For safety reasons and in order to maintain the scientific nature of the display, no children under the age of 16 (except infants under 6 months of age carried in arms at all times) will be allowed in the Expo Hall. Strollers and infants in backpacks are not permitted in the Expo Hall or Poster Hall at anytime.

Certificate of Attendance Admission Badges Photo/Audio/Video Recording Proof of attendance is available on request from Name badges will be issued for the Pre- Photographing or audio/video recording of any J Spargo at the registration desk. Continuing Congress and Scientific Programs and are session for personal or commercial purposes Education Credit information is located in the required for admission. Spouse/guest badges without permission is prohibited. front of the Pre-Congress Course syllabi, the will be issued and are required for admission to Scientific Congress Program, and online. spouse/guest activities and the Expo Hall.

Room numbers of sessions are listed in the meeting app, the foldout Schedule-at-a-Glance, and on signage throughout the convention center.

nd 72 ASRM Scientific Congress & Expo 24 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Participate in the ASRM 2016 Twitter Wall! During the ASRM 2016 Scientific Congress, all participants are invited to post opinions, reports, and feedback on the Congress's Twitter Wall. The Twitter Wall can be viewed in the Convention Center’s Main Lobby. All you need is a mobile device with an installed Twitter app, or a web browser.

SETTING UP A TWITTER ACCOUNT Go to www.twitter.com, and sign up. You will need to enter identifying information and agree to the terms of service. You will need to verify your email address before continuing. Twitter will walk you through a setup wizard of sorts, and ask you to follow five or more people. This is optional, though the website doesn’t give you an option to skip it. Search for “#ASRM2016” if you wish to follow the messages at the conference, and search for “@ReprodMed” if you also wish to follow ASRM’s Twitter feed. Otherwise, at this point, if you don’t want to go any further in the setup wizard, go back to www.twitter.com and independently update your profile page and if desired, add a photo. Other Twitter users like to see photos of tweeters.

INSTALL A TWITTER APPLICATION ON YOUR MOBILE DEVICE One option for using Twitter is to install a Twitter app on your mobile device. Go to https://twitter.com/download or to the app store and select your device. If you do not wish to install an app for Twitter, you can still use Twitter within your web browser.

SENDING A TWEET TO THE ASRM 2016 TWITTER WALL You can do this within the Twitter app on your mobile device, or on the Twitter website. On the website, you can post a tweet by clicking on Home and then type inside the center box. You are limited to 140 characters in a single tweet. At the end of each message, in order for your message to appear on the Twitter wall, you must put #ASRM2016 at the end, such as:

Watching a grt pres. on endometriosis by Plenary Speaker Dr. Smith starting now -

Dr. Smith. Fantastic new data w/2000 pts! or hall packed, exciting, standing rm only! #ASRM2016 #ASRM2016

TWITTER ETIQUETTE All incoming tweets are monitored by ASRM staff, and those tweets that show up with the hashtag #ASRM2016 and that pass moderation will be posted to the Twitter Wall. In order for a tweet to pass moderation, the following guidelines should be kept in mind: • Messages must be about Congress content or activities. • Messages cannot contain personal information. • Messages cannot personally attack another person. • Messages that ASRM considers unprofessional will not be displayed on the Twitter Wall.

We hope you’ll join us in tweeting the ASRM 2016 Scientific Congress!

You can use the hashtag #ASRM2016 for Instagram too! Use the hashtags #IVF4VETS and #ACCESS2IVF too!

nd 72 ASRM Scientific Congress & Expo 25 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Group and Affiliated Society Members’ Meetings CME CE ARS

Sunday, October 16, 2016 Monday, October 17, 2016 Tuesday, October 18, 2016 5:00 pm – 6:00 pm 5:30 pm - 6:15 pm 7:00 am - 8:45 am • Nurses’ Professional Group • Access to Care Group • Women's Council Breakfast • Chinese Special Interest Group 5:15 pm – 6:00 pm • Complementary and Alternative 5:30 pm - 6:15 pm • Mental Health Professional Group Medicine Special Interest Group • Contraception Special Interest Group • Preimplantation Genetic Diagnosis • Environment and Reproduction • Early Pregnancy Special Interest Special Interest Group Special Interest Group Group • Health Disparities Special Interest • Endometriosis Special Interest Group 6:00 pm - 7:30 pm Group • Fibroids Special Interest Group • Society of Reproductive Biologists and • Indian Group • Genetic Counseling Special Interest Technologists • Legal Professional Group Group • Menopause and Ovarian Insufficiency • Imaging in Reproductive Medicine Special Interest Group Special Interest Group • Nutrition Special Interest Group • Lesbian, Gay, Bisexual, Transgender, • Physician-Scientists’ Special Interest and Questioning (LGBTQ) Group Group • Pediatric and Adolescent Gynecology • and Stem Cell Special Interest Group Biology Special Interest Group • Society for Male Reproduction and • Reproductive Immunology Special Urology Interest Group • Society for Reproductive • Turkish Special Interest Group Endocrinology and Infertility

5:30 pm - 7:00 pm 6:15 pm - 7:00 pm • Society for Assisted Reproductive • Association of Reproductive Managers Technology

6:15 pm - 7:00 pm • Fertility Preservation Special Interest Group

6:15 pm - 8:00 pm • Society of Reproductive Surgeons

nd 72 ASRM Scientific Congress & Expo 26 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

OCTOBER 17-19, 2016 | SALT LAKE CITY, UT

Continuing Education/ CME Sessions • Pre-Congress Courses 32-50 • ASRM 2016 Congress Grid 53 • Daily Schedule 54-62 • Plenary Sessions 77-81 • Lectures 82 • Symposia 83-98 • Interactive Sessions 99-110 • Additional Sessions 111-114

SPONSORED BY THE AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE ASRM 2O16 SCIENTIFIC CONGRESS

The educational programs of the ASRM 2016 Scientific Congress were supported by educational grants by the following: AbbVie Cook Medical Ferring Pharmaceuticals, Inc. GE Healthcare Illumina Merck Pfizer

The Premier Supporters of the ASRM 2016 Scientific Congress:

Ruby Level AbbVie Cook Medical Ferring Pharmaceuticals, Inc.

Platinum Level Pfizer

Gold Level Silver Level Counsyl Genesis Genetics

EMD Serono Bronze Level Illumina America Medic & Science Merck GE Healthcare Natera Women's Health USA VirtaMed, AG

nd 72 ASRM Scientific Congress & Expo 28 Salt Lake City, Utah ET S Y M P O S I U M Monday ABOG Foundation - Kenneth J. Ryan Ethics Symposium: October 17 Germline Editing: Perspectives from Science, 1:00 pm-2:30 pm Ethics, and Law

Supported by a 2013 endowment from the American Board of Obstetrics and Gynecology

George Q. Daley, M.D., Ph.D. (Chair) Boston Children’s Hospital Henry T. Greely, J.D. Stanford University Aaron Kheriaty, M.D. University of California, Irvine

Identify the advantages and limitations of programmable nuclei used for gene editing, and the efficiency, fidelity, and risk of “off-target” mutations in somatic cells, gametes, and embryos subjected to attempts at gene editing. Summarize the arguments for and against the practice of gene editing of human embryos, and the recent calls for a moratorium on the editing of embryos in the context of assisted reproduction.

AR L E C T U R E

David and Rosemary Adamson Lecture on Excellence in Reproductive Medicine: CDC Zika Update: What Do We Know?

Endowed by Advanced Reproductive Care, Inc. Define Zika and cite examples of its effects. Denise J. Jamieson, M.D., M.P.H. Describe the epidemiology of Zika. Centers for Disease Control and Prevention Assess the clinical implications of Zika.

Tuesday October 18 1:15 pm-2:15 pm ASRM 2O16 SCIENTIFIC CONGRESS Continuing Professional Development: Continuing Medical Education / Continuing Education

ASRM Continuing Education Programs

The goal of ASRM is to sponsor educational activities that provide learners with the tools needed to conduct research, practice the best medicine, and provide the best, most current care to patients. As a sponsor accredited by the Accreditation Council for Continuing Medical Education (ACCME) and as a member of the Council of Societies, the American Society for Reproductive Medicine must ensure balance, independence, objectivity, and scientific rigor in all its educational activities.

CME activities must address specific, documented, clinically important gaps in physician knowledge, competence, or performance; be documented to be effective at increasing physician knowledge, competence, performance, or patient outcomes; and conform to the ACCME Standards for Commercial Support.

All individuals involved in planning or development of educational activities must disclose to the audience any commercial interest, financial interest, and/or other relationship with any entity producing, marketing, re-selling, or distributing health-care goods or services consumed by, or used on, patients. All relationships, whether or not they directly apply to a particular CME event, must be disclosed. All non-FDA approved uses of products must be clearly identified.

These disclosures were reviewed by the Subcommittee for Standards of Commercial Support of the ASRM CME Committee and the Executive Program Committee, which resolved potential conflicts of interest.

NON- NON- CME All activitiesCE AR areS for CME, unless otherwise noted.CME CE ARS Indicates Audience Response System (ARS) will be used during session.

The following may receive honoraria and/or Disclosures of faculty and presenters for the Pre-Congress and discounted or free registration: Plenary, Symposia, Scientific Congress may be in a presentation slide, printed material, and Interactive Session speakers, and Pre-Congress or oral statement, and will be in the ASRM Final Program. Abstract faculty. Honoraria are not provided for Roundtable authors’ disclosures will be in the 2016 Final Program. Roundtable presenters, Oral and Poster Abstract presenters, and presenters should provide a copy of their disclosure to participants at Video presenters. their table.

nd 72 ASRM Scientific Congress & Expo 30 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

How to Claim Continuing Medical Education / Continuing Education Credits

Final date to claim credit is December 31, 2016. Questions? [email protected]

The Accreditation Council for Continuing Pre-Congress Courses 1, 2, 3, 4, 5, 6, 9, 10, Psychological Association to sponsor Medical Education (ACCME) 11, 12, 13, 15, 16, 17, 18, 19; and 4 Cognates continuing education for psychologists. MHPG The American Society for Reproductive to Courses 7, 8, 20, and 21. maintains responsibility for this program and Medicine is accredited by the Accreditation its content. Pre-Congress Course 10 will offer American Board of Bioanalysis (ABB) Council for Continuing Medical Education The American Society for Reproductive 6.5 CEs. Congress sessions: MHPG Symposia to provide continuing medical education for Medicine has been approved to provide I, II, III will each offer 1.5 CEs; MHPG Clinical physicians. Professional Enrichment Education Sessions 01-04 will each offer 1.0 CE; other selected sessions will also offer CEs. ASRM 2016 Scientific Congress Renewal (PEER) credit through the Designation Statement American Board of Bioanalysis for this National Association of Social Workers The American Society for Reproductive event. Up to 0.65 PEER CEUs (6.5 hours (NASW) Medicine designates this live activity for each) will be recognized for Pre-Congress Pre-Congress Courses 2 and 10 have each a maximum of 15.75 AMA PRA Category 1 Courses 1, 2, 9, 11, 13, 15, 16, 18, and 22. been approved by the National Association Credits™. Physicians should claim only the of Social Workers (Approval #886496548) Credits: National Association of credit commensurate with the extent of for 6.5 Social Work continuing education Nurse Practitioners in Women’s Health their participation in the activity. contact hours. (NPWH) ASRM 2016 Pre-Congress Program The Continuing Education Approval Program National Society of Genetic Counselors (NSGC) Designation Statement of the National Association of Nurse The National Society of Genetic Counselors The American Society for Reproductive Practitioners in Women’s Health has approved (NSGC) has authorized the American Society Medicine designates Courses1-6, 9-19 the Scientific Congress for a maximum of for Reproductive Medicine to offer up to 1.42 for a maximum of 6.5 AMA PRA Category 15.75 contact hours of continuing education CEUs or 14.25 Category 1 contact hours for 1 Credits™ per course. Physicians should credit, including 13.0 contact hours of the event: 2016 ASRM Scientific Congress; 0.65 claim only the credit commensurate pharmacology credits. Pre-Congress Course CEUs or 6.5 Category 1 contact hours for the with the extent of their participation in 1 has been approved for a maximum of 6.5 event: 2016 ASRM Pre-Congress Course 02; and the activity. Courses 7, 8, 20, and 21 are contact hours, including 0.0 contact hours of up to 0.65 CEUs or 6.5 Category 1 contact hours approved for a maximum of 4.0 AMA PRA pharmacology credit. Pre-Congress Course for the event: 2016 ASRM Pre-Congress Course Category 1 Credits™. Course 22: CME/CE 10 has been approved for a maximum of 6.5 13. The American Board of Genetic Counseling credits available through CAP. contact hours, including 0.75 contact hours of (ABGC) will accept CEUs earned at this pharmacology credit. program for the purposes of genetic counselor The American College of Obstetricians certification and recertification. Participants and Gynecologists American Psychological Association (APA) The American College of Obstetricians and The Mental Health Professional Group (MHPG) requesting NSGC CEUs will be invoiced for the Gynecologists has assigned 16 Cognates of the American Society for Reproductive CEU fee of $25 per participant that is paid to to the Scientific Congress; 7 Cognates to Medicine is approved by the American the National Society of Genetic Counselors for the filing and awarding of CEU certificates.

nd 72 ASRM Scientific Congress & Expo 31 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

49TH ANNUAL PRE-CONGRESS PROGRAM

PRE-CONGRESS ASRM 2016 PRE-CONGRESS PROGRAM PROGRAM COMMITTEE Glenn L. Schattman, M.D. SATURDAY, OCTOBER 15, 2016 Chair Karine Chung, M.D., M.S.C.E. Interprofessional Course: Misconception: A Legal Guide to Managing/ Co-Chair PC01 Avoiding Gamete and Embryo Mishaps NON- Developed in Cooperation with NPG, LPG, SRBT, and SART CME CE ARS Irene Su, M.D., M.S.C.E. Coordinating Chair Faculty care, handling, and storage of gametes and Sue Jasulaitis, M.S.N., R.N. (Chair) embryos in the reproductive endocrinology Richard H. Reindollar, M.D. Fertility Centers of Illinois and infertility setting. Presenters will explore ASRM Chief Executive Officer Nidhi Desai, J.D. various ways that fertility centers can prevent Andrew R. La Barbera, Ph.D., Ballard, Desai & Miller gamete mishaps and maintain gamete chain G. David Ball, Ph.D., H.C.L.D. of custody. They also will review several H.C.L.D. Seattle Reproductive Medicine cases in which gametes were intentionally or ASRM Chief Scientific Officer Kevin J. Doody, M.D., H.C.L.D. unintentionally mishandled, the implications Meredith Sauls, M.A. Center for Assisted Reproduction for fertility centers, as well as the intended ASRM Education & Research and unintended parents. Presented from Program Administrator Needs Assessment and Course clinical, risk management, laboratory, and Description legal perspectives, this course has the intended Fertility centers around the world are outcome of sharing and improving upon best WEEKEND COURSES uniquely faced with the challenge to maintain practices. DATES: a couple’s genetic integrity while they are Saturday, October 15th in the midst of medical parenting. Once ACGME Competency Sunday, October 16th gametes are outside the patient’s body, it Systems-based Practice becomes the responsibility of the medical HOURS: team to maintain the genetic “chain of Interprofessional Competency custody” until the appropriate gametes are Roles/responsibilities for Collaborative 8:15 am – 5:00 pm returned to the patient. Practice Lunch is from Noon – 1:00 pm With the wide variety of fertility treatment Learning Objectives Courses PC01-PC06 are 1-day options available, the ability to maintain a At the conclusion of this course, courses on Saturday couple’s genetic integrity is becoming more participants should be able to: Courses PC09-PC19 and PC 22 complicated. Traditional fertility treatment 1. Identify key practice areas that involve options, such as intrauterine significant medical and legal risk. are 1-day courses on Sunday and in vitro fertilization allow to use 2. Describe ways to monitor practice Courses PC07 and PC08 are standard identification tools to ensure gamete risk through Quality Improvement half-day hands-on courses on integrity during the medical treatment cycle. and Risk Management interventions. Saturday With newer , patients can now 3. Examine litigious incidences of add a variety of options including the use of gamete/embryo mishaps and Courses PC20 and PC21 are half- anonymous/known donor gametes, traditional resulting lawful penalties. day hands-on courses on Sunday and gestational , parenting for same- 4. Explain ways to decrease practice sex couples, anonymous/known embryo risk exposure and manage untoward donation, and embryo adoption. The addition cases. of multiple gamete sources to the fertility Pre-Congress Course Syllabi treatment cycle can potentially create a higher Credits Available will be posted online only in degree of gamete errors. • CME September 2016 for registered PC • ACOG course participants. Electronic In this live, interprofessional course, physicians, • NPWH copies may be downloaded in the embryologists, nurses, and legal professionals • PEER registration area. will learn to manage risk associated with the

nd 72 ASRM Scientific Congress & Expo 32 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

49TH ANNUAL PRE-CONGRESS PROGRAM

Interprofessional Course: Clinical Genetics in Reproductive Medicine PC02 Developed in Cooperation with SREI, SRBT, GCSIG Faculty ACGME Competency Lawrence C. Layman, M.D. (Chair) Patient Care Augusta University Nathan R. Treff, Ph.D. Interprofessional Competency Reproductive Medicine Associates of New Jersey Interprofessional Teamwork and Team-based Care Erin Armenti, M.S. Reprogenetics Learning Objectives At the conclusion of this course, participants should be able to: Needs Assessment and Course Description 1. Apply the latest advances in molecular genetics to There is a general belief that genetic methods are being the interpretation of the results of genetic testing to instituted into clinical practice before there are appropriate individualizing patient care. data. How does the clinician keep up and know how to identify genetic disorders, perform proper testing, interpret molecular Credits Available results, and use this information for patient care? This live, • CME interprofessional course will address modern basic laboratory • ACOG and clinical components of reproductive genetics important • NASW to the practice of reproductive endocrinology and infertility, • NSGC including genetic counseling, clinical testing of genetic disorders in patients, and testing of embryos. Faculty will present clinical cases on preimplantation genetic diagnosis, preimplantation genetic screening, and genetic testing for disorders in patients to enable reproductive medicine physicians, geneticists, laboratory scientists, and allied health professionals to apply the latest advances in molecular genetics to the interpretation of genetic testing results to better individualize patient care.

nd 72 ASRM Scientific Congress & Expo 33 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

49TH ANNUAL PRE-CONGRESS PROGRAM

NON- Current and Future Therapies for Common Problems in Reproductive Endocrinology CME CE ARS PC03 Developed in Cooperation with SREI Faculty 3. Thyroid abnormalities and reproduction: Gap: When Robert N. Taylor, M.D., Ph.D. (Chair) to treat women with evidence of autoimmune thyroid Wake Forest School of Medicine disease for infertility and recurrent pregnancy loss (RPL). Sarah L. Berga, M.D. Recommendation: The use of thyroid treatment in Wake Forest School of Medicine women with normal thyroid function and for subclinical Emri Seli, M.D. hypothyroidism desiring pregnancy has recently Yale School of Medicine changed. REI physicians need to be updated as to the recommendations and the evidence supporting such Needs Assessment and Course Description recommendations. This live course for reproductive endocrinology and infertility 4. Estrogen/progestin pharmacodynamics and disease: Gap: (REI) physicians, physicians in training, and allied health Use of different combination contraceptive preparations professionals will review challenging clinical problems for the treatment of disease states. Recommendation: The encountered frequently in practice, including amenorrhea, interaction of natural or synthetic estrogens with differing follicle growth, medical treatment of endometriosis, progestins results in changes in endogenous levels of in the brain, ovarian aging and failure, androgens and sex-hormone binding globulin which may endometrial function during implantation, thyroid physiology benefit treatment of conditions such as hirsutism and in infertility and early pregnancy, and new treatments endometriosis. for uterine fibroids, with priority given to advances in 5. Medical treatment of endometriosis: Gap: Availability pathophysiology and emerging treatment options for these of new hormonal treatments. Recommendation: The disorders. availability of new drugs for the medical treatment of endometriosis includes oral GnRH agonist, selective Many REI specialists spend the majority of their time in the progesterone receptor modulating agents, and practice of infertility with less emphasis on the practice of intrauterine/vaginal devices. reproductive endocrinology. Thus, there are many professional practice gaps that have developed in the field of reproductive ACGME Competency endocrinology that need to be addressed. An example from Patient Care each planned presentation is given. 1. Neo-vagina development: Gap: How to perform creation Learning Objectives of a neo-vagina in conditions of vaginal agenesis. At the conclusion of this course, participants should be able to: Recommendation: The surgical options for neo- 1. Explain recent advances in the pathophysiology of vaginal creation have changed dramatically in the last common anatomical and functional disorders seen by decade with new techniques of manual dilatation and reproductive endocrinologists. surgical procedures utilizing traction devices and new 2. Implement currently recommended treatment options for skin substitutes such as buccal mucosa. The number common reproductive endocrine disorders. of physicians capable of such procedures has steadily 3. Discuss new evidence supporting the development of decreased due to lack of knowledge. emerging treatments for amenorrhea, endometriosis, 2. Evaluation of the pituitary macroadenoma: Gap: How ovarian failure, fibroids, and transgender conditions. to evaluate pituitary function in the patient with a macroadenoma. Recommendation: The techniques Credits Available for evaluation of pituitary function have changed with • CME time with less reliance on risky testing such as insulin- • ACOG induced hypoglycemia and more emphasis on the use of hypothalamic-derived factors. There is a need to update physicians on the use of these compounds.

nd 72 ASRM Scientific Congress & Expo 34 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

49TH ANNUAL PRE-CONGRESS PROGRAM

NON- Surgical Approaches to Optimize Fertility CME CE ARS PC04 Developed in Cooperation with SRS Faculty ACGME Competency Ceana H. Nezhat, M.D. (Chair) Patient Care Nezhat Medical Center Samantha M. Pfeifer, M.D. Learning Objectives Weill Cornell Medical College At the conclusion of this course, participants should be able to: Jeffrey M. Goldberg, M.D. 1. Review available technological advances in minimally Cleveland Clinic invasive reproductive surgery. Keith Isaacson, M.D. 2. Incorporate strategies for navigating abnormal pelvic Harvard Medical School anatomy, patient positioning, peritoneal access, uterine manipulation, tissue extraction, and diagnostic and Needs Assessment and Course Description operative hysteroscopy. With the advancement of assisted reproductive surgery, 3. Demonstrate the fundamentals and technique of fertility- there has been an increase in reproductive outcomes in enhancing surgery. females with reproductive issues. However, there are still 4. Discuss strategies for the surgical management of mild to certain structural abnormalities as well as pathology that advanced endometriosis. require surgical correction to increase chances of a successful 5. Apply skills for managing and minimizing the risks of outcome. This live course will address these issues with the complications in operative laparoscopy and hysteroscopy. goal of improved outcomes and decreased complications. Using video-based and didactic instruction in a surgical tutorial Credits Available format, gynecologic surgeons and allied surgical care providers • CME will explore fundamental surgical principles necessary for a • ACOG successful experience in minimally invasive/minimal access reproductive surgery.

NON- Are We Telling Our Patients Everything They Need to Know about Polycystic Ovary Syndrome (PCOS)?CME CE ARS PC05 Developed in Cooperation with AESIG and AE-PCOS Society Faculty assessment of mood and anxiety disorders, effects of current Anuja Dokras, M.D., Ph.D. (Chair) treatments on cardiometabolic health, comprehensive University of Pennsylvania counseling of women with PCOS, and genetics of PCOS. Richard S. Legro, M.D. Penn State College of Medicine ACGME Competency Andrea Dunaif, M.D. Patient Care Northwestern University Feinberg School of Medicine Enrico Carmina, M.D. Learning Objectives University of Palermo At the conclusion of this course, participants should be able to: 1. Determine an accurate diagnosis of PCOS in adolescents Needs Assessment and Course Description and adults. Polycystic ovary syndrome (PCOS) is the most common 2. Counsel women regarding menstrual regulation, fertility endocrine disorder affecting up to 15% of women of outcomes, cardiometabolic health in perimenopause, reproductive age. Results from international patient and mood disorders, and health-related quality of life. physician surveys indicate gaps in knowledge and care for this 3. Discuss genetic links associated with PCOS. disorder. In this live course, reproductive medicine physicians, nurse practitioners, nurses, psychologists, nutritionists, Credits Available fellows, and obstetric and gynecology residents will be able • CME to apply to their practice the latest information on diagnostic • ACOG pitfalls in adolescents and adults, optimum fertility treatments,

nd 72 ASRM Scientific Congress & Expo 35 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

49TH ANNUAL PRE-CONGRESS PROGRAM

WARR Room: Workshop for Authors, Reviewers, and Readers PC06 Developed in Cooperation with Fertility and Sterility Faculty ACGME Competency Antonio Pellicer, M.D. (Co-chair) Practice-based Learning and Improvement Instituto Valenciano Infertilidad Professionalism Craig S. Niederberger, M.D. (Co-chair) University of Illinois at Chicago Learning Objectives Robert E. Brannigan, M.D. At the conclusion of this course, participants should be able to: Northwestern University 1. Describe the different types of study designs, appropriate Nicolás Garrido Puchalt, Ph.D., M.Sc. analyses, relevant checklists, disclosure procedures, Instituto Universitario IVI Valencia and submission processes for reproductive medical Steven R. Lindheim, M.D., M.M.M. communications. Wright State University Boonshoft School of Medicine 2. Evaluate critically the scientific merit and value of a Steven F. Palter, M.D. submitted manuscript. Gold Coast IVF 3. Explain what constitutes ethical behavior in writing, Anne Z. Steiner, M.D., M.P.H. reviewing, and publishing a scientific work in reproductive University of North Carolina medicine. 4. Specify the various media resources available for readers, Needs Assessment and Course Description authors, and reviewers to interact in the communication of Publication of studies in reproductive medicine is central reproductive medical science. to advancement in the field. Fertility and Sterility currently rejects approximately 80% of submitted manuscripts, often Credits Available due to insufficiently designed studies, unsuitable analyses, • CME incomplete checklists or submission requirements, and other • ACOG addressable issues. Although much literature is available regarding how to write and submit scientific papers, interactive learning is required to educate authors. This course addresses that need based on communications among authors, reviewers, and editors as documented in Fertility and Sterility’s electronic peer-review system, EES.

In this live course, physicians and scientists in reproductive medicine and biology will learn from the editors of Fertility and Sterility the keys to designing a good study and effectively communicating its results, as well as strategies for critically evaluating manuscripts. A limited number of participants will have the opportunity on the following day to discuss their manuscripts in one-on-one sessions with a Fertility and Sterility editor, who will provide individualized feedback.

nd 72 ASRM Scientific Congress & Expo 36 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

49TH ANNUAL PRE-CONGRESS PROGRAM

Procedure and Technique for Embryo Transfer in Humans PC07 (Half-day hands-on course – morning with the ASRM Embryo Transfer Simulator) Faculty Needs Assessment and Course Description Alan S. Penzias, M.D. (Chair) Reproductive health professionals receive training in various Harvard Medical School/Boston IVF aspects of assisted reproductive technology and other Kristin A. Bendikson, M.D. procedures comprising infertility treatment. There is, however, USC Fertility a widespread gap in training in embryo transfer. There currently David Frankfurter, M.D. is no standardized embryo transfer procedure or method for George Washington University training professionals entering the field. The objective of this Thomas Louis Toth, M.D. live course for reproductive health professionals who perform Massachusetts General Hospital embryo transfer procedures is to learn the common best Julie D. Lamb, M.D. practices in embryo transfer and practice embryo transfer Pacific Northwest Fertility techniques using a virtual reality–based simulator. Learners Mamie R. McLean, M.D. will use modules of progressive difficulty to develop motor and University of Alabama at Birmingham cognitive skills for performing embryo transfer. The hands-on James H. Segars, M.D. portion of the course will provide virtually simulated operative Johns Hopkins School of Medicine steps with increasing levels of complexity, and will store G. Wright Bates, Jr., M.D. performance metrics for all users for export in standard data University of Alabama at Birmingham formats. The goal is for practitioners to improve their embryo Christopher P. Montville, M.D., M.S. transfer technique. Nashville Fertility Center James P. Toner, M.D., Ph.D. ACGME Competency Atlanta Center for Reproductive Medicine Patient Care Keith A. Ray, B.A. American Society for Reproductive Medicine Learning Objectives At the conclusion of this course, participants should be able to: 1. Describe the steps of an embryo transfer procedure in humans. 2. Discuss best practice for embryo transfer in humans. 3. Implement the hands-on experience gained with the embryo transfer simulator in practice.

Credits Available • CME • ACOG

nd 72 ASRM Scientific Congress & Expo 37 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

49TH ANNUAL PRE-CONGRESS PROGRAM

Procedure and Technique for Embryo Transfer in Humans PC08 (Half-day hands-on course – afternoon with the ASRM Embryo Transfer Simulator) Faculty Needs Assessment and Course Description Alan S. Penzias, M.D. (Chair) Reproductive health professionals receive training in various Harvard Medical School/Boston IVF aspects of assisted reproductive technology and other Kristin A. Bendikson, M.D. procedures comprising infertility treatment. There is, however, USC Fertility a widespread gap in training in embryo transfer. There currently David Frankfurter, M.D. is no standardized embryo transfer procedure or method for George Washington University training professionals entering the field. The objective of this Thomas Louis Toth, M.D. live course for reproductive health professionals who perform Massachusetts General Hospital embryo transfer procedures is to learn the common best Julie D. Lamb, M.D. practices in embryo transfer and practice embryo transfer Pacific Northwest Fertility techniques using a virtual reality–based simulator. Learners Mamie R. McLean, M.D. will use modules of progressive difficulty to develop motor and University of Alabama at Birmingham cognitive skills for performing embryo transfer. The hands-on James H. Segars, M.D. portion of the course will provide virtually simulated operative Johns Hopkins School of Medicine steps with increasing levels of complexity, and will store G. Wright Bates, Jr., M.D. performance metrics for all users for export in standard data University of Alabama at Birmingham formats. The goal is for practitioners to improve their embryo Christopher P. Montville, M.D., M.S. transfer technique. Nashville Fertility Center James P. Toner, M.D., Ph.D. ACGME Competency Atlanta Center for Reproductive Medicine Patient Care Keith A. Ray, B.A. American Society for Reproductive Medicine Learning Objectives At the conclusion of this course, participants should be able to: 1. Describe the steps of an embryo transfer procedure in humans. 2. Discuss best practice for embryo transfer in humans. 3. Implement the hands-on experience gained with the embryo transfer simulator in practice.

Credits Available • CME • ACOG

nd 72 ASRM Scientific Congress & Expo 38 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

49TH ANNUAL PRE-CONGRESS PROGRAM

SUNDAY, OCTOBER 16, 2016

Interprofessional Course: Optimizing Embryo Implantation PC09 Developed in Cooperation with SART and SRBT Faculty ACGME Competency Richard T. Scott, Jr., M.D. (Co-chair) Patient Care Reproductive Medicine Associates of New Jersey Andrew D. Dorfmann, M.S., E.L.D. (A.B.B.) (Co-chair) Interprofessional Competency Genetics & IVF Institute Interprofessional Teamwork and Team-based Care Bruce S. Shapiro, M.D., Ph.D. Fertility Center of Las Vegas Learning Objectives David H. McCulloh, Ph.D., H.C.L.D. (A.B.B.), C.C. (A.B.B.) At the conclusion of this course, participants should be able to: New York University Langone Medical Center 1. Discuss and implement laboratory techniques to improve embryo competence. Needs Assessment and Course Description 2. Evaluate and treat factors affecting endometrial The practice of in vitro fertilization (IVF) is changing rapidly receptivity. with new methods of assessing both the embryo and 3. Improve embryo transfer techniques. endometrium for implantation potential. A 2014 gap analysis of ASRM educational participants identified a number of critical Credits Available areas of educational need including implantation factors, • CME preimplantation genetic screening, optimizing embryo transfer • ACOG techniques, “freeze-all” cycles, and natural cycle IVF. In this • PEER live, interprofessional course, physicians, embryologists, and IVF clinical and laboratory personnel will learn to apply methods to improve embryo competence and implantation with IVF, which may ultimately result in increased pregnancy rates while decreasing multiple gestations.

nd 72 ASRM Scientific Congress & Expo 39 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

49TH ANNUAL PRE-CONGRESS PROGRAM

NON- Interprofessional Course: Reducing Treatment Burden and Improving Care for Fertility PatientsCME and Staff:CE ARS PC10 An Integrated Model of Care Developed in Cooperation with MHPG, NPG, and SART Faculty ACGME Competency Alice D. Domar, Ph.D. (Chair) Patient Care Boston IVF Interpersonal and Communication Skills Tamara Tobias, A.R.N.P Seattle Reproductive Medicine Interprofessional Competency Kevin J. Doody, M.D., H.C.L.D. Interprofessional Communication Center for Assisted Reproduction Interprofessional Teamwork and Team-based Care

Needs Assessment and Course Description Learning Objectives The multiple psychosocial challenges associated with At the conclusion of this course, participants should be able to: undergoing infertility treatment are well known. However, 1. List the multiple sources of patient treatment burden. patient-specific psychological intervention may not be the 2. Describe the psychological and physical toll of treatment most effective strategy to improve patient coping. Clinic- and burden. treatment-related concerns as well as organization problems 3. Explain the ways in which providers and staff can reduce also contribute to patient distress and premature treatment treatment burden. termination. 4. Propose strategies for reducing treatment burden.

In this live, interprofessional course, mental and medical Credits Available health providers and staff will learn about multiple and • CME complex factors that can contribute to patient distress • ACOG and dissatisfaction during fertility treatment, and how to • NPWH work within an integrated model of care to improve patient • NASW satisfaction and treatment experience. Such a model • APA would need to identify the causes of burden across patient, treatment, and clinic domains. Tailored interventions should then be integrated into routine care and implemented by fertility clinic staff to optimize the treatment experience. In addition, mental health professionals should expand their treatment focus to include staff and help staff improve communication and coping skills that would also serve to benefit patients. The goal is better treatment experiences for patients, leading to improved quality of life and lower discontinuation rates. An integrated model of care should also benefit staff by lower work overload and stress from working with a less distressed patient population. Finally, it should benefit the clinic itself through lower discontinuation, as suggested by recent systematic reviews of compliance studies, and consequently, higher success rates and higher patient satisfaction.

nd 72 ASRM Scientific Congress & Expo 40 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

49TH ANNUAL PRE-CONGRESS PROGRAM

NON- Interprofessional Course: Overcoming Challenges in Reproduction: Environment, Nutrition, and CMEVulnerableCE ARS PC11 Populations Developed in Cooperation with ERSIG, NutraSIG, and HDSIG Faculty ACGME Competency Victor Y. Fujimoto, M.D. (Chair) Medical Knowledge University of California, San Francisco Kaylon L. Bruner-Tran, Ph.D. Interprofessional Competency Vanderbilt University School of Medicine Interprofessional Teamwork and Team-based Care Catherine Racowsky, Ph.D., H.C.L.D. Brigham and Women’s Hospital, Harvard Medical School Learning Objectives Heather Huddleston, M.D. At the conclusion of this course, participants should be able to: University of California, San Francisco 1. Describe effects of environmental exposures, including in the IVF laboratory, on clinical outcomes associated with Needs Assessment and Course Description reproduction in disparate populations. Humans are exposed to an astonishing array of natural and man- 2. Describe the ethnic differences in polycystic ovary made toxicants, many of which are known to act as endocrine syndrome and insulin resistance and the role of obesity disruptors. Studies to date suggest that toxicants and diets that and extremes of weight on fertility outcomes. promote inflammatory processes can also negatively affect 3. Describe ethnic, nutritional, and lifestyle factors that are reproduction and development. Environmental influences in important in the infertility patient and approaches to nutrition and lifestyle are reflected in vulnerable populations, minimize impairment of fertility. racial and ethnic disparities, metabolic abnormalities, maternal 4. Describe common epigenetic mechanisms that have been weight, and paternal preconception health and impact linked to environmental exposures. reproductive and birth outcomes. In addition, the current high utilization rate of assisted reproductive technology requires a Credits Available thorough analysis of the potential environmental exposures • CME that may influence gametes and embryos within the in vitro • ACOG fertilization (IVF) laboratory. • PEER

In this live, interprofessional course, reproductive medicine physicians, nurses, and embryologists will be able to apply to their clinical practice information on environmental exposures and reproductive medicine through discussion and review of: the interactive roles of nutrition and environmental exposures; unique health disparities in vulnerable populations; environmental exposures during IVF; quality-control standards within an IVF laboratory; and nutritional choices that may reduce systemic inflammation and positively influence establishment and maintenance of pregnancy.

nd 72 ASRM Scientific Congress & Expo 41 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

49TH ANNUAL PRE-CONGRESS PROGRAM

Interprofessional Course: Creating a Patient-focused Five-star Service Program PC12 Developed in Cooperation with ARM Faculty ACGME Competency Colin D. Thomas, M.H.A. (Chair) Systems-based Practice Columbia University Brad J. T. Senstra, M.H.A. Interprofessional Competency Seattle Reproductive Medicine Roles/responsibilities for Collaborative Practice Lisa Duran, B.S. Reconceived Learning Objectives Lora B. Stamper, R.N., M.H.A. At the conclusion of this course, participants should be able to: Seattle Reproductive Medicine 1. Describe what a patient-based service program entails. Paul C. Lin, M.D. 2. Measure and track outcomes. Seattle Reproductive Medicine 3. Engage the entire team and patients to focus on patient service. Needs Assessment and Course Description A recent survey of members of the Association of Reproductive Credits Available Managers indicated a need for strategies for creating a patient- • CME based service program, specifically for patient engagement • ACOG and improving staff/patient/customer service interactions. In this live, interprofessional course, members of the reproductive health-care team, including administrators, medical directors, physicians, managers, and clinical staff will learn about the many facets of building a patient-based service program, including how to measure success and how to create a culture of patient service within an organization by soliciting feedback from patients, engaging staff, demonstrating excellence in clinical care, and providing leadership.

nd 72 ASRM Scientific Congress & Expo 42 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

49TH ANNUAL PRE-CONGRESS PROGRAM

NON- Interprofessional Course: Preparing for Pregnancy and Genetic Testing – What Should You Consider?CME CE ARS PC13 Developed in Cooperation with EPSIG and GCSIG Faculty ACGME Competency Sacha Krieg, M.D., Ph.D. (Co-chair) Patient Care Oregon Health & Science University Amy Jordan, M.S., L.C.G.C. (Co-chair) Interprofessional Competency Reprogenetics Interprofessional Teamwork and Team-based Care Gabriel A. Lazarin, M.S., C.G.C. Counsyl Learning Objectives Mary Stephenson, M.D., M.Sc. At the conclusion of this course, participants should be able to: University of Illinois at Chicago 1. Develop an appropriate, evidence-based preconception and early pregnancy assessment and evaluation for Needs Assessment and Course Description the infertile or recurrent loss couple and integrate this A 2014 ASRM gap and educational needs analysis identified counseling into their daily practice. several practice gaps related to preconception health and 2. Acknowledge the settings in which preimplantation genetic issues impacting the conception, progression, and genetic screening for the idiopathic recurrent pregnancy maintenance of a healthy pregnancy. In recent years, options loss patient should be recommended and its limitations. for preconception testing, preimplantation genetic testing, and 3. Explain different translocations, their evaluation, and antenatal testing have increased significantly. These advances treatment options. require changes in practice patterns and further education for 4. Evaluate the different types of genetic screening currently the reproductive medicine professional. available and choose the most appropriate modality for patients and in third-party reproduction. In this live, interdisciplinary course for physicians, nurses, genetic counselors, laboratory scientists, and allied Credits Available health professionals, faculty will update participants on • CME preconception care and available genetic testing options, as • ACOG well as genetic counseling and testing prior to pregnancy and • PEER in early pregnancy, emphasizing evaluation and treatment of • NSGC genetic causes of recurrent pregnancy loss. Specialized topics will include noninvasive genetic testing, parental karyotyping, and translocations for the recurrent pregnancy loss patient as well as cost-benefit of karyotyping products of conception.

nd 72 ASRM Scientific Congress & Expo 43 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

49TH ANNUAL PRE-CONGRESS PROGRAM

Value-based Care of the Infertile Male PC14 Developed in Cooperation with SMRU Faculty ACGME Competency Daniel H. Williams, IV, M.D. (Chair) Systems-based Practice University of Wisconsin School of Medicine and Public Health Aaron Spitz, M.D. Learning Objectives University of California, Irvine At the conclusion of this course, participants should be able to: James M. Hotaling, M.D., M.S., F.E.C.S.M. 1. Define value-based health care. University of Utah 2. Describe the cost-effective workup of the male partner of Christina Broadwell, M.D. an infertile couple. University of Wisconsin School of Medicine and Public Health 3. Explain the proper diagnoses and codes to use when James M. Dupree, M.D., M.P.H. evaluating and treating male infertility. University of Michigan 4. Establish effective working relationships between male and female fertility providers. Needs Assessment and Course Description Value-based health care is here. Providers need to know what Credits Available this means, what the role of the government is in this new era of • CME health care, and more specifically how this applies to the care of infertile couples. As male infertility is either the sole cause of or a contributor in up to 50% of infertility, clinicians need to know how to provide timely and cost-effective male-factor fertility evaluations and treatments, as well as how to do so within the various structures of health-care delivery systems, including men’s health clinics. Furthermore, the care of both the infertile man and woman needs to be effectively coordinated and managed by infertility specialists so as to accomplish the goal of safe, effective, timely, and cost-effective care.

This live course for urologists, reproductive endocrinologists, andrologists, and advanced practice providers will focus on the value of caring for the male partner of infertile couples. Topics will include: how to provide cost-conscious evaluations and treatments of male infertility; issues surrounding insurance, billing, and coding for male reproductive care; and timely and effective collaboration with reproductive endocrinologists to offer the best comprehensive care for patients faced with infertility.

nd 72 ASRM Scientific Congress & Expo 44 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

49TH ANNUAL PRE-CONGRESS PROGRAM

Life beyond Cancer: Fertility Preservation and Reproductive Survivorship Issues after Cancer Treatment PC15 Developed in Cooperation with FPSIG Faculty ACGME Competency James F. Smith, M.D., M.S. (Chair) Practice-based Learning and Improvement University of California, San Francisco Patient Care Daniel Michael Green, M.D. St. Jude Children’s Research Hospital Learning Objectives Lisa Madlensky, Ph.D., C.G.C. At the conclusion of this course, participants should be able to: University of California, San Diego 1. Describe common late effects of cancer treatments related Jennifer E. Mersereau, M.D., M.S.C.I. to reproductive health. University of North Carolina 2. Apply knowledge and demonstrate competence in managing fertility and preconception care of young cancer Needs Assessment and Course Description survivors who have completed cancer treatments. In the United States, there are nearly 500,000 women and 3. Explain cancer risks in survivors and their offspring. men of reproductive age who have a history of cancer. After 4. Discuss the role of contraception in the post-treatment undergoing cancer treatments, these survivors are at high period for male and female cancer survivors. risk of late effects related to reproductive health, including infertility, limited contraception options, and pregnancy- Credits Available related complications. Increasing data also show significant • CME long-term morbidities in young cancer survivors. Together • ACOG these late effects have a major negative impact on quality of • PEER life after cancer.

In this live course, reproductive medicine specialists and allied health professionals will learn about the risks of infertility and other reproductive health–related late effects of cancer treatment. In addition, a review of the clinical evidence for evaluating and treating these late effects in cancer survivors will enable care providers to provide outstanding care in managing fertility, pregnancy, and family planning for these patients.

nd 72 ASRM Scientific Congress & Expo 45 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

49TH ANNUAL PRE-CONGRESS PROGRAM

NON- Stop Throwing Away Your Money: Coding to Maximize Reimbursement CME CE ARS PC16 Developed in Cooperation with the ASRM Coding Committee Faculty ACGME Competency John T. Queenan, Jr., M.D. (Chair) Systems-based Practice University of Rochester Medical Center George A. Hill, M.D. Learning Objectives Nashville Fertility Center At the conclusion of this course, participants should be able to: Beth W. Rackow, M.D. 1. Demonstrate correct coding of diagnostic conditions that Columbia University Medical Center are typically encountered in the practice of reproductive endocrinology. Needs Assessment and Course Description 2. Identify the correct Current Procedural Terminology (CPT) Every reproductive medicine practice has a legal and ethical code for surgical procedures encountered in the practice of obligation to follow a specific set of rules and regulations that reproductive endocrinology and list additional resources determine how reimbursements are calculated. Failure to follow available to aid with correct coding procedures in the future. these rules can result in unfair practices to patients and/or legal 3. Summarize the rules and regulations required by third- consequences from government or third-party payers. The problem party payers regarding documentation guidelines to is those rules and regulations have become so complex that most verify that physician services were rendered according people cannot understand them without receiving special training. to medical necessity and in accordance with the In addition, the nature of diagnosis codes in the new ICD-10 require requirements of CPT. a new, detailed knowledge of coding. 4. Describe the proper steps for successful verification or negotiation of coverage in obtaining third-party payer In this live course, physicians, practice managers, billers, coders, coverage for fertility services. office managers, sonographers, laboratory managers, and physician assistants will learn the correct way to report diagnosis codes, Credits Available select appropriate procedure codes, minimize errors, and improve • CME accuracy of patient billing with systems-based resources. • ACOG • PEER

Optimal Prevention and Diagnosis of Miscarriage PC17 Developed in Cooperation with ESHRE Faculty and potential errors in early pregnancy scanning, contribution Siobhan Quenby, M.D., F.R.C.O.G. (Chair) of lifestyle and its effects on the intrauterine environment on University of Warwick miscarriage and application of evidence-based medicine to Astrid Marie Kolte, M.D. miscarriage. University Hospital Copenhagen Emma Kirk, M.D., M.R.C.O.G. ACGME Competency North Middlesex University London Patient Care Rebecca C. Painter, M.D., Ph.D. Academic Medical Centre, Amsterdam Learning Objectives At the conclusion of this course, participants should be able to: Needs Assessment and Course Description 1. Review the new terminology needed to describe early Miscarriage is the most common complication of pregnancy pregnancy loss with the widespread availability of high- and a distressing outcome of a badly wanted pregnancy. resolution ultrasonography. The traditional approach of “it’s nature’s way” is no longer 2. Discuss diagnostic dilemmas. acceptable to couples. 3. Explain why miscarriage may be preventable and describe preventative strategies. In this live course, faculty will update reproductive medicine clinicians, researchers, counselors, and other allied health Credits Available providers on new advances in imaging and clinical science that • CME challenge traditional concepts of miscarriage diagnosis and • ACOG prevention. Topics to be addressed include definitions and controversies in the literature, strategies to improve accuracy

nd 72 ASRM Scientific Congress & Expo 46 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

49TH ANNUAL PRE-CONGRESS PROGRAM

Strategies for Promoting Uterine Receptivity PC18 Developed in Cooperation with ChSIG and CSRM Faculty ACGME Competency Huai L. Feng, Ph.D., H.C.L.D. (Chair) Patient Care New York Hospital Queens Jie Qiao, M.D., Ph.D. (Co-Chair) Learning Objectives Peking University Third Hospital At the conclusion of this course, participants should be able to: Yulian Zhao, M.D., Ph.D., M.B.A. 1. Utilize stem cells or intrauterine infusion of platelet-rich Johns Hopkins University School of Medicine plasma for thin endometrium or endometrial adhesions. Rui Huang, M.D., Ph.D. 2. Describe factors associated with endometrial cavity fluid Sixth Affiliated Hospital of Sun Yat-sen University and their impact on in vitro fertilization-embryo transfer outcomes, especially cesarean scar. Discuss options to Needs Assessment and Course Description eliminate the fluid. The presence of thin endometrium or intrauterine adhesions, 3. Discuss endometrial protein profiles in the window of and endometrial cavity fluid related to cesarean scar are related implantation after -releasing hormone to poor embryo implantation rate and are difficult to manage antagonist to improve embryo implantation. in the assisted reproductive technology clinic. However, stem 4. Utilize an ultra-long protocol for frozen embryo transfer cells, intrauterine infusion of platelet-rich plasma, and repair of in idiopathic repeated implantation failure patients and cesarean scar are making progress in improving the intrauterine endometriosis patients. microenvironment. Strategies such as the ultra-long protocol 5. Introduce a progestin-primed ovarian-stimulation protocol and Shanghai protocol have been applied with promising clinical into clinical practice. results. In this live course, reproductive medicine physicians will learn about new progress to promote embryo implantation Credits Available in an intrauterine microenvironment and how to apply these • CME strategies to clinical practice. • ACOG • PEER

nd 72 ASRM Scientific Congress & Expo 47 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

49TH ANNUAL PRE-CONGRESS PROGRAM

NON- Controlled Ovarian Stimulation: from Basic to Advanced Principles CME CE ARS PC19 Developed in Cooperation with MEFS Faculty ACGME Competency Johnny T. Awwad, M.D. Patient Care American University of Beirut Medical Center Mohamed A. Aboulghar, M.D. Learning Objectives Cairo University At the conclusion of this course, participants should be able to: Robert W. Rebar, M.D. 1. Discuss the endocrine control of the hypothalamic- Western Michigan University Homer Stryker M.D. School of pituitary-ovarian axis and design ovarian stimulation Medicine protocols for women with hypothalamic amenorrhea. Alan DeCherney, M.D. 2. Identify predictors of ovarian response to oral agents Eunice Kennedy Shriver National Institute of Child Health and in women with polycystic ovary syndrome (PCOS) and Human Development, NIH choose appropriate oral stimulation regimens on the basis of a PCOS phenotype. Needs Assessment and Course Description 3. Identify the various applications of gonadotropin-releasing While controlled ovarian stimulation remains the cornerstone hormone (GnRH) agonist suppression protocols and adapt of fertility , recently a major shift of paradigm was clinical applications to patient characteristics. established away from the past dictum of “more is always 4. Describe the follicular dynamics associated with GnRH better” in favor of “safety comes first,” and away from antagonist suppression protocols and tailor a stimulation standardized protocols in favor of more personalized ones. protocol to the patient, taking them into consideration. Many controversial details nonetheless remain in choice of 5. Explain the impact of biomarkers on the quality of ovarian the stimulation protocol, namely the type of , stimulation and design personalized protocols on the basis need for luteinizing hormone supplementation, modality of these biomarkers. of pituitary suppression, and trigger approaches to final 6. Review predictors of ovarian hyper-response during the follicle maturation. Furthermore, patient- and cycle-specific course of ovarian stimulation and manipulate ovarian characteristics appear to affect the follicular response to stimulation in PCOS to ensure safety. stimulation, adding an extra dimension to the intricacy of 7. Summarize current evidence on how to achieve the best stimulation protocol design. follicular response in poor responders and develop ovarian stimulation protocols for women with diminished ovarian This live course will be an active learning experience, allowing response. reproductive endocrinologists, infertility specialists, and 8. Explain the principles of endometrial receptivity and allied health professionals in the field of assisted reproductive manipulate luteal supplementation in fertility treatment technology to discuss basic endocrine physiology of cycles. hypothalamic-pituitary-ovarian control and follicular events 9. Discuss the risks and predictors of ovarian in ovulatory and non-ovulatory women, offering a platform hyperstimulation syndrome and develop a risk-free to the development of comprehensive ovarian stimulation strategy for ovarian stimulation in infertile women. protocols. Using problem-solving and team-based learning strategies, the course also will review the role of patient Credits Available characteristics and reproductive biomarkers in predicting • CME follicular response, providing the basis for individualization • ACOG of stimulation protocols, with the aim of improving efficacy without compromising safety. The course format is a shift in learning paradigm and a departure from the traditional passive lecture format. The learning momentum evolves around group discussions enhancing thought exchange and experience sharing.

nd 72 ASRM Scientific Congress & Expo 48 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

49TH ANNUAL PRE-CONGRESS PROGRAM

Procedure and Technique for Embryo Transfer in Humans PC20 (Half-day hands-on course – morning with the ASRM Embryo Transfer Simulator) Faculty Needs Assessment and Course Description Alan S. Penzias, M.D. (Chair) Reproductive health professionals receive training in various Harvard Medical School/Boston IVF aspects of assisted reproductive technology and other Kristin A. Bendikson, M.D. procedures comprising infertility treatment. There is, however, USC Fertility a widespread gap in training in embryo transfer. There currently David Frankfurter, M.D. is no standardized embryo transfer procedure or method for George Washington University training professionals entering the field. The objective of this Thomas Louis Toth, M.D. live course for reproductive health professionals who perform Massachusetts General Hospital embryo transfer procedures is to learn the common best Julie D. Lamb, M.D. practices in embryo transfer and practice embryo transfer Pacific Northwest Fertility techniques using a virtual reality–based simulator. Learners Mamie R. McLean, M.D. will use modules of progressive difficulty to develop motor and University of Alabama at Birmingham cognitive skills for performing embryo transfer. The hands-on James H. Segars, M.D. portion of the course will provide virtually simulated operative Johns Hopkins School of Medicine steps with increasing levels of complexity, and will store G. Wright Bates, Jr., M.D. performance metrics for all users for export in standard data University of Alabama at Birmingham formats. The goal is for practitioners to improve their embryo Christopher P. Montville, M.D., M.S. transfer technique. Nashville Fertility Center James P. Toner, M.D., Ph.D. ACGME Competency Atlanta Center for Reproductive Medicine Patient Care Keith A. Ray, B.A. American Society for Reproductive Medicine Learning Objectives At the conclusion of this course, participants should be able to: 1. Describe the steps of an embryo transfer procedure in humans. 2. Discuss best practice for embryo transfer in humans. 3. Implement the hands-on experience gained with the embryo transfer simulator in practice.

Credits Available • CME • ACOG

nd 72 ASRM Scientific Congress & Expo 49 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

49TH ANNUAL PRE-CONGRESS PROGRAM

Procedure and Technique for Embryo Transfer in Humans PC21 (Half-day hands-on course – afternoon with the ASRM Embryo Transfer Simulator) Faculty Needs Assessment and Course Description Alan S. Penzias, M.D. (Chair) Reproductive health professionals receive training in various Harvard Medical School/Boston IVF aspects of assisted reproductive technology and other procedures Kristin A. Bendikson, M.D. comprising infertility treatment. There is, however, a widespread USC Fertility gap in training in embryo transfer. There currently is no David Frankfurter, M.D. standardized embryo transfer procedure or method for training George Washington University professionals entering the field. The objective of this live course for Thomas Louis Toth, M.D. reproductive health professionals who perform embryo transfer Massachusetts General Hospital procedures is to learn the common best practices in embryo Julie D. Lamb, M.D. transfer and practice embryo transfer techniques using a virtual Pacific Northwest Fertility reality–based simulator. Learners will use modules of progressive Mamie R. McLean, M.D. difficulty to develop motor and cognitive skills for performing University of Alabama at Birmingham embryo transfer. The hands-on portion of the course will provide James H. Segars, M.D. virtually simulated operative steps with increasing levels of Johns Hopkins School of Medicine complexity, and will store performance metrics for all users for G. Wright Bates, Jr., M.D. export in standard data formats. The goal is for practitioners to University of Alabama at Birmingham improve their embryo transfer technique. Christopher P. Montville, M.D., M.S. Nashville Fertility Center ACGME Competency James P. Toner, M.D., Ph.D. Patient Care Atlanta Center for Reproductive Medicine Keith A. Ray, B.A. Learning Objectives American Society for Reproductive Medicine At the conclusion of this course, participants should be able to: 1. Describe the steps of an embryo transfer procedure in humans. 2. Discuss best practice for embryo transfer in humans. 3. Implement the hands-on experience gained with the embryo transfer simulator in practice.

Credits Available • CME • ACOG

College of American Pathologists (CAP) Reproductive Laboratory Accreditation Program PC22 Inspector Training Seminar (CME credits are available through CAP)

To register for this course, go to https://learn.cap.org/ Learning Objectives activity/3770971/detail.aspx. For questions or more At the conclusion of this course, participants should be able to: information, contact a representative of the CAP Learning 1. Prepare and perform an inspection using CAP resources. Division at 800-323-4040, Option 1 or [email protected] 2. Use generally accepted techniques to produce consistent inspection findings. Needs Assessment and Course Description 3. Identify deficiencies, determine recommendations, and In this live course, laboratory professionals will learn effective appropriately document findings of an inspection of a inspection techniques, focusing on the overall inspection process, reproductive laboratory. compliance with accreditation requirements unique to embryology, 4. Summarize compliance requirements unique to andrology, and cryobiology testing as well as requirements from embryology, andrology, and cryobiology. the Laboratory General, All Common, and Chemistry checklists, and requirements specific to the laboratory director. Credits Available • PEER

nd 72 ASRM Scientific Congress & Expo 50 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Additional Non-CME Activities SUNDAY, OCTOBER 16, 2016 TUESDAY, OCTOBER 18, 2016 5:30 am 8:00 am – 3:45 pm 7th Annual ASRM 5K Run & Walk NON- Society for Reproductive Endocrinology and CME CESupportedARS by EMD Sorono Infertility (SREI) Members' Retreat $250 Fee

SREI Members' Retreat for SREI Members Only This non-CME retreat is for SREI members only and is geared toward improving the framework of your practice, building a better work environment, optimizing marketing strategy through the use of social media and facing legal challenges in today's world.

3:00 pm – 5:00 pm Workshop $20 Fee

NON- Personal Finance for Physicians CME CE ARS Stuart S. Howards, M.D. Salt Lake City University of Virginia

In this non-CME workshop, attendees will receive objective advice and education regarding personal finances (practice finances will not be covered). Topics will include the following: insurance, legal considerations, investments (general principles), retirement investments and planning, savings for college expenses, and estate planning.

SEVENTH ANNUAL ASRM7 5K FUN RUN/WALK FOR REPRODUCTIVE HEALTH 2O16

nd 72 ASRM Scientific Congress & Expo 51 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS ASRM 2016 Scientific Congress

NEEDS ASSESSMENT AND DESCRIPTION

The theme of the 2016 Scientific Congress of the American Society for Reproductive Medicine is “Scaling New Heights in Reproductive Medicine.” The scope of reproductive medicine is broad, ranging from to menopause, including men and women, and having a focus that is both molecular and macroscopic. The impact of reproduction on overall health, both on an individual and a global scale, will be explored at this Congress. The program is balanced between assessment of the latest molecular and genetic techniques and how reproduction influences public health globally. This live program is designed for physicians, nurses, andrology and embryology laboratory personnel, genetic counselors, social workers, practice and laboratory managers, as well as specialists in mental health, law, and ethics to advance exemplary medical care and disseminate cutting-edge research. These goals will be addressed by a wide array of educational activities.

The CME/CE portion of the Scientific Congress will include plenary lectures, symposia, and interactive sessions interweaving the theme of the annual Congress. Plenary lectures will feature outstanding speakers covering a wide range of topics in reproductive research and clinical medicine including: health policy and access to fertility care; the role of reproductive genetics in clinical medicine; the result of widespread implementation of long-acting contraception; research in epigenetics related to reproduction; the relationship between stress and reproduction; preconceptional treatments of adrenal disorders; hormone therapy for men with infertility; and novel strategies in minimally invasive fetal surgery. The symposia will provide more in-depth coverage of basic and clinical topics. Topics range from emerging biomarkers for endometriosis, stimulation of the polycystic ovary syndrome patient, the influence of diet on male reproduction, nonsurgical management of fibroids, frozen donor banks, regenerative therapies for treating infertility, pitfalls of preimplantation genetic diagnosis, and updates from the Food and Drug Administration and National Institutes of Health on current policies and research initiatives.

Included in the diverse program are “tracks” for fertility preservation, access to care, contraception, and male fertility. The interactive sessions cover a wide range of controversial topics and are meant to be a forum for discussion and interaction, including topics such as how and when to conduct genetic testing of embryos, ethics, and the role of evolving and novel therapies. Supplementing the CME program will be non-CME roundtable luncheons, which will provide participants in-depth discussion with experts in small-group settings, and oral and poster scientific abstract presentations, which will provide investigators the opportunity to present cutting- edge scientific research in reproductive medicine and biology.

The 2016 Scientific Congress should provide ample opportunity for learning, improvement of clinical competence and skills, and potential scientific collaboration.

LEARNING OBJECTIVES ACGME COMPETENCIES

At the conclusion of the Scientific Congress, participants should Interpersonal and Communication Skills be able to: Medical Knowledge 1. Discuss how access to infertility care is limited globally by sociocultural, geographic, financial, technological, and Patient Care emotional factors. Practice-based Learning and Improvement 2. Propose strategies to preserve the future reproductive Professionalism function of female and male patients to allow them maximal reproductive freedom. Systems-based Practice 3. Describe the relevance of genetics and genomics to reproductive care. 4. Apply the latest scientific advances in embryo biology and INTERPROFESSIONAL COMPETENCIES assessment to the optimization of embryo transfer. 5. Summarize current knowledge of endometriosis, fibroids, Values/ethics for Interprofessional Practice menopause, contraception, and polycystic ovary syndrome. Roles/responsibilities for Collaborative Practice 6. Explain the ethical, legal, and psychosocial ramifications of Interprofessional Communication third-party reproduction. 7. Select appropriate treatments for reproductive dysfunctions Interprofessional Teamwork and Team-based Care in females and males at different ages throughout life— childhood, adolescence, adulthood, and reproductive senescence.

nd 72 ASRM Scientific Congress & Expo 52 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

ASRM 2016 CONGRESS SCHEDULE DATE SATURDAY SUNDAY MONDAY TUESDAY WEDNESDAY TIME TIME 15-Oct 16-Oct 17-Oct 18-Oct 19-Oct

0700 0700 Posters Posters

0715 0715 7:00 am - 8:45 am 7:00 am - 8:45 am

0730 0730

0745 0745

0800 0800 Opening Ceremony ASRM Members' Meeting &

0815 Pre-Congress Courses Pre-Congress Courses 0815 8:00 am - 9:00 am Program Prize Presentation

0830 8:15 am - 5:00 pm 8:15 am - 5:00 pm 0830 8:00 am - 8:45 am

0845 0845 Break

0900 0900 Plenary 1: President's Lecture Plenary 4 Plenary 7

0915 0915 9:00 am - 9:45 am 9:00 am - 9:45 am 9:00 am - 9:45 am

0930 0930

0945 0945 Plenary 2: Nezhat Lecture Plenary 5: SRS Lecture Plenary 8: Bruce Stewart AUA Lecture

1000 1000 9:45 am - 10:30 am 9:45 am - 10:30 am 9:45 am - 10:30 am

1015 1015

1030 1030 Break Break Break

1045 1045 10:30 am - 11:15 am 10:30 am - 11:15 am 10:30 am - 11:15 am

1100 1100

1115 1115 Oral Abstracts Oral Abstracts Oral Abstracts

1130 1130 11:15 am - 12:45 pm 11:15 am - 12:45 pm 11:15 am - 12:45 pm

1145 1145 Scientific Congress Prize Papers Scientific Congress Prize Papers

1200 1200 11:15 am - 12:45 pm 11:15 am - 12:45 pm

1215 1215 Telesurgery

1230 1230 11:15 am - 12:45 pm

1245 1245 Break/Lunch Break/Lunch Break/Lunch

1300 1300 1:00 pm - 2:30 pm 1:00 pm - 2:30 pm 1:00 pm - 2:30 pm

1315 1315 Roundtables Roundtables Roundtables

1330 1330 1:00 pm - 2:00 pm 1:00 pm - 2:00 pm 1:00 pm - 2:00 pm

1345 1345 Interactive Sessions Interactive Sessions Interactive Sessions

1400 1400 1:15 pm - 2:15 pm Adamson Lecture 1:15 pm - 2:15 pm

1415 1415 1:15 pm - 2:15 pm

1430 1430 Plenary 3 Plenary 6 Plenary 9: SSR Exchange Lecture

1445 1445 2:30 pm - 3:15 pm 2:30 - 3:15 pm Menopause Keynote Lecture

1500 1500 2:30 pm - 3:15 pm

1515 1515 Break Break Break 3:15 pm - 3:30 pm

1530 1530 3:15 pm - 4:00 pm 3:15 pm - 4:00 pm Symposia

1545 1545 3:30 pm - 5:00 pm

1600 1600 Symposia Symposia

1615 1615 4:00 pm - 5:30 pm 4:00 pm - 5:30 pm

1630 1630

1645 1645

1700 1700

1715 1715 Members Meetings 1730 1730 Members' Meetings Members' Meetings 5:15 pm - 6:00 pm 1745 1745 5:30 pm - 6:15 pm 5:30 pm - 6:15 pm

1800 1800

1815

1830

1845

1900

2000

nd 72 ASRM Scientific Congress & Expo 53 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS 2016 Scientific Congress Daily Schedule Plenary lectures will be simultaneously translated into Spanish and Mandarin Chinese for members of the audience.

Daily Schedule Key to Abbreviations TRACK COLOR INDEX Affiliated Societies Access to Care SART Society for Assisted Reproductive Technology AC SMRU Society for Male Reproduction and Urology SRBT Society of Reproductive Biologists and Technologists AN Andrology SREI Society for Reproductive Endocrinology and Infertility SRS Society of Reproductive Surgeons AR Assisted Reproductive Technology Professional Groups ARM Association of Reproductive Managers Contraception LPG Legal Professional Group CO MHPG Mental Health Professional Group NPG Nurses’ Professional Group

EP Early Pregnancy Special Interest Groups AESIG Androgen Excess Special Interest Group Endometriosis CSIG Contraception Special Interest Group ED CAMSIG Complementary and Special Interest Group ChSIG Chinese Special Interest Group EM Embryology EndoSIG Endometriosis Special Interest Group EPSIG Early Pregnancy Special Interest Group

ERSIG Environment and Reproduction Special Interest Group ET Ethics FPSIG Fertility Preservation Special Interest Group FSIG Fibroids Special Interest Group

GCSIG Genetic Counseling Special Interest Group FP Fertility Preservation HDSIG Health Disparities Special Interest Group IRMSIG Imaging in Reproductive Medicine SIG Fibroids MOISIG Menopause and Ovarian Insufficiency Special Interest Group FI NutriSIG Nutrition Special Interest Group PAGSIG Pediatric and Adolescent Gynecology Special Interest Group GE Genetics PGDSIG Preimplantation Genetic Diagnosis Special Interest Group PSSIG Physician-Scientists’ Special Interest Group

RISIG Reproductive Immunology Special Interest Group ME Menopause RMSCBSIG Regenerative Medicine and Stem Cell Special Interest Group TSIG Turkish Special Interest Group

WC Women’s Council MH Mental Health

Partner Groups Nursing AE-PCOS Society Androgen Excess and Polycystic Ovary Syndrome Society NU ALMER Latin American Association for Reproductive Medicine AMMR Mexican Association of Reproductive Medicine PC Polycystic Ovary Syndrome CSRM Chinese Society of Reproductive Medicine ESHRE European Society of Human Reproduction and Embryology

ISAR Indian Society for Assisted Reproduction PM Practice Management JSAR Japan Society of Assisted Reproduction MEFS Middle East Fertility Society

SSR Society for the Study of Reproduction-AT-A-GLNAGTER RE Reproductive Endocrinology

RS Reproductive Surgery

SC Stem Cells

nd 72 ASRM Scientific Congress & Expo 54 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS 2016 Scientific Congress Daily Schedule Plenary lectures will be simultaneously translated into Spanish and Mandarin Chinese for members of the audience.

GE 9:45 am - 10:30 am MH 11:45 am - 12:45 pm NON- SUNDAY, OCTOBER 16, 2016 Plenary MHPG Clinical Session CME CE ARS Camran Nezhat, M.D. Lectureship How to Design a Good Qualitative 8:00 am – 3:45 pm NON- SREI Members' Retreat CME CEin InnovationsARS in Medicine Lecture: Research Study Maternal Plasma DNA Sequencing Mary P. Riddle, Ph.D. Provides a New Perspective on Fetal, The Pennsylvania State University 1:00 pm – 5:00 pm NON- Poster Set-up CME CEPlacental,ARS and Maternal Health Endowed by a 2011 gift from Camran 1:00 pm - 2:30 pm Nezhat, M.D. Dr. Camran Nezhat 3:00 pm – 5:00 pm NON- Break/Lunch Workshop CME CEpioneeredARS techniques of video-assisted Personal Finance for Physicians endoscopic surgery, which revolutionized 1:00 pm - 2:00 pm NON- CME CE ARS Stuart S. Howards, M.D. modern-day surgery. He along with his Roundtable Discussions University of Virginia brothers, Drs. Farr and Ceana Nezhat,

performed some of the most advanced ET 1:00 pm - 2:30 pm procedures with these techniques for 5:00 pm – 6:00 pm NON- Symposium Members' Meeting CME CEthe firstAR Stime, thus opening the vistas for ABOG Foundation - Kenneth J. Ryan • Nurses' Professional Group endoscopic surgeons all over the world. Ethics Symposium: Germline Editing: Richard J. Paulson, M.D. (Introducer) Perspectives from Science, Ethics, and Law Diana W. Bianchi, M.D. Supported by a 2013 endowment from 5:15 pm – 6:00 pm NON- Members' Meetings CME CETufts ARUniversityS School of Medicine the American Board of Obstetrics and • Mental Health Professional Group Gynecology • Preimplantation Genetic Diagnosis 10:30 am - 11:15 am George Q. Daley, M.D., Ph.D. (Chair) Special Interest Group Break Boston Children's Hospital Henry T. Greely, J.D. Stanford University 6:00 pm - 7:30 pm NON- MH 10:45 am - 11:30 am NON- CME CE ARS Members' Meeting CME CE ARMHPGS Clinical Session Aaron Kheriaty, M.D. • Society of Reproductive Biologists and The Myth of Anonymity: Are We University of California, Irvine Technologists Misleading Our Patients?

Elaine R. Gordon, Ph.D. AC 1:15 pm - 2:15 pm Santa Monica/UCLA Hospital Interactive Session Roving Speaker Format 11:15 am - 12:45 pm NON- Access to Infertility Care in the United MONDAY, OCTOBER 17, 2016 Scientific Congress Prize Paper CME CEStates:AR SThe State of Insurance Coverage Session 1 and Its Impact on Care 7:00 am - 8:00 am NON- Opening Ceremony Continental CME CE ARS Barbara L. Collura, M.A. RESOLVE: The National Infertility Breakfast 11:15 am - 12:45 pm NON- Oral Abstract Sessions CME CEAssociationARS 8:00 am - 9:00 am • Access to Care 1 NON- Opening Ceremony CME CE• ContraceptionARS and Family Planning AN 1:15 pm - 2:15 pmNON- • Male Reproduction and Urology: Interactive SessionCME CE ARS Traveling Scholars Case Presentations Format 8:00 am – 12:00 pm NON- Poster Set-up CME CE• ReproductiveARS Endocrinology: Reversal versus Sperm Research Retrieval 9:00 am - 9:45 am • Reproductive Surgery 1 Peter N. Schlegel, M.D. (Chair) AC Weill Cornell Medicine Plenary • Imaging in Reproductive Medicine President's Guest Lecture: Access to • Preimplantation Genetic Testing 1 Sheldon H. F. Marks, M.D. Care: A House Divided • ART: Clinical 1 International Center for Vasectomy Endowed by a 1987 grant from Ortho • Embryo Biology 1 Reversal Women's Health • Embryo Transfer Bruce R. Gilbert, M.D., Ph.D. Owen K. Davis, M.D. (Introducer) • Environment and Reproduction The Smith Institute for Urology, Hofstra Eli Y. Adashi, M.D., M.S. • Fertility Preservation Northwell School of Medicine The Warren Alpert Medical School, • Polycystic Ovary Syndrome Brown University • Outcome Predictors: ART 1

nd 72 ASRM Scientific Congress & Expo 55 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS 2016 Scientific Congress Daily Schedule Plenary lectures will be simultaneously translated into Spanish and Mandarin Chinese for members of the audience.

EM 1:15 pm - 2:15 pmNON- RE 1:15 pm - 2:15 pm CO 4:00 pm - 5:30 pm Interactive SessionCME CE ARS Interactive Session Symposium Case Presentations Format Debate Contraception Track Symposium: Embryo Disposition: Out of the Freezer Do We Always Need Evidence from Contraception and Human and into the Abyss: What Are We Going to Randomized Controlled Trials in Immunodeficiency Virus (HIV) Do with All These Embryos? Reproductive Medicine? Thomas D. Kimble, M.D. (Chair) Sangita K. Jindal, Ph.D., H.C.L.D. (Chair) Cynthia Farquhar, M.B.Ch.B., M.P.H., M.D., Eastern Virginia Medical School Albert Einstein College of Medicine F.R.A.N.Z.C.O.G. (Chair) Jenell Coleman, M.D., M.P.H. Nidhi Desai, J.D. University of Auckland Johns Hopkins University Ballard, Desai, & Miller Robert A. Wild, M.D., Ph.D., M.P.H. Katharine Simmons, M.D., M.P.H. Judith Kottick, L.C.S.W. Oklahoma University Health Sciences Center Centers for Disease Control and Prevention Reproductive Medicine Associates of New Ben Mol, M.D., Ph.D. Jersey The University of Adelaide AR MH 4:00 pm - 5:30 pm Denny Sakkas, Ph.D. Symposium Boston IVF GE 1:15 pm - 2:15 pmNON- Mental Health Symposium I: Self- Interactive SessionCME CE ARS Kurt T. Barnhart, M.D., M.S.C.E. disclosure, Biases, and Other Clinical Debate University of Pennsylvania Dilemmas in Treating Fertility Patients Should Preimplantation Genetic Testing Supported in part by an educational grant for Aneuploidy Be Performed on Every CO 1:15 pm - 2:15 pm from Cook Medical Patient? Interactive Session Janet Jaffe, Ph.D. (Chair) Supported in part by an educational grant Panel Discussion Center for Reproductive Psychology from Illumina Contraception Track Lauri Pasch, Ph.D. Lawrence C. Layman, M.D. (Chair) Interactive Session: University of California, San Francisco Augusta University Essure®: Uses and Liabilities Aileen Gariepy, M.D., M.P.H. (Chair) Glenn L. Schattman, M.D. NU 4:00 pm - 5:30 pm Yale School of Medicine Weill Cornell Medicine Symposium Diana H. Wu, M.D. Richard T. Scott, Jr., M.D. Nurses’ Symposium I: See One, Do One, Oregon Health & Science University Reproductive Medicine Associates of New Teach One: Is It Really that Simple? Jersey Jeanette Rodriguez Tomasino, M.S., 2:30 pm - 3:15 pm CO R.N.C., M.N.N. (Chair) Plenary Progyny 1:15 pm - 2:15 pmNON- AR CME The Importance of Long-acting Lora Stamper, R.N., M.H.A. Interactive Session CE ARS Reversible Contraception Case Presentations Format Seattle Reproductive Medicine Endowed by a 1990 grant from Astra-Zeneca SART National Report: Where Are We Going? Jamie Leonard, R.N., B.S.N. Jeffrey T. Jensen, M.D., M.P.H. Supported in part by an educational grant Bennett Fertility Institute (Introducer) from Cook Medical Jeffrey F. Peipert, M.D., Ph.D. James P. Toner, M.D., Ph.D. AR PM 4:00 pm - 5:30 pm Indiana University School of Medicine Atlanta Center for Reproductive Medicine Symposium Practice Managers’ Symposium I: The Amy E. T. Sparks, Ph.D., H.C.L.D. University of Iowa and Clinics 3:15 pm - 4:00 pm "ART" of Informed Consent: Using Words Break that Work (Joint Symposium with LPG) Supported in part by an educational grant 1:15 pm - 2:15NON- pm FP RS CME 4:00 pm - 5:30 pmNON- from Cook Medical Interactive SessionCE ARS PC CME CE ARS Brad J. T. Senstra, M.H.A. (Chair) Panel Discussion Symposium Seattle Reproductive Medicine Reproductive Surgery Track Old Tricks and New Ideas for Stimulating Deborah L. Forman, J.D. Interactive Session: Fertility-sparing the Polycystic Ovary Syndrome (PCOS) Whittier Law School Surgical Options in the Management of Patient Lisa A. Rinehart, R.N., B.S.N., J.D. Gynecologic Malignancies Rebecca S. Usadi, M.D. (Chair) LegalCare Consulting, Inc. Mary Ellen Pavone, M.D., M.S.C.I. (Chair) Carolinas Medical Center Northwestern University Peter R. Casson, M.D. Togas Tulandi, M.D., M.H.C.M. Northeastern Reproductive Medicine McGill University G. Wright Bates, Jr., M.D. Farr R. Nezhat, M.D. University of Alabama at Birmingham Weill Cornell Medical College

nd 72 ASRM Scientific Congress & Expo 56 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS 2016 Scientific Congress Daily Schedule Plenary lectures will be simultaneously translated into Spanish and Mandarin Chinese for members of the audience.

AC AR 4:00 pm - 5:30NON- pm RE 4:00 pm - 5:30 pm SymposiumCME CE ARS Symposium TUESDAY, OCTOBER 18, 2016 ALMER Symposium: Cuanto Hemos CSRM Symposium: Hot Topics in Human 5:30 am NON- Avanzado en Acceso en Latinoamérica Reproduction 7th Annual ASRM 5K Run & Walk CME CE ARS y Resto del Mundo Desde las Distintas Jie Qiao, M.D., Ph.D. (Co-chair) Perspectivas Peking University Third Hospital 7:00 am - 8:45 am NON- Presented in Spanish Zi-Jiang Chen, M.D. (Co-chair) Members' Meeting CME CE ARS Supported in part by an educational grant Center for Reproductive Medicine, • Women’s Council Breakfast from Cook Medical Shandong University Sergio Papier, M.D. (Chair) Yun Sun, M.D., Ph.D. 7:00 am - 8:45 am President, ALMER Shanghai Jiao Tong University Poster Abstract Session and NON- Marcelo J. Barrionuevo, M.D., F.A.C.O.G. Yunxia Cao, M.D., Ph.D. Continental Breakfast CME CE ARS IVF Florida Reproductive Associates Anhui Medical University Miguel Angel Checa, M.D., Ph.D. RE 9:00 am - 9:45 am Hospital del Mar 4:00 pm - 5:30 pm NON- Plenary CME CE ARS Marcos Horton, M.D. Video Session 1 Ovarian Function Entrains Pregna Medicina Reproductiva Cardiovascular Health over the Life 5:30 pm - 6:15 pm NON- Course: From Monkeys to Women CME CE ARS AR 4:00 pm - 5:30 pm Members' Meetings Endowed by a 1992 grant from Wyeth Symposium • Access to Care Group Clarisa R. Gracia, M.D., M.S.C.E. Overview of Food and Drug • Chinese Special Interest Group (Introducer) Administration (FDA) Regulations of • Complementary and Alternative Jay Ross Kaplan, M.D. Products Used to Treat Reproductive Medicine Special Interest Group Wake Forest School of Medicine Conditions in Women • Environment and Reproduction Supported in part by an educational grant Special Interest Group RS 9:45 am - 10:30 am from Cook Medical • Health Disparities Special Interest Plenary Yun-shang Piao, Ph.D., R.A.C. (Chair) Group SRS Lecture: Fetoscopic Surgery for Center for Devices and Radiological • Indian Group Congenital Birth Defects: From Bench to Health, Food and Drug Administration • Legal Professional Group Bedside Rhonda M. Hearns-Stewart, M.D. • Menopause and Ovarian Endowed by a 1990 grant from Ethicon Center for Drug Evaluation and Research, Insufficiency Special Interest Group Endo-Surgery, Inc. Food and Drug Administration • Nutrition Special Interest Group Peter Chan, M.D. (Introducer) Shelley R. Slaughter, M.D., Ph.D. • Physician-Scientists' Special Interest Jan Deprest, M.D., Ph.D., F.R.C.O.G. Center for Drug Evaluation and Research, Group University of Leuven Food and Drug Administration • Regenerative Medicine and Stem Cell Richard D. McFarland, M.D., Ph.D. Biology Special Interest Group 10:30 am - 11:15 am Center for Biologics Evaluation and • Reproductive Immunology Special Break Research, Food and Drug Administration Interest Group Monica Garcia, Ph.D. • Turkish Special Interest Group Center for Devices and Radiological Health, Food and Drug Administration 5:30 pm - 7:00 pm NON- Michael T. Bailey, Ph.D. Members' Meeting CME CE ARS Center for Devices and Radiological • Society for Assisted Reproductive Health, Food and Drug Administration Technology

6:15 pm - 7:00 pm NON- Members' Meeting CME CE ARS • Fertility Preservation Special Interest Group

6:15 pm - 8:00 pm NON- Members' Meeting CME CE ARS • Society of Reproductive Surgeons

nd 72 ASRM Scientific Congress & Expo 57 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS 2016 Scientific Congress Daily Schedule Plenary lectures will be simultaneously translated into Spanish and Mandarin Chinese for members of the audience.

RS 11:15 am - 12:45 pm RS FI 1:00 pm - 2:30 pm FP RE 1:15 pm - 2:15NON- pm Telesurgery Surgical Tutorial Interactive CMESessionCE ARS Reproductive Surgery Track Telesurgery: Reproductive Surgery Track Pediatric and Adolescent Gynecology: Hysteroscopic Leiomyoma Resection Surgical Tutorial: Tissue Removal: Preserving Future Reproductive Function Techniques Using the Resectoscope and Fibroids, Cysts, and Other Masses (Joint Session with the North American Morcellator Supported in part by an educational grant Society for Pediatric and Adolescent Steven R. Lindheim, M.D., M.M.M. from AbbVie Gynecology) (Surgeon) Ceana H. Nezhat, M.D. (Chair) Beth W. Rackow, M.D. (Chair) Wright State University Boonshoft School Nezhat Medical Center Columbia University Medical Center of Medicine Charles E. Miller, M.D., F.A.C.O.G. Staci E. Pollack, M.D., M.S. Samantha Simpson, M.D. Advocate Lutheran General Hospital Albert Einstein College of Medicine Wright State University Boonshoft School Antonio R. Gargiulo, M.D. Leslie A. Appiah, M.D. of Medicine Harvard Medical School University of Kentucky College of Medicine Bala Bhagavath, M.D.

University of Rochester Medical Center AC AR 1:15 pm - 2:15 pm AR EM 1:15 pm - 2:15NON- pm Keith B. Isaacson, M.D. Interactive Session Interactive CMESessionCE ARS Harvard Medical School Roving Speaker Format Roving Speaker Format Steven F. Palter, M.D. Access to Care: Sociocultural Factors Before Things Go Wrong: Minimizing Gold Coast IVF Supported in part by an educational grant Drama in the Embryology Laboratory from Cook Medical Supported in part by an educational grant 11:15 am - 12:45 pm Ann V. Bell, Ph.D. (Chair) from Cook Medical Scientific Congress Prize Paper NON- University of Delaware Klaus E. Wiemer, Ph.D., H.C.L.D., A.C.E. Session 2 CME CEArthurAR L.S Greil, Ph.D. (Chair) Alfred University Poma Fertility 11:15 am - 12:45 pm NON- Dawn A. Kelk, Ph.D., H.C.L.D. CME CE ARS Oral Abstract Sessions AN RS 1:15 pm - 2:15 pm Yale Fertility Center • Access to Care 2 Interactive Session

• Reproductive Surgery 2 Debate PC 1:15 pm - 2:15 pmNON- • Male Reproduction and Urology: Reproductive Surgery Track Interactive SessionCME CE ARS Clinical 1 Interactive Session: Surgical Sterilization: Case Presentations Format • Reproductive Endocrinology: Clinical 1 Vasal versus Tubal Occlusion Do We Need to Diagnose Polycystic Ovary • Reproductive and Stem Cell Biology Stanton Honig, M.D. Syndrome (PCOS) in Adolescents? • ART: Clinical 2 Yale Urology Lubna Pal, M.B.B.S., M.Sc., F.R.C.O.G., • Oocyte Biology Jeffrey T. Jensen, M.D., M.P.H. F.A.C.O.G. (Chair) • Ovarian Stimulation Oregon Health & Science University Yale School of Medicine • Preimplantation Genetic Testing 2 Marla Lujan, Ph.D.

• Mental Health FP 1:15 pm - 2:15 pm Cornell University • Male Factor Interactive Session Tania S. Burgert, M.D. • Ovarian Reserve Reproductive Health Needs in Cancer Children’s Mercy Hospital • Outcome Predictors: ART 2 Survivors: Fertility, Contraception, and

and Frozen Preconception Counseling RE 1:15 pm - 2:15 pmNON- Embryo Transfer Irene Su, M.D., M.S.C.E. (Chair) Interactive SessionCME CE ARS University of California, San Diego Debate 1:00 pm - 2:30 pm Amy Jordan, M.S., L.C.G.C. Optimizing Endometrial Receptivity Break/Lunch Reprogenetics Bruce Lessey, M.D., Ph.D. (Chair) James F. Smith, M.D., M.S. Greenville Health System – USC School of 1:00 pm - 2:00 pm NON- University of California, San Francisco Medicine Roundtable Discussions CME CE ARS Carlos Simón, M.D., Ph.D. Valencia University Steven L. Young, M.D., Ph.D. University of North Carolina School of Medicine

nd 72 ASRM Scientific Congress & Expo 58 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS 2016 Scientific Congress Daily Schedule Plenary lectures will be simultaneously translated into Spanish and Mandarin Chinese for members of the audience.

AR 1:15 pm - 2:15 pm SC 4:00 pm - 5:30 pm AR NU 4:00 pm - 5:30 pm Lecture Symposium Symposium David and Rosemary Adamson Lecture on KY Cha Symposium in Stem Cell Nurses' Symposium II: Ice, Ice Fertility Excellence in Reproductive Medicine: CDC Technology and Reproductive Medicine: Babies Zika Update: What Do We Know? Regenerative Therapies for Treating Supported in part by an educational grant Endowed by Advanced Reproductive Care, Infertility from Cook Medical Inc. Supported by the Asia-Pacific Biomedical Maria M. Jackson, M.A., R.N. (Chair) Rebecca Z. Sokol, M.D., M.P.H. Research Foundation IRMS at Saint Barnabas (Introducer) Kyle Orwig, Ph.D. (Chair) Aimee Eyvazzadeh, M.D., M.P.H. Denise J. Jamieson, M.D., M.P.H. (Chair) University of Pittsburgh Private Practice Centers for Disease Control and Prevention Takehiko Ogawa, M.D., Ph.D. Zsolt Peter Nagy, M.D., Ph.D., H.C.L.D. Yokohama City University Association of Reproductive Biology Associates

RE 2:30 pm - 3:15 pm Medical Science

Plenary Teresa K. Woodruff, Ph.D. AR PM 4:00 pm - 5:30NON- pm Herbert H. Thomas Lecture: An Update Northwestern University SymposiumCME CE ARS on Congenital Adrenal Hyperplasia Practice Managers' Symposium II: Revenue

Endowed by a 1990 grant from TAP AR GE 4:00 pm - 5:30 pm Cycle Management - Global Pricing Pharmaceuticals Symposium Supported in part by an educational grant Richard H. Reindollar, M.D. (Introducer) Mosaicism in Preimplantation Genetic from Cook Medical Maria I. New, M.D. Testing and Its Relationship to Cell Division Lisa Duran, B.S. (Chair) Icahn School of Medicine at Mount Sinai Kinetics and Developmental Potential Reconceived Supported in part by educational grants Lawrence Jay Friedman 3:15 pm - 4:00 pm from Cook Medical and Illumina IntegraMed Break Dieter Egli, Ph.D. (Chair) Sheldon B. Josephs, F.A.C.H.E. Columbia University Reproductive Science Center of the San

ED 4:00 pm - 5:30 pmNON- Nathan Treff, Ph.D. Francisco Bay Area Symposium CME CE ARS Reproductive Medicine Associates of

Biomarkers and Emerging Diagnostics of New Jersey AR 4:00 pm - 5:30 pm Endometriosis Renee A. Reijo Pera, Ph.D. Symposium Supported in part by an educational grant Montana State University MEFS Symposium: Are We Transferring from AbbVie Too Many Embryos?

Serdar E. Bulun, M.D. (Chair) AR MH 4:00 pm - 5:30 pm Supported in part by an educational grant Northwestern University Symposium from Cook Medical Linda C. Giudice, M.D., Ph.D., M.Sc. Mental Health Symposium II: The Suheil J. Muasher, M.D. (Chair) University of California, San Francisco Whole Is More than the Sum of Its Parts: Duke University Hugh S. Taylor, M.D. Professionally Coordinating the Medical, Dmitry Kissin, M.D., M.P.H. Yale University School of Medicine Psychological, and Legal Logistics of the Centers for Disease Control and Assessment of All Gestational Carrier Prevention (CDC)

EP 4:00 pm - 5:30 pm Participants Bradley J. Van Voorhis, M.D. Symposium Supported in part by an educational grant University of Iowa Hospitals and Clinics Developmental Origins of Health and from Cook Medical Disease: Contributions from Mom, Dad, Tara H. Simpson, Psy.D. (Chair) and Placenta Shady Grove Fertility Center David Weinberg, Ph.D. (Chair) Pasquale Patrizio, M.D., M.B.E. Eunice Kennedy Shriver National Institute of Yale University School of Medicine Child Health and Human Development, NIH Melissa B. Brisman, J.D. Leslie Myatt, Ph.D., F.R.C.O.G. Melissa B. Brisman, Esq., LLC Oregon Health & Science University Marisa S. Bartolomei, Ph.D. University of Pennsylvania Perelman School of Medicine Stephen A. Krawetz, Ph.D. Wayne State University School of Medicine

nd 72 ASRM Scientific Congress & Expo 59 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS 2016 Scientific Congress Daily Schedule Plenary lectures will be simulaneously translated into Spanish and Mandarin Chinese for members of the audience.

• Genetic Counseling ED FI PC 4:00 pmNON- - 5:30 pm SymposiumCME CE ARS WEDNESDAY, OCTOBER 19, 2016 • ART: Clinical 3 ISAR Symposium: Managing the • Clinical Reproductive Laboratory "Big Three" in Infertility (Fibroids, 7:00 am - 8:45 am • Endometriosis Endometriosis, and Polycystic Ovary Poster Abstract Session & NON- • Fibroids CME CE ARS Syndrome) Continental Breakfast • Health Disparities Supported in part by an educational grant • Obesity and Metabolism from AbbVie 8:00 am - 8:45 am • Early Pregnancy Narendra Malhotra, M.D., F.I.C.O.G., ASRM Members' Meeting & NON- • Embryo Biology 2 CME CE ARS F.I.C.S., F.R.C.O.G. (Chair) Congress Prize Presentation • Late-breaking Abstracts President, ISAR 9:00 am - 9:45 am GE Prakash H. Trivedi, M.D., D.G.O., F.C.P.S., Plenary MH 11:45 am - 12:45 pm NON- CME CE ARS D.N.B. Why Parents Matter (Epigenetically): MHPG Clinical Session Total Healthcare Private, Ltd. Genomic Imprinting in Health and Disease Ethics in Known Gamete Donation Firuza R. Parikh, M.D., D.G.O., D.F.P., Endowed by a 1992 grant from EMD Claudia Pascale, Ph.D. F.C.P.S., DIP.N.B.E. Serono, Inc. Institute for Reproductive Medicine and Jaslok Hospital & Research Center Christos Coutifaris, M.D. (Introducer) Sciences at Saint Barnabas Marisa S. Bartolomei, Ph.D. Erica J. Mindes, Ph.D. 4:00 pm - 5:30 pm NON- University of Pennsylvania Perelman Covington & Hafkin and Associates CME CE ARS Video Session 2 School of Medicine 1:00 pm - 2:30 pm 5:30 pm - 6:15 pm NON- 9:45 am - 10:30 am Break/Lunch CME CEAN ARS Members' Meetings Plenary • Contraception Special Interest AUA Bruce Stewart Memorial Lecture: 1:00 pm - 2:00 pm Group NON- The Futures of (Male(Reproductive)) Roundtable Discussions CME CE ARS • Early Pregnancy Special Interest Medicine Group Supported by a grant from the American 1:15 pm - 2:15 pm • Endometriosis Special Interest AC AR Urological Association Interactive Session Group Douglas T. Carrell, Ph.D., H.C.L.D. Roving Speaker Format • Fibroids Special Interest Group (Introducer) Access to Care: Modifying Assisted • Genetic Counseling Special Interest Craig Niederberger, M.D., F.A.C.S. Reproductive Technology Techniques Group University of Illinois at Chicago Supported in part by an educational grant • Imaging in Reproductive Medicine from Cook Medical Special Interest Group 10:30 am - 11:15 am Kevin J. Doody, M.D., H.C.L.D. (Chair) • Lesbian, Gay, Bisexual, Transgender, Break Center for Assisted Reproduction and Questioning (LGBTQ) Group • Pediatric and Adolescent Gynecology MH 10:30 am - 11:30 am NON- 1:15 pm - 2:15 pmNON- Special Interest Group CME CEAN ARS CME MHPG Clinical Session Interactive Session CE ARS • Society for Male Reproductive and Cultural Considerations in the Psychological Letterman Format Urology Testing of Third-party Participants How to Counsel Men with Male Factor • Society for Reproductive Linda D. Applegarth, Ed.D. Infertility Endocrinology and Infertility Weill Medical College of Cornell University Jay Sandlow, M.D. (Chair) Ariadna Cymet Lanski, Psy.D. Medical College of Wisconsin 6:15 pm - 7:00 pm NON- Fertility Centers of Illinois CME CE ARS Ajay K. Nangia, M.B.B.S. Members' Meeting University of Kansas Medical Center • Association of Reproductive 11:15 am - 12:45 pm NON- William D. Petok, Ph.D. CME ARS Managers Oral Abstract Sessions CEThomas Jefferson University • Access to Care 3 • ASRM Research Grant Presentations • Male Reproduction and Urology: Clinical 2 • Reproductive Endocrinology: Clinical 2 • Reproductive Biology

nd 72 ASRM Scientific Congress & Expo 60 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS 2016 Scientific Congress Daily Schedule Plenary lectures will be simulaneously translated into Spanish and Mandarin Chinese for members of the audience.

EP 1:15 pm - 2:15 pmNON- ED RS 1:15 pm - 2:15NON- pm FI RE 3:30 pm - 5:00NON- pm Interactive SessionCME CE ARS Interactive CMESessionCE ARS SymposiumCME CE ARS Panel Discussion Case Presentations State-of-the-Art Nonsurgical Should We Be Screening and Treating Reproductive Surgery Track Interactive Management of Fibroids Chronic Endometritis for Recurrent Session: Controversies in the Supported in part by an educational grant Pregnancy Loss and Failed In Vitro Management of Advanced Endometriosis from AbbVie Fertilization? and Endometrioma William H. Catherino, M.D., Ph.D. (Chair) Thomas M. Price, M.D. (Chair) Supported in part by an educational grant Uniformed Services University of the Duke University from AbbVie Health Sciences Humberto Scoccia, M.D. Mark W. Surrey, M.D. (Chair) James B. Spies, M.D., M.P.H. University of Illinois College of Medicine at Southern California Reproductive Center MedStar Georgetown University Hospital Chicago Tommaso Falcone, M.D. Jacques G. Donnez, M.D. Cleveland Clinic Société de Recherche pour l'Infertilité,

GE AR 1:15 pm - 2:15NON- pm Grace M. Janik, M.D. Brussels Interactive CMESessionCE ARS Reproductive Specialty Center

Case Presentations AR 3:30 pm - 5:00 pmNON- CME CE ARS Managing the Gray Results with ME 1:15 pm - 2:15 pm Symposium Preimplantation Genetic Testing: What Interactive Session Howard and Georgeanna Jones Do We Tell Patients When the Results Are Meet the Professor Endowed Symposium on Advanced Not Black or White? Menopause Track Interactive Session: Reproductive Technology: Fresh versus Supported in part by educational grants Hormone Therapy in Postmenopausal Frozen Donor from Cook Medical and Illumina Women: Update on Clinical Trials Endowed by a 2010 educational grant Lauri Black, M.S., L.C.G.C. (Chair) Nanette F. Santoro, M.D. (Chair) from EMD Serono, Inc. Pacific Reproductive Genetic Counseling University of Colorado School of Medicine Frank L. Barnes, Ph.D., H.C.L.D., C.C. Emily Mounts, M.S., C.G.C. (Chair)

Oregon Reproductive Medicine RE 2:30 pm - 3:15 pm IVF Labs, L.L.C. Alyssa C. Snider, Ph.D., M.S., L.C.G.C. Plenary Ana Cobo Cabal, Ph.D. IviGen SSR Exchange Lecture: Plasticity and IVI Valencia Placental Health Jamie A. Grifo, M.D., Ph.D.

CO 1:15 pm - 2:15 pm William E. Roudebush, Ph.D., H.C.L.D. NYU Langone Medical Center Ryan Fellows Showcase (Introducer) Masashige Kuwayama, Ph.D. Contraception Track Ryan Fellows Michael J. Soares, Ph.D. Repro-Support Medical Research Centre Showcase: Emerging Research in University of Kansas Medical Center

Contraception (in Cooperation with the MH 3:30 pm - 5:00 pm

Society of Family Planning) ME 2:30 pm - 3:15 pm Symposium Lisa Haddad, M.D., M.S., M.P.H. (Chair) Keynote Mental Health Symposium III: Challenges Emory University School of Medicine Menopause Track Keynote Lecture: and Controversies in Treating Lesbian, Melissa J. Chen, M.D., M.P.H. Postmenopausal Sexuality: Not an Gay, Bisexual, Transgender, and University of California, Davis Oxymoron Questioning Patients Shandhini Raidoo, M.D. Julia V. Johnson, M.D. (Introducer) Angela K. Lawson, Ph.D. University of Hawaii Sheryl A. Kingsberg, Ph.D. Northwestern University Ivana Thompson, M.D., M.S.C.I. University Hospitals Case Medical Center Sarah Holley, Ph.D. Vanderbilt University School of Medicine San Francisco State University Christy M. Boraas, M.D., M.P.H. 3:15 pm - 3:30 pm Colleen M. Quinn, J.D. University of Minnesota Break President, American Academies of Holly Bullock, M.D., M.P.H. Adoption Attorneys and Assisted University of Utah Reproductive Technology Attorneys Megan Lawley, M.D. Emory University

nd 72 ASRM Scientific Congress & Expo 61 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS 2016 Scientific Congress Daily Schedule Plenary lectures will be simulaneously translated into Spanish and Mandarin Chinese for members of the audience.

NU 3:30 pm - 5:00 pm AC AR 3:30 pm - 5:00 pm ME 3:30 pm - 5:00 pm Symposium Symposium Symposium Nurses' Symposium III: Healthy Women, AMMR Symposium: Diferencias Menopause Track Symposium: The Healthy Babies: Maximizing Overall Geográficas de Acceso a los Tratamientos Declining Oocyte Pool: Is It Simply Health to Improve Fertility Outcomes de Reprodución Asistida en América a Preprogramed Event or Does the Anne Judge, R.N. Presented in Spanish Environment Have a Significant Seattle Reproductive Medicine Supported in part by an educational grant Influence? Judy B. Simon, M.S., R.D.N., C.D., C.H.E.S. from Cook Medical Julia V. Johnson, M.D. (Chair) Mind Body Nutrition, PLLC Emilio Valerio, M.D. (Chair) University of Massachusetts Medical School Alice D. Domar, Ph.D. President, AMMR Amber R. Cooper, M.D. Domar Center/Boston IVF Sergio Papier, M.D. Centers for Reproductive Medicine and Center of Studies in Genetics and Wellness

PM 3:30 pm - 5:00 pm Gynecology Karl R. Hansen, M.D., Ph.D. Symposium J. Ricardo Loret de Mola, M.D., F.A.C.S., University of Oklahoma College of Medicine Practice Managers' Symposium III: F.A.C.O.G. Management Techniques Using Lean Southern Illinois University Principles Alberto Kably Ambe, M.D. Colin D. Thomas, M.H.A. (Chair) Centro Mexicano de Fertilidad Columbia University Center for Women’s

Reproductive Care EP 3:30 pm - 5:00 pmNON- Steve Hunsaker, B.S., S.P.H.S.C., V.E. Symposium CME CE ARS University of Utah JSAR Symposium: Implantation Disorder: Luca Boi, M.H.A. What Are the Japanese Strategies? University Health Care Yoshiharu Morimoto, M.D., Ph.D. HORAC Grand Front Osaka Clinic

FP SC 3:30 pm - 5:00 pm Hidetaka Okada, M.D., Ph.D. Symposium Kansai Medical University ESHRE Symposium: Stem Cell–based Masahide Shiotani, M.D., Ph.D. Strategies and Future Challenges for Hanabusa Women’s Clinic Fertility Preservation in Boys Aisaku Fukuda, M.D., Ph.D., H.C.L.D. Stefan Schlatt, Ph.D. (A.B.B.) University Münster, Germany IVF Osaka Clinic Kirsi Jahnukainen, M.D., Ph.D.

Children's Hospital, Helsinki University AN 3:30 pm - 5:00 pmNON- Central Hospital, Helsinki, Finland Symposium CME CE ARS You Are What Your Father Ate: Does Paternal Diet Matter for Fertility? Alex J. Polotsky, M.D., M.S. University of Colorado, Denver Jorge E. Chavarro, M.D., Sc.D. Harvard T. H. Chan School of Public Health Hassan W. Bakos, Ph.D. Monash IVF Group

nd 72 ASRM Scientific Congress & Expo 62 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

Advancing Science and Practice to Improve Access in Reproductive Care 2016 NICHD-ASRM WORKSHOP

The Eunice Kennedy Shriver National Institute of Child Health and Human Development and The American Society for Reproductive Medicine

Needs Assessment and Description Designation Statement It is estimated that only 24% of infertile couples in the United The American Society for Reproductive Medicine designates this States have access to all of the care they would need to have live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. a live-born baby. Access to care is limited by sociocultural, Physicians should claim only the credit commensurate with the geographic, financial, technological, and emotional factors. extent of their participation in the activity. Individuals face a number of challenges when considering reproductive health pathways. Practitioners of reproductive medicine must strive to broaden access by modifying assisted reproductive technology (ART) practices to lower the cost of SCHEDULE care. Improvements in ART could be facilitated by focused Wednesday, October 19, 2016 discussions of advances in the science, technology, and clinical 6:00 pm Registration & Box Dinner practice of reproductive medicine. The goal of this live workshop for physicians, scientists, and allied health professionals in the 6:30 pm Keynote Lecture: Access to Care (Eli Adashi) fields of reproductive medicine and biology is to promote such 7:00 pm – 9:00 pm Session 1 – Advancing Science (Marisa discussions in order to identify promising areas of future research. Bartolomei, Takehiko Ogawa, Renee Reijo Pera) Learning Objectives Thursday, October 20, 2016 At the conclusion of this workshop, participants should be able to: 6:30 am Registration & Breakfast 1. Propose research strategies to develop procedures for the production of male and female gametes in vitro. 7:00 am – 9:00 am Session 2 – Advancing Technology 2. Summarize the current state of knowledge of technologies (Catherine Racowsky, Sue Hammoud, for optimizing gamete and embryo development. Aaron Hsueh) 3. Discuss innovations in the clinical application of assisted 9:00 am Coffee Break reproductive technologies. 9:20 am – 11:20 am Session 3 – Advancing Clinical Practice (Steve Young, Robert Taylor, Anne Steiner, ACGME Competency Karine Chung, Kevin Doody, Denny Sakkas, Patient Care Kurt Barnhart) Systems-based Practice 11:20 am Refreshment Break 11:40 am Summary and Next Steps (Christos Coutifaris) Continuing Medical Education The Accreditation Council for Continuing Medical Education 12:00 pm Adjourn (ACCME) This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Register for the Workshop at www.asrmcongress.org. It is not Accreditation Council for Continuing Medical Education necessary to register for the ASRM Scientific Congress & Expo in (ACCME) through the joint providership of the American order to register for the Workshop. Cost is $160 per person. Society for Reproductive Medicine (ASRM) and the Eunice Food and beverage provided by ASRM and not supported by NICHD. Kennedy Shriver National Institute of Child Health and Human Breaks and meals are non-CME. Development. The ASRM is accredited by the ACCME to provide continuing medical education for physicians.

nd 72 ASRM Scientific Congress & Expo 63 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

SCIENTIFIC PROGRAM DAILY SCHEDULE BY TRACK MONDAY, OCTOBER 17, 2016

9:00 am - 9:45 am Plenary President's Guest Lecture: Access to Care: A House Divided 1:15 pm - 2:15 pm Interactive Session Access to and Underwriting of Infertility Care in the United States: Public and Private Policies AC 4:00 pm - 5:30 pm Symposium ALMER Symposium: Cuanto Hemos Avanzado en Acceso en Latinoamérica y Resto del Mundo Desde las Distintas Perspectivas

AN 1:15 pm - 2:15 pm Interactive Session versus Sperm Retrieval

1:15 pm - 2:15 pm Interactive Session SART National Report: Where Are We Going? 4:00 pm - 5:30 pm Symposium Mental Health Symposium I: Self-disclosure, Biases, and Other Clinical Dilemmas in Treating Fertility Patients 4:00 pm - 5:30 pm Symposium Practice Managers’ Symposium I: The "ART" of Informed Consent: Using Words that AR Work (Joint Symposium with LPG) 4:00 pm - 5:30 pm Symposium ALMER Symposium: Cuanto Hemos Avanzado en Acceso en Latinoamérica y Resto del Mundo Desde las Distintas Perspectivas 4:00 pm - 5:30 pm Symposium Overview of Food and Drug Administration (FDA) Regulations of Products Used to Treat Reproductive Conditions in Women

1:15 pm - 2:15 pm Interactive Session Essure®: Uses and Liabilities CO 2:30 pm - 3:15 pm Plenary The Importance of Long-acting Reversible Contraception 4:00 pm - 5:30 pm Symposium Contraception and Human Immunodeficiency Virus (HIV)

1:15 pm - 2:15 pm Interactive Session Embryo Disposition: Out of the Freezer and into the Abyss: What Are We Going to Do EM with All These Embryos?

1:00 pm - 2:30 pm Symposium ABOG Foundation - Kenneth J. Ryan Ethics Symposium: Germline Editing: Perspectives ET from Science, Ethics, and Law

FP 1:15 pm - 2:15 pm Interactive Session Fertility-sparing Surgical Options in the Management of Gynecologic Malignancies

9:45 am - 10:30 am Plenary Camran Nezhat, M.D. Lectureship in Innovations in Medicine Lecture: Maternal Plasma GE DNA Sequencing Provides a New Perspective on Fetal, Placental, and Maternal Health 1:15 pm - 2:15 pm Interactive Session Should Preimplantation Genetic Testing for Aneuploidy Be Performed on Every Patient?

10:30 am - 11:30 am Clinical Session The Myth of Anonymity: Are We Misleading Our Patients? 11:45 am - 12:45 pm Clinical Session How to Design a Good Qualitative Research Study MH 4:00 pm - 5:30 pm Symposium Mental Health Symposium I: Self-disclosure, Biases, and Other Clinical Dilemmas in Treating Fertility Patients

NU 4:00 pm - 5:30 pm Symposium Nurses’ Symposium I: See One, Do One, Teach One: Is It Really that Simple?

4:00 pm - 5:30 pm Symposium Practice Managers’ Symposium I: The “ART” of Informed Consent: Using Words that PC Work (Joint Symposium with LPG)

Practice Managers’ Symposium I: The “ART” of Informed Consent: Using Words that PM 4:00 pm - 5:30 pm Symposium Work (Joint Symposium with LPG) 1:15 pm - 2:15 pm Interactive Session Access to and Underwriting of Infertility Care in the United States: Public and Private Policies RE 1:15 pm - 2:15 pm Interactive Session Do We Always Need Evidence from Randomized Controlled Trials in Reproductive Medicine? 4:00 pm - 5:30 pm Symposium CSRM Symposium: Hot Topics in Human Reproduction

RS 1:15 pm - 2:15 pm Interactive Session Fertility-sparing Surgical Options in the Management of Gynecologic Malignancies ASRM 2O16 SCIENTIFIC CONGRESS

SCIENTIFIC PROGRAM DAILY SCHEDULE BY TRACK TUESDAY, OCTOBER 18, 2016

AC 1:15 pm - 2:15 pm Interactive Session Access to Care: Sociocultural Factors

AN 1:15 pm - 2:15 pm Interactive Session Surgical Sterilization: Vasal versus Tubal Occlusion

1:15 pm - 2:15 pm Interactive Session Access to Care: Sociocultural Factors 1:15 pm - 2:15 pm Interactive Session Before Things Go Wrong: Minimizing Drama in the Embryology Laboratory 1:15 pm - 2:15 pm Lecture David and Rosemary Adamson Lecture on Excellence in Reproductive Medicine: CDC Zika Update: What Do We Know? 4:00 pm - 5:30 pm Symposium Mosaicism in Preimplantation Genetic Testing and Its Relationship to Cell Division AR Kinetics and Developmental Potential 4:00 pm - 5:30 pm Symposium The Whole Is More than the Sum of Its Parts: Professionally Coordinating the Medical, Psychological, and Legal Logistics of the Assessment of All Gestational Carrier Participants 4:00 pm - 5:30 pm Symposium Nurses' Symposium II: Ice, Ice Fertility Babies 4:00 pm - 5:30 pm Symposium Practice Managers' Symposium II: Revenue Cycle Management - Global Pricing 4:00 pm - 5:30 pm Symposium MEFS Symposium: Are We Transferring Too Many Embryos?

4:00 pm - 5:30 pm Symposium Biomarkers and Emerging Diagnostics of Endometriosis ED 4:00 pm - 5:30 pm Symposium ISAR Symposium: Managing the “Big Three” in Infertility (Fibroids, Endometriosis, and Polycystic Ovary Syndrome)

EM 1:15 pm - 2:15 pm Interactive Session Before Things Go Wrong: Minimizing Drama in the Embryology Laboratory

EP 4:00 pm - 5:30 pm Symposium Developmental Origins of Health and Disease: Contributions from Mom, Dad, and Placenta

1:15 pm - 2:15 pm Interactive Session Reproductive Health Needs in Cancer Survivors: Fertility, Contraception, Preconception Counseling FP 1:15 pm - 2:15 pm Interactive Session Pediatric and Adolescent Gynecology: Preserving Future Reproductive Function (Joint Session with the North American Society for Pediatric and Adolescent Gynecology)

1:00 pm - 2:30 pm Surgical Tutorial Tissue Removal: Fibroids, Cysts, and Other Masses FI 4:00 pm - 5:30 pm Symposium ISAR Symposium: Managing the “Big Three” in Infertility (Fibroids, Endometriosis, and Polycystic Ovary Syndrome)

4:00 pm - 5:30 pm Symposium Mosaicism in Preimplantation Genetic Testing and Its Relationship to Cell Division GE Kinetics and Developmental Potential

4:00 pm - 5:30 pm Symposium Mental Health Symposium II: The Whole Is More than the Sum of Its Parts: Professionally MH Coordinating the Medical, Psychological, and Legal Logistics of the Assessment of All Gestational Carrier Participants

NU 4:00 pm - 5:30 pm Symposium Nurses’ Symposium II: Ice, Ice Fertility Babies

PC 1:15 pm - 2:15 pm Interactive Session Do We Need to Diagnose Polycystic Ovary Syndrome (PCOS) in Adolescents?

PM 4:00 pm - 5:30 pm Symposium Practice Managers’ Symposium II: Revenue Cycle Management - Global Pricing

9:00 am - 9:45 am Plenary Ovarian Function Entrains Cardiovascular Health over the Life Course: From Monkeys to Women 1:15 pm - 2:15 pm Interactive Session Pediatric and Adolescent Gynecology: Preserving Future Reproductive Function RE (Joint Session with the North American Society for Pediatric and Adolescent Gynecology) 1:15 pm - 2:15 pm Interactive Session Optimizing Endometrial Receptivity 2:30 pm - 3:15 pm Plenary Herbert H. Thomas Lecture: An Update on Congenital Adrenal Hyperplasia

9:45 am - 10:30 am Plenary SRS Lecture: Fetoscopic Surgery for Congenital Birth Defects: From Bench to Bedside 11:15 am - 12:45 pm Telesurgery Hysteroscopic Leiomyoma Resection Techniques Using the Resectoscope and Morcellator RS 1:00 pm - 2:30 pm Surgical Tutorial Tissue Removal: Fibroids, Cysts, and Other Masses 1:15 pm - 2:15 pm Interactive Session Surgical Sterilization: Vasal versus Tubal Occlusion

4:00 pm - 5:30 pm Symposium KY Cha Symposium in Stem Cell Technology and Reproductive Medicine: Regenerative SC Therapies for Treating Infertility ASRM 2O16 SCIENTIFIC CONGRESS

SCIENTIFIC PROGRAM DAILY SCHEDULE BY TRACK WEDNESDAY, OCTOBER 19, 2016

1:15 pm - 2:15 pm Interactive Session Access to Care: Modifying Assisted Reproductive Technology Techniques AC 3:30 pm - 5:00 pm Symposium AMMR Symposium: Diferencias Geográficas de Acceso a los Tratamientos de Reprodución Asistida en América

9:45 am - 10:30 am Plenary AUA Bruce Stewart Memorial Lecture: The Futures of (Male(Reproductive)) Medicine AN 1:15 pm - 2:15 pm Interactive Session How to Counsel Men with Male Factor Infertility 3:30 pm - 5:00 pm Symposium You Are What Your Father Ate: Does Paternal Diet Matter for Fertility?

1:15 pm - 2:15 pm Interactive Session Access to Care: Modifying Assisted Reproductive Technology Techniques 1:15 pm - 2:15 pm Interactive Session Managing the Gray Results with Preimplantation Genetic Testing: What Do We Tell Patients When the Results Are Not Black or White? AR 3:30 pm - 5:00 pm Symposium Howard and Georgeanna Jones Endowed Symposium on Advanced Reproductive Technology: Fresh versus Frozen Donor Eggs 3:30 pm - 5:00 pm Symposium AMMR Symposium: Diferencias Geográficas de Acceso a los Tratamientos de Reprodución Asistida en América

CO 1:15 pm - 2:15 pm Ryan Fellows Showcase Emerging Research in Contraception (in Cooperation with the Society of Family Planning)

1:15 pm - 2:15 pm Interactive Session Should We Be Screening and Treating Chronic Endometritis for Recurrent Pregnancy EP Loss and Failed In Vitro Fertilization? 3:30 pm - 5:00 pm Symposium JSAR Symposium: Implantation Disorder: What Are the Japanese Strategies?

ED 1:15 pm - 2:15 pm Interactive Session Controversies in the Management of Advanced Endometriosis and Endometrioma

FP 3:30 pm - 5:00 pm Symposium ESHRE: Stem Cell-based Strategies and Future Challenges for Fertility Preservation in Boys

FI 3:30 pm - 5:00 pm Symposium State-of-the-Art Nonsurgical Management of Fibroids

9:00 am - 9:45 am Plenary Why Parents Matter (Epigenetically): Genomic Imprinting in Health and Disease GE 1:15 pm - 2:15 pm Interactive Session Managing the Gray Results with Preimplantation Genetic Testing: What Do We Tell Patients When the Results Are Not Black or White? 1:15 pm - 2:15 pm Interactive Session Hormone Therapy in Postmenopausal Women: Update on Clinical Trials 2:30 pm - 3:15 pm Keynote Lecture Postmenopausal Sexuality: Not an Oxymoron ME 3:30 pm - 5:00 pm Symposium The Declining Oocyte Pool: Is It Simply a Preprogrammed Event or Does the Environment Have a Significant Influence?

10:30 am - 11:30 am MHPG Clinical Session Cultural Considerations in the Psychological Testing of Third-party Participants 11:45 am - 12:45 am MHPG Clinical Session Ethics in Known Gamete Donation MH 3:30 pm - 5:00 pm Symposium Mental Health Symposium III: Challenges and Controversies in Treating Lesbian, Gay, Bisexual, Transgender, and Questioning Patients

3:30 pm - 5:00 pm Symposium Nurses’ Symposium III: Healthy Women, Healthy Babies: Maximizing Overall Health to NU Improve Fertility Outcomes

PM 3:30 pm - 5:00 pm Symposium Practice Managers’ Symposium III: Management Techniques Using Lean Principles 2:30 pm - 3:15 pm Plenary SSR Exchange Lecture: Plasticity and Placental Health RE 3:30 pm - 5:00 pm Symposium State-of-the-Art Nonsurgical Management of Fibroids

RS 1:15 pm - 2:15 pm Interactive Session Controversies in the Management of Advanced Endometriosis and Endometrioma

SC 3:30 pm - 5:00 pm Symposium ESHRE: Stem Cell-based Strategies and Future Challenges for Fertility Preservation in Boys ASRM 2O16 SCIENTIFIC CONGRESS

CO Contraception Track

Monday, October 17 Tuesday, October 18

11:15 am - 12:45 pm * Oral Abstract Presentations NON- 7:00 am - 8:45 am * Posters NON- Contraception and Family Planning CME CE Contraception/FamilyARS Planning Poster Session CME CE ARS Oral Abstract Session 1:00 pm - 2:00 pm * Roundtable NON- CME CE ARS 1:00 pm - 2:00 pm * Roundtable NON- Contraceptive Dual Use among Adolescents: Factors that Influence Pain Experience CME CE Barriers,ARS Facilitators, and the Influence of during Outpatient Gynecologic Procedures Relationships Tiffany Hailstorks, M.D. Shandhini Raidoo, M.D. Emory University University of Hawaii

1:15 pm - 2:15 pm * Interactive Session Essure®: Uses and Liabilities Aileen Gariepy, M.D., M.P.H. (Chair) Yale School of Medicine Wednesday, October 19 Diana H. Wu, M.D. Oregon Health & Science University 1:15 pm - 2:15 pm * Ryan Fellows Showcase Emerging Research in Contraception 2:30 pm - 3:15 pm * Plenary (in Cooperation with the Society of Family Planning) The Importance of Long-acting Reversible Contraception Lisa Haddad, M.D., M.S., M.P.H. (Chair) Jeffrey F. Peipert, M.D., Ph.D. Emory University School of Medicine Indiana University School of Medicine Melissa J. Chen, M.D., M.P.H. University of California, Davis 4:00 pm - 5:30 pm * Symposium Shandhini Raidoo, M.D. Contraception and Human Immunodeficiency Virus (HIV) University of Hawaii Thomas D. Kimble, M.D. (Chair) Ivana Thompson, M.D., M.S.C.I. Eastern Virginia Medical School Vanderbilt University School of Medicine Jenell Coleman, M.D., M.P.H. Christy M. Boraas, M.D., M.P.H. Johns Hopkins University University of Minnesota Katharine Simmons, M.D., M.P.H. Holly Bullock, M.D., M.P.H. University of North Carolina University of Utah Megan Lawley, M.D. Emory University

nd 72 ASRM Scientific Congress & Expo 67 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

ME Menopause Track

Wednesday, October 19

7:00 am - 8:45 am * Posters NON- Menopause Poster Session CME CE ARS

1:00 pm - 2:00 pm * Roundtable NON- Menopause Transition: Cardiovascular Risk CME CE ARS Robert A. Wild, M.D., Ph.D., M.P.H. Oklahoma University Health Sciences Center

1:15 pm - 2:15 pm * Interactive Session Hormone Therapy in Postmenopausal Women: Update on Clinical Trials Nanette F. Santoro, M.D. (Chair) University of Colorado School of Medicine

2:30 pm - 3:15 pm * Menopuase Track Keynote Lecture Postmenopausal Sexuality: Not an Oxymoron Sheryl A. Kingsberg, Ph.D. University Hospitals Case Medical Center

3:30 pm - 5:00 pm * Symposium The Declining Oocyte Pool: Is It Simply a Preprogrammed Event or Does the Environment Have a Significant Influence? Julia V. Johnson, M.D. (Chair) University of Massachusetts Medical School Amber R. Cooper, M.D. St. Louis University Karl R. Hansen, M.D., Ph.D. University of Oklahoma College of Medicine

nd 72 ASRM Scientific Congress & Expo 68 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

RS Reproductive Surgery Track 11:15 am - 12:45 pm * Telesurgery Monday, October 17 Hysteroscopic Leiomyoma Resection Techniques Using the Resectoscope and Morcellator 11:15 am - 12:45 pm * Oral Abstract Presentations Steven R. Lindheim, M.D., M.M.M. (Surgeon) NON- Wright State University Boonshoft School of Medicine Reproductive Surgery 1 Abstract Session CME CE ARS Samantha Simpson, M.D. Wright State University Boonshoft School of Medicine 1:15 pm - 2:15 pm * Interactive Session Bala Bhagavath, M.D. Fertility-sparing Surgical Options in theNON- University of Rochester Medical Center Management of Gynecologic MalignanciesCME CE ARS Mary Ellen Pavone, M.D., M.S.C.I. (Chair) Keith B. Isaacson, M.D. Northwestern University Harvard Medical School Togas Tulandi, M.D., M.H.C.M. Steven F. Palter, M.D. McGill University Gold Coast IVF Farr R. Nezhat, M.D. Weill Cornell Medical College 1:00 pm - 2:00 pm * Roundtables

1:00 pm - 2:00 pm * Roundtables Tips on Micro-TESE NON- Peter N. Schlegel, M.D. CME CE ARS Weill Cornell Medical College Sperm Retrieval with Testicular Mapping NON- for Non-obstructive Azoospermia CME CE ARS Myoma Management for the Infertile Patient: NON- Paul J. Turek, M.D. CME CE ARS The Turek Clinic Clinical Management and Surgical Approach Divya K. Shah, M.D. University of Pennsylvania Hydrosalpinges: Removal, Repair, or Observe? NON- Mark W. Surrey, M.D. CME CE ARS Southern California Reproductive Center Management Options for Cesarean Scar NON- Pregnancy CME CE ARS Humberto Scoccia, M.D. Surgical Management of Large Uterine NON- University of Illinois College of Medicine at Chicago Fibroids CME CE ARS Bala Bhagavath, M.D. University of Rochester Medical Center 1:00 pm - 2:30 pm * Surgical Tutorial Tissue Removal: Fibroids, Cysts, and Other Masses Supported in part by an educational grant from AbbVie 2:30 pm - 3:15 pm * Plenary Ceana H. Nezhat, M.D. (Chair) SRS Lecture: Fetoscopic Surgery for Congenital Birth Nezhat Medical Center Defects: From Bench to Bedside Jan Deprest, M.D., Ph.D., F.R.C.O.G. Charles E. Miller, M.D., F.A.C.O.G. University of Leuven Advocate Lutheran General Hospital Antonio R. Gargiulo, M.D. Harvard Medical School

Tuesday, October 18 1:15 pm - 2:15 pm * Interactive Session Surgical Sterilization: Vasal versus Tubal Occlusion

7:00 am - 8:45 am * Posters NON- Stanton Honig, M.D. (Chair) Female Reproductive Surgery Poster Session CME CE YaleARS Urology Jeffrey T. Jensen, M.D., M.P.H. Oregon Health & Science University 11:15 am - 12:45 pm * Oral Abstract Presentations NON- Reproductive Surgery 2 Abstract Session CME CE ARS

nd 72 ASRM Scientific Congress & Expo 69 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

RS Reproductive Surgery Track

Wednesday, October 19

1:00 pm - 2:00 pm * Roundtables

Varicocelectomy NON- Marc Goldstein, M.D. CME CE ARS Weill Cornell Medical College

Current Approaches to Endometriosis- NON- associated Infertility CME CE ARS Richard O. Burney, M.D., M.Sc. Madigan Healthcare System

Preparing for Complex Endometriosis NON- : Tips and Tricks CME CE ARS Mohamed A. Bedaiwy, M.D., Ph.D., F.A.C.O.G., F.R.C.S.C. The University of British Columbia

1:15 pm - 2:15 pm * Interactive Session Controversies in the Management of NON- Advanced Endometriosis and EndometriomaCME CE ARS Supported in part by an educational grant from AbbVie Mark W. Surrey, M.D. (Chair) Southern California Reproductive Center Tommaso Falcone, M.D. Cleveland Clinic Grace M. Janik, M.D. Reproductive Specialty Center

nd 72 ASRM Scientific Congress & Expo 70 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

AR Assisted Reproductive Technology Track

Supported in part by an educational grant from Cook Medical

Monday, October 17 Overview of Food and Drug Administration (FDA) Regulations of Products Used to Treat Reproductive Conditions in Women 1:15 pm - 2:15 pm * Interactive Session NON- CME Yun-shang Piao, Ph.D., R.A.C. (Chair) SART National Report: Where Are We Going? CE ARS Center for Devices and Radiological Health, Food and Drug James P. Toner, M.D., Ph.D. (Chair) Atlanta Center for Reproductive Medicine Administration Amy E. T. Sparks, Ph.D., H.C.L.D. Rhonda M. Hearns-Stewart, M.D. University of Iowa Hospitals and Clinics Center for Drug Evaluation and Research, Food and Drug Administration 4:00 pm - 5:30 pm * Symposia Shelley R. Slaughter, M.D., Ph.D. Center for Drug Evaluation and Research, Food and Drug Mental Health Symposium I: Self-disclosure, Biases, and Administration Other Clinical Dilemmas in Treating Janet Jaffe, Ph.D. (Chair) Richard D. McFarland, M.D., Ph.D. Center for Reproductive Psychology Center for Biologics Evaluation and Research, Food and Drug Administration Lauri Pasch, Ph.D. University of California, San Francisco Monica Garcia, Ph.D. Center for Devices and Radiological Health, Food and Drug Administration Practice Managers' Symposium I: The "ART" of Informed Michael T. Bailey, Ph.D. Consent: Using Words that Work Center for Devices and Radiological Health, Food and Drug (Joint Symposium with LPG) Administration Brad J. T. Senstra, M.H.A. (Chair) Seattle Reproductive Medicine Deborah L. Forman, J.D. Whittier Law School Tuesday, October 18 Lisa A. Rinehart, R.N., B.S.N., J.D. 1:15 pm - 2:15 pm * Interactive Sessions LegalCare Consulting, Inc. Access to Care: Socio-cultural Factors Ann V. Bell, Ph.D. (Chair) ALMER Symposium: Cuanto Hemos AvanzadoNON- CME CE ARS University of Delaware en Acceso en Latinoamérica y Resto del Mundo Arthur L. Greil, Ph.D. Desde las Distintas Perspectivas Alfred University Presented in Spanish Sergio Papier, M.D. (Chair) Before Things Go Wrong: Minimizing Drama in the President, ALMER Embryology Laboratory Marcelo J. Barrionuevo, M.D., F.A.C.O.G. Klaus E. Wiemer, Ph.D., H.C.L.D., A.C.E. (Chair) IVF Florida Reproductive Associates Poma Fertility Miguel Angel Checa, M.D., Ph.D. Dawn A. Kelk, Ph.D., H.C.L.D. Hospital del Mar Yale Fertility Center Marcos Horton, M.D. Pregna Medicina Reproductiva

nd 72 ASRM Scientific Congress & Expo 71 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

AR Assisted Reproductive Technology Track

Supported in part by an educational grant from Cook Medical

Tuesday, October 18 Wednesday, October 19

4:00 pm - 5:30 pm * Symposia 1:15 pm - 2:15 pm * Interactive Sessions Mosaicism in Preimplantation Genetic Testing and Its Access to Care: Modifying Assisted Reproductive Technology Relationship to Cell Division Kinetics and Developmental Techniques Potential Kevin J. Doody, M.D., H.C.L.D. (Chair) Dieter Egli, Ph.D. (Chair) Center for Assisted Reproduction Columbia University Nathan Treff, Ph.D. Managing the Gray Results with PreimplantationNON- Reproductive Medicine Associates of New Jersey Genetic Testing: What Do We Tell PatientsCME CE ARS Renee A. Reijo Pera, Ph.D. When the Results Are Not Black or White? Montana State University Lauri Black, M.S., L.C.G.C. (Chair) Pacific Reproductive Genetic Counseling Mental Health Symposium II: The Whole Is More than the Emily Mounts, M.S., C.G.C. Sum of Its Parts: Professionally Coordinating the Medical, Oregon Reproductive Medicine Psychological, and Legal Logistics of the Assessment of All Alyssa C. Snider, Ph.D., M.S., L.C.G.C. Gestational Carrier Participants IviGen Tara H. Simpson, Psy.D. (Chair) Shady Grove Fertility Center 3:30 pm - 5:00 pm * Symposium Pasquale Patrizio, M.D., M.B.E. AMMR Symposium: Diferencias Geográficas de Acceso a los Yale University School of Medicine Tratamientos de Reprodución Asistida en América Melissa B. Brisman, J.D. Presented in Spanish Melissa B. Brisman, Esq., LLC Emilio Valerio, M.D. (Chair) President, AMMR Nurses' Symposium II: Ice, Ice Fertility Babies Sergio Papier, M.D. Maria M. Jackson, M.A., R.N. (Chair) Center of Studies in Genetics and Gynecology IRMS at Saint Barnabas J. Ricardo Loret de Mola, M.D., F.A.C.S., F.A.C.O.G. Aimee Eyvazzadeh, M.D., M.P.H. Southern Illinois University Private Practice Alberto Kably Ambe, M.D. Zsolt Peter Nagy, M.D., Ph.D., H.C.L.D. Centro Mexicano de Fertilidad Reproductive Biology Associates

Practice Managers' Symposium II: NON- Revenue Cycle Management - Global CMEPricingCE ARS Lisa Duran, B.S. (Chair) Reconceived Lawrence Jay Friedman IntegraMed Sheldon B. Josephs, F.A.C.H.E. Reproductive Science Center of the San Francisco Bay Area

MEFS Symposium: Are We Transferring Too Many Embryos? Suheil J. Muasher, M.D. (Chair) Duke University Dmitry Kissin, M.D., M.P.H. Centers for Disease Control and Prevention (CDC) Bradley J. Van Voorhis, M.D. University of Iowa Hospitals and Clinics

nd 72 ASRM Scientific Congress & Expo 72 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

FI Fibroids Track

Supported in part by an educational grant from AbbVie

Tuesday, October 18

1:00 pm - 2:30 pm * Surgical Tutorial Tissue Removal: Fibroids, Cysts, and Other Masses Ceana H. Nezhat, M.D. (Chair) Nezhat Medical Center Charles E. Miller, M.D., F.A.C.O.G. Advocate Lutheran General Hospital Antonio R. Gargiulo, M.D. Harvard Medical School

4:00 pm - 5:30 pm * Symposium ISAR Symposium: Managing the "BigNON- Three" in Infertility (Fibroids, Endometriosis, andCME CE ARS Polycystic Ovary Syndrome) Narendra Malhotra, M.D., F.I.C.O.G., F.I.C.S., F.R.C.O.G. (Chair) President, ISAR Prakash H. Trivedi, M.D., D.G.O., F.C.P.S., D.N.B. Total Healthcare Private, Ltd. Firuza R. Parikh, M.D., D.G.O., D.F.P., F.C.P.S., DIP.N.B.E. Jaslok Hospital & Research Center

Wednesday, October 19

3:30 pm - 5:00 pm * Symposium State-of-the-Art Nonsurgical ManagementNON- of Fibroids CME CE ARS William H. Catherino, M.D., Ph.D. (Chair) Uniformed Services University of the Health Sciences James B. Spies, M.D., M.P.H. MedStar Georgetown University Hospital Jacques G. Donnez, M.D. Société de Recherche pour l'Infertilité, Brussels

nd 72 ASRM Scientific Congress & Expo 73 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

ED Endometriosis Track

Supported in part by an educational grant from AbbVie

Tuesday, October 18

4:00 pm - 5:30 pm * Symposia Biomarkers and Emerging DiagnosticsNON- of Endometriosis CME CE ARS Serdar E. Bulun, M.D. (Chair) Northwestern University Linda C. Giudice, M.D., Ph.D., M.Sc. University of California, San Francisco Hugh S. Taylor, M.D. Yale University School of Medicine

ISAR Symposium: Managing the "BigNON- Three" in Infertility (Fibroids, Endometriosis, andCME CE ARS Polycystic Ovary Syndrome) Narendra Malhotra, M.D., F.I.C.O.G., F.I.C.S., F.R.C.O.G. (Chair) President, ISAR Prakash H. Trivedi, M.D., D.G.O., F.C.P.S., D.N.B. Total Healthcare Private, Ltd. Firuza R. Parikh, M.D., D.G.O., D.F.P., F.C.P.S., DIP.N.B.E. Jaslok Hospital & Research Center

Wednesday, October 19

1:15 pm - 2:15 pm * Interactive Session Controversies in the Management of NON-Advanced Endometriosis and Endometrioma CME CE ARS Mark W. Surrey, M.D. (Chair) Southern California Reproductive Center Tommaso Falcone, M.D. Cleveland Clinic Grace M. Janik, M.D. Reproductive Specialty Center

nd 72 ASRM Scientific Congress & Expo 74 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

GE Genetics Track

Supported in part by an educational grant from Illumina

Monday, October 17

1:15 pm - 2:15 pm * Interactive Session Should Preimplantation Genetic TestingNON- for Aneuploidy Be Performed on Every Patient?CME CE ARS Lawrence C. Layman, M.D. (Chair) Augusta University Glenn L. Schattman, M.D. Weill Cornell Medicine Richard T. Scott, Jr., M.D. Reproductive Medicine Associates of New Jersey

Tuesday, October 18

4:00 pm - 5:30 pm * Symposia Mosaicism in Preimplantation Genetic TestingNON- and Its Relationship to Cell Division KineticsCME CE ARS and Developmental Potential Dieter Egli, Ph.D. (Chair) Columbia University Nathan Treff, Ph.D. Reproductive Medicine Associates of New Jersey Renee A. Reijo Pera, Ph.D. Montana State University

Wednesday, October 19

1:15 pm - 2:15 pm * Interactive Session Managing the Gray Results with PreimplantationNON- Genetic Testing: What Do We Tell PatientsCME WhenCE ARS the Results Are Not Black or White? Lauri Black, M.S., L.C.G.C. (Chair) Pacific Reproductive Genetic Counseling Emily Mounts, M.S., C.G.C. Oregon Reproductive Medicine Alyssa C. Snider, Ph.D., M.S., L.C.G.C. IviGen

nd 72 ASRM Scientific Congress & Expo 75 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS 2016 Resident Reporter Track

Supported in part by an educational grant from GE Healthcare

Purpose ASRM is committed to facilitating and promoting education of reproductive health professionals at all levels. As part of this mission, the Society develops and coordinates educational activities for resident physicians in training in reproductive medicine. The Resident Reporter program will also emphasize the understanding of complex topics, interaction with other disciplines, and psychosocial sequelae and ethical concerns in human reproduction. Residents will also be exposed to a variety of interactive educational methods for use in their careers and have an opportunity to network/interact with faculty with expertise in the specific topic for the day.

Description ASRM has organized a series of educational sessions coupled with corresponding scientific symposia. On each day of the Scientific Program (Monday, Tuesday, Wednesday) there will be interactive educational presentations corresponding to a symposium on each of those days. The activities will be evidence based, free from bias, and independent of commercial influence. The discussions, which will utilize several different learning pedagogies, will require advance independent study of articles, videos, or handouts relevant to the topic of ~20-30 minutes.

Procedure 1. The track is open to residents in obstetrics and gynecology or urology who have preregistered. 2. Registrants will receive an email 2 weeks in advance of the Scientific Congress with a link to the reference reading materials for each symposium. 3. On each day of the Scientific Congress, registrants will gather for a luncheon learning session (lunch provided) with a prominent medical educator and a speaker from the day’s corresponding subject symposium. Each day will employ an interactive learning modality that will require a small amount of advance preparation: question-and-answer discussion of clinical cases and team- based learning. 4. Registrants will attend the afternoon symposium corresponding to the day’s learning session.

Schedule Monday, October 17, 2016 4:00 pm – 5:30 pm 1:00 pm – 2:30 pm Symposium: “Biomarkers and Emerging Diagnostics of Resident Learning Session: Team-based Learning Endometriosis” Facilitator: Steven Lindheim, M.D., M.M.M. , Carol Wheeler, M.D. (Medical Education Committee Members) Wednesday, October 19, 2016 Content Expert: Rebecca S. Usadi, M.D. 1:00 pm – 2:30 pm Resident Learning Session: Team-based Learning 4:00 pm – 5:30 pm Facilitator: Ranjith Ramasamy, M.D. (Medical Education Symposium: “Old Tricks and New Ideas for Stimulating the Committee Member) Polycystic Ovary Syndrome (PCOS) Patient” Content Expert: Stefan Schlatt, Ph.D.

Tuesday, October 18, 2016 3:30 pm – 5:00 pm 1:00 pm – 2:30 pm Symposium: “ESHRE Symposium: Stem Cell–based Strategies Resident Learning Session: Case Discussions and Future Challenges for Fertility Preservation in Boys” Facilitator: Ertug Kovanci, M.D. (Medical Education Committee Member) Content Expert: Serdar E. Bulun, M.D.

Brought to you by the ASRM Undergraduate, Graduate, Medical, and Postgraduate Education Committee, Professor Ann J. Davis, M.D., Chair

nd 72 ASRM Scientific Congress & Expo 76 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Plenary Sessions

Monday, October 17, 2016 AC AN 9:00 am - 9:45 am Plenary 1

President’s Guest Lecture: Access to Care: A House Divided that the right to procreate is universally honored and that appropriate resources are brought to bear. This session will Endowed by a 1987 grant from Ortho Women’s Health provide health-care providers and allied health professionals with tools and approaches to address these disparities. Owen K. Davis, M.D. (Introducer) Learning Objectives Eli Y. Adashi, M.D., M.S. At the conclusion of this session, participants should be able to: The Warren Alpert Medical School, Brown University 1. Define the right to procreate and its implications. 2. Describe global and national disparities in access to care. Needs Assessment and Description 3. Outline a path forward to assure social justice in access to In many parts of the globe including the United States, care. access to infertility care in general and assisted reproductive endocrinology in particular has become a function of economic ACGME Competency prowess. This state of affairs is socially unjust and in need of Systems-based Practice redress. Going forward, every effort must be made to assure

Monday, October 17, 2016 GE 9:45 am - 10:30 am Plenary 2

Camran Nezhat, M.D. Lectureship in Innovations in Medicine and testing options, the importance of positive and negative Lecture: Maternal Plasma DNA Sequencing Provides a New predictive values, and the underlying biological explanations Perspective on Fetal, Placental, and Maternal Health for false-positive results. The target audience is any health professional. Endowed by a 2011 gift from Camran Nezhat, M.D. Dr. Camran Nezhat pioneered techniques of video-assisted endoscopic Learning Objectives surgery, which revolutionized modern-day surgery. He along At the conclusion of this session, participants should be able to: with his brothers, Drs. Farr and Ceana Nezhat, performed some 1. Discuss the benefits and limitations of maternal plasma of the most advanced procedures with these techniques for the cell-free DNA testing as a screen for aneuploidy. first time, thus opening the vistas for endoscopic surgeons all 2. Describe the various underlying biological reasons for a over the world. false-positive test result.

Richard J. Paulson, M.D. (Introducer) ACGME Competency Practice-based Learning and Improvement Diana W. Bianchi, M.D. Tufts University School of Medicine

Needs Assessment and Description Noninvasive prenatal genetic testing using analysis of cell-free DNA in maternal plasma has translated to and transformed clinical care. This session will discuss advances in technology

nd 72 ASRM Scientific Congress & Expo 77 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Plenary Sessions

Monday, October 17, 2016 CO 2:30 pm - 3:15 pm Plenary 3

The Importance of Long-acting Reversible Contraception proven to be effective, yet underutilized. This session will inform practitioners and allied health professionals about the Endowed by a 1990 grant from Astra-Zeneca implications of unintended pregnancy on public health.

Jeffrey T. Jensen, M.D., M.P.H. (Introducer) Learning Objectives At the conclusion of this session, participants should be able to: Jeffrey F. Peipert, M.D., Ph.D. 1. Describe the significance and public health implications of Indiana University School of Medicine unintended pregnancy in the United States.

Needs Assessment and Description ACGME Competency Unintended pregnancy and teen pregnancy continue to be Systems-based Practice important health problems in the United States. Long-acting reversible contraception (LARC) is one strategy that has

Tuesday, October 18, 2016 RE 9:00 am - 9:45 am Plenary 4

Ovarian Function Entrains Cardiovascular Health Over the including obstetricians/gynecologists, fertility specialists, Life Course: From Monkeys to Women general practitioners, especially those seeing college students and large numbers of reproductive-aged women, and Endowed by a 1992 grant from Wyeth physicians in identifying FHA and providing appropriate interventions. Clarisa R. Gracia, M.D., M.S.C.E. (Introducer) Learning Objectives Jay Ross Kaplan, Ph.D. At the conclusion of this session, participants should be able to: Wake Forest School of Medicine 1. Evaluate data for the hypothesis that FHA is a stress- induced condition that hastens the progression of Needs Assessment and Description coronary artery atherosclerosis and possibly bone loss Functional hypothalamic amenorrhea (FHA) is a reversible in both monkeys and women, an outcome that places form of ovulatory dysfunction that occurs along a spectrum individuals at increased risk for coronary heart disease from mild luteal-phase deficiencies in progesterone to during the postmenopausal years. oligomenorrhea, anovulation, and complete cessation of 2. Infer that treatment with estrogen-containing oral menses. Despite its common occurrence, the actual frequency contraceptives may effectively inhibit the progression of in women of reproductive age is not known with certainty stress-induced atherosclerosis, but not without potentially because it often presents subclinically. Studies in nonhuman deleterious effects on bone density. primates suggest that even mild (i.e., subclinical) FHA is 3. Discuss the importance of managing premenopausal associated with precocious acceleration of coronary artery ovarian dysfunction as a strategy for reducing the potential atherosclerosis and reductions in bone density. Although postmenopausal health burden. FHA may be multifactorial in cause, indirect evidence from women and direct evidence from monkeys indicates that ACGME Competency psychosocial stress plays a major role. While physicians, Medical Knowledge especially obstetricians/gynecologists, may be aware that FHA exists, they often do not appreciate that the syndrome is both relatively common and potentially pathogenic to the arteries and bones. This session is designed to assist clinicians,

nd 72 ASRM Scientific Congress & Expo 78 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Plenary Sessions

Tuesday, October 18, 2016 RS 9:45 am - 10:30 am Plenary 5

SRS Lecture: Fetoscopic Surgery for Congenital Birth Learning Objectives Defects: From Bench to Bedside At the conclusion of this session, participants should be able to: 1. Describe essential criteria for congenital malformations to Endowed by a 1990 grant from Ethicon Endo-Surgery, Inc. be eligible for prenatal surgery. 2. Discuss the level of evidence for some fetal surgeries. Peter Chan, M.D. (Introducer) 3. Explain which surgeries are necessarily still open, and which can be minimally invasive. Jan Deprest, M.D., Ph.D., F.R.C.O.G. 4. Indicate the effect of fetal surgery on future reproductive University of Leuven life.

Needs Assessment and Description ACGME Competency Ultrasound screening programs can pick up congenital Patient Care malformations, of which some are eligible for prenatal surgical repair. Some procedures are possible by fetoscopy, while others require a hysterotomy. Outcomes and level of evidence will be discussed, as well as the impact of fetal surgery on the future reproductive life of the mother. This session is designed to assist clinicians with using and understanding the role of fetal surgery.

Tuesday, October 18, 2016 RE 2:30 pm - 3:15 pm Plenary 6

Herbert H. Thomas Lecture: An Update on Congenital effects and growth hormone to delay puberty, as well as Adrenal Hyperplasia surgical options, including prenatal therapy. Also discussed will be newer methods of newborn screening, including molecular Endowed by a 1990 grant from TAP Pharmaceuticals genetic testing.

Richard H. Reindollar, M.D. (Introducer) Learning Objectives At the conclusion of this session, participants should be able to: Maria I. New, M.D. 1. Review the basic pathophysiology of congenital adrenal Icahn School of Medicine at Mount Sinai hyperplasia. 2. Describe current standard treatments and new modalities. Needs Assessment and Description 3. Discuss newer methods of newborn screening, including Congenital adrenal hyperplasia is a common inherited form molecular genetic testing. of adrenal insufficiency due to mutations (genetic defects) in the genes coding for several enzymes needed to produce vital ACGME Competency adrenal cortex . This plenary lecture will provide Medical Knowledge clinicians and scientists with an update on newer treatment modalities, such as drug therapy with androgen-blocking

nd 72 ASRM Scientific Congress & Expo 79 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Plenary Sessions

Wednesday, October 19, 2016 GE 9:00 am - 9:45 am Plenary 7

Why Parents Matter (Epigenetically): Genomic Imprinting in occur during germ-cell formation and early development, Health and Disease coinciding with procedures used in assisted reproductive technology (ART), have been associated with imprinting Endowed by a 1992 grant from EMD Serono, Inc. disorders.

Christos Coutifaris, M.D. (Introducer) Learning Objectives At the conclusion of this session, participants should be able to: Marisa S. Bartolomei, Ph.D. 1. Discuss the importance of imprinted genes and how their University of Pennsylvania Perelman School of Medicine inappropriate regulation is associated with imprinting disorders, such as Beckwith-Wiedemann syndrome, Needs Assessment and Description Russell-Silver syndrome, Prader-Willi syndrome, and This plenary session for reproductive medicine clinicians and Angelman syndrome. scientists will focus on a small class of genes in the mammalian 2. Explain that procedures used in ART are implemented at genome called imprinted genes, which are expressed in a a time when germ cells and the early embryonic genomes parent-of-origin specific manner and are critical for normal are being reprogrammed. development. Defects in imprinted genes or their inappropriate regulation are associated with imprinting disorders such as ACGME Competency Beckwith-Wiedemann syndrome, Russell-Silver syndrome, and Medical Knowledge Angelman syndrome, which are evident at birth. Additionally, this lecture will cover how environmental perturbations that

Wednesday, October 19, 2016 AN 9:45 am - 10:30 am Plenary 8

AUA Bruce Stewart Memorial Lecture: The Futures of Learning Objectives (Male(Reproductive)) Medicine At the conclusion of this session, participants should be able to: 1. List the technological development systems that are Supported by a grant from the American Urological Association available for any innovator in the public at large. 2. Describe how anyone can prototype a medical device Douglas T. Carrell, Ph.D., H.C.L.D. (Introducer) solution.

Craig Niederberger, M.D., F.A.C.S. ACGME Competency University of Illinois at Chicago Practice-based Learning and Improvement

Needs Assessment and Description Technology has always defined medicine, and reproductive care is an extraordinary example. With powerful computers in everything from toasters to laptops, highly accessible development systems, and 3D printers available to all, the future of medicine is in the hands of multitudes of innovators. This presentation addresses the accessible technologies for innovating the future of reproductive medicine, and is designed for all caregivers in the field.

nd 72 ASRM Scientific Congress & Expo 80 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Plenary Sessions

Wednesday, October 19, 2016 RE 2:30 pm - 3:15 pm Plenary 9

SSR Exchange Lecture: Plasticity and Placental Health Learning Objectives At the conclusion of this session, participants should be able to: William E. Roudebush, Ph.D., H.C.L.D. (Introducer) 1. Describe how animal models can be used effectively to investigate hemochorial placentation. Michael J. Soares, Ph.D. 2. Explain that placentation exhibits plasticity and the University of Kansas Medical Center capacity to adapt to environmental challenges. 3. Discuss how mechanisms controlling trophoblast cell Needs Assessment and Description adaptations provide insight into placental development The hemochorial placenta is a dynamic structure endowed and disease. with responsibilities to control the safe extraction of maternal 4. Predict that placental disease results when trophoblast resources, ensuring fetal development and preserving the cell–adaptive responses are overwhelmed or dysregulated. health of the mother. Failures in placental development and function impact the health of the mother and fetus and have ACGME Competency long-lasting effects on postnatal health. This presentation is Medical Knowledge targeted to scientists with interests in the establishment of pregnancy and placentation.

nd 72 ASRM Scientific Congress & Expo 81 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Lectures

Tuesday, October 18, 2016 AR 1:15 pm - 2:15 pm Lecture

David and Rosemary Adamson Lecture on Excellence in are limited, providing preconception counseling following Reproductive Medicine: CDC Zika Update: What Do We Know? possible Zika virus exposure is challenging. Decisions about pregnancy timing are personal and complex, and discussions Endowed by Advanced Reproductive Care, Inc. with patients should be individualized, particularly with the use of reproductive technologies. This session will provide Rebecca Z. Sokol, M.D., M.P.H. (Introducer) guidance for reproductive health-care providers caring for Denise J. Jamieson, M.D., M.P.H. (Chair) women and men with possible Zika virus exposure. Centers for Disease Control and Prevention Learning Objectives Needs Assessment and Description At the conclusion of this session, participants should be able to: Increasing epidemiologic, clinical, laboratory, and pathologic 1. Define Zika and cite examples of its effects. evidence supports a link between Zika virus during 2. Describe the epidemiology of Zika. pregnancy and adverse pregnancy and birth outcomes, 3. Assess the clinical implications of Zika. including pregnancy loss, microcephaly, and brain and eye abnormalities. A critical knowledge gap for health-care ACGME Competency providers counseling women and men about reproduction Patient Care is the level of risk for adverse pregnancy and birth outcomes associated with Zika virus infection. In addition, testing for Zika is complicated by the limited availability of tests and lack of validation for semen testing. Because currently available data

Wednesday, October 19, 2016 ME 2:30 pm - 3:15 pm Keynote

Menopause Track Keynote Lecture: Postmenopausal biopsychosocial condition. Misunderstandings about Sexuality: Not an Oxymoron HSDD exist, along with health-care provider discomfort in discussing sexual concerns or taking a sexual history, leaving Julia V. Johnson, M.D. (Introducer) few clinicians feeling competent to inquire about or treat this condition. This session is designed to assist clinicians and Sheryl A. Kingsberg, Ph.D. allied health providers in treating women with HSDD. University Hospitals Case Medical Center Learning Objectives Needs Assessment and Description At the conclusion of this session, participants should be able to: Hypoactive sexual desire disorder (HSDD) is the most prevalent 1. Describe models of female sexual function. sexual dysfunction in postmenopausal women. Women with 2. Define the female sexual disorders that are common in HSDD have impaired body image, self-confidence, and self- postmenopausal women, particularly HSDD. worth, feel less connected to their partners, and are concerned 3. Outline techniques for the diagnosis of HSDD. over partner infidelity. Total health-care expenditures are 4. Identify treatment options for postmenopausal women higher for women with HSDD than women without HSDD, with HSDD. including outpatient office visits, prescription medication use, and other medical services including , laboratory, ACGME Competency and outpatient surgeries. Research on the neuroendocrine Patient Care central mechanisms of sexual desire has led to an improved Interpersonal and Communication Skills understanding of the underlying pathophysiology of this

nd 72 ASRM Scientific Congress & Expo 82 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Symposia

Monday, October 17, 2016 ET 1:00 pm - 2:30 pm Symposium

ABOG Foundation - Kenneth J. Ryan Ethics Symposium: genetic engineering of the human germline, which some Germline Editing: Perspectives from Science, Ethics, and argue is a promising means of preventing the transmission Law of devastating genetic diseases, while others raise alarm for misuse of the technologies to create designer babies. Supported by a 2013 endowment from the American Board of This session is designed to provide practitioners of assisted Obstetrics and Gynecology reproduction with critical information about the potential pitfalls and safety concerns pertaining to gene-editing George Q. Daley, M.D., Ph.D. (Chair) techniques. Boston Children’s Hospital Henry T. Greely, J.D. Learning Objectives Stanford University At the conclusion of this session, participants should be able to: Aaron Kheriaty, M.D. 1. Identify the advantages and limitations of programmable University of California, Irvine nucleases used for gene editing, and the efficiency, fidelity, and risk of “off-target” mutations in somatic cells, gametes, Needs Assessment and Description and embryos subjected to attempts at gene editing. Rapid advances in technologies for editing genes in human 2. Summarize the arguments for and against the practice of cells have transformed scientists’ ability to study the gene editing of human embryos, and the recent calls for relationship between genetic variation and disease, and offer a moratorium on the editing of embryos in the context of powerful new strategies for therapeutic reversion of disease- assisted reproduction. associated mutations. Gene-editing technologies have been used to engineer genetic changes in mice and monkeys, and ACGME Competency the first report of gene editing in human embryos has appeared Patient Care in the scientific literature. This has raised the prospect of

Monday, October 17, 2016 PC 4:00 pm - 5:30 pm

NON- Symposium CME CE ARS

Old Tricks and New Ideas for Stimulating the Polycystic syndrome (OHSS) in women with PCOS undergoing IVF. Ovary Syndrome (PCOS) Patient The symposium will review strategies to prevent OHSS. This interactive session for clinicians and allied health-care Rebecca S. Usadi, M.D. (Chair) providers involved in infertility care will discuss the medical Carolinas Medical Center evidence for these treatments, provide an update on OI for Peter R. Casson, M.D. women with PCOS, and engage the audience in conversation Northeastern Reproductive Medicine regarding their questions and experiences. G. Wright Bates, Jr., M.D. University of Alabama at Birmingham Learning Objectives At the conclusion of this session, participants should be able to: Needs Assessment and Description 1. Discuss oral agents, adjunctive The target audience for this symposium are providers who therapy, and alternative protocols. manage oral ovulation induction (OI) or in vitro fertilization 2. Describe the role of weight and metabolic management in (IVF) stimulation protocols for women with polycystic ovary the treatment of anovulatory PCOS. syndrome (PCOS). Many off-label oral OI agents, adjuncts, 3. Describe optimal IVF stimulation for women with PCOS. and alternative OI protocols have been described for the management of anovulatory infertility in women with PCOS. ACGME Competency New evidence demonstrates effective protocols and therapy Patient Care for prevention and management of ovarian hyperstimulation

nd 72 ASRM Scientific Congress & Expo 83 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Symposia

Monday, October 17, 2016 CO 4:00 pm - 5:30 pm Symposium

Contraception Track Symposium: health-care providers will examine the role of contraception Contraception and Human Immunodeficiency Virus (HIV) in individuals with HIV and selection of the most appropriate methods, as well as counseling about ways to reduce risk of Thomas D. Kimble, M.D. (Chair) vertical transmission for those who do and do not wish to have Eastern Virginia Medical School children. Jenell Coleman, M.D., M.P.H. Johns Hopkins University Learning Objectives Katharine Simmons, M.D., M.P.H. At the conclusion of this session, participants should be able to: Centers for Disease Control and Prevention 1. List effective contraceptive therapies for men and women with HIV. Needs Assessment and Description 2. Discuss the interactions of contraceptive agents with HIV Women and men living with HIV often have unmet needs treatments and appropriate steps to mitigate risks. for family-planning services, and they rely on their HIV-care providers for these services. While most contraceptive methods ACGME Competency are safe and effective for HIV-positive individuals, there is the Patient Care potential for drug interaction with hormonal contraception and certain antiretroviral drugs, as well as other treatments, such as for tuberculosis. This symposium for clinicians and allied

Monday, October 17, 2016 MH 4:00 pm - 5:30 pm Symposium

Mental Health Symposium I: Self-disclosure, Biases, and Learning Objectives Other Clinical Dilemmas in Treating Fertility Patients At the conclusion of this session, participants should be able to: 1. Define self-disclosure. Supported in part by an educational grant from Cook Medical 2. Identify risks, benefits, and ethical considerations of self- disclosure to patients, and understand the need for one’s Janet Jaffe, Ph.D. (Chair) own self-care. Center for Reproductive Psychology 3. Identify one’s personal experiences, biases, and values and Lauri Pasch, Ph.D. understand how these can influence work with patients. University of California, San Francisco 4. Discuss strategies to help ensure that professionals support patient autonomy and choice. Needs Assessment and Description This symposium explores the complexities of the relationship ACGME Competency between patients and clinicians, including mental health and Interpersonal and Communication Skills medical professionals. Clinicians and medical staff will learn how awareness of their own internal narratives and emotional states can affect their work with patients. Participants will gain insight into how the interaction of events in patients’ lives and in their own can be used constructively as infertility patients navigate their reproductive journeys.

nd 72 ASRM Scientific Congress & Expo 84 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Symposia

Monday, October 17, 2016 NU 4:00 pm - 5:30 pm Symposium

Nurses’ Symposium I: See One, Do One, Teach One: Is It metrics used in performance improvement, evidence-based Really that Simple? practice, and research-conducted point of care. It is vital to consider the whole person and both personal and professional Jeanette Rodriguez Tomasino, M.S., R.N.C., M.N.N. (Chair) determinates for enculturation into a new organization. Progyny This activity will address the educational needs of the new Lora Stamper, R.N., M.H.A. nurse and provide guidelines for goals, outcomes, and nurse Seattle Reproductive Medicine competencies in an orientation program. The target audience Jamie Leonard, R.N., B.S.N. will include nurses, nurse educators, and nurse managers. Bennett Fertility Institute Learning Objectives Needs Assessment and Description At the conclusion of this session, participants should be able to: Nurses compose a large and integral part of the reproductive 1. Describe an operating context for new hires for knowledge endocrinology and infertility (REI) medical team, yet there is no transfer and application to practice. standardized orientation for nurses practicing in the assisted 2. Illustrate best practices to help transition and integrate reproductive technology clinical setting. When implementing new REI nurses into the assigned practice setting. a new hire orientation, it is best to build on structures and processes of best practices identified in the literature. It is ACGME Competency important to introduce the new REI nurse to Systems-based Practice

Monday, October 17, 2016 PM AR 4:00 pm - 5:30 pm Symposium

Practice Managers’ Symposium I: The “ART” of Informed informed consent process used in centers today. As this is Consent: Using Words that Work (Joint Symposium with LPG) intended as a practical application and approach to informed consent for ART centers, the audience will include physicians, Supported in part by an educational grant from Cook Medical practice managers, nurses, embryologists, mental health professionals, and allied health personnel. Brad J. T. Senstra, M.H.A. (Chair) Seattle Reproductive Medicine Learning Objectives Deborah L. Forman, J.D. At the conclusion of this session, participants should be able to: Whittier Law School 1. Draft functional and appropriate cycle-specific informed Lisa A. Rinehart, R.N., B.S.N., J.D. consent documents, including language appropriate LegalCare Consulting, Inc. for the wide scope of parenting arrangements, clear suggestions for future embryo disposition, and information Needs Assessment and Description on dealing with the impact of the patient’s perspective in The process of informed consent in reproductive medicine is this process. often lengthy and complex. Unwieldy forms, multiple patients, 2. Assess a need to identify an element of duress in consent varied providers, and confusion as to whether these consents documents. are contracts are merely some of the concerns that assisted 3. Discuss guidance as to how ART centers can write clear and reproductive technology (ART) centers face in trying to meet consistent informed consent guidelines for their practices. all of their obligations regarding informed consent. This live symposium is intended to address some of these issues by ACGME Competency looking at the intersection of the paper involved, the people Systems-based Practice giving and receiving information, and the future impact of the

nd 72 ASRM Scientific Congress & Expo 85 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Symposia

Monday, October 17, 2016 AR 4:00 pm - 5:30 pm

NON- Symposium CME CE ARS

ALMER Symposium: Cuanto Hemos Avanzado en Acceso Learning Objectives en Latinoamérica y Resto del Mundo Desde las Distintas At the conclusion of this session, participants should be able to: Perspectivas 1. Summarize the availability of ART services in Latin America and around the world. Supported in part by an educational grant from Cook Medical 2. Describe services and coverage available in the United States, Europe, and Latin America. Presented in Spanish 3. Evaluate the best way to increase services around the world. Sergio Papier, M.D. (Chair) President, ALMER ACGME Competency Marcelo J. Barrionuevo, M.D., F.A.C.O.G. Systems-based Practice IVF Florida Reproductive Associates Miguel Angel Checa, M.D., Ph.D. Hospital del Mar Marcos Horton, M.D. Pregna Medicina Reproductiva

Needs Assessment and Description As Latin American countries and the rest of the world have become more affluent, the middle class has expanded and assisted reproductive technology (ART) has become available. However, the penetration of services has been limited, and there are great differences in the quality of services provided. Therefore, there is great interest in studying these differences and how to make reproductive services available to the larger population of Latin Americans and around the world. This educational activity is intended for obstetricians/gynecologists, reproductive endocrinology and infertility specialists, embryologists, in vitro fertilization laboratory directors, and other health-care professionals involved in ART, with emphasis on the distribution and availability of services throughout Latin America. This symposium will be presented in Spanish.

nd 72 ASRM Scientific Congress & Expo 86 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Symposia

Monday, October 17, 2016 AR 4:00 pm - 5:30 pm Symposium

Overview of Food and Drug Administration (FDA) The second presentation will address the process for novel Regulations of Products Used to Treat Reproductive drug development through the regulatory review process, Conditions in Women interaction of the Office of New Drugs (OND) with industry, the in-house multidisciplinary review process, and post-marketing Supported in part by an educational grant from Cook Medical surveillance, as well as the approval process and safety monitoring for reproductive drug products. Yun-shang Piao, Ph.D., R.A.C. (Chair) Center for Devices and Radiological Health, Food and Drug The third presentation will address new and innovative Administration therapeutic/diagnostic medical devices and treatment options Rhonda M. Hearns-Stewart, M.D. for infertility. The Center for Devices and Radiological Health Center for Drug Evaluation and Research, Food and Drug (CDRH) provides regulatory oversight for clinical investigations Administration during product development, makes decisions regarding Shelley R. Slaughter, M.D., Ph.D. marketing approval or clearance for new medical devices, and Center for Drug Evaluation and Research, Food and Drug provides guidance to regulated industry on a wide variety of Administration clinical, scientific, and regulatory aspects. Richard D. McFarland, M.D., Ph.D. Center for Biologics Evaluation and Research, Food and Drug Learning Objectives Administration At the conclusion of this session, participants should be able to: Monica Garcia, Ph.D. 1. Identify CBER-regulated products, including HCT/Ps Center for Devices and Radiological Health, Food and Drug regulated under 21 CFR 1271 regulations. Administration 2. Determine donor eligibility in accordance with existing and Michael T. Bailey, Ph.D. recently published rulemaking and guidance documents. Center for Devices and Radiological Health, Food and Drug 3. Discuss The Final Rule: Revisions to Exceptions Applicable Administration to Certain HCT/Ps and its potential impact on reproductive establishments that recover reproductive HCT/Ps and Needs Assessment and Description perform donor eligibility determinations. The US Food and Drug Administration (FDA) is responsible 4. Summarize the FDA regulatory process for drug product for protecting the public health by assuring the safety, development and approval. effectiveness, quality, and security of human drugs, biologics, 5. Explain when an Investigational New Drug Application and medical devices. This session is designed to provide (IND) is required for studies involving human subjects, and clinicians, researchers, all members of the health-care team, how to initiate the IND application process. and industry representatives with information on regulation 6. Describe the FDA’s multidisciplinary approach to IND and of medical products intended for assisted reproduction. FDA New Drug Application (NDA) reviews. representatives from the Center for Biologics Evaluation and 7. Summarize the NDA approval process. Research (CBER), Center for Drug Evaluation and Research 8. Discuss the Prescription Drug User Fee Act (PDUFA). (CDER), and Center for Devices and Radiological Health (CDRH) 9. Identify the types of regulatory submissions for medical will present three perspectives on FDA regulation related to devices. reproductive medicine. 10. Summarize medical device regulations for assisted reproduction technology and the 510(k) process for The first presentation will include the history of tissue clearance of medical devices used in assisted reproductive regulations, examples of human cells, tissues, and cellular and technology. tissue-based products (HCT/Ps) and the tiered-risk regulatory framework for HCT/Ps, focusing on reproductive tissues. It ACGME Competency will summarize the generally applicable tissue rules, including Systems-based Practice registration and donor eligibility and provide an in-depth discussion of donor eligibility, including donor screening and testing and donor eligibility determination. It will conclude with an overview of recently published rulemaking and guidance relevant to reproductive HCT/Ps and donor eligibility of interest to reproductive tissue establishments.

nd 72 ASRM Scientific Congress & Expo 87 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Symposia

Monday, October 17, 2016 RE 4:00 pm - 5:30 pm Symposium

CSRM Symposium: Hot Topics in Human Reproduction synthesis involved in ovulation. The target audience is reproductive clinicians, embryologists, and researchers. Jie Qiao, M.D., Ph.D. (Co-chair) Peking University Third Hospital Learning Objectives Zi-Jiang Chen, M.D. (Co-chair) At the conclusion of this session, participants should be able to: Center for Reproductive Medicine, Shandong University 1. Summarize the role of mitochondria in oocyte and embryo Yun Sun, M.D., Ph.D. development. Shanghai Jiao Tong University 2. Outline mitochondrial disorders related to infertility and Yunxia Cao, M.D., Ph.D. how to prevent inherited mitochondrial disease. Anhui Medical University 3. Describe the effect of proinflammatory cytokine IL-1 beta on the biosynthesis of progesterone in human granulosa Needs Assessment and Description cells, thus identifying the potential role of inflammation in Emerging evidence demonstrates the role of mitochondria in ovulation. mammalian reproduction. Inflammation has key physiologic roles in ovarian folliculogenesis and ovulation. This study will ACGME Competency help us better understand the process of female reproduction Medical Knowledge to recognize the relationship between mitochondrial dysfunction and infertility, inflammation, and hormone

Tuesday, October 18, 2016 ED 4:00 pm - 5:30 pm

NON- Symposium CME CE ARS

Biomarkers and Emerging Diagnostics of Endometriosis Learning Objectives At the conclusion of this session, participants should be able to: Supported in part by an educational grant from AbbVie 1. List some of the currently available or emerging biomarkers useful for the diagnosis of endometriosis. Serdar E. Bulun, M.D. (Chair) Northwestern University ACGME Competency Linda C. Giudice, M.D., Ph.D., M.Sc. Medical Knowledge University of California, San Francisco Hugh S. Taylor, M.D. Yale University School of Medicine

Needs Assessment and Description The diagnostic tools and biomarkers currently used in medical practice for endometriosis do not adequately serve the needs of patients and clinicians. This session for reproductive health clinicians and scientists will provide a better understanding of the use of these existing tools and the development of new diagnostic biomarkers for endometriosis, which are urgently required for this common gynecologic disorder.

nd 72 ASRM Scientific Congress & Expo 88 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Symposia

Tuesday, October 18, 2016 EP 4:00 pm - 5:30 pm Symposium

Developmental Origins of Health and Disease: health of mother, developing fetus, and child. Understanding Contributions from Mom, Dad, and Placenta these inputs is essential to providing the best clinical guidance during pregnancy and beyond. This symposium is for health- David Weinberg, Ph.D. (Chair) care providers who care for pregnant women, infants, and Eunice Kennedy Shriver National Institute of Child Health and children. Human Development, NIH Leslie Myatt, Ph.D., F.R.C.O.G. Learning Objectives Oregon Health & Science University At the conclusion of this session, participants should be able to: Marisa S. Bartolomei, Ph.D. 1. Summarize the influence of mother, father, and placenta University of Pennsylvania Perelman School of Medicine on pregnancy and fetal/child development. Stephen A. Krawetz, Ph.D. 2. Describe the role of epigenetics in the placenta and its Wayne State University School of Medicine influence on pregnancy.

Needs Assessment and Description ACGME Competency A wide range of maternal environmental inputs serve to Medical Knowledge influence pregnancy outcome and the short- and long-term

Tuesday, October 18, 2016 SC 4:00 pm - 5:30 pm Symposium

KY Cha Symposium in Stem Cell Technology and “Regenerative Therapies for Treating Infertility” will describe Reproductive Medicine: Regenerative Therapies for pioneering methods to produce eggs or sperm for individuals Treating Infertility who are not able to produce functional gametes naturally. Medical professionals, researchers, bioethicists, and others Supported by the Asia-Pacific Biomedical Research Foundation with interest in stem cells, regenerative medicine, and assisted reproduction will benefit from this session’s update in cutting- Kyle Orwig, Ph.D. (Chair) edge information. University of Pittsburgh Takehiko Ogawa, M.D., Ph.D. Learning Objectives Yokohama City University Association of Medical Science At the conclusion of this session, participants should be able to: Teresa K. Woodruff, Ph.D. 1. Describe causes of infertility that are not amenable to Northwestern University current assisted reproductive technologies. 2. Identify experimental methods for generating functional Needs Assessment and Description eggs or sperm, in vitro, and describe how those methods Assisted reproductive technologies that helped an infertile might be deployed in the fertility clinic. couple in Great Britain have the world’s first test tube baby, 3. Discuss how gene therapy might be utilized to treat male Louise Brown (born July 25, 1978), have now produced over infertility as well as ethical concerns related to germline 5 million children worldwide and led to the 2010 Nobel Prize gene therapy. in Medicine for work done by Drs. Patrick Steptoe (physician) and Robert Edwards (researcher). However, current assisted ACGME Competency reproductive technologies remain beyond the reach of many Medical Knowledge couples because they are not able to produce mature sperm or Patient Care eggs due to their genetics, disease, medical treatment, injury, age, or other circumstances. The 2016 Ky Cha Symposium on Stem Cell Technology and Reproductive Medicine,

nd 72 ASRM Scientific Congress & Expo 89 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Symposia

Tuesday, October 18, 2016 AR 4:00 pm - 5:30 pm Symposium

Mosaicism in Preimplantation Genetic Testing and Its developmental consequences and the molecular mechanisms Relationship to Cell Division Kinetics and Developmental of mosaicism are not well understood. This presentation is Potential designed to assist clinicians and laboratory professionals to predict the developmental potential of preimplantation-stage Supported in part by educational grants from Cook Medical embryos. and Illumina Learning Objectives Dieter Egli, Ph.D. (Chair) At the conclusion of this session, participants should be able to: Columbia University 1. Discuss the developmental consequences of mosaicism on Nathan Treff, Ph.D. developmental potential. Reproductive Medicine Associates of New Jersey 2. Assess the correlation of morphological nuclear Renee A. Reijo Pera, Ph.D. abnormalities with mosaicism. Montana State University ACGME Competency Needs Assessment and Description Medical Knowledge Chromosomal segregation errors in preimplantation development are frequent and result in mosaicism. The

Tuesday, October 18, 2016 MH AR 4:00 pm - 5:30 pm Symposium

Mental Health Symposium II: The Whole Is More than the carrier participants. In addition, this interactive session will Sum of Its Parts: Professionally Coordinating the Medical, highlight suggested best practices in the coordination of the Psychological, and Legal Logistics of the Assessment of All multidisciplinary approaches through review of the existing Gestational Carrier Participants guidelines and examination of clinical case vignettes.

Supported in part by an educational grant from Cook Medical Learning Objectives At the conclusion of this session, participants should be able to: Tara H. Simpson, Psy.D. (Chair) 1. Identify and address the separate components of each Shady Grove Fertility Center discipline (legal, medical, and psychological) involved in Pasquale Patrizio, M.D., M.B.E. the screening of the gestational carrier, the assessment of Yale University School of Medicine the intended parents, and during the establishment and Melissa B. Brisman, J.D. maintenance of the relationship of all gestational carrier Melissa B. Brisman, Esq., LLC participants. 2. Describe the overlap, integration, and coordination of the Needs Assessment and Description distinct multidisciplinary elements involved in working Perhaps in no other arrangement in the world of fertility with gestational carrier participants. are the legal, medical, and psychological complexities of reproduction as fraught with issues as in traditional surrogacy ACGME Competency and gestational carrier arrangements. This symposium is Professionalism designed to assist professionals in the various disciplines of assisted reproduction in identifying the key components of the medical, psychological, and legal considerations involved in the assessment and screening of all gestational

nd 72 ASRM Scientific Congress & Expo 90 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Symposia

Tuesday, October 18, 2016 NU AR 4:00 pm - 5:30 pm Symposium

Nurses’ Symposium II: Ice, Ice Fertility Babies management are typically the responsibility of the nursing staff that must coordinate seamlessly with all parties to ensure a Supported in part by an educational grant from Cook Medical successful outcome. Nurses, nurse practitioners, physicians, and support staff who are part of a third-party team providing Maria M. Jackson, M.A., R.N. (Chair) care to egg-donor recipients would benefit from this lecture. IRMS at Saint Barnabas Aimee Eyvazzadeh, M.D., M.P.H. Learning Objectives Private Practice At the conclusion of this session, participants should be able to: Zsolt Peter Nagy, M.D., Ph.D., H.C.L.D. 1. List advantages and disadvantages of using the egg-bank Reproductive Biology Associates option for potential recipients. 2. Discuss the selection process and cycle coordination. Needs Assessment and Description An increasing number of patients are opting to use egg banks ACGME Competency rather than clinic-recruited or agency donors for a myriad Systems-based Practice of reasons. Communications with the egg bank and patient

Tuesday, October 18, 2016 AR 4:00 pm - 5:30 pm

NON- Symposium CME CE ARS

Practice Managers’ Symposium II: Revenue Cycle Learning Objectives Management - Global Pricing At the conclusion of this session, participants should be able to: 1. Discuss the concept of global rates in a reproductive Supported in part by an educational grant from Cook Medical medicine practice. 2. Describe the potential impact of global and bundled rates Lisa Duran, B.S. (Chair) on various practice stakeholders. Reconceived Lawrence Jay Friedman ACGME Competency IntegraMed Systems-based Practice Sheldon B. Josephs, F.A.C.H.E. Reproductive Science Center of the San Francisco Bay Area

Needs Assessment and Description This seminar will discuss the impact that global rates have on a practice. More and more payers are looking to simplify the infertility world. Bundling fees are here and becoming more popular. This discussion will talk about the value of global rates, considerations for creating bundled rates, potential pitfall areas, and concerns such as how to handle services provided beyond the global rate, operational considerations, impact on accounts receivable, and the potential impact on physician compensation. This seminar is intended for practice administrators, finance directors, billing and collection managers, and physicians looking for improved billing processes.

nd 72 ASRM Scientific Congress & Expo 91 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Symposia

Tuesday, October 18, 2016 AR 4:00 pm - 5:30 pm Symposium

MEFS Symposium: Are We Transferring Too Many Embryos? to patient characteristics, the twin rate has not decreased substantially in the last 10–15 years. There is a constant need Supported in part by an educational grant from Cook Medical to educate practitioners on the guidelines and to continually address modifications in order to minimize the twin rate. The Suheil J. Muasher, M.D. (Chair) target audience for this symposium is clinicians, residents, Duke University fellows in training, and scientists who are interested in Dmitry Kissin, M.D., M.P.H. discussing this topic and recommending solutions to this Centers for Disease Control and Prevention (CDC) problem. Bradley J. Van Voorhis, M.D. University of Iowa Hospitals and Clinics Learning Objectives At the conclusion of this session, participants should be able to: Needs Assessment and Description 1. Cite the incidence of multiple pregnancy resulting from IVF The multiple pregnancy rate from in vitro fertilization in the United States in the last few years. (IVF) continues to be high and problematic in the United 2. Discuss options for minimizing the twin rate. States. Despite repeated efforts by the American Society for Reproductive Medicine and the Society for Assisted ACGME Competency Reproductive Technology to publish guidelines on the number Systems-based Practice of embryos to transfer in different age groups and according

Tuesday, October 18, 2016 ED FI PC 4:00 pm - 5:30 pm

NON- Symposium CME CE ARS

ISAR Symposium: Managing the “Big Three” in Infertility Learning Objectives (Fibroids, Endometriosis, and Polycystic Ovary Syndrome) At the conclusion of this session, participants should be able to: 1. Describe how fibroids, polycystic ovary syndrome, and Supported in part by an educational grant from AbbVie endometriosis affect infertility. 2. Discuss standard evidence-based treatment protocols. Narendra Malhotra, M.D., F.I.C.O.G., F.I.C.S., F.R.C.O.G. (Chair) 3. Summarize diagnosis, investigations, and treatment of President, ISAR these three common and important gynecologic problems Prakash H. Trivedi, M.D., D.G.O., F.C.P.S., D.N.B. of women that lead to infertility and reproductive failure. Total Healthcare Private, Ltd. Firuza R. Parikh, M.D., D.G.O., D.F.P., F.C.P.S., DIP.N.B.E. ACGME Competency Jaslok Hospital & Research Center Patient Care

Needs Assessment and Description Infertility in women is mainly due to the “Big Three”: fibroids, polycystic ovary syndrome, and endometriosis. Controversy continues to exist in many aspects of diagnosis and management of these three common conditions leading to various management protocols. This interactive session for general practitioners, obstetricians/gynecologists, infertility and assisted reproductive technology physicians, and allied health professionals will discuss ideal management of these three enigmatic conditions.

nd 72 ASRM Scientific Congress & Expo 92 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Symposia

Wednesday, October 19, 2016 FI RE 3:30 pm - 5:00 pm

NON- Symposium CME CE ARS

State-of-the-Art Nonsurgical Management of Fibroids clinicians and allied health providers with an understanding of both the role of nonsurgical treatment, and the patient Supported in part by an educational grant from AbbVie characteristics most likely to benefit from these interventions.

William H. Catherino, M.D., Ph.D. (Chair) Learning Objectives Uniformed Services University of the Health Sciences At the conclusion of this session, participants should be able to: James B. Spies, M.D., M.P.H. 1. Explain the risks, benefits, and optimal patient MedStar Georgetown University Hospital characteristics for radiologic treatment, with a focus on Jacques G. Donnez, M.D. uterine artery embolization. Société de Recherche pour l’Infertilité, Brussels 2. Explain the risks, benefits, and optimal patient characteristics for medical treatment, with a focus on Needs Assessment and Description ulipristal acetate therapy. Nonsurgical treatment of uterine leiomyomas is rapidly advancing, due both to improved understanding of leiomyoma ACGME Competency biology and limitations in surgical intervention. The session Patient Care will focus on the most up-to-date advances and data on radiologic and medical treatments. This session will provide

Wednesday, October 19, 2016 AR 3:30 pm - 5:00 pm

NON- Symposium CME CE ARS

Howard and Georgeanna Jones Endowed Symposium on Learning Objectives Advanced Reproductive Technology: Fresh versus Frozen At the conclusion of this session, participants should be able to: Donor Eggs 1. Demonstrate that a vitrified-oocyte donation program can be as effective as a fresh-oocyte donor program. Endowed by a 2010 educational grant from EMD Serono, Inc. 2. Define the parameters for determining adequate oocyte numbers to achieve and/or required for storage Frank L. Barnes, Ph.D., H.C.L.D., C.C. (Chair) for fertility preservation. IVF Labs, L.L.C. 3. Define successful protocols for oocyte vitrification. Ana Cobo Cabal, Ph.D. IVI Valencia ACGME Competency Jamie A. Grifo, M.D., Ph.D. Patient Care NYU Langone Medical Center Masashige Kuwayama, Ph.D. Repro-Support Medical Research Centre

Needs Assessment and Description Improvement in methodologies for the vitrification of oocytes and embryos in recent years has led to the implementation of new strategies that improve patient management and outcomes. This symposium for clinicians, researchers, laboratory scientists, and allied health-care providers will present three lectures on the methodology, storage, and use of vitrified oocytes in ovum-donation programs and provide comparative data from fresh-ovum donation cycles.

nd 72 ASRM Scientific Congress & Expo 93 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Symposia

Wednesday, October 19, 2016 MH 3:30 pm - 5:00 pm Symposium

Mental Health Symposium III: Challenges and Controversies treating LGBTQ patients and will provide direction to medical in Treating Lesbian, Gay, Bisexual, Transgender, and and mental health-care professionals as well as attorneys Questioning Patients regarding how to best address these issues.

Angela K. Lawson, Ph.D. (Chair) Learning Objectives Northwestern University At the conclusion of this session, participants should be able to: Sarah Holley, Ph.D. 1. Identify legal issues that arise for LGBTQ couples pursuing San Francisco State University fertility treatment. Colleen M. Quinn, J.D. 2. Demonstrate sensitivity to the psychological issues President, American Academies of Adoption Attorneys and surrounding LGBTQ patients who present for fertility Assisted Reproductive Technology Attorneys treatment. 3. Examine their own clinic’s practices and determine what Needs Assessment and Description changes need to be made to make their clinic a safer and Assisted reproductive technology (ART) practitioners routinely more supportive environment for LGBTQ patients. offer fertility treatment to patients who identify as lesbian, 4. Discuss the unique treatment-related ethical issues that gay, bisexual, transgender, or questioning (LGBTQ). Research may arise in the course of fertility treatment with LGBTQ has shown that LGBTQ patients may experience discriminatory patients. treatment in fertility clinics. Even in the absence of discriminatory behaviors, LGBTQ patients must overcome ACGME Competency unique hurdles (e.g., biological, social, and legal) in fertility Patient Care treatment that require the awareness and attention of ART Professionalism practitioners and mental health professionals alike. This course will address the psychological, ethical, and legal issues of

Wednesday, October 19, 2016 NU 3:30 pm - 5:00 pm Symposium

Nurses’ Symposium III: Healthy Women, Healthy Babies: and early pregnancy nutrition, the challenges of assisting Maximizing Overall Health to Improve Fertility Outcomes women with known psychopathology, and typical fertility distress through early pregnancy, and the nursing role in this Anne Judge, R.N. (Chair) transition. Seattle Reproductive Medicine Judy B. Simon, M.S., R.D.N., C.D., C.H.E.S. Learning Objectives Mind Body Nutrition, PLLC At the conclusion of this session, participants should be able to: Alice D. Domar, Ph.D. 1. Develop improved communication styles and clinical Domar Center/Boston IVF practices to support nutrition and mental health needs from preconception through early pregnancy. Needs Assessment and Description Patients often want the fastest path to pregnancy, while ACGME Competency preconception health involves incremental change with large Patient Care future benefits. Once pregnant, many patients are surprised Interpersonal and Communication Skills by their continued anxiety and overwhelmed by the physical and emotional challenges of early pregnancy. How do clinics currently educate women on preconception health and support them in early pregnancy, and how could practices be improved? This symposium for nurse clinicians and other health-care professionals reviews research on preconception

nd 72 ASRM Scientific Congress & Expo 94 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Symposia

Wednesday, October 19, 2016 PM 3:30 pm - 5:00 pm Symposium

Practice Managers’ Symposium III: Management Techniques Learning Objectives Using Lean Principles At the conclusion of this session, participants should be able to: 1. Describe the principles of Lean Management (value added, Colin D. Thomas, M.H.A. (Chair) standard works, etc.). Columbia University Center for Women’s Reproductive Care 2. Discuss how to integrate and implement Lean Steve Hunsaker, B.S., S.P.H.S.C., V.E. Management principles into their practice. University of Utah Luca Boi, M.H.A. ACGME Competency University Health Care Systems-based Practice

Needs Assessment and Description With increased importance being placed on value, members of professional medical practices need to know how to implement “value-added” activities and continue improvements, such as workflow and protocol standardization, as well as how to create a culture of team problem-solving to bring value to the health-care team and patients. This session is intended to help practice members of all levels learn about value-added techniques to apply to their everyday work and management of their practice.

nd 72 ASRM Scientific Congress & Expo 95 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Symposia

Wednesday, October 19, 2016 SC EP 3:30 pm - 5:00 pm Symposium

ESHRE Symposium: Stem Cell-based Strategies and Future This interactive session for clinicians and scientists involved in Challenges for Fertility Preservation in Boys reproductive medicine and clinical and oncology summarizes the present evidence of treatment-associated Stefan Schlatt, Ph.D. (Chair) testicular toxicity in male cancer survivors and after HSCT. University Münster, Germany Challenges and limitations will be discussed and an attempt Kirsi Jahnukainen, M.D., Ph.D. will be made to judge the availability of novel procedures for Children’s Hospital, Helsinki University Central Hospital, Helsinki, prepubertal boys in the near future. Finland

Needs Assessment and Description Learning Objectives Advances in the treatment of childhood, adolescent, and young At the conclusion of this session, participants should be able to: adult cancers have greatly improved the 5-year survival rate, 1. Identify cancer survivors at high risk of infertility. which now exceeds 80%. Due to the growing population of 2. Discuss variations in with time after long-term survivors, the impact of cancer treatment–related cancer treatment and how spermatogenetic recovery chronic health conditions on quality of survival has become impacts fertility. evident. A prominent concern among male survivors is the 3. Summarize surveillance methods for evaluating cancer increased risk of gonadotoxicity. Conditioning therapies treatment effects on testicular function. for hematopoietic stem cell transplantation (HSCT), very 4. Discuss the biology of male germline stem cells. high cumulative doses of alkylating agents, and irradiation 5. Explain the options for fertility preservation via germ-cell exposure on testis are widely believed to cause impaired transplantation and xenografting. spermatogenesis. However, relatively few published studies 6. Evaluate options for and risks and limitations of in vitro using semen analysis can be identified, and there are several spermatogenesis. significant gaps in current knowledge. ACGME Competency While cryopreservation of sperm is the standardized method Medical Knowledge of fertility preservation in adult patients facing gonadotoxic Patient Care oncological therapy, this strategy cannot be applied in prepubertal boys. Spermatogonial stem cells (SSCs) may provide novel strategies for male fertility preservation. These cells colonize the testes from birth to adulthood; their regenerative capacity to re-colonize the testicular stem cell niches and reconstitute spermatogenesis after germ-cell depletion has been revealed in experimental studies. In vitro expansion of SSCs provides novel and broad perspectives. Germ-cell transplantation is considered a promising strategy. The generation of sperm in xeno- or autografts as well as in vitro generation of sperm have recently evoked enormous scientific interest. However, no studies using isolated germ cells have as yet resulted in an efficient process resulting in abundant numbers of sperm. Numerous studies have recently revealed worthy pieces of information and showed that restoration of the microenvironment may enable pre-meiotic germ cells to undergo meiosis in vitro.

nd 72 ASRM Scientific Congress & Expo 96 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Symposia

Wednesday, October 19, 2016 AR 3:30 pm - 5:00 pm Symposium

AMMR Symposium: Diferencias Geográficas de Acceso a los there is great interest in studying these differences and Tratamientos de Reprodución Asistida en América how to make reproductive services available to the larger population of Latin Americans in their respective countries. Supported in part by an educational grant from Cook Medical This educational activity is intended for obstetricians/ gynecologists, reproductive endocrinology and infertility Presented in Spanish specialists, embryologists, IVF laboratory directors, and other health-care professionals involved in ART, with emphasis on Emilio Valerio, M.D. (Chair) the distribution and availability of services throughout Latin President, AMMR America. This symposium will be presented in Spanish. Sergio Papier, M.D. Center of Studies in Genetics and Gynecology Learning Objectives J. Ricardo Loret de Mola, M.D., F.A.C.S., F.A.C.O.G. At the conclusion of this session, participants should be able to: Southern Illinois University 1. Summarize the availability of ART services in Latin Alberto Kably Ambe, M.D. America. Centro Mexicano de Fertilidad 2. Describe services and coverage available in Mexico, the United States, and Argentina. Needs Assessment and Description 3. Evaluate the best way to increase services in Latin America. As Latin American countries have become more affluent, their middle class has expanded and assisted reproductive ACGME Competency technology (ART) has become available. However, the Systems-based Practice penetration of services has been limited, and there are great differences in the quality of services provided. Therefore,

Wednesday, October 19, 2016 EP 3:30 pm - 5:00 pm

NON- Symposium CME CE ARS

JSAR Symposium: Implantation Disorder: What Are the and embryo. Japanese scientists have explored and developed Japanese Strategies? unique methods for the solution of this problem. This session for physicians, nurses, embryologists, scientists, and Yoshiharu Morimoto, M.D., Ph.D. (Chair) researchers will facilitate better understanding of implantation HORAC Grand Front Osaka Clinic disorder. Hidetaka Okada, M.D., Ph.D. Kansai Medical University Learning Objectives Masahide Shiotani, M.D. At the conclusion of this session, participants should be able to: Hanabusa Women Clinic 1. Explain what implantation disorder is from an Aisaku Fukuda, M.D., Ph.D., H.C.L.D. (A.B.B.) immunological and endocrinological point of view, IVF Osaka Clinic including an understanding of the concept of implantation window. Needs Assessment and Description 2. Describe what kinds of tests and analyses are needed for a The fertilization problem was almost solved by solution to implantation disorder. intracytoplasmic sperm injection, and embryos have been 3. Discuss available options for the treatment of implantation cultured to by the development of sophisticated disorder. culture methods. However, we do have not enough measures to deal with implantation disorder. In reproductive medicine, ACGME Competency “implantation” is a black box, because the phenomenon Patient Care is comprised of complex physiological reactions by the endometrium itself or the cross-action of both endometrium

nd 72 ASRM Scientific Congress & Expo 97 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Symposia

Wednesday, October 19, 2016 AN 3:30 pm - 5:00 pm

NON- Symposium CME CE ARS

You Are What Your Father Ate: Does Paternal Diet Matter for endocrinologists, other clinicians, nurses, and clinical and Fertility? basic scientists with insight into the role of paternal nutrition in fertility outcomes. Alex J. Polotsky, M.D., M.S. (Chair) University of Colorado, Denver Learning Objectives Jorge E. Chavarro, M.D., Sc.D. At the conclusion of this session, participants should be able to: Harvard T. H. Chan School of Public Health 1. Summarize evidence on the impact of diet on sperm Hassan W. Bakos, Ph.D. parameters and male fertility. Monash IVF Group 2. Discuss the association of sperm parameters and male phenotype with fertility outcomes above and beyond Needs Assessment and Description fertilization and conception. Women are the target of most advice regarding lifestyle modification for improving fertility. However, increasing ACGME Competency evidence suggests that lifestyle modifications in male partners Patient Care may have major impact on semen quality parameters and clinical outcomes. This session will provide reproductive

Wednesday, October 19, 2016 ME 3:30 pm - 5:00 pm Symposium

Menopause Track Symposium: The Declining Oocyte Pool: Is Learning Objectives It Simply a Preprogrammed Event or Does the Environment At the conclusion of this session, participants should be able to: Have a Significant Influence? 1. Discuss existing literature and data surrounding actual follicular pool measurements as well as natural population Julia V. Johnson, M.D. (Chair) studies. University of Massachusetts Medical School 2. Review the genetic associations, variation, or loci Amber R. Cooper, M.D. associated with key ovarian functions. Centers for Reproductive Medicine and Wellness 3. Describe the potential impact of environmental exposures Karl R. Hansen, M.D., Ph.D. such as tobacco, endocrine-disrupting chemicals, and University of Oklahoma College of Medicine cytotoxic therapies on the ovary.

Needs Assessment and Description ACGME Competency Both natural and pathologic ovarian aging remain poorly Medical Knowledge understood. While there is a clear age-dependent decline in oocyte quality and quantity, the variability among women is difficult to predict and study. The large variation in ovarian aging and age at cessation of menses among women may be preprogrammed due to genetic influence but also affected by environmental exposures. Improved knowledge of the mechanisms involved in oocyte pool endowment and decline over time is critical. This symposium will provide a current update of the literature surrounding this complex puzzle for clinicians and scientists in reproductive medicine.

nd 72 ASRM Scientific Congress & Expo 98 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Interactive Sessions

Monday, October 17, 2016 AC 1:15 pm - 2:15 pm Interactive Session

Access to Infertility Care in the United States: The State of any professional entrusted with the reproductive health of men Insurance Coverage and Its Impact on Care and women. Roving Speaker Format Learning Objectives Barbara L. Collura, M.A. At the conclusion of this session, participants should be able to: RESOLVE: The National Infertility Association 1. Describe the role of underwriting (insurance coverage) in the assurance of access to infertility care. Needs Assessment and Description 2. Identify the public and private entities involved in Access to infertility care in general and assisted reproductive infertility underwriting. technology in particular is substantially compromised 3. Identify strategies to remedy this situation in the United in the United States when assessed relative to other States. developed nations. At the core of this challenge is the state of underwriting (insurance coverage) of relevant benefits as it ACGME Competency currently exists in the United States. This interactive session Systems-based Practice will discuss the status quo and point out potential remedies. It follows that this interactive session is of potential interest to

Monday, October 17, 2016 AN 1:15 pm - 2:15 pm

NON- Interactive Session CME CE ARS

Vasectomy Reversal versus Sperm Retrieval Learning Objectives Case Presentations At the conclusion of this session, participants should be able to: 1. Describe the advantages and disadvantages of vasectomy Peter N. Schlegel, M.D. (Chair) reversal for post-vasectomy infertility. Weill Cornell Medicine 2. Discuss the cost implications of treatment with vasectomy Sheldon H. F. Marks, M.D. reversal or in vitro fertilization with sperm retrieval. International Center for Vasectomy Reversal Bruce R. Gilbert, M.D., Ph.D. ACGME Competency The Smith Institute for Urology, Hofstra Northwell School of Patient Care Medicine Systems-based Practice

Needs Assessment and Description The management of couples with post-vasectomy infertility is a common clinical scenario. The target audience for this session includes male fertility experts and female fertility experts who counsel or provide treatment for post-vasectomy infertility, as well as others interested in learning about treatment options in this scenario.

nd 72 ASRM Scientific Congress & Expo 99 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Interactive Sessions

Monday, October 17, 2016 EM 1:15 pm - 2:15 pm

NON- Interactive Session CME CE ARS

Embryo Disposition: Out of the Freezer and into the Abyss: making disposition decisions, and others are simply walking What Are We Going to Do with All These Embryos? away and abandoning their embryos altogether. Even clinics Case Presentations with established protocols for dealing with embryo disposition and abandonment may feel uncomfortable following those Sangita K. Jindal, Ph.D., H.C.L.D. (Chair) protocols when they are forced to be the decision maker. This Albert Einstein College of Medicine interactive session is intended for clinicians and scientists Nidhi Desai, J.D. involved in reproductive medicine, and will involve audience Ballard, Desai, & Miller participation via case presentation, expert discussion, and Judith Kottick, L.C.S.W. audience response questions. Reproductive Medicine Associates of New Jersey Learning Objectives Needs Assessment and Description At the conclusion of this session, participants should be able to: Decisions regarding embryo disposition can test a person’s 1. Identify the psychological challenges and barriers for ethical compass, religious faith, mental health, and ideas patients considering each embryo disposition option. about family. When in treatment, many patients are laser- 2. Discuss best practices for storage management workflows focused on getting pregnant and do not anticipate the of cryopreserved embryos in the lab and the legal challenge of choosing among available options for their complications that surround them. hard-won embryos. With rapid advances in the vitrification 3. Describe best practices for standard operating procedures of oocytes and embryos, combined with a growing subset of surrounding embryo storage and embryo abandonment patients who are transferring their embryos post-thaw either and the legal implications of these policies. after being frozen intact or following genetic screening, the number of cryopreserved embryos in the United States has increased each year. But with every advance in technology ACGME Competency comes unintended consequences. Our storage tanks are filling Systems-based Practice up, our patients are conflicted, and our clinics are faced with complex compliance and liability problems that are becoming increasingly intricate. Some patients are having difficulty

Monday, October 17, 2016 GE 1:15 pm - 2:15 pm

NON- Interactive Session CME CE ARS

Should Preimplantation Genetic Testing for Aneuploidy Be fertilization (IVF), but what is the evidence? This session Performed on Every Patient? is designed to assist clinicians and scientists with a better Debate understanding of the methods employed with PGS, including the advantages and limitations, as well as the selection of patients. Supported in part by an educational grant from Illumina Learning Objectives Lawrence C. Layman, M.D. (Chair) At the conclusion of this session, participants should be able to: Augusta University 1. Discuss the most common methods used for PGS and their Glenn L. Schattman, M.D. advantages and disadvantages. Weill Cornell Medicine 2. Discuss the evidence for PGS in unexplained refractory Richard T. Scott, Jr., M.D. infertility, failed IVF, and all patients. Reproductive Medicine Associates of New Jersey ACGME Competency Needs Assessment and Description Patient Care Many reproductive medicine practitioners are using Systems-based Practice preimplantation genetic screening (PGS) prior to in vitro

nd 72 ASRM Scientific Congress & Expo 100 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Interactive Sessions

Monday, October 17, 2016 AR 1:15 pm - 2:15 pm

NON- Interactive Session CME CE ARS

SART National Report: Where Are We Going? ART practitioners, practice managers, and others involved in Case Presentations clinic outcomes reporting will illustrate the improvements, demonstrate how to filter the outcomes that best reflect a Supported in part by an educational grant from Cook Medical clinic’s practice pattern, answer any questions about the new report, and solicit suggestions for further improvement. James P. Toner, M.D., Ph.D. (Chair) Atlanta Center for Reproductive Medicine Learning Objectives Amy E. T. Sparks, Ph.D., H.C.L.D. At the conclusion of this session, participants should be able to: University of Iowa Hospitals and Clinics 1. Illustrate the full range of filters available to display outcomes. Needs Assessment and Description 2. Identify the differences among the “primary,” The new Society for Assisted Reproductive Technology Clinic “subsequent,” and “cumulative” outcomes per intended Summary Report corrects deficiencies in the prior reporting of retrieval. assisted reproductive technology (ART), but is more complex. “Freeze-all” cycles, embryo accumulation, preimplantation ACGME Competency genetic screening, and other current practices made the Systems-based Practice prior reporting misleading, if not invalid. This session for

Monday, October 17, 2016 RS FP 1:15 pm - 2:15 pm

NON- Interactive Session CME CE ARS

Reproductive Surgery Track Interactive Session: Learning Objectives Fertility-sparing Surgical Options in the Management of At the conclusion of this session, participants should be able to: Gynecologic Malignancies 1. Describe and discuss the surgical management of Panel Discussion women of reproductive-age diagnosed with gynecologic malignancies. Mary Ellen Pavone, M.D., M.S.C.I. (Chair) 2. Describe and discuss methods of fertility preservation in Northwestern University women of reproductive-age diagnosed with gynecologic Togas Tulandi, M.D., M.H.C.M. malignancies. McGill University Farr R. Nezhat, M.D. ACGME Competency Weill Cornell Medical College Patient Care

Needs Assessment and Description It is estimated that 21% of gynecologic cancers affect women of reproductive age. Standard treatment for many gynecologic cancers often includes removal of the ovary and/or uterus. Fertility-preserving options are promising, but the majority of these procedures are not considered the standard of care. This session for clinicians and allied health-care providers will describe and discuss fertility preservation options for this group of women.

nd 72 ASRM Scientific Congress & Expo 101 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Interactive Sessions

Monday, October 17, 2016 RE 1:15 pm - 2:15 pm Interactive Session

Do We Always Need Evidence from Randomized Controlled Needs Assessment and Description Trials in Reproductive Medicine? Randomized controlled trials (RCTs) are considered the best Debate research design to establish effectiveness, yet in the field of reproductive medicine they are not always available. This Cynthia Farquhar, M.B.Ch.B., M.D., M.P.H., F.R.A.N.C.O.G., debate will cover the need (or not) for RCTs and why they are C. R.E.I. (Chair) often overlooked in this field. All ASRM members whether they University of Auckland are physicians, nurse, psychologists, or scientists should find Robert A. Wild, M.D., Ph.D., M.P.H., this debate of interest. Oklahoma University Health Sciences Center Ben Mol, M.D., Ph.D. Learning Objectives The University of Adelaide At the conclusion of this session, participants should be able to: Denny Sakkas, Ph.D. 1. Explain the need for evidence from randomized controlled Boston IVF trials in reproductive medicine. Kurt T. Barnhart, M.D., M.S.C.E. 2. Summarize the barriers to undertaking well-designed University of Pennsylvania randomized trials in reproductive medicine.

ACGME Competency Systems-based Practice

Monday, October 17, 2016 CO 1:15 pm - 2:15 pm Interactive Session

Contraception Track Interactive Session: Learning Objectives Essure®: Uses and Liabilities At the conclusion of this session, participants should be able to: Panel Discussion 1. Analyze existing data on hysteroscopic sterilization. 2. Interpret the FDA’s black box warning on Essure®. Aileen Gariepy, M.D., M.P.H. (Chair) 3. Determine future directions for Essure® research and Yale School of Medicine clinical care. Diana H. Wu, M.D. Oregon Health & Science University ACGME Competency Practice-based Learning and Improvement Needs Assessment and Description In February of 2016, the US Food and Drug Administration issued a black box warning for Essure®, the only hysteroscopic sterilization device available, and mandated the manufacturers of the device to conduct a new clinical study “to determine heightened risks for particular women.” What does this warning mean for patients and clinicians? This interactive session is for clinicians and researchers interested in methods of permanent sterilization, use of hysteroscopic sterilization for infertility treatment, and evaluation of new medical devices.

nd 72 ASRM Scientific Congress & Expo 102 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Interactive Sessions

Tuesday, October 18, 2016 AC 1:15 pm - 2:15 pm Interactive Session

Access to Care: Sociocultural Factors Learning Objectives Roving Speaker At the conclusion of this session, participants should be able to: 1. Demonstrate and reveal the social, cultural, historical, and Supported in part by an educational grant from Cook Medical geographic barriers in access to care. 2. Identify barriers to care that go beyond financial barriers Ann V. Bell, Ph.D. (Chair) and biomedical solutions. University of Delaware Arthur L. Greil, Ph.D. ACGME Competency Alfred University Systems-based Practice

Needs Assessment and Description This live session focuses on access to health care, specifically the social, cultural, and geographic barriers shaping such access. This session is designed for all health-care professionals, especially those interested in health equity and factors beyond .

Tuesday, October 18, 2016 RS AN 1:15 pm - 2:15 pm Interactive Session

Reproductive Surgery Track Interactive Session: Learning Objectives Surgical Sterilization: Vasal versus Tubal Occlusion At the conclusion of this session, participants should be able to: Debate 1. Describe the different male and female sterilization procedure techniques. Stanton Honig, M.D. (Chair) 2. Discuss the risks of vasectomy, tubal ligation, and Yale Urology hysteroscopic sterilization procedures. Jeffrey T. Jensen, M.D., M.P.H. 3. Summarize the long-term success and outcomes of both Oregon Health & Science University male vasectomy and female tubal sterilization procedures.

Needs Assessment and Description ACGME Competency There is a practice gap in clinician understanding of the risks, Patient Care benefits, and alternatives of permanent sterilization options for men and women. This session, for practicing obstetricians/ gynecologists, urologists, and primary-care providers who treat men and women of reproductive age considering family-planning options, will provide information about the risks, success rates, and long-term outcomes of permanent sterilization procedures for men and women. Presenters will discuss an algorithm to help providers assess the minimally invasive nature and better understand the success rates of male and female permanent contraception options, including long-term outcomes. Participants also will learn to identify the barriers to patient understanding when learning about permanent sterilization options.

nd 72 ASRM Scientific Congress & Expo 103 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Interactive Sessions

Tuesday, October 18, 2016 FP 1:15 pm - 2:15 pm Interactive Session

Reproductive Health Needs in Cancer Survivors: Fertility, that take into account their prior cancer history. Through Contraception, and Preconception Counseling a case-based format, this session will cover fertility/birth Roving Speaker control, pregnancy, and preconception genetic counseling considerations for this population. This interactive session is Irene Su, M.D., M.S.C.E. (Chair) intended for reproductive endocrinologists, urologists, nurses, University of California, San Diego genetic counselors, and other allied health providers who Amy Jordan, M.S., L.C.G.C. provide care for young cancer survivors. Reprogenetics James F. Smith, M.D., M.S. University of California, San Francisco Learning Objectives At the conclusion of this session, participants should be able to: Needs Assessment and Description 1. Manage fertility and preconception care of young cancer After undergoing cancer treatments, young female and male survivors who have completed cancer treatments. cancer survivors are at high risk of late effects related to reproductive health, including infertility, limited contraception ACGME Competency options, and pregnancy-related complications. Young survivors Patient Care seek reproductive health counseling and management

Tuesday, October 18, 2016 FP 1:15 pm - 2:15 pm

NON- Interactive Session CME CE ARS

Pediatric and Adolescent Gynecology: Preserving Future syndrome (PCOS) and future fertility; and management of Reproductive Function (Joint Session with the North the incidental uterine septum in adolescents and young American Society for Pediatric and Adolescent Gynecology) adults. This session is targeted to health-care providers of all Case Presentations levels, students, and anyone with an interest in pediatric and adolescent populations. Beth W. Rackow, M.D. (Chair) Columbia University Medical Center Learning Objectives Staci E. Pollack, M.D., M.S. At the conclusion of this session, participants should be able to: Albert Einstein College of Medicine 1. Describe available options for fertility preservation in Leslie A. Appiah, M.D. children and adolescents with cancer. University of Kentucky College of Medicine 2. Describe management options for PCOS that may benefit an adolescent’s future fertility. Needs Assessment and Description In children and adolescents with medical and surgical ACGME Competency disorders, attention to preserving future reproduction is Patient Care important. Providers should be able to address some of the unique aspects of care for this young population. This interactive session will review three timely topics in pediatric and adolescent gynecology: fertility preservation in children and adolescents with cancer; adolescent polycystic ovary

nd 72 ASRM Scientific Congress & Expo 104 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Interactive Sessions

Tuesday, October 18, 2016 EM AR 1:15 pm - 2:15 pm

NON- Interactive Session CME CE ARS

Before Things Go Wrong: Minimizing Drama in the Learning Objectives Embryology Laboratory At the conclusion of this session, participants should be able to: Roving Speaker 1. Discuss successful tools, strategies, and systems for labeling and tracking laboratory specimens to minimize Supported in part by an educational grant from Cook Medical the potential for errors. 2. Establish procedures with a proper chain of command and Klaus E. Wiemer, Ph.D., H.C.L.D., A.C.E. (Chair) witnessing protocols to reduce the potential for errors. Poma Fertility 3. Discuss previous errors that have occurred and what can Dawn A. Kelk, Ph.D., H.C.L.D. be learned from these. Yale Fertility Center 4. Establish methods that will reduce the severity of any errors that may occur. Needs Assessment and Description Embryologists strive to reduce the potential for laboratory ACGME Competency mishaps and the consequences when errors do occur. Systems-based Practice Increased use of blastocyst culture, vitrification, and embryo biopsy for preimplantation genetic diagnosis and screening have all contributed to an increase in the complexity of tasks performed by embryologists. This increase in complexity of tasks also brings an increased potential for laboratory mishaps. Errors may occur throughout the laboratory process and include mishandling or mislabeling of specimens, improper chain of custody, or lack of witnesses for procedures. Many systems exist to reduce the potential for errors in the lab, but few if any of these procedures have been standardized and are used consistently in all labs today. This interactive session for laboratory and nursing personnel, clinical staff, as well as physicians who work in the area of assisted reproductive technology will cover systems that can be proactively put in place to reduce the potential of lab errors and reduce the severity of risks. Attendees are encouraged to actively participate in this session and share thoughts as well as suggestions.

nd 72 ASRM Scientific Congress & Expo 105 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Interactive Sessions

Tuesday, October 18, 2016 PC 1:15 pm - 2:15 pm

NON- Interactive Session CME CE ARS

Do We Need to Diagnose Polycystic Ovary Syndrome (PCOS) Learning Objectives in Adolescents? At the conclusion of this session, participants should be able to: Case Presentations 1. Explain the overlap between “normal” adolescent development and manifestations of adolescent PCOS in Lubna Pal, M.B.B.S., M.Sc., F.R.C.O.G., F.A.C.O.G. (Chair) order to appreciate the subtle yet important differences in Yale School of Medicine criteria for diagnosing PCOS in adolescent girls compared Marla Lujan, Ph.D. with adult women. Cornell University 2. Describe the metabolic burden of PCOS and become Tania S. Burgert, M.D. familiar with common management approaches to Children’s Mercy Hospital improving health. 3. Individualize management of PCOS-related signs and Needs Assessment and Description symptoms in adolescent girls. Polycystic ovary syndrome (PCOS) is the most common endocrinopathy of reproductive years. While genetic ACGME Competency predisposition, metabolic underpinnings, and primary Patient Care dysfunction of the hypothalamic-pituitary axis are suggested as mechanisms underlying the endocrine and metabolic disturbances of PCOS, the pathophysiology of this common disorder is not entirely clear. The last three decades have witnessed an evolution in efforts aimed at standardization of the nomenclature and criteria for diagnosing PCOS. Notably, however, applicability of the existing diagnostic criteria is limited to the adult woman. In the pediatric population, diagnosing PCOS can be particularly challenging given that acne and menstrual irregularity, clinical stigmata recognized as hallmarks of the condition, are the norm in the period of adolescence. Management of PCOS in the pediatric population should take into consideration not just the presenting symptoms, but must additionally harness the covert risks to this population, which include disorders of mood and affect, metabolic disturbances, cardiovascular disease, type II diabetes, and reproductive concerns. This symposium will provide women’s health-care providers, allied health professionals, and trainees caring for adolescents and young adults with an understanding of concepts related to diagnosing PCOS in the adolescent population, and insight into the various treatment options available to address the common signs and symptoms.

nd 72 ASRM Scientific Congress & Expo 106 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Interactive Sessions

Tuesday, October 18, 2016 RE 1:15 pm - 2:15 pm

NON- Interactive Session CME CE ARS

Optimizing Endometrial Receptivity Learning Objectives Debate At the conclusion of this session, participants should be able to: 1. Identify the indications and limitations of available Bruce Lessey, M.D., Ph.D. (Chair) screening tests for endometrial receptivity. Greenville Health System – USC School of Medicine 2. Interpret results and adjust clinical recommendations Carlos Simon, M.D., Ph.D. based on endometrial receptivity test results. Valencia University Steven L. Young, M.D., Ph.D. ACGME Competency University of North Carolina School of Medicine Patient Care

Needs Assessment and Description Tests for endometrial receptivity have increased in number over the past 10 years, and confusion exists over their utility. This interactive session for clinicians, researchers, and laboratory scientists will debate the use of array-based screening methods versus single or focused biomarkers for the assessment of endometrial receptivity.

Wednesday, October 19, 2016 AC AR 1:15 pm - 2:15 pm Interactive Session

Access to Care: Modifying Assisted Reproductive Learning Objectives Technology Techniques At the conclusion of this session, participants should be able to: Roving Speaker 1. Explain why standard protocols for delivering ART services in the USA result in limited access to care for some couples Supported in part by an educational grant from Cook Medical and individuals. 2. Critically evaluate standard and “cutting-edge” practices Kevin J. Doody, M.D., H.C.L.D. (Chair) employed in the context of value-based health care. Center for Assisted Reproduction 3. Discuss the concept of “diminishing returns” as applied to efforts to improve ART outcomes. Needs Assessment and Description Assisted reproductive technology (ART) as conventionally ACGME Competency practiced in the United States is complicated and expensive. Patient Care Geographic access is limited to larger metropolitan areas. Systems-based Practice Presenters of this session for ART care providers who are frustrated by an inability to provide needed care to their patients will discuss potential solutions to well-documented impediments to access ART treatment. The focus of this presentation will be re-examination of what we know about optimal in vitro fertilization pre-cycle evaluation, drug protocols, cycle monitoring, and embryology laboratory services. Presenters will discuss options to lessen these burdens without significant compromise to the chance of success.

nd 72 ASRM Scientific Congress & Expo 107 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Interactive Sessions

Wednesday, October 19, 2016 AN 1:15 pm - 2:15 pm

NON- Interactive Session CME CE ARS

How to Counsel Men with Male Factor Infertility Learning Objectives Letterman Format At the conclusion of this session, participants should be able to: 1. Discuss men’s reactions to infertility. Jay Sandlow, M.D. (Chair) 2. Identify effective methods and techniques for working with Medical College of Wisconsin infertile men. Ajay K. Nangia, M.B.B.S. University of Kansas Medical Center ACGME Competency William D. Petok, Ph.D. Interpersonal and Communication Skills Thomas Jefferson University

Needs Assessment and Description Males with infertility comprise a significant percentage of the infertile population. Men’s emotional reactions to a diagnosis of infertility have been studied far less than those of women. However, there is a growing body of research which indicates that men do feel the loss associated with a failure to conceive and have unique methods of adapting. This session is designed for clinicians and allied health professionals involved in infertility care and counseling.

Wednesday, October 19, 2016 EP 1:15 pm - 2:15 pm

NON- Interactive Session CME CE ARS

Should We Be Screening and Treating Chronic Endometritis Learning Objectives for Recurrent Pregnancy Loss and Failed In Vitro At the conclusion of this session, participants should be able Fertilization? to: Panel Discussion 1. Identify the lack of outcome-based diagnostic criteria for chronic endometritis. Thomas M. Price, M.D. (Chair) 2. Discuss the current literature on a relationship between Duke University chronic endometritis and implantation failure. Humberto Scoccia, M.D. 3. Explain the current knowledge relating chronic University of Illinois College of Medicine at Chicago endometritis to recurrent pregnancy loss.

Needs Assessment and Description ACGME Competency In an informal format, this session will briefly review the Medical Knowledge current literature on chronic endometritis and then open the session to audience participation. This session for reproductive endocrinology and infertility (REI) physicians, gynecologists with an interest in infertility and recurrent pregnancy loss, REI fellows, obstetrics/gynecology residents, medical students, and nurse practitioners providing fertility care will strive to gather opinions on a possibly neglected area of infertility care.

nd 72 ASRM Scientific Congress & Expo 108 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Interactive Sessions

Wednesday, October 19, 2016 AR 1:15 pm - 2:15 pm

NON- Interactive Session CME CE ARS

Managing the Gray Results with Preimplantation Genetic of uncertain significance and detect mosaicism in a biopsied Testing: What Do We Tell Patients When the Results Are Not sample. However, there are no professional guidelines on how Black or White? to act on such results. This interactive session will provide a Case Presentations forum for preimplantation genetic diagnosis providers, such as physicians, embryologists, genetic counselors, and nurses, to Supported in part by educational grants from Cook Medical discuss these issues. and Illumina Learning Objectives Lauri Black, M.S., L.C.G.C. At the conclusion of this session, participants should be able to: Pacific Reproductive Genetic Counseling 1. Identify preimplantation genetic test results that are Emily Mounts, M.S., C.G.C. unclear or controversial and may warrant further Oregon Reproductive Medicine consideration in discussion with patients. Alyssa C. Snider, Ph.D., M.S., L.C.G.C. 2. Review challenges associated with such results. IviGen 3. Suggest ways to manage such results with patients.

Needs Assessment and Description ACGME Competency As preimplantation genetic testing technology expands, we Patient Care may find ourselves in uncharted territory regarding counseling Interpersonal and Communication Skills our patients about results that are unclear or controversial. For example, technology now allows us to test embryos for variants

Wednesday, October 19, 2016 RS ED 1:15 pm - 2:15 pm

NON- Interactive Session CME CE ARS

Reproductive Surgery Track Interactive Session: Needs Assessment and Description Controversies in the Management of Advanced This session for reproductive specialists treating patients with Endometriosis and Endometrioma endometriosis with and without pelvic pain and structural Case Presentations defects will address the value and timing of medical and surgical intervention prior to and subsequent to assisted Supported in part by an educational grant from AbbVie reproductive technology. Learning Objectives Mark W. Surrey, M.D. (Chair) At the conclusion of this session, participants should be able to: Southern California Reproductive Center 1. Identify appropriate treatment and timing of interventions Grace M. Janik, M.D. for women with endometriosis who pursue assisted Reproductive Specialty Center reproductive technology. Tommaso Falcone, M.D. Cleveland Clinic ACGME Competency Patient Care

nd 72 ASRM Scientific Congress & Expo 109 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Interactive Sessions

Wednesday, October 19, 2016 ME 1:15 pm - 2:15 pm Interactive Session

Menopause Track Interactive Session: Learning Objectives Hormone Therapy in Postmenopausal Women: Update on At the conclusion of this session, participants should be able to: Clinical Trials 1. Enumerate the known benefits of menopausal hormone Meet the Professor therapy on the long-term health of menopausal women. 2. Discuss the health risks of menopausal hormone therapy Nanette F. Santoro, M.D. (Chair) on the long-term health of menopausal women. University of Colorado School of Medicine ACGME Competency Needs Assessment and Description Patient Care Recent clinical trials in hormone therapy have sought to describe the long-term health outcomes of women who have received menopausal hormone therapy interventions and to test the hypothesis that a critical window of estrogen exposure exists, during which time key benefits to the cardiovascular system and possibly to the brain will be realized. This session will equip the non-menopause specialist with an in-depth discussion of the results of recent clinical trials and their implications for clinical care.

nd 72 ASRM Scientific Congress & Expo 110 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Additional Sessions

Tuesday, October 18, 2016 RS 11:15 am - 12:45 pm Telesurgery

Reproductive Surgery Track Telesurgery: This live telesurgery presentation will present two cases of Hysteroscopic Leiomyoma Resection Techniques Using the uterine submucosal leiomyoma utilizing both methods of Resectoscope and Morcellator resection. This presentation is designed for reproductive surgeons interested in the hysteroscopic management of Steven R. Lindheim, M.D., M.M.M. (Surgeon) uterine submucosal leiomyomata. Wright State University Boonshoft School of Medicine Samantha Simpson, M.D. Learning Objectives Wright State University Boonshoft School of Medicine At the conclusion of this session, participants should be able to: Bala Bhagavath, M.D. 1. Explain how to resect submucosal uterine leiomyomata University of Rochester Medical Center using both the resectoscope and morcellator. Steven F. Palter, M.D. 2. Discuss adjunctive methods to assure adequate resection Gold Coast IVF including the use of intra-operative ultrasound and decompression. Needs Assessment and Description 3. Describe options to prevent postoperative adhesion Submucosal leiomyoma is a cause of both abnormal uterine formation including the use of a pediatric Foley catheter bleeding and infertility. The historical standard for removal has and hormone supplementation. been resectoscopy, but an alternative surgical method employs the use of the hysteroscopic morcellator. ACGME Competency Patient Care

Tuesday, October 18, 2016 RS FI 1:00 pm - 2:30 pm Surgical Tutorial

Reproductive Surgery Track Surgical Tutorial: myomectomy, decreasing the possibility of conversion to Tissue Removal: Fibroids, Cysts, and Other Masses laparotomy. This session is designed to assist reproductive surgeons and other health-care providers in procedural Supported in part by an educational grant from AbbVie decision making and counseling for myomectomy.

Ceana H. Nezhat, M.D. (Chair) Learning Objectives Nezhat Medical Center At the conclusion of this session, participants should be able to: Charles E. Miller, M.D., F.A.C.O.G. 1. Identify the risks of intraperitoneal tissue dissemination Advocate Lutheran General Hospital during surgery. Antonio R. Gargiulo, M.D. 2. Explain methods to decrease the risk of parasitic myoma Harvard Medical School and similar iatrogenic conditions. 3. Counsel patients regarding the risks and benefits involved Needs Assessment and Description with tissue extraction techniques. The dilemma surrounding morcellation and its impact on minimally invasive surgery in the past few years have ACGME Competency influenced the surgical approach in reproductive surgery. In Patient Care this video-based tutorial, we will discuss the pearls and pitfalls of tissue extraction with a focus on laparoscopy and robotic

nd 72 ASRM Scientific Congress & Expo 111 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Additional Sessions

Monday, October 17, 2016 MH 10:30 am - 11:30 am

NON- MHPG Clinical Session CME CE ARS

The Myth of Anonymity: Are We Misleading Our Patients? Learning Objectives At the conclusion of this session, participants should be able to: Elaine R. Gordon, Ph.D. 1. Summarize why the promise of anonymity in third-party Santa Monica/UCLA Hospital arrangement is a myth. 2. Describe the motivation for promoting anonymity in Needs Assessment and Description donation arrangements. Transparency is the catchphrase of the 21st century, making 3. Identify how anonymity has been compromised in today’s secrets, privacy, and anonymity things of the past when it technological world. comes to reproductive medicine and third-party arrangements. Technological advancements have given individuals access into ACGME Competency worlds previously unknown as social media, facial recognition Professionalism programs, and finder’s applications enable access to information about almost anyone at any time. Such searching generally takes basic computer know-how and a modicum of information to identify someone’s personal information. This session for providers of mental health in reproductive care explains how offers of anonymity to patients in their professional practices represent false promise and must not continue.

Monday, October 17, 2016 MH 11:45 am - 12:45 pm

NON- MHPG Clinical Session CME CE ARS

How to Design a Good Qualitative Research Study Learning Objectives At the conclusion of this session, participants should be able to: Mary P. Riddle, Ph.D. 1. Differentiate between qualitative and quantitative The Pennsylvania State University research. 2. Describe how to generate ideas that come from clinical Needs Assessment and Description practice. Although advanced reproductive technologies are well 3. Apply qualitative methods of recruitment, sampling, and established medically, the number of studies examining coding and how to use these methods to illuminate the psychosocial aspects of these technologies continues to lag subjective experience of research participants. behind. Mental health professionals who are clinicians and work with these populations may not always be actively ACGME Competency involved in research. However, mental health professionals Practice-based Learning and Improvement are uniquely qualified to engage in qualitative research in that it is “hypothesis-generating” research, which often can be developed directly out of clinical practice. This session will focus on qualitative research and how mental health professionals who specialize in reproductive medicine can develop this type of research. The session will focus on how to design a qualitative study, including all the elements necessary to develop, design, and collaborate on qualitative research projects.

nd 72 ASRM Scientific Congress & Expo 112 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Additional Sessions

Wednesday, October 19, 2016 MH 10:30 am - 11:30 am

NON- MHPG Clinical Session CME CE ARS

Cultural Considerations in the Psychological Testing of Learning Objectives Third-party Participants At the conclusion of this session, participants should be able to: 1. Develop an awareness of the various cultural issues that Linda D. Applegarth, Ed.D. may impact the assessment of egg donors, gestational Weill Medical College of Cornell University carriers, and intended parents. Ariadna Cymet Lanski, Psy.D. 2. Examine and integrate an understanding of cultural Fertility Centers of Illinois differences on psychometric assessment instruments and clinical interviews, with an emphasis primarily on clients Needs Assessment and Description from Spanish-speaking, Asian, and Eastern European Increasing diversity in our society offers a special challenge to backgrounds. the psychological assessment community. Therefore, there is an ongoing need by mental health professionals to have a ACGME Competency broader and current clinical understanding of how cultural Professionalism diversity impacts the assessment of participants in third-party reproduction. This Mental Health Professional Group clinical session will explore the multicultural factors and challenges of the psychosocial evaluation of third-party populations.

Wednesday, October 19, 2016 MH 11:45 am - 12:45 pm

NON- MHPG Clinical Session CME CE ARS

Ethics in Known Gamete Donation Learning Objectives At the conclusion of this session, participants should be able to: Claudia Pascale, Ph.D. 1. Apply a basic model for ethical reasoning in the counseling Institute for Reproductive Medicine and Sciences at Saint and evaluation of known gamete donor arrangements. Barnabas 2. Identify the practice guidelines and ethical principles Erica J. Mindes, Ph.D. applicable to the counseling and evaluation of participants Covington & Hafkin and Associates in known gamete donor collaborations.

Needs Assessment and Description ACGME Competency Known third-party arrangements can be complicated and Professionalism challenging, replete with potential overt and covert ethical Interpersonal and Communication Skills dilemmas involving all participants. This clinical consultation session is designed to assist the mental health professional in identifying ethical issues and to present a model for ethical reasoning in the counseling and evaluation of known gamete donor arrangements. Ethical principles from several sources and case vignettes will be utilized to present the material.

nd 72 ASRM Scientific Congress & Expo 113 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Additional Sessions

Wednesday, October 19, 2016 CO 1:15 pm - 2:15 pm Ryan Fellows Showcase

Contraception Track Ryan Fellows Showcase: Needs Assessment and Description Emerging Research in Contraception (in Cooperation with Significant time elapses between new research findings in the the Society of Family Planning) field of contraception and the publication of such findings. Clinicians and researchers in the field of contraception have Lisa Haddad, M.D., M.S., M.P.H. (Chair) identified that early presentation and discussion of emerging Emory University School of Medicine data are highly beneficial to those on the “front lines” to assist Melissa J. Chen, M.D., M.P.H. them in providing optimal patient care. University of California, Davis Shandhini Raidoo, M.D. Learning Objectives University of Hawaii At the conclusion of this session, participants should be able to: Ivana Thompson, M.D., M.S.C.I. 1. Discuss emerging data in the field of contraceptive care. Vanderbilt University School of Medicine Christy M. Boraas, M.D., M.P.H. ACGME Competency University of Minnesota Patient Care Holly Bullock, M.D., M.P.H. University of Utah Megan Lawley, M.D. Emory University

nd 72 ASRM Scientific Congress & Expo 114 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

OCTOBER 17-19, 2016 | SALT LAKE CITY, UT

Non-CME Educational Sessions • Video Sessions 116-124 • Roundtables 125-130 • Abstract Review Commitees 131, 132 • Oral Abstract Presentations 133-164 • Poster Abstract Presentations 165-235 • Abstract Topic Index 236-238 • Abstract Author Index 239-266 • Speaker Index 267-269 • Disclosures 270-288

SPONSORED BY THE AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE ASRM 2O16 SCIENTIFIC CONGRESS

NON- Video Sessions CME CE ARS

ASRM Video Committee Steven F. Palter, M.D., Video Program Chair Balasubramanian Bhagavath, M.D. James M. Hotaling, M.D., M.S. Ceana H. Nezhat, M.D. T. Arthur Chang, Ph.D. Kathleen Hwang, M.D. Dana A. Ohl, M.D. Michael I. Eisenberg, M.D. Edward D. Kim, M.D. David L. Olive, M.D. Tommaso Falcone, M.D. Steven R. Lindheim, M.D. Marc P. Portmann, M.T., M.H.A., E.L.D. Emilio Fernandez, M.D. Philip S. Li, M.D. Togas Tulandi, M.D. Antonio R. Gargiulo, M.D. Marius Meintjes, D.V.M., Ph.D.

Monday, October 17, 2016 4:00 pm - 5:30 pm

NON- Video Session 1 CME CE ARS

Moderators: Tommaso Falcone, Ceana Nezhat, Bala Bhagavath

V-1 4:00 PM V-2 4:08 PM ROBOTIC PARTIAL CYSTECTOMY FOR DEEPLY INFILTRATING SEGMENTAL BLADDER RESECTION FOR ENDOMETRIOSIS. C. ENDOMETRIOSIS OF THE BLADDER WALL. F. Nezhat,1 N. Nezhat, A. Nezhat; Center for Special Minimally Invasive and Lakhi2; 1Weill Cornell Medicine, New York, NY, 2Department Robotic Surgery, Palo Alto, CA. of Obstetrics and Gynecology, Richmond University Medical Center, Staten Island, NY. The genitourinary system is involved in about 1-2% of endometriosis cases. The bladder is most commonly involved, OBJECTIVE: To demonstrate techniques for safely resecting followed by ureter and kidney, in a ratio of 40:50:1. Treatment a deeply infiltrating endometriotic nodule invading the full of genitourinary endometriosis depends in part on the extent thickness of the bladder wall. of disease, both within the genitourinary system and in other locations, as well as future fertility desires of the patient. Surgical METHODOLOGY: The patient is a 29 year old, para 2002, management is preferred in intrinsic disease of the bladder, due presenting with non-cyclical pelvic pain of one year duration. to high rate of recurrence with medical management. Her surgical history included two previous cesarean deliveries and a diagnostic laparoscopy which confirmed the presence We present a 30-year-old nulligravida, who underwent of endometriosis involving the anterior cul-del-sac and operative laparoscopy for pain. Extensive treatment of uterosacral ligaments. On physical examination, there was endometriosis was performed and a mass consistent with a 4x4 cm palpable painful mass in the wall of the posterior endometriosis was observed in the bladder. Patient returned wall bladder. Cystoscopy confirmed a mass in the posterior for segmental bladder resection. bladder mucosa consistent with an infiltrative bladder wall endometriosis. Pre-procedure, bilateral ureteral catheters were The patient was discharged the same day and returned one placed under cystoscopy guidance. The patient had a robotic week later for ureteral stent removal. Cystoscopy at the time of assisted partial cystectomy and excision of all endometriotic stent removal demonstrated that the bladder was healing well. lesions. In order to complete the procedure, complete Cystogram was performed 2 weeks post-operatively. mobilization of the bladder from the lower uterine segment and cervix was necessary. The nodule was circumferential excised en-bloc. The defect was closed in two layers to form a V-3 4:15 PM tight seal. RECURRENT MASSIVE ASCITES DUE TO MOSSY CONCLUSIONS: Pathology confirmed DIE involving the full ENDOMETRIOSIS. E. C. Dun,1 C. Nezhat2; 1Obstetrics, thickness of the bladder wall. The patient was discharged on Gynecology, and Reproductive Science, Yale School of post-operative day one with a Foley catheter in place for one Medicine, New Haven, CT, 2Atlanta Center for Minimally Invasive week. Cystogram done two weeks post-operatively showed Surgery and, Atlanta, GA. complete healing of the bladder wall. The patient did well and was pain free at six weeks and three months of follow-up.

OBJECTIVE: The video presents a 26 year-old G0 female of Nigerian heritage with recurrent ascites. Three years previously she underwent an exploratory laparotomy for

nd 72 ASRM Scientific Congress & Expo 116 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Video Sessions CME CE ARS Monday, October 17, 2016 NON- 4:00 pm - 5:30 pm Video Session 1 CME CE ARS similar symptoms, and 7 liters of hemorrhagic ascites was entered through a tenting of the peritoneum, the ureter evacuated from her abdomen. Friable lesions covering the traced from the pelvic brim to the uterine artery and the peritoneum of the uterus, bladder, and Pouch of Douglas were pelvic vasculature identified with a combination of blunt and biopsied and consistent with endometriosis. There was also sharp dissection, facilitating safe excision of densely adherent hyperpigmented tissue within the umbilicus that was resected endometriosis in the peritoneum. and found to be cutaneous umbilical endometriosis. After her initial surgery, the patient was hormonally suppressed with goserelin for 3 months and oral medroxyprogesterone for 1 year. She then stopped the medications to attempt pregnancy, V-5 4:29 PM but was unsuccessful. She used clomiphene for 3 months and SAFE ENDOSCOPIC LASER EXCISION AND VAPORIZATION OF the ascites reaccumulated. The patient was started on depot PERITONEAL ENDOMETRIOSIS. C. Nezhat, A. Nezhat; Center for leuprolide and oral norethindrone, but the ascites persisted. Special Minimally Invasive and Robotic Surgery, Palo Alto, CA. METHODOLOGY: The patient underwent small diameter laparoscopy using a multi-puncture technique, evacuation of The use of C02 laser, along with hydrodissection, allows for safe 7.8 liters of hemorrhagic ascites, enterolysis, appendectomy, surgical treatment of endometriosis over sensitive areas. C02 and excision and treatment of the endometriosis with neutral laser has several advantages including: precise application, argon plasma. Diffuse olive-green “mossy” endometriosis lesions minimal tissue damage, minimal risk of thermal damage to blanketed the pelvic and abdominal peritoneum like moss. No adjacent structures, and excellent hemostatic properties. postoperative hormonal suppression was given to the patient Hydrodissection allows for: separation of peritoneum from because she desired pregnancy. At 6 months after her second underlying structures and protecting underlying structures surgery, the patient had not achieved pregnancy, but the ascites from penetration and consequence damage by C02 laser beam. had not reaccumulated. She was referred for further infertility care. This is a video presentation on how to execute safe laser excision and vaporization for peritoneal endometriosis. CONCLUSIONS: This rare form of mossy endometriosis often mimics ovarian cancer and abdominal tuberculosis but can be treated and symptoms subsided with drainage of the ascites and thorough ablation of the diffuse, superficial lesions, and V-6 4:35 PM restoration of anatomy. OF MICE AND WOMEN: A LAPAROSCOPIC MOUSE MODEL FOR ENDOMETRIOSIS. D. P. Peterse,1 M. Binda,1 K. De Clercq,1 D. O,1 A. Vanhie,2 A. Fassbender,1 J. Vriens,1 T. D’Hooghe1; 1 V-4 4:21 PM Development and Regeneration, KU Leuven, Leuven, Belgium, 2Obstetrics and Gynaecology, University Hospital Leuven, Leuven, Belgium. THE RETROPERITONEAL APPROACH TO ENDOMETRIOSIS. J. A. Gingold, T. Falcone; Women’s Health Institute, Cleveland Clinic Foundation, Cleveland, OH. OBJECTIVE: Studying endometriosis in a relevant animal model remains challenging. New and less traumatic animal OBJECTIVE: Laparoscopic surgery for advanced-stage endometriosis models are urgently required to study the endometriosis with dense peritoneal adhesions and an pathogenesis of this disease. Sampson’s theory of retrograde obliterated cul-de-sac is most safely performed with a is the most accepted theory to explain retroperitoneal approach. Critical retroperitoneal structures the pathogenesis of endometriosis, stating that during must be preserved while excising the endometriotic implants. menstruation endometrial cells flow backwards through the fallopian tubes into the peritoneal cavity where they can attach METHODOLOGY: This video highlights the key steps in a and form lesions. In order to mimic this theory in a rodent successful surgery for stage 4 endometriosis using live-patient model, their endogenous estrous cycle has to be replaced surgical clips. Particular attention is given to techniques for by an artificial . In addition, induction of safe entry into the retroperitoneum, reliable identification of endometriosis has to be performed via a relevant technique. the ureter and its course in a patient with distorted anatomy, Therefore, the aim of this video is to present a novel mouse identification of branches of the internal iliac vessels and endometriosis model induced with syngeneic menstrual techniques for safe excision of endometriotic implants. endometrium using a laparoscopic approach. CONCLUSIONS: This video highlights the techniques employed METHODOLOGY: Oopherectomized donor mice received for safely completing laparoscopic excision of deeply a series of estrogen injections to simulate the estrogen- infiltrating endometriosis. The retroperitoneum is reliably

nd 72 ASRM Scientific Congress & Expo 117 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Video Sessions CME CE ARS Monday, October 17, 2016 NON- 4:00 pm - 5:30 pm Video Session 1 CME CE ARS dominant phase of the menstrual cycle. Next, a progesterone this has been completed and reperfusion noted, connection to pellet was administered, together with a second series of the recipient vaginal cuff is then performed. estrogen injections, to mimic the progesterone-dominant phase. Furthermore, of the endometrium CONCLUSIONS: Uterine transplantation, although currently was induced with an intra-uterine stimulus. Four days later, experimental, has gained the potential to become the first the progesterone pellet was removed and the menstruation true treatment for uterine factor infertility. This procedure started. Afterwards, the menstrual tissue was harvested and can become a promising option for the approximately 1.5 used to induce endometriosis in recipient mice. million women worldwide for whom pregnancy is not possible because of the absence of the uterus or presence of a non- Syngeneic recipient mice received a laparoscopy to induce functional uterus. Deceased donor uterine transplantation will endometriosis. Mice were anesthetized and ten menstrual further serve to broaden accessibility for this procedure. endometrium biopsies were inoculated in the peritoneal cavity, four on the right side, two between the uterine fundus and distal colon, and four on the right side. The intra-abdominal insufflation pressure of 15 mmHg allowed the biopsies to V-8 4:57 PM stay in place without the need of suturing. Moreover, it is OVARAIN TRANSPOSITION: A SURGICAL OPTION FOR postulated that this pressure causes mesothelial damage, FERTILITY PRESERVATION. S. Arian, L. R. Goodman, R. Flyckt, resulting in better lesion implantation. All mice recovered fast T. Falcone; Obstetrics, Gynecology, and Women’s Health after laparoscopic inoculation. Laparotomy was performed Institute, Cleveland Clinic, Cleveland, OH. to retrieve the lesions, one week after inoculation. These endometriotic lesions can be used for morphologic, genetic, transcriptomic and proteomic analysis. OBJECTIVE: The purpose of this investigation is to describe ovarian transposition, a fertility preserving surgery that can CONCLUSIONS: In summary, here we show a novel methodology be offered to reproductive-aged women with the diagnosis of to induce endometriosis in a mouse model using laparoscopic cancer, prior to undergoing . inoculation of menstrual endometrium from syngeneic mice. When compared to currently available rodent models, our METHODOLOGY: This video represents a case of a young model offers a less invasive and more physiological way for woman with the diagnosis of rectal cancer requiring radiation fundamental and preclinical endometriosis research. and chemotherapy. Prior to undergoing cancer treatment, laparoscopy was performed, with laparoscopic ovarian transposition of one ovary, followed by laparoscopic ovarian decortication of the contralateral ovary for fertility preservation V-7 4:51 PM that were both performed in one surgery. DECEASED DONOR UTERINE TRANSPLANTATION. R. Flyckt,1 CONCLUSIONS: Ovarian transposition is a great surgical option A. Kotlyar,2 S. Arian,3 A. G. Tzakis,4 T. Falcone5; 1Cleveland Clinic, for fertility preservation in reproductive-aged women prior to Beachwood, OH, 2Ob/Gyn and Women’s Health Institute, The undergoing gonadotoxic therapy, and can be done via different Cleveland Clinic Foundation, Cleveland, OH, 3Cleveland Clinic, surgical techniques. Laparoscopic ovarian transposition is Cleveland, OH, 4Transplant Surgery, Cleveland Clinic Florida, the preferred surgical technique described, as it is associated Weston, FL, 5Ob Gyn, Cleveland Clinic, Cleveland, OH. with more rapid recovery and less post-operative pain. This technique has been reported to have a success rate of 88.6% OBJECTIVE: To describe the first-ever deceased donor uterine for preservation of ovarian function after cancer treatment transplant performed in the United States. and is considered to be a safe and effective surgical option for fertility preservation. METHODOLOGY: Absolute uterine factor infertility impairs fertility in approximately 1 out of every 500 women of reproductive age. Fertility options have been limited to either surrogacy or adoption; however, uterine transplantation V-9 5:05 PM offers a third option which can overcome previous barriers to TECHNIQUES OF LAPAROSCOPIC MEDIAL OVARIAN motherhood. Essential steps in the uterine transplant process TRANSPOSITION FOR FERTILITY RESTORATION. S. Kim, R. include selecting an overall healthy donor with no history of Flyckt; Cleveland Clinic, Beachwood, OH. infertility or uterine malformations. In this video, we outline the key steps in uterine transplantation which involve establishing end-to-side vascular anastomoses between the donor uterine OBJECTIVE: Ovarian transposition is a surgical method of artery and vein and the recipient’s external iliac vessels. Once ovarian function preservation in patients undergoing pelvic

nd 72 ASRM Scientific Congress & Expo 118 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Video Sessions CME CE ARS Monday, October 17, 2016 NON- 4:00 pm - 5:30 pm Video Session 1 CME CE ARS radiation therapy. The fertility rates are yet unknown however approach was undertaken with immediate intramuscular injection with 60-80% of ovarian function preservation quoted in of methotrexate per standard dosing and subsequent intrafetal the literature, it is likely that fertility rates are favorable. As potassium chloride (KCl) injection to halt the growth of the fetus such, it is unknown at this time if reversal of oophoropexy and decrease vascularity. The patient received methotrexate on increases fertility rates. The method of ovarian transposition the day of presentation and presented the following day for her or oophoropexy is well described in the literature; however, procedure. She underwent IV sedation with propofol and was the reversal is not. The method of reversal of right ovarian prepped and draped in dorsal lithotomy position. A transvaginal transposition is described here. ultrasound probe with needle guide was used to visualize the pregnancy and document fetal cardiac activity with doppler flow. METHODOLOGY: With a RUMI uterine manipulator in situ, A 16-gauge double lumen needle was carefully introduced into the pelvis is explored with five 5-mm laparoscopic ports with the amniotic sac and then into the fetus. Subsequently, 1 milliliter the patient in steep Trendelenburg position. Right pelvic (mL) of a 20 milliequivalent per mL KCl solution injected into the sidewall is noted to have the right ovary transposed above fetus. The cessation of fetal cardiac activity was observed after the level of the pelvic brim and Fallopian tube immediately this injection and no further KCl was needed. The needle was next. Chromopertubation confirms patency. After identifying carefully removed and the pelvis examined with no evidence of the infundibulopelvic ligament, right ovary is freed from the bleeding. The patient was discharged home on the same day. abdominal wall peritoneum with sharp and blunt dissection, Her bhCG values were trended and returned to zero by six weeks with judicious use of electrocautery for hemostasis. Traction post-procedure. Follow up ultrasound at four weeks revealed a and counter-traction are used to continue dissecting in blood clot in the cervix and no fetus. The patient had intermittent cranio-caudad fashion, allowing the length of the pedicle to cramping and moderate bleeding for a short duration at 5 weeks be adequate for the position of the ovary in the pelvis without post-procedure. Final ultrasound at 8 weeks post-procedure any tension. Using a size 0 synthetic monofilament absorbable revealed resolution of the cervical clot and a catheter was able to suture, the right ovary is stitched to the area where the utero- be passed to the uterine fundus. ovarian ligament was previously present. Multiple interrupted sutures are placed intracorporeally to ensure stability of the CONCLUSIONS: Multiple approaches for management of ovary to the uterus. The Fallopian tube is mobilized with sharp cervical ectopic pregnancy have been described. More dissection to allow it to fall into the pelvis near the right ovary invasive surgical approaches are associated with high rates while avoiding any injuries to the fimbria. of hemorrhage necessitating hysterectomy. Here we describe successful intrafetal KCl injection with subsequent resolution. CONCLUSIONS: Laparoscopic medial ovarian transposition after pelvic irradiation can be a good choice of fertility V-11 5:16 PM restoration in well-selected surgical candidates. In the future, further studies on ovarian transposition reversal are needed to LAPAROSCOPIC MYOMECTOMY IN CERVICAL FIBROID-TIPS assess the efficacy on fertility outcome. AND TRICKS. A. Kriplani, R. Mahey, D. S. Karthik, K. Garima; Obstetrics & Gynaecology, All India Institute of Medical Sciences, New Delhi, India.

V-10 5:11 PM Fibroids are most common benign pelvic tumour especially SUCCESSFUL MANAGEMENT OF CERVICAL ECTOPIC in women of reproductive age with 5-10% of infertile couples PREGNANCY USING INTRAFETAL INJECTION OF POTASSIUM being affected. The incidence of cervical fibroid is 1%. Majority CHLORIDE. D. E. Broughton, M. M. Schulte, C. E. Boots, K. of fibroids are asymptomatic but may cause infertility, Omurtag, E. Jungheim; Obstetrics and Gynecology, Washington menorrhagia, dysmenorrhea and pressure symptoms like University, St Louis, MO. urinary retention, constipation. Technical challenges in myomectomy depends on the location, number and size of the OBJECTIVE: To describe and demonstrate the successful fibroids. Expertise is required in operating the cervical fibroids management of a cervical ectopic pregnancy using as the chances of injury to the ureters, bladder and rectum is transvaginal ultrasound guided intra-fetal injection of very high due to closeness of those organs to cervical fibroids; potassium chloride. opening of the cervical canal should be avoided as there can be chances of cervical stenosis, infertility and hematometra .

METHODOLOGY: A 36 year-old G1 was referred to an academic Pre operative fibroid mapping and intraoperative assessment reproductive endocrinology office for management of a of the fibroid should be done. Tracing ureter before and after cervical ectopic pregnancy. This was a natural conception and surgery is a must to ensure ureteral integrity. Surgical expertise, ultrasound revealed a viable fetus measuring 6 weeks 5 days and knowledge of anatomy, meticulous dissection and surgical a measuring 1.5 x 0.7 centimeters (cm). A staged expertise are key to success.

nd 72 ASRM Scientific Congress & Expo 119 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Video Sessions CME CE ARS

Tuesday, October 18, 2016 4:00 pm - 5:30 pm

NON- Video Session 2 CME CE ARS

Moderators: Arthur Chang, James Hotaling, Antonio Gargiulo

V-12 4:00 PM segregation. The spindle formation analyses demonstrated a case of bipolar spindle formation during the first cleavage SPATIOTEMPORAL DYNAMICS OF THE CHROMOSOME even though some 3PN zygotes had four centrosomes. This SEGREGATION APPARATUS DURING FIRST CLEAVAGE IN spatiotemporal analysis system is thus a powerful tool for 1 HUMAN TRIPRONUCLEAR ZYGOTES IN VITRO. Y. Kai, A. investigating the complicated characteristics of chromosome 2 3,1 1 Kurimasa, Y. Mio ; Fertility Research Centre, Mio Fertility segregation in abnormal zygotes such as those generated by 2 Clinic, Yonago, Japan, Department of Radiation Biology polyspermy. and Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan, 3Reproductive Centre, Mio Fertility Clinic, Yonago, Japan. V-13 4:08 PM OBJECTIVE: Most tripronuclear (3PN) zygotes obtained PREIMPLANTATION GENETIC SCREENING (PGS). L. D. Erickson; through assisted reproductive technology (ART) show an RE&I, Center for Reproductive Medicine, Minneapolis, MN. abnormal cleavage pattern, such as multipolar mitosis. We previously demonstrated that 3PN zygotes derived from intra- cytoplasmic sperm injection (ICSI) had two centrosomes, OBJECTIVE: This is a novel informational educational video whereas almost all of those derived from conventional in vitro designed to introduce patients to the basic concepts of fertilization (c-IVF) had four centrosomes. To investigate the preimplantation genetic screening (PGS). What is it? Why correlation between shape of the apparatus for chromosome should it be used? Who is a candidate? What are the risks? All segregation and cleavage pattern, we established a of these questions are answered using a basic question and spatiotemporal analysis system to visualize the dynamics of answer technique by utilizing a new creative drawing-talking centrosomes, the genome, and during the first teaching tool which reinforces your message and holds your cleavage. patient’s attention. METHODOLOGY: We constructed plasmids encoding a METHODOLOGY: I started with a written script which was fluorescent protein fused with histone H2B, pericentrin, or paired with custom whiteboard animation video provided MAP4 expressed via the T7 promoter, and synthesized the by the TruScribe artist. These hand drawn illustrations with respective mRNAs using an mMESSAGE mMACHINE® T7 Ultra audio narration are designed to increase attention, retention Kit (Thermo Fisher Scientific Inc., USA). The mRNAs were and learning. These are demonstrations that captivate and then injected into human 3PN zygotes (ICSI: n = 6, c-IVF: tend to stick with the audience. The videos are designed so n = 13) donated for this study. The zygotes were analyzed that patients can begin to grasp the basics about the complex three-dimensionally by imaging 51 optical slices of 0.8 μm in world of high tech IVF through this multi-modal approach. depth, acquired in the z-axis every 5 minutes using a CV1000 The completed project is a short efficient teaching tool for system (YOKOGAWA, Japan) at two different wavelengths of patients which can be used on any interface. The ability to excitation, 488 nm and 561 nm. Finally, tracking datasets were edit or update the information is easily accomplished. generated for spatiotemporal analysis using R program and CONCLUSIONS: Doctors need time saving teaching tools to ImageJ. get patients through the maze of shared decision making. CONCLUSIONS: Our centrosome tracking analyses revealed The burden of repetition can be lessened and the overall day that all 3PN zygotes derived from ICSI had two centrosomes brightened a bit by using these creative digital teaching tools. that each moved smoothly and in opposite directions during Patient education always needs improvement. Optimizing the genome segregation, resulting in 2-cell divisions. In contrast, physicians time with the patient will be the goal. the 3PN zygotes derived from c-IVF showed no common pattern of centrosome or genome dynamics, and almost all zygotes had four centrosomes with a genome divided into 3-4 components during the first cleavage. The four centrosomes moved in different directions following genome segregation, with some centrosomes seemingly not involved in genome

nd 72 ASRM Scientific Congress & Expo 120 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Video Sessions CME CE ARS Monday, October 17, 2016 NON- 4:00 pm - 5:30 pm Video Session 2 CME CE ARS V-14 4:12 PM solution. In IVF clinics, vitrification is conducted manually by highly skilled embryologists. Processing one oocyte/ IMPROVED NONLASER TROPHECTODERM BIOPSY FOR PGD embryo takes the embryologist approximately 15 minutes, AND PGS INTEGRATED WITH TIME LAPSE OBSERVATION depending on the protocols chosen to implement. Due to poor AND A SECURE METHOD FOR PLACING BIOPSY SAMPLES reproducibility and inconsistency across operators, the success 1 1 1 1 INTO PCR TUBES. M. Mukai, J. Otsuki, Y. Goto, M. Matsuura, and survival rates also vary significantly. We have developed a 1 1 2 1 2 K. Furuhashi, Y. Tsuji, T. Yorita, T. Iwasaki, T. Mukaida, M. robotic vitrification (RoboVitri) technology, aiming to transform 1 1 Shiotani ; Hanabusa Women’s Clinic, Kobe Hyogo, Japan, clinical vitrification from manual operation to fully automated 2 Hiroshima HART Clinic, Hiroshima, Japan. robotic operation. The RoboVitri system is built around an inverted microscope. A robotic manipulator and a motorized PGD and PGS are regulated by the Japan Society of Obstetrics syringe are used to automatically pick-and-place embryos or and Gynecology. Hence these procedures are not performed oocytes. A custom-designed carrier plate is placed on the XY routinely in Japan. Since many studies have reported increased stage to hold an embryo culture dish, a multi-well plate, and implantation rates and avoiding the transfer of aneuploid multiple vitrification straws. Our robotic system is embedded embryos, Japan now permits research on the effects of PGS with two contact detection methods, based on computer in some registered facilities. As the success of PGS greatly vision microscopy, to determine the relative z positions of depends on the biopsy technique, Japanese embryologists the vitrification micropipette, embryo, and vitrification straw. will be trained in the use of this technique, before it is used A three dimensional (3D) tracking algorithm was developed clinically. Our aim is to establish a reliable and secure biopsy for visually served embryo transfer and real-time monitoring method. A biopsy which does not require a laser system for of embryo volume changes during vitrification. The robotic TE dissection, makes it possible to reduce the time of the system closely mimics how embryologists conduct vitrification procedure and may also reduce the number of damaged and is capable of processing multiple embryos. With parallel cells resulting from multiple laser pulses, that are required time scheduling, tests on mouse embryos demonstrate that for detaching TE cells for sampling. We also plan to perform the system performs vitrification with a throughput at least non-laser TE biopsy after the embryo is fully hatched. It is three times that of manual operation. Experiments using considered that removal of more than 10 TE cells would cause mouse embryos show that the system can achieve nearly severe damage to the embryo. Removal of a minimum number 100% success rate and over 93.8% development rate after of cells required for the biopsy is essential. However, if less thawing. The unique advantages of the robotic vitrification than 5 TE cells are collected it is difficult to locate them and system include: (1) all existing vitrification protocols can position them in a PCR tube under the stereo microscope. be implemented into the instrument; (2) excess medium is Moreover, contamination with fragmented cells and granulosa automatically removed from around the vitrified embryo on cells causes inaccurate results. Hence, we have developed a the vitrification straw to achieve a high cooling rate; (3) the novel method for placing a biopsy sample directly into a PCR system is also able to monitor embryo volume change in VS tube, employing an inverted microscope immediately after a in real time, to realize individualized washing time control to TE biopsy. In this video presentation, we show an improved minimize toxicity in VS. Human clinical trial is in process. The and effective non-laser TE biopsy method for PGD/PGS. This RoboVitri technology may standardize embryo and oocyte is combined with time-lapse observations of the hatching vitrification for cost saving, higher consistency, and higher process in order to find an optimal time to perform the TE success rate. biopsy. Subsequently we show the novel method for placing a biopsy sample directly into a PCR tube.

V-16 4:32 PM FERTILITY PRESERVATION IN PEDIATRIC CANCER PATIENTS. V-15 4:20 PM S. Arian, R. Flyckt, T. Falcone; Obstetrics, Gynecology, and Women’s Health Institute, Cleveland Clinic, Cleveland, OH. ROBOTIC VITRIFICATION OF EMBRYOS AND OOCYTES. J. Liu, Z. Zhang, D. K. Luu, Y. Sun; University of Toronto, Toronto, ON, Canada. OBJECTIVE: The purpose of this investigation is to present removal of the ovarian tissue followed by ovarian tissue cryopreservation in a pediatric patient, offered as a surgical This video presents the first-of-its-kind robotic system for option for fertility preservation. This procedure can be automated vitrification of embryos and oocytes. Vitrification performed safely via a minimally invasive technique and the involves multiple steps of stringently timed pick-and-place harvested ovarian tissue can be used for future ovarian re- operation for processing an oocyte/embryo in vitrification implantation after completion of cancer treatment.

nd 72 ASRM Scientific Congress & Expo 121 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Video Sessions CME CE ARS Monday, October 17, 2016 NON- 4:00 pm - 5:30 pm Video Session 2 CME CE ARS METHODOLOGY: This is a video that represents the case V-18 4:46 PM of a 6-year old pediatric patient diagnosed with a blood malignancy. In an attempt for immediate preservation of her TURED FOR EJACULATORY DUCT OBSTRUCTIONS. J. R. 1 1 1 2 1 fertility prior to undergoing bone marrow transplantation, Palmer, M. Jurewicz, C. M. Lynne, T. Hakky, R. Ramasamy ; 1 2 her family was counseled thoroughly regarding the possible Urology, University of Miami, Miami, FL, Advanced Urology, option for performing a unilateral oophorectomy in order to Snellville, GA. harvest and freeze the ovarian cortical tissue for future ovarian re-implantation. This video represents this procedure that is OBJECTIVE: To demonstrate a step-by-step approach to performed laparoscopically, followed by preparation of ovarian transurethral resection of ejaculatory duct in a man with tissue for cryopreservation. ejaculatory duct obstruction and infertility. CONCLUSIONS: There has been a significant improvement in DESIGN: Video presentation ovarian cryopreservation and re-implantation in the last century from experimental animal studies to its applications in human. SETTING: University of Miami Ovarian tissue harvesting and cryopreservation has been reported PATIENTS: A 55 year-old man with primary infertility and as a safe and feasible procedure and an emerging option for dry ejaculate for 3 years diagnosed with ejaculatory duct fertility preservation in pediatric patients, pre-pubertal girls obstruction after a transrectal ultrasound guided seminal and female adolescents. In this patient population, standard vesicle aspiration. fertility preservation strategies including oocyte and are not suitable, as the ovaries are not yet INTERVENTIONS: Transurethral resection of ejaculatory duct responsive to the exogenous gonadotropins used for controlled ovarian stimulation as part of assisted reproductive technologies. MAIN OUTCOME MEASURES: Intraoperative technique with commentary highlighting tips for a successful resection RESULTS: This video will provide an introduction of azoospermia and anejaculation, and then present a man with V-17 4:38 PM dry ejaculate and ejaculatory duct obstruction. We describe IMPORTANCE OF MALE INFERTILITY MICROSURGERY the technique of transurethral resection of ejaculatory duct TRAINING. F. Neto,1 B. V. Stone,1 B. B. Najari,1 P. V. Bach,2 M. along with seminal vesiculography. Feliciano,1 P. N. Schlegel,1 M. Goldstein,3 P. S. Li1; 1Urology, Weill CONCLUSIONS: Transurethral resection of ejaculatory duct is a Cornell Medical College, New York, NY, 2Weill Cornell Medical successful treatment for men with ejaculatory duct obstruction College, New York, NY, 3Male Reproductive Medicine, and and offers the chance for natural conception. Urology, Weill Cornell Medical College, New York Presbyteri, New York, NY.

OBJECTIVE: Male infertility microsurgery (MIM) training V-19 4:58 PM is crucial for improving microsurgical skills and surgical outcomes. An important tool for MIM training is the use of ELECTRO-OCCLUSION OF UTERINE OSTIA BEFORE IVF IN 1 carefully edited training videos that can help the teaching CASES OF HYDROSALPINX USING MINI-SCOPE. S. Gupta, A. 2,3 4 1 process and decrease the leaning curve. K. Gupta, E. Gupta ; Gynaec & Obstet., Urogyn ART Centre, Delhi, India, 2Urology, Consultant Urologist, Delhi, India, 3Jaipur METHODOLOGY: In this video we use several small clips and Golden Hospital, Delhi, India, 4AIIMS-Delhi, Delhi, India. illustrations to teach the trainee the basic components of a MIM training lab, commonly used sutures for MIM, and how OBJECTIVE: Pre-existing tubal/pelvic pathology is a known to develop a good sitting position and instrument holding deterrent in the success of any in-vitro fertilization (IVF) protocol. position. Furthermore, the video shows step by step how to To improve success of IVF, various modalities have been described control the needle, how to place a microsurgical stitch, and to isolate uterine cavity by tubal occlusion before embryo transfer. how to tie a microsurgical knot, skills that are crucial for We present a novel mode of achieving tubal blockade by electro- achieving good outcomes in MIM. occlusion using mini-scope with its advantages over hysteroscope. CONCLUSIONS: MIM training program is important for acquiring Caliber of instrument used has a direct relation with the incidence MIM skills, and training videos are an useful tool during the of complications of operative hysteroscopy and an inverse relation learning process. with the ease of trans-cervical introduction. METHODOLOGY: Instead of conventional hysteroscope, we utilize 6F semi-rigid ureteroscope (mini-URS) for examination

nd 72 ASRM Scientific Congress & Expo 122 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Video Sessions CME CE ARS Monday, October 17, 2016 NON- 4:00 pm - 5:30 pm Video Session 2 CME CE ARS of uterine cavity. Since caliber of mini-URS is quite small, CONCLUSIONS: REITA is a unique and easy to use tool that it can be introduced easily without cervical dilatation. allows for an effective learning environment, with future After anatomical assessment, tubal ostia are fulgurated applications across multiple different medical specialties. using 3F bugbee electrode working on mono-polar electro- cautery. In initial few cases, tubal blockade was confirmed by hysterosalpingography (HSG) done after 6 weeks and subsequently, routine post-operative HSG has been replaced V-21 5:09 PM by sono-HSG. Because of easy availability of at SHAVING OF BOWEL ENDOMETRIOSIS. C. Nezhat, A. Nezhat; our centre, we do the procedure under short anesthesia using Center for Special Minimally Invasive and Robotic Surgery, Palo propofol, however, the procedure can be easily performed Alto, CA. under sedation on an out-patient basis. Total operating time for the procedure varies from 9-15 min [Video 1]. The technique was attempted with pre-approval from Senior This video demonstrates how to properly and effectively shave Management Team of the hospital and valid informed consent bowel endometriosis, in order to prevent the patient from from the patients. We did have failures with electro-occlusion undergoing bowel resection. of tubal ostia in our initial cases when we were using This is a case of a 35 year old female with extensive pelvic conventional hysteroscope. But, in our last 8 cases which we pain, gastrointestinal symptoms concurrent with menses and did with mini-URS, we did not encounter any failed occlusion infertility. of tubal ostia. No untoward complication in the form of post-operative pain abdomen, febrile reaction, bleeding, At the conclusion of the case, the posterior cul du sac has perforation or water intoxication was encountered. returned to normal anatomy and proctoscopy confirmed bowel integrity. CONCLUSIONS: In IVF protocol, for isolation of uterine cavity in cases of hydrosalpinx and other pelvic , electro- occlusion of tubal ostia using mini-scope is a safe, simple, effective, economical and daycare procedure. Mini-scope V-22 5:12 PM scores over conventional hysteroscope by virtue of its small caliber which permits easy entry of the scope as well as free VIDEO-ASSISTED THORACOSCOPIC SURGERY FOR egress of irrigating fluid. Hysteroscopic electro-occlusion ENDOMETRIOSIS. C. Nezhat, A. Nezhat; Center for Special scores over laparoscopic clipping as (a) it does not transgress Minimally Invasive and Robotic Surgery, Palo Alto, CA. virginity of peritoneal cavity and (b) it achieves blockage of fallopian tube starting from ostium. Thoracic Endometriosis Syndrome (TES) is an uncommon condition with an overwhelming occurrence in the right hemithorax. The symptoms of thoracic endometriosis are typically catamenial, occurring within 24-48 hours of the onset V-20 5:01 PM of menstruation. Diagnosis of thoracic endometriosis is made REITA: REPRODUCTIVE ENDOCRINOLOGY INTERACTIVE clinically, but is often delayed due to lack of association of TEACHING APPLICATION. F. Licciardi,1 N. M. Sachdev2; symptoms to menses. 1OBGYN, New York University Langone Medical Center, New This is a case of a 40 year old para II with history of extensive York, NY, 2Obstetrics and Gynecology, New York University endometriosis, who presented with a new onset cyclic right Fertility Center, New York, NY. sided chest pain and worsening pelvic pain, not responding to medical therapy. She was scheduled for video-assisted OBJECTIVE: REITA is an interactive smart phone based thoracoscopic surgery of the right lung for suspected thoracic application that serves as a fast and efficient way to catalog endometriosis. statistics and obtain attending feedback for reproductive endocrinology fellows. Surgical treatment of thoracic endometriosis is required if symptoms persist despite hormonal suppression of METHODOLOGY: REITA allows the trainee to document the ectopic endometrium. Patients with TES may also present number of ultrasounds, patient counseling and management with recurrent catamenial pneumothorax, hemothorax, or encounters, and mock transfers performed within a given hemoptysis. day from the convenience of their smart phone. In addition, REITA has the capability of allowing instantaneous attending feedback for various aspects of clinical training within this same application.

nd 72 ASRM Scientific Congress & Expo 123 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Video Sessions CME CE ARS Monday, October 17, 2016 NON- 4:00 pm - 5:30 pm Video Session 2 CME CE ARS V-23 5:15 PM ROBOTIC UPPER VAGINECTOMY AFTER PREVIOUS HYSTERECTOMY FOR SEVERE STAGE IV ENDOMETRIOSIS INVOLVING THE VAGINAL CUFF AND RECTO-VAGINAL SEPTUM. G. Feuer,1 C. Marchand,2 N. Lakhi3; 1Department of , Northside Hospital, Atlanta, GA, 2OB/ GYN, Richmond University Medical Center, Staten Island, NY, 3Department of Obstetrics and Gynecology, Richmond University Medical Center, Staten Island, NY.

OBJECTIVE: To demonstrate a technique for upper vaginectomy in a case of severe endometriosis and scared rectovaginal septum. METHODOLOGY: This is a 35 year old, nulliparous women, with a long history of severe endometriosis requiring multiple previous surgical intervention, including a laparoscopic assisted vaginal hysterectomy 8 years previously for dysfunctional bleeding. She now presented with severe pelvic pain. On pelvic examination she had a 4x4 cm mass at the top the vagina and obliteration of the recto-vaginal septum. The patient underwent a robotic upper vaginectomy to completely excise the endometriosis nodule. We first enter the para-rectal space and develop it distally until we reach a point beyond the scar plane. From this point, we are able to approach the recto-vaginal space and mobilize the scared rectovaginal septum. The ureters are then lateralized and dissected distally to a point past the uterine arteries. We then secure hemostasis at the uterine arteries. We then were able to perform an upper vaginectomy and completely excise the nodule. CONCLUSIONS: The steps for upper vaginectomy with severe endometriosis include dissection of the para-rectal space distally, to then safely take down the retovaginal scar. The dissection of the ureters past the uterine vessels is necessary to divide the utero-sacral and cardinal ligaments.

nd 72 ASRM Scientific Congress & Expo 124 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Roundtables CME CE ARS

MONDAY, OCTOBER 17, 2016 CONTRACEPTION LEGAL RTM07 RTM14 Factors that Influence Pain Experience Fertility in Uniform: Legal Issues and ANDROGEN EXCESS during Outpatient Gynecologic Concerns Specific to the Military RTM01 Procedures Stephanie Caballero, J.D. Lifestyle Strategies in Polycystic Ovary Tiffany Hailstorks, M.D. The Surrogacy Law Center Syndrome Emory University Heather Huddleston, M.D. RTM15 University of California, San Francisco EARLY PREGNANCY Updates in the Affordable Care Act Melissa B. Brisman, J.D. RTM08 ASSISTED REPRODUCTIVE Melissa B. Brisman, Esq. Progesterone Treatment in Recurrent TECHNOLOGY Pregnancy Loss MALE REPRODUCTION AND RTM02 Danny J. Schust, M.D. Vaginal Incubation for Oocyte University of Missouri UROLOGY Fertilization and Embryo Development RTM16 Claude J. Ranoux, M.S. Selective Estrogen Receptor INVO Bioscience ENDOMETRIOSIS Modulators, Aromatase Inhibitors, and RTM09 Male Hypogonadism RTM03 Endometriosis: Novel Etiologies and David Shin, M.D. Managing an Assisted Reproductive Treatments Hackensack University Medical Center Technology Practice Hugh S. Taylor, M.D. Angeline N. Beltsos, M.D. Yale University School of Medicine RTM17 Fertility Centers of Illinois Management of Obstructive Azoospermia FERTILITY PRESERVATION with RTM04 Paul R. Shin, M.D. Fertility Preservation in Cancer RTM10 Shady Grove Fertility Patients Implementing a Pediatric and Anna C. Nackley, M.D. Adolescent Fertility Preservation RTM18 Center for Assisted Reproduction Program: Pearls and Pitfalls Optimizing Fertility in Klinefelter Leslie A. Appiah, M.D. Syndrome University of Kentucky CHINESE REPRODUCTIVE Darius A. Paduch, M.D., Ph.D. Weill Cornell Medical College MEDICINE RTM11 Fertility Preservation in Children RTM05 MENTAL HEALTH Stem Cells and their Role in Karine Chung, M.D., M.S.C.E. Endometrial Regeneration USC Keck School of Medicine RTM19 Huai L. Feng, Ph.D., H.C.L.D. Advanced Paternal Age: Psychosocial Weill Cornell Medical College of Cornell GENETIC COUNSELING and Genetic Risk Factors University Linda D. Applegarth, Ed.D RTM12 Weill Cornell Medical College Family Medical History Eligibility COMPLEMENTARY & Guidelines for Gamete Donors RTM20 ALTERNATIVE MEDICINE Kara Baldwin, M.S., L.C.G.C. A Couple's Dilemma: How to Approach California Cryobank RTM06 Counseling When the Couple Has Dose-dependent Acupuncture and Different Family-Building Goals the Positive Impact on In Vitro HEALTH DISPARITIES Lisa Schuman, L.C.S.W. Fertilization RTM13 RMA of Connecticut Lee Hullender Rubin, D.A.O.M., L.Ac., Racial Disparities in Assisted F.A.B.O.R.M. Reproductive Technology NURSES Portland Acupuncture Studio Fady I. Sharara, M.D. RTM21 Virginia Center for Reproductive Medicine Partnering with Our Patients: Lessening the Burden of Care from Infertility to Birth Anne Tepper, B.S.N., R.N. RMA of New Jersey

nd 72 ASRM Scientific Congress & Expo 125 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Roundtables CME CE ARS

RTM22 RTM29 HOT TOPICS The Hidden Patient: Toward Workup and Options When Euploid Understanding Men's Experience with Blastocysts Fail to Implant RTM36 Infertility Eric J. Forman, M.D., F.A.C.O.G., H.C.L.D/ Uterus Transplant for Absolute Uterine Eleanor L. Stevenson, Ph.D., R.N. AL.D. Infertility: A 360° Conversation from Duke University School of Medicine Reproductive Medicine Associates of New Ethical to Technical Issues Jersey Tommaso Falcone, M.D. PREIMPLANTATION GENETIC Cleveland Clinic RTM30 TESTING Nonsurgical Management for RTM23 Endometriosis-related Pelvic Pain: Is Routine Use of Preimplantation A Team Approach Aneuploidy Testing Indicated as a Erika B. Johnston-MacAnanny, M.D. TUESDAY, OCTOBER 18, 2016 Standard Practice? Wake Forest Center for Reproductive Santiago Munne, Ph.D. Medicine ASSISTED REPRODUCTIVE Reprogenetics TECHNOLOGY REPRODUCTIVE MANAGERS REGENERATIVE MEDICINE AND RTT01 RTM31 Public Reporting of Assisted STEM CELL BIOLOGY Identifying the Process Hurdles Reproductive Technology Outcomes RTM24 that Get in the Way of Offering a Amy E. T. Sparks, Ph.D., H.C.L.D. The Advancement of Cell Therapy in World-class Patient Experience University of Iowa Hospitals and Clinics Reproductive Medicine: Asherman Lisa Duran, B.S. Syndrome and Atrophic Endometrium Reconceived RTT02 Carlos A. Simon, M.D., Ph.D. Quality Management in Assisted Valencia University REPRODUCTIVE SURGERY Reproductive Technology Robin L. Thomas, M.D. RTM32 Center for Assisted Reproduction REPRODUCTIVE BIOLOGY AND Sperm Retrieval with Testicular TECHNOLOGY Mapping for Non-obstructive RTT03 RTM25 Azoospermia Conducting Research Using the SART Paul J. Turek, M.D. Setting Up an In Vitro Fertilization CORS Database The Turek Clinic Laboratory in 2016 Sangita K. Jindal, Ph.D. Jason E. Swain, Ph.D., H.C.L.D. Montefiore Institute for Reproductive Fertility Lab Sciences RTM33 Medicine and Health Hydrosalpinges: Removal, Repair, or RTM26 Observe? Mark W. Surrey, M.D. CHINESE REPRODUCTIVE Time-lapse: Is It Ready for Primetime? Charles L. Bormann, Ph.D., H.C.L.D. Southern California Reproductive Center MEDICINE Massachusetts General Hospital Fertility RTT04 Center RTM34 Endometrial Evaluation by Surgical Management of Large Uterine Ultrasonography in Assisted RTM27 Fibroids Reproductive Technology Bala Bhagavath, M.D. Quality Control in the Embryology Lab Jie Qiao, M.D., Ph.D. Rebecca L. Krisher, Ph.D. University of Rochester Medical Center Peking University Third Hospital Colorado Center for Reproductive Medicine TURKISH REPRODUCTIVE CONTRACEPTION REPRODUCTIVE MEDICINE RTT05 ENDOCRINOLOGY AND RTM35 Contraceptive Dual Use among INFERTILITY Current Efficiency of Ovarian Adolescents: Barriers, Facilitators, and Cryopreservation and Transplantation the Influence of Relationships RTM28 in Children and Adults Shandhini Raidoo, M.D. Elective Egg Freezing? Who is Kutluk Oktay, M.D., Ph.D., F.A.C.O.G. University of Hawaii Appropriate and When Should She New York Medical College Bank? Jennifer E. Mersereau, M.D. University of North Carolina School of Medicine

nd 72 ASRM Scientific Congress & Expo 126 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Roundtables CME CE ARS

EARLY PREGNANCY HEALTH DISPARITIES MENTAL HEALTH RTT06 RTT12 RTT19 Antiphospholipid and Antithyroid Health Disparities in Uterine Fibroids: Beyond Bodies: What Mental Health Antibodies Biological, Environmental, and Social Professionals Should Know about William H. Kutteh, M.D., Ph.D., H.C.L.D. Factors Transgender Identity, Assisted Vanderbilt University Medical Center Erica E. Marsh, M.D. Reproductive Technology, and Fertility University of Michigan Preservation ENDOMETRIOSIS Jamie M. Joseph, Ph.D. IMAGING Weston Cognitive Behavior Therapy and RTT07 Evaluation Therapy for RTT13 Endometriosis Bicornuate versus Septate Uterus: The RTT20 Serdar E. Bulun, M.D. Role of 3-D Ultrasound Navigating the Emotional Minefield: Northwestern University Silvina M. Bocca, M.D., Ph.D., H.C.L.D. Helping Veterans and Their Partners The Jones Institute for Reproductive Cope with Combat Injury–acquired Medicine ENVIRONMENT AND Infertility REPRODUCTION Laura S. Covington, M.S.W. LEGAL Shady Grove Fertility RTT08 Endocrine-disrupting Chemicals and RTT14 Reproduction Informed Consent Documents: NURSES John C. Petrozza, M.D. Practical Tips to Meet Legal RTT21 Massachusetts General Hospital Fertility Requirements Managing Food and Drug Center Margaret E. Swain, J.D., R.N. Administration (FDA) Audit: How to Private Practice, Baltimore Avoid Common FDA Pitfalls FERTILITY PRESERVATION Carolyn A. Collins, R.N., B.S.N. RTT15 Reproductive Medicine Associates of New RTT09 Legal Considerations in Caring for Jersey Challenges in Male Fertility Transgendered Patients Preservation Andrew W. Vorzimer, J.D. RTT22 Jay I. Sandlow, M.D. Vorzimer Masserman Fertility and Family Leading from the Front: Conversations Medical College of Wisconsin Law Center in Leadership with Nurse Educators and Preceptors in a Reproductive FIBROIDS MALE REPRODUCTION AND Endocrinology and Infertility Setting RTT10 UROLOGY Kathleen R. Bugge, B.S.N., M.S.Ed. Shady Grove Fertility Center Current Management of Uterine RTT16 Fibroids: Novel and Emerging Lifestyle Effects in Male Fertility Therapies Joseph P. Alukal, M.D. NUTRITION William H. Catherino, M.D., Ph.D. NYU School of Medicine RTT23 Uniformed Services University of the Endometriosis and Diet: What Can We Health Sciences RTT17 Learn from Animal Models? When Does Sperm DNA Fragmentation Kaylon L. Bruner-Tran, Ph.D. GENETIC COUNSELING Matter? Vanderbilt University Medical Center RTT11 Cigdem Tanrikut, M.D. What Can Preimplantation Genetic Massachusetts General Hospital PREIMPLANTATION GENETIC Screening Really Tell Us about Embryo TESTING Mosaicism? RTT18 Alyssa C. Snider, M.S., Ph.D., L.C.G.C. Management of Steroid-induced RTT24 IviGen Hypogonadism Novelties in Preimplantation Genetic Ranjith Ramasamy, M.D. Diagnosis of Single-gene Disorders University of Miami Svetlana Rechitsky, Ph.D. Reproductive Genetic Innovations

nd 72 ASRM Scientific Congress & Expo 127 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Roundtables CME CE ARS

REGENERATIVE MEDICINE/ REPRODUCTIVE SURGERY RTW03 Ethics Considerations in Assisted STEM CELL BIOLOGY RTT32 Reproductive Technology RTT25 Tips on Micro-TESE Paula Amato, M.D. Peter N. Schlegel, M.D. Innovative Techniques in Cell and Oregon Health & Science University Gamete Cryopreservation for the Weill Cornell Medical College Research Lab and the In Vitro RTW04 RTT33 Fertilization Lab Impact of Endometriosis on Assisted Myoma Management for the Infertile Pasquale Patrizio, M.D., H.C.L.D. Reproductive Technology Outcomes Yale University IVF Program Patient: Clinical Management and Orhan Bukulmez, M.D. Surgical Approach UT Southwestern Fertility and Advanced Divya K. Shah, M.D. Reproductive Medicine REPRODUCTIVE BIOLOGY AND University of Pennsylvania TECHNOLOGY RTT26 RTT34 CHINESE REPRODUCTIVE Vitrification Update Management Options for Cesarean MEDICINE Juergen Liebermann, Ph.D., H.C.L.D. Scar Pregnancy RTW05 Fertility Centers of Illinois - River North IVF Humberto Scoccia, M.D. Endometrium and Embryos: Molecular University of Illinois College of Medicine at Basis of Implantation and Clinical Chicago RTT27 Applications What Is Really in that Media? Yulian Zhao, M.D., Ph.D., H.C.L.D. Dean E. Morbeck, Ph.D., H.C.L.D. TURKISH REPRODUCTIVE Johns Hopkins Medicine Fertility Associates, Auckland, New MEDICINE Zealand RTT35 COMPLEMENTARY & REPRODUCTIVE Obesity and Reproduction ALTERNATIVE MEDICINE Zaher Merhi, M.D. RTW06 ENDOCRINOLOGY AND New York University School of Medicine Menopause Symptom Management INFERTILITY Using Supplements and Complementary RTT28 HOT TOPICS & Alternative Medicine The Future of Information RTT36 Coleen Smith, D.A.O.M., L.Ac., F.A.B.O.R.M. Dissemination in Infertility Innovative Educational Technologies Point of Origin Acupuncture Lowell T. Ku, M.D. JoAnn Major, M.S., M.B.A. Dallas IVF ASRM Educational Resource Consultant, EARLY PREGNANCY Major Instructional Design Solutions RTT29 RTW07 Thyroid Disease and Fertility: Anatomical Causes of Recurrent An Update Pregnancy Loss Jennifer L. Eaton, M.D., M.S.C.I. Asher Bashiri, M.D. Duke University WEDNESDAY, OCTOBER 19, 2016 Ben-Gurion University of Negev

RTT30 ANDROGEN EXCESS FERTILITY PRESERVATION Reality Bites: Does Diet Affect RTW01 RTW08 Reproductive Health and Fertility Effects of Salicylate Therapy on Discussing Fertility Preservation with Outcomes? Ovarian Function in Polycystic Ovary Patients Emily S. Jungheim, M.D. Mary Ellen G. Pavone, M.D. Washington University School of Medicine Syndrome Frank González, M.D. Northwestern University Indiana University School of Medicine REPRODUCTIVE MANAGERS FIBROIDS RTT31 ASSISTED REPRODUCTIVE RTW09 Marketing in a Reproductive TECHNOLOGY Fibroid Stem Cells and Developmental Endocrinology and Infertility Practice: Epigenetic Reprogramming A Multi-faceted Approach RTW02 Ayman Al-Hendy, M.D., Ph.D. Jacqueline A. Sharpe, B.S. Value-oriented Fertility Care Medical College of Georgia HRC Fertility Alexander M. Dlugi, M.D., M.B.A. Optum

nd 72 ASRM Scientific Congress & Expo 128 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Roundtables CME CE ARS

GENETIC COUNSELING MENTAL HEALTH REPRODUCTIVE BIOLOGY AND RTW10 RTW18 TECHNOLOGY Carrier Screening and Preimplantation Sex and Infertility RTW25 Genetic Diagnosis Mindy R. Schiffman, Ph.D. Navigating through an Institutional Neha Kumar, M.Sc. NYU Langone Fertility Center Review Board Recombine William E. Roudebush, Ph.D., H.C.L.D., RTW19 University of South Carolina School of IMAGING Non-traditional Therapeutic Medicine Greenville Interventions for Pregnancy Loss RTW11 Julie Bindeman, Psy.D. Techniques in Tubal Imaging RTW26 Integrative Therapy of Greater Rats or Mice: Which Rodent Model Michael J. Heard, M.D. Washington The Heard Institute to Use as a Model for Endometriosis Research? NURSES Kathy L. Sharpe-Timms, Ph.D., H.C.L.D., LEGAL C.L.C. RTW20 University of Missouri School of Medicine RTW12 Preimplantation Genetic Screening: Changing Borders: Worldwide How Does the Patient Decide? Developments in Surrogacy Marty B. Gebhart, D.N.P., N.P.-B.C., RTW27 Michelle A. Keeyes, J.D. R.N.F.A. The Latest in Genetic Testing of Reproductive Law Center, Inc. Mississippi Reproductive Medicine Embryos Matthew C. Goering, Ph.D., H.C.L.D. Kansas University School of Medicine RTW13 RTW21 Case Law Updates: Gestational The Impact of Infertility, Age, and Surrogacy in the United States Mental Health on Recovery from REPRODUCTIVE Molly O'Brien, Esq., J.D. Miscarriage: A Bayesian Approach The Law Offices of Molly O'Brien ENDOCRINOLOGY AND Carolyn S. Huffman, Ph.D., W.H.N.P. INFERTILITY Appalachian State University MALE REPRODUCTION AND RTW28 UROLOGY NUTRITION Yoga and Acupuncture Incorporation into Your Practice: Is It Truly RTW14 RTW22 Complementary? Effects of Cancer and Cancer Therapies Micronutrients and Conception Jennifer E. Hirshfeld-Cytron, M.D. on Male Fertility Lauren A. Wise, Sc.D. Fertility Centers of Illinois Kathleen Hwang, M.D. Boston University School of Public Health The Alpert Medical School of Brown RTW29 University PREIMPLANTATION GENETIC Premature Progesterone Elevation and TESTING Assisted Reproductive Techonology RTW15 Outcomes Sexual Dysfunction and Male Infertility RTW23 Micah J. Hill, D.O., F.A.C.O.G. James M. Hotaling, M.D. Current Approaches for Walter Reed National Military Medical University of Utah Preimplantation Aneuploidy Testing: Center Advantages and Disadvantages RTW16 Nathan Treff, Ph.D. RTW30 Varicocele: When to Treat, When to Reproductive Medicine Associates of The Optimization of In Vitro Observe New Jersey Fertilization Cycle Outcomes in Mary K. Samplaski, M.D. the Challenging Polycystic Ovary University of Southern California REGENERATIVE MEDICINE AND Syndrome Patient STEM CELL BIOLOGY Larisa Gavrilova-Jordan, M.D. MENOPAUSE AND OVARIAN Augusta University RTW24 AGING The Advancement of Cell Therapy in RTW17 Reproductive Medicine: Male Fertility REPRODUCTIVE MANAGERS Menopause Transition: Cardiovascular Preservation RTW31 Risk Kyle E. Orwig, Ph.D. Staff Appreciation: Methods and Robert A. Wild, M.D., Ph.D., M.P.H. University of Pittsburgh Motivation Oklahoma University Health Sciences Lindsey N. McBain, B.A. Center RMA of New Jersey

nd 72 ASRM Scientific Congress & Expo 129 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Roundtables CME CE ARS

REPRODUCTIVE SURGERY RTW32 Varicocelectomy Marc Goldstein, M.D. Weill Cornell Medical College

RTW33 Current Approaches to Endometriosis- associated Infertility Richard O. Burney, M.D., M.Sc. Madigan Healthcare System

RTW34 Preparing for Complex Endometriosis Surgeries: Tips and Tricks Mohamed A. Bedaiwy, M.D., Ph.D., F.A.C.O.G., F.R.C.S.C. The University of British Columbia

TURKISH REPRODUCTIVE MEDICINE RTW35 Minimal Stimulation In Vitro Fertilization John J. Zhang, M.D., Ph.D. New Hope Fertility Center ASRM Is Paperless! The Final Program for the ASRM 2016 At the Congress, you will receive a Scientifc Congress & Expo in Salt Lake printed copy of: City will be posted online and available for download prior to, during, and after • Pocket calendar with room numbers the Scientifc Congress & Expo. The • Pocket listing of oral abstracts with FUTURE downloadable online PDF program will room numbers include complete, detailed program • Pocket listing of poster abstracts ASRM SCIENTIFIC information, including the Daily • Listing of exhibits CONGRESS & EXPO Schedule and CME/CE materials (needs assessments/descriptions, learning There will be a free mobile app listing all DATES objectives) for all CME activities (Pre- of the activities, including oral and poster Congress courses, plenary lectures, abstracts, with their room numbers for October 28 – November 1, 2017 symposia, interactive sessions). both the Pre-Congress Program and San Antonio, Texas the Scientific Congress. The complete abstracts will be available on the: October 6 – 10, 2018 * * * Denver, Colorado THERE WILL NOT • Mobile app • Fertility and Sterility website October 12 – 16, 2019 BE A PRINTED • Fertility and Sterility mobile app Philadelphia, Pennsylvania PROGRAM BOOK • Abstracts2View website

October 17 – 21, 2020 For your convenience, there will be Portland, Oregon free wireless mobile hotspots in the Convention Center.

nd 72 ASRM Scientific Congress & Expo 130 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

Abstract Review Committees Mohamed Aboulghar Kevin Doody Susan Klock Glen Adaniya Erma Drobnis Jennifer Knudtson Ashok Agarwal Cindy Duke Peter Kolettis Ayman Al-Hendy James Dupree Efstratios Kolibianakis Joseph Alukal Eyup Duran Rashmi Kudesia Ruben Alvero Jennifer Eaton Anver Kuliev Paula Amato Alison Edelman Satu Kuokkanen Larry Amesse Amir El-Shalakany William Kutteh Tony Anderson Lawrence Engmann Joanne Kwak Kim Marlane Angle Navid Esfandiari Dolores Lamb Puneet Arora Eve Feinberg Shannon Laughlin-Tommaso G. David Ball Bo Feng Dan Lebovic Alison Bartolucci Rita Fields Michael Lee G. Wright Bates Eric Forman Bruce Lessey Mohamed Bedaiwy Bhushan Gangrade Gerard Letterie Claudio Benadiva Forest Garner Eric Levens Dara Berger Larisa Gavrilova-Jordan Philip Li Ricardo Bertolla Mehmet Genc Frederick Licciardi Zeev Blumenfeld Elizabeth Ginsburg Juergen Liebermann Silvina Bocca Gnanaratnam Giritharan Creighton Likes III Jeff Boldt Kathryn Go Paul Lin Christina Boots James Goldfarb Richard Lucidi Carolina Borghi Frank Gonzalez Marla Lujan Andrea Borini Adam Griffin Barbara Luke Nancy Brackett Daniel Grow Charles Lynne Christine Briton-Jones Jackie Gutmann Henry Malter Orhan Bukulmez Karl Hansen Courtney Marsh Maria Bustillo Russ Hauser Wellington Martins Erkan Buyuk Michael Heard Joe Massey Arthur Castelbaum Jose Hernandez Sachiko Matsuzaki Nicholas Cataldo Patrcia Hershberger Jenna McCarthy William Catherino Laura Hewistson Elizabeth McGee Grace Centola Tim Hickman Zaher Merhi Arthur Chang Micah Hill Jennifer Mersereau Jorge Chavarro David Hill Benjie Mills Lindsay Childress-Beatty Kathy Hoeger Lidia Minguez-Alarcon Gregory Christman Sarah Holley Stacey Missmer Alicia Christy James Hotaling Thomas Molinaro Charles Coddington Susan Hudson Dean Morbeck Pierre Comizzoli Bradley Hurst Patricia Morris Amber Cooper Kathleen Hwang Anna Nackley Alan Copperman Lauren Isley Zsolt Peter Nagy Ali Dabaja Kristen Ivani Ajay Nangia Gaurang Daftary Beth Johnson Kanad Nayar Michael Dahan Erika Johnston-MacAnanny George Ndukwe Mark Damario Amy Jordan Evelyn Neuber Ann Davis Emily Jungheim Ceana Nezhat Lynn Davis Michael Jurewicz John Nichols Alan DeCherney Dimitrios Kafetzis Warren Nothnick Chris Deibert Caleb Kallen Nicole Noyes Laura Detti Sinem Karipcin Evan Ntrivalas Todd Deutch James Kashanian Oroma Nwanodi Kate Devine Parviz Kavoussi Dana Ohl Irene Dimitriadis Helen Kim Tom O'Leary Edward Ditkoff Thomas Kimble Joao Batista Oliveira Anuja Dokras Nancy Klein Lubna Pal

nd 72 ASRM Scientific Congress & Expo 131 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

Abstract Review Committees (cont.) Gianpiero Palermo Linda Siano Jennifer Wood Alex Pastuszak Elena Silva Matthew Wosnitzer Mary Pavone Joe Leigh Simpson Diane Wright Marina Peluffo James Smith Diana Wu Alan Penzias Yolanda Smith Al Wun John Petrozza Victoria Snegovskikh Belinda Yauger Bruce Pier Alyssa Snider Steven Young Margareta Pisarska Irene Souter Liang Yu Staci Pollack Steven Spandorfer Musa Zamah Nikolaos Polyzos Amy Sparks Yulian Zhao Jessica Prenni Jessica Spencer Khaled Zohni Sam Prien Maya Srivastava Gail Prins Rajesh Srivastava Anthony Propost Serene Srouji Gwendolyn Quinn Aleksander Stanic-Kostic Beth Rackow Andrea Stein Tayyab Rahil Michael Steinkampf Ranjith Ramasamy Judy Stern Leslie Ramirez Eleanor Lowndes Stevenson Valerie Ratts Pamela Stratton Svetlana Rechitsky Michelle Strecker Alice Rhoton-Vlasak Aaron Styer Jared Robins Irene Su Randal Robinson Carlos Sueldo Ginny Ryan Eric Surrey Denny Sakkas Jason Swain Christina Salazar Takumi Takeuchi Jennifer Salcedo Reshef Tal Mary Samplaski Tao Tao Joseph Sanfilippo Laura Tatpati Xiomara Santos Hugh Taylor Ann Scalia Tyl Taylor Eva Schenkman Robin Thomas Mitch Schiewe Non Tidswell Alessandro Schuffner James Toner Maureen Schulte Nam Tran Danny Schust Nathan Treff Humberto Scoccia Meike Uhler Richard T. Scott, Jr. Rebecca Usadi David Seifer Brad Van Voorhis Helmy Selman Kedra Wallace Aimee Seungdamrong Thomas Walsh Divya Shah Pradeep Warikoo Daniel Shapiro Marie Werner Fady Sharara Lynn Westphal Prati Sharma Carol Wheeler David Shin Eric Widra Paul Shin Robert Wild Donna Shoupe Barry Witt Yimin Shu Anne Wold

nd 72 ASRM Scientific Congress & Expo 132 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

Monday, October 17, 2016 11:15 am - 12:45 pm

NON- Prize Paper Session CME CE ARS

SCIENTIFIC CONGRESS PRIZE PAPER SESSION 1 The first six papers are candidates for the ASRM Scientific Congress Prize Paper Awards. Six additional candidates will be presented during the Prize Paper Candidates’ session on Tuesday. Moderators: Erica Marsh, William Catherino

11:15 AM O-1 MATERNAL AND PATERNAL 12:00 PM O-4 VERIFICATION OF ACCURACY & SAFETY PRECONCEPTION PHTHALATE EXPOSURE FOR OVARIAN RESERVE ASSESSMENT AND BIRTHWEIGHT OF IVF SINGLETONS. WITH OPTICAL COHERENCE TOMOGRAPHY C. Messerlian,1 J. M. Braun,2 L. Minguez- USING MOUSE OVARY. S. Takae,1 K. Alarcon,1 P. Williams,3 J. B. Ford,1 A. Calafat,4 Tsukada,2 N. Okamoto,1 Y. Sato,1 T. R. Hauser1; 1Environmental Health, Harvard Kawahara,1 N. Suzuki1; 1Obstetrics and T.H. Chan School of Public Health, Boston, Gynecology, St. Marianna University MA, 2Epidemiology, Brown University School of Medicine, Kawasaki City, Japan, School of Public Health, Providence, RI, 2Department of Applied Physics and 3Biostatistics and Epidemiology, Harvard T. Physico-Informatics, Faculty of Science, Keio H. Chan School of Public Health, Boston, MA, University, Yokohama City, Japan. 4CDC, Atlanta, GA. 12:15 PM O-5 CO-TRANSPLANTATION OF HUMAN 11:30 AM O-2 EARLY LIFE DEVELOPMENTAL EXPOSURE OVARIAN TISSUE WITH AMH-PRODUCING TO ENDOCRINE DISRUPTING CHEMICALS ENDOTHELIAL CELLS INHIBITS INCREASES THE RISK OF ADULT ONSET RECRUITMENT OF PRIMORDIAL OF UTERINE FIBROIDS BY PERMANENTLY FOLLICLES. L. Man, R. Bodine, L. Park, N. REPROGRAMING THE EPIGENOME OF Zaninovic, Z. Rosenwaks, G. L. Schattman, D. MYOMETRIAL STEM CELLS TOWARDS James; The Ronald O. Perelman and Claudia A PRO-FIBROID LANDSCAPE. Q. Yang,1 Cohen CRM, Weill Cornell Medical College, L. Trevino,2 A. Mas,1 A. Laknaur,1 M. P. New York, NY. Diamond,1 C. L. Walker,2 A. Al-Hendy1; 1OB/ 2 GYN, Augusta University, Augusta, GA, Texas 12:30 PM O-6 RANDOMIZED CONTROLLED TRIAL OF A&M Health Science Center, Houston, TX. LOW (5%) VS. ULTRALOW (2%) OXYGEN TENSION FOR IN VITRO DEVELOPMENT OF 11:45 AM O-3 MTOR INHIBITORS PRESERVE HUMAN EMBRYOS. D. J. Kaser,1 B. Bogale,1 FERTILITY IN A MURINE MODEL: A V. Sarda,2 L. V. Farland,1,3 C. Racowsky1; NOVEL PHARMACOLOGIC APPROACH 1Dept of Obstetrics & Gynecology, Brigham & TO FERTILITY PRESERVATION DURING Women’s Hospital, Harvard Medical School, GONADOTOXIC CHEMOTHERAPY. K. N. Boston, MA, 2Boston Children’s Hospital, Goldman,1 D. Chenette,2 D. L. Keefe,1 J. Boston, MA, 3Dept of Epidemiology, Harvard Grifo,1 R. J. Schneider2; 1New York University, Chan School, Boston, MA. New York, NY, 2Cancer Institute, NYU School of Medicine, New York, NY.

nd 72 ASRM Scientific Congress & Expo 133 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

Monday, October 17, 2016 11:15 am - 12:45 pm

NON- Oral Abstract Sessions CME CE ARS

• Access to Care 1 12:00 PM O-10 LETROZOLE + GONADOTROPIN PROTOCOL • Contraception and Family Planning FOR SUPEROVULATION INDUCTION/ INSEMINATION CYCLES: A NOVEL • Male Reproduction and Urology: Traveling Schoars APPROACH TO INCREASE ACCESS OF CARE • Reproductive Endocrinology: Research AND VALIDATED BY SUPPLY & DEMAND CURVE ANALYSIS. M. X. Ransom; OB/GYN, • Reproductive Surgery 1 Quillen College of Medicine, Johnson City, TN. • Imaging in Reproductive Medicine • Preimplantation Genetic Testing 1 12:15 PM O-11 CAN AFFORDABILITY AND ACCESS TO CARE • ART: Clinical 1 BE ENHANCED BY MINIMAL STIMULATION IVF (MS-IVF) AND SINGLE EMBRYO • Embryo Biology 1 TRANSFER (SET)? S. C. Carr, E. E. Ramos, • Embryo Transfer M. Modelski, L. S. Morrison, G. Kovalevsky, R. F. Feinberg; Reproductive Associates of • Environment and Reproduction Delaware, Newark, DE. • Fertility Preservation • Polycystic Ovary Syndrome 12:30 PM O-12 ANSWERS ON DEMAND: INCREASING • Outcome Predictors: ART 1 ACCESS TO REPRODUCTIVE GENETIC COUNSELING THROUGH TELECOUNSELING. 1 1 1 ACCESS TO CARE 1 N. C. Paolino, U. Canteenwalla, L. Rassaby, Moderators: Violanda Grigorescu, Lusine Aghajanova S. Yarnall,1 S. Rodriguez,1 I. Carlsson2; 1Recombine, New York, NY, 2Medical Affairs, 11:15 AM O-7 EMPLOYER ENGAGEMENT AND EDUCATION Recombine, New York, NY. INCREASES ACCESS TO CARE AND ESET UTILIZATION. G. Harton,1 M. Larman,2 K. Ajmani,3 J. R. Tomasino,4 G. Bartasi5; 1 2 Progyny, New York, NY, Progyny, San CONTRACEPTION AND FAMILY PLANNING Francisco, CA, 3Progyny, Inc., New York, NY, Moderators: Jennifer Salcedo, Laura Cooney 4Progyny, 5Progyny, Inc., 47th Floor, NY. 11:15 AM O-13 A PROGRESSIVE ELIMINATION STRATEGY FOR SCREENING MEIOTIC INHIBITORS AS 11:30 AM O-8 INCREASED ACCESS TO CARE THROUGH NOVEL CONTRACEPTIVES. C. Hanna,1 S. CREATION OF PRIVATE FOUNDATIONS: 1 1 2 3 1 1 Yao, F. Xu, R. Cuellar, J. Jensen ; Division THE CHICAGO EXPERIENCE. E. C. Feinberg, of Reproductive and Developmental A. Borowiecki,2 R. Morris,3 L. Rinehart,4 N. 5 6 1 Science, Oregon National Primate Research Desai, J. E. Hirshfeld-Cytron ; Fertility 2 2 Center, Beaverton, OR, Department of Centers of Illinois, Highland Park, IL, Kevin Medical Chemistry, University of Minnesota, J. Lederer Life Foundation, Highland Park, IL, 3 3 4 Minneapolis, MN, Department of OB/GYN, IVF1, Naperville, IL, Legal Care Consulting, OHSU, Portland, OR. Inc., Burr Ridge, IL, 5Ballard, Desai, & Miller, Chicago, IL, 6Fertility Centers of Illinois, Chicago, IL. 11:30 AM O-14 HORMONAL REGULATION OF OVIDUCTAL GLYCOPROTEIN 1 (OVGP1; MUC9) IN THE MACAQUE CERVIX: A NOVEL INDICATOR 11:45 AM O-9 INFERTILITY & FAMILY-BUILDING OF PROGESTOGEN ACTION. O. D. Slayden, E. A. Duthie,1 A. Cooper,2 J. PRIORITIES. F. K. Friason, A. R. Calhoun, K. R. Bond; B. Davis,3 J. Sandlow,1 K. D. Schoyer,1 E. Y. Reproductive & Developmental Sciences, Strawn,1 K. E. Flynn1; 1Medical College of Oregon National Primate Research Center; Wisconsin, Milwaukee, WI, 2Duke University, Oregon Health & Science University, Durham, NC, 3Michigan State University, Beaverton, OR. Grand Rapids, MI.

nd 72 ASRM Scientific Congress & Expo 134 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

11:45 AM O-15 EFFICACY AND SAFETY OF A LOW-DOSE 11:30 AM O-20 IMPACT OF CLOMIPHINE CITRATE ON LEVONORGESTREL INTRAUTERINE PROSTATE SPECIFIC ANTIGEN VALUES FOR SYSTEM (LNG-IUS12) ACCORDING TO AGE, MEN BEING TREATED FOR INFERTILITY. PARITY, AND BODY MASS INDEX OVER L. DiGiorgio,1 D. Shin,2 R. P. Bonitz1; 5 YEARS OF USE. T. A. Faustmann,1 K. 1Rutgers University, Newark, NJ, 2Urology, Gemzell-Danielsson,2 D. Apter,3 K. A. Rosen,4 Hackensack University Medical Center, T. Schmelter,1 M. Merz,1 A. Nelson5; 1Bayer Hackensack, NJ. Pharma AG, Berlin, Germany, 2Karolinska Institutet and Karolinska University Hospital, 11:45 AM O-21 PERIPUBERTAL BLOOD LEAD LEVELS Stockholm, Sweden, 3VL-Medi Clinical 4 AND SEMEN QUALITY IN A PROSPECTIVE Research Center, Helsinki, Finland, Bayer L. 5 COHORT STUDY OF RUSSIAN MEN. Healthcare, Whippany, NJ, Los Angeles Minguez-Alarcon,1 O. Sergeyev,2 J. S. Biomedical Research Institute, Torrance, CA. Burns,3 P. Williams,4 M. M. Lee,5 S. Korrick,6 L. Smigulina,7 B. A. Revich,8 R. Hauser9; 12:00 PM O-16 FERTILITY CONCERNS ARE ASSOCIATED 1Harvard T H Chan School of Public Health, WITH LOWER CONTRACEPTION RATES Boston, MA, 2Department of Genomics and IN BREAST CANCER SURVIVORS. T. Human Genetics, Vavilov Institute of General Toloubeydokhti, S. Lederhandler, I. Su; Genetics, Moscow, Russian Federation, Reproductive Medicine, University of 3Environmental Health, Harvard T.H.Chan California, San Diego, La Jolla, CA. School of Public Health, Boston, MA, 4Biostatistics and Epidemiology, Harvard T. 12:15 PM H. Chan School of Public Health, Boston, MA, O-17 UTILIZATION OF IMMEDIATE POSTPARTUM 5 ETONOGESTREL CONTRACEPTIVE and Cell Developmental Biology, B. B. Mills, J. Van Deman III, E. C. University of Massachusetts Medical School, IMPLANT. 6 Heberlein, A. H. Picklesimer; Department Worcester, MA, Department of Medicine, of Obstetrics and Gynecology, Greenville Brigham and Women’s Hospital, Harvard 7 Health System, Greenville, SC. Medical Scho, Boston, MA, Chapaevsk Medical Association, Chapaevsk, Russian Federation, 8Environmental Health, Public 12:30 PM O-18 ETHNIC AND RACIAL DIFFERENCES IN THE Health, Moscow, Russian Federation, PREVALENCE OF INFERTILITY: NATIONAL 9Harvard Chan School of Public Health, SURVEY OF FAMILY GROWTH (NSFG). J. Boston, MA. D. Peck,1 A. Janitz,2 L. B. Craig3; 1Dept of Biostatistics and Epidemiology, OU Health Sciences Center, Oklahoma City, OK, 2Dept 12:00 PM O-22 ALLEVIATING EFFECTS OF VARIOUS of Biostatistics and Epidemiology, OU Health CONCENTRATIONS OF ETHANOLIC Science Center, Oklahoma City, OK, 3Section EXTRACT OF LYCOPODIUM CLAVATUM of REI; Dept of Ob/Gyn, OU Health Science ON AGING INDUCED TESTICULAR Center, Oklahoma City, OK. PATHOLOGY IN WISTAR ALBINO RATS. G. Lakshmanan,1 P. Seppan2; 1Department of Anatomy, Research Scholar, Chennai, India, 2Department of Anatomy, Assosciate MALE REPRODUCTION AND UROLOGY: Proffessor, Chennai, India. TRAVELING SCHOLARS Moderators: Nancy Brackett, Cigdem Tanrikut 12:15 PM O-23 MAPPING GENETIC HETEROGENEITY OF VIABLE AND NON-VIABLE SPERM. L. 11:15 AM O-19 MORE THAN A FLAGELLAR PROTEIN: Nagirnaja,1 M. J. Noordam,2 D. Conrad1; IFT140 IS A MALE INFERTILITY CANDIDATE 1Genetics, Washington University School GENE THAT MAY MODULATE CELL of Medicine, St. Louis, MO, 2Clinical A. S. Herati,1 P. R. Butler,1 C. SIGNALING. Genetics, Maastricht University, Maastricht, Cengiz,1 D. J. Lamb2; 1Urology, Baylor College Netherlands. of Medicine, Houston, TX, 2Urology/Center for Reproductive Medicine/MCB, Baylor College of Medicine, Houston, TX.

nd 72 ASRM Scientific Congress & Expo 135 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

12:30 PM O-24 MOLECULAR MECHANISMS BEHIND 12:00 PM O-28 ISOLATION AND IDENTIFICATION OF GHRELIN-MEDIATED PREVENTION OF EXTRACELLULAR VESICLES IN THE HUMAN POST-SURGICAL ADHESIONS. E. Bianchi,1 ENDOMETRIAL FLUID. D. Bolumar,1 I. K. Boekelheide,2 M. Sigman,3 S. J. Hall,4 Moreno,2 S. Cabanillas,3 C. Simon,4 F. K. Hwang2; 1Division of Urology, Brown Vilella5; 1Research, Fundacion IVI, Paterna University, Providence, RI, 2Brown University, (Valencia), Spain, 2Fundacion IVI, Paterna Providence, RI, 3Surgery (Urology), Brown (Valencia), Spain, 3Gynecologist, Valencia, University and Lifespan, Providence, RI, Spain, 4Fundacion Instituto Valenciano de 4Pathology, Saunderstown, RI. Infertilidad, Paterna, Spain, 5Fundacion IVI / Incliva, Paterna, Spain.

12:15 PM O-29 BISPHENOL-A (BPA) EXPOSURE ON THE REPRODUCTIVE ENDOCRINOLOGY: RESEARCH DAY OF IMPLANTATION ALTERS UTERINE Moderators: Elizabeth McGee, Deidre Gunn EPIGENOME DISRUPTING FETAL GROWTH: 11:15 AM O-25 COMPLEX DIFFERENTIAL EXPRESSION A MOUSE MODEL. I. Robertshaw, J. M. OF COLONY STIMULATING FACTOR (CSF) Sroga, M. A. Thomas; Obstetrics and LIGANDS AND RECEPTORS IN THE HUMAN Gynecology, University of Cincinnati, West ENDOMETRIUM. H. S. Hoff,1 L. Yuan,1 B. A. Chester, OH. Lessey,2 S. L. Young1; 1Obstetrics & Gynecology, University of North Carolina, Chapel Hill, NC, 12:30 PM O-30 GPER MEDIATED ACTION OF ESTROGEN 2Obstetrics and Gynecology, Reproductive IN EDOMETRIAL RECEPTIVITY OF WOMEN Endocrinology and Infertility, Greenville, SC. WITH HIGH SERUM ESTRADIOL LEVEL ON HCG DAY. Y. Shi, C. Fang, R. Huang, X. Liang; 11:30 AM O-26 LONGITUDINAL FOLLOW-UP IN FEMALE The Sixth Affiliated Hospital of Sun Yat-Sen CHILDHOOD CANCER SURVIVORS: University, Guangzhou, China. NO SIGNS OF ACCELERATED OVARIANFUNCTION LOSS. A. L. van der Kooi,1,2,3 M. M. van den Heuvel-Eibrink,4,3 S. M. Pluijm,3 S. J. Neggers,1 E. van Dulmen-den REPRODUCTIVE SURGERY 1 Broeder,5 W. van Dorp,1 J. S. Laven1; 1Div. Moderators: Bala Bhagavath, Ndeye-Aicha Gueye Reproductive Medicine, Erasmus Medical 11:15 AM O-31 HUMAN ADHESION FIBROBLASTS ARE Center Rotterdam, Rotterdam, Netherlands, CHARACTERIZED BY A REDUCTION IN 2Pediatric Oncology, Princess Maxima 3 THE LEVEL OF PLURIPOTENCY MARKERS Center, Utrecht, Netherlands, Pediatric AS COMPARED OT NORMAL PERITONEAL Oncology/Hematology, Erasmus MC- Sophia FIBROBLASTS. N. M. Fletcher,1 A. Juhani,1 Children’s Hospital, Rotterdam, Netherlands, M. S. Abusamaan,2 M. P. Diamond,3 G. M. 4 Pediatric Oncology, Princess Maxima Saed1; 1Obstetrics and Gynecology, Wayne 5 Center, Rotterdam, Netherlands, Pediatric State University School of Medicine, Detroit, Oncology/Hematology, Erasmus Medical MI, 2Wayne State University, Detroit, MI, Center Rotterdam, Rotterdam, Netherlands. 3Augusta University, Augusta, GA.

11:45 AM O-27 THE DISRUPTION OF GENES INVOLVED IN 11:30 AM O-32 DEMOGRAPHIC CHARACTERISTICS IS SIGNIFICANTLY ASSOCIATED OF WOMEN WITH UTERINE FACTOR WITH LONGER TIME OR FAILURE TO ACHIEVE INFERTILITY SEEKING INFORMATION ON LIVE BIRTH IN PATIENTS UNDERGOING S. Arian,1 R. 1 1 1 UTERINE TRANSPLANTATION. IVF. R. Berro, D. Parfitt, S. Arunajadai, Flyckt,1 A. G. Tzakis,2 T. Falcone1; 1Obstetrics, 1 1 2 C. Clementi, K. Kalmbach, B. Miller, J. Gynecology, and Women’s Health Institute, 3 4 5 Gutmann, F. Arredondo, A. B. Copperman, Cleveland Clinic, Cleveland, OH, 2Transplant 1 1 P. Yurttas Beim ; Celmatix Inc, New York, NY, Surgery, Cleveland Clinic Florida, Weston, FL. 2RMA of Michigan, Rochester Hills, MI, 3RMA of Philadelphia, Philadelphia, PA, 4RMA of Texas, San Antonio, TX, 5Obstetrics and Gynecology, RMANY-Mount Sinai, New York, NY.

nd 72 ASRM Scientific Congress & Expo 136 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

11:45 AM O-33 UTERINE AND OVARIAN VIABILITY IN IMAGING IN REPRODUCTIVE MEDICINE THE BABOON WITH BILATERAL UTERO- Moderators: G. Wright Bates, Roohi Jeelani OVARIAN MICROVASCULAR ANASTOMOSES 1 1 11:15 AM O-37 EXPERIENCE IN TRANSABDOMINAL ALONE. B. D. Beran, K. S. Arnolds, M. C. C. E. Shockley,1 K. Rivas,2 M. L. Sprague,1 OOCYTE RETREIVALS: A CASE SERIES. Shenoy, C. Coddington, Z. Khan, T. L. Jones, M. Medina III,3 P. Escobar,4 A. G. Tzakis,5 J. Jensen; Reproductive Endocrinology & T. Falcone,6 S. Zimberg1; 1Division of Infertility, Mayo Clinic, Rochester, MN. Minimally Invasive Gynecology, Cleveland Clinic Florida, Weston, FL, 2Mannheimer Foundation, Homestead, FL, 3Plastic 11:30 AM O-38 HOME-BASED ULTRASOUND MONITORING Surgery, Cleveland Clinic Florida, Weston, FOR IN VITRO FERTILIZATION IS A FEASIBLE FL, 4Gynecologic Oncology and Reproductive METHOD OF IN CYCLE MONITORING. N. Medicine, The University of Texas MD Resetkova,1,2 D. Sakkas,3 S. Bayer,2 A. Penzias,2 Anderson Cancer Center, Houston, TX, M. M. Alper2; 1Obstetrics and Gynecology, Beth 5Transplant Surgery, Cleveland Clinic Florida, Israel Deaconess Medical Center, Boston, Weston, FL, 6Obstetrics & Gynecology, MA, 2Boston IVF / Harvard Medical School, Cleveland Clinic, Cleveland, OH. Waltham, MA, 3Boston IVF, Waltham, MA.

12:00 PM O-34 UNILATERAL SALPINGECTOMY AND 11:45 AM O-39 UTERINE STRUCTURE AND PERFUSION METHOTREXATE ARE ASSOCIATED STUDY USING CONTRAST-ENHANCED WITH SIMILAR RECURRENCE RATE OF ULTRASOUND (CE-US) AND FRACTIONAL ECTOPIC PREGNANCY IN PATIENTS MOVING BLOOD VOLUME (FMBV). E. I. UNDERGOING IVF. M. Irani,1 A. Robles,2 V. Gil Arribas,1 P. Royo,2 I. Amat-Roldan,3 R. Gunnala,3 Z. Rosenwaks,4 S. D. Spandorfer5; Gilabert,4 J. Serna1; 1IVI Zaragoza, Zaragoza, 1Reproductive Endocrinology and Infertility, Spain, 2IVI Pamplona, Pamplona, Spain, Weill Cornell Medicine, New York, NY, 3Ymaging, Barcelona, Spain, 4Ymaging, Senior 2Resident Physician at NYP Weill Cornell, Consultant Radiologist, Barcelona, Spain. New York, NY, 3OB/GYN, REI Fellow, New 4 York, NY, Weill Cornell Medicine - Center for 12:00 PM O-40 INCIDENCE AND RECURRENCE OF UTERINE Reproductive Medicine, 1305 York Avenue, POLYPS IN WOMEN UNDERGOING EMBRYO 5 New York, NY, Cornell University Medical TRANSFER. J. M. DeVita,1 K. Merriam,2 R. S. Center, New York City, NY. Usadi,3 P. Marshburn,3 M. Matthews,3 B. S. Hurst3; 1Medical University of South Carolina, 12:15 PM O-35 ASSESSING IMPORTANCE OF Charleston, SC, 2Obstetrics and Gynecology, REPRODUCTIVE SURGERY TRAINING Carolinas HealthCare System, Charlotte, NC, IN GRADUATING REPRODUCTIVE 3Reproductive Endocrinology and Infertility, ENDOCRINOLOGY & INFERTILITY FELLOWS. Carolinas HealthCare System, Charlotte, NC. L. R. Goodman,1 Z. Khan,2 J. M. Goldberg1; 1 Women’s Health Institute, Cleveland Clinic, 12:15 PM O-41 OPTIMAL FOLLICULAR SIZE FOR OVULATORY 2 Cleveland, OH, Reproductive Endocrinology TRIGGER IN NATURAL AND CLOMIPHENE & Infertility, Mayo Clinic, Rochester, MN. CITRATE INTRAUTERINE INSEMINATION CYCLES. K. Hancock, N. Pereira, J. P. Lekovich, 12:30 PM O-36 THE INCIDENCE OF RENAL ANOMALIES P. H. Chung, Z. Rosenwaks; The Ronald O. IN PATIENTS WITH SEPTATE UTERI. D. E. Perelman and Claudia Cohen Center for Broughton,1 K. Anderson,1 E. Jungheim,1 Reproductive Medicine, Weill Cornell Medicine, C. Siegel2; 1Obstetrics and Gynecology, New York, NY. Washington University, St. Louis, MO, 2 Radiology, Washington University, St. 12:30 PM O-42 THE DIFFERENCE IN SIZE BETWEEN SINGLE Louis, MO. PRONUCLEI AFTER ICSI AND AFTER IVF. C. Igashira, J. Otsuki, K. Furuhashi, Y. Katada, T. Sumimoto, K. Kishi, M. Matsuura, M. Mukai, C. Sumi, Y. Tsuji, Y. Matsumoto, S. Kokeguchi, M. Shiotani; Hanabusa Women’s Clinic, Kobe Hyogo, Japan.

nd 72 ASRM Scientific Congress & Expo 137 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

PREIMPLANTATION GENETIC TESTING 1 12:15 PM O-47 SINGLE EMBRYO TRANSFER (SET) Moderators: Svetlana Rechitsky, Suneeta Senapati FOLLOWING COMPHREHENSIVE CHROMOSOME SCREENING (CCS) IS MORE 11:15 AM O-43 CELLS EXCLUDED FROM DEVELOPMENT COST EFFECTIVE THAN UNSCREENED IN HUMAN BLASTOCYSTS ARE NOT 1 1 SEQUENTIAL SET. S. Neal, S. J. Morin, J. M. S. REPRESENTATIVE OF EMBRYO PLOIDY. Franasiak,1 C. R. Juneau,1 Y. Zhan,2 R. T. Scott Sadowy,1 L. Ribustello,2 L. C. Grossman,3 Jr.1; 1RMANJ, Basking Ridge, NJ, 2FEC, NJ, NJ. M. Guarnaccia,4 K. Satriani,1 M. V. Sauer5; 1ObGyn, Columbia University, New York, NY, 2Reprogenetics, Livingston, NJ, 3Obstetrics 12:30 PM O-48 UNRAVELING THE COMPLEXITIES OF and Gynecology, Columbia University MOSAICISM IN HUMAN BLASTOCYSTS. S. Medical Center, New York, NY, 4REI, Columbia McReynolds, M. Schweitz, S. McCormick, J. C. University, New York, NY, 5OB GYN, Columbia Parks, W. B. Schoolcraft, M. Katz-Jaffe; Colorado University, New York, NY. Center for Reproductive Medicine, Lone Tree, CO.

11:30 AM O-44 DOES EUPLOID EMBRYO RANKING BY TROPHECTODERM CELL MITOCHONDRIAL ART: CLINICAL 1 DNA CONTENT CORRESPOND WITH Moderators: Christina Boots, Kara Ehlers RANKING BY BLASTOCYST MORPHOLOGY WITHIN AN INDIVIDUAL PATIENT’S 11:15 AM O-49 NON-INVASIVE FIRST-TRIMESTER COHORT OF BLASTOCYSTS? J. Kort, ANEUPLOIDY SCREENING USING CELL- R. Lathi, B. Behr; Stanford Fertility and FREE DNA IN A FERTILITY PRACTICE: Reproductive Medicine Center, Palo Alto, CA. ACCEPTABILITY AND OUTCOMES. K. R. Hammond,1 N. A. Cataldo,1,2 B. A. Malizia,1 1 1 1 11:45 AM J. A. Hubbard, M. P. Steinkampf ; Alabama O-45 PREVALENCE AND CLINICAL SIGNIFICANCE 2 OF SEGMENTAL ANEUPLOIDY IN HUMAN Fertility Specialists, Birmingham, AL, Dept. OOCYTES AND PREIMPLANTATION EMBRYOS. of Epidemiology, UAB, Birmingham, AL. D. Babariya,1 E. Fragouli,2 S. Alfarawati,2 K. Spath,1 A. Raberi,1 S. Taylor,2 N. Kubikova,2 D. 11:30 AM O-50 ALTERED LIVE BIRTH GENDER RATIO Wells2; 1Nuffield Department of Obstetrics FOLLOWING FROZEN SINGLE EUPLOID and Gynaecology, University of Oxford and BLASTOCYST TRANSFER. M. Katz-Jaffe, B. Reprogenetics UK, Oxford, United Kingdom, K. Brown, M. R. Mansfield, J. M. Stevens, C. B. 2Reprogenetics UK, Oxford, United Kingdom. Pospisil, W. B. Schoolcraft; Colorado Center for Reproductive Medicine, Lone Tree, CO. 12:00 PM O-46 PGS ANALYSIS OF OVER 33,000 BLASTOCYSTS USING HIGH RESOLUTION NEXT GENERATION 11:45 AM O-51 (DONOR) AGE IS ONLY A NUMBER: A SEQUENCING (HRNGS)OF OVER 33,000 COMPARISON OF OOCYTE DONORS. M. K. BLASTOCYSTS USING HIGH RESOLUTION Pierce,1 T. A. Molinaro,2 P. A. Bergh3; 1Nursing, NEXT GENERATION SEQUENCING (HRNGS). RMA of NJ, Basking Ridge, NJ, 2Reproductive S. Munne,1 M. Large,2 L. Ribustello,1 J. Blazek,3 Medicine Associates of New Jersey, F. Gouw,4 J. Grifo,5 G. Haddad,6 W. Chang,7 Eatontown, NJ, 3RMA, Basking Ridge, NJ. G. M. Grunert,8 A. Huang,9 F. Yelian,10 M. 11 1 Hughes ; Reprogenetics, Livingston, NJ, 12:00 PM 2 3 O-52 ASSISTED REPRODUCTIVE TECHNOLOGY Genesis Genetics, Houston, TX, Research and CYCLE AND OBSTETRIC OUTCOMES AMONG Development, Genesis Genetics, Houston, TX, 4 5 UNDERWEIGHT AND OVERWEIGHT WOMEN. Reprogenetics, Los Angeles, CA, NYU Langone J. F. Kawwass,1 A. Kulkarni,2 H. Hipp,3 S. 6 Medical Center, New York, NY, Houston Fertility Crawford,4 D. M. Kissin,2 D. J. Jamieson4; 7 Institute, Tomball, TX, ART Reproductive 1Reproductive Endocrinology and Infertility, Center, Southern California Reproductive Emory University Reproductive Center (& 8 Center, Beverly Hills, CA, Houston Fertility CDC), Atlanta, GA, 2Division of Reproductive 9 Specialists, Houston, TX, Reproductive Health, Centers for Disease Control and Partners Medical Group, Redondo Beach, CA, Prevention, Atlanta, GA, 3Gynecology and 10 Reproduction Endocrinology, Life IVF Center, Obstetrics, Emory University School of 11 Irvine, CA, Molecular Genetics, Genesis Medicine, Atlanta, GA, 4CDC, Atlanta, GA. Genetics, Plymouth, MI.

nd 72 ASRM Scientific Congress & Expo 138 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

12:15 PM O-53 IN VITRO FERTILIZATION AND School of Medicine, New York, NY, 3Seattle DEVELOPMENT OF HUMAN OOCYTES Reproductive Medicine, Seattle, WA, 4IVF RECONSTITUTED BY SPINDLE NUCLEAR Florida Reproductive Associates, Margate, TRANSFER TO REPLACE MUTATED FL, 5Brigham and Women’s Hospital ART MITOCHONDRIAL DNA. H. Liu,1 Z. Lu,1 Center, Boston, MA, 6Reprogenetics, Oxford, S. Luo,2 A. Chavez-Badiola,3 J. Blazek,4 S. United Kingdom. Munne,5 T. Huang,2 J. Zhang1; 1New Hope 2 Fertility Center, New York, NY, Division 12:00 PM O-58 TRANSFER OF BLASTOCYSTS WITH of Human Genetics, Cincinnati Children’s LOWER MITOCHONDRIAL DNA (MTDNA) Hospital Medical Center, Cincinnati, 3 QUANTITIES IMPROVES IVF OUTCOMES. OH, New Hope Fertility Center Mexico, K. Ravichandran,1 C. McCaffrey,2 J. Grifo,3 M. 4 Guadalajara, Mexico, Research and Perloe,4 A. M. Rosen,5 T. Singer,6 S. Munne,1 Development, Genesis Genetics, Houston, D. Wells,7 E. Fragouli7; 1Reprogenetics, 5 TX, Reprogenetics, Livingston, NJ. Livingston, NJ, 2OB/Gyn, NYU Fertility Center, New York, NY, 3NYU Langone Medical 12:30 PM O-54 HYPERESTROGENIC MILIEU DURING Center, New York, NY, 4Georgia Reproductive FRESH IN VITRO FERTILIZATION CYCLES Specialists, Atlanta, GA, 5Mercy Hospital AND LOW BIRTH WEIGHT: DOES A and Medical Center, Chicago IL, Manhattan SUPRAPHYSIOLOGIC THRESHOLD Beach, CA, 6ObGyn, Lenox Hill Hospital, EXIST? N. Pereira, R. Elias, K. Hancock, Roslyn, NY, 7Reprogenetics, Oxford, United J. P. Lekovich, Z. Rosenwaks; The Ronald Kingdom. O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell 12:15 PM O-59 RNA SEQUENCING OF ANEUPLOID Medicine, New York, NY. BLASTOCYSTS REVEALED ENRICHED PATHWAYS ASSOCIATED WITH COMPROMISED IMPLANTATION POTENTIAL. B. R. McCallie, J. C. Parks, M. EMBRYO BIOLOGY 1 Denomme Tignanelli, W. B. Schoolcraft, M. Moderators: Yulian Zhao, Cecily Bishop Katz-Jaffe; Colorado Center for Reproductive 11:15 AM O-55 COMPREHENSIVE CHROMOSOME Medicine, Lone Tree, CO. SCREENING AND GENE EXPRESSION ANALYSIS FROM THE SAME BIOPSY. N. 12:30 PM O-60 SEXUAL DIMORPHISM AND IMPLANTATION R. Treff,1 Y. Wang,1 X. Tao,2 R. T. Scott Jr.1; POTENTIAL: IS THERE A DIFFERENCE? 1RMANJ, Rutgers-RWJ, Basking Ridge, NJ, L. Sekhon,1,2 J. Rodriguez-Purata,1 J. A. 2The Foundation for Embryonic Competence, Lee,1 C. Briton-Jones,1 A. B. Copperman1,2; Basking Ridge, NJ. 1Reproductive Medicine Associates of New York, New York, NY, 2Obstetrics, Gynecology 11:30 AM O-56 MITOCHONDRIAL DNA CONTENT IS & Reproductive Science, Icahn School of INCREASED IN THE ANEUPLOID MOUSE Medicine at Mount Sinai, New York, NY. BLASTOCYST. X. Tao,1 J. N. Landis,1 R. T. Scott III,1 N. Treff,2 A. Lonczak1; 1Foundation for Embryonic Competence, Basking Ridge, NJ, 2RMANJ, Rutgers-RWJ, Basking Ridge, NJ. EMBRYO TRANSFER Moderators: Arlene Morales, Irene Woo

11:45 AM O-57 USE OF SINGLE NUCLEOTIDE 11:15 AM O-61 EMBRYO SPECIFIC GRAVITY CAN DETECT POLYMORPHISM (SNP) ARRAYS AND CRYODAMAGE, GENETIC INFORMATION NEXT GENERATION SEQUENCING AND ESTABLISH PREGNANCY. C. E. (NGS) TO STUDY THE INCIDENCE, TYPE Wessels,1 L. Penrose,2 S. Prien3; 1Animal AND ORIGIN OF ANEUPLOIDY IN THE Science, Texas Tech University, Lubbock, HUMAN PREIMPLANTATION EMBRYO. M. TX, 2Department of Obstetrics and Konstantinidis,1 K. Milligan,1 A. S. Berkeley,2 Gynecology, Texas Tech University Health J. Kennedy,3 W. Maxson,4 C. Racowsky,5 Sciences Center, Lubbock, TX, 3Ob/Gyn, D. Wells,6 S. Munne1; 1Reprogenetics, Texas Tech University Health Sciences Livingston, NJ, 2NYU Fertility Center, NYU Center, Lubbock, TX.

nd 72 ASRM Scientific Congress & Expo 139 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

11:30 AM O-62 RECURRENCE RISK OF ECTOPIC ENVIRONMENT AND REPRODUCTION PREGNANCY IS NOT INCREASED FOR Moderators: Irene Souter, Asima Ahmad PATIENTS WITH PREVIOUS ECTOPIC 11:15 AM O-67 FRUIT AND VEGETABLE INTAKE PREGNANCY COMPARED WITH THOSE AND THEIR PESTICIDE RESIDUES IN WITHOUT PREVIOUS ECTOPIC PREGNANCY RELATION TO OUTCOMES OF ASSISTED IN FROZEN BLASTOCYST TRANSFER REPRODUCTIVE TECHNOLOGY. Y. Chiu,1 CYCLES: A STUDY BASED ON MORE THAN A. J. Gaskins,1 P. Williams,2 M. W. Gillman,3 30,000 CYCLES. T. Du, Y. Fan, Q. Chen, L. Minguez-Alarcon,4 T. L. Toth,5 R. Hauser,4 Q. Lyu, Y. Kuang; Department of Assisted J. E. Chavarro1; 1Department of Nutrition, Reproduction, Shanghai Ninth People’s Harvard T.H. Chan School of Public Health, Hospital, Shanghai, China. Boston, MA, 2Biostatistics and Epidemiology, Harvard T. H. Chan School of Public Health, 11:45 AM O-63 LIVE BIRTH RATE FOLLOWING EMBRYO Boston, MA, 3Obesity Prevention Program, TRANSFER IS SIGNIFICANTLY INFLUENCED Department of Population Medicine, Harvard BY THE PHYSICIAN PERFORMING THE Medical School and Harvard Pilgrim Health TRANSFER: DATA FROM 2707 EUPLOID Care Institute, Boston, MA, 4Environmental BLASTOCYST TRANSFERS BY 11 Health, Harvard T.H. Chan School of Public PHYSICIANS. S. J. Morin, J. M. Franasiak, Health, Boston, MA, 5OB/GYN, Massachusetts C. R. Juneau, R. T. Scott Jr.; Reproductive General Hospital, Boston, MA. Medicine Associates of New Jersey, Basking Ridge, NJ. 11:30 AM O-68 THE EFFECT OF THE ENDOCRINE DISRUPTING CHEMICAL DEHP ON THE 12:00 PM O-64 CLINICAL PREGNANCY RATES AFTER OVARIAN AND ADIPOSE TRANSCRIPTOME. ELECTIVE VERSUS NON-ELECTIVE SINGLE N. M. Grindler,1 I. Yang,2 K. Rajendiran,3 K. EMBRYO TRANSFER IN PGT CYCLES. O. Kannan,3 A. J. Polotsky,1 D. Schwartz,2 T. Barash, K. Ivani, S. Willman, L. Weckstein, Powell,4,5 T. Jansson4; 1OBGYN, Division of E. Rosenbluth, D. Wachs, M. Hinckley; REI, University of Colorado, Aurora, CO, Reproductive Science Center of the San 2Department of Medicine and Integrated Francisco Bay Area, San Ramon, CA. Center for Genes, Environment, and Health, University of Colorado Denver, Aurora, CO, 12:15 PM O-65 STRATEGIC IMPLEMENTATION OF 3Wadsworth Center, New York State Dept of EXTENDED CULTURE RESULTS IN Health and School of Public Health, SUNY DIFFERENT CLINICAL OUTCOMES at Albany, Albany, NY, 4OBGYN, Division COMPARED TO ROUTINE BLASTOCYST of Reproductive Sciences, University of CULTURE. V. Libby,1 B. G. Reed,1 S. Babayev,1 Colorado Denver, Aurora, CO, 5Pediatrics, K. Doody2; 1UT Southwestern Medical Center, Section of Neonatology, University of Dallas, TX, 2Center for Assisted Reproduction, Colorado Denver, Aurora, CO. Bedford, TX. 11:45 AM O-69 MULTI-CENTER STUDY: INNOVATIVE 12:30 PM O-66 COMPARISON OF ANEUPLOID RATES CONTROL OF AMBIENT AIR QUALITY AMONG DAY 5, 6, AND 7 BIOPSIED IN MULTIPLE IVF LABORATORIES IS BLASTOCYSTS. J. Shah,1 C. Vanijgul,2 S. ASSOCIATED WITH STATISTICALLY Chauhan,3 R. D. Dunn,4 W. A. Wun5; 1UT- SIGNIFICANT IMPROVEMENTS IN CLINICAL Houston/Memorial Hermann Hospital, OUTCOMES - ANALYSIS OF 5319 CYCLES. S. Houston, TX, 2Houston Fertility Specialists, Palter,1 K. DiPaola,2 A. E. Sparks,3 S. Degelos,4 Houston, TX, 3Houston Fertility Specialist, G. T. Koulianos,4 J. Young,5 C. Halicigil,6 T. Sugarland, TX, 4Houston Fertility Speicialists, Yalcinkaya,6 E. She,7 A. Bartolucci8; 1Gold Houston, TX, 5IVF lab, SART, Houston, TX. Coast IVF, Woodbury, NY, 2University of Cincinnati, West Chester, OH, 3University of Iowa, Iowa City, IA, 4The Center for Reproductive Medicine, Mobile, AL, 5The Fertility Center, Grand Rapids, MI, 6Carolinas Fertility Institute, Winston Salem, NC, 7NEFI, Stanford, CT, 8CARS, Farmington, CT.

nd 72 ASRM Scientific Congress & Expo 140 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

12:00 PM O-70 EXPOSURE TO PHTHALATE, AN 11:30 AM O-74 SECOND CHILDREN BORN AFTER ENDOCRINE DISRUPTING CHEMICAL, AUTOTRANSPLANTATION OF ALTERS FIRST TRIMESTER PLACENTAL CRYOPRESERVED OVARIAN TISSUE IN A GENE EXPRESSION IN WOMEN. N. M. YOUNG PATIENT PREVIOUSLY TREATED Grindler,1 I. Yang,2 K. Rajendiran,3 K. Kannan,3 WITH CHEMOTHERAPY FOR ASKIN’S D. A. Schwartz,2 S. Teal,4 A. J. Polotsky,1 T. DISEASETHE SUCCESSFUL OF FERTILITY L. Powell,5,6 T. Jansson6; 1OBGYN, Division PRESERVATION PROGRAM. F. Lorenzo,1 M. of REI, University of Colorado, Aurora, CO, Villamayor,1 J. Viola,2 M. Tiveron,1 E. Young1; 2Department of Medicine and Integrated 1Reproductive Medicine, IFER, Buenos Aires, Center for Genes, Environment, and Argentina, 2Fertility, IFER, Ciudad Autonoma Health, University of Colorado, Aurora, CO, de Buenos Aires, Argentina. 3New York State Dept of Health, Albany, 4 NY, OBGYN, Division of Family Planning, 11:45 AM O-75 RANDOM START STIMULATION ALLOWS University of Colorado, Aurora, CO, FOR MINIMAL TREATMENT DELAYS 5Pediatrics, University of Colorado, Aurora, 6 WITH NEOADJUVANT BREAST CANCER CO, OBGYN, Division of Reproductive TREATMENT. J. Letourneau,1 K. A. Sciences, University of Colorado, Aurora, CO. Wald,2 N. Sinha,1 E. Harris,1 E. Mok-Lin,1 M. Rosen1; 1Obstetrics, Gynecology and 12:15 PM O-71 BISPHENOL A (BPA) EXPOSURE IS NOT Reproductive Sciences, University of ASSOCIATED WITH LONGITUDINAL CHANGE California, San Francisco, San Francisco, IN OVARIAN RESERVE PARAMETERS. M. CA, 2OB/GYN, University of Washington, Quinn, R. R. Gerona, M. Cedars; Department Seattle, WA. of Obstetrics, Gynecology and Reproductive Sciences, University of California, San 12:00 PM O-76 OOCYTE Francisco, San Francisco, CA. COLLECTION AT DIFFERENT PHASES OF THE MENSTRUAL CYCLE AMONG WOMEN 12:30 PM O-72 EFFECT OF ENVIRONMENTAL ENDOCRINE REQUIRING URGENT CHEMOTHERAPY. DISRUPTOR’S EXPOSURE ON SPERM H. Creux,1 P. Monnier,1,2 W. Son,3 T. QUALITY AND ANEUPLOIDY RATES IN Tulandi,4 W. Buckett5; 1Obstetrics and FERTILE SPERM DONORS. C. Rubio,1 Gynecology, MUHC Reproductive Center, I. Campos-Galindo,2 R. Rivera Egea,3 N. Montreal, QC, Canada, 2MUHC Research Garrido,4 C. Simon,5 F. Dominguez6; 1Igenomix; institute, Montreal, QC, Canada, 3MUHC Fundacion Instituto Valenciano de Infertilidad, Reproductive Center, Monteral, QC, Paterna, Spain, 2Igenomix, Valencia, Spain, Canada, 4Obstetrics and Gynecology, 3Andrology Laboratory, Instituto Universitario McGill University, Montreal, QC, Canada, IVI Valencia, Valencia, Spain, 4Andrology 5McGill University, Montreal, QC, Canada. Laboratory, Instituto Valenciano IVI Valencia, 5 Valencia, Spain, Parque Cientifico Universidad 12:15 PM 6 O-77 COST EFFECTIVENESS OF EGG BANKING de valencia, Paterna, Spain, Research, FIVI- FOR CANCER PATIENTS. B. M. Lyttle,1 N. INCLIVA, Valencia, Spain. S. Grover,2 T. B. Mesen,3 A. Z. Steiner,4 J. E. Mersereau5; 1Obstetrics and Gynecology, Division of Reproductive Endocrinology, University of North Carolina, Chapel Hill, FERTILITY PRESERVATION NC, 2Hematology, University of North Moderators: Elizabeth Ginsburg, Juan Alvarez Carolina, Chapel Hill, NC, 3Obstetrics and 11:15 AM O-73 PREDICTING THE LIKELIHOOD OF LIVE BIRTH Gynecology, Division of Reproductive FOR ELECTIVE : Endocrinology, University North Carolina 4 A COUNSELING TOOL FOR PHYSICIANS AND Chapel Hill, Chapel Hill, NC, University of 5 PATIENTS. R. H. Goldman,1 C. Racowsky,1 North Carolina, Chapel Hill, NC, REI, UNC, L. V. Farland,1 S. Munne,2 L. Ribustello,2 J. H. Chapel Hill, NC. Fox1; 1Dept of Obstetrics and Gynecology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, 2Reprogenetics, Livingston, NJ.

nd 72 ASRM Scientific Congress & Expo 141 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

12:30 PM O-78 VALUING WORK SUCCESS AND FAMILY 12:00 PM O-82 CHANGES IN OVARIAN MORPHOLOGY PLANNING: ATTITUDES ON PREGNANCY ASSOCIATED WITH BARIATRIC SURGERY PLANNING, DELAYED CHILDBEARING, AND AMONG WOMEN WITH POLYCYSTIC OVARY THE ACCEPTABILITY OF REPRODUCTIVE SYNDROME (PCOS). J. Christ, T. Falcone; TECHNOLOGIES AMONG CAREER-FOCUSED Cleveland Clinic, Cleveland, OH. WOMEN. M. Simoni,1 L. Mu,2 S. C. Collins1; 1 Department of Obstetrics, Gynecology, 12:15 PM O-83 INCREASED LIPID-STIMULATED and Reproductive Sciences, Yale University 2 INTERLEUKIN-6 (IL-6) RELEASE FROM School of Medicine, New Haven, CT, Yale MONONUCLEAR CELLS (MNC) IS LINKED TO School of Medicine, New Haven, CT. EXCESS OVARIAN ANDROGEN SECRETION IN POLYCYSTIC OVARY SYNDROME (PCOS). O. A. Abdelhadi,1 R. V. Considine,2 A. J. Acton,2 F. Gonzalez1; 1Obstetrics and Gynecology, POLYCYSTIC OVARY SYNDROME Indiana University School of Medicine, Moderators: Jennifer Eaton, Gretchen Collins Indianapolis, IN, 2Medicine, Indiana University 11:15 AM O-79 HYPERANDROGENISM IS ASSOCIATED School of Medicine, Indianapolis, IN. WITH PREFERENTIAL FAT DEPOSITION OF VISCERAL VERSUS SUBCUTANEOUS 12:30 PM O-84 THE MORPHOKINETIC CHARACTERISTICS (SC) ABDOMINAL FAT IN LEAN POLYCYSTIC OF EMBRYOS DERIVED FROM PCOS OVARY SYNDROME (PCOS) WOMEN. A. L. PATIENTS. N. Aono,1,2 R. Obata,1 S. Akopians,1 V. Madrigal,1 S. Fisch,1 E. Ramirez,2 Maekawa,1 N. Oka,1 T. Takeuchi,1 H. Igarashi,2 D. Margolis,3 M. K. Sarma,3 M. A. Thomas,3 K. Kyono2,1; 1Kyono ART Clinic Takanawa, T. Grogan,4 D. H. Abbott,5 R. Haykal,1 G. Minatoku, Tokyo, Japan, 2Kyono ART Clinic, D. Chazenbalk,1 D. A. Dumesic1; 1OB/GYN, Sendai, Miyagi, Japan. UCLA, Los Angeles, CA, 2Medicine, UCLA, Los Angeles, CA, 3Radiological Science, UCLA, Los Angeles, CA, 4Medicine Statistics Core, UCLA, Los Angeles, CA, 5OB/GYN, Wisconsin National OUTCOME PREDICTORS: ART 1 Primate Research Center, Madison, WI. Moderators: Lynn Westphal, Chantel Cross 11:15 AM O-85 SERUM ANTI-MÜLLERIAN HORMONE 11:30 AM O-80 SATURATED FAT INGESTION STIMULATES (AMH) LEVELS INDEPENDENTLY PREDICT SUPRESSOR OF CYTOKINE SIGNALING-3 MISCARRIAGE RATES FOLLOWING IN VITRO (SOCS-3) AND TOLL-LIKE RECEPTOR-4 FERTILIZATION-EMBRYO TRANSFER. B. (TLR-4) GENE EXPRESSION IN POLYCYSTIC Tarasconi,1 T. Tadros,1 E. Adda-Herzog,1 1 OVARY SYNDROME (PCOS). O. A. Abdelhadi, S. Belloc,2 J. Ayoubi,3 R. Fanchin1; 2 2 1 R. V. Considine, A. J. Acton, F. Gonzalez ; 1Reproductive Medicine, Hospital Antoine 1 Obstetrics and Gynecology, Indiana Beclere-University of Paris Sud, Clamart, University School of Medicine, Indianapolis, France, 2Eylau-Unilabs Laboratory, Paris, 2 IN, Medicine, Indiana University School of France, 3Ob-Gyn, Hospital Foch-University of Medicine, Indianapolis, IN. Paris Ouest, Suresnes, France.

11:45 AM O-81 ANTI-INFLAMMATORY THERAPY 11:30 AM O-86 ARE ALL TWINS FOLLOWING ELECTIVE SUPPRESSES PROINFLAMMATORY SINGLE EMBRYO TRANSFER (ESET) CYTOKINE SECRETION FROM MONOZYGOTIC? ANALYSIS OF 32,600 ESET MONONUCLEAR CELLS AND REDUCES CYCLES REPORTED TO SART. S. Zaghi,1 M. HYPERANDROGENISM IN LEAN WOMEN G. Vega,2 E. Buyuk,3 R. Fritz,1 S. K. Jindal4; WITH POLYCYSTIC OVARY SYNDROME 1Albert Einstein College of Medicine, Bronx, 1 2 (PCOS). F. Gonzalez, R. V. Considine, O. NY, 2Department of Obstetrics & Gynecology & 1 2 1 A. Abdelhadi, A. J. Acton ; Obstetrics and Women’s Health, Montefiore Medical Center/ Gynecology, Indiana University School Albert Einstein College of Medicine, Bronx, 2 of Medicine, Indianapolis, IN, Medicine, NY, 3Albert Einstein College of Medicine / Indiana University School of Medicine, Montefiore M, Bronx, NY, 4ObGyn and Women’s Indianapolis, IN. Health, Montefiore’s Institute for Reproductive Medicine and Health, Hartsdale, NY.

nd 72 ASRM Scientific Congress & Expo 142 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

11:45 AM O-87 MATERNAL AND NEONATAL OUTCOMES 12:15 PM O-89 IVF IN WOMEN OF 45 YEARS AND OLDER: IN WOMEN OF ADVANCED MATERNAL THE LARGEST SINGLE CENTER COHORT TO AGE (AMA) UNDERGOING TWO IN DATE. V. Gunnala, M. Irani, Z. Rosenwaks, S. VITRO FERTILIZATION (IVF) SINGLETON D. Spandorfer; The Ronald O. Perelman and , AS COMPARED TO ONE IVF Claudia Cohen CRM, Weill Cornell Medicine, TWIN PREGNANCY. S. Amrane,1 P. Ghosh,1 New York, NY. D. E. Reichman,2 Z. Rosenwaks,2 S. E. Gelber1; 1 Obstetrics and Gynecology, New York 12:30 PM O-90 DOES A WORSENING IN ENDOMETRIAL Presbyterian- Weill Cornell Medicine, New 2 STRIPE PATTERN CORRELATE WITH York, NY, Center for Reproductive Medicine INCREASING PROGESTERONE LEVELS and Infertility, Weill Cornell Medical College, IN IVF CYCLES? M. W. Healy,1 H. Wolfe,2 New York, NY. B. Yauger,2 R. Chason,2 N. Banks,1 C. M. Owen,1 A. DeCherney,1 J. Csokmay,2 M. J. 12:00 PM O-88 RETRIEVAL OF LARGER OOCYTE COHORTS Hill1; 1National Institutes of Health- NICHD, MAXIMIZES IN VITRO FERTILIZATION (IVF) Bethesda, MD, 2Department of OB/GYN, BIRTH RATES PER CYCLE. M. T. Connell,1 Walter Reed National Military Medical K. S. Richter,2 M. J. Tucker,2 J. Graham,2 Center, Bethesda, MD. A. DeCherney,1 M. J. Hill,1 M. Levy2; 1NIH, Bethesda, MD, 2Shady Grove Fertility Reproductive Science Center, Rockville, MD.

nd 72 ASRM Scientific Congress & Expo 143 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

Tuesday, October 20, 2015 11:15 am - 12:45 pm

NON- Prize Paper Session CME CE ARS

SCIENTIFIC CONGRESS PRIZE PAPER SESSION 2 These papers are candidates for the ASRM Scientific Congress Prize Paper Awards. Six additional candidates will be presented during the Prize Paper Candidates’ session on Monday. Moderators: Jorge Chavarro, Lubna Pal

11:15 AM O-91 PREOVULATORY PROTEIN RESTRICTION 12:00 PM O-94 CAN WE EXPECT TO IMPROVE AGE (PPR): DISRUPTED AMINO ACID (AA) AT MENOPAUSE PREDICTIONS WITH KINETICS AND MITOCHONDRIAL REPEATED AMH MEASUREMENTS? A. C. de STRUCTURE AND FUNCTION IN THE RAT Kat,1 Y. T. van der Schouw,2 R. Eijkemans,2 M. OOCYTE. A. Schutt,1 C. S. Blesson,1 J. W. Verschuren,3 F. J. Broekmans1; 1Reproductive Hsu,2 W. E. Gibbons,1 C. T. Valdes,1 F. Jahoor,2 Medicine and Gynecology, University Medical C. Yallampalli1; 1Ob/Gyn, Baylor College of Center Utrecht, Utrecht, Netherlands, 2Julius Medicine, Houston, TX, 2Pediatrics-Nutrition, Center for Health Sciences and Primary Care, Baylor College of Medicine, Houston, TX. University Medical Center Utrecht, Utrecht, Netherlands, 3National Institute for Public 11:30 AM O-92 EFFECTS OF RESVERATROL ON POLYCYSTIC Health and the Environment, Bilthoven, OVARY SYNDROME. A. Duleba,1 B. Netherlands. Banaszewska,2 J. Wrotyńska-Barczyńska,2 R. Z. Spaczynski,2 L. Pawelczyk2; 1Reproductive 12:15 PM O-95 OOCYTES WITH IMPAIRED MEIOTIC Medicine, University of California, San Diego, MATURATION CONTAIN AN INCREASED La Jolla, CA, 2Gynecology, Obstetrics and LOAD OF MUTATED MITOCHONDRIAL DNA. Gynecological Oncology, Poznan University J. Kofinas,1 M. Seth-Smith,2 D. H. McCulloh,3 of Medical Sciences, Poznan, Poland. Y. G. Kramer,4 J. Grifo,5 D. L. Keefe6; 1Division of Reproductive Endocrine/Infertility, NYU, 2 3 11:45 AM O-93 GENOME-WIDE DNA METHYLATION New York, NY, NYU, New York, NY, Obstetrics and Gynecology, New York University CHANGES IN MOUSE ZYGOTES ASSOCIATED 4 B. Yu1,2; 1OBGYN, Fertility Center, New York, NY, NYU Fertility WITH SUPEROVULATION. 5 University of Washington, Seattle, WA, Center, New York, NY, NYU Langone Medical 6 2Albert Einstein College of Medicine, Bronx, Center, NY, NY, ObGyn, New York University NY. Langone Medical Center, New York, NY.

12:30 PM O-96 LOW LEVEL MOSAICISM: INCIDENCE AND IMPLICATIONS ON CLINICAL PREGNANCIES. D. A. Kelk,1 J. Lo,1 J. Martin,2 M. Hughes3; 1Yale Fertility Center, Yale University, Ob/Gyn, New Haven, CT, 2OB/GYN Dept, Yale University, REI Section, Yale REI, New Haven, CT, 3Molecular Genetics, Genesis Genetics, Plymouth, MI.

nd 72 ASRM Scientific Congress & Expo 144 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

Tuesday, October 18, 2016 11:15 am - 12:45 pm

NON- Oral Abstract Sessions CME CE ARS

• Access to Care 2 12:15 PM O-101 LIMITATIONS ON THE COMPENSATION OF • Reproductive Surgery 2 GAMETE DONORS: A SURVEY OF PUBLIC SUPPORT AND OPINION. M. S. Lee,1 L. • Male Reproduction and Urology: Cinical 1 V. Farland,2 S. A. Missmer,2 E. S. Ginsburg1; • Reproductive Endocrinology: Clinical 1 1Dept of Obstetrics & Gynecology, Brigham • Reproductive and Stem Cell Biology & Women’s Hospital and Harvard Medical 2 • ART: Clinical 2 School, Boston, MA, Dept of Epidemiology, Harvard Chan School, Boston, MA, Boston, MA. • Oocyte Biology • Ovarian Stimulation 12:30 PM O-102 COMPASSIONATE CORPS: CREATING • Preimplanataion Genetic Testing 2 ACCESS TO IVF MEDICATIONS FOR • Mental Health INJURED VETERANS. J. A. Drum; EMD • Male Factor Serono, Mooresville, NC. • Ovarian Reserve • Outcome Predictors: ART 2 • Cryopreservation and Frozen Embryo Transfer REPRODUCTIVE SURGERY 2 Moderators: Fabiola Balmir, Rashmi Kudesia 11:15 AM O-103 IMPORTANCE OF MALE INFERTILITY 1 ACCESS TO CARE 2 MICROSURGERY TRAINING. F. Neto, B. 2 2 1 1 Moderators: Andrea Stein, Heather Hoff Stone, P. V. Bach, B. B. Najari, M. Feliciano, P. S. Li,1 P. N. Schlegel,1 M. Goldstein3; 11:15 AM O-97 DECISION MAKING BY PATIENTS SEEKING 1Urology, Weill Cornell Medical College, New CARE FOR FERTILITY PROBLEMS. A. York, NY, 2Weill Cornell Medical College, New Cooper,1 E. A. Duthie,2 K. D. Schoyer,2 J. B. York, NY, 3Male Reproductive Medicine, and Davis,3 J. Sandlow,2 E. Y. Strawn,2 K. E. Flynn2; Urology, Weill Cornell Medical College, New 1Duke University, Durham, NC, 2Medical York Presbyteri, New York, NY. College of Wisconsin, Milwaukee, WI, 3Michigan State University, Grand Rapids, MI. 11:30 AM O-104 UTERINE VIABILITY FOLLOWING INTERRUPTION OF THE UTERINE VEIN- A 11:30 AM O-98 IN VITRO FERTILIZATION SUCCESS RATES PILOT STUDY TO ASSESS ALTERNATIVE BY PATIENT OCCUPATION, INCOME AND VENOUS RETURN FOR UTERINE EDUCATIONAL LEVEL. J. Anderson, D. TRANSPLANT. K. Arnolds,1 B. Beran,1 M. Anderson-Bialis; FertilityIQ, San Francisco, CA. Shockley,1 K. Rivas,2 M. L. Sprague,1 A. Tzakis,3 T. Falcone,4 S. Zimberg1; 1Gynecology, 11:45 AM O-99 THE IMPORTANCE OF PRAYER AND Cleveland Clinic Florida, Weston, FL, 2 RELIGIOUS LEADERS TO U.S. WOMEN Mannheimer Foundation, Homestead, FL, 3 FACING INFERTILITY. S. Kim,1 E. Chan,2 Transplant, Cleveland Clinic Florida, Weston, S. C. Collins1; 1Department of Obstetrics, FL, 4OB GYN, Cleveland Clinic, Cleveland, OH. Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, 11:45 AM O-105 UNEXPLAINED INFERTILITY :LAPAROSCOPY 2 Sociology, Yale University, New Haven, CT. FIRST OR ART.DIRECTLY. A. Algergawy,1 A. Alhalwagy,1 A. Shehata,1 H. Salem,1 A. 2 1 12:00 PM O-100 ART OF INFERTILITY: CURATING PATIENT- Abd Alnaby ; Obstetrics and Gynecology CENTERED PERSPECTIVES VIA AN Department, Faculty of Medicine, Tanta 2 ARTIFACT ORAL HISTORY METHODOLOGY. University, Tanta, Egypt, Obstetrics and E. Walker, M. Novotny; The ART of Infertility, Gynecology Department, Clinical Pharmcist, Jackson, MI. Tanta, Egypt.

nd 72 ASRM Scientific Congress & Expo 145 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

12:00 PM O-106 UTERINE VIABILITY IN THE BABOON 11:30 AM O-110 CHANGES IN PRACTICE PATTERNS IN MALE FOLLOWING INTERRUPTION OF INFERTILITY CASES IN THE UNITED STATES - THE UTERINE ARTERIES AND VEINS THE TREND TOWARD SUBSPECIALIZATION. BILATERALLY. M. E. Shockley,1 K. S. Arnolds,1 P. V. Bach,1 B. B. Najari,1 C. Oromendia,2 F. Neto,2 B. D. Beran,1 K. Rivas,2 M. L. Sprague,1 A. G. M. Goldstein,3 J. C. Hu,1 J. Kashanian1; 1Urology, Tzakis,3 P. Escobar,4 T. Falcone,5 S. Zimberg1; Weill Cornell Medical College, New York, NY, 1Minimally Invasive Gynecology, Cleveland 2Weill Cornell Medical College, New York, NY, Clinic Florida, Weston, FL, 2Mannheimer 3Male Reproductive Medicine, and Urology, Weill Foundation, Homestead, FL, 3Transplant Cornell Medical College, New York Presbyteri, Surgery, Cleveland Clinic Florida, Weston, FL, New York, NY. 4Gynecologic Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX, 11:45 AM 5 O-111 RELATIONSHIP BETWEEN MALE AGE AND Obstetrics & Gynecology, Cleveland Clinic, SUCCESS OF VASECTOMY REVERSAL. J. M. Cleveland, OH. Rehmer,1 H. Sayles,2 A. Perkins,3 S. L. Gustin,1 S. H. Marks,3 C. M. Deibert4; 1Department 12:15 PM O-107 REPRODUCTIVE SURGERY MALPRACTICE of Obstetrics and Gynecology, University PATTERNS. L. R. Matthews,1 F. A. Alvi,2 M. of Nebraska Medical Center, Omaha, NE, P. Milad3; 1OB/GYN, Northwestern Feinberg 2Department of Biostatistics, University School of Medicine, Chicago, IL, 2Department of Nebraska Medical Center, Omaha, of Obstetrics and Gynecology, Northwestern NE, 3International Center for Vasectomy University Feinberg School of Medicine, Reversal, Tucson, AZ, 4Division of Urologic Chicago, IL, 3Northwestern University, Surgery, University of Nebraska Medical Chicago, IL. Center, Omaha, NE.

12:30 PM O-108 A PROSPECTIVE RANDOMIZED 12:00 PM O-112 RNA-SEQENCING TO ASSESS EMBRYONIC SINGLE BLINDED STUDY OF OFFICE DEVELOPMENTAL COMPETENCE OF THE BASED EVALUATION OF PATIENTS MALE GAMETE. T. Cozzubbo, N. Pereira, PRESENTING WITH ABNORMAL UTERINE S. Cheung, Z. Rosenwaks, G. D. Palermo; BLEEDING USING CONCURRENT OFFICE Reproductive Medicine, Weill Cornell HYSTEROSCOPY AND ENDOMETRIAL Medicine, New York, NY. BIOPSY. DOES THE ORDER OF THE 1 PROCEDURES MATTER? A. N. Imudia, R. 12:15 PM 2 3 4 1 O-113 POSTVASECTOMY REVERSAL SEMEN Schickler, S. M. Plosker, E. Mikhail ; OB/ ANALYSIS: A PREDICTOR OF PREGNANCY. GYN, University of South Florida, Tampa, FL, A. Majzoub,1 A. S. Polackwich,2 R. Sharma,3 A. 2 Department of Obstetrics and Gynecology, Agarwal,3 E. S. Sabanegh4; 1Urology, Glickman University of South Florida Morsani Urological and Kidney Institute, Cleveland 3 College of Med, Tampa, FL, Obstetrics Clinic Foundation, Cleveland, OH, 2Urology, and Gynecology, University of South Columbia University Medical Center, Miami Florida Morsani College of Med, Tampa, FL, Beach, FL, 3Urology, American Center for 4 University of South Florida, Tampa, FL. Reproductive Medicine, Cleveland, OH, 4Urology, Cleveland Clinic, Cleveland, OH.

MALE REPRODUCTION AND UROLOGY: CLINICAL 1 12:30 PM O-114 EFFECT OF ANTIOXIDANT Moderators: Stanton Honig, Ali Dabaja SUPPLEMENTATION ON SPERM PARAMETERS IN 11:15 AM O-109 POLICY ON POSTHUMOUS SPERM OLIGOASTHENOTERATOZOOSPERMIA, RETRIEVAL: SURVEY OF 50 MAJOR WITH AND WITHOUT VARICOCELE: A ACADEMIC MEDICAL CENTERS. N. Waler,1 DBPC STUDY. G. Busetto,1 M. A. Virmani,2 R. Ramasamy2; 1UMM School of Medicine, G. Antonini,1 G. Ragonesi,1 E. De Berardinis,1 Miami, FL, 2University of Miami, Miami, FL. A. Agarwal,3 V. Gentile1; 1Urology, Sapienza Rome University Policlinico Umberto I, Roma, Italy, 2Sigma-tau HealthScience, Utrecht, Netherlands, 3Urology, Cleveland Clinic, Cleveland, OH.

nd 72 ASRM Scientific Congress & Expo 146 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

REPRODUCTIVE ENDOCRINOLOGY: CLINICAL 1 DISPROPORTIONAL INCREASES BETWEEN Moderators: Paula Amato, Shannel Adams 17α-OH AND OTHER STEROIDOGENIC ENZYMES. N. Akin,1 G. Bildik,1 A. Seyhan,2 11:15 AM O-115 PROSPECTIVE, RANDOMIZED STUDY OF B. Urman,3,2 O. Oktem3,2; 1School of Medicine THE ENDOMETRIAL RECEPTIVITY ANALYSIS and the Graduate School of Health Sciences, (ERA) TEST IN THE INFERTILITY WORK- Koc University, Istanbul, Turkey, 2Women’s UP TO GUIDE PERSONALIZED EMBRYO Health Center Assisted Reproduction TRANSFER VERSUS FRESH TRANSFER OR Unit, American Hospital, Istanbul, Turkey, C. Simon,1 DEFERRED EMBRYO TRANSFER. 3Obstetrics and Gynecology, Koc University I. K. Vladimirov,2 G. Castillon Cortes,3 I. Ortega,4 School of Medicine, Istanbul, Turkey. S. Cabanillas,5 C. Vidal,6 J. Giles,6 A. Izquierdo,7 S. Portela,8 I. Fernandez,9 M. Ferrando,10 S. Mackens,11 S. Barrera,12 A. Pellicer13; 1Parque 12:15 PM O-119 Abstract withdrawn Cientifico Universidad de Valencia, Paterna, Spain, 2Dpt. IVF Unit, SBALAGRM, Sofia, Bulgaria, 12:30 PM O-120 REPEAT IN VITRO FERTILIZATION 3IVI Barcelona, Barcelona, Spain, 4Medicina SUCCESS RATES ARE LOWER IN PATIENTS Reproductiva, IVI Madrid, Madrid, Spain, 5IVI WHO DELIVER VIA CESAREAN SECTION Valencia - Medicina Reproductiva, Valencia, WHEN USING EMBRYOS FROM THE SAME Spain, 6Unidad de Medicina Reproductiva, COHORT. M. K. Hayes,1,2 P. A. Bergh,1 C. IVI Valencia, Valencia, Spain, 7Medicina M. Bergh,3 T. A. Molinaro4; 1RMA, Basking Reproductiva, Madrid, Spain, 8Gynecologist, Ridge, NJ, 2Drexel University College of Vigo, Spain, 9IVI Vigo, Vigo, Spain, 10IVI Bilbao, Medicine, Philadelphia, PA, 3Nursing, RMANJ, Leioa, Spain, 11Centrum Voor Reproductieve Basking Ridge, NJ, 4Reproductive Medicine Geneeskunde, Brussel, Belgium, 12IVI Panama, Associates of New Jersey, Eatontown, NJ. Panama, Panama, 13Hospital Universitari i Politecnic La Fe, Valencia, Spain.

11:30 AM O-116 DIMINISHED BUT NOT DECLINING: REPRODUCTIVE AND STEM CELL BIOLOGY LONGITUDINAL ANDROGEN PRODUCTION Moderators: Pasquale Patrizio, Marla Lujan AND FOLLICULAR MEASURES OF OVARIAN 11:15 AM O-121 ANDROGEN AND ESTROGEN PROMOTE RESERVE IN CANCER SURVIVORS COMPARED MACAQUE PREANTRAL FOLLICLE SURVIVAL TO HEALTHY CONTROLS. K. Cameron,1 M. D. 2 3 4 1 AND GROWTH IN THE ABSENCE OF FSH Sammel, M. M. Prewitt, M. E. Lynch, C. Gracia ; T. 1 DURING 3-DIMENSIONAL CULTURE. University of Pennsylvania, Philadelphia, Baba,1,2 A. Y. Ting,1 O. Tkachenko,1 J. Xu,1 2 PA, Biostatistics and Epidemiology, Univ. of R. L. Stouffer1; 1Division of Reproductive & Pennsylvania, Perelman School of Medicine, Developmental Sciences, Oregon National 3 Philadelphia, PA, Obstetrics and Gynecology, Primate Research Center, Oregon Health University of Pennsylvania School of Medicine, & Science University, Beaverton, OR, 4 Philadelphia, PA, University of Pennsylvania 2Department of Obstetrics and Gynecology, School of Medicine, Ardmore, PA. Sapporo Medical University, Hokkaido, Japan.

11:45 AM O-117 THE PSYCHOLOGICAL IMPACT OF OVARIAN 11:30 AM O-122 OOCYTE-SPECIFIC EMBRYONIC POLY (A)- RESERVE TESTING: A QUALITATIVE BINDING PROTEIN (EPAB) IS REQUIRED ANALYSIS. Y. O’Brien,1 M. Wingfield,1 C. 2 1 FOR GRANULOSA CELL ERK SIGNALING Kelleher ; Reproductive Medicine, Merrion IN RESPONSE TO FSH. C. Yang, K. FertilityClinic, National Maternity Hospital, Lowther, M. D. Lalioti, H. S. Taylor, E. Seli; 2 Dublin 2, Ireland, PHS Department of Department of Obstetrics, Gynecology, Psychology, Royal College of Surgeons in and Reproductive Sciences, Yale School of Ireland, Dublin 2, Ireland. Medicine, New Haven, CT.

12:00 PM O-118 FSH PROMOTES PREMATURE 11:45 AM O-123 UTILIZATION OF ADIPOSE DERIVED STEM PROGESTERONE OUTPUT IN HUMAN CELLS FOR THE IN VITRO MATURATION GRANULOSA CELLS WITHOUT OF PRIMARY AND EARLY SECONDARY LUTEINIZATION BY UP-REGULATING THE OVARIAN FOLLICLES. L. J. Green,1 H. EXPRESSION OF 3β-HSD AND INDUCING

nd 72 ASRM Scientific Congress & Expo 147 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

Zhou,1 A. Shikanov2; 1OBGYN, University Annapolis, MD, 3Fertility Centers of Illinois, of Michigan, Ann Arbor, MI, 2University of Chicago, IL, 4EMD Serono, Inc., Rockland, MA. Michigan, Ann Arbor, MI. 11:45 AM O-129 INTRAUTERINE HUMAN CHORIONIC 12:00 PM O-124 A MOUSE 5-FLUOROURACIL BASED GONADOTROPIN (HCG) INFUSION PRIOR SUBMYELOABLATION MODEL FOR THE TO EMBRYO TRANSFER (ET) MAY BE STUDY OF BONE MARROW-DERIVED DETRIMENTAL TO PREGNANCY RATE. M. CELL TRAFFICKING IN REPRODUCTION. Volovsky,1 M. Healey,2 V. B. MacLachlan,3 R. Tal, Y. Liu, N. Pluchino, S. Shaikh, R. B. J. Vollenhoven4; 1Monash University, Mamillapalli, H. S. Taylor; Yale School of Melbourne, Australia, 2University of Medicine, New Haven, CT. Melbourne, Malvern East, Australia, 3Monash IVF, Victoria, Australia, 4Obstetrics and 12:15 PM O-125 DETERMINATION OF TIMING AND Gynaecology, Monash University, Melbourne, MECHANISM OF DIPLOIDIZATION OF Australia. HAPLOID PARTHENOGENETIC AND ANDROGENETIC HUMAN EMBRYOS. L. 12:00 PM O-130 AS GOOD AS IT GETS: DONOR EGGS AND A C. Grossman,1,2 G. Chia,1 M. Zuccaro,1 S. GESTATIONAL CARRIER. R. J. Chetkowski,1 Sadowy,2 R. Prosser,2 M. V. Sauer,1,2 D. Egli1,3; A. C. Eisenberg2; 1Alta Bates IVF, Berkeley, CA, 1Columbia University Medical Center, New 2Alta Bates IVF, Oakland, CA. York, NY, 2Center for Women’s Reproductive Care at Columbia University, New York, 12:15 PM 3 O-131 ARE WE TRANSFERRING TOO MANY NY, The New York Stem Cell Foundation EMBRYOS IN THE MOST FAVORABLE (NYSCF), New York, NY. GROUP OF FRESH AUTOLOGOUS IVF CYCLES: A 2013 UPDATE. S. Keyhan,1 12:30 PM O-126 THE RHO GUANINE NUCLEOTIDE EXCHANGE K. S. Acharya,1 C. R. Acharya,2 S. J. Li,1 S. FACTOR (RHO-GEF) DOMAIN OF A-KINASE J. Muasher1; 1Division of Reproductive ANCHORING PROTEIN-13 (AKAP13) IS Endocrinology and Infertility, Duke NECESSARY FOR OPTIMAL GONADOTROPIN University Medical Center, Durham, NC, SIGNALING IN GRANULOSA CELLS. K. C. 2Dept. Of Biostatistics and Bioinformatics, Cayton,1 C. M. Owen,2 P. Driggers,1 J. Segars1; Duke Computational Biology and 1GYN/OB, Johns Hopkins School of Medicine, Bioinformatics, Durham, NC. Baltimore, MD, 2NIH/NICHD/PRAE, Bethesda, MD. 12:30 PM O-132 EVALUATING PREGNANCY AND LIVE BIRTH OUTCOMES IN A REAL-WORLD ANALYSIS OF A US DATABASE OF 66,051 ART: CLINICAL 2 TRANSFERS OVER 6.5 YEARS. K. S. Richter,1 Moderators: Yimin Shu, Caroline Juneau G. L. Mottla,2 B. Kaplan,3 B. Hayward,4 M. C. 4 1 11:15 AM O-127 COMPROMISED DEVELOPMENTAL Mahony ; Research, Shady Grove Fertility COMPETENCE OF DAY 7 HUMAN Reproductive Science Center, Rockville, 2 BLASTOCYSTS. S. McCormick, K. A. MD, Research, Shady Grove Fertility LaRocque, K. Hammes, J. M. Stevens, W. B. Reproductive Science Center, Annapolis, MD, 3 4 Schoolcraft, M. Katz-Jaffe; Colorado Center Fertility Centers of Illinois, Chicago, IL, EMD for Reproductive Medicine, Lone Tree, CO. Serono, Inc., Rockland, MA.

11:30 AM O-128 CHANGE IN DAY OF EMBRYO TRANSFER OOCYTE BIOLOGY (ET) BY AGE AND PRIMARY DIAGNOSIS Moderators: Johnathan Edmonds, Sangita Jindal IN A REAL-WORLD US DATABASE STUDY OF 66,051 TRANSFERS OVER 6.5 YEARS. 11:15 AM O-133 MITOCHONDRIAL STRESS RESPONSE K. S. Richter,1 G. L. Mottla,2 B. Kaplan,3 IS REQUIRED FOR FEMALE FERTILITY. B. Hayward,4 M. C. Mahony4; 1Research, T. Wang, E. Babayev, K. Lowther, E. Seli; Shady Grove Fertility Reproductive Science Department of Obstetrics, Gynecology, Center, Rockville, MD, 2Research, Shady and Reproductive Sciences, Yale School of Grove Fertility Reproductive Science Center, Medicine, New Haven, CT.

nd 72 ASRM Scientific Congress & Expo 148 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

11:30 AM O-134 TISSUE RECOVERY AND IN VITRO OVARIAN STIMULATION MATURATION OF IMMATURE OOCYTES AS A Moderators: Basil Tarlatzis, Allison Lange FERTILITY PRESERVATION STRATEGY FOR 11:15 AM O-139 THE CONCENTRATION OF COMMERCIAL HCG TANDEM OVARIAN, OOCYTE, AND EMBRYO 1 TRIGGER IS IMPRECISE AND INACCURATE. CRYOPRESERVATION. Y. Sugishita, N. I. Woo,1 E. Davenport,1 S. A. Ingles,2 F. Z. Suzuki,2 F. Moy,1 K. H. Oktay1; 1Obstetrics Stanczyk,3 K. Chung,1 K. Bendikson,1 R. & Gynecology, New York Medical College, Paulson1; 1University of Southern California, Valhalla, NY, 2Obstetrics and Gynecology, St. Los Angeles, CA, 2Preventive Medicine, Marianna University, Kawasaki, Japan. University of Southern California, Los Angeles, CA, 3Obstetrics & Gynecoogy, Keck School of 11:45 AM O-135 EFFECT OF GALACTOSE AND ITS Medicine of USC, Los Angeles, CA. METABOLITES ON DEVELOPMENT AND QUALITY OF MURINE EMBRYOS PRODUCED 1 2 11:30 AM O-140 NEUTRALIZATION OF VASCULAR IN VITRO. M. Thakur, F. Shaeib, H. Kohan- Ghadr,2 S. Khan,1 F. Qadri,2 B. Gonik,3 H. ENDOTHELIAL GROWTH FACTOR Abu-Soud2; 1Division of Reproductive (VEGF) DURING CONTROLLED OVARIAN Endocrinology and Infertility, Department STIMULATION (COS) CYCLES ALTERS of Obstetrics and Gynecology, Wayne State PRODUCTION OF ANGIOGENIC FACTORS University School of Medicine, Detroit, MI, BY RHESUS MACAQUE GRANULOSA CELLS. C. V. Bishop; Division of Reproductive & 2CS Mott Center for Human Growth and Developmental Sciences, Oregon National Development, Department of Obstetrics Primate Research Center, Beaverton, OR. and Gynecology, Wayne State University School of Medicine, Detroit, MI, 3Department of Obstetrics and Gynecology, Wayne State 11:45 AM O-141 CELL-FREE DNA IN SERUM AS PROGNOSTIC University School of Medicine, Detroit, MI. BIOMARKER FOR OVARIAN RESPONSE TO STIMULATION. E. Scalici,1 A. Gala,2 S. Belloc,3 C. Vincens,2 S. Hamamah1; 1ART-PGD 12:00 PM O-136 EPAB IS REQUIRED FOR THE Department, INSERM U1203, CHU Montpellier, DEVELOPMENT OF OOCYTE-SOMATIC Montpellier, France, 2ART-PGD Department, CELL COMMUNICATION IN PREANTRAL CHU Montpellier, Montpellier, France, 3Eylau- FOLLICLES. K. Lowther, C. Yang, H. S. Unilabs Laboratory, Paris, France. Taylor, E. Seli; Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, CT. 12:00 PM O-142 THE EFFECT OF SUPPORT ON PREGNANCY RATES IN INTRAUTERINE INSEMINATION CYCLES 12:15 PM O-137 RELATIONSHIP BETWEEN PRE ICSI FOLLOWING OVARIAN STIMULATION MEIOTIC SPINDLE ANGLE, OVARIAN WITH GONADOTROPINS- A RANDOMIZED RESERVE, GONADOTROPIN STIMULATION CONTROLLED TRIAL. J. Han,1 T. Motan2; AND PREGNANCY OUTCOMES. A. 1Obstetrics and Gynecology, University of Mahfoudh,1 E. Garcia-Cerrudo,1 J. Moon,2 Alberta, Edmonton, AB, Canada, 2University S. Henderson,1 W. Son,1 M. Dahan3; 1MUHC of Alberta, Edmonton, AB, Canada. Reproductive Center, Montreal, QC, Canada, 2Stanford Children Hospital Fertility and Reproductive Health, SunnyVale, CA, 3McGill 12:15 PM O-143 PROSPECTIVE DOUBLE-BLIND University, Montreal, QC, Canada. RANDOMIZED PLACEBO CONTROLLED CLINICAL TRIAL COMPARING PREGNANCY RATES AFTER CO-ADMINISTRATION OF 12:30 PM O-138 SPECIAL RESEARCH PUBLICATION: LOW DOSE HCG AT THE TIME OF GNRH- GLOBAL TRANSCRIPTIONAL SILENCING AGONIST TRIGGER OR 35 HOURS LATER, IN THE OOCYTE IS MEDIATED BY AN MRNA 1 FOR THE PREVENTION OF OHSS. B. DECAY ACTIVATOR. H. Cook-Andersen, L. Maslow,1 D. Griffin,2 C. A. Benadiva,1 J. Dumdie,1 M. Ramaiah,1 K. Cho,2 D. J. Nulsen,1 L. Engmann1; 1University of Skarbrevik,1 M. Wilkinson1; 1Reproductive Connecticut, Farmington, CT, 2Boston IVF at Medicine, University of California, San Diego, the Women’s Hospital, Newburgh, IN. La Jolla, CA, 2University of California, San Diego, La Jolla, CA.

nd 72 ASRM Scientific Congress & Expo 149 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

12:30 PM O-144 DIETARY SUPPLEMENTATION WITH IN-VITRO FERTILIZATION WITH ELECTIVE COENZYME Q10 IN POOR RESPONDER SINGLE EMBRYO TRANSFER IN A GOOD PATIENTS UNDERGOING IVF-ICSI PROGNOSIS POPULATION? A. Schufreider,1 TREATMENT. T. Caballero, F. Fiameni, D. McQueen,2 J. Mathews,3 J. Liebermann,3 A. Valcarcel, J. Buzzi; IFER Instituto de M. L. Uhler,4 E. C. Feinberg5; 1The University Ginecologia y Fertilidad, Buenos Aires, of Chicago, Chicago, IL, 2University of Illinois Argentina. Chicago, Chicago, IL, 3Fertility Centers of Illinois, Chicago, IL, 4Reproductive Endocrinology and Infertility, Fertility Centers of Illinois, Warrenville, IL, 5Fertility PREIMPLANTATION GENETIC TESTING 2 Centers of Illinois, Highland Park, IL. Moderators: Virginia Mensah, Christine Briton-Jones 11:15 AM O-145 TRANSFER FRESH OR VITRIFY AFTER 12:30 PM O-150 IVF PATIENTS OVER AGE 39 EXPERIENCE BLASTOCYST BIOPSY? RESULTS OF AN DECREASED COST EFFECTIVENESS RCT. A. Coates,1 A. Kung,2 E. Mounts,1 J. S. AND LIVE BIRTH RATES WITH Hesla,1 B. J. Bankowski,1 E. Barbieri,1 B. Ata,3 PREIMPLANTATION GENETIC SCREENING: J. Cohen,4 S. Munne5; 1Oregon Reproductive A DECISION ANALYTIC MODEL AND COST Medicine, Portland, OR, 2Reprogenetics, EFFECTIVENESS ANALYSIS. W. Salem, J. R. Portland, OR, 3Koc University School of Ho, K. A. Bendikson, K. Chung, R. Paulson; Medicine, Istanbul, Turkey, 4ART Institute of University of Southern California, Los Washington, Livingston, NJ, 5Reprogenetics, Angeles, CA. Livingston, NJ.

11:30 AM O-146 COMPREHENSIVE REVIEW OF MENTAL HEALTH CHROMOSOME REARRANGEMENT CASES Moderators: Patricia Hershberger, Lindsay Childress-Beatty ANALYZED BY PREIMPLANTATION GENETIC SCREENING. E. Cameron, J. Klavanian, T. 11:15 AM O-151 DOES STRESS AFFECT IN VITRO T. Gordon, M. R. Hughes; Genesis Genetics, FERTILIZATION (IVF) OUTCOME? M. F. Plymouth, MI. Costantini-Ferrando,1,2 M. Joseph-Sohan,2 E. Grill,2 E. Rauch,1 S. D. Spandorfer2; 1 11:45 AM Reproductive Medicine Associates of New O-147 NO DIAGNOSIS AFTER DAY 3 BIOPSY: 2 INDICATIVE OF EMBRYO PROGNOSIS OR Jersey, Basking Ridge, NJ, Weill Cornell BIOPSY ERROR. E. Yeboah,1 S. Munne,1 T. Medical College, New York, NY. Escudero,1 N. Cekleniak,2 J. L. Frattarelli,3 D. Tortoriello,4 S. G. Prough,5 A. Coates6; 11:30 AM O-152 BEATING BIOLOGY AND BUYING TIME: 1Reprogenetics, Livingston, NJ, 2IRMS AN UPDATE SURVEY OF WOMENS’ Reproductive Medicine at Saint Barnabas, EXPERIENCES AFTER OOCYTE Livingston, NJ, 3Fertility Institute of CROPRESERVATION (OC) FOR DEFERRED Hawaii, Honolulu, HI, 4Sher Institute for REPRODUCTION. B. Hodes-Wertz, S. Reproductive Medicine, New York, NY, Druckenmiller, M. Smith, Y. G. Kramer, N. 5Tulsa Fertility Center, Tulsa, OK, 6Oregon Noyes; NYU Langone Medical Center, New Reproductive Medicine, Portland, OR. York, NY.

12:00 PM O-148 RESULTS OF ART WITHOUT PGD 11:45 AM O-153 STRESS, DEPRESSION, AND THE DESIRE AMONG PATIENTS WITH RECIPLOCAL FOR SOCIAL SUPPORT AMONG MALE TRANSLOCATION AND ROBERTOSONIAN PATIENTS IN FERTILITY AND CANCER TRANSLOCATION. A. Yoshida, M. Kobayashi, CLINICS. S. A. Miner,1 D. M. Daumler,1 P. K. Sano, K. Sakakibara, M. Tanaka; Kiba Park Chan,2 K. Lo,3 A. Gupta,4 Z. Rosberger,5 P. Clinic, Tokyo, Japan. Zelkowitz1,6; 1Department of , Jewish General Hospital, Montreal, QC, 2 12:15 PM Canada, McGill University Health Center, O-149 IS PREIMPLANTATION GENETIC 3 SCREENING WITH FROZEN SINGLE Montreal, QC, Canada, Mount Sinai EMBRYO TRANSFER SUPERIOR TO FRESH Hospital, University of Toronto, Toronto, ON, Canada, 4Princess Margaret Cancer Centre,

nd 72 ASRM Scientific Congress & Expo 150 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

University of Toronto, Toronto, ON, Canada, D. Palermo; Reproductive Medicine, Weill 5Psychology, Jewish General Hospital, Cornell Medicine, New York, NY. Montreal, QC, Canada, 6Lady Davis Institute for Medical Research, Jewish General 11:45 AM O-159 RECONSIDERATION OF HUMAN ROUND Hospital, Montreal, QC, Canada. INJECTION INTO THE OOCYTE (ROSI) USEFULNESS. A. Tanaka, 12:00 PM O-154 AN INTERNET-BASED MIND/BODY M. Nagayoshi, Y. Takemoto; Saint Mother INTERVENTION TO MITIGATE DISTRESS Hospital, Kitakyusyu, Japan. IN WOMEN EXPERIENCING INFERTILITY: 1 A RANDOMIZED PILOT TRIAL. J. Clifton, J. 12:00 PM O-160 HEREDITARY RISK IN ICSI WITH SPERM Parent,1 G. Worrall,2 M. Seehuus,3 M. Evans,1 1 4 1 FROM NON-MOSAIC KLINEFELTER R. Forehand, A. D. Domar ; Psychological SYNDROME PATIENTS. T. Miki,1 A. Tanaka,1 Science, University of Vermont, Burlington, VT, M. Nagayoshi,1 S. Watanabe2; 1Saint Mother 2 College of Medicine, University of Vermont, Hospital, Kitakyusyu, Japan, 2Anatomical 3 Burlington, VT, Psychology, Middlebury Science, Hirosaki University Graduate school 4 College, Middlebury, VT, Domar Center for of Medicine, Hirosaki, Japan. Mind/Body Health, Boston IVF, Waltham, MA.

12:15 PM O-161 ALTERED METHYLOME IN 12:15 PM O-155 BURDEN OF CARE IS THE PRIMARY REASON NORMOZOOSPERMIC MALES WHY INSURED WOMEN TERMINATE IVF 1 2 CONTRIBUTES TO POOR EMBRYOGENESIS. TREATMENT. A. D. Domar, K. Rooney, C. M. Denomme Tignanelli, B. R. McCallie, J. 1 3 2 4 Rich, M. R. Hacker, D. Sakkas, L. E. Dodge ; C. Parks, W. B. Schoolcraft, M. Katz-Jaffe; 1 Domar Center for Mind/Body Health, Boston Colorado Center for Reproductive Medicine, 2 IVF, Waltham, MA, Boston IVF, Waltham, Lone Tree, CO. MA, 3Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Brookline, MA, 4Obstetrics and Gynecology, Boston, MA. 12:30 PM O-162 WHEN TO REQUEST KARYOTYPE ANALYSIS IN INFERTILE MAN? A NEW PREDICTIVE MODEL. P. Capogrosso,1 E. Ventimiglia,2 12:30 PM O-156 A PROSPECTIVE COMPARATIVE P. Filippo,1 F. Montorsi,2 A. Salonia1; 1IRCCS STUDY EXAMINING THE ATTITUDES Ospedale San Raffaele, Milan, Italy, 2Division AND RESPONSES TO FERTILITY of Experimental Oncology/Unit of Urology, MEDICATIONS AND MONITORING Milan, Italy. IN WOMEN UNDERGOING OOCYTE CRYOPRESERVATION VS IN VITRO FERTILIZATION. S. S. Lee, S. Lee, M. R. OVARIAN RESERVE Schiffman, Y. G. Kramer, D. H. McCulloh, F. Moderators: Donna Shoupe, Hanh Cottrell Licciardi; NYU Fertility Center, New York, NY. 11:15 AM O-163 BIOMARKERS OF OVARIAN RESERVE AS PREDICTORS OF INFERTILITY. A. Z. MALE FACTOR Steiner,1 F. Z. Stanczyk,2 J. S. Kesner,3 J. W. Moderators: Sam Prien, Grace Centola Meadows,4 D. Baird5; 1University of North Carolina, Chapel Hill, NC, 2Obstetrics & 11:15 AM O-157 HIV-1 INFECTION AND ANTIRETROVIRAL Gynecoogy, Keck School of Medicine of USC, THERAPY ON SEMEN PARAMETERS AND Los Angeles, CA, 3NIOSH/CDC, Cincinnati, 1 SPERM DNA INTEGRITY. V. Savasi, A. OH, 4National Institute for Occupational 2 2 1 2 Laoreti, M. Oneta, P. Antonazzo, I. Cetin ; Safety & Health, Cincinnati, OH, 5NIEHS, 1 Obstetrics and Gynecology, Hospital, Research Triangle Pard, NC. University of Milan, Milan, Italy, 2Obstetrics and Gynecology, Hospital “L.Sacco”, University of Milan, Milan, Italy. 11:30 AM O-164 PSYCHOLOGICAL STRESS AND OVARIAN RESERVE AMONG WOMEN WITH UNEXPLAINED INFERTILITY. W. Vitek,1 11:30 AM O-158 ANEUPLOIDY SCREENING AND GENOME E. S. Barrett,2 K. Hoeger,1 M. P. Diamond,3 PROFILING IN INFERTILE COUPLES. S. M. Cedars,4 A. Z. Steiner5,6; 1University of Cheung, T. Cozzubbo, Z. Rosenwaks, G. Rochester Medical Center, Rochester, NY,

nd 72 ASRM Scientific Congress & Expo 151 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

2Obstetrics and Gynecology, University University School of Medicine, Detroit, MI, of Rochester, Rochester, NY, 3Augusta 4OB/GYN, University of Tennessee Health University, Augusta, GA, 4Obstetrics, Science Center, Memphis, TN. Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, CA, 5University of North Carolina, Chapel Hill, NC, 6for the OUTCOME PREDICTORS: ART 2 Cooperative Reproductive Medicine Moderators: Barry Witt, Courtney Failor Network, Bethesda, MD. 11:15 AM O-169 TARGETED NGS PROVIDES ACCURATE PREDICTIONS OF SEGMENTAL (SEG) 11:45 AM O-165 ELEVATED SERUM LEVELS OF ANEUPLOIDY AND PROGNOSTICATES BIOLOGICALLY ACTIVE OMEGA-3 FATTY REDUCED REPRODUCTIVE POTENTIAL OF ACIDS ARE ASSOCIATED WITH BETTER THE HUMAN BLASTOCYST. M. D. Werner,1 D. 1 OVARIAN RESERVE. M. E. Skaznik-Wikiel, M. Goodrich,2 X. Tao,3 Y. Zhan,3 J. M. Franasiak,4 2 1 1 C. Rudolph, D. C. Swindle, A. J. Polotsky ; C. R. Juneau,5 R. T. Scott Jr.,6 N. R. Treff7; 1 Obstetrics and Gynecology, University of 1REI, RMANJ, Rutgers-RWJ, Basking Ridge, Colorado School of Medicine, Aurora, CO, NJ, 2Rutgers-RWJMS, Basking Ridge, NJ, 2 Endocrinology, Diabetes, and Metabolism, 3FAEEC, Basking Ridge, NJ, 4RMANJ, NJ, University of Colorado School of Medicine, NJ, 5Reproductive Medicine Associates Aurora, CO. of New Jersey, Basking Ridge, NJ, 6REI, RMANJ,Rutgers-RWJ, Basking Ridge, NJ, 12:00 PM O-166 FMR1 PREMUTATION CARRIERS ARE 7RMANJ, Rutgers-RWJ, Basking Ridge, NJ. PREDISPOSED TO POOR OVARIAN RESPONSE, BUT EXHIBIT NO DIMINUTION 11:30 AM O-170 QUANTITATIVE RELATIONSHIP BETWEEN IN OVERALL OOCYTE EFFICIENCY, MITOCHONDRIAL DNA (MTDNA) AMOUNTS BLASTULATION RATE OR INCREASE IN AND IMPLANTATION CAN HELP IMPROVE 1 1 ANEUPLOIDY. S. J. Morin, J. M. Franasiak, PREGNANCY OUTCOMES. J. Rosenfeld,1 1 1 2 C. R. Juneau, M. D. Werner, J. Johnson, A. Kung,2 K. Ravichandran,1 E. Yeboah,3 N. 3 1 1 A. Pellicer, R. T. Scott Jr. ; Reproductive Goodall,4 E. Barbieri,5 A. Coates,5 E. Mounts,5 E. Medicine Associates of New Jersey, Fragouli,6 S. Munne1; 1Reprogenetics, Livingston, 2 Basking Ridge, NJ, Department of OB/ NJ, 2Reprogenetics, Portland, OR, 3Applied GYN & Reproductive Sciences, Yale School Genomics, Reprogenetics, Livingston, NJ, 3 of Medicine, New Haven, CT, Instituto 4Molecular Lab, Reprogenetics LLC, Livingston, Valenciano de Infertilidad, Valencia, Spain. NJ, 5Oregon Reproductive Medicine, Portland, OR, 6Reprogenetics UK, Oxford, United Kingdom. 12:15 PM O-167 SPECIAL RESEARCH PRESENTATION: A ROLE FOR CHTF18 IN FEMALE FERTILITY 11:45 AM O-171 PREDICTIVE FACTORS FOR LIVE BIRTH 1 2 AND OVARIAN AGING. B. Mukerji, A. Harris, AFTER FRESH BLASTOCYST TRANSFER IN 2 2 2 1 F. Dia, T. Singh, K. Berkowitz ; OBGYN, WOMEN AGED 40-43 YEARS. S. Tannus, Monmouth Medical Center, Long Branch, A. Gilman, G. Younes, T. Shavit, W. Son, M. 2 NJ, Biochemistry and Molecular Biology Dahan; McGill University, Montreal, QC, and OB-GYN, Drexel University College of Canada. Medicine, Philadelphia, PA. 12:00 PM O-172 OOCYTE AGEING IS ASSOCIATED WITH 12:30 PM O-168 ANTI-MULLERIAN HORMONE (AMH) FOR ALTERED METABOLIC STRESS RESPONSE PREVENTION OF TISSUE ACTIVATION AFTER AND LOWER MITOCHONDRIAL DNA VITRIFIED/THAWED OVARIAN CORTEX COPY NUMBER THAT CORRELATE 1 XENOTRANSPLANTATION. L. Detti, N. M. WITH INTRACELLULAR NADH AND FAD 2 3 1 Fletcher, G. M. Saed, R. A. Uhlmann, A. MEASURED BY FLUORESCENCE LIFETIME 1 4 1 M. Tobiasz, L. J. Williams ; Obstetrics and IMAGING MICROSCOPY (FLIM). E. Babayev,1 Gynecology, University of Tennessee Health T. Wang,1 T. Sanchez,2 K. Lowther,1 H. S. 2 Science Center, Memphis, TN, Obstetrics and Taylor,1 D. Sakkas,3 D. Needleman,2 E. Seli1; Gynecology, Wayne State University, Detroit, 1Department of Obstetrics, Gynecology 3 MI, Obstetrics and Gynecology, Wayne State and Reproductive Sciences, Yale School of

nd 72 ASRM Scientific Congress & Expo 152 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

Medicine, New Haven, CT, 2Harvard School Science, Icahn School of Medicine at Mount of Engineering and Applied Sciences, Sinai, New York, NY, 3Obstetrics, Gynecology Cambridge, MA, 3Boston IVF, Waltham, MA. & Reproductive Science, Icahn School of Medicine at Mount Sinai West-Mount Sinai 12:15 PM O-173 CLINICAL APPLICATION OF St. Luke’s, New York, NY. MITOCHONDRIAL DNA QUANTIFICATION FOR EMBRYO VIABILITY ASSESSMENT: A 11:45 AM O-177 COMPARISON OF AQUEOUS BLINDED PROSPECTIVE NON-SELECTION SUBCUTANEOUS VS VAGINAL STUDY. E. Fragouli,1 K. Ravichandran,2 S. PROGESTERONE IN FROZEN EMBRYO Munne,2 J. Grifo,3 C. McCaffrey,4 D. Wells5; TRANSFER (FET) CYCLES. V. Arun Muthuvel, 1Reprogenetics UK, Oxford, United Kingdom, N. Sanjeeva Reddy; Sri Ramachandra 2Reprogenetics, Livingston, NJ, 3NYU university, Chennai, India. Langone Medical Center, New York, NY, 4OB/ Gyn, NYU Fertility Center, New York, NY, 12:00 PM 5 O-178 THE NUMBER OF CHILDREN LIVING AT Reprogenetics, Oxford, United Kingdom. HOME AND THE DURATION OF EMBRYO CRYOPRESERVATION ARE SIGNIFICANT 12:30 PM O-174 TECHNOLOGICAL ADVANCEMENTS RISK FACTORS FOR CRYOPRESERVED TRANSLATE TO BIGGER BABIES: AN 11 EMBRYO ABANDONMENT. C. R. Sweet,1 YEAR TREND IN ART OUTCOME AT A G. Papkov,2 K. C. Wiedman-Klayum,3 E. L. SINGLE PRACTICE. J. Rodriguez-Purata,1 Norton,4 K. F. Miles5; 1Embryo Donation L. Sekhon,1,2 J. A. Lee,1 M. C. Whitehouse,1 International, Fort Myers, FL, 2Florida T. Mukherjee,1,2 B. Sandler,1,2 A. B. Gulf Coast University, Fort Myers, FL, Copperman1,2; 1Reproductive Medicine 3Nova Southeastern University College of Associates of New York, New York, NY, Osteopathic Medicine, Fort Lauderdale, 2Obstetrics, Gynecology and Reproductive FL, 4University of Florida, Gainesville, FL, Science, Icahn School of Medicine at Mount 5Specialists In Reproductive Medicine & Sinai, New York, NY. Surgery, Fort Myers, FL.

12:15 PM O-179 FREEZE-ALL POLICY IN NORMAL CRYOPRESERVATION AND FROZEN EMBRYO TRANSFER RESPONDERS. M. Roque,1 M. Valle,1 F. Moderators: Bradley Hurst, Nicole Banks Guimaraes,2 A. F. Kostolias,3 M. Sampaio,4 5 1 11:15 AM O-175 CLOSED SYSTEM EMBRYO VITRIFICATION S. Geber ; Reproductive Medicine, ORIGEN IS ASSOCIATED WITH A HIGHER - Center for Reproductive Medicine, Rio 2 BIRTHWEIGHT COMPARED TO FRESH de Janeiro, Brazil, ORIGEN - Center for EMBRYOS REPLACEMENT. E. Maris,1 Reproductive Medicine, Rio de Janeiro, 3 A. Gala,2 T. Mullet,3 S. Hamamah4; Brazil, Clinica Origen, Rio de Janeiro, Brazil, 4 1Dæpartement de Medecine de la ORIGEN - Center for Reproductive Medicine, 5 Reproduction CHRU de Montpellier, Belo Horizonte, Brazil, Origen, Belo Montpellier Cedex 5, France, 2CHU Horizonte, Brazil. Montpellier, Montpellier, France, 3ART PDG Department, Montpellier, France, 4ART/PGD 12:30 PM O-180 VITRIFICATION AND THAWING OF Department, Arnaud de Villeneuve Hospital, PREIMPLANTATION EMBRYOS DOES Montpellier, France. NOT AFFECT PERINATAL OUTCOME. L. Sekhon,1,2 N. Herlihy,1,2 J. Rodriguez- 1 1 1,2 1,3 11:30 AM O-176 FRESH VERSUS FROZEN EUPLOID EMBRYO Purata, J. A. Lee, B. Sandler, D. E. Stein, 1,2 1 TRANSFER INTO A SYNTHETICALLY A. B. Copperman ; Reproductive Medicine PREPARED ENDOMETRIAL CAVITY: Associates of New York, New York, NY, 2 EXAMINING THE EFFECT OF BLASTOCYST Obstetrics, Gynecology & Reproductive VITRIFICATION ON CYCLE OUTCOME. L. Science, Icahn School of Medicine at Mount 3 Sekhon,1,2 D. Aharon,1,2 N. Herlihy,1,2 J. Sinai, New York, NY, Obstetrics, Gynecology Rodriguez-Purata,1 J. A. Lee,1 B. Sandler,1,2 D. and Reproductive Science, Icahn School of E. Stein,1,3 A. B. Copperman1,2; 1Reproductive Medicine at Mount Sinai West-Mount Sinai Medicine Associates of New York, New York, St. Luke’s, New York, NY. NY, 2Obstetrics, Gynecology & Reproductive

nd 72 ASRM Scientific Congress & Expo 153 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

Wednesday, October 19, 2016 11:15 am - 12:45 pm

NON- Oral Abstract Sessions CME CE ARS

• Access to Care 3 12:00 PM O-184 ASSESSING ACCESS TO ASSISTED • ASRM Research Grant Presentations REPRODUCTIVE SERVICES FOR HIV SERODISCORDANT COUPLES. A. A. • Male Reproduction and Urology: Cinical 2 Leech,1 P. Bortoletto,2 M. Drainoni,1 C. L. • Reproductive Endocrinology: Clinical 2 Christiansen,1 B. P. Linas,3 C. M. Roeca,2 M. • Reproductive Biology R. Curtis,4 M. Sullivan3; 1Health Law, Policy • Genetic Counseling and Mgmt, Boston Univ School of Public Health, Boston, MA, 2OB & Gyne, Brigham • ART: Clinical 3 and Women’s Hosp and Massachusetts • Clinical Reproductive Laboratory General Hosp, Boston, MA, 3Sect of • Endometriosis Infectious Diseases, Boston Univ Med Ctr, Boston, MA, 4Dept of Med, Tulane Univ, • Fibroids New Orleans, LA. • Health Disparities • Obesity and Metabolism 12:15 PM O-185 INCREASE ACCESS TO FERTILITY • Early Pregnancy PRESERVATION CARE USING A PATIENT • Embryo Biology 2 NAVIGATOR MODEL. K. N. Smith,1 A. K. Lawson,2 S. Klock,3 M. Pavone2; 1OB/ • Late-breaking Abstracts GYN, Northwestern Medicine, Chicago, IL, 2Northwestern University, Chicago, IL, 3Obstetrics & Gynecology and Psychiatry, Northwestern Medicine, Chicago, IL. ACCESS TO CARE 3 Moderators: Kara Goldman, Erica Anspach Will 12:30 PM O-186 MODIFIED NATURAL CYCLE IVF INCREASES 11:15 AM O-181 PATIENT PREFERENCES REGARDING VALUE AND ACCESS TO CARE OVER SOCIAL MEDIA USE IN AN REI PRACTICE. TRADITIONAL IVF FOR GOOD PROGNOSIS D. E. Broughton, K. M. Cipolla, E. Jungheim, PATIENTS: A DECISION ANALYTIC MODEL K. Omurtag; Obstetrics and Gynecology, AND COST EFFECTIVENESS ANALYSIS. W. Washington University, St. Louis, MO. Salem, J. Ho, K. A. Bendikson, K. Chung, R. Paulson; University of Southern California, 11:30 AM O-182 OUTCOMES FROM A UNIVERSITY-BASED, Los Angeles, CA. LOW COST IVF PROGRAM PROVIDING ACCESS OF CARE TO A SOCIOCULTURALLY DIVERSE URBAN COMMUNITY. Y. Anaya, M. Noel, H. Cakmak, C. N. Herndon, M. Cedars; ASRM RESEARCH GRANT PRESENTATIONS Center for Reproductive Health, UCSF, San Moderators: Karen Berkowitz, Alessandro Schuffner Francisco, CA. 11:15 AM O-187 SPECIAL RESEARCH PRESENTATION: THE ASSOCIATION BETWEEN 11:45 AM O-183 SPERM WASHING FOR HIV ANTIHYPERTENSIVES AND MALE SERODISCORDANT COUPLES USING DOUBLE INFERTILITY USING INSURANCE CLAIMS DENSITY GRADIENT WITH SWIM UP FOR DATA. M. Eisenberg,1 S. Li,2 L. Baker1; INTRAUTERINE INSEMINATION: DEFINING 1Urology, Stanford University, Stanford, CA, FAVORABLE MALE AND FEMALE FACTORS 2Stanford University, Palo Alto, CA. FOR ACHIEVING SUCCESSFUL PREGNANCY. L. Z. Safier, J. Y. Hsu, L. C. Grossman, M. V. Sauer, N. C. Douglas; Columbia University Medical Center, New York, NY.

nd 72 ASRM Scientific Congress & Expo 154 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

11:30 AM O-188 SPECIAL RESEARCH PRESENTATION. STEM CELLS DEVELOPS INTO EMBRYO. S. NEUTRALIZING TISSUE INHIBITOR OF Park,1 K. Marquis,1 A. H. DeCherney,2 E. F. METALLOPROTEINASE 1 (TIMP1) IN Wolff3; 1NICHD, NIH, Bethesda, MD, 2Eunice OVARIES FROM AN ENDOMETRIOSIS Kennedy Shriver National Institute of Child MODEL RESTORES OVULATORY FUNCTION Health and Human Development, NIH, AND FERTILITY WITHOUT TOXICITY. K. Bethesda, MD, 3NIH, Bethesda, MD. L. Sharpe-Timms,1 H. Nabli,2 C. Besch- Williford3; 1Obstetrics, Gynecology and Women’s Health, The University of Missouri, Columbia, MO, 2Department of Ob, Gyn MALE REPRODUCTION AND UROLOGY: CLINICAL 2 & Women’s Health, The University of Moderators: Ranjith Ramasamy, James Hotaling Missouri, Columbia, MO, 3IDEXX Bio Research 11:15 AM Laboratories, Columbia, MO. O-193 UROLOGISTS’ ATTITUDES TOWARDS PENILE TRANSPLANTATION. B. B. Najari,1 P. V. Bach,2 A. Bolyakov,1 R. Lischer,1 D. Paduch3; 11:45 AM O-189 SPECIAL RESEARCH PRESENTATION: 1Urology, Weill Cornell Medical College, New VITAMIN D REVERSES THE ADVERSE York, NY, 2Weill Cornell Medical College, EFFECTS OF ADVANCED GLYCATION END New York, NY, 3Dept of Urology, Weill Cornell PRODUCTS ON GRANULOSA CELLS. Z. Medical College, New York, NY. Merhi,1 S. Wang,2 M. J. Cipolla3; 1NYU School of Medicine, New York, NY, 2Obstetrics 11:30 AM and Gynecology, NYU School of Medicine, O-194 SPERM DNA FRAGMENTATION AS New York, NY, 3Obstetrics and Gynecology, TREATMENT GUIDANCE FOR INFERTILE T. Paniza,1 T. Cozzubbo,1 A. and Neurological Sciences, University of COUPLES. Parrella,1 S. Cheung,1 M. Goldstein,2 Z. Vermont, Burlington, VT. Rosenwaks,1 G. D. Palermo1; 1Reproductive Medicine, Weill Cornell Medicine, New York, 12:00 PM O-190 SPECIAL RESEARCH PRESENTATION: NY, 2Urology, Weill Cornell Medicine, New GENE VARIANTS IN AURORA KINASE York, NY. COULD BE PREDICTIVE OF MATERNAL OOCYTE ANEUPLOIDY. K. Schindler,1 D. 11:45 AM Marin,2 A. Nguyen,1 A. Zhou,1 Y. Wang,2 A. O-195 SLEEP AND MALE FECUNDITY IN A NORTH Fedick,2 D. M. Taylor,3 J. Xing,1 N. Treff2; AMERICAN PRECONCEPTION COHORT L. A. Wise,1 C. Mckinnon,1 A. 1Genetics, Rutgers University, Piscataway, STUDY. Wesselink,1 K. J. Rothman,1,2 E. E. Hatch1; NJ, 2RMANJ, Rutgers-RWJ, Basking Ridge, 1Department of Epidemiology, Boston NJ, 3Pediatrics, University of Pennsylvania, University School of Public Health, Boston, Philadelphia, PA. MA, 2RTI International, Research Triangle Park, NC. 12:15 PM O-191 SPECIAL RESEARCH PRESENTATION: DIRECT CONVERSION OF HUMAN 12:00 PM O-196 SPERM SURVIVAL ASSAY FOR TOXICITY SOMATIC CELLS TO INDUCED GERM-LIKE EVALUATION IN ULTRASOUND GELS CELLS BY GENETIC REPROGRAMMING. J. V. Medrano,1,2 J. M. Miguez,1 I. Moreno,3 AND VAGINAL LUBRICANTS USED IN M. Soriano,1 I. C. Simon1,3,4; 1Fundación Instituto REPRODUCTIVE MEDICINE. Molina,1 S. Sadeghi,2 J. Martinez,1 R. Rogel,1 Valenciano de Infertilidad (FIVI), Paterna, S. Lujan,1 S. Balasch,3 P. Fernandez,1 J. Spain, 2Reproduction Unit, IIS La Fe, Rubio,4 A. Pellicer4; 1Hospital Universitari i Valencia, Spain, 3Igenomix S.L., Paterna, Politècnic La Fe, Valencia, Spain, 2Universitat Spain, 4Department of Obstetrics de València, Valencia, Spain, 3Universitat and Gynecology, Stanford University, Politècnica de València, Valencia, Spain, Stanford, CA. 4Hospital Universitari i Politecnic La Fe, Valencia, Spain. 12:30 PM O-192 SPECIAL RESEARCH PRESENTATION: EGG FROM OVARIAN STEM CELLS DEVELOPS INTO EMBRYORESEARCH PRESENTATION: EGG FROM OVARIAN STEM CELLS DEVELOPS INTO EMBRYOFROM OVARIAN

nd 72 ASRM Scientific Congress & Expo 155 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

12:15 PM O-197 MANAGEMENT AND OUTCOMES OF Reproduction Unit, American Hospital, Istanbul, PATIENTS WITH ACUTE EXTERNAL Turkey, 3Obstetrics and Gynecology, Koc GENITAL TRAUMA: A 12-YEAR COMBINED University School of Medicine, Istanbul, Turkey. INSTITUTION EXPERIENCE. M. C. 1 2 Hehemann, J. Kashanian, A. M. 12:00 PM O-202 HIGH FOLLICLE-STIMULATING Kandabarow,3 J. Tse,4 D. J. Mazur,4 G. Barton,3 3 4 1 HORMONE(FSH) PROMOTES TUMOR A. Farooq, R. E. Brannigan ; Loyola University ANGIOGENESIS OF BREAST CARCINOMA Health Systems, Department of Urology, S. Shi; Zhejiang 2 OF MENOPAUSAL WOMEN. Maywood, IL, Department of Urology, Weill Normal University, Jinhua, China. Cornell Medicine, New York, NY, 3Department of Urology, Loyola University Health Systems, Maywood, IL, 4Department of Urology, 12:15 PM O-203 TIMING OF INITIATION OF HORMONE Northwestern University Feinberg School of REPLACEMENT THERAPY AND COGNITIVE 1 2 3 Medicine, Chicago, IL. FUNCTION. S. Iliodromiti, M. Magnus, J. Pell, N. Sattar,4 D. Lawlor,2 A. Fraser,2 S. M. Nelson1; 1School of Medicine, University of Glasgow, 12:30 PM O-198 REPRODUCIBILITY OF TWO MORNING TOTAL Glasgow, United Kingdom, 2MRC Integrative TESTOSTERONE (TT) MEASUREMENTS Epidemiology Unit, University of Bristol, USING LIQUID CHROMATOGRAPHY- Bristol, United Kingdom, 3Institute of Health MASS SPECTROMETRY (LCMS); CLINICAL and Wellbeing, University of Glasgow, Glasgow, 1,2 3 IMPLICATIONS. D. Paduch, A. Bolyakov, United Kingdom, 4Institute of Cardiovascular 4 1 5,2 A. Mielnik, J. Collazos, R. J. Lischer, P. N. and Medical Sciences, University of Glasgow, 4 1 Schlegel ; Dept of Urology, Weill Cornell Glasgow, United Kingdom. Medical College, New York, NY, 2Consulting Research Services, Inc, North Bergen, NJ, 3Weill Cornell Medicine, New York, NY, 4Urology, Weill 12:30 PM O-204 PLATELETS FOR ENDOMETRIAL Cornell Medical College, New York, NY, 5United REGENERATION: A NOVEL APPROACH. L. States Tennis Association, North Bergen, NJ. Aghajanova, S. Houshdaran, S. Balayan, J. Irwin, H. Huddleston, L. Giudice; Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San REPRODUCTIVE ENDOCRINOLOGY: CLINICAL 2 Francisco, CA. Moderators: Yolanda Smith, Julia Johnson 11:15 AM O-199 ANTIMÜLLERIAN HORMONE IN PREPUBESCENT AND ADOLESCENT GIRLS. REPRODUCTIVE BIOLOGY J. R. Ho,1 L. Houghton,2 W. Salem,1 L. Ma,1 A. Moderators: Peter Nagy, Lisa Green Kumar,3 B. Kalra,3 M. Terry,2 F. Z. Stanczyk1; 1University of Southern California, Los 11:15 AM O-205 INTEGRATED ANALYSIS OF MICRORNA Angeles, CA, 2Columbia University, New York, (MIR) AND MESSENGER RNA (MRNA) NY, 3AnshLabs, Webster, TX. EXPRESSION PROFILES REVEALS MIR REGULATION IN SEX STEROID ACTIONS IN THE MOUSE UTERUS. S. Kuokkanen,1 11:30 AM O-200 FSHR SER680ASN: CORRELATION WITH J. W. Pollard2; 1Obstetrics & Gynecology, 1 1 FSH LEVELS. S. L. Bristow, M. Gold, Montefiore Medical Center/Albert Einstein 1 1 2 R. Shraga, M. Berliss, D. I. Hoffman ; College of Medicine, Bronx, NY, 2MRC Centre 1 2 Recombine, New York, NY, IVF Florida for Reproductive Health, University of Reproductive Associates, Margate, FL. Edinburgh, Edinburg, United Kingdom.

11:45 AM O-201 IMATINIB MESYLATE ACCELERATES FOLLICLE 11:30 AM O-206 FRESH IVF CYCLES ARE ASSOCIATED WITH DEATH AND IS NOT PROTECTIVE AGAINST POTENTIALLY DELETERIOUS CHANGES CHEMOTHERAPY INDUCED DAMAGE IN IN KEY MATERNAL SERUM FACTORS HUMAN OVARY. G. Bildik,1 N. Akin,1 D. Urman,1 2 2 3,2 3,2 ASSOCIATED WITH ANGIOGENESIS AND I. Keles, B. Balaban, B. Urman, O. Oktem ; S. Senapati, J. Vresilovic, 1 VASCULOGENESIS. School of Medicine and the Graduate School T. Ord, C. Coutifaris, K. Barnhart, M. A. Mainigi; of Health Sciences, Koc University, Istanbul, University of Pennsylvania, Philadelphia, PA. Turkey, 2Women’s Health Center Assisted

nd 72 ASRM Scientific Congress & Expo 156 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

11:45 AM O-207 EXCESS PROVISION OF NUTRIENTS IN 11:30 AM O-212 THE INCIDENTAL FINDING CULTURE MEDIUM REDUCES BLASTOCYST OF MICRODELETIONS AND QUALITY. A. Greene, J. Herrick, W. B. MICRODUPLICATIONS DURING Schoolcraft, R. L. Krisher; Colorado Center PREIMPLANTATION GENETIC DIAGNOSIS for Reproductive Medicine, Lone Tree, CO. (PGD) - TEST IMPLICATION AND CLINICAL CORRELATION. R. Cabey,1 D. Goldberg- 1 1 2 12:00 PM O-208 DEVELOPMENTAL POTENTIAL OF OOCYTES Strassler, M. Konstantinidis, A. Hershlag, M. Cohen,2 M. Rausch,2 M. Guarnaccia,3 J. WITH SMOOTH ENDOPLASMIC RETICULUM 4 5 1 1 CLUSTERS AND THEIR BEHAVIORS Grifo, R. Prates, S. Munne ; Reprogenetics, Livingston, NJ, 2Northwell Fertility, OBSERVED BY TIME-LAPSE RECORDING 3 C. Mizoguchi,1 K. Iwata,1 M. Manhasset, NY, REI, Columbia University, SYSTEM. 4 Tsuneto,2 K. Yumoto,2 Y. Mio1; 1Reproductive New York, NY, NYU Langone Medical Center, 5 Centre, Mio Fertility Clinic, Yonago, Japan, New York, NY, Reprogenetics, Miami, FL. 2Mio Fertility Clinic, Yonago, Japan. 11:45 AM O-213 THE ROLE OF THE GENETIC COUNSELOR 12:15 PM IN THE PREIMPLANTATION GENETIC O-209 STEM CELL MARKERS DESCRIBE A 1 2 TRANSITION FROM SOMATIC TO SCREENING DECISION. J. Isaac, E. Mounts, L. Williamson Dean,1 T. Von Wald,3 E. PLURIPOTENT CELL STATES IN A RAT 2 4 3 1 MODEL OF ENDOMETRIOSIS. E. R. Othman,1 Barbieri, Q. Stein, J. Flanagan ; University F. Y. Meligy,2 A. A. Sayed,3 M. A. Elmokhtar,4 A. of Arkansas for Medical Sciences, Little 2 M. Elrefaiy5; 1OB-GYN, Center of Excellence of Rock, AR, Oregon Reproductive Medicine, 3 Stem Cells and Regenerative Medicine CESRM, Portland, OR, Sanford Health, Sioux Falls, 4 Assiut University, Assiut, Egypt, 2Histology SD, Augustana University, Sioux Falls, SD. Department, Assiut University, Assiut, Egypt, 3Medical Biochemistry Department, Assiut 12:00 PM O-214 INCREASED FETAL CHROMOSOME University, Assiut, Egypt, 4Microbiology and DETECTION WITH THE USE OF OPERATIVE Immunology, Assiut University, Assiut, Egypt, HYSTEROSCOPY DURING EVACUATION OF 5Pathology Department, Assiut University, PRODUCTS FOR MISCARRIAGE. A. Cholkeri- Assiut, Egypt. Singh,1 K. Deli,1 I. Zamfirova,2 C. E. Miller3; 1Gynecology, The Advanced Gynecologic 2 12:30 PM O-210 MYELOPEROXIDASE AND ACTIVATED Surgery Institute, Naperville, IL, Gynecology, James R. & Helen D. Russell Institute for MACROPHAGES ALTER METAPHASE II 3 MOUSE OOCYTE QUALITY BY DISASSEMBLY Research & Innovation, Park Ridge, IL, The OF MICROTUBULE ORGANIZING CENTER. Advanced IVF Institute, Naperville, IL. S. Khan,1 F. Shaeib,2 R. Jeelani,3 M. Thakur,4 H. Abu-Soud1; 1Wayne State University, 12:15 PM O-215 EXPERIENCES IN SINGLE GENE Detroit, MI, 2OB/GYN-Physiology, Wayne DISORDER (SGD) PREIMPLANTATION State University/Medical School, Detroit, MI, GENETIC DIAGNOSIS (PGD): A FOCUS 3REI, Wayne State University, Royal Oak, MI, ON INDICATION FOR TESTING, FAMILY 4Division of Reproductive Endocrinology, MEMBER AVAILABILITY AND ITS INFLUENCE Department, Wayne State University/ Detroit ON TEST DESIGN PARADIGMS. J. M. Medical Center, Detroit, MI. Eccles,1 A. Iturriaga,1 C. Jalas,1,2 A. Behrens,1 E. Kleinman,2 R. T. Scott Jr.,1,3 N. Treff,3 R. Zimmerman1; 1Foundation for Embryonic Competence, Basking Ridge, NJ, 2Bonei GENETIC COUNSELING Olam, Brooklyn, NY, 3Reproductive Medicine Moderator: Amy Jordan Associates of New Jersey, Basking Ridge, NJ. 11:15 AM O-211 THE FREQUENCY OF INCIDENTAL FINDINGS IN EXPANDED CARRIER SCREENING. K. K. Wong, G. A. Lazarin, I. S. Haque; Counsyl, South San Francisco, CA.

nd 72 ASRM Scientific Congress & Expo 157 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

12:30 PM O-216 MAXIMIZING EFFICIENCY AND MITIGATING INTRACYTOPLASMIC SPERM INJECTION RISK: WHY PATIENTS CHOOSE PRE- (ICSI). S. A. Hebisha,1 B. A. Aboelazm,1 H. M. IMPLANTATION GENETIC SCREENING Adel,1 A. I. Ahmed2; 1Gynecology, Alexandria (PGS). J. K. Blakemore,1 Y. G. Kramer,2 D. University - Faculty of Medicine, Alexandria, H. McCulloh,3 J. Grifo,4 K. N. Goldman5; Egypt, 2Obstetric and Gynecology, MFM 1New York University, New York, NY, 2OBS- Division, Department of , GYN, NYU Fertility Center, New York, NY, Wayne State University, Detroit, MI. 3Obstetrics and Gynecology, New York University Fertility Center, New York, NY, 12:15 PM O-221 MATERNAL ENDOMETRIAL SECRETIONS 4NYU Langone Medical Center, New York, 5 24 HOURS PRIOR TO FROZEN NY, Obstetrics and Gynecology, New York EMBRYO TRANSFER IS PREDICTIVE OF University, New York, NY. IMPLANTATION OUTCOME. J. C. Parks,1 B. R. McCallie,1 J. A. Reisz,2 M. J. Wither,2 W. B. Schoolcraft,1 M. Katz-Jaffe1; 1Colorado Center for Reproductive Medicine, Lone Tree, CO, ART: CLINICAL 3 2University of Colorado Denver, Aurora, CO. Moderators: Lorna Marshall, Fangyin Meng

11:15 AM O-217 EARLY SUBCHORIONIC BLEED (SCB) IN 12:30 PM O-222 SUCCESSIVE SINGLE EMBRYO TRANSFER ASSISTED REPRODUCTIVE TECHNOLOGY CYCLES LEAD TO REDUCED RISK WITHOUT (ART) PREGNANCIES DOES NOT COMPROMISING SUCCESS RATES IN INFLUENCE BIRTH WEIGHT. L. Nervi,1 P. WOMEN UNDER 38. K. Hunter Cohn,1 H. A. Bergh,2 T. A. Molinaro3; 1Reproductive Wu,1 J. Schnorr,2 F. Arredondo,3 B. Miller,4 M. Medicine Associates of New Jersey, Basking P. Leondires,5 J. Gutmann,6 L. Weckstein,7 Ridge, NJ, 2RMA, Basking Ridge, NJ, J. Nulsen,8 S. E. Katz,9 P. C. Lin,10 A. B. 3Reproductive Medicine Associates of New Copperman,11 E. A. Widra,12 P. Yurttas Beim1; Jersey, Eatontown, NJ. 1Celmatix Inc, New York, NY, 2Coastal Fertility Specialists, Mount Pleasant, SC, 3RMA of 4 11:30 AM O-218 CUMULATIVE LIVE BIRTH RATE AFTER Texas, San Antonio, TX, RMA of Michigan, 5 FRESH ELECTIVE SINGLE BLASTOCYST Rochester Hills, MI, RMA of CT, Norwalk, 6 TRANSFER AND SUBSEQUENT FROZEN CT, RMA of Philadelphia, Philadelphia, 7 SINGLE BLASTOCYST TRANSFER PA, Reproductive Science Center of the COMPARED TO INITIAL FRESH DOUBLE San Francisco Bay Area, San Ramon, CA, 8 BLASTOCYSTS TRANSFER IN WOMEN AGED Center for Advanced Reproductive Services, 9 40-43 YEARS. S. Tannus, A. Gilman, G. Farmington, CT, REACH, Charlotte, NC, 10 Younes, W. Son, T. Shavit, M. Dahan; McGill Seattle Reproductive Medicine, Seattle, WA, 11 University, Montreal, QC, Canada. Obstetrics and Gynecology, RMANY-Mount Sinai, New York, NY, 12Shady Grove Fertility, Washington, DC. 11:45 AM O-219 METHOTREXATE TREATMENT OF ECTOPIC PREGNANCY DOES NOT IMPACT OVARIAN RESERVE OR CLINICAL OUTCOME, REGARDLESS CLINICAL REPRODUCTIVE LABORATORY OF THE DURATION OF TIME SINCE Moderators: Arthur Chang, Mary Peavey EXPOSURE. L. Sekhon,1,2 J. Rodriguez- Purata,1 J. A. Lee,1 M. C. Whitehouse,1 A. 11:15 AM O-223 TROPHECTODERM BIOPSIES WITH HIGHER B. Copperman1,2; 1Reproductive Medicine ESTIMATED CELLULARITY INCREASE RISK Associates of New York, New York, NY, OF PREGNANCY LOSS AND MONOZYGOTIC 2Obstetrics, Gynecology & Reproductive TWINNING. S. J. Morin,1 J. M. Franasiak,1 Science, Icahn School of Medicine at C. R. Juneau,1 X. Tao,2 R. T. Scott Jr.1; Mount Sinai, New York, NY. 1Reproductive Medicine Associates of New Jersey, Basking Ridge, NJ, 2Foundation for 12:00 PM O-220 IMPACT OF THE OXYTOCIN RECEPTOR Embryonic Competence, Basking Ridge, NJ. ANTAGONIST (ATOSIBAN) ADMINISTERED SHORTLY BEFORE EMBRYO TRANSFER ON PREGNANCY OUTCOME AFTER

nd 72 ASRM Scientific Congress & Expo 158 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

11:30 AM O-224 PROSPECTIVE STUDY OF AUTOMATED ENDOMETRIOSIS VS. MANUAL ANNOTATION OF EEVA™ Moderators: Steven Young, Reshef Tal TIME-LAPSE MARKERS. D. J. Kaser,1 L. V. 11:15 AM Farland,1,2 S. A. Missmer,1,2 C. Racowsky1; O-229 THE IMPACT OF ELAGOLIX ON QUALITY OF 1Dept of Obstetrics & Gynecology, Brigham & LIFE IN WOMEN WITH ENDOMETRIOSIS- Women’s Hospital, Harvard Medical School, ASSOCIATED PAIN: RESULTS FROM TWO Boston, MA, 2Dept of Epidemiology, Harvard RANDOMIZED, PLACEBO-CONTROLLED Chan School, Boston, MA. STUDIES USING THE ENDOMETRIOSIS HEALTH PROFILE QUESTIONNAIRE. H. S. Taylor,1 E. Surrey,2 A. M. Soliman,3 J. Castelli- 11:45 AM O-225 PREGNANCY RATES ARE SIGNIFICANTLY Haley,3 J. P. Rowan,3 K. Chwalisz,3 J. W. HIGHER WHEN SELECTING EMBRYOS Thomas,3 B. Schwefel,3 L. A. Williams,3 R. I. FOR TRANSFER ACCORDING TO THE Jain3; 1Yale School of Medicine, New Haven, CLASSIFICATION PROVIDED BY AN CT, 2Colorado Center for Reproductive AUTOMATIC DIAGNOSTIC TEST. B. Medicine, Lone Tree, CO, 3AbbVie Inc., North 1 2 3 Aparicio-Ruiz, N. Basile, L. Romany, T. Chicago, IL. Viloria,4 J. Remohi Gimenez,1 M. Meseguer5; 1IVI Valencia, Valencia, Spain, 2IVI Madrid, 11:30 AM Madrid, Spain, 3Embryologist, Valencia, O-230 DIRECT AND INDIRECT COSTS ASSOCIATED Spain, 4IVF Laboratory, IVI Valencia, Valencia, WITH ENDOMETRIOSIS-RELATED SURGERY A. Spain, 5Clinical Embryology, Valencia, Spain. AMONG EMPLOYED WOMEN IN THE US. M. Soliman,1 H. S. Taylor,2 M. Bonafede,3 J. K. Nelson,3 J. Castelli-Haley,4 C. A. Winkel5; 12:00 PM O-226 EFFECT OF STRICT SPERM MORPHOLOGY 1AbbVie Inc, North Chicago, IL, 2Yale School ON INTRAUTERINE INSEMINATION of Medicine, New haven, CT, 3Truven Health PREGNANCY SUCCESS: A SYSTEMATIC Analytics, An IBM Company, Ann Arbor, 1 REVIEW AND META-ANALYSIS. T. P. Kohn, MI, 4AbbVie, North Chicago, IL, 5Obstetrics 2 3 1 S. A. Shabtaie, R. Ramasamy ; Baylor and Gynecology, Georgetown University, 2 College of Medicine, Houston, TX, University Shepherdstown, WV. of Miami Miller School of Medicine, Miami, FL, 3University of Miami, Miami, FL. 11:45 AM O-231 NEW PROCEDURE FOR THE ENDOMETRIOSIS DIAGNOSIS. X. 12:15 PM O-227 DYSREGULATION OF THE HIPPO PATHWAY Santamaria, J. Vallve; IVI Barcelona, IN SELECTIVE THECA CELL PHOSPHATASE Barcelona, Spain. AND TENSIN HOMOLOG (TPTEN) MUTANT MICE EXHIBITING A POLYCYSTIC OVARIAN 12:00 PM O-232 THE EFFECT OF ELAGOLIX ON THE SYNDROME (PCOS)-LIKE PHENOTYPE. K. A. Ehlers, B. Lin, X. Li, K. Pagidas, Z. Lei; OB/GYN ENDOMETRIUM: SAFETY RESULTS and Women’s Health, University of Louisville FROM TWO RANDOMIZED, PLACEBO- Health Sciences Center, Louisville, KY. CONTROLLED STUDIES IN WOMEN WITH ENDOMETRIOSIS-ASSOCIATED PAIN. M. P. Diamond,1 J. Simon,2 B. A. Lessey,3 H. 12:30 PM O-228 INITIAL EXPERIENCE WITH FLUORESCENCE S. Taylor,4 J. P. Rowan,5 K. Chwalisz,5 B. ACTIVATED CELL SORTING OF Schwefel,5 J. W. Thomas,5 R. I. Jain,5 L. A. SPERMATOZOA FROM TESTIS TISSUE: A Williams5; 1Augusta University, Augusta, GA, NOVEL METHOD FOR SPERM ISOLATION 2Women’s Health and Research Consultants 1 2 AFTER TESE. S. Mittal, A. Mielnik, A. and George Washington University, 3 2 4 Bolyakov, P. N. Schlegel, D. Paduch ; Washington, DC, 3Obstetrics and Gynecology, 1 Urology, New York Presbyterian / Weill Reproductive Endocrinology and Infertility, 2 Cornell Medicine, New York, NY, Urology, Greenville Health System, Greenville, SC, Weill Cornell Medical College, New York, NY, 4Yale School of Medicine, New Haven, CT, 3 4 Weill Cornell Medicine, New York, NY, Dept 5AbbVie Inc., North Chicago, IL. of Urology, Weill Cornell Medical College, New York, NY.

nd 72 ASRM Scientific Congress & Expo 159 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

12:15 PM O-233 EMBRYO-ENDOMETRIAL DIALOGUE IS 12:00 PM O-238 RACIAL AND ETHNIC DIFFERENCES ALTERED IN ENDOMETRIOSIS PATIENTS IN UTERINE FIBROID PREVALENCE THROUGH MICRORNA REGULATION. L. IN A DIVERSE COHORT OF YOUNG N. Henry, J. C. Parks, B. R. McCallie, W. B. ASYMPTOMATIC WOMEN (18-30 YO). S. Schoolcraft, M. Katz-Jaffe; Colorado Center Chibber, G. Mendoza, L. Cohen, E. E. Marsh; for Reproductive Medicine, Lone Tree, CO. Obstetrics and Gynecology, Feinberg School of Medicine-Northwestern University, 12:30 PM O-234 PERIOPERATIVE TREATMENT WITH BETA- Chicago, IL. BLOCKER AND ANDROGRAPHOLIDE ABROGATES SURGERY-INDUCED 12:15 PM O-239 THREE-MONTH TREATMENT WITH ACCELERATION OF ENDOMETRIOSIS ULIPRISTAL ACETATE PRIOR TO DEVELOPMENT IN MOUSE. X. Liu,1 Q. LAPAROSCOPIC MYOMECTOMY OF LARGE Long,1 S. Guo2; 1Gynecology, Shanghai OB/ MYOMAS. S. Ferrero, A. Racca, E. Tafi, C. GYN Hospital, Fudan University, Shanghai, Scala, P. Venturini, U. Leone Roberti Maggiore; China, 2Research Institute, Shanghai OB/GYN Unit of Obstetrics and Gynaecology, IRCCS Hospital, Fudan University, Shanghai, China. AOU San Martino – IST, DiNOGMI, University of Genova, Genova, Italy.

12:30 PM O-240 3-DIMENSIONAL (3D) CULTURES FIBROIDS PROVIDE A RENEWABLE IN VIVO Moderators: Gregory Christman, Renju Raj RESOURCE FOR THE STUDY OF UTERINE 11:15 AM O-235 RESULTS OF THE ASTEROID (ASSESS FIBROIDS IN A MOUSE XENOGRAFT SAFETY AND EFFICACY OF VILAPRISAN MODEL: GROSS, HISTOLOGICAL AND IN PATIENTS WITH UTERINE FIBROIDS) 1 IMMUNOHISTOCHEMICAL ANALYSES. J. L. STUDY: A PHASE 2, PLACEBO-CONTROLLED Britten, M. Malik, W. H. Catherino; Obstetrics DOSE FINDING STUDY. L. Bradley,1 X. and Gynecology, Uniformed Services Ren,2 E. Groettrup-Wolfers,3 K. Petersdorf,3 University of the Health Scienc, Bethesda, MD. C. Seitz3; 1Cleveland Clinic, Cleveland, OH, 2Bayer HealthCare, Beijing, China, 3Bayer Pharma AG, Berlin, Germany. HEALTH DISPARITIES Moderators: Nidhee Sachdev, Eve Feinberg 11:30 AM O-236 A KINASE ANCHORING PROTEIN 13 REPRESSES LIGAND-DEPENDENT VITAMIN 11:15 AM O-241 COMPARISON OF GENETIC ETHNICITY D RECEPTOR ACTIVITY THROUGH A RHOA BETWEEN AMERICAN AND EUROPEAN SIGNALING PATHWAY IN FIBROID CELLS. FERTILITY PATIENTS: IMPLICATIONS FOR C. Washington,1 P. Driggers,1 F. S. Chuong,1 K. CLINICAL PRACTICE. N. Kumar,1 S. Yarnall,1 C. Cayton Vaught,1 M. Malik,2 A. Al-Hendy,3 J. R. Shraga,1 S. Ghadir,2 J. Grifo3; 1Recombine, Segars1; 1Gyn/OB, Johns Hopkins School of New York, NY, 2Southern California Medicine, Baltimore, MD, 2OBG, Uniformed Reproductive Center, Beverly Hills, CA, 3NYU Services University of the Health Sciences, Langone Medical Center, New York, NY. Bethesda, MD, 3Obstetrics & Gynecology, Medical College of Georgia, Georgia Regents 11:30 AM O-242 RACIAL DISPARITIES IN LIVE BIRTH University, Augusta, GA. PREGNANCY OUTCOMES FOLLOWING FRESH ELECTIVE SINGLE EMBRYO 11:45 AM O-237 MYOMETRIAL PROGESTERONE HYPER- TRANSFER: A SART-CORS ANALYSIS RESPONSIVNESS IS ASSOCIATED WITH 2004-2013. A. K. Styer,1 S. L. Mumford,2 T. INCREASED RISK FOR THE DEVELOPMENT Plowden,3 A. M. Lee,1 A. Christy,4 V. L. Baker5; OF HUMAN UTERINE FIBROIDS. M. K. 1Massachusetts General Hospital/Harvard Omar,1,2 Q. Yang,1 A. Laknaur,1 A. Al-Hendy1; Medical School, Boston, MA, 2NICHD, 1OB/GYN, Augusta University, Augusta, NIH, Rockville, MD, 3NIH, Bethesda, MD, GA, 2Obstetrics and Gynecology, Tanta 4Contraception Discovery and Development University, Tanta, Egypt. Branch, NIH, Rockville, MD, 5Division of REI, Department of Obstetrics and Gynecology, Stanford University, Stanford, CA.

nd 72 ASRM Scientific Congress & Expo 160 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

11:45 AM O-243 RACIAL DISPARITIES: IN VITRO School of Public Health, Boston, MA, 3OB/ FERTILIZATION (IVF) OUTCOMES IN GYN, Washington University in St. Louis, St. DONOR OOCYTE RECIPIENTS. X. Zhou,1 Louis, MO, 4Environmental Health Sciences, D. McQueen,2 A. Schufreider,1 M. L. Uhler,3 Columbia Mailman School of Public Health, E. C. Feinberg4; 1The University of Chicago, New York, NY, 5Department of Population Chicago, IL, 2University of Illinois Chicago, Medicine, Harvard Medical School and Harvard Chicago, IL, 3Reproductive Endocrinology Pilgrim Health Care Institute, Boston, MA. and Infertility, Fertility Centers of Illinois, 4 Warrenville, IL, Fertility Centers of Illinois, 11:30 AM O-248 INTENSIVE LIFESTYLE INTERVENTION Highland Park, IL. INCLUDING EMOTIONALLY-FOCUSED COUPLES THERAPY LEADS TO MORE 12:00 PM O-244 THE IMPACT OF RACE AND ETHNICITY ON PREGNANCIES AND WEIGHT LOSS IN ASSISTED REPRODUCTIVE TECHNOLOGY OBESE INFERTILE COUPLES. A. K. Moore,1 R. (ART) OUTCOMES: A RETROSPECTIVE Rasmussen,2 J. Sandberg,3 J. Holt-Lunstad,4 COHORT STUDY. E. L. McClennen,1 K. S. D. T. Carrell,5 J. Straseski,6 C. M. Peterson,7 E. Richter,2 K. Moon,3 I. Sasson,4 L. A. Bishop5; B. Johnstone8; 1Obstetrics and Gynecology, 1Ob/Gyn, Lankenau Medical Center, University of Utah School of Medicine, Salt Lake Philadelphia, PA, 2Research, Shady Grove City, UT, 2USA, Provo, UT, 3Professor Brigham Fertility Reproductive Science Center, Young University, Lindon, UT, 4Psychology and Rockville, MD, 3Shady Grove Fertility, Neuroscience, Brigham Young University, Provo, Washington, DC, 4Shady Grove Fertility UT, 5Surgery (Urology), University of Utah School of PA, Wayne, PA, 5Shady Grove Fertility of Medicine, Salt Lake City, UT, 6University of Reproductive Science Center, Rockville, MD. Utah/ARUP Laboratories, Salt Lake City, UT, 7Divsion of Reproductive Endocrinology and 12:15 PM Infertility, University of Utah, Salt Lake City, UT, O-245 GAPS IN KNOWLEDGE IN DIAGNOSIS AND 8 MANAGEMENT OF POLYCYSTIC OVARY Obstetrics & Gynecology, University of Utah, SYNDROME. S. Saini,1 M. Gibson-Helm,2 L. Salt Lake City, UT. Cooney,1 H. Teede,2 A. Dokras1; 1Obstetrics and Gynecology, University of Pennsylvania, 11:45 AM O-249 LOWER AMH IS ASSOCIATED WITH LOWER Philadelphia, PA, 2Monash Centre for Health OOCYTE YIELD AND LIVE BIRTH RATE AMONG Research and Implementation, Monash OBESE WOMEN; ANALYSIS OF 36,334 IVF University, Melbourne, Australia. CYCLES. W. Vitek,1 S. Jin,2 V. L. Baker,3 A. K. Styer,4 M. S. Christianson,5 J. E. Stern,6 A. J. 7 1 12:30 PM O-246 PRELIMINARY RESULTS FOR ANEUPLOIDY Polotsky ; University of Rochester Medical Center, Rochester, NY, 2Yale University, New SCREENING IN SOUTH ASIAN WOMEN 3 COMPARED TO CAUCASIANS UNDERGOING Haven, CT, Division of REI, Department of F. Sharara,1,2 M. Goodwin,1 G. A. Abdo3; Obstetrics and Gyne, Stanford University, PGS. 4 1Virginia Center for Reproductive Medicine, Stanford, CA, Massachusetts General Hospital/ 5 Reston, VA, 2Ob/gyn, George Washington Harvard Medical Sch, Boston, MA, Gynecology University, Washington, DC, 3Virginia Center and Obstetrics, Johns Hopkins University School 6 for Reproductive Medcicne, Reston, VA. of Medicine, Lutherville, MD, Obstetrics and Gynecology, Dartmouth-Hitchcock, Lebanon, NH, 7University of Colorado, Aurora, CO.

OBESITY AND METABOLISM 12:00 PM O-250 ARE THE BIGGEST LOSING? ANALYZING Moderators: Meera Shah, Courtney Marsh THE EFFECT OF BODY MASS INDEX (BMI) ON PREGNANCY RATES IN EUPLOID 11:15 AM O-247 MATERNAL FAT INTAKE DURING FROZEN EMBYRO TRANSFER (FET) CYCLES. PREGNANCY IN RELATION TO IGF2 AND M. B. Smith,1 B. Hodes-Wertz,2 J. Grifo,3 K. A. J. H19 METHYLATION IN NEWBORNS. N. Goldman4; 1NYU School of Medicine, New Gaskins,1 H. Laue,2 K. Moley,3 A. Baccarelli,4,2 York, NY, 2Ob/Gyn, NYU Langone Medical M. W. Gillman,1,5 J. E. Chavarro1; 1Department Center, New York, NY, 3NYU Langone Medical of Nutrition, Harvard T.H. Chan School of Center, NY, NY, 4Obstetrics and Gynecology, Public Health, Boston, MA, 2Department of New York University, New York, NY. Environmental Health, Harvard T.H. Chan

nd 72 ASRM Scientific Congress & Expo 161 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

12:15 PM O-251 RECENT WEIGHT-CONTROL EFFORTS SINGLE EMBRYO TRANSFER (ESET) VERSUS BEFORE TRYING TO CONCEIVE, DOUBLE EMBRYO TRANSFER (DET) IN FECUNDABILITY, AND OVULATION AMONG UNITED STATES IVF CLINICS. A. Mancuso,1 FECUND WOMEN. R. Radin,1 S. L. Mumford,1 S. Boulet,2 E. H. Duran,1 E. M. Munch,1 D. M. R. M. Silver,2 A. M. Lynch,3 N. Perkins,1 L. Kissin,2 B. J. Van Voorhis1; 1Obstetrics and Sjaarda,1 E. Schisterman1; 1NICHD, NIH, Gynecology, University of Iowa Hospitals Bethesda, MD, 2Obstetrics and Gynecology, and Clinics, Iowa City, IA, 2Division of Unversiy of Utah, Salt Lake City, UT, 3Dept. Reproductive Health, Centers for Disease , University of Colorado, Control and Prevention, Atlanta, GA. Aurora, CO. 12:00 PM O-256 RISK OF MATERNAL MORBIDITY IN IVF 12:30 PM O-252 THE PLACENTAL METABOLOME IS A AND NON-IVF BIRTHS: A US STUDY IN WINDOW TO LONG-TERM METABOLIC FIVE STATES. B. Luke,1 M. B. Brown,2 L. HEALTH: LESSONS FROM AN OBESOGENIC G. Spector3; 1Obstetrics, Gynecology, and MOUSE MODEL. K. O’Neill,1 T. Stuart,2 M. Reproductive Biology, Michigan State A. Mainigi,1 R. Simmons2; 1Department of University, East Lansing, MI, 2Biostatistics, Obstetrics and Gynecology, University of University of Michigan, Ann Arbor, MI, Pennsylvania, Philadelphia, PA, 2Pediatrics, 3Pediatrics, University of Minnesota, University of Pennsylvania, Philadelphia, PA. Minneapolis, MN.

12:15 PM O-257 HUMAN CHORIONIC GONADOTROPIN RISE IN EARLY PREGNANCY DIFFERS BY EARLY PREGNANCY VALUE AT PRESENTATION. K. Barnhart,1 Moderators: Janet McLaren-Bouknight, Mamie McLean W. Guo,2 K. Chung,3 P. Takacs,4 S. Senapati,1 2 1 11:15 AM O-253 ENDOMETRIAL GENE EXPRESSION OF M. D. Sammel ; OB-GYN, University of 2 WOMEN WITH RECURRENT PREGNANCY Pennsylvania, Philadelphia, PA, Biostatistics LOSSES AND INFERTILITY. L. Wu,1,2 D. and Epidemiology, University of Katukurundage,3 N. Sung,1 M. D. Salazar Pennsylvania, Perelman School of Medicine, 3 Garcia,1 A. M. Skariah,1 S. V. Dambaeva,3 A. Philadelphia, PA, USC Keck School of 4 Gilman-Sachs,3 K. Beaman,3 J. Kwak-Kim1,3; Medicine, Los Angeles, CA, Eastern Virginia 1Rosalind Franklin University of Medicine Medical School, Norfolk, VA. and Science, Vernon Hills, IL, 2Reproductive Medicine Center, Anhui Provincial Hospital 12:30 PM O-258 IS BLASTOCYST TRANSFER ASSOCIATED Affiliated to Anhui Medical University, WITH A SIGNIFICANTLY LOWER INCIDENCE Hefei, Anhui, China, 3Clinical Immunology OF ECTOPIC PREGNANCY? A STRICTLY Laboratory Rosalind Franklin University, CONTROLLED RETROSPECT COHORT North Chicago, IL. STUDY BASED ON MORE THAN 30,000 FROZEN EMBRYO TRANSFER CYCLES. T. 11:30 AM O-254 KISSPEPTIN AS NEW SERUM BIOMARKER Du, Q. Chen, Q. Lyu, Y. Kuang; Department TO DISCRIMINATE MISCARRIAGE FROM of Assisted Reproduction, Shanghai Ninth VIABLE INTRAUTERINE PREGNANCY. C. People’s Hospital, Shanghai, China. S. Sullivan-Pyke,1 D. J. Haisenleder,2 M. D. Sammel,3 S. Senapati,1 O. L. Nicolais,1 E. Eisenberg,4 K. Barnhart1; 1OB-GYN, University of Pennsylvania, Philadelphia, EMBRYO BIOLOGY 2 PA, 2Center for Research in Reproduction, Moderators: Juergen Liebermann, Nina Resetkova University of Virginia, Charlottesville, VA, 11:15 AM 3 O-259 LEVELS OF TROPHECTODERM Biostatistics and Epidemiology, University MITOCHONDRIAL DNA DO NOT PREDICT of Pennsylvania, Philadelphia, PA, 4 THE REPRODUCTIVE POTENTIAL OF Reproductive Medicine Network, NICHD, HUMAN BLASTOCYSTS. N. R. Treff,1 Y. Zhan,2 Bethesda, MD. X. Tao,2 M. Olcha,1 M. Han,2 J. Rajchel,2 L. Morrison,2 S. Morin,1 R. T. Scott Jr.1; 1RMANJ, 11:45 AM O-255 LIVE BIRTH AND MULTIPLE BIRTH RATES Rutgers-RWJ, Basking Ridge, NJ, 2FEC, IN WOMEN UNDER AGE 38 BY ELECTIVE Basking Ridge, NJ.

nd 72 ASRM Scientific Congress & Expo 162 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

11:30 AM O-260 THE SUPRAPHYSIOLOGIC PERI- LATE-BREAKING ABSTRACTS IMPLANTATION ENVIRONMENT Moderators: Danny Schust, Karl Hansen FOLLOWING SUPEROVULATION IS 11:15 AM O-265 ACUPUNCTURE AND CLOMIPHENE ASSOCIATED WITH ALTERED PLACENTAL FOR INFERTILITY IN THE POLYCYSTIC VASCULOGENESIS: EVIDENCE FROM A OVARY SYNDROME: A MULTICENTRE 1 MOUSE MODEL OF ART. M. A. Mainigi, RONDOMIZED CONTROLLED TRIAL. X. R. S. Weinerman,2 T. Ord,1 C. Coutifaris1; Wu,1 E. Stener-Victorin,2,1 J. Liu,3 T. Wu,4 E. 1University of Pennsylvania, Philadelphia, Ng,5 R. S. Legro,6,1 H. Zhang7; 1Department PA, 2Case Western Reserve University, of Obstetrics and Gynecology, Heilongjiang Cleveland, OH. University of Chinese Medicine, Harbin, China, 2Department of Physiology and Pharmacology, Karolinska Institutet, 11:45 AM O-261 ANEUPLOIDY RATES ARE NOT INCREASED Stockholm, Sweden, 3Centre for Evidence- IN PATIENTS WITH RECURRENT Based Chinese Medicine, Beijing University PREGNANCY LOSS. H. Nonez,1 J. Rodriguez- of Chinese Medicine, Beijing, China, 4Chinese Purata,1 J. A. Lee,1 M. C. Whitehouse,1 R. Clinical Trial Registry, Chinese Ethics 1 1 1 Committee of Registering Clinical Trials, Slifkin, R. A. Moschini, M. Duke, A. B. 5 Copperman,1,2 B. Sandler,1,2 C. Briton-Jones1; Chengdu, China, Department of Obstetrics 1 and Gynecology, The University of Hong Reproductive Medicine Associates of New 6 2 Kong, Hong Kong, China, Department of York, New York, NY, Obstetrics, Gynecology Obstetrics and Gynecology, Penn State and Reproductive Science, Icahn School of University College of Medicine, Hershey, PA, Medicine at Mount Sinai, New York, NY. 7Department of Biostatistics, Yale School of Public Health, New Haven, CT 12:00 PM O-262 THE EFFECT OF PROGESTERONE ON EARLY EMBRYO METABOLISM. M. P. Provost, D. 11:30 AM O-266 ALLOGENEIC TRANSPLANTATION OF J. Raburn, Q. Dai, T. M. Price; Division of OVARIAN TISSUE WITH SOLE USE Reproductive Endocrinology & Infertility, OF NOVEL IMMUNOMODULATOR, Duke University, Durham, NC. PREIMPLANTATION FACTOR (PIF), RESTORED OVARIAN FUNCTION IN BABOONS. M. Feichtinger,1,2 E. R. Barnea,3,4 12:15 PM O-263 SEQUENTIAL (SEQ) VS. MONOPHASIC A. Nyachieo,5 M. Brannstrom,6 S. Kim7,8; (MONO) MEDIA IMPACT TRIAL (SUMMIT): 1Department of Obstetrics and Gynecology, Medical University of Vienna, Vienna, ANALYSIS OF DELIVERY OUTCOMES 2 AMONGST EMBRYOS CULTURED IN Austria, Wunschbaby Institut Feichtinger, Vienna, Austria, 3BioIncept LLC, Cherry Hill, DIFFERENT MEDIA FORMULATIONS. M. NJ, 4SIEP – Society for the Investigation D. Werner,1 S. Morin,2 J. M. Franasiak,3 C. R. 4 5 6 of Early Pregnancy, Cherry Hill, NJ, Juneau, K. M. Upham, T. A. Molinaro, R. T. 5Institute of Primate Research (IPR), Karen, Scott Jr.7; 1REI, RMANJ, Rutgers-RWJ, Basking Nairobi, Kenya, 6University of Gothenburg, Ridge, NJ, 2Rutgers-Robert Wood Johnson Gothenburg, Sweden, 7University of Kansas, Medical School, Maplewood, NJ, 3RMANJ, NJ, Kansas City, KS, 8American-Sino Women’s NJ, 4RMANJ, Basking Ridge, NJ, 5RMA, NJ, NJ, and Children’s Hospital, Shanghai, China 6Reproductive Medicine Associates of New Jersey, Eatontown, NJ, 7REI, RMANJ,Rutgers- 11:45 AM O-267 FIRST LIVE BIRTH USING HUMAN OOCYTES RWJ, Basking Ridge, NJ. RECONSTITUTED BY SPINDLE NUCLEAR TRANSFER FOR MITOCHONDRIAL DNA MUTATION CAUSING LEIGH SYNDROME. 12:30 PM O-264 L-CARNITINE IMPROVES THE HUMAN J. Zhang,1 1 2 1 H. Liu, S. Luo, A. Chavez- BLASTOCYST DEVELOPMENT. T. Tanaka, Badiola,3 Z. Liu,1 m. yang,1 S. Munne,4 M. M. Satoh,1 S. Hashimoto,1 Y. Nakaoka,1 Y. Konstantinidis,4 D. Wells,5 T. Huang6; 1New Morimoto2; 1IVF Namba Clinic, the Centre for Hope Fertility Center, New York, NY, 2Division Reproductive Medicine and Infertility, Osaka, of Human Genetics, Cincinnati Children’s Japan, 2HORAC Grand Front Osaka Clinic, Hospital Medical Center, Cincinnati, OH, 3 Osaka, Japan. New Hope Fertility Center, Guadalajara, Mexico, 4Reprogenetics, Livingston, NJ, 5Reprogenetics, Oxford, United Kingdom, 6Human Genetics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

nd 72 ASRM Scientific Congress & Expo 163 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Oral Abstracts CME CE ARS

12:00 PM O-268 FIRST US-BASED PHASE 3 STUDY OF ULIPRISTAL ACETATE (UPA) FOR SYMPTOMATIC UTERINE FIBROIDS (UF): RESULTS OF VENUSI. J. Simon,1 W. H. Catherino,2 J. Segars,3 R. Blakesley,4 A. Chan,4 V. Sniukiene,4 A. Al-Hendy5; 1Women’s Health and Research Consultants, Washington, DC, 2Uniformed Services University of the Health Sciences, Bethesda, MD, 3Johns Hopkins University School of Medicine, Baltimore, MD, 4Allergan plc, Jersey City, NJ, 5Augusta University, Augusta, GA

12:15 PM O-269 FREEZE-ALL VERSUS FRESH EMBRYO TRANSFER IN IVF/ICSI, A RANDOMISED CONTROLLED TRIAL (NCT02471573). L. T. Vuong,1 V. Q. Dang,2 T. M. Ho,2 B. G. Huynh,3 D. T. Ha,4 T. D. Pham,3 L. K. Nguyen,3 R. J. Norman,5 B. W. Mol6; 1OB/GYN, University of Medicine and at Ho Chi Minh, Ho Chi Minh City, Viet Nam, 2Research Center for Genetics and Reproductive Health, School of Medicine, Vietnam National University Ho Chi Minh City, Ho Chi Minh, Viet Nam, 3IVFMD, My Duc hospital, Ho Chi Minh, Viet Nam, 4Intensive Care Unit, national hospital of can tho, can tho, Viet Nam, 5Robinson Research Institute, University of Adelaide, Tranmere, Australia, 6Obstetrics & Gynaecology, The University of Adelaide, North Adelaide, Australia

12:30 PM O-270 RELIABLE DETECTION OF SEGMENTAL ANEUPLOIDY IDENTIFIED BY NEXT GENERATION SEQUENCING (NGS). C. R. Juneau,1 K. Scott,2 S. Neal,1 S. J. Morin,1 Y. Zhan,2 R. S. Zimmerman,2 N. Treff,1 J. M. Franasiak,1 R. T. Scott1; 1RMANJ, BR, NJ, 2FEC, BR, NJ

nd 72 ASRM Scientific Congress & Expo 164 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Tuesday, October 18, 2016 P-001 - P-356 7:00 am - 8:45 am

NON- Poster Abstract Sessions CME CE ARS

Continental breakfast provided. ACCESS TO CARE

ASRM invites you to meet the poster presenters of posters P-1 through P-356 on Tuesday morning and enjoy a P-1 WIDENING ACCESS TO INFERTILITY CARE BY continental breakfast. Authors of posters P-357 through OFFERING AFFORDABLE IVF PROTOCOLS: A. Davila; P-712 will present their posters on Wednesday morning. THE MEXICAN EXPERIENCE. Reproductive Medicine and Andrology, Instituto para el Estudio de la Concepcion Please note that on Monday, posters will be open from Humana, Monterrey, Mexico. 12:00 pm until 5:00 pm. On Tuesday, posters will be open from 7:00 am until 5:00 pm. On Wednesday, posters will be open from 7:00 am until 2:00 pm. P-2 DESIGNING EDUCATIONAL MATERIALS TO IMPROVE ATTITUDES ABOUT IN VITRO ASRM cannot be responsible for removing and/or returning FERTILIZATION. D. M. Fankhauser,1 J. B. posters. All posters not removed will be discarded. Corwin,2 C. M. Skubisz3; 1President, Fertility Within Reach, Newton Highlands, MA, 2Health Communication, Emerson College, Boston, MA, 3Communication, Emerson College, • Access to Care P-1 - P-14 Boston, MA. • Contraception/Family Planning P-15 - P-20 P-3 ABSTRACT WITHDRAWN • Mental Health P-21 - P-28 • Nursing P-29 - P-33 P-4 CONTRIBUTION OF THIRD PARTY • Ovarian Function P-34 - P-39 REPRODUCTION TO THE BIRTH COHORT 1,2 • Ovarian Reserve P-40 - P-48 FOLLOWING ART IN THE U.S.A. V. A. Kushnir, D. H. Barad,1,3 S. Darmon,1 D. Albertini,1,4 N. • Fertility Preservation P-49 - P-73 Gleicher1,5; 1Center for Human Reproduction, • Cryopreservation and P-74 - P-101 New York, NY, 2Wake Forest School of Medicine, Frozen Embryo Transfer Winston-Salem, NC, 3Albert Einstein College of Medicine, Bronx, NY, 4University of Kansas • Preimplantation Genetic Testing P-102 - P-158 Medical Center, Kansas City, KS, 5Rockefeller • ART Outcome Predictors - Clinical P-159 - P-208 University, New York, NY. • Oocyte Biology P-209 - P-220 • Oocyte Maturation P-221 - P-227 P-5 RACIAL AND ETHNIC DISPARITIES IN THE USE OF THIRD-PARTY ART IN THE U.S. A. • Ovarian Stimulation P-228 - P-251 Shapiro,1,2 D. H. Barad,2,3 S. Darmon,2 D. • Embryo Transfer P-252 - P-276 Albertini,2,4 N. Gleicher,2,5 V. A. Kushnir2,6; 1 • Endometrium P-277 - P-299 Rutgers New Jersey Medical School, West New York, NJ, 2Center for Human Reproduction, • Female Reproductive Surgery P-300 - P-312 New York, NY, 3Albert Einstein College of • Imaging and Reproductive Medicine P-313 - P-314 Medicine, Bronx, NY, 4University of Kansas Medical Center, Kansas City, KS, 5Rockefeller • Male Factor - ART P-315 - P-336 University, New York, NY, 6Wake Forest School • Male Reproduction and Urology - Research P-337 - P-356 of Medicine, Winston-Salem, NC.

nd 72 ASRM Scientific Congress & Expo 165 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-6 PARTNERSHIP FOR FAMILIES PROGRAM: Daneshmand,1,2 C. E. Bedient,1,2 F. Garner,1,2 A NON-PROFIT MODEL FOR ACCESS TO B. S. Shapiro1,2; 1Fertility Center of Las Vegas, IVF. T. Segal,1 S. Thakore,2 G. Collins,3 J. M. Las Vegas, NV, 2University of Nevada School of Goldfarb4; 1Reproductive Endocrinology Medicine, Las Vegas, NV. & Infertility, University Hospitals Case 2 Medical Center, Beachwood, OH, Case P-13 SMARTPHONE FERTILITY APP USE Western Reserve University, Cleveland, AMONG COUPLES OF REPRODUCTIVE OH, 3University Hospitals Fertility 4 AGE: POTENTIAL USE OF BIG DATA TO Center, Beachwood, OH, Reproductive IMPROVE FERTILITY CARE AND ADVANCE Endocrinology and Infertility, Case Western REPRODUCTIVE HEALTH RESEARCH. A. Reserve University, Cleveland, OH. Lange,1 J. Yeh,1 C. Messerlian,2 R. Hauser,3 J. E. Chavarro,4 A. J. Gaskins,5 T. L. Toth6; P-7 FACTORS AFFECTING CANCER PATIENTS’ 1Massachusetts General Hospital Fertility DECISION TO PROCEED WITH FERTILITY Center, Boston, MA, 2Environmental Health, PRESERVATION (FP) TREATMENTS Harvard T.H. Chan School of Public Health, AND THIER RELATION TO DELAY IN Boston, MA, 3Harvard Chan School of Public CHEMOTHERAPY. M. A. Clapp, E. H. Illions, E. Health, Boston, MA, 4Department of Nutrition, Buyuk; Albert Einstein College of Medicine/ Harvard School of Public Health, Boston, MA, Montefiore M, Bronx, NY. 5Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, 6OB/GYN, P-8 WHAT DOES A SINGLE SEMEN SAMPLE TELL Massachusetts General Hospital, Boston, MA. YOU? IMPLICATIONS FOR THE DIAGNOSIS OF MALE FACTOR INFERTILITY. Y. Chiu,1 R. P-14 THE DOCTOR WILL TWEET YOU NOW: Edifor,2 F. Nassan,3 A. J. Gaskins,4 L. Minguez- EXPANDING ACCESS TO CARE THROUGH Alarcon,3 P. Williams,5 C. Tanrikut,6 R. Hauser,7 SOCIAL MEDIA ENGAGEMENT. S. H. J. E. Chavarro8; 1Nutrition, Harvard T.H. Chen,1 S. Sehnert,2 W. Ash,3 N. Kumar,2 S. Chan School of Public Health, Boston, MA, Foster,2 S. Yarnall,2 I. Carlsson4; 1Gynecology 2Global Health and Population, Harvard and Obstetrics, IRMS at Saint Barnabas, T.H. Chan School of Public Health, Boston, Livingston, NJ, 2Recombine, New York, NY, MA, 3Environmental Health, Harvard T.H. 3Today’s Business, Pine Brook, NJ, 4Medical Chan School of Public Health, Boston, MA, Affairs, Recombine, New York, NY. 4Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, 5Biostatistics and Epidemiology, Harvard T. CONTRACEPTION/FAMILY PLANNING H. Chan School of Public Health, Boston, MA, 6Urology, Massachusetts General Hospital, Boston, MA, 7Harvard Chan School of Public P-15 EVALUATION OF TUBAL PATENCY WITH Health, Boston, MA, 8Department of Nutrition, HYSTEROSALGINGOGRAPY (HSG) IN Harvard School of Public Health, Boston, MA. BABOONS: EFFECT OF MENSTRUAL CYCLE PHASE. J. Jensen,1 C. Hanna,2 S. Yao,2 O. D. Slayden2; 1Department of OB/GYN, OHSU, P-9 Abstract withdrawn Portland, OR, 2Division of Reproductive and Developmental Sciences, Oregon National P-10 IMPROVED PATIENT CARE THROUGH Primate Research Center, Beaverton, OR. LAWSUIT PROTECTION AND PREVENTION. G. Mangelson; American Society for Asset P-16 ZP2 BEADS THAT SELECT HUMAN Protection, Las Vegas, NV. SPERM IN VITRO, DECOY MOUSE SPERM IN VIVO, AND PROVIDE REVERSIBLE P-11 INFERTILITY AS A WOMEN’S HEALTH ISSUE. CONTRACEPTION. M. Avella,1 B. Baibakov,2,1 J. S. Place; Physiology and Health Science, M. Jimenez-Movilla,3 A. Burkart Sadusky,1 Ball State University, Muncie, IN. J. Dean4; 1Laboratory of Cellular and Developmental Biology, NIDDK, National Institutes of Health, Bethesda, MD, 2NIDDK/ P-12 EXPANDING SAME-SEX COUPLES’ ACCESS NIH, Bethesda, MD, 3Department of Cell TO ASSISTED REPRODUCTION. S. Biology and , Medical School,

nd 72 ASRM Scientific Congress & Expo 166 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Murcia, Spain, 4Laboratory of Cellular and Grifo1; 1New York University, New York, NY, Developmental Biology, NIDDK, National 2Northwestern University, Chicago, IL. Institutes of Health, Bethesda, MD. P-22 KNOWLEDGE OF EGG FREEZING AMONG P-17 ETHNIC AND RACIAL DIFFERENCES IN THE MEDICAL STUDENTS AND THE IMPORTANCE UTILIZATION OF INFERTILITY SERVICES: OF EMPLOYER COVERAGE OF ELECTIVE NATIONAL SURVEY OF FAMILY GROWTH EGG FREEZING ON DECISION MAKING. D. (NSFG). A. Janitz,1 J. D. Peck,1 L. B. Craig2; E. Ikhena,1 R. Confino,1 N. J. Shah,2 A. K. 1Dept of Biostatistics and Epidemiology, OU Lawson,3 S. Klock,4 M. G. Pavone1; 1Obstetrics Health Sciences Center, Oklahoma City, OK, and Gynecology, Prentice Women’s Hospital, 2Section of REI; Dept of Ob/Gyn, OU Health Northwestern University Feinberg School Science Center, Oklahoma City, OK. of Medicine, Chicago, IL, 2Northwestern University - Feinberg School of Medicine, 3 P-18 AN EX VIVO MODEL FOR ASSESSING ACUTE Chicago, IL, Obstetrics and Gynecology, Northwestern Medicine, Chicago, IL, EFFECTS OF TRANSCERVICAL POLIDOCANOL 4 FOAM IN THE MACAQUE FALLOPIAN TUBE. Obstetrics & Gynecology and Psychiatry, S. Yao,1 C. Hanna,1 O. D. Slayden,1 J. Jensen2; Northwestern Medicine, Chicago, IL. 1Division of Reproductive & Developmental Sciences, Oregon National Primate Research P-23 FOLLOW UP OF MEXICAN EGG DONORS Center, Beaverton, OR, 2Department of OB/ EXPERIENCES AND REACTIONS. A. GYN, OHSU, Portland, OR. Braverman,1 C. Palatchi Cohen,2 C. Chapa,2 J. C. Rosales,3 R. Santos,4 P. Diaz5; 1Obstetrics & Gynecology, Thomas Jefferson University, P-19 DIGITAL WOMENS HEALTH BASED ON 2 P. Stein,1 Philadelphia, PA, Centro de Fertilidad WEARABLES AND BIG DATA. 3 L. Falco,1 F. Kuebler,1 S. Annaheim,2 A. IECH, Monterrey N.L, Mexico, REI, Centro de 4 Lemkaddem,3 R. Delgado-Gonzalo,3 C. Verjus,3 Fertilidad IECH, Monterrey, Mexico, Centro de 5 B. Leeners4; 1Ava AG, Zurich, Switzerland, Fertilidad IECH, Monterrey, Mexico, Centro de 2EMPA - Swiss Federal Laboratories for Fertilidad IECH, Monterrey N.L, Macao. Materials Science and Technology, St. Gallen, Switzerland, 3CSEM - Centre Suisse P-24 FERTILITY PRESERVATION COUNSELING: d’Electronique et de Microtechnique, DECISION MAKING AND REGRET. A. Lawson, Neuchâtel, Switzerland, 4University G. Mendoza, K. N. Smith, E. Confino, E. E. Hospital Zurich - Clinic for Reproductive Marsh; Obstetrics and Gynecology, Feinberg Endocrinology, Zurich, Switzerland. School of Medicine-Northwestern University, Chicago, IL. P-20 SHARED MEDICAL APPOINTMENTS FOR VASECTOMY CONSULTATION: PROSPECTIVE P-25 ANXIETY SYMPTOMS AS PREDICTORS OF ASSESSMENT OF PATIENT SATISFACTION FERTILITY TREATMENT OUTCOMES. K. AND COUNSELING EFFECTIVENESS. E. Chan,1 Saiki,1 J. Clifton,2 M. Seehuus,3 G. Worrall,1 P. D. J. Mazur,1 J. Kashanian,2 A. W. Choi,1 J. Moss,1 R. Casson,4 A. Rellini,2 R. Raj,5,1 E. McGee5,1; R. E. Brannigan1; 1Department of Urology, 1University of Vermont, Burlington, VT, Northwestern University Feinberg School of 2Psychological Science, University of Vermont, Medicine, Chicago, IL, 2Department of Urology, Burlington, VT, 3Psychology, Middlebury Weill Cornell Medicine, New York, NY. College, Middlebury, VT, 4Northeastern Reproductive Medicine, Colchester, VT, 5University of Vermont Center for Reproductive Medicine, Burlington, VT. MENTAL HEALTH P-26 DISTRESS AND EARLY DECISIONAL P-21 PREDICTORS OF DECISION REGRET CONFLICT AND SATISFACTION IN WOMEN FOLLOWING PREIMPLANTATION GENETIC CONSIDERING FERTILITY PRESERVATION SCREENING (PGS). K. N. Goldman,1 J. K. PRIOR TO CANCER TREATMENT. A. 1 2 1,3 Blakemore,1 Y. G. Kramer,1 A. K. Lawson,2 J. Bradford, L. Covarrubias, T. L. Woodard ; 1Gynecologic Oncology and Reproductive

nd 72 ASRM Scientific Congress & Expo 167 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Medicine, The University of Texas MD P-31 PATIENT AND NURSE EVALUATION OF Anderson Cancer Center, Houston, TX, 2Health THE IMPROVED FOLLITROPIN ALFA PEN Services Research, The University of Texas INJECTOR FOR INFERTILITY TREATMENT. MD Anderson Cancer Center, Houston, TX, J. Schertz,1 B. Feilding,2 H. Worton2; 1EMD 3Obstetrics and Gynecology, Baylor College of Serono, Billerica, MA, 2Aequus Research, Medicine, Houston, TX. London, United Kingdom.

P-27 PROVIDER PERCEPTION OF P-32 COMPARISON OF FERTILITY QUALITY PSYCHOLOGICAL CONDITIONS AND OF LIFE BETWEEN URBAN AND RURAL INFERTILITY. H. S. Hoff,1 N. M. Crawford,2 J. INFERTILE COUPLES. Y. Dong,1 F. Zhou2; E. Mersereau3; 1Reproductive Endocrinology 1Reproductive Medicine, Zhengzhou, China, and Infertility, University of North Carolina, 2The First Affiliated Hospital of Zhengzhou Chapel Hill, NC, 2Obstetrics and Gynecology, University, Zhengzhou, China. University of North Carolina, Chapel Hill, NC, 3 REI, UNC, Chapel Hill, NC. P-33 Abstract withdrawn

P-28 AN ONLINE EDUCATION PROGRAM ON THE DISPOSITION OPTIONS OF CRYOPRESERVED EMBRYOS. M. Martens; Vanderbilt University OVARIAN FUNCTION School of Nursing, Nashville, TN. P-34 INSULIN-LIKE GROWTH FACTOR-2 (IGF2) PRODUCTION AND REGULATION IN MACAQUE PREANTRAL FOLLICLES NURSING DURING 3-DIMENSIONAL CULTURE. O. Tkachenko,1 A. Y. Ting,2 J. Xu,3 R. L. Stouffer4; P-29 HOW CAN WE MAKE A GOOD EXPERIENCE 1Reproductive and Developmental Sciences, EVEN BETTER: WAYS TO ENHANCE THE ONPRC, OHSU, Beaverton, OR, 2Division of FERTILITY JOURNEY. R. Kudesia,1,2 D. Reproductive & Developmental Sciences, Bhasin,1,2 J. A. Lee,1 C. Briton-Jones,1 M. Oregon National Primate Research Center, Daneyko,1 B. Collura,3 A. B. Copperman1,2; Beaverton, OR, 3Oregon Health & Science 1Reproductive Medicine Associates of New University, Beaverton, OR, 4ONPRC, OHSU, York, New York, NY, 2Obstetrics, Gynecology Beaverton, OR. and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, NY, 3 P-35 EFFECT OF REGULAR EXERCISE ON RESOLVE: The National Infertility Association, REPRODUCTIVE FUNCTION OF AGED McLean, VA. FEMALE MICE. K. Lee,1 N. Park,2 J. Joo,1 S. Kim,1 S. Lee1; 1Pusan National University P-30 THE PSYCHO-EMOTIONAL IMPACT OF Hospital, Busan, Korea, Republic of, 2Urology, WOMEN RECEIVEING DONOR EGGS AND THE Pusan National University Hospital, Busan, INFLUENCE ON DECISION TREATMENT. C. Korea, Republic of. T. Kimati,1 H. L. Montagnini,2 T. C. Bonetti,3,4 5,6 7,3 7,3 P. C. Serafini, E. Motta, T. S. Domingues ; P-36 ADIPOCITY AND FETAL FOLLICULAR 1Nursing, Huntington Medicina Reprodutiva, 2 DEVELOPMENT: AN ASSOCIATION BETWEEN Sao Paulo, Brazil, Psychology, Huntington LEPTIN AND CORD BLOOD AMH. S. Butts,1 Medicina Reprodutiva, Sao Paulo, Brazil, S. Senapati,2 C. Coutifaris,3 M. S. Bartolomei4; 3 Gynecology, Universidade Federal de 1Obstetrics and Gynecology, Perelman School 4 São Paulo, Sao Paulo, Brazil, Scientific, of Medicine, Philadelphia, PA, 2Obstetrics Huntington Medicina Reprodutiva, Sao Paulo, & Gynecology, Reproductive Endocrinolog, 5 Brazil, Discipline of Ginecolgy, Hospital das University of Pennsylvania, Philadelphia, PA, 6 Clinicas, Un, Sao Paulo, Brazil, Clinical Head, 3University of Pennsylvania, Philadelphia, PA, Huntington Medicina Reprodutiva, Sao Paulo, 4University of Pennsylvania Perelman School 7 Brazil, Huntington Medicina Reprodutiva, of Medicine, Philadelphia, PA. Sao Paulo, Brazil.

nd 72 ASRM Scientific Congress & Expo 168 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-37 ANTI-MULLERIAN HORMONE (AMH) Gdansk, Poland, 3Department of Obstetrics and REGULATES BRCA1 AND BRCA2 GENE Gynecology, Center of Postgraduate Education, EXPRESSION IN AN OVARIAN CORTEX Warsaw, Poland. TRANSPLANTATION MODEL. L. Detti,1 N. M. Fletcher,2 G. M. Saed,3 R. A. Uhlmann,1 M. 4 5 1 P-42 NEW AUTOMATED ANTIMÜLLERIAN Christiansen, L. J. Williams ; Obstetrics and HORMONE (AMH) ASSAYS ARE MORE Gynecology, University of Tennessee Health 2 RELIABLE THAN THE MANUAL ASSAY IN Science Center, Memphis, TN, Obstetrics and PATIENTS WITH REDUCED ANTRAL FOLLICLE Gynecology, Wayne State University, Detroit, T. Tadros, B. Tarasconi, J. Nassar, 3 COUNT (AFC). MI, Obstetrics and Gynecology, Wayne State J. Benhaim, J. Taieb, R. Fanchin; Reproductive 4 University School of Medicine, Detroit, MI, The Medicine, Hospital Antoine Beclere-University of University of Tennessee Health and Science Paris Sud, Clamart, France. Center COM, Memphis, TN, 5OB/GYN, University of Tennessee Health Science Center, Memphis, TN. P-43 OF GRANULOSA CELLS AND CLINICAL OUTCOMES BETWEEN NORMAL P-38 EFFECT OF ANTIOXIDANT AND METABOLIC AND POOR OVARIAN RESERVE PATIENTS NUTRIENTS ON OOCYTES DEVELOPMENT IN UNDERGOING IVF/ICSI. Y. Fan, L. Wei, Y. IVF MODEL IN MICE. A. Virmani; Innovation, Shi, J. Chen, X. Liang; Reproductive Medical Research and Development, Sigma Tau Center, The Sixth Affiliated Hospital of Sun HealthScience, Utrecht, Netherlands. Yat-sen University, Guangzhou, China.

P-39 IMPAIRED REPRODUCTIVE FUNCTION IN P-44 IN WOMEN UNDERGOING ELECTIVE EGG A WOMAN WITH A TELOMEROPATHY. L. G. CRYOPRESERVATION WITH LESS-THAN- Robinson,1 Y. G. Kramer,2 R. N. Pimentel,3 F. 1 4 1 EXPECTED OVARIAN RESERVE A 4 MONTH Wang, D. L. Keefe ; Ob/Gyn, NYU Langone BREAK FROM COMBINED HORMONAL Medical Center, New York, NY, 2OBS-GYN, 3 CONTRACEPTIVES IS ASSOCIATED WITH NYU Fertility Center, New York, NY, OB/GYN, A 50% INCREASE IN OOCYTE YIELD. J. Specialist in Human Reproduction, Goiania, Letourneau, H. Cakmak, M. Quinn, N. Sinha, 4 Brazil, ObGyn, New York University Langone M. Cedars, M. Rosen; Obstetrics, Gynecology Medical Center, New York, NY. and Reproductive Sciences, University of California, San Francisco, San Francisco, CA.

OVARIAN RESERVE P-45 LOW ANTI-MÜLLERIAN HORMONE (AMH) IS A PREDICTOR OF HIGHER CLINICAL PREGNANCY PROBABILITY IN YOUNGER P-40 INCREASED TISSUE OMEGA-3 TO OMEGA-6 WOMEN COMPARED TO OLDER WOMEN. V. FATTY ACID RATIO RESULTS IN IMPROVED Mensah,1 R. Alvero,1 Y. Zhang,2 Y. Huang,2 S. MARKERS OF OVARIAN RESERVE AND Wang1; 1OB GYN/Division of Reproductive ALTERED SYSTEMIC CYTOKINES. M. Endocrinology and Infertility, Women & Infants E. Skaznik-Wikiel,1 D. C. Swindle,1 T. K. Hospital, Providence, RI, 2Biostatistics, School of Soderborg,2 J. E. Friedman,2 A. J. Polotsky1; Public Health, Brown University, Providence, RI. 1Department of OB/GYN, University of Colorado School of Medicine, Aurora, CO, P-46 ANTIMÜLLERIAN HORMONE 2Department of Pediatrics, University of (AMH) IS A BETTER PREDICTOR OF Colorado School of Medicine, Aurora, CO. RESPONSE TO CONTROLLED OVARIAN HYPERSTIMULATION (COH) THAN ANTRAL P-41 EVALUATION OF THE PERFORMANCE OF FOLLICLE COUNT (AFC) IN WOMEN WITH THE NEW AMH ASSAY AND ITS PRINCIPAL DISCORDANT MARKERS OF OVARIAN APPLICATIONS. K. Lukaszuk,1,2 J. Zabielska,1,2 RESERVE. V. Klenov,1 E. Jungheim2; G. Kloss,1 I. Malinowska,1 G. Jakiel,1,3 A. 1Obstetrics and Gynecology, Washington Lukaszuk1; 1INVICTA Fertility and Reproductive University School of Medicine, St. Louis, MO, Center, Gdansk, Poland, 2Department of 2Obstetrics and Gynecology, Washington Obstetrics and Gynecological Nursing, Faculty of University, St. Louis, MO. Health Sciences, Medical University of Gdansk,

nd 72 ASRM Scientific Congress & Expo 169 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-47 DO DIMINISHED OVARIAN RESERVE P-51 POLYMORPHISM IN MTHFR 677 C>T AND MARKERS NECESSARILY REFLECT LOWER 1298 A>C IN PATERNAL SPERM DNA IS OOCYTE QUALITY IN YOUNG PATIENTS? THE ASSOCIATED WITH INCREASED RISK OF EFFECT OF ANTRAL FOLLICLE COUNT. S. RETINOBLASTOMA IN INDIAN CHILDREN. Behbehani,1 W. Buckett,1 W. Son,2 Y. Hasson1; S. Bisht,1 B. Chawla,2 R. Dada3; 1Laboratory 1McGill University, Montreal, QC, Canada, for Molecular Reproduction and Genetics, All 2MUHC Reproductive Center, Monteral, QC, India Institute of Medical Sciences, New Delhi, Canada. India, 2AIIMS, New Delhi, India, 3Anatomy, Lab For Molecular Reproduction and Genetics, P-48 THE DEGREE OF COMPARABILITY OF New Delhi, India. TWO COMMERCIALLY AVAILABLE AMH IMMUNOASSAYS VARIES ACROSS CLINICAL P-52 EFFECTS OF ACROLEIN AND MESNA ON POPULATIONS IN REPRODUCTIVE FERTILIZATION OF MOUSE OOCYTE. R. MEDICINE. H. Huddleston,1 M. P. Diamond,2,3 Jeelani,1 F. Shaeib,2 S. Khan,3 F. Qadri,4 R. M. Cedars,4 N. Santoro,5 R. S. Legro,6,3 D. J. Morris,5 H. M. Abu-Soud6; 1REI, Wayne State Haisenleder7; 1University of California at San University, Royal Oak, MI, 2OB/GYN-Physiology, Francisco School of Medicine, San Francisco, Wayne State University/Medical School, CA, 2Augusta University, Augusta, GA, Detroit, MI, 3Wayne State University, Detroit, MI, 3Reproductive Medicine Network, Bethesda, 4OB/GYN, Wayne State University, Detroit, MI, MD, 4Obstetrics, Gynecology and Reproductive 5REI, Wayne State University, Detroit, MI, 6Ob/ Sciences, University of California, San Gyn, Wayne State University, Detroit, MI. Francisco, San Francisco,, CA, 5Obstetrics and Gynecology, University of Colorado School of P-53 CLINICAL OUTCOMES OF TESTICULAR Medicine, Aurora, CO, 6Penn State University 7 SPERM EXTRACTION (TESE) AND EMBRYONIC College of Medicine, Hershey, PA, Medicine, DEVELOPMENT IN PATIENTS WITH POST University of Virginia, Charlottesville, VA. CHEMOTHERAPY NON-OBSTRUCTIVE AZOOSPERMIA. N. Arita,1 S. Mizuta,1 K. Yamaguchi,2 R. Nishiyama,1 Y. Takaya,1 K. Kitaya,1 H. Matsubayashi,1 T. Ishikawa1; FERTILITY PRESERVATION 1Reproduction Clinic Osaka, Osaka, Japan, 2Ishikawa hospital, Urology, Himeji, Japan. P-49 THE SYNERGISTIC EFFECT OF MELATONIN AND GHRELIN ON PREVENTING CISPLATIN- P-54 CANCER DIAGNOSIS IS ASSOCIATED INDUCED PRIMORDIAL FOLLICLE LOSS WITH EQUIVALENT OVARIAN RESERVE, DURING CHEMOTHERAPY. Y. Choi,1 H. Jang,1 RESPONSE TO OVARIAN STIMULATION E. Chang,2 M. Park,2 H. Lee,2 E. Yu,2 Y. Hur,2 T. AND FERTILITY PRESERVATION OUTCOME K. Yoon,3 W. Lee2; 1Biomedical Science, CHA WHEN COMPARED TO ELECTIVE OOCYTE University, Seoungnam-si, Korea, Republic of, CRYOPRESERVATION. M. Quinn, H. 2CHA Fertility Center, Seoul, Korea, Republic Cakmak, J. Letourneau, M. Cedars, M. Rosen; of, 3Fertility Center, Seoul, Korea, Republic of. Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, CA.

P-50 PROTECTIVE EFFECT OF SILYMARIN ON P-55 TITRATION OF LETROZOLE TO MAINTAIN CYCLOPHOSPHAMİDE TOXICITY IN OVARIAN LOW ESTRADIOL (E2) LEVELS DURING TISSUE. P. Turk,1 G. Kuspinar,2 K. Ozerkan,1 FERTILITY PRESERVATION CYCLES FOR B. Avci3; 1Department of Gynecology and ESTROGEN RECEPTOR POSITIVE (ER+) Obstetric, Uludag University Medical Faculty, BREAST CANCER PATIENTS DOES NOT Bursa, Turkey, 2Department of Histology IMPACT OVARIAN RESPONSE OR MATURE and Embryology, Uludag University Medical OOCYTE YIELD. M. Quinn, H. Cakmak, J. Faculty, Bursa, Turkey, 3Department of Letourneau, M. Cedars, M. Rosen; Department Histology and Embryology, Department of of Obstetrics, Gynecology and Reproductive Gynecology and Obstetric IVF Center, Uludag Sciences, University of California, San University Medical Faculty, Bursa, Turkey. Francisco, San Francisco, CA.

nd 72 ASRM Scientific Congress & Expo 170 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-56 REPRODUCTIVE OUTCOME OF 128 PGD PRESERVATION DECISION AID FOR YOUNG CYCLES FOR BREAST CANCER. S. Rechitsky,1 L. WOMEN WITH CANCER. A. Mathur,1 L. P. Shulman,2 T. Pakhalchuk,3 M. Prokhorovich,1 Covarrubias,2 A. Bradford,1 J. Shah,3 T. L. G. San Ramon,1 A. Kuliev3; 1Preimplantation Woodard1,4; 1Gynecologic Oncology and Molecular Genetics, Reproductive Genetic Reproductive Medicine, The University of Innovations, Northbrook, IL, 2Division of Texas MD Anderson Cancer Center, Houston, Obstetrics and Gynecology-Clinical Genetics, TX, 2Health Services Research, The University Northwestern University: Feinberg School of of Texas MD Anderson Cancer Center, Medicine, Chicago, IL, 3Reproductive Genetic Houston, TX, 3Obstetrics, Gynecology and Innovations, Northbrook, IL. Reproductive Science, UT Houston McGovern Medical School, Houston, TX, 4Obstetrics P-57 UMBILICAL CORD BLOOD MESENCHYMAL and Gynecology, Baylor College of Medicine, STEM CELLS AS AN INFERTILITY TREATMENT Houston, TX. FOR CHEMOTHERAPY INDUCED PREMATURE OVARIAN FAILURE. S. A. Mohamed,1,2 S. M. P-62 INFERTILITY, FERTILITY TREATMENT, AND Shalaby,3,2 S. Brakta,4 L. Stone,4 M. Ellakany,1 MAMMOGRAPHIC DENSITY IN THE NURSES’ A. Al-Hendy4; 1Obgyn, Mansoura Medical HEALTH STUDY II. L. V. Farland,1,2 R. M. School, Mansoura, Egypt, 2Obgyn, Augusta Tamimi,2,3 K. A. Bertrand,4 A. Eliassen,2,3 J. E. Medical Center, Augusta, GA, 3Pharma, Chavarro,5,3 F. Grodstein,2,3 S. A. Missmer1,2,3; Tanta Medical School, Tanta, Egypt, 4Obgyn, 1Dept of Obstetrics & Gynecology, Brigham Augusta Medical School, Augusta, GA. & Women’s Hosp and Harvard Med School, Boston, MA, 2Dept of Epidemiology, Harvard Chan School of Public Health, Boston, MA, P-58 IMPACT OF CHEMOTHERAPY ON ANDROGEN 3 AND FOLLICULAR MEASURES OF OVARIAN Channing Division of Network Medicine, K. Brigham & Women’s Hosp and Harvard Med RESERVE IN FEMALE CANCER SURVIVORS. 4 Cameron,1 M. D. Sammel,2 M. M. Prewitt,3 M. E. School, Boston, MA, Slone Epidemiology 5 Lynch,4 C. Gracia1; 1University of Pennsylvania, Cntr, Boston Uni, Boston, MA, Dept of Philadelphia, PA, 2Biostatistics and Epidemiology, Nutrition and Epidemiology, Harvard Chan Univ. of Pennsylvania, Perelman School of School of Public Health, Boston, MA. Medicine, Philadelphia, PA, 3Obstetrics and Gynecology, University of Pennsylvania School P-63 IMPACT OF TAMOXIFEN ON FERTILITY of Medicine, Philadelphia, PA, 4University of IN BREAST CANCER SURVIVORS. L. M. Pennsylvania School of Medicine, Ardmore, PA. Shandley,1 J. Spencer,2 A. Fothergill,3 A. Mertens,4 E. Paplomata,5 P. P. Howards3; 1 2 P-59 PERURETHRAL TRANSVESICAL ROUTE FOR Emory University, Atlanta, GA, Emory Reproductive Center, Atlanta, GA, OOCYTE RETRIEVAL: AN OLD TECHNIQUE 3 M. Khrouf, M. Epidemiology, Emory University, Atlanta, GA, FOR A NEW INDICATION. 4 Bouyahia, K. Berjeb, M. Braham, H. Elloumi, Pediatrics, Emory University, Atlanta, GA, 5 G. Merdassi, A. Zhioua, F. Zhioua; Obstetrics Oncology, Emory, Atlanta, GA. and Gynecology, ART center Aziza Othmana Hospital, Tunis, Tunisia. P-64 FERTILITY PRESERVATION (FP) DOES NOT ADVERSELY IMPACT LONG-TERM CANCER 1 2 P-60 NEOVAGINAL CONDYLOMATOSIS OUTCOMES. M. B. Moravek, A. K. Lawson, R. Confino,2 K. N. Smith,2 M. E. Pavone2; AND CARCINOMA FOLLOWING 1 D. A. Schirmer,1 University of Michigan, Ann Arbor, MI, MCINDOEVAGINOPLASTY. 2 A. N. Gordon,1 C. P. Roberts2; 1Department Northwestern University, Chicago, IL. of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA, P-65 HIGH DOSE RADIOIODINE THERAPY 2Reproductive Surgical Specialists, Northside AFFECTS OVARIAN RESERVE. F. Azem,1 Hospital, Atlanta, GA. I. Yaish,2 M. Cerebra,1 G. Shefer1; 1Sourasly Medical Center, Tel-Aviv, Israel, 2Institute of P-61 ONCOLOGY PROVIDERS’ Endocrinology, Sourasly Medical Center, Tel- RECOMMENDATIONS FOR THE Aviv, Israel. DEVELOPMENT OF A FERTILITY

nd 72 ASRM Scientific Congress & Expo 171 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-66 DO CANCER SURVIVORS WHO REPORT Gerais, Belo Horizonte, Brazil, 2Division of INFERTILITY MEET THEIR REPRODUCTIVE Human Reproduction, Universidade Federal GOALS? P. P. Howards,1 M. H. Jacobson,1 A. de Minas Gerais, Belo Horizonte, Brazil. Fothergill,1 L. M. Shandley,2 J. Spencer,3 A. 4 1 Mertens ; Epidemiology, Emory University, P-72 SUBJECTIVE AND OBJECTIVE EVALUATION Atlanta, GA, 2Emory University, Atlanta, GA, 3 OF A TEACHING HOSPITAL ONCOFERTILITY Emory Reproductive Center, Atlanta, GA, M. McEvoy, S. Molakatalla, M. 4 SERVICE. Pediatrics, Emory University, Atlanta, GA. Cheah; Flinders Fertility, Flinders Medical Centre, South Australia, Australia. P-67 CURRENT SUCCES AND EFFICIENCY OF AUTOLOGOUS OVARIAN TRANSPLANTATION P-73 A NOVEL PREDICTIVE MODEL OF THE WITH CRYOPRESERVED TISSUE: A META- PROBABILITY OF LIVE BIRTH WHEN USING ANALYSIS. F. S. Pacheco, K. H. Oktay; VITRIFIED HUMAN OOCYTES AS A MEANS OF Obstetrics & Gynecology, NY Medical College, FERTILITY PRESERVATION. A. L. Mauner,1 Valhalla, NY. E. Surrey,2 R. L. Gustofson,2 L. A. Kondapalli,2 W. B. Schoolcraft2; 1Embryology, Fertility P-68 COMPARISON OF GNRH AGONIST AND HCG Laboratories of Colorado, Lone Tree, CO, FOR PRIMING IN VITRO MATURATION (IVM) 2Colorado Center for Reproductive Medicine, CYCLES IN CANCER PATIENTS UNDERGOING Lone Tree, CO. URGENT FERTILITY PRESERVATION (FP). C. Sonigo,1 H. El Hachem,2 J. Benard,3 A. Benoit,1 N. Sermondade,4 M. Grynberg1; 1Reproductive Medicine, Hñpital Jean Verdier, Bondy, France, CRYOPRESERVATION AND FROZEN EMBRYO TRANSFER 2Obstetrics and Gynecology, University of Montreal, Montreal, QC, Canada, 3Hopital Jean Verdier, Bondy, France, 4Service Biologie P-74 THE OPTIMAL TIMING OF BLASTOCYST de la Reproduction - CECOS, Hopital Jean VITRIFICATION AFTER TROPHECTODERM Verdier, Bondy, France. BIOPSY OF PREIMPLANTATION GENETIC SCREENING. C. Lee,1,2 T. Lee,1,3 M. Lee1,3; 1Department of Obstetrics and Gynecology, P-69 WOMEN WITH OVARIAN FUNCTION AFTER Chung Shan Medical University Hospital, BREAST CANCER RECOVER HALF OF Taichung, Taiwan, 2Department of Obstetrics and THEIR ANTRAL FOLLICLE COUNT 1 YEAR Gynecology, National Taiwan University Hospital, AFTER EXPOSURE TO CYTOXAN-BASED Taipei, Taiwan, 3Institute of Medicine, Chung 1 2 CHEMOTHERAPY. J. Letourneau, K. A. Wald, Shan Medical University, Taichung, Taiwan. M. Quinn,1 E. Mok-Lin,1 M. Cedars,1 M. Rosen1; 1Obstetrics, Gynecology and Reproductive Sciences, University of California, San P-75 EFFECT OF COLONY-STIMULATING GROWTH Francisco, San Francisco, CA, 2OB/GYN, FACTOR ON OUTCOME OF FROZEN-THAWED University of Washington, Seattle, WA. EMBRYO TRANSFER IN PATIENTS WITH REPEATED IMPLANTATION FAILURE. D. Obidniak,1 A. Gzgzyan,2 L. Dzhemlikhanova,1 A. P-70 EVALUATION OF TESTIS SPERM EXTRACTION Feoktistov3; 1Medical Faculty, Saint-Petersburg (TESE) AND TESTIS HISTOLOGY IN THE State University, Saint-Petersburg, Russian GENDER CONFIRMING SURGERY PATIENT. Federation, 2Saint-Petersburg State University, 1 2 1 M. Lao, S. C. Honig ; Urology, University of Saint-Petersburg, Russian Federation, 3Medical Connecticut Health Center, Farmington, CT, Faculty, Medical Group “Mother and Child”, 2 Urology, Yale University, New Haven, CT. Saint-Petersburg, Russian Federation.

P-71 FERTILITY PRESERVATION WITH THE P-76 CRYO-INJURY OF HUMAN BLASTOCYSTS USE OF GNRH ANALOGUE IN WOMEN IN A CLOSED SYSTEM, RE-VITRIFICATION UNDERGOING CHEMOTHERAPY FOR MODEL: COMPARISON OF UNSTABLE AND LYMPHOMA: A SYSTEMATIC REVIEW AND METASTABLE SOLUTIONS. M. C. Schiewe, L. 1 1 META-ANALYSIS. R. L. Tavares, J. C. Senra, A. Gamboa, J. Borba, K. Waggoner, S. Zozula; 1 2 1 M. C. Talim, F. M. Reis ; Obstetrics and ART Lab, Ovation Fertility, Newport Beach, CA. Gynecology, Universidade Federal de Minas

nd 72 ASRM Scientific Congress & Expo 172 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-77 EFFECTS OF CYCLIC ADENOSINE VITRIFIED-WARMED CYCLES. T. Shavit,1 H. MONOPHOSPHATE MODULATORS ON S. Weibel,2 A. Hershko Klement,3 Y. Hasson,1 INTEGRITY AND MATURATION OF VITRIFIED- W. Son,4 W. Buckett2; 1McGill University- WARMED MOUSE GERMINAL VESICLE MUHC Reproductive Center, Montreal, QC, OOCYTES. J. Youm,1,2 H. Lee,1 S. Kim,1,2 J. Canada, 2McGill University, Montreal, QC, Lee,1,2 B. Jee,1,2 C. Suh,1,2 S. Kim,2 S. Kim3; Canada, 3Physician, Kiryat Ono, Israel, 4MUHC 1Department of Obstetrics and Gynecology, Reproductive Center, Monteral, QC, Canada. Seoul National University Bundang Hospital, Seongnam-si, Korea, Republic of, 2 P-83 RE-EXPANSION OF WARMED VITRIFIED Department of Obstetrics and Gynecology, BLASTOCYSTS BEFORE EMBRYO TRANSFER; Seoul National University College of Medicine, N. Esfandiari,1 3 ARE WE TOO CONCERNED? Seoul, Korea, Republic of, Center for Fertility D. B. Dela Cruz,2 K. Rao,3 R. Casper4; 1OB-Gyn and Reproduction, American-Sino Women’s and Pathology, Dartmouth Hitchcock Medical and Children’s Hospital, Kansas City, KS. Center, Lebanon, NH, 2Human Embryology and Andrology Laboratory, Embryologist, P-78 REDUCED DEVELOPMENTAL EFFICIENCY Hanover, NH, 3IVF, Embryologist, Toronto, ON, OF VITRIFIED DONOR OOCYTES (DOS) Canada, 4Professor, University of Toronto, IS EXPLAINED BY WIDE VARIATION IN Toronto, ON, Canada. FERTILIZATION SUCCESS. S. J. Morin,1 T. A. Molinaro,2 J. M. Franasiak,1 C. R. Juneau,1 1 1 P-84 FROZEN EMBRYO TRANSFER (FET) R. T. Scott Jr. ; Reproductive Medicine OUTCOMES FROM DAY 4 EUPLOID Associates of New Jersey, Basking Ridge, NJ, M. E. Thompson,1 M. P. 2 BLASTOCYSTS. Reproductive Medicine Associates of New Portmann,1 B. Scott,1 M. Kelly,2 M. J. Tucker,3 Jersey, Eatontown, NJ. I. Sasson,1 M. Avella1; 1Shady Grove Fertility of PA, Wayne, PA, 2Society Hill Reproductive P-79 FRESH VS FROZEN EMBRYO TRANSFER Medicine, Philadelphia, PA, 3IVF, Shady Grove IN FROZEN DONOR EGG IVF AND Fertility, Rockville, MD. PREIMPLANTATION GENETIC SCREENING CYCLES. J. Shah,1 C. Huang,1 A. Vigil,1 C. Barr,2 3 3 3 P-85 LIVE BIRTH FROM IN-VITRO MATURED, S. K. Nurudeen, W. Wei-Hua, M. Abdallah ; C. 1 VITRIFIED AND WARMED OOCYTES. UT-Houston/Memorial Hermann, Houston, Chang,1,2 T. A. Elliott,1,2 J. Linn,1,2 A. A. Toledo,1,2 2 TX, University of Houston, Houston, TX, D. Shapiro,1,2 Z. P. Nagy1,2; 1Reproductive 3 Houston Fertility Institute, Houston, TX. Biology Associates, Atlanta, GA, 2My Egg Bank. com, Atlanta, GA. P-80 LASER COLLAPSE OF BLASTOCYSTS PRIOR TO VITRIFICATION LEADS TO LOWER P-86 SURPLUS FROZEN EMBRYOS. WHAT SPONTANEOUS ABORTION RATES. N. J. PATIENTS DECIDE ABOUT THEM? J. Molina,1 George, R. Halverson, C. R. McCann, C. Hibray, M. Riqueros,1 M. Florensa,2 A. Ballesteros G. Letterie, G. Ball; Seattle Reproductive Boluda,3 M. Esbert1; 1IVF Laboratory, IVI Medicine, Seattle, WA. Barcelona, Barcelona, Spain, 2IVF laboratory, IVF Director, Barcelona, Spain, 3IVI Barcelona, P-81 GNRH AGONIST VERSUS HUMAN CHORIONIC Barcelona, Spain. GONADOTROPIN FOR TRIGGERING OVULATION IN ANTAGONIST CYCLES: A P-87 A NOVEL HIERARCHICAL CLASSIFICATION RANDOMIZED CONTROLLED TRIAL. M. I. METHOD BASED ON MORPHOLOGY DYNAMICS Mostafa,1 E. A. Elgindy,2 H. Sibai,2 E. Darwish,3 3 1 OF VITRIFIED-WARMED BLASTOCYSTS TO H. Maghraby ; Ob/Gyn, Cairo University, A. 2 FORECAST IMPLANTATION POTENTIAL. Cairo, Egypt, Ob/Gyn, Zagazig University, Coello, A. Cobo, A. Galan, L. Alegre, M. Nohales, 3 Zagazig, Egypt, Ob/Gyn, Alexandria M. Meseguer; IVI, Valencia, Spain. University, Alexandria, Egypt.

P-88 SUCCESSFUL VITRIFICATION OF HUMAN P-82 BLASTOCYST EXPANSION SCORE MAY EMBRYOS USING EQUILIBRATION PREDICT SUCCESSFUL PREGNANCY AND SOLUTION. O. Bern,1 Y. Natan,2 R. Ron-El,1 A. LIVE BIRTH RATE IN SINGLE BLASTOCYST

nd 72 ASRM Scientific Congress & Expo 173 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Arav2; 1IVF, Assaf Harofeh, Yaacov, Israel, P-95 FREEZE-ALL POLICY IN POOR RESPONDERS. 2FertileSafe Ltd., Ness Ziona, Israel. M. Roque,1 M. Valle,1 F. Guimaraes,2 A. Kostolias,1 M. Sampaio,3 S. Geber3; 1 P-89 TIME FROM EGG RETRIEVAL TO FIRST Reproductive Medicine, ORIGEN - Center for EMBRYO TRANSFER DOES NOT AFFECT Reproductive Medicine, Rio de Janeiro, Brazil, 2ORIGEN - Center for Reproductive Medicine, LIVE BIRTH RATES IN A FREEZE-ALL 3 STRATEGY. K. Lattes,1 R. Vassena,2 D. Rio de Janeiro, Brazil, Reproductive Garcia,3 M. Brassesco,1 V. Vernaeve4; 1Centro Medicine, ORIGEN - Center for Reproductive de Infertilidad y Reproducciðn Humana, Medicine, Belo Horizonte, Brazil. Barcelona, Spain, 2Clinica EUGIN, Barcelona, Spain, 3Fundacio Privada EUGIN, Barcelona, P-96 LIVE BIRTH RATE AFTER FRESH OR FROZEN- Spain, 4Eugin, Barcelona, Spain. THAWED EMBRYO TRANSFERS IN RELATION TO MATERNAL AGE: A RETROSPECTIVE P-90 PROGNOSIS OF SLOW GROWING HUMAN COCHORT STUDY OF 13426 CYCLES. X. Li, EMBRYOS IN PRONUCLEAR STAGE FROZEN- R. Huang, C. Fang, Y. Wang, X. Liang; Sixth THAW EMBRYO TRANSFER CASES. M. Affiliated Hospital of Sun Yat-sen University, Thakur,1 A. O. Awonuga,1 H. Kohan-Ghadr,2 L. R. Guangzhou, China. Hoyos,2 E. E. Puscheck,1 N. J. Joshi3; 1Division of Reproductive Endocrinology, Department P-97 BANKING OFFERS POOR of Obstetrics and Gynecology, Wayne State PROGNOSIS PATIENTS HIGH IMPLANTATION University School of Medicine, Detroit, MI, AND CLINCAL PREGNANY RATES. A. E. 2Department of Obstetrics and Gynecology, Batcheller,1 W. B. Schoolcraft,2 M. Katz-Jaffe3; Wayne State University School of Medicine, 1CCRM Minneapolis, Edina, MN, 2Medical Detroit, MI, 3ART laboratory Director, Wayne Director, Colorado Center for Reproductive State University Physician Group, Detroit, MI. Medicine, Lone Tree, CO, 3Colorado Center for Reproductive Medicine, Lone Tree, CO. P-91 IMPACT OF DIFFERENT VITRIFICATION DEVICES ON OOCYTE DNA INTEGRITY IN P-98 CLINICAL OUTCOME OF TWO POPULAR OOCYTES. H. L. Feng, T. Tsai; Ob/Gyn, New VITRIFICATION DEVICES FOR HUMAN York -Presbyterian Health System Queens, IVF. T. Tsai, H. L. Feng; Ob/Gyn, New York Cornell University, New York, NY. Presbyterian Health System Queens, Cornell University, New York, NY. P-92 Abstract withdrawn P-99 MOTHER DOESN’T ALWAYS KNOW BEST: P-93 THE EFFECT OF ASSISTED HATCHING ON EMBRYOS DERIVED FROM CYROPRESERVED FROZEN EMBRYO TRANSFER LIVE BIRTH OOCYTES EXHIBIT DEVELOPMENTAL DELAY J. Knudtson,1 PRIOR TO ZYGOTIC TRANSITION. A. K. RATE AND CLINIC TRENDS. 1 2 3 C. Failor,1 J. Gelfond,2 T. A. Chang,1 R. S. Masbou, S. Druckenmiller, D. H. McCulloh, 4 5 2 1 Schenken,1 R. D. Robinson1; 1Obstetrics C. McCaffrey, K. N. Goldman, N. Noyes ; NYU 2 and Gynecology, University of Texas Health Fertility Center, New York, NY, NYU School 3 Science Center San Antonio, San Antonio, TX, of Medicine, New York, NY, Obstetrics and 2Epidemiology and Biostatistics, University of Gynecology, New York University Fertility 4 Texas Health Science Center San Antonio, San Center, New York, NY, OB/Gyn, New York Antonio, TX. University Fertility Center, New York, NY, 5Obstetrics and Gynecology, New York University, New York, NY. P-94 VITRIFIED/WARMED DONOR OOCYTES: IS 8 BETTER THAN 6? S. L. Fisher,1 N. Klein,2 A. R. Criniti,3 T. E. Fisher,4 G. Ball5; 1Embryology, P-100 OPTIMAL PARAMETERS FOR DETERMINING Seattle Reproductive Medicine, Seattle, WA, THE LH SURGE IN NATURAL CYCLEFROZEN- 1 23Seattle Reproductive Medicine, Seattle, THAWED EMBRYO TRANSFERS. M. Irani, 2 3 4 WA, 4SRM Spokane, Spokane Valley, WA, 5IVF A. Robles, V. Gunnala, D. E. Reichman, Z. 5 1 Laboratory, Seattle Reproductive Medicine, Rosenwaks ; Reproductive Endocrinology Seattle, WA. and Infertility, Weill Cornell Medicine, New York, NY, 2Obstetrics and Gynecology, Weill

nd 72 ASRM Scientific Congress & Expo 174 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Cornell Medicine, New York, NY, 3OB/GYN, P-105 IS THERE AN INCREASE IN ANEUPLOIDY REI Fellow, New York, NY, 4Cornell, New RATE WITH DELAYED BLASTULATION, York, NY, 5Weill Cornell Medicine - Center for MULTINUCLEATION OR CLEAVAGE Reproductive Medicine, New York, NY. ANOMALIES? N. Desai,1 P. Rambhia2; 1OB- GYN/Women’s Health Institute, Cleveland 2 P-101 THE SIGNIFICANT EFFECT OF Clinic, Beachwood, OH, Case Western CRYOPRESERVATION IN FRESH IN VITRO Reserve School of Medicine, Case University, FERTILIZATION (FRESH) AND PREVIOUSLY- Cleveland, OH. CRYOPRESERVED OOCYTE THAW CYCLES (OOT) IS APPARENT EARLY AND UNRELATED P-106 DAY 7 BLASTOCYST EUPLOIDY AND TO PLOIDY. A. K. Masbou,1 D. H. McCulloh,2 IMPLANTATION RATES WARRANT M. Black,3 N. Noyes,4 J. Grifo5; 1NYU Fertility IMPLENTATION FOR ALL PROGRAMS USING Center, New York, NY, 2Obstetrics and PREIMPLANTATION GENETIC SCREENING Gynecology, New York University Fertility (PGS). J. B. Whitney,1 R. E. Anderson,2 M. C. Center, New York, NY, 3NYU Langone School Schiewe1; 1Research Division, Ovation Fertility, of Medicine, New York, NY, 4NYU School Newport Beach, CA, 2SCCRM, Southern of Medicine, New York, NY, 5NYU Langone California Center for Reproductive Medicine, Medical Center, New York, NY. Newport Beach, CA.

P-107 SINGLE BLASTOCYST TRANSFER: DOES PGS IMPROVE OUTCOME? COMPARISON PREIMPLANTATION GENETIC TESTING OF SINGLE THAWED EUPLOID EMBRYO TRANSFERS (STEET) WITH FRESH (FSET) P-102 HIGH VARIABILITY IN CHROMOSOME AND FROZEN (ZSET) MORPHOLOGY- ABNORMALITY RATES IN EMBRYOS FROM BASED SINGLE EMBRYO TRANSFERS IN YOUNG INFERTILE WOMEN. S. S. Sawarkar,1 GOOD PROGNOSIS PATIENTS (GPP). S. J. Zhang,2 D. L. Hill,3 J. S. Hesla,4 A. Coates,4 Druckenmiller, N. Noyes, D. H. McCulloh, J. L. Ribustello,5 S. Ghadir,6 S. Munne5; Grifo; NYU Fertility Center, New York, NY. 1Research, Reprogenetics, Livingston, NJ, 2New Hope Fertility Center, New York, P-108 THE TIMING OF ONSET OF MOSAICISM IN NY, 3ART Reproductive Center, Beverly HUMAN BLASTOCYSTS IMPACTS THE UTILITY Hills, CA, 4Oregon Reproductive Medicine, OF NEXT GENERATION SEQUENCING (NGS). Portland, OR, 5Reprogenetics, Livingston, NJ, G. Garrisi,1 R. H. Walmsley,2 K. Bauckman,3 6Southern California Reproductive Center, C. Dela Cerna,1 P. Colls,4 S. Munne4; 1Institute Beverly Hills, CA. for Reproductive Medicine and Science at Saint Barnabas, Livingston, NJ, 2IRMS at Saint 3 P-103 ELEVATED MITOCHONDRIAL DNA IN Barnabas, Livingston, NJ, Reprogenetics, 4 EMBRYOS REFLECTS ANEUPLOIDY AND Highland Park, IL, Reprogenetics, Livingston, NJ. CORRELATES WITH DEVELOPMENTAL ARREST. J. R. Ho,1 N. Arrach,2 W. Salem,1 P-109 PGS PREGNANCY OUTCOME FOR DAY 5 AND S. Ingles,1 K. Bendikson,1 K. Chung,1 R. DAY 6 TRANSFERS. A. R. Anderson, D. Taylor, Paulson,1 A. Ahmady1; 1University of Southern K. C. Chiles, A. S. Browne, U. Balthazar, F. California, Los Angeles, CA, 2Progenesis Inc, La Arredondo; Reproductive Medicine Associates Jolla, CA. of Texas, San Antonio, TX.

P-104 EMBRYONIC CELL FREE DNA (CFDNA) P-110 CORRECTION FACTOR REVEALS UNIFORM AS A TOOL FOR NON-INVASIVE LEVELS OF MITOCHONDRIAL DNA IN HUMAN PREIMPLANTATION GENETIC SCREENING BLASTOCYSTS IRRESPECTIVE OF PLOIDY, AND DIAGNOSIS. M. Surdo,1 A. Biricik,1 AGE, OR IMPLANTATION POTENTIAL. M. S. Bono,1 M. Minasi,2 E. Cursio,2 E. Greco,2 Viotti, A. R. Victor, A. J. Brake, C. G. Zouves, F. L. E. Cotroneo,1 F. Fiorentino,1 F. Spinella1; Barnes; Zouves Fertility Center, Foster City, CA. 1Genoma Group, Rome, Italy, 2Centre for Reproductive Medicine European Hospital,

Rome, Italy.

nd 72 ASRM Scientific Congress & Expo 175 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-111 ANEUPLOIDY RATES DO NOT DIFFER P-116 EVOLUTION OF CHROMOSOMAL BETWEEN BLASTOCYSTS BIOPSIED ON DAY ABNORMALITIES FROM CONCEPTION TO 5 (D5) VERSUS DAY 6 (D6). C. M. Owen,1 L. A. PREGNANCY LOSS: A COMPARATIVE STUDY Bishop,2 K. Koniares,3 M. W. Healy,1 N. Banks,1 OF PGS AND MISCARRIAGE SAMPLES. K. S. Richter,2 K. Devine,4 A. DeCherney,1 M. J. M. N. Strecker,1 T. Sahoo,1 N. Dzidic,1 S. Hill,1 J. Doyle2; 1PRAE, NICHD, NIH, Bethesda, Commander,2 T. H. Taylor,1 K. Hovanes1; MD, 2Shady Grove Fertility Reproductive 1CombiMatrix, Irvine, CA, 2Genetic Counseling Science Center, Rockville, MD, 3Georgetown Services, CombiMatrix, Irvine, CA. University School of Medicine, Washington, 4 DC, Shady Grove Fertility Reproductive P-117 STRATEGIES FOR ASSESSING FEASIBILITY OF Science Center, Washington, DC. PREIMPLANTATION GENETIC DIAGNOSIS FOR VARIANTS OF UNCERTAIN SIGNIFICANCE. P-112 THE DEGREE TO WHICH PGS INCREASES S. I. Maithripala,1 D. Shah,1 A. S. Machaj,2 A. IVF EFFICIENCY IS CORRELATED WITH Kuliev,1 S. Rechitsky1; 1Reproductive Genetic INCREASED MATERNAL AGE. L. Sekhon,1,2 Innovations, Northbrook, IL, 2Genetic T. G. Nazem,1,2 A. Zgodic,3 K. Hunter Cohn,3 Counselor, Northbrook, IL. H. Wu,4 L. Grunfeld,1,2 P. Yurttas Beim,3 A. 1,2 1 B. Copperman ; Reproductive Medicine P-118 THE HIGH RATE OF ABNORMAL EMBRYOS Associates of New York, New York, NY, 2 IN DONOR CYCLES IS REFLECTED IN DONOR Obstetrics, Gynecology & Reproductive OOCYTE PREGNANCY OUTCOMES. N. M. Science, Icahn School of Medicine at Mount Sachdev,1 S. M. Maxwell,2 L. Ribustello,3 E. 3 Sinai, New York, NY, Celmatix Inc, New Liu,3 D. H. McCulloh,1 S. Munne,3 J. Grifo4; 4 York, NY, Analytics Team, Celmatix Inc., 1Obstetrics and Gynecology, New York New York, NY. University Fertility Center, New York, NY, 2OB/ GYN, New York University Fertility Center, New P-113 IMPACT OF OVARIAN RESERVE ON PGD. M. York, NY, 3Reprogenetics, Livingston, NJ, 4NYU Cetinkaya, C. Pirkevi Cetinkaya, S. Kahraman; Langone Medical Center, NY, NY. Assisted Reproductive Technologies and Reproductive Genetics Center, Istanbul P-119 IMPACT OF 24-CHROMOSOME ANEUPLOIDY Memorial Hospital, Istanbul, Turkey. TESTING ON THE OUTCOME OF PGD FOR SINGLE GENE DISORDERS. S. Rechitsky,1 T. P-114 HIGHLY SUCCESSFUL PREIMPLANTATION Pakhalchuk,1 M. Prokhorovich,1 G. San Ramon,1 GENETIC DIAGNOSIS FOR INDIVIDUALS Z. Zlatopolsky,2 A. Kuliev3; 1Preimplanatation WITH DE NOVO MUTATIONS. K. McWilliams, Molecular Genetics, Reproductive Genetic T. K. McWilliams, J. Kitchen, M. Hughes; Innovations, Northbrook, IL, 2Cytogenetics, Genesis Genetics, Plymouth, MI. Reproductive Genetic Innovations, Northbrook, IL, 3Research, Reproductive P-115 OUTCOMES FROM 9822 ARRAY Genetic Innovations, Northbrook, IL. COMPARATIVE GENOMIC HYBRIDIZATION (ACGH) CYCLES FOR PREIMPLANTATION P-120 DISCORDANCE AMONG SERIAL BIOPSIES GENETIC SCREENING (PGS). A. Jordan,1 OF MOSAIC EMBRYOS. G. Garrisi,1 R. H. H. Nisson,1 P. Colls,1 H. Danzer,2 J. Barritt,3 Walmsley,1 K. Bauckman,2 R. J. Mendola,1 P. E. Mounts,4 J. J. Zhang,5 A. Becker,6 C. Colls,3 S. Munne3; 1Institute for Reproductive Wagner Coughlin,7 L. B. Werlin,8 S. Munne1; Medicine and Science at Saint Barnabas, 1Reprogenetics, Livingston, NJ, 2Southern Livingston, NJ, 2Reprogenetics, Highland Park, California Reproductive Center, Beverly Hills, IL, 3Reprogenetics, Livingston, NJ. CA, 3ART Reproductive Center, Beverly Hills, 4 CA, Oregon Reproductive Medicine, Portland, P-121 TIME-LAPSE IMAGING OF MULTINUCLEATED OR, 5New Hope Fertility Center, New York, NY, 6 EMBRYOS AND THE ASSOCIATION Embryology, New Hope Fertility Center, New WITH ANEUPLOIDY DETERMINED BY York, NY, 7Aparent IVF Laboratory, Highland 8 PREIMPLANTATION GENETIC SCREENING. Park, IL, Medical Director, Coastal Fertility L. R. Goodman, J. M. Goldberg, T. Falcone, N. Medical Center, Irvine, CA. Desai; Women’s Health Institute, Cleveland Clinic, Cleveland, OH.

nd 72 ASRM Scientific Congress & Expo 176 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-122 ACCURATE DETECTION OF SEGMENTAL NJ, 2Reproductive Medicine Associates of New ANEUPLOIDY IN PREIMPLANTATION Jersey, Basking Ridge, NJ. GENETIC SCREENING USING TARGETED NEXT-GENERATION DNA SEQUENCING. M. P-129 ASSOSIATION BETWEEN HIGH A. Umbarger, K. Germain, A. Gore, B. Breton, GONADOTROPIN DOSAGE, EUPLOIDY AND L. C. Walters-Sen, T. Mullen, N. Faulkner; Good PREGNANCY RATES IN PGT CYCLES. O. Start Genetics, Cambridge, MA. Barash, K. Ivani, L. Weckstein, S. Willman, E. Rosenbluth, D. Wachs, M. Hinckley; P-123 SEGMENTAL ANEUPLOIDY IN Reproductive Science Center of the San PREIMPLANTATION GENETIC SCREENING Francisco Bay Area, San Ramon, CA. STRATIFIED BY AGE AND CLINICAL INDICATION USING TARGETED NEXT- P-130 THE INCIDENCE OF DELETIONS AND GENERATION DNA SEQUENCING. N. DUPLICATIONS IN PREIMPLANTATION Faulkner, L. C. Walters-Sen, B. Breton, A. Gore, EMBRYOS AS DETERMINED BY ENHANCED M. Zhu, K. Robinson, S. E. Hallam; Good Start NEXT GENERATION SEQUENCING. P. Genetics, Cambridge, MA. R. Brezina,1 K. Tobler,2 R. A. Kaufmann,3 R. Ross,4 A. K. Dubey,5 W. G. Kearns6; P-124 MISCARRIAGE AND ANEUPLOIDY RATES 1Reproductive Endocrinology and Infertility, ARE HIGHER IN VERY YOUNG DONORS. J. Vanderbilt University School of Medicine, LLACER, J. Guerrero, B. Lledo, J. Ortiz, J. Ten, Memphis, TN, 2Reproductive Endocrinology R. Bernabeu; Reproductive Medicine, Instituto and Infertility, Womack Army Med Ctr Bernabeu, Alicante, Spain. Obstetrics and Gynecology, Fort Bragg, NC, 3Reproductive Endocrinology and Infertility, Fort Worth Fertility, Fort Worth, TX, 4Fort P-125 THE INTERCHROMOSOMAL EFFECT IN 5 EMBRYOS DERIVED FROM BALANCED Worth Fertility, Fort Worth, TX, AdvaGenix and NorthCarolina IVF Labs, Fayetteville, CHROMOSOMAL REARRANGEMENT CARRIERS. 6 J. Kim,1 Y. Hur,1 H. Lee,1 J. Kim,1 W. Lee,1 S. Shim2; NC, AdvaGenix and Johns Hopkins Medical 1Obstetrics and Gynecology, Fertility Center, CHA Institutions, Rockville, MD. Gangnam Medical Center, CHA University, Seoul, Korea, Republic of, 2Genetics Laboratory, Fertility P-131 THE ASSOCIATION BETWEEN Center, CHA Gangnam Medical Center, CHA MITOCHONDRIAL DNA CONTENT AND University, Seoul, Korea, Republic of. IMPLANTATION POTENTIAL DURING IVF AND PREIMPLANTATION GENETIC 1 P-126 IMPROVING EUPLOIDY RATES IN PATIENTS SCREENING CYCLES. A. K. Dubey, K. J. Tobler,2 N. Massahi,3 J. Crochet,4 W. G. UNDERGOING PREIMPLANTATION GENETIC 3 4 1 S. Dogan,1 E. Slutsky,2 M. Kearns, V. Schnell ; NorthCarolina IVF labs, SCREENING (PGS). 2 Urich,1 J. W. Ayers,3 I. Khan,1 A. Hammoud,1 Fayetteville, NC, Obstetrics and Gynecology, F. Li,1 F. N. Shamma1; 1IVF Michigan Fertility Womack Army Medical Center, Fayetteville, 3 4 Center, Bloomfield Hills, MI, 2Dept.of NC, Advagenix, Rockville, MD, Center of Obstetrics Gynecology, Toledo, OH, 3IVF Reproductive Medicine, Webster, TX. Michigan, Ypsilanti, MI. P-132 PREGNANCY AND SPONTANEOUS P-127 MOSAICISM DETECTION BY QPCR VERSUS ABORTION RATES FOLLOWING PGD FOR NGS BASED CCS. N. R. Treff,1 D. Goodrich,1 X. TRANSLOCATIONS COMBINED WITH Tao,2 Y. Zhan,2 R. T. Scott Jr.1; 1RMANJ, Rutgers- 24-CHROMOSOME ANEUPLOIDY TESTING. RWJ, Basking Ridge, NJ, 2The Foundation for A. Kuliev, Z. Zlatopolsky, G. San Ramon, S. Embryonic Competence, Basking Ridge, NJ. Rechitsky; Reproductive Genetic Innovations, Northbrook, IL.

P-128 PROSPECTIVE RANDOMIZED AND BLINDED COMPARISON OF NGS CCS PLATFORMS. R. P-133 THE TIMING OF CYTOKINESIS IN EMBRYOS S. Zimmerman,1 N. Treff,2 Y. Zhan,1 X. Tao,1 R. T. WITH PATERNALLY OR MATERNALLY Scott III,1 K. Scott,1 R. T. Scott Jr.2; 1Foundation DERIVED CHROMOSOMAL ABNORMALITY for Embryonic Competence, Basking Ridge, USING TIME-LAPSE SYSTEM. M. J. Ryu, S. Bark, J. Kim, M. J. You, H. S. Kim, M. H. Kim,

nd 72 ASRM Scientific Congress & Expo 177 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

H. J. Jeong, M. Chung; Seoul Rachel Fertility New York, NY, 4Obstetrics and Gynecology, Center, Seoul, Korea, Republic of. Reproductive Endocrinology, Philadelphia, PA, 5Gynecology and Obstetrics, IRMS at Saint 6 P-134 NON-INVASIVE CHROMOSOME SCREENING OF Barnabas, Livingston, NJ, REI, University of HUMAN EMBRYOS BY GENOME SEQUENCING Connecticut, Farmington, CT. FROM BLASTOCYST CULTURE MEDIUM: VALIDATION & A PILOT STUDY. S. Lu,1 L. P-139 PREIMPLANTATION GENETIC DIAGNOSIS Cai,2 B. Yao,2 X. Xie3; 1Yikon Genomcis Co., Ltd., OF RECIPROCAL TRANSLOCATIONS USING Shanghai, China, 2The Reproductive Medical POLAR BODIES - FIRST VALIDATION Center of Nanjing Jinling Hospital, Nanjing, USING A NEXT-GENERATION SEQUENCING China, 3Harvard University, Cambridge, MA. PLATFORM. S. M. Taylor,1 S. Knebel,2 S. Alfarawati,1 E. Fragouli,1 D. Wells,3 K. R. Held2; 1 P-135 SELECTION OF SINGLE BLASTOCYSTS FOR Reprogenetics UK, Oxford, United Kingdom, 2Reprogenetics Germany GmbH, Hamburg, TRANSFER VIA TIME-LAPSE MONITORING 3 ALONE AND WITH NEXT-GENERATION Germany, Reprogenetics, Oxford, United SEQUENCING TO REDUCE MULTIPLE Kingdom. PREGNANCIES: A RANDOMIZED PILOT STUDY. Z. Yang,1 J. Lin,2 S. Zhang,3 Y. Kuang,4 P-140 TRANSLOCATIONS AND SEX-DOES SIZE J. Liu5; 1Clinical Research, ZytoGen, Timonium, MATTER? T. Escudero,1 E. M. Armenti,1 A. MD, 2ART, Reproductive Fertility Center, Irvine, S. Berkeley,2 J. M. Norian,3 D. Shapiro,4 S. J. CA, 3ART, Sir Run Run Shaw Hospital, Zhe Jiang Chantilis,5 C. Racowsky,6 L. Ribustello,1 E. Liu1; University School of Medicine, Hangzhou, 1Reprogenetics, Livingston, NJ, 2NYU Fertility China, 4ART, Ninth People’s Hospital, Shanghai Center, NYU School of Medicine, New York, NY, Jiao Tong University School of Medicine, 3HRC Fertility, Pasadena, CA, 4RBA, Atlanta, Shanghai, China, 5ART, Jiaen Deyun Hospital, GA, 5Dallas-Fort Worth Fertility Associates, Beijing, China. Dallas, TX, 6Brigham and Women’s Hospital ART Center, Boston, MA. P-136 THE RATE OF MOSAIC EMBRYOS FROM DONOR EGG AS DETECTED BY NEXT P-141 Abstract withdrawn GENERATION SEQUENCING (NGS) VARIES 1 BY IVF LABORATORY. N. M. Sachdev, L. P-142 TRIPLOIDY - A CRITICAL YET Ribustello,2 E. Liu,2 D. H. McCulloh,1 J. Grifo,3 2 1 UNDERDIAGNOSED EMBRYO S. Munne ; Obstetrics and Gynecology, New ABNORMALITY: REVIEW OF DATA FROM York University Fertility Center, New York, NY, 2 3 PREIMPLANTATION GENETIC SCREENING Reprogenetics, Livingston, NJ, NYU Fertility VIA SINGLE NUCLEOTIDE POLYMORPHISM Center, New York, NY. MICROARRAYS WITH BIOINFORMATICS. K. J. Doody,1 K. Merrion,2 M. K. Maisenbacher,2 P-137 DISCORDANCE RATES BETWEEN DAY 3 D. Kijacic,2 M. Kiehl2; 1Center for Assisted AND DAY 6 CHROMOSOME RESULTS AND Reproduction, Bedford, TX, 2Natera, Inc., San THE PREDICTIVE VALUE OF TIME-LAPSE Carlos, CA. MORPHOKINETICS. J. R. Ho,1 N. Arrach,2 W. Salem,1 S. A. Ingles,1 K. Bendikson,1 K. 1 1 1 1 P-143 HOW OFTEN DO PATIENTS UNDERGOING IVF- Chung, R. Paulson, A. Ahmady ; University PGS FOR ACTUALLY HAVE of Southern California, Los Angeles, CA, J. Kort,1 R. C. McCoy,2 Z. Demko,3 2 A CHOICE? Genetics, Progenesis, La Jolla, CA. R. Lathi1; 1Reproductive Endocrinology and Infertility, Stanford University, Stanford, CA, P-138 KARYOMAPPING: THE GOLD STANDARD FOR 2Genome Sciences, University of Washington, PREIMPLANTATION GENETIC DIAGNOSIS. Seattle, WA, 3Natera, Inc., San Carlos, CA. K. M. Doyle,1 R. Prates,2 C. Stimach,1 F. 3 4 5 Licciardi, A. Dokras, S. H. Chen, T. K. CHROMOSOME 9 OPEN READING 1 6 1 P-144 ALS/FTD McWilliams, C. A. Benadiva, J. Kitchen, M. FRAME 72 EXPANSION (C9ORF72-EXP) Konstantinidis2; 1Genesis Genetics, Plymouth, 2 3 PREIMPLANTATION GENETIC DIAGNOSIS MI, Reprogenetics, Livingston, NJ, OBGYN, (PGD) AND DISEASE-SPECIFIC HUMAN New York University Langone Medical Center,

nd 72 ASRM Scientific Congress & Expo 178 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

EMBRYONIC STEM CELL (DS-HESC) (PGS). H. Lee, D. H. McCulloh, E. Macanas, DERIVATION: A FAMILY’S WIN/WIN AND C. McCaffrey, J. Grifo; OB/GYN, New York CONTRIBUTION TO SCIENCE. G. D. Smith,1 University Fertility Center, New York, NY. L. Keller,1 A. Dorfmann,2 K. Tran,2 H. Stern,2 B. Mariani2; 1Ob/Gyn, University of Michigan, Ann 2 P-151 MISCARRIAGE RATE COMPARISON OF Arbor, MI, Genetics & IVF Institute, Fairfax, VA. PGS CYCLES PERFORMED WITH ARRAY COMPARATIVE GENOME HYBRIDIZATION P-145 HEALTHY BABY AFTER INTRAUTERINE (ACGH) AND NEXT GENERATION TRANSFER OF MONOSOMIC EMBRYOS. P. SEQUENCING (NGS). H. Nisson,1 R. Kiltz,2 N. Rubino, L. Dearden, L. Guan, R. Ruiz De Assin, K. Cekleniak,3 J. J. Zhang,4 M. Surrey,5 A. Jordan,1 Mazmanian, B. A. Kolb, J. Nelson, J. M. Norian, J. S. Munne1; 1Reprogenetics, Livingston, NJ, Wilcox, T. Tan; HRCFertility, Pasadena, CA. 2CNY Fertility, Syracuse, NY, 3IRMS at Saint Barnabas, Livingston, NJ, 4New Hope Fertility 5 P-146 DIAGNOSTIC AND CLINICAL OUTCOMES OF Center, New York, NY, Southern California 694 CYCLES USING KARYOMAPPING FOR Reproductive Center, Beverly Hills, CA. PREIMPLANTATION GENETIC DIAGNOSIS (PGD) OF SINGLE GENE DISORDERS. D. P-152 PLOIDY OUTCOMES FOR DAY5 AND Goldberg-Strassler,1 R. Cabey,1 A. Jordan,1 R. 6 BLASTOCYSTS ANALYZED BY NEXT Prates,2 E. Mounts,3 e. barbieri,3 A. Hershlag,4 GENERATION SEQUENCING FOR M. Guarnaccia,5 M. Surrey,6 S. Munne1; PREIMPLANTATION GENETIC SCREENING. 1Reprogenetics, Livingston, NJ, 2Molecular, K. J. Tobler,1 N. Massahi,2 R. Kaufmann,3 P. R. Reprogenetics, Livingston, FL, 3Oregon Brezina,4 A. K. Dubey,5 W. G. Kearns2; 1Obstetrics Reproductive Medicine, Portland, OR, 4Hofstra and Gynecology, Womack Army Medical Center, Northwell School of Medicine, Manhasset, NY, Fayetteville, NC, 2Advagenix, Rockville, MD, 3Fort 5REI, Columbia University, NY, NY, 6Southern Worth Fertility, Fort Worth, TX, 4Reproductive California Reproductive Center, Beverly Hills, CA. Endocrinology and Infertility, Vanderbilt University School of Medicine, Memphis, TN, 5 P-147 VALIDATION OF DETECTING MONOGENETIC North Carolina IVF Labs, Fayetteville, NC. DISEASES & ANEUPLOIDY SIMULTANEOUSLY BY NEXT GENERATION SEQUENCING WITH P-153 CHROMOSOMAL CONSTITUTION AND LINKAGE ANALYSIS. S. Lu,1 J. Qiao,2 X. Xie3; MORPHOKINETICS OF ARRESTED AND 1Yikon Genomics Co., Ltd., Shanghai, China, NON-VIABLE EMBRYOS. K. Sorby,1,2 E. 2Department of Obstetrics and Gynecology, Dimitriadis,1 T. Osianlis3; 1Hudson Institute of Third Hospital, Peking University, Beijing, Medical Research, Clayton, Australia, 2Monash China, 3Harvard University, Cambridge, MA. University, Clayton, Australia, 3Ritchie Centre, Monash University, Melbourne, Australia. P-148 CLINICAL EXPERIENCE WITH A TARGETED NGS-BASED PREIMPLANTATION GENETIC P-154 INTRACYTOPLASMIC MORPHOLOGICALLY SCREENING ASSAY. N. Faulkner, L. Walters- SELECTED SPERM INJECTION (IMSI) DOES Sen, D. Neitzel, B. Breton, S. Hallam; Good NOT IMPROVE CLINICAL OUTCOMES Start Genetics, Cambridge, MA. AND EMBRYO PLOIDY IN ASSISTED REPRODUCTIVE CYCLES. L. Keskintepe,1 Z. 2 3 3 2 P-149 SUB-OPTIMAL OVARIAN RESPONDERS Beyhan, M. Dayal, J. Hart, M. Keskintepe ; 1SIRM/Integramed Management, Las Vegas, NV, HAVE AN INCREASED EMBRYO ANEUPLOIDY 2 3 RATE. B. LLEDO,1 J. A. ORTIZ,1 R. MORALES,1 SIRM, Las Vegas, NV, SIRM, Creve Coeur, MO. E. GARCIA-HERNANDEZ,1 J. Ten,2 J. LLACER,3 R. Bernabeu2; 1INSTITUTO BERNABEU BIOTECH, P-155 DAY 5, 6, AND 7 BLASTOCYST PLOIDY ALICANTE, Spain, 2Instituto Bernabeu, STATUS STRATIFIED BY PATIENT AGE. J. Alicante, Spain, 3Reproductive Medicine, Nguyen,1 R. A. Fields,2 A. Picou,3 K. Silverberg,4 Instituto Bernabeu, Alicante, Spain. M. VerMilyea1; 1Ovation Fertility, Austin, TX, 2Fairfax EggBank, Austin, TX, 3Embryology, 4 P-150 GENDER RATIO AND LIVE BIRTH AFTER Ovation Fertility, Austin, TX, Texas Fertility PREIMPLANTATION GENETIC SCREENING Center, Austin, TX.

nd 72 ASRM Scientific Congress & Expo 179 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-156 BLASTOCYST MORPHOLOGY IS A POOR of Child Health and Human Development, INDICATOR OF EUPLOID STATUS. A. Picou,1 Bethesda, MD. A. Hellmers,2 K. Silverberg,3 M. VerMilyea2; 1Embryology, Ovation Fertility, Austin, TX, 2 3 P-162 INFLUENCE OF PATERNAL AGE ON Ovation Fertility, Austin, TX, Texas Fertility PERINATAL OUTCOMES IN PREGNANCIES Center, Austin, TX. ACHIEVED WITH ASSISTED REPRODUCTIVE TECHNOLOGIES. E. G. Hurley, E. DeFranco; P-157 LIVE BIRTHS AFTER TRANSFER OF OBGYN, University of Cincinnati Medical REBIOPSY AND REVITRIFICATION OF Center, Cincinnati, OH. BLASTOCYST THAT HAD “NO DIAGNOSIS” FOLLOWING TROPHECTODERM BIOPSY. H. P-163 CYCLE DAY, ESTROGEN LEVEL, AND LEAD Lee, D. H. McCulloh, R. Olivares, A. Goldstein- FOLLICLE SIZE: ANALYSIS OF 25,000 Tufaro, C. McCaffrey, J. Grifo; OB/GYN, New IVF CYCLES AND THEIR OUTCOMES TO York University Fertility Center, New York, NY. DETERMINE OPTIMAL CRITERIA FOR ANTAGONIST INITIATION. B. M. Lyttle,1 P-158 THE EFFECT OF EMBRYO SELECTION BY J. E. Mersereau,2 A. Z. Steiner3; 1Obstetrics PREIMPLANTATION GENETIC DIAGNOSIS and Gynecology, Division of Reproductive FOR ANEUPLOIDY (PGD-A) IN PATIENTS Endocrinology, University of North Carolina, WITH ADVANCED MATERNAL AGE. A. Chapel Hill, NC, 2REI, UNC, Chapel Hill, NC, Vereczkey, G. Teglas, L. Nanassy; Versys Clinics 3University of North Carolina, Chapel Hill, NC. Human Reproduction Institute, Budapest, Hungary. P-164 PILOT CLINICAL STUDY TO PREDICT IVF OUTCOMES USING EMBRYO MECHANICAL PARAMETERS. L. Z. Yanez,1 O. Sedan,2 V. L. Baker,2 B. Behr,2 D. B. Camarillo1; ART OUTCOME PREDICTORS - CLINICAL 1Bioengineering, Stanford University, Stanford, CA, 2Department of Obstetrics and Gynecology, P-159 PERINATAL OUTCOMES FOLLOWING Stanford University, Palo Alto, CA. INTRACYTOPLASMIC SPERM INJECTION (ICSI) VERSUS CONVENTIONAL IN VITRO P-165 IMPACT OF OVARIAN AGING ON PERINATAL FERTILIZATION (IVF). S. Keyhan,1 Y. Li,2 T. OUTCOMES: ANALYSIS OF 135,252 ART Truong,2 T. Jackson-Bey,1 J. L. Eaton1; 1Division CYCLES REPORTED TO SART. M. G. Vega,1 of Reproductive Endocrinology and Infertility, S. Zaghi,2 S. K. Jindal,3 E. Buyuk,4 B. Yu5; Duke University Medical Center, Durham, NC, 1Department of Obstetrics & Gynecology & 2Dept of Biostatistics and Bioinformatics, Women’s Health, Montefiore Medical Center/ Duke University, Durham, NC. Albert Einstein College of Medicine, Bronx, NY, 2Albert Einstein College of Medicine, Bronx, 3 P-160 DAY 3 EMBRYO TRANSFER (ET) VERSUS NY, ObGyn and Women’s Health, Montefiore’s PUSHING TO DAY 5 IN PATIENTS WITH FEW Institute for Reproductive Medicine and 4 EMBRYOS. K. A. Green,1 G. Patounakis,1 A. Health, Hartsdale, NY, Albert Einstein College 5 DeCherney,1 J. Graham,2 M. J. Tucker,2 E. of Medicine / Montefiore M, Bronx, NY, OBGYN, A. Widra,2 M. Levy,2 M. J. Hill1; 1NIH- NICHD, University of Washington, Seattle, WA. Bethesda, MD, 2Shady Grove Fertility, Rockville, MD. P-166 RISKS OF ADVERSE PREGNANCY AND BIRTH OUTCOMES BY PLURALITY AND MATERNAL 1 2 P-161 TOTAL NUMBER OF OOCYTES AND 2PN FERTILITY STATUS. B. Luke, D. Gopal, H. 3 4 1 EMBRYOS ARE PREDICTIVE OF LIVEBIRTH Diop, J. E. Stern ; Obstetrics, Gynecology, PREGNANCY IN FRESH DONOR OOCYTE and Reproductive Biology, Michigan State 2 CYCLES. E. Hariton,1 K. Kim,2 S. L. Mumford,2 University, East Lansing, MI, Boston M. Palmor,1 P. Bortoletto,1 E. R. Cardozo,1 A. University School of Public Health, Boston, 3 Karmon,1 A. K. Styer1; 1Massachusetts General MA, Mass Department of Public Health, 4 Hospital/Harvard Medical School, Boston, MA, Boston, MA, Obstetrics and Gynecology, 2Eunice Kennedy Shriver National Institute Geisel School of Medicine at Dartmouth, Lebanon, NH.

nd 72 ASRM Scientific Congress & Expo 180 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-167 TIME-LAPSE EMBRYO MORPHOKINETICS P-173 BIRTH WEIGHT IN SINGLETONS AFTER FOLLOWING GNRH AGONIST OR HCG AUTOLOGOUS FRESH TRANSFER TRIGGERING. G. Oron, O. Sapir, R. Garor, Y. ACCORDING TO THE OVARIAN Shufaro, H. Pinkas, B. Fisch, A. Ben-Haroush; HYPERSTIMULATION PROTOCOL USED. L. IVF and infertility Unit, Beilinson Hospital, C. Londra,1 S. L. Mumford2; 1Reproductive Rabin Medical Center, Petach Tikva, Israel. Endocrinology and Infertility, Ohio State University, Columbus, OH, 2NICHD, NIH, P-168 POSSIBLE PATIENTS CONCERNS REGARDING Rockville, MD. THE BLASTOCYST EUPLOIDY RATES OF DONOR OOCYTES. R. E. Anderson,1 J. B. P-174 EFFECT OF ELEVATED PROGESTERONE ON Whitney,2 K. Waggoner,2 M. C. Schiewe2; DAY OF TRIGGER ON LIVE BIRTH WITH A DAY 1SCCRM, Ovation Fertility, Newport Beach, CA, 5 VERSUS DAY 6 BLASTOCYST TRANSFER. 2ART Lab, Ovation Fertility, Newport Beach, CA. M. W. Healy,1 K. S. Richter,2 M. Yamasaki,3 N. Banks,1 C. M. Owen,1 A. DeCherney,1 K. Devine,2 M. J. Hill1; 1National Institutes P-169 RISKS OF ADVERSE PERINATAL AND INFANT 2 OUTCOMES BY PLURALITY AND MATERNAL of Health- NICHD, Bethesda, MD, Shady B. Luke,1 D. Gopal,2 H. Grove Fertility Reproductive Science Center, FERTILITY STATUS. 3 Diop,3 J. E. Stern4; 1Obstetrics, Gynecology, and Rockville, MD, Department of OB/GYN, Reproductive Biology, Michigan State University, Walter Reed National Military Medical Center, East Lansing, MI, 2Community Health Sciences, Bethesda, MD. Boston University School of Public Health, Boston, MA, 3Mass Department of Public Health, P-175 CONVERSION TO IUI VERSUS CONTINUANCE Mass Department of Public Health, Boston, WITH IVF IN LOW RESPONDER PATIENTS: MA, 4Obstetrics and Gynecology, Dartmouth- A SYSTEMATIC REVIEW. D. T. Fujii, R. Hitchcock, Lebanon, NH. Heitmann; OB/GYN, US Army, Tacoma, WA.

P-170 FMR1 CGG REPEAT LENGTH AND OVARIAN P-176 IVF OUTCOMES IN YOUNG PATIENTS WITH FUNCTION IN A DONOR POPULATION. N. UNEXPLAINED INFERTILITY: AN ANALYSIS OF Banks,1 G. Patounakis,1 C. M. Owen,1 M. W. 273,779 CYCLES FROM THE 2011-2013 SOCIETY Healy,1 B. W. Whitcomb,2 M. E. Hartman,3 FOR ASSISTED REPRODUCTIVE TECHNOLOGY K. Devine,3 K. S. Richter,3 A. DeCherney,1 CLINIC OUTCOME REPORTING SYSTEM E. Levens,3 M. J. Hill1; 1NICHD, Bethesda, REGISTRY. G. Collins, S. Thakore, J. M. Goldfarb; MD, 2University of Massachusetts Amherst, Reproductive Endocrinology and Infertility, Case Amherst, MA, 3Shady Grove Fertility Western Reserve University, Cleveland, OH. Reproductive Science Center, Rockville, MD. P-177 ANTI-MULLERIAN HORMONE LEVELS DOES P-171 LACK OF PROGESTERONE RISE POST- NOT PREDICT OUTCOMES OF IVF CYCLES TRIGGER CORRELATES WITH SUB-OPTIMAL UNDERGOING PRE-IMPLANTATION GENETIC CLINICAL OUTCOMES DESPITE NORMAL SCREENING (PGS). J. Jayakumaran, C. FERTILIZATION RATE. J. Rodriguez- Silva, B. K. Gangrade, S. Patel; Center for Purata,1 L. Sekhon,1,2 J. A. Lee,1 M. Luna,1 T. Reproductive Medicine, Orlando, FL. Mukherjee,1,2 A. B. Copperman,1,2 B. Sandler1,2; 1Reproductive Medicine Associates of New 2 P-178 ARE REPRODUCTIVELY COMPETENT York, New York, NY, Obstetrics, Gynecology BLASTOCYSTS WITH POOR and Reproductive Science, Icahn School of MORPHOLOGICAL GRADE AT AN INCREASED Medicine at Mount Sinai, New York, NY. RISK FOR ADVERSE PERINATAL OUTCOME? L. Sekhon,1,2 J. Rodriguez-Purata,1 J. A. P-172 CYCLE OUTCOMES Lee,1 C. Briton-Jones,1 A. B. Copperman1,2; ACCORDING TO RECIPIENT PROGESTERONE 1Reproductive Medicine Associates of New LEVEL ON THE DAY OF FRESH BLASTOCYST York, New York, NY, 2Obstetrics, Gynecology TRANSFER. R. Sherbahn, M. Catenacci; & Reproductive Science, Icahn School of Advanced Fertility Center of Chicago, Gurnee, IL. Medicine at Mount Sinai, New York, NY.

nd 72 ASRM Scientific Congress & Expo 181 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-179 ANTI-MULLERIAN HORMONE(AMH) IN 6Obstetrics and Gynecology, Division of SERUM AND FOLLICULAR FLUID AND Reproductive Endocrinology and Infertility, APOPTOSIS OF MURAL GRANULOSA AND McGill University, Montreal, QC, Canada. CUMULUS CELLS IN PATIENTS UNDERGOING IVF/ICSI. Y. Fan, L. Wei, J. Chen, Y. Shi, X. P-183 HIGH PREGNANCY RATES CAN BE ACHIEVED Liang; Reproductive Medical Center, The Sixth WITH ELECTIVE SINGLE EMBRYO TRANSFER Affiliated Hospital of Sun Yat-sen University, OFFERED TO ALL PATIENTS. V. Garzo,1 Guangzhou, China. A. Yeo,1 I. Su,2 H. Cook-Andersen,3 D. R. Meldrum,4 A. Duleba5; 1Reproductive Partners P-180 BLASTOCYST COLLAPSE. VALIDATION Fertility Center - San Diego, La Jolla, CA, 2UC OF PREVIOUS DATA. R. Herrer Saura,1 J. San Diego, San Diego, CA, 3Sanford Center Marcos,2 P. Valero,1 V. Ramirez,1 J. Serna,1 E. I. for Regenerative Medicine, La Jolla, CA, Gil Arribas,3 M. Meseguer4; 1IVF, IVI Zaragoza, 4Reproductive Partners La Jolla, La Jolla, Zaragoza, Spain, 2IVF, IVI Murcia, Murcia, CA, 5Reproductive Medicine, University of Spain, 3IVI Zaragoza, Zaragoza, Spain, 4Clinical California, San Diego, La Jolla, CA. Embryology, Valencia, Spain. P-184 INCREASED RATE OF ADVERSE NEONATAL P-181 DEVELOPMENT OF PERSONALIZED OUTCOMES AMONG TWINS FOLLOWING PREDICTIVE MODELS FOR NON-IVF AND ASSISTED REPRODUCTIVE TECHNOLOGY. IVF PROCEDURES IN LESBIAN AND SINGLE A. Y. Wang; Faculty of Health, University of WOMEN SHEDS LIGHT ON APPLICABILITY OF Technology Sydney, Ultimo NSW, Australia. INFERTILITY BIOMARKERS TO WOMEN OF 1 UNKNOWN FERTILITY STATUS. A. Santistevan, P-185 THE BASELINE ANTIMÜLLERIAN HORMONE K. Hunter Cohn,1 J. Schnorr,2 F. Arredondo,3 4 5 6 (AMH) LEVEL AS AN INDEPENDENT PREDICTOR B. Miller, M. P. Leondires, J. Gutmann, L. OF LIVE BIRTH RATE OF FROZEN-THAWED Weckstein,7 S. E. Katz,8 J. Nulsen,9 P. C. Lin,10 A. 11 12 1 EMBRYO TRANSFERS: A MULTIVARIATE B. Copperman, E. A. Widra, P. Yurttas Beim ; X. Li, R. Huang, C. 1 2 ANALYSIS OF 828 CYCLES. Celmatix Inc, New York, NY, Coastal Fertility Fang, J. Li, X. Liang; Sixth Affiliated Hospital of 3 Specialists, Mount Pleasant, SC, Reproductive Sun Yat-sen University, Guangzhou, China. Medicine Associates of Texas, San Antonio, TX, 4RMA of Michigan, Rochester Hills, MI, 5RMA of CT, Norwalk, CT, 6RMA of Philadelphia, P-186 ADVERSE PERINATAL OUTCOMES Philadelphia, PA, 7Reproductive Science ASSOCIATED WITH FERTILITY TREATMENT Center of the San Francisco B, San Ramon, CA, IN LATE PRETERM INFANTS. L. W. 1 2 3 8REACH, Charlotte, NC, 9Center for Advanced Sundheimer, E. T. Wang, C. Quant, C. 4 5 6 1 Reproductive Services, Farmington, CT, 10Seattle Spades, C. F. Simmons, M. D. Pisarska ; OB/ Reproductive Medicine, Seattle, WA, 11Obstetrics GYN, Division of Reproductive Endocrinology and Gynecology, RMANY-Mount Sinai, New York, and Infertility, Cedars-Sinai Medical Center, 2 NY, 12Shady Grove Fertility, Washington, DC. Los Angeles, CA, Obstetrics and Gynecology, Cedars Sinai Medical Center, Los Angeles, CA, 3Family Medicine, Cedars-Sinai Medical P-182 FRESH SINGLE EMBRYO TRANSFER Center, Los Angeles, CA, 4OB/GYN, Cedars- OUTCOME MAY PREDICT THE RESULT OF A Sinai Medical Center, Los Angeles, CA, SUBSEQUENT VITRIFIED-WARMED SINGLE 5Pediatrics, Cedars Sinai Medical Center, Los BLASTOCYST TRANSFER ORIGINATING Angeles, CA, 6OB/GYN, Division REI, Cedars- 1 FROM THE SAME COHORT. T. Shavit, H. S. Sinai Medical Center, Los Angeles, CA. Weibel,2 A. Hershko Klement,3 Y. Hasson,4 W. Son,5 S. Tannus,6 W. Buckett2; 1MUHC Reproductive Center- McGill University, McGill P-187 IMPACT OF OVULATION METHOD AND University- MUHC Reproductive Center, CYCLE STIMULATION ON PREGNANCY Montreal, QC, Canada, 2McGill University, OUTCOMES: A RETROSPECTIVE COHORT Montreal, QC, Canada, 3Physician, Kiryat Ono, STUDY OF INTRA-UTERINE INSEMINATION Israel, 4McGill University- MUHC Reproductive WITH DONOR SEMEN IN A HOSPITAL-BASED Center, Montreal, QC, Canada, 5MUHC CLINIC. J. S. Lam, F. Tekpetey, K. Shepherd, A. Reproductive Center, Monteral, QC, Canada, Vilos; Obstetrics and Gynaecology, University of Western Ontario, London, ON, Canada.

nd 72 ASRM Scientific Congress & Expo 182 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-188 OOCYTE UTILIZATION RATE AS PREGNANCY P-193 PHYSICIAN PREDICTION MODEL FOR LIVE POTENTIAL INDICATOR (A MULTICENTRIC BIRTH AND MULTIPLE BIRTHS AFTER STUDY). S. Hamamah,1 P. Barriere2; 1ART/ ASSISTED REPRODUCTIVE TECHNOLOGY. B. PGD Department, Arnaud de Villeneuve Luke,1 M. B. Brown,2 E. Wantman3; 1Obstetrics, Hospital, Montpellier, France, 2CHU Nantes, Gynecology, and Reproductive Biology, Nantes, France. Michigan State University, East Lansing, MI, 2Biostatistics, University of Michigan, Ann Arbor, 3 P-189 IS YOUNGER BETTER? DONOR AGE LESS MI, Redshift Technologies, Inc., New York, NY. THAN 25 DOES NOT PREDICT MORE FAVORABLE OUTCOMES AFTER IN VITRO P-194 REPRODUCTIVE OUTCOMES IN RECIPIENTS FERTILIZATION. L. A. Humphries,1,2 L. E. ARE NOT ASSOCIATED WITH OOCYTE Dodge,1,2 E. B. Kennedy,1 K. C. Humm,1,2 M. R. DONOR BODY MASS INDEX (BMI): A COHORT Hacker,1,2 D. Sakkas3; 1Department of Obstetrics STUDY OF 2927 CYCLES. F. Martinez, E. Clua, and Gynecology, Beth Israel Deaconess Medical A. Kava, I. Rodriguez, D. Rodriguez, B. Coroleu; Center, Boston, MA, 2Department of Obstetrics, Obstetrics, Gynecology and Reproductive, Gynecology and Reproductive Biology, Harvard Salud de la mujer Dexeus, Barcelona, Spain. Medical School, Boston, MA, 3Boston IVF, Waltham, MA. P-195 RISK FACTORS FOR ABNORMAL UMBILICAL CORD INSERTIONS AMONG TERM P-190 HOW DOES ART SINGLETONS DIFFER FROM SINGLETON ART PREGNANCIES. S. Furuya, NATURALLY CONCEIVED (NC) SINGLETONS; T. Yamaguchi, T. Kagawa, H. Takahashi, K. COMPARISON OF PERINATAL DATA OF 872 Kubonoya, K. Kubonoya; Kubonoya Ob/Gyn ART TO 19317 (NC) SINGLETON BABIES. Clinic, Kashiwa-City, Chiba Prefecture, Japan. A. Khudhari,1 R. Hemmings,2 S. Phillips,3 A. 4 5 1 M. Badeghiesh, W. Jamal ; Gynecologist/ P-196 REVISED PATIENT PREDICTION MODEL FOR Infertility and Reproductive Endocrinology, 2 LIVE BIRTH AND MULTIPLE BIRTH AFTER Montreal, QC, Canada, Ob-Gyn, McGill B. 3 ASSISTED REPRODUCTIVE TECHNOLOGY. University, Westmount, QC, Canada, OVO Luke,1 M. B. Brown,2 E. Wantman3; 1Obstetrics, 4 Fertility, Montreal, QC, Canada, Mcgill Gynecology, and Reproductive Biology, 5 University, Montreal, QC, Canada, OBGYN Michigan State University, East Lansing, MI, University of Montreal, OVO Clinic, Montreal, 2Biostatistics, University of Michigan, Ann Arbor, QC, Canada. MI, 3Redshift Technologies, Inc., New York, NY.

P-191 A HIGH PREVALENCE OF ABNORMAL P-197 ECTOPIC PREGNANCY RISK DEPENDS ON EMBRYOS AFTER AN IVF/PGS CYCLE SHOULD THE ASSISTED REPRODUCTION PROTOCOL. NOT DETER PATIENTS FROM PURSUING S. Daneshmand,1,2 C. E. Bedient,1,2 F. Garner,1,2 1 A SECOND CYCLE. J. Rodriguez-Purata, B. S. Shapiro1,2; 1Fertility Center of Las Vegas, 1,2 1 1 L. Sekhon, J. A. Lee, M. C. Whitehouse, Las Vegas, NV, 2Obstetrics and Gynecology, 1 1 1 E. Cervantes, M. Luna, C. Briton-Jones, T. University of Nevada School of Medicine, Las 1,2 1,2 1,2 Mukherjee, A. B. Copperman, B. Sandler ; Vegas, NV. 1Reproductive Medicine Associates of New York, New York, NY, 2Obstetrics, Gynecology and Reproductive Science, Icahn School of P-198 PEAK SERUM ESTRADIOL AND NEONATAL Medicine at Mount Sinai, New York, NY. BIRTH WEIGHT FOLLOWING IN VITRO FERTILIZATION. T. Jackson-Bey,1 S. Keyhan,1 Y. Li,2 T. Truong,2 J. L. Eaton1; 1Division of P-192 THE CONFOUNDING EFFECT OF A LIVE Reproductive Endocrinology and Infertility, DELIVERED PREGNANCY OR NOT IN THE Duke University Medical Center, Durham, FIRST FRESH EMBRYO TRANSFER (ET) ON NC, 2Department of Biostatistics and THE OUTCOME OF THE FIRST FROZEN ET. Bioinformatics, Duke University, Durham, NC. J. H. Check,1 R. Cohen,2 C. Wilson2; 1Dept. OB/GYN, Cooper Medical School of Rowan University, Melrose Park, PA, 2Cooper Institute P-199 PRECONCEPTION THYROID STIMULATING for Reproductive and Hormonal Disorders, HORMONE LEVEL DOES NOT AFFECT P.C., Mt. Laurel, NJ. THE PREGNANCY OUTCOME IN WOMEN

nd 72 ASRM Scientific Congress & Expo 183 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

UNDERGOING IN VITRO FERTILIZATION. City, UT, 2Obstetrics and Gynecology, H. Kim,1 S. Park,1 J. Yoon,1 K. Pak,1 J. Ahn,1 J. University of Utah, Salt Lake City, UT, Cha,1 J. Lee,2 S. Shin,1 Y. Kim,1 S. Lee,1 H. Cha,1 3Obstetrics and Gynecology, ASRM, West J. Kim1; 1Agaon Fertility Clinic, Seoul, Korea, Valley City, UT, 4University of Utah, SLC, Republic of, 2IVF Lab., Agaon Fertility Clinic, UT, 5Surgery (Urology), University of Utah Seoul, Korea, Republic of. School of Medicine, Salt Lake City, UT, 6Divsion of Reproductive Endocrinology and Infertility, University of Utah, Salt Lake City, P-200 THE FREQUENCY OF PLASMINOGEN 7 ACTIVATOR INHIBITOR (PAI) UT, Surgery (Urology), University of Utah, POLYMORPHISM AND ITS EFFECTS ON Salt Lake City, UT. RECURRENT IVF FAILURE. E. Ersoy,1 N. Yilmaz,2 A. Ersoy,3 A. Karatas,4 Y. Engin-Ustun1; P-204 ANGIOGENIC PROFILES IN IN-VITRO 1Obstetrics and Gynecology, Zekai Tahir Burak FERTILIZATION/EMBRYO TRANSFER Women’s Healthcare Training and Research (IVF/ET) TREATMENTS: RELATIONSHIP Hospital, Ankara, Turkey, 2Reproductive TO HYPERTENSIVE COMPLICATIONS Endocrinology Department, ZTB, Ankara, IN IVF-CONCEIVED PREGNANCIES. E. Turkey, 3Zekai Tahir Burak Women’s Weedin, P. Javadian, E. Nguyen, C. Ketch, Healthcare Training and Research Hospital, R. Bhattacharya, R. A. Wild, K. R. Hansen, A. Ankara, Turkey, 4Obstetrics and Gynecology, Quaas; Obstetrics and Gynecology, University Abant Izzet Baysal University, Bolu, Turkey. of Oklahoma Health Sciences Center, Oklahoma City, OK. P-201 IS THERE ANY PREDICTIVE CAPABILITY OF THE FIRST ß-HCG LEVEL IN IN VITRO P-205 IMPACT OF THE NUMBER OF LEAD FERTILIZATION CYCLES. B. A. Ozkok,1 N. FOLLICLES AT TIME OF TRIGGER ON Yilmaz,2 A. Karatas,3 A. Tokmak,4 S. Cavdar5; INTRAUTERINE INSEMINATION (IUI) 1Zekai Tahir Burak Women’s Health Education PREGNANCY OUTCOMES. L. N. Beliveau,1 A. and Research Hospital, Ankara, Turkey, Vilos,1 F. Tekpetey,2 K. Shepherd,2 C. Newton,2 2Reproductive Endocrinology Department, B. Abu-Rafea,1 J. Hollett-Caines,1 M. Rebel1; ZTB, Ankara, Turkey, 3Obstetrics and 1University of Western Ontario, London, ON, Gynecology, Abant Izzet Baysal University, Canada, 2The Fertility Clinic, LHSC, London, Bolu, Turkey, 4Obstetrics and Hynecology, ON, Canada. Zekai Tahir Burak Women’s Health Education and Research Hospital, Ankara, Turkey, 5 P-206 IN-VITRO FERTILIZATION CYCLES AMONG Umraniye Community Health Center, WOMEN AGES 40 AND OLDER. H. Hipp,1 Provincial Public Health Directorate of S. Crawford,2 J. F. Kawwass,1 S. Boulet,2 D. Istanbul, Istanbul, Turkey. A. Grainger,3 D. M. Kissin,2 D. J. Jamieson2; 1Reproductive Endocrinology and Infertility, P-202 SUPERNUMERARY BLASTOCYSTS Emory University Reproductive Center (& AVAILABLE FOR CRYOPRESERVATION IN CDC), Atlanta, GA, 2Division of Reproductive FRESH IVF CYCLES: PROGNOSTIC VALUE Health, Centers for Disease Control and FOR IVF OUTCOMES? N. Pereira, A. P. Prevention, Atlanta, GA, 3The Center for Hutchinson, A. P. Melnick, J. P. Lekovich, Reproductive Medicine, Wichita, KS. I. Kligman, Z. Rosenwaks; The Ronald O. Perelman and Claudia Cohen Center P-207 HCG LEVELS AT DIFFERENT TIME POINTS for Reproductive Medicine, Weill Cornell DURING OVARIAN STIMULATION ARE Medicine, New York, NY. NOT ASSOCIATED WITH OUTCOME IN ICSI CYCLES. F. Sharara,1,2 M. R. Goodwin1; P-203 DOES OUTCOME OF THE FIRST IVF CYCLE 1Virginia Center for Reproductive Medicine, ALLOW SELECTION OF CANDIDATES Reston, VA, 2Ob/gyn, George Washington FOR REPEAT IVF PRIOR TO PGS? E. B. University, Washington, DC. Johnstone,1 M. Link,2 B. Patel,3 J. Hotaling,4 A. K. Moore,2 J. Dorais,1 D. T. Carrell,5 C. 6 7 1 P-208 IS THE PROGESTERONE TO OOCYTE M. Peterson, K. I. Aston ; Obstetrics & RATIO A BETTER PREDICTIVE TOOL FOR Gynecology, University of Utah, Salt Lake ART SUCCESS THAN PROGESTERONE

nd 72 ASRM Scientific Congress & Expo 184 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

ALONE? M. W. Healy,1 B. W. Whitcomb,2 G. P-213 EFFICACY OF MULTIPLE OVULATION Patounakis,1 E. Levens,3 A. DeCherney,1 E. INDUCTION BY MODULATING ANGIOTENSIN A. Widra,3 K. S. Richter,3 M. J. Hill1; 1National II RECEPTOR DURING IN VITRO MATURATION Institutes of Health- NICHD, Bethesda, MD, OF MURINE OVARIAN FOLLICLE. Y. Kim, S. 2Biostatistics and Epidemiology, University of Lee, S. Yang, H. Choi, J. Lee, H. Whang, K. Yi, Massachusetts Amherst, Amherst, MA, 3Shady H. Park, J. Shin, T. Kim, J. Hur; Obstetrics and Grove Fertility Reproductive Science Center, Gynecology, Korea University Guro Hospital, Rockville, MD. Seoul, Korea, Republic of.

P-214 FERTILIZATION RATES ARE NOT IMPROVED OOCYTE BIOLOGY BY USE OF ICSI VERSUS CONVENTIONAL INSEMINATION IN IVF CASES USING DONOR 1 1,2 P-209 TRANSCRIPTOMIC ANALYSIS OF ISOLATED SPERM. J. Rodriguez-Purata, L. Sekhon, 1 1 1 SINGLE PRIMORDIAL AND PRIMARY J. A. Lee, M. C. Whitehouse, R. Slifkin, M. 1 1 1,2 FOLLICLE USING RNA-SEQ IN HUMAN. E. Duke, C. Briton-Jones, A. B. Copperman, 1,2 1 Chang,1 S. Yoon,2 J. Kim,3 Y. Hur,4 E. Yu,5 W. B. Sandler ; Reproductive Medicine Lee,6 Y. Choi7; 1CHA Fertility Center, Seoul, Associates of New York, New York, NY, 2 Korea, Republic of, 2Post Doc, Seoul, Korea, Obstetrics, Gynecology and Reproductive Republic of, 3Fertility Center, CHA Gangnam Science, Icahn School of Medicine at Mount Medical Center, Seoul, Korea, Republic of, Sinai, New York, NY. 4CHA Gangnam Medical Center, Seoul, Korea, Republic of, 5Fertility Center, CHA Gangnam P-215 DYNAMIC ANALYSIS OF HUMAN Medical Center, CHA University, Seoul, PARTHENOGENETIC ZYGOTES INDUCED BY Korea, Republic of, 6Ob/Gyn Dept., Gangnam ARTIFICIAL OOCYTE ACTIVATION. A. Tanaka, CHA Hospital, Seoul, Korea, Republic K. Yumoto, K. Iwata, C. Mizoguchi, M. Tsuneto, of, 7Biomedical Science, CHA University, Y. Mio; Reproductive Centre, Mio Fertility Seoungnam-si, Korea, Republic of. Clinic, Yonago, Japan.

P-210 LIVE CELL IMAGING AND QUANTIFICATION P-216 EFFECT OF OOCYTE ACTIVATION WITH OF CYTOPLASMIC LIPID DROPLETS AS CALCIUM IONOPHORE ON ICSI OUTCOMES IN BIOMARKERS IN OOCYTES OF MICE OF PATIENTS WITH PREVIOUS FERTILIZATION DIFFERENT BODY COMPOSITION. L. J. FAILURE. S. A. Hebisha,1 B. A. Aboelazm,1 H. M. Green,1 J. Jasensky,1 Z. Chen,1 G. D. Smith2; Adel,1 A. A. Aboali,1 A. I. Ahmed2; 1Gynecology, 1OBGYN, University of Michigan, Ann Arbor, MI, Alexandria University - Faculty of Medicine, 2Ob/Gyn, University of Michigan, Ann Arbor, MI. Alexandria, Egypt, 2Obstetrics and Gynecology, MFM Division, Department of Medical Genetics, P-211 IS THERE A RELATIONSHIP BETWEEN THE Perinatology Research Branch, Wayne State OOCYTE CYTOPLASMIC MATURATION, University, Detroit, MI. METAPHASE PLATE CONFORMATION AND ANEUPLOIDIES? C. Alvarez Sedo, M. B. P-217 THE POLAR BODY DOES NOT ACCURATELY Miguens, D. Lorenzi, N. Ortiz Maffei, F. Nodar, REPRESENT THE MITOCHONDRIAL M. Bilinski, H. Uriondo, S. Papier; CEGYR MUTATIONAL LOAD WITHIN ITS (Reproductive Medicine and Genetics), CORRESPONDING OOCYTE. J. Kofinas,1 L. Buenos Aires, Argentina. Robinson,2 M. Seth-Smith,3 Y. G. Kramer,4 D. H. McCulloh,5 F. Wang,2 J. Grifo,6 D. L. Keefe7; 1 P-212 REVISITING OOLEMMA CHARACTERISTICS Division of Reproductive Endocrinology/ 2 DURING ICSI IN RELATION TO Infertility, NYU, New York, NY, Department 3 FERTILIZATION PATTERNS AND EMBRYO of ObGyn, NYU, New York, NY, NYU, New 4 DEVELOPMENT AND IMPLANTATION. York, NY, OBS-GYN, NYU Fertility Center, New 5 N. Pereira, T. Cozzubbo, S. Cheung, Z. York, NY, Obstetrics and Gynecology, New Rosenwaks, G. D. Palermo; The Ronald York University Fertility Center, New York, NY, 6 O. Perelman and Claudia Cohen Center NYU Langone Medical Center, New York, NY, 7 for Reproductive Medicine, Weill Cornell ObGyn, New York University Langone Medical Medicine, New York, NY. Center, New York, NY.

nd 72 ASRM Scientific Congress & Expo 185 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-218 CYTOKINE ANTIBODY ARRAY PROFILING and Infertility, Weill Cornell Medicine, New IN HUMAN FOLLICULAR FLUID AS A York, NY, 2OB/GYN, REI Fellow, New York, NY, POTENTIAL MARKER FOR OOCYTE QUALITY. 3Obstetrics, Gynecolology and Reproductive M. Pavone,1 J. M. Kelsh,2 S. Malpani,3 R. Medicine, Weill Cornell Medical Center, Confino,1 S. Jasti,2 S. M. Briley,2 J. X. Zhang,1 Manhattan, NY, 4Weill Cornell Medicine - Center F. E. Duncan2; 1Obstetrics and Gynecology, for Reproductive Medicine, New York, NY. Northwestern, Chicago, IL, 2Anatomy and Cell Biology, University of Kansas Medical 3 P-224 DOES SHORT-TERM EXPOSURE OF OOCYTES Center, Kansas City, KS, Northwestern TO IN VITRO MATURATION (IVM) MEDIUM University, Chicago, IL. PRIOR TO IVF/ICSI IMPROVE MATURE OOCYTE AND EMBRYO YIELD IN PATIENTS P-219 UNEARTHING ANEUPLOIDY: INVESTIGATING WITH HIGH OOCYTE IMMATURITY? C. R. DOUBLE-STRAND BREAKS IN OOCYTES Sacha,1 D. J. Kaser,1 L. V. Farland,1,2 S. Srouji,1 OF CAENORHABDITIS ELEGANS. F. Balmir, S. A. Missmer,1,2 C. Racowsky1; 1Dept of J. L. Yanowitz; Obstetrics, Gynecology, and Obstetrics & Gynecology, Brigham & Women’s Reproductive Science, Magee-Womens Hospital and Harvard Medical School, Boston, Research Institute, Pittsburgh, PA. MA, 2Dept of Epidemiology, Harvard Chan School, Boston, MA. P-220 ARTIFICIAL OOCYTE ACTIVATION IN ICSI CYCLES USING TESTICULAR SPERMATOZOA. P-225 A ‘FOLLICLE-STIMULATING HORMONE A. Sdrigotti,1 F. A. Leocata Nieto,2 L. Dacharry,1 BOOST’ ADMINISTERED AT THE TIME OF G. Rey Valzacchi1; 1Procrearte, Buenos Aires, HUMAN CHORIONIC GONADOTROPIN Argentina, 2Embriologyst, Buenos Aires, TRIGGER DOES NOT AFFECT IVF CYCLE Argentina. OUTCOMES. C. R. Juneau,1 S. J. Morin,1 J. M. Franasiak,1 J. N. Landis,2 T. A. Molinaro,1 R. T. Scott Jr.1; 1Reproductive Medicine Associates of New Jersey, Basking Ridge, NJ, 2Foundation for OOCYTE MATURATION Embryonic Competence, Basking Ridge, NJ.

P-221 SILENCING OF RAD51 IMPAIRS OOCYTE P-226 SINGLE CELL TRANSCRIPTOME REVEAL MATURATION VIA MITOCHONDRIAL CHARACTERISTIC FEATURES OF EMBRYOS DYSFUNCTION AND MITOPHAGY. K. Kim, J. FROM TWO CASE OF RTFF PATIENTS. L. 1 2 1 1 Park, E. Kim, J. Ko, K. Park, K. Lee; Department Suo, Y. Zhou, Y. Kuang ; Shanghai Ninth 2 of Biomedical Science, College of Life Science, People’s Hospital, Shanghai, China, Shanghai CHA University, Pangyo, Korea, Republic of. Jiaotong University, Shanghai, China.

P-222 COMBINED GNRH-AGONIST AND HUMAN P-227 ADDITION OF ENDOTHELIN-1 TO CULTURE CHORIONIC GONADOTROPIN TRIGGER MEDIUM PROMOTES HUMAN OOCYTE ENHANCES OOPLASMIC MATURITY AND MATURATION. Y. Ye; Women’s Hospital, IMPROVES ICSI CYCLE OUTCOMES IN Zhejiang University School of Medicine, PATIENTS WITH POOR FERTILIZATION. N. Hangzhou, China. Pereira, R. Elias, T. Cozzubbo, L. Artusa, R. S. Gerber, G. D. Palermo, Z. Rosenwaks; The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill OVARIAN STIMULATION Cornell Medicine, New York, NY. P-228 THE ESPART RANDOMIZED CONTROLLED P-223 DOES TRIGGER OF FINAL OOCYTE TRIAL IN POOR OVARIAN RESPONDERS MATURATION WITH PURE GNRH-AGONIST ALIGNED WITH THE BOLOGNA CRITERIA: HAVE ADVERSE EFFECTS ON PREGNANCY A POST HOC SUBGROUP ANALYSIS OUTCOMES OF DONOR/RECIPIENT CYCLES? ACCORDING TO POOR OVARIAN RESPONSE M. Irani,1 V. Gunnala,2 D. E. Goldschlag,3 Z. INCLUSION CRITERIA. J. Hubbard,1 Rosenwaks4; 1Reproductive Endocrinology W. Chin,2 P. Humaidan3; 1Global Clinical

nd 72 ASRM Scientific Congress & Expo 186 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Development Center, EMD Serono Research P-233 NOVEL THERAPY FOR OVARIAN and Development Institute, Billerica, MA, DYSFUNCTION BY REDUCING ADVANCED 2Global Biostatistics & Epidemiology, GLYCATION END-PRODUCT: HISHI- EMD Serono Research and Development EXTRACT, ANTI-GLYCATION FUNCTIONAL Institute, Billerica, MA, 3Faculty of Health, FOOD, INCREASES PREGNANCY RATES Aarhus University, The Fertility Clinic Skive, IN AGED ART REPEATERS. M. Jinno,1 M. Skive, Denmark. Takeuchi,2 A. Watanabe,1 S. Takeshita,3 M. Yamada3; 1Women’s Clinic Jinno, Tokyo, 2 P-229 OPTIMAL OOCYTE YIELD FOR CUMULATIVE Japan, Department of Advanced Medicine, LIVE-BIRTH RATE: ANALYSIS OF 257,398 Kanazawa Medical University, Medical Research Institute, Kahoku, Ishikawa, IVF CYCLES AND THEIR LINKED FRESH AND 3 FROZEN EMBRYO TRANSFERS. S. M. Nelson,1 Japan, Research and Development Division, A. Smith,2 K. Tilling,2 D. A. Lawlor3; 1School Hayashikane Sangyo Co., Ltd, Shimonoseki of Medicine, University of Glasgow, Glasgow, City, Yamaguchi, Japan. United Kingdom, 2University of Bristol, Bristol, United Kingdom, 3MRC Integrative P-234 TEMPORAL CHANGES IN OOCYTE DONOR Epidemiology Unit, University of Bristol, TREATMENT REGIMENS IN A REAL-WORLD Glasgow, United Kingdom. ANALYSIS OF A US DATABASE OF 7971 DONOR CYCLES OVER 6.5 YEARS. B. Kaplan,1 2 3 4 P-230 HOW MANY OOCYTES ARE OPTIMAL TO K. S. Richter, G. L. Mottla, B. Hayward, M. C. Mahony4; 1Fertility Centers of Illinois, MAXIMIZE THE CUMULATIVE NUMBER OF 2 LIVE BIRTHS WITH ONE STIMULATION? D. Chicago, IL, Research, Shady Grove Fertility A. Vaughan,1 A. Leung,2 N. Resetkova,3 A. S. Reproductive Science Center, Rockville, MD, 3 Penzias,4 R. Ruthazer,5 D. Sakkas,6 M. M. Alper7; Research, Shady Grove Fertility Reproductive 4 1Obstetrics and Gynecology, Tufts Medical Science Center, Annapolis, MD, EMD Serono, Center, Boston, MA, 2Tufts Medical Center, Inc., Rockland, MA. Boston, MA, 3Beth Israel Deaconess Medical Center, Boston, MA, 4Boston IVF / Harvard P-235 LOW COST OVARIAN STIMULATION Medical School, Waltham, MA, 5Medicine, PROTOCOL IS ASSOCIATED WITH LOWER Tufts CTSI / Tufts medical Center, Boston, PREGNANCY RATE IN NORMAL RESPONDERS MA, 6Boston IVF, Waltham, MA, 7Boston IVF/ IN COMPARISON TO LONG PROTOCOL. I. Harvard Medical School, Waltham, MA. Elnashar,1 T. A. Farghaly,2 A. S. Abdalbadie,1 E. Badran,3 A. A. Abdelaleem,4 A. M. Ismail,5 E. Elsenosy1; 1Assiut University, Assiut, Egypt, P-231 PREGNANCY RATES IN FROZEN-THAWED 2 CYCLES AFTER GNRH-AGONIST OR Obstetrics and Gynecology, IVF Unit, Assiut R. Mirisol,1 P. F. Unive, Assiut University IVF Unit, Assiut, ANTAGONIST PROTOCOLS. 3 Peregrino,1 S. P. Goncalves,1 P. G. Petersen,1 Egypt, Obstetrics and Gynecology and Assiut J. Miorin,1 M. G. Fujii,1 A. P. Gomes,1 T. C. IVF Unit, Assiut University, Assiut, Egypt, 4 Bonetti,2 P. A. Monteleone3,1; 1Monteleone Assiut University IVF Unit, Assiut, Egypt, 5 Centro de Reproducao Humana, Sao Paulo, Obstetrics and Gynecology, Women’s Health Brazil, 2Gynecology, Universidade Federal Hospital, Assiut, Egypt. de Sao Paulo, Sao Paulo, Brazil, 3Discipline of Ginecology, Hospital das Clinicas, U, Sao P-236 BLIND VALIDATION OF ESTROGEN Paulo, Brazil. MONITORING IN CONTROLLED OVARIAN STIMULATION IVF CYCLES USING A P-232 COMPARISON BETWEEN RANDOM-STRT “PATIENT-FRIENDLY” SALIVA-BASED ESTRADIOL ASSAY. M. M. Alper,1 M. Matin,2 AND CONVENTIONAL-START STIMULATION 3 4 5 ACCORDING TO ANTI-MULLERIAN HORMONE B. French, E. A. Widra, A. B. Copperman, M. Levy,6 J. A. Lee,7 S. W. Granger,2 K. Rooney,3 D. (AMH) LEVELS IN PATIENTS WITHOUT 3 1 C. Takahashi, H. Matsubayashi, S. Sakkas ; Boston IVF/Harvard Medical School, CANCER. 2 Mizuta, K. Yamaguchi, R. Nishiyama, Y. Takaya, Waltham, MA, Salimetrics LLC, Carlsbad, 3 4 K. Kitaya, T. Ishikawa; Reproduction Clinic CA, Boston IVF, Waltham, MA, Shady Grove 5 Osaka, Osaka, Japan. Fertility, Washington, DC, Obstetrics and Gynecology, RMANY-Mount Sinai, New York,

nd 72 ASRM Scientific Congress & Expo 187 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

NY, 6Shady Grove Fertility, Rockville, MD, CYCLES. I. Dimitriadis,1 G. Christou,2 J. C. 7Reproductive Medicine Associates of New Petrozza,3 I. Souter4; 1Tufts Medical Center, York, New York, NY. Boston, MA, 2Massachusetts General Hospital, Boston, MA, 3Obstetrics and Gynecology, Massachusetts General Hospital, Boston, P-237 ACTIVATION OF THE COAGULATION SYSTEM 4 DURING IVF CYCLES EXTENDS WELL AFTER MA, Harvard Medical School-Massachusetts OVUM PICKUP. Y. Cohen,1 E. Zohav,1 B. General Hospital, Boston, MA. Almog,2 A. Cohen2; 1Obstetrics & Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky P-243 NATURAL IS NOT BETTER: GONADOTROPIN Medical, Tel Aviv, Israel, 2Lis Maternity STIMULATION DOES NOT INCREASE Hospital, Tel Aviv Sourasky Medical, Tel Aviv, ANEUPLOIDY OR DIMINISH IMPLANTATION Israel. RATES OF EUPLOID EMBRYOS. K. H. Hong, E. J. Forman, M. D. Werner, J. M. Franasiak, C. R. P-238 SHORTENED STIMULATION LENGTH IS Juneau, S. J. Morin, C. Whitehead, N. Treff, R. ASSOCIATED WITH ADVERSE OUTCOMES T. Scott Jr.; RMANJ, Basking Ridge, NJ. IN IVF CYCLES. P. Kovacs,1 S. Simpson,2 R. Maxwell,2 S. R. Lindheim3; 1Kaali Institute P-244 IS THE LUTEAL-PHASE OVARIAN IVF Center, Budapest, Hungary, 2Dept. of STIMULATION A FEASIBLE CHOICE FOR ALL OBGYN, Wright state University, Boonshoft PATIENTS? M. Zheng,1 R. Hu,2,3 F. Wang,2,3 R. School of Medicine, Dayton, OH, 3Obstetrics & Lu4; 1Ningxia Medical University, Yinchuan, Gynecology, Wright State University Boonsoft China, 2Reproductive Medicine Center, General School of Medicin, Dayton, OH. Hospital of Ningxia Medical University, Yinchuan, China, 3Key Laboratory of Fertility Preservation and Maintenance of Ministry of P-239 THE TREE ANALYSIS MODEL AS A GUIDE 4 FOR THE SELECTION OF THE OPTIMUM Education, Yinchuan, China, General Hospital OVULATION INDUCTION METHOD TO of Ningxia Medical University, Yinchuan, China. IMPROVE THE QUALITY OF OOCYTES. A. Tanaka, M. Nagayoshi, I. Tanaka, T. Miki, T. P-245 REPRODUCTIVE OUTCOMES IN POOR- Yamaguchi, A. Tanaka; Saint Mother Hospital, RESPONDER PATIENTS USING SURGICALLY Kitakyusyu, Japan. RETRIEVED SPERM. A. Gilman, G. Younes, S. Tannus, W. Son, P. Chan, W. Buckett; McGill P-240 THE COMPETENT FUNCTION OF University, Montreal, QC, Canada. GRANULOSA CELLS DURING PPOS IN NORMALOVULATORY WOMEN UNDERGOING P-246 TESTOSTERONE UNDECANOATE TREATMENT IVF/ICSI TREATMENTS. L. Zhou, Y. Kuang, IN WOMEN WITH POOR OVARIAN RESPONSE W. Chai; Shanghai Ninth People’s Hospital, UNDERGOING IVF: PREGNANCY AND LIVE Shanghai, China. BIRTH RATES. G. Mskhalaya,1 E. Eltsova,1 M. Malysheva,2 E. Lubimkina,2 V. Zaletova,2 S. 3 1 P-241 EXTENDING OVARIAN STIMULATION IN Kalinchenko ; Andrology and Endocrinology, Center for Reproductive Medicine MAMA, PATIENTS WHO ARE SLOW TO RESPOND: 2 DOES PERSISTENCE PAY OFF? L. Sekhon,1,2 Moscow, Russian Federation, Gynecology, J. Rodriguez-Purata,1 J. A. Lee,1 L. Grunfeld,1,2 Center for Reproductive Medicine MAMA, 3 A. B. Copperman1,2; 1Reproductive Medicine Moscow, Russian Federation, Peoples’ Associates of New York, New York, NY, Friendship University of Russia, Moscow, 2Obstetrics, Gynecology & Reproductive Russian Federation. Science, Icahn School of Medicine at Mount Sinai, New York, NY. P-247 ADJUNCTIVE CLOMIPHENE CITRATE WITH LOW-DOSE GONADOTROPINS VERSUS P-242 THE IMPACT OF PEAK SERUM ESTRADIOL HIGH-DOSE GONADOTROPINS FOR IN VITRO FERTILIZATION IN POOR RESPONDERS. N. (E2) LEVELS ON BIRTH WEIGHTS (BW) AND ADVERSE PREGNANCY OUTCOMES (APO) Pereira, J. P. Lekovich, K. Winter, I. Kligman, FOLLOWING GONADOTROPIN-INDUCTION/ Z. Rosenwaks; The Ronald O. Perelman and INTRAUTERINE INSEMINATION (GN/IUI) Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, New York, NY.

nd 72 ASRM Scientific Congress & Expo 188 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-248 AFFECT OF GNRH AGONIST TRIGGER P-254 DOES FRESH EMBRYO TRANSFER FOLLOWED BY LOW DOSE HCG ON ACCENTUATE THE PERINATAL RISKS OF REPRODUCTIVE OUTCOME IN AT RISK DICHORIONIC TWIN GESTATIONS? L. OHSS PATIENTS: A COMPARISON BETWEEN Sekhon,1,2 K. Shaia,1,2 J. Rodriguez-Purata,1 FRESH AND FROZEN TRANSFER. K. D. Nayar, J. A. Lee,1 A. B. Copperman1; 1Reproductive A. Mohan, S. Chulet, R. Ahuja, G. Kant, N. Medicine Associates of New York, New York, Sharma, M. Saxena; Akanksha IVF Centre, NY, 2Obstetrics, Gynecology and Reproductive Mata Chana Devi Hospital, New Delhi, India. Science, Icahn School of Medicine at Mount Sinai, New York, NY. P-249 CLINICAL PREGNANCY RATES ACCORDING TO THE SERUM PROGESTERONE LEVEL ON P-255 ABSTRACT WITHDRAWN THE HUMAN CHORIONIC GONADOTROPIN DAY. J. M. Sad Larcher, L. M. Ganzer, V. M. P-256 NUMBER OF SUPERNUMERARY EUPLOID Maccari, P. M. Estofan, M. Hernandez, D. E. EMBRYOS FROM AN IVF CYCLE CORRELATES Estofan; CIGOR, Cordoba, Argentina. WITH AN ONGOING PREGNANCY RATE AFTER SUBSEQUENT SINGLE, EUPLOID P-250 BASELINE OVARIAN CYST FORMATION EMBRYO TRANSFER (SET). M. Kon,1,2 L. FOLLOWING GONADOTROPIN-RELEASING Sekhon,1,3 K. Shaia,1,3 M. C. Whitehouse,1 J. HORMONE ANALOGUES: THEIR A. Lee,1 R. Slifkin,1 E. Flisser,1 J. Klein,1 M. PREVALENCE AND IMPACT ON IN VITRO Lederman,1 L. Grunfeld,1,3 T. Mukherjee,1,3 B. FERTILIZATION OUTCOME. C. Failor, J. F. Sandler,1,3 A. B. Copperman,1,3 D. E. Stein1,2; Knudtson, R. S. Schenken, R. D. Robinson; 1Reproductive Medicine Associates of New University of Texas Health Science Center at York, New York, NY, 2Obstetrics, Gynecology San Antonio, San Antonio, TX. and Reproductive Science, Icahn School of Medicine at Mount Sinai West-Mount Sinai St. 3 P-251 LUTEAL ESTRADIOL PRIMING ISN`T Luke’s, New York, NY, Obstetrics, Gynecology SUPERIOR TO CONVENTIONAL GNRH- and Reproductive Science, Icahn School of ANTAGONIST PROTOCOL IN POOR Medicine at Mount Sinai, New York, NY. RESPONDER PATIENTS WITH DIFFERENT ANTI-MüLLERIAN HORMONE LEVELS. P-257 DO TRAINED REPRODUCTIVE A. P. Cil, Y. Sahin, S. Kahraman; Assisted ENDOCRINOLOGISTS DO BETTER Reproductive Technologies and Reproductive THAN THEIR TRAINEES? COMPARING Genetics Center, Istanbul Memorial Hospital, IMPLANTATION RATES AND CLINICAL Istanbul, Turkey. PREGNANCY RATES AFTER TRANSFER OF FRESH SINGLE BLASTOCYSTS. S. Behbehani, Y. Hasson, W. Son, T. Tulandi, W. Buckett; McGill University, Montreal, QC, Canada. EMBRYO TRANSFER P-258 PATIENTS OF ADVANCED MATERNAL AGE P-252 THE ROAD TO THE LAST ABDOMINAL SHOULD ONLY TRANSFER ONE EUPLOID ULTRASOUND USE IN IVF. A. Revel,1 G. BLASTOCYST: A COMPARATIVE ANALYSIS. 1 2 3 Karavany,1 Y. Shufaro,1,2 J. Hyman,1 A. Ben- C. Gordon, J. B. Whitney, I. Hatch, R. E. 4 2 1 Meir1; 1Obstetrics and Gynecology, Hadassah Anderson, M. C. Schiewe ; OB/GYN, University University Hospital, Jerusalem, Israel, of California Irvine Medical Center, Orange, CA, 2 2Obstetrics and Gynecology, Rabin Medical ART Lab, Ovation Fertility, Newport Beach, CA, 3 Center, Petah-Tikva, Israel. Southern California Fertility Center, Irvine, CA, 4Southern California Center for Reproductive Medicine, Newport Beach, CA. P-253 A COMPARISON BETWEEN FRESH EUPLOID EMBRYO TRANSFER AT LATE DAY 5 VERSUS DAY 6. H. Zaki,1 A. Hussien,1 N. Mohamed,1 P-259 PERINATAL OUTCOMES IN LIVE BIRTHS H. A. Alkhader2; 1Ganin Fertility Center, Cairo, FROM FRESH VERSUS FROZEN SINGLE 1,2 Egypt, 2IVF, Ganin Fertility Centre, Cairo, Egypt. EMBRYO TRANSFERS. L. Sekhon, K. Connolly,1,2 N. Herlihy,1,2 J. Rodriguez-Purata,1 J. A. Lee,1 A. B. Copperman1,2; 1Reproductive

nd 72 ASRM Scientific Congress & Expo 189 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Medicine Associates of New York, New York, 2Obstetrics and Gynecology, New York University NY, 2Obstetrics, Gynecology & Reproductive Fertility Center, New York, NY, 3OB/GYN, New Science, Icahn School of Medicine at Mount York University Fertility Center, New York, NY, Sinai, New York, NY. 4NYU Langone Medical Center, New York, NY.

P-260 SHOULD WE CONSIDER DAY-2 AND DAY-3 P-265 IMMEDIATE AMBULATION AFTER EMBRYO EMBRYO MORPHOLOGY BEFORE DAY-5 TRANSFER HAS NO EFFECT ON ONGOING TRANSFER WHEN BLASTOCYSTS REACH A PREGNANCY RATES IN FRESH OR FROZEN IVF SIMILAR GOOD QUALITY? C. Herbemont,1 CYCLES WITH OR WITHOUT COMPREHENSIVE N. Sermondade,2 I. Cedrin,3 M. Grynberg,4 C. CHROMOSOMAL SCREENING. A. Frankel,1 T. A. Sifer5; 1Biologie de la Reproduction - Hopital Molinaro,2 P. A. Bergh3; 1Nursing, Reproductive Jean Verdier, Bondy, France, 2Service Biologie Medicine Associates of NJ, Basking Ridge, NJ, de la Reproduction - CECOS, Hopital Jean 2Reproductive Medicine Associates of New Verdier, Bondy, France, 3Hopital Jean Verdier, Jersey, Eatontown, NJ, 3RMA, Basking Ridge, NJ. Bondy, France, 4Reproductive Medicine, 5 Hñpital Jean Verdier, Bondy, France, IVF P-266 PROSPECTIVE, RANDOMIZED, CLINICAL Unit, University Hospital Jean Verdier, Bondy, TRIAL TO COMPARE TWO ENDOMETRIAL France. PREPARATION PROTOCOLS. P. Ferrer Molina,1 C. Calatayud Lliso,2 R. Carreras P-261 IS THERE A DIFFERENCE IN CLINICAL Collado,3 M. Munoz Garcia,1 M. Diaz Bachiller,1 OUTCOME WHEN A VITRIFIED-WARMED J. Blanes Espi,1 M. Checa4; 1Crea Medicina BLASTOCYST IS TRANSFERRED AFTER FIVE de la Reproduccion, Gynecologist, Valencia, VERSUS SIX DAYS OF PROGESTERONE Spain, 2Crea Medicina de la Reproduccion, SUPPLEMENTATION IN AN ARTIFICIAL Doctor, Valencia, Spain, 3Hospital del Mar, CYCLE? T. Shaulov,1 A. Alserri,2 W. Son,1 Gynecologist, Barcelona, Spain, 4Hospital del J. Chung,1 W. Buckett1; 1McGill University, Mar, Barcelona, Spain. Montreal, QC, Canada, 2Obstetrics and Gynecology, Kuwait University, Jabriya, P-267 PREGNANCY OUTCOMES OF SINGLE Kuwait. VERSUS DOUBLE EMBRYO TRANSFER IN WOMEN WITH A CONGENITAL P-262 IS THE INCIDENCE OF RETAINED EMBRYOS UNICORNUATE UTERUS. X. Li,1 Y. Ouyang,2 SIMILAR IN FRESH VERSUS FROZEN ET’S? Y. Yi2; 1Reproductive and Genetic Hospital J. Rodriguez-Purata,1 L. Sekhon,1,2 J. A. Lee,1 of CITIC-Xiangya, Chang-sha, China, M. C. Whitehouse,1 E. Cervantes,1 M. Luna,1 T. 2Institute of Reproductive & Stem Cell Mukherjee,1,2 A. B. Copperman,1,2 B. Sandler1,2; Engineering, Central South University, 1Reproductive Medicine Associates of New Changsha, China. York, New York, NY, 2Obstetrics, Gynecology and Reproductive Science, Icahn School of P-268 ELECTIVE SINGLE EMBRYO TRANSFER Medicine at Mount Sinai, New York, NY. CRITERIA SHOULD BE APPLIED TO FROZEN EMBRYO TRANSFER CYCLES. M. R. Freeman,1 P-263 SEQUENTIAL EMBRYO SCORING SYSTEM M. Hinds,1 K. G. Howard,1 J. Howard,1 G. Hill2; CAN SUBSTITUTE FOR TIME LAPSE 1Ovation Fertility, Nashville, TN, 2Nashville MONITORING SYSTEM. Y. Kim,1 H. Sun,2 H. Fertility Center, Nashville, TN. Chi,1 S. Kim,1 K. Lee,2 S. Kwak,1 J. Park,1 C. 1 2 1 Yoo, J. Kim ; Babydream Research Center, P-269 STRATEGIC IMPLEMENTATION OF Mamapapa & Baby OBGY Clinic, Ulsan, Korea, 2 EXTENDED CULTURE RESULTS IN DIFFERENT Republic of, Mamapapa & Baby OBGY Clinic, CLINICAL OUTCOMES COMPARED TO Ulsan, Korea, Republic of. ROUTINE BLASTOCYST CULTURE IN DONOR CYCLES. V. Libby,1 S. Babayev,1 B. G. Reed,1 P-264 WHY DOES A EUPLOID EMBRYO FAIL TO K. Doody2; 1UT Southwestern Medical Center, IMPLANT? LESSONS FROM PATIENTS WHO Dallas, TX, 2Center for Assisted Reproduction, GET A SECOND TRANSFER. A. W. Tiegs,1 N. M. Bedford, TX. Sachdev,2 S. M. Maxwell,3 J. Grifo4; 1OB/GYN, NYU Langone School of Medicine, New York, NY,

nd 72 ASRM Scientific Congress & Expo 190 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-270 OLD HABITS DIE HARD: USE OF P-276 DIFFICULTY OF EMBRYO TRANSFER DOES CORTICOSTEROIDS AND ANTIBIOTICS PRIOR NOT PREDICT FAILED ATTEMPT AT VAGINAL TO EMBRYO TRANSFER. L. A. Kaye,1 C. B. DELIVERY IN SINGLETON PREGNANCIES. E. Bartels,1 A. Bartolucci,2 B. L. Maslow,1 J. Nulsen,2 Barnard,1 T. L. Jones,2 L. E. Vaughan,3 K. Mara,1 C. A. Benadiva2; 1University of Connecticut, C. Coddington1; 1Mayo Clinic, Rochester, MN, Farmington, CT, 2Center for Advanced 2Reproductive Endocrinology and Infertility, Reproductive Services, Farmington, CT. Mayo Clinic, Rochester, MN, 3Division of Biomedical Statistics and Informatics, Mayo P-271 CAN EMBRYO CATHETER LOADING HAVE AN Clinic, Rochester, MN. INFLUENCE ON THE INCIDENCE OF ECTOPIC PRGNANCY IN IVF/ET CYCLES? M. E. Eid,1 M. Alshoumoury,2 S. E. Elsaid3; 1Obst/Gyne, Professor of Obst/Gyne, Cairo Univ., Egypt, Dubai, United ENDOMETRIUM Arab Emirates, 2IVF (Lab Director), Fakih IVF 3 Center, Dubai, United Arab Emirates, IVF, Fakih P-277 ADENOMYOSIS IS ASSOCIATED WITH IVF Center, Dubai, United Arab Emirates. DIMINISHED ENDOMETRIAL EXPRESSION OF BONE MORPHOGENETIC PROTEINS BMPR1B P-272 EFFECT OF PGS ON IVF OUTCOMES AND SMAD4. E. G. Richards,1 S. A. El-Nashar,2 J. K. FOLLOWING ELECTIVE SINGLE EMBRYO Schoolmeester,3 M. R. Hopkins,1 A. O. Famuyide,1 TRANSFER (ESET) IN OOCYTE DONATION G. S. Daftary1; 1Department of Obstetrics and IN THE UNITED STATES: 2005 TO 2013. D. Gynecology, Mayo Clinic, Rochester, MN, 2Division H. Barad,1,2 S. Darmon,1 V. A. Kushnir,1,3 E. of Female Pelvic Medicine and Reconstructive Lazzaroni-Tealdi,1 Q. Wang,1 D. Albertini,1,4 N. Surgery, University Hospitals Case Medical Center Gleicher1,5; 1Center for Human Reproduction, Case Western Reserve University, Cleveland, New York, NY, 2Albert Einstein College of OH, 3Department of Laboratory Medicine and Medicine, Bronx, NY, 3Wake Forest School of Pathology, Mayo Clinic, Rochester, MN. Medicine, Winston-Salem, NC, 4University of Kansas Medical Center, Kansas City, KS, P-278 - PATHWAY IS 5 Rockefeller University, New York, NY. INVOLVED IN THE DECREASE OF ESTROGEN RECEPTOR-α BY CLOMIPHENE CITRATE IN P-273 INDIVIDUAL COMPONENTS OF A GARDNER’S HUMAN ENDOMETRIAL CELLS. M. Amita,1 H. BLASTOCYST GRADE AND A SUMMARIZED Saito,1 T. Takahashi2; 1Division of Reproductive SCORE ARE PREDICTIVE OF IMPLANTATION Medicine, National Center for Child Health FOR MULTIPLE BUT NOT SINGLE EMBRYO and Development, Setagaya, Tokyo, Japan, TRANSFERS. J. E. Gray,1 M. A. Fritz,2,1 D. 2Fukushima Medical Center for Children S. Berger3,1; 1UNC Fertility, Raleigh, NC, and Women, Fukushima Medical University, 2Obstetrics and Gynecology, University of Fukushima-City, Fukushima, Japan. North Carolina Chapel Hill, Chapel Hill, NC, 3 Penn Fertility Care, Philadelphia, PA. P-279 EFFECTS OF SUPRAPHYSIOLOGIC LEVELS OF ESTRADIOL ON ENDOMETRIAL P-274 INNER CELL MASS AND TROPHECTODERM DECIDUALIZATION AND HOXA10 EXPRESSION. QUALITY AS PREDICTIVE PARAMETERS H. Cottrell,1 J. Spencer,1 N. Sidell,2 A. Rajakumar2; OF PREGNANCY AND IMPLANTATION. L. 1Emory Reproductive Center, Atlanta, Iraurgui,1 F. Ayerdi,1 M. Ferrando,1 F. Quintana,2 GA, 2Division of Research, Department of Z. Larreategui1; 1IVI Bilbao, Leioa, Spain, Gynecology and Obstetrics, Emory University 2Andrology Laboratory, IVI Bilbao, Leioa, Spain. School of Medicine, Atlanta, GA.

P-275 TIMING OF EMBRYO TRANSFER AFTER P-280 MIRNA EXPRESSION IN RECEPTIVE VERSUS HYSTEROSCOPIC DOES POST-RECEPTIVE ENDOMETRIUM IN NOT EFFECT PREGNANCY RATES. Z. Diken,1 PATIENTS UNDERGOING IVF. F. P. Rodrigues,1,2 A. Rodriguez,2 Y. Lin,1 J. Crochet3; 1OB GYN, T. C. Bonetti,2,3 C. V. de Carvalho,2 F. Vigo,4 UTMB, Galveston, TX, 2University of Texas R. Fraietta,5 F. Vilella,6 C. Simon,7 E. Motta8,2; Medical Branch, Galveston, TX, 3Center of 1Clinical, Huntington Medicina Reprodutiva, Reproductive Medicine, Webster, TX. Sao Paulo, Brazil, 2Gynecology, Universidade

nd 72 ASRM Scientific Congress & Expo 191 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Federal de Sao Paulo, Sao Paulo, Brazil, P-285 A NEW WAY TO DETERMINE UTERINE 3Scientific, Huntington Medicina Reprodutiva, RECEPTIVITY BY MOLECULAR PROFILING OF Sao Paulo, Brazil, 4UNIFESP, Sao Paulo, ENDOMETRIAL BIOPSIES. S. V. Dambaeva,1 Brazil, 5Department of Surgery, Division of D. Katukurundage,1 L. Wu,2 N. Sung,2 M. D. Urology, Human, Sao Paulo Federal University, Salazar Garcia,2 A. Skariah,2 A. Gilman-Sachs,1 Sao Paulo, Brazil, 6Fundacion IVI / INCLIVA, J. Kwak-Kim,2 K. Beaman1; 1Dept. Microbiology Paterna, Spain, 7Department of Obstetrics and and Immunology, Clinical Immunology Gynecology, Fundacion Instituto Valenciano Laboratory, Rosalind Franklin University de Infertilidad (FIVI); Instituto Universitario IVI/ of Medicine and Science, North Chicago, INCLIVA, Valencia University, School of Medicine, IL, 2Dept. of Obstetrics and Gynecology, Stanford University, Paterna, Spain, 8Huntington Reproductive Medicine Center, Chicago Medicina Reprodutiva, Sao Paulo, Brazil. Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL. P-281 EXOGENOUS GONADOTROPINS UPREGULATE PRIMARY ENDOMETRIAL P-286 THE UTILITY OF ENDOMETRIAL AND STROMAL CELL DECIDUALIZATION IN FRESH UTERINE VASCULARITY MEASUREMENT IN VITRO FERTILIZATION CYCLES. M. M. BY TRANSVAGINAL ULTRASONOGRAPHY Schulte,1 C. S. Stephens,2 K. Moley3; 1Ob/Gyn, IN PREDICTING PREGNANCY OUTCOME Washington University in St Louis, St Louis, DURING FROZEN-THAWED EMBRYO MO, 2OB/GYN, Washington University School of TRANSFER CYCLES. K. Lee,1 J. Joo,1 J. Choi,2 Medicine, St. Louis, MO, 3OB/GYN, Washington S. Kim,1 S. Lee1; 1Pusan National University University in St. Louis, St. Louis, MO. Hospital, Busan, Korea, Republic of, 2Eroom Women’s Hospital, Busan, Korea, Republic of. P-282 ACTIVATING TRANSCRIPTION FACTOR 3 (ATF3) FACILITATES DECIDUAL PROLACTIN P-287 OBSTETRIC OUTCOMES FOLLOWING FROZEN SECRETION IN HUMAN ENDOMETRIAL EMBRYO TRANSFER (FET) IN PATIENTS STROMAL CELLS BY INCREASING FORKHEAD WITH AN ENDOMETRIAL THICKNESS BOX O1 (FOXO1) EXPRESSION. X. Cheng, C. MEASURING <7MM. C. R. Juneau, J. M. Huang, Q. Yan, J. Shen, R. Jiang, Z. Diao, L. Franasiak, S. J. Morin, T. A. Molinaro, R. T. Scott Ding, X. Zhen, G. Yan, H. Sun; The Affiliated Jr.; Reproductive Medicine Associates of New Drum Tower Hospital of Nanjing University Jersey, Basking Ridge, NJ. Medical School, Nanjing, China. P-288 HUMAN ENDOMETRIAL RECEPTIVITY- P-283 EFFECT OF GNRH AGONIST FOR LUTEAL ASSOCIATED MIRNAS: BEYOND THE GENES. PHASE SUPPORT ON HUMAN ENDOMETRIAL C. Innocenti,1 D. Haouzi,2 L. Drissennek,3 RECEPTIVITY AFTER OVARIAN STIMULATION Y. Antoine,4 F. Entezami,5 L. Delaroche,6 C. USING LONG PROTOCOL. Y. Li,1 Y. Feng,1 X. Brunet,7 S. Hamamah8; 1Unitæ 1203 IRMB Wu,2 H. Sha,3 Z. Niu1; 1Reproductive Medical Montpellier, Montpellier, France, 2U1203 Center, Ruijin Hospital Affiliated to Shanghai - IRMB - CHRU Montpellier, Montpellier, Jiao Tong University School of Medicine, France, 3INSERM U1203, Human Early Shanghai, China, 2Reproductive Medical Embryonic Development and Pluripotency, Center, Women and Children’s Hospital Montpellier, France, 4U1203-IRMB, Clermont- of Shanxi Province, Taiyuan, China, 3State l’Hærault, France, 5IVF Laboratory Eylau- Key Laboratory of Medical Neurobiology, UNILABS, Clinique de La Muette-Ramsay Shanghai Medical College, Fudan University, GDS, Paris, France, 6Eylau-Unilabs IVF Shanghai, China. Laboratory, Neuilly-sur-Seine, France, 7Endocrinologist, Montpellier, France, 8ART/ P-284 OBESE WOMEN EXPERIENCE IMPAIRED PGD Department, Arnaud de Villeneuve IN VITRO DECIDUALIZATION DUE TO Hospital, Montpellier, France. DECREASED AUTOPHAGY. M. M. Schulte,1 C. S. Stephens,1 K. Moley2; 1Ob/Gyn - REI, P-289 CDKN1C (P57): THE DETERMINANT OF Washington University in St Louis, St Louis, HUMAN ENDOMETRIAL STROMAL CELL MO, 2OB/GYN, Washington University in St. DECIDUALIZATION. L. Wang, L. Huang, Louis, St. Louis, MO. H. Zhang, K. Qian; Tongji Hospital, Tongji

nd 72 ASRM Scientific Congress & Expo 192 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Medical College, Huazhong University of Associates of New York, New York, NY, 2Obstetrics, Science and Technology, Reprodoctive Gynecology & Reproductive Science, Icahn Medical Center, Wuhan, China. School of Medicine at Mount Sinai, New York, NY.

P-290 ENDOMETRIAL VASCULARITY AND INCREASING P-295 FOUR AND A HALF LIM DOMAINS 1 (FHL1) ENDOMETRIAL THICKNESS CAN PREDICT POSITIVELY REGULATES EMBRYO ADHESION LIVE BIRTH: A RETROSPECTIVE ANALYSIS OF VIA BINDING HOMEOBOXA10 (HOXA10). Q. 1575 FET CYCLES. H. Konar,1 S. Sharma,2 P. Yan, X. Cheng, J. Shen, C. Huang, R. Jiang, Chakraborty,3 I. Saha,2 R. Chattopadhyay,4 S. Z. Diao, L. Ding, X. Zhen, G. Yan, H. Sun; The Ghosh,5 B. Chakravarty6; 1Professor, Obstetrics Affiliated Drum Tower Hospital of Nanjing & Gynecology, Kolkata, India, 2ART, Consultant, University Medical School, Nanjing, China. Kolkata, India, 3Infertility, Scientist, Kolkata, India, 4 Reproductive Medicine, Embryologist, Kolkata, P-296 IDENTIFICATION OF HUMAN ENDOMETRIAL India, 5Assisted Reproduction, Consultant, 6 MICRORNAS ASSOCIATED WITH REPEATED Kolkata, India, Reproductive Medicine, Director, IMPLANTATION FAILURES. D. Haouzi,1 L. Kolkata, India. Drissennek,1 Y. Antoine,2 F. Entezami,3 A. Gala,4 T. Mullet,1 C. Vincens,5 S. Hamamah6; 1U1203 - P-291 ER MAP ALLOW THE RELIABLE IRMB - CHRU Montpellier, Montpellier, France, DETERMINATION OF THE WINDOW OF 2U1203-IRMB, Clermont-l’Hærault, France, IMPLANTATION IN INFERTILE WOMEN. J. 3IVF Laboratory Eylau-UNILABS, Clinique de A. Horcajadas,1 M. Enciso,2 J. Sarasa,2 J. La Muette, Paris, France, 4CHU Montpellier, P. Carrascosa,1 P. Martinez,2 J. Aizpurua,3 Montpellier, France, 5CHU ADV, Montpellier, S. Munne4; 1Genetics, University Pablo de France, 6ART/PGD Department, Arnaud de Olavide, Sevilla, Spain, 2Genetics, IGLS, Villeneuve Hospital, Montpellier, France. Alicante, Spain, 3IVF Spain, Alicante, Spain, 4 Genetics, Reprogenetics, Livingston, NJ. P-297 POTENTIAL MECHANISM BY WHICH GLUCOSE REGULATES DECIDUALIZATION IN P-292 HUMAN ENDOMETRIAL MICRORNAS HUMAN ENDOMETRIAL STROMAL CELLS. H. ASSOCIATED WITH . L. Tamura, N. Sugino; Obstetrics & Gynecology, Drissennek,1 D. Haouzi,2 Y. Antoine,3 F. Yamaguchi University Graduate School of Entezami,4 S. Bringer,5 S. Hamamah6; 1INSERM Medicine, Ube, Japan. U1203, Human Early Embryonic Development 2 and Pluripotency, Montpellier, France, U1203 P-298 KISSPEPTIN REGULATES THE MOTILITY OF - IRMB - CHRU Montpellier, Montpellier, HUMAN DECIDUAL ENDOMETRIAL STROMAL France, 3U1203-IRMB, Clermont-l’Hærault, 4 CELLS: EFFECT ON EMBRYO IMPLANTATION France, IVF Laboratory Eylau-UNILABS, AND PREGNANCY BEYOND THE BRAIN. H. Clinique de La Muette-Ramsay GDS, Paris, Wu, H. Huang, H. Wang, Y. Soong; Department 5 France, Medical Doctor, Montpellier, France, of Obstetrics and Gynecology, Chang Gung 6 ART/PGD Department, Arnaud de Villeneuve Memorial Hospital Linkou Medical Center, Hospital, Montpellier, France. Taoyuan, Taiwan.

P-293 QUANTITATIVE ASSESSMENT OF P-299 BCL6 AND SIRT1 EXPRESSION IN ENDOMETRIAL VOLUME AND UTERINE UNEXPLAINED INFERTILITY VERSUS VASCULARITY AND PREGNANCY OUTCOME IN UNEXPLAINED RECURRENT PREGNANCY LOSS. FROZEN-THAWED EMBRYO TRANSFER CYCLES. C. W. Fox,1 S. L. Young,2 J. Jeong,3 W. A. Palomino,4 K. Lee, J. Joo, S. Kim, S. Lee; Pusan National B. A. Lessey5; 1OB/GYN, Greenville Health System, University Hospital, Busan, Korea, Republic of. Greenville, SC, 2Obstetrics & Gynecology, UNC School of Medicine, Chapel Hill, NC, 3Obstetrics, P-294 THE PRESENCE OF A THIN ENDOMETRIAL Gynecology and Reproductive Biology College STRIPE IN EXTREMELY LOW BMI PATIENTS of Human Medicine, Michigan State University, IS NOT ASSOCIATED WITH LOWER Grand Rapids, MI, 4Obstetric&Gynecology, IMPLANTATION RATES. L. Sekhon,1,2 K. Shaia,1,2 University of Chile, Santiago Chile, Chile, J. Rodriguez-Purata,1 J. A. Lee,1 L. Grunfeld,1,2 5Obstetrics and Gynecology, Reproductive A. B. Copperman1,2; 1Reproductive Medicine Endocrinology and Infertility, Greenville, SC.

nd 72 ASRM Scientific Congress & Expo 193 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

FEMALE REPRODUCTIVE SURGERY University, Assiut, Egypt, 2Obstetrics and Gynecology, Mayo Clinic, Rochester, MN. P-300 IMPACT OF THE FOOD AND DRUG ADMINISTRATION (FDA) SAFETY P-305 PREVALENCE OF PRIOR REPRODUCTIVE COMMUNICATION ON MORCELLATION ON SURGERY AMONG WOMEN SCHEDULED FOR SURGICAL PRACTICE AND PERIOPERATIVE IVF. A. M. Abdelmagied, M. K. Ali, D. M. Habib, MORBIDITY FOLLOWING MYOMECTOMY. N. C. A. A. Abdelaleem, T. A. Farghaly, E. Badran, A. Stentz,1 L. Cooney,1 M. D. Sammel,2 D. K. Shah1; A. Nassr, O. S. Abdalmageed, I. Elnashar, A. 1Reproductive Endocrinology & Infertility, Abbas; Obstetrics and Gynecology, Women University of Pennsylvania, Philadelphia, Health Hospital, Assiut University, Assiut, PA, 2Biostatistics and Epidemiology, Univ. of Egypt. Pennsylvania, Perelman School of Medicine, Philadelphia, PA. P-306 DEVELOPMENT OF A NEW TUBAL RECANALIZATION METHOD USING THE P-301 LAPAROSCOPIC RESECTION AND REPAIR OF COMBINATION OF HYSTEROSCOPE AND UTERINE ISTHMOCELE. C. E. Miller,1 C. Steller,2 LAPAROSCOPE IN THE TREATMENT OF A. Cholkeri-Singh,3 K. Sasaki4; 1The Advanced OBSTRUCTED FALLOPIAN TUBES. A. Tanaka, IVF Institute, Naperville, IL, 2Advocate Lutheran M. Nagayoshi, I. Tanaka, T. Miki, T. Yamaguchi; General Hospital, Park Ridge, IL, 3Gynecology, Saint Mother Hospital, Kitakyusyu, Japan. The Advanced Gynecologic Surgery Institute, Naperville, IL, 4Advanced Gynecologic Surgery P-307 COST-EFFECTIVENESS OF ROBOTIC Institute, Naperville, IL. SALPINGOSTOMY FOR MANAGEMENT OF ECTOPIC PREGNANCY. S. A. Singer, P-302 AIR INFUSED SALINE FOR PREDICTING J. P. Shepherd; Department of Obstetrics, TUBAL PATENCY WITH FLEXIBLE OFFICE Gynecology, & Reproductive Sciences, UPMC- HYSTEROSCOPY IS CORRELATED WITH Magee Womens Hospital, Pittsburgh, PA. POST-HYSTEROSCOPY CHANGES IN CUL-DE-SAC FLUID VOLUME. J. Aldred,1 P-308 HYSTEROSCOPIC POLYPECTOMY ON THE D. M. Riche,2 W. May,3 S. E. Wilson,4 J. M. DAY OF EGG RETRIEVAL FOLLOWED BY Shwayder,1 J. P. Parry4; 1OB/GYN, University EMBRYO TRANSFER ON DAY 3 OR DAY 5 of Mississippi Medical Center, Jackson, MS, DOES NOT SEEM TO NEGATIVELY AFFECT 2Pharmacy Practice, School of Pharmacy, IMPLANTATION: A CASE SERIES. J. P. UMMC, Jackson, MS, 3School of Health Rouleau, R. Garcia, J. Hernandez, A. Palumbo; Related Professions, UMMC, Jackson, MS, Reproductive Endocrinology, Centro de 4OB/GYN-REI, UMMC, Jackson, MS. Asistencia a la Reproducciðn Humana de Canarias, La Laguna, Spain. P-303 HYSTEROSCOPIC SURGERY AS A SURROGATE MARKER FOR LOCAL ENDOMETRIAL INJURY P-309 TYPE OF THE FEMALE GENITAL MUTILATION IN FRESH IVF CYCLES. A. M. Abdelmagied,1 O. AND SEXUAL FUNCTION IN SUDANESE S. Abdalmageed,1 A. Abbas,1 T. A. Farghaly,1 M. WOMEN. A. A. Rouzi, S. Alkafy, N. Alsahly, K. Ali,1 A. A. Nassr,1 S. A. Shazly,2,1 D. M. Habib1; H. Abduljabbar, F. Alzaben; Obstetrics and 1Obstetrics and Gynecology, Women Health Gynecology, King Abdulaziz University, Hospital, Assiut University, Assiut, Egypt, Jeddah, Saudi Arabia. 2Obstetrics and Gynecology, Mayo Clinic, Rochester, MN. P-310 HIDDEN ENDOMETRIAL ABNORMALITIES IN WOMEN AGED 35 YEARS OR MORE AND P-304 IMPACT OF PRIOR REPRODUCTIVE SURGERY SCHEDULED FOR IVF; HOW THEIR UTERI ON HEALTH RELATED QUALITY OF LIFE WILL BEHAVE AFTER RESECTION OF THE AMONG IVF WOMEN. A. M. Abdelmagied,1 ABNORMALITIES ? A. M. Abdelmagied, A. Abbas, O. S. Abdalmageed,1 A. A. Abdelaleem,1 T. T. A. Farghaly, A. A. Abdelaleem, E. Badran, M. K. A. Farghaly,1 E. Badran,1 S. A. Shazly,2,1 M. K. Ali, d. m. habib, O. S. Abdalmageed, I. Elnashar; Ali,1 I. Elnashar,1 A. Abbas1; 1Obstetrics and Obstetrics and Gynecology, Women Health Gynecology, Women Health Hospital, Assiut Hospital, Assiut University, Assiut, Egypt.

nd 72 ASRM Scientific Congress & Expo 194 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-311 INCIDENCE OF URINARY TRACT INJURY 1Reproduction Clinic Osaka, Osaka, Japan, IN BENIGN GYNECOLOGIC LAPAROSCOPY: 2Ishikawa Hospital, Urology, Himeji, Japan. A SYSTEMATIC REVIEW. J. M. Wong,1 2 1 1 P. Bortoletto, M. J. Jung, M. P. Milad ; P-317 ICSI HAS SIGNIFICANTLY INCREASED THE 1Northwestern University, Chicago, IL, 2 PREGNANCY RATE COMPARED TO THE Brigham and Women’s Hospital, Boston, MA. CONVENTIONAL IVF IN THE PATIENTS WITH HIGH SPERM DNA FRAGMENTATION P-312 THE REPRODUCTIVE OUTCOME AFTER INDEX. J. Park,1 K. Lee,2 H. Sun,2 H. Chi,1 HYSTEROSCOPIC IN S. Kwak,1 S. Kim,1 Y. Kim,1 J. Kim,2 C. Yoo1; PATIENTS WITH DEEP UTERINE SEPTUM 1Mamapapa&baby OBGY Clinic, Ulsan, Korea, AND T-SHAPED UTERUS. Y. Şœkœr,1 B. Republic of, 2Mamapapa&baby OBGY, Ulsan, Yakistiran,2 M. M. Seval,1 B. Ozmen,1 M. Korea, Republic of. Sonmezer,1 B. Berker,1 C. S. Atabekoglu1; 1Obstetrics and Gynecology, Ankara 2 P-318 REPRODUCTIVE OUTCOMES FOLLOWING University, Ankara, Turkey, Obstetrics and SURGICAL SPERM RETRIEVAL IN COUPLES Gynecology Assistant, Ankara, Turkey. WITH OBSTRUCTIVE AZOOSPERMIA (OA), NON-OBSTRUCTIVE AZOOSPERMIA (NOA) AND REPEATED IN VITRO FERTILIZATION (IVF) FAILURE. G. Younes, A. Gilman, S. IMAGING AND REPRODUCTIVE MEDICINE Tannus, W. Son, P. Chan, W. Buckett; McGill University, Montreal, QC, Canada. P-313 FIRST EVER “5K” ULTRA-HD HIGHEST RESOLUTION VIDEO IMAGING OF GAMETES P-319 EFFECTS OF SPERM QUALITY ON THE AND EMBRYOS: PILOT STUDY FOR SUCCESS OF INTRACYTOPLASMIC SPERM MORPHOLOGICAL ASSESSMENT. S. F. Palter,1 INJECTION (ICSI) WITH TESTICULAR SPERM M. Meseguer,2 J. de los Santos,2 J. Romero,2 IN COUPLES WITH RECURRENT ICSI FAILURE A. Pellicer3; 1Gold Coast IVF, Woodbury, NY, WITH EJACULATED SPERM. B. Herrero,1 2IVI Valencia, Valencia, Spain, 3Hospital M. Lusignan,2 W. Son,1 W. Buckett,1 P. Chan2; Universitari i Politecnic La Fe, Valencia, Spain. 1Obstetrics & Gynecology Department, McGill University Health Centre, Montreal, QC, Canada, 2 P-314 ROLE OF THREE DIMENSIONAL Urology Department, McGill University Health ENDOMETRIAL VOLUME AND THICKNESS IN Centre, Montreal, QC, Canada. PREDICTING THE OUTCOME OF IVF CYCLES. N. Singh, A. Yadav, V. Perumal; Department of P-320 MALE FACTOR INFERTILITY AND Obstetrics & Gynaecology, All India Institute ANEUPLOIDY: DO COUPLES WITH MALE Of Medical Sciences, Delhi, India. FACTOR INFERTILITY HAVE A LOWER RATE OF EUPLOID EMBRYOS? A. L. Ganza,1,2 M. C. Whitehouse,1 J. A. Lee,1 P. G. McGovern,2,3 N. Bar-Chama,1,3 A. B. Copperman,1,3 D. E. Stein1,2; 1Reproductive Medicine Associates of New MALE FACTOR - ART York, New York, NY, 2Obstetrics, Gynecology and Reproductive Science, Icahn School of P-315 INCREASED ARREST PRIOR TO COMPACTION IN Medicine at Mount Sinai West-Mount Sinai St. EMBRYOS DERIVED FROM TESTICULAR SPERM. Luke’s, New York, NY, 3Obstetrics, Gynecology P. K. Gill, N. Desai; OB-GYN/Women’s Health and Reproductive Science, Icahn School of Institute, Cleveland Clinic, Beachwood, OH. Medicine at Mount Sinai, New York, NY.

P-316 INTRACYTOPLASMIC SPERM INJECTION P-321 DETECTING Y-CHROMOSOME (ICSI) OUTCOME USING IMMOTILE MICRODELETIONS USING NEXT SPERMATOZOA EVEN AFTER PENTOXIFYLLIN GENERATION SEQUENCING (NGS) DATA. ADMINISTRATION IN NON-OBSTRUCTIVE R. Shraga,1 M. C. Akana,2 S. L. Bristow,1 A. AZOOSPERMIC PATIENTS. S. Mizuta,1 K. Manoharan,1 O. Puig1; 1Recombine, New York, Yamaguchi,2 R. Nishiyama,1 Y. Takaya,1 K. NY, 2Lab, Recombine, New York City, NY. Kitaya,1 H. Matsubayashi,1 T. Ishikawa1;

nd 72 ASRM Scientific Congress & Expo 195 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-322 EPIGENOME ANALYSIS USING INFINIUM THAWED TESTICULAR SPERMATOZOA 450K BEADCHIP ARRAYS IDENTIFIES RETRIEVED FROM NON-OBSTRUCTIVE ABERRANT DNA METHYLATION IN AZOOSPERMIC PATIENTS. C. Pirkevi SPERMATOZOA OF MALES WITH Çetinkaya, H. K. Yelke, M. Basar, S. Kahraman; UNEXPLAINED INFERTILITY. M. M. Laqqan,1 Assisted Reproductive Technologies and Y. A. Alkhaled,1 S. Tierling,2 J. Walter,2 M. Reproductive Genetics Center, Istanbul E. Hammadeh1; 1Obstetrics & Gynecology, Memorial Hospital, Istanbul, Turkey. Saarland University, Germany, Homburg, 2 Germany, Genetik/Epigenetik, Saarland P-328 CLINICAL OUTCOMES AFTER ICSI FROM University, Germany, Saarbruecken, Germany. SPERM EXTRACTION OR EJACULATED SPERM FROM MODERATE AND SEVERE P-323 DOES SEVERE TERATOZOOSPERMIA OLIGO-ASTHENO-TERATOZOOSPERMIA IN IS CORRELATED WITH EMBRYONIC A COHORT OF GOOD PROGNOSIS FEMALE ANEUPLOIDY RATES? J. Rodriguez-Purata,1 PATIENTS. J. Martinez, I. Molina, S. Lujan, L. Sekhon,1,2 J. A. Lee,1 M. C. Whitehouse,1 R. J. Rubio, A. Pellicer; Hospital Universitari i Slifkin,1 E. Flisser,1 M. Duke,1 A. B. Copperman,3,2 Politècnic La Fe, Valencia, Spain. B. Sandler,1,2 N. Bar-Chama1,2; 1Reproductive Medicine Associates of New York, New York, P-329 Abstract withdrawn NY, 2Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, NY, 3Obstetrics and P-330 TOTAL MOTILE COUNT IS MORE PREDICTIVE OF Gynecology, RMANY-Mount Sinai, New York, NY. CLINICAL PREGNANCY AT OLDER MATERNAL AGE. E. B. Mankus,1 J. F. Knudtson,1 A. E. Holden,2 R. S. Schenken1; 1Obstetrics and Gynecology, P-324 SUCCESSFUL TREATMENTS FOR University of Texas Health Science Center at San KARTAGENER SYNDROME WITH Antonio, San Antonio, TX, 2Epidemiology and COMPLETELY IMMOTILE SPERM OR Biostatistics, University of Texas Health Science AZOOSPERMIA. A. Tanaka, M. Nagayoshi, I. Center at San Antonio, San Antonio, TX. Tanaka, T. Miki, T. Yamaguchi; Saint Mother Hospital, Kitakyusyu, Japan. P-331 PATERNALLY DERIVED EMBRYONIC ANEUPLOIDY IS COMMON BUT NOT P-325 OUTCOMES OF ICSI CYCLES WITH EITHER ASSOCIATED WITH MALE FACTOR FRESH OR FROZEN-THAWED TESTICULAR INFERTILITY. M. Shah,1 R. Lathi,2 M. SPERMATOZOA IN CONSECUTIVE CYCLES OF Eisenberg3; 1Stanford University, Palo Alto, NON-OBSTRUCTIVE AZOOSPERMIC PATIENTS. CA, 2REI, Stanford University, Stanford, CA, 1 2 1 U. Ozdemir, E. E. Nal, H. K. Yelke, C. Pirkevi 3Urology, Stanford University, Stanford, CA. Cetinkaya,1 M. M. Basar,1 S. Kahraman1; 1Assisted Reproductive Technologies and Reproductive Genetics Center, Istanbul Memorial Hospital, P-332 IMPACT OF PATERNAL AGING WITH OR Istanbul, Turkey, 2Memorial Sisli Hospital, WITHOUT SEMINAL ABNORMALITIES ON Istanbul, Turkey. OOCYTE DONOR CYCLES OUTCOMES. A. G. Castaneda,1 A. Davila,2 E. A. Amaro,3 C. R. Chapa,4 P. Galache,1 P. Patrizio5; 1IECH Fertility P-326 RELATIONSHIP OF SPERM DNA Center, Monterrey, Mexico, 2Reproductive FRAGMENTATION (TUNEL) TO Medicine and Clinical Andrology, Instituto BLASTULATION AND EUPLOIDY AFTER IVF. para el Estudio de la Concepcion Humana, 1 1 2 1 V. Gunnala, M. Irani, A. Bolyakov, Q. Zhan, Monterrey, Mexico, 3IECH Fertility Center, 1 2 1 D. E. Reichman, D. Paduch, N. Zaninovic, Z. Cuauhtæmoc, Mexico, 4I.E.C.H Fertility Center, 1 1 Rosenwaks ; The Ronald O. Perelman and Monterrey, Mexico, 5Obstetrics, Gynecology & Claudia Cohen CRM, Weill Cornell Medicine, Reproductive Sciences, Yale Fertility Center & 2 New York, NY, Reproductive Medicine and Fertility Preservati, New Haven, CT. Urology, Weill Cornell Medicine, New York, NY.

P-333 SPERM DNA FRAGMENTATION HAS P-327 IMPACT OF FEMALE AGE AND OVARIAN A NEGATIVE CORRELATION WITH RESERVE ON THE OUTCOMES OF ICSI PROGRESSIVE MOTILITY AND STRICT CYCLES WITH EITHER FRESH OR FROZEN-

nd 72 ASRM Scientific Congress & Expo 196 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

MORPHOLOGY. C. Alvarez Sedo, D. Lorenzi, P-340 SEMINAL OXIDATION REDUCTION M. Bilinski, H. Uriondo, F. Fulco, G. Alvarez, S. POTENTIAL CAN DIFFERENTIATE FERTILE Papier; CEGYR (Reproductive Medicine and FROM INFERTILE MEN. M. M. Arafa,1,2 H. Genetics), Buenos Aires, Argentina. Elbardisi,1 A. Agarwal,3 A. Majzoub,4 R. Sharma,3 S. S. Alsaid,1 K. B. Bjugstad,5 K. Khalafalla,6 k. R. AlRumaihi1; 1Urology, Hamad Medical P-334 OUTCOMES OF INTRACYTOPLASMIC 2 SPERM INJECTION IN MEN WITH Corporation, Doha, Qatar, Andrology, Cairo University Hospital, Cairo, Egypt, 3Urology, OLIGOASTHENOTSPERMIA AND 4 BACTERIOSPERMIA. L. Li, Y. Zhang, S. Cleveland Clinic, Cleveland, OH, Urology, W. Li; Reproductive Medical Center, West Glickman Urological and Kidney Institute, China Second University Hospital,Sichuan Cleveland Clinic Foundation, Cleveland, OH, 5 6 University, Chengdu, China. Aytu BioScience, Englewood, CO, Hamad Medical Corporation, Doha, Qatar.

P-335 EUPLOID BLASTOCYST TRANSFER IS A VIABLE CLINICAL OPTION FOR MALE P-341 NEXT GENERATION DNA SEQUENCING FOR FACTOR INFERTILITY WITH HIGH SPERM IDENTIFICATION OF NEW GENETIC POINT DNA FRAGMENTATION. J. M. Stevens, A. MUTATION IN FAMILAIL IDIOPATHIC NON- Schneiderman, K. Maruniak, B. Findley, W. B. OBSTRUCTIVE AZOOSPERMIA PATIENTS. Schoolcraft, M. Katz-Jaffe; Colorado Center H. Elbardisi, M. M. Arafa, S. S. Alsaid, k. R. for Reproductive Medicine, Lone Tree, CO. AlRumaihi, A. A. AlAnsari; Urology, Hamad Medical Corporation, Doha, Qatar.

P-336 TESTICULAR SPERM CORRELATES WITH A SIMILAR RATE OF EUPLOID EMBRYO P-342 ABSTRACT WITHDRAWN DEVELOPMENT COMPARED TO CYCLES USING EJACULATED SPERM. M. Li, M. P-343 INFERTILE MEN HAVE A REDOX IMBALANCE Shamonki, G. Hubert, R. Tassin, R. P. Buyalos; THAT DISTINGUISHES THEM FROM Fertility and Surgical Associates of California, FERTILE MEN. A. Ayaz,1 K. B. Bjugstad,2 Thousand Oaks, CA. D. Bar-Or,3 A. Armagan4; 1Yildiz Technical University, Istanbul, Turkey, 2Aytu BioScience, Englewood, CO, 3Trauma Research, Swedish Medical Center, Englewood, CO, 4Urology, MALE REPRODUCTION AND UROLOGY - RESEARCH Bezmi Alem Vakif University, Istanbul, Turkey.

P-337 THE DOWN EXPRESSION OF NPAS2 P-344 THE CONSEQUENCES OF SOMATIC SEX PREDICTS LOW TESTOSTERONE LEVELS DUE CHROMOSOMAL ABNORMALITIES ON TO DECREASED EXPRESSION OF STAR. A. MEIOSIS AND SPERM PRODUCTION IN S. Herati,1 C. Cengiz,2 D. J. Lamb3; 1Urology, INFERTILE MEN. H. Ren, K. Ferguson, Baylor College of Medicine, Houston, TX, E. Wong, V. Chow, S. Ma; Obstetrics and 2Urology, Technician, Houston, TX, 3Urology/ Gynacology, University of British Columbia, Center for Reproductive Medicine/MCB, Vancouver, BC, Canada. Baylor College of Medicine, Houston, TX. P-345 INHIBITION OF SERTOLI CELL P-338 THE EFFECT OF ADHD MEDICATIONS ON SUMOYLATION REGULATES INDUCIBLE 1 SEMEN ANALYSIS IN SUB-FERTILE COUPLES. B. NITRIC OXIDE PATHWAY. K. Okada, K. 1 1 1 1,2 Patel,1 E. B. Johnstone,1 A. Presson,2 C. Zhang,2 T. Hwang, C. Rapelje, L. Mitchell, P. L. Morris ; 1 2 Jenkins,3 K. I. Aston,3 D. T. Carrell,3 J. M. Hotaling3; Population Council, New York, NY, The 1Obstetrics & Gynecology, University of Utah, Salt Rockefeller University, New York, NY. Lake City, UT, 2Epidemiology, University of Utah, Salt Lake City, UT, 3Urology, University of Utah, P-346 MALE INFERTILITY AND FSHR GENE Salt Lake City, UT. POLYMORPHISMS IN IVF. I. Zhylkova,1,2 O. Feskov2; 1Karazin National University, Kharkiv, 2 P-339 Abstract withdrawn Ukraine, Center of Human Reproduction, Kharkiv, Ukraine.

nd 72 ASRM Scientific Congress & Expo 197 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-347 AN EFFICIENT ANDROGEN RESPONSE, P-352 IDENTIFYING DIFFERENTIAL MRNA & ANTIOXIDANT DEFENSE AND PROTEOSOMAL MIRNA EXPRESSION PATTERNS IN PATHWAY MAINTAIN FERTILITY IN DONORS MICROSURGICALLY ISOLATED INDIVIDUAL WITH ROS-POSITIVE SPERM. L. Samanta,1,2 SEMINIFEROUS TUBULES REVEALS UNIQUE A. Agarwal,2 R. Sharma,2 N. Kothandaraman,2 “NICHE” FOR SPERMATOGENESIS IN MEN N. Swain1,2; 1Redox Biology Laboratory, School WITH SEVERE FORMS OF INFERTILITY. of Life Sciences, Ravenhaw University, Orissa, S. Mittal,1 A. Mielnik,2 A. Bolyakov,2 P. N. India, 2American Center for Reproductive Schlegel,2 D. Paduch3; 1Urology, New York Medicine, Department of Urology, Cleveland Presbyterian / Weill Cornell Medical College, Clinic, Cleveland, OH. New York, NY, 2Urology, Weill Cornell Medical College, New York, NY, 3Dept of Urology, Weill P-348 CIGARETTE SMOKING AND ASSOCIATED Cornell Medical College, New York, NY. EFFECTS ON THE RATE OF AGING IN SPERM DNA METHYLATION PATTERNS. T. Jenkins,1 D. P-353 SIGNIFICANT IMPACT OF BODY MASS T. Carrell,2 J. Hotaling,1 K. I. Aston3; 1University INDEX ON A MODIFIED SPERM MOTILITY- of Utah, Salt Lake City, UT, 2Surgery (Urology), MORPHOLOGY ALGORITHM. W. University of Utah School of Medicine, Salt Roudebush,1,2 L. K. Hill2; 1Biomedical Sciences, Lake City, UT, 3Surgery (Urology), University of University of South Carolina School of Utah, Salt Lake City, UT. Medicine Greenville, Greenville, SC, 2Regional Urology, Greenville Health System, Greenville, P-349 NELL1 AND CTDSPL: NOVEL GENETIC SC. FACTORS PREDISPOSING TO PEYRONIE’S AND DUPUYTREN’S DISEASES. A. W. P-354 CAPACITATION DEFECTS ARE COMMON IN Pastuszak,1 J. Bournat,2 Y. Cabeza-Arvelaiz,3 L. MEN QUESTIONING THEIR FERTILITY AND I. Lipshultz,1 D. J. Lamb4; 1Scott Department of ARE INDEPENDENT OF STANDARD SEMEN Urology, Baylor College of Medicine, Houston, ANALYSIS PARAMETERS. A. J. Travis,1 TX, 2Baylor College of Medicine, Houston, TX, C. Cardona,2 A. Simpson,2 M. A. Moody,2 3Center for Reproductive Medicine, Baylor E. Seaman,3 G. C. Ostermeier2; 1Cornell College of Medicine, Houston, TX, 4Urology/ University, Ithaca, NY, 2Androvia LifeSciences, Center for Reproductive Medicine/MCB, Mountainside, NJ, 3Urology Group of New Baylor College of Medicine, Houston, TX. Jersey, Millburn, NJ.

P-350 IDENTIFICATION OF LIVE SPERM BY FLOW P-355 TESTOSTERONE TO ESTRADIOL CYTOMETRY USING VISIBLE SPECTRUM, RATIO CORRELATES WITH SPERM MEMBRANE PERMEABLE SYTO RED NUCLEIC CONCENTRATION IMPROVEMENT IN ACID STAINS. A. Bolyakov,1 S. Mittal,2 A. HYPOGONADAL OLIGOZOOSERMIC Mielnik,3 M. Feliciano,3 P. N. Schlegel,3 D. PATIENTS TREATED WITH ANASTROZOLE. N. Paduch4; 1Weill Cornell Medicine, New York, NY, Abhyankar,1 O. Shoshany,1 C. Niederberger2; 2Urology, New York Presbyterian / Weill Cornell 1Urology, University of Illinois at Chicago, Medicine, New York, NY, 3Urology, Weill Cornell Chicago, IL, 2University of Illinois at Chicago, Medical College, New York, NY, 4Dept of Urology, Chicago, IL. Weill Cornell Medical College, New York, NY. P-356 CONTRIBUTION OF , P-351 A SAFETY STUDY OF CLOMIPHENE DEFECTIVE SPERM AND WHITE BLOOD CITRATE; EVALUATING ITS EFFECTS ON CELLS IN SPERM SENESCENCE. E. Tirado,1 F. PSA, HEMOGLOBIN AND ESTRADIOL. N. Gomez-Chavez,1 D. M. Pelczar,1 B. Barrett,2 B. Abhyankar,1 O. Shoshany,1 M. Kathrins,1 M. Leader,3 D. Sakkas2; 1Andrology, ReproSource Abern,1 C. Niederberger2; 1Urology, University Inc, Woburn, MA, 2Boston IVF, Waltham, MA, of Illinois at Chicago, Chicago, IL, 2University 3Clinical Research Division, ReproSource Inc, of Illinois at Chicago, Chicago, IL. Woburn, MA.

nd 72 ASRM Scientific Congress & Expo 198 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Wednesday, October 19, 2016 P357 - P712 7:00 am - 8:45 am

NON- Poster Abstract Sessions CME CE ARS

Continental breakfast provided. MENOPAUSE

ASRM invites you to meet the poster presenters of posters P-357 through P-712 on Wednesday morning and enjoy P-357 THE RELATIONSHİP BETWEEN BREAST a continental breakfast. Authors of posters P-1 through DENSITY & BONE MINERAL DENSITY IN P-356 will present their posters on Tuesday morning. NEVER USERS OF POSTMENOPAUSAL HORMONE THERAPY. B. Seckin,1 M. Kuru Pekcan,1 H. A. Inal,2 C. Gulerman1; 1Zekai Please note that on Monday, posters will be open from Tahir Burak Women’s Health Research and 12:00 pm until 5:00 pm. On Tuesday, posters will be open Education Hospital, Ankara, Turkey, 2IVF Unit, from 7:00 am until 5:00 pm. On Wednesday, posters will Konya Education and Research Hospital, be open from 7:00 am until 2:00 pm. Konya, Turkey. ASRM cannot be responsible for removing and/or returning posters. All posters not removed will be discarded. P-358 RESTORATION OF YOUNG OVARIAN FUNCTION TO POSTREPRODUCTIVE FEMALE • Menopause P-357 - P-361 MICE SIGNIFICANTLY INFLUENCED GLUCOSE • Reproductive Endocrinology - Clinical P-362 - P-376 METABOLISM AND IMMUNE FUNCTION. J. • Reproductive Endocrinology - Research P-377 - P-381 B. Mason; School of , Utah State University, Logan, UT. • Polycystic Ovary Syndrome P-382 - P-415 • Obesity and Metabolism P-416 - P-429 P-359 RETROSPECTIVE ANALYSIS OF THE EFFICACY • Endometriosis P-430 - P-463 OF ART AND REPRODUCTIVE OUTCOMES • Leimyoma P-464 - P-471 IN FEMALES WITH FRAGILE X ASSOCIATED • Environment and Toxicology P-472 - P-481 PRIMARY OVARIAN INSUFFICIENCY. L. Tan,1 • Oxidative Stress P-482 - P-488 L. Krichevsky,2 E. Greenblatt,3 R. Casper,4 C. A. 5 6 7 8 • Male Reproduction and Urology - Clinical P-489 - P-518 Laskin, S. Sierra, T. Hannam, M. F. Karnis, C. L. Librach,9 P. A. Sharma10; 1Obstetrics & • Sperm Biology P-519 - P-527 Gynaecology, University of Toronto, Toronto, • Sperm Preparation P-528 - P-535 ON, Canada, 2Faculty of Medicine, University • Clinical Reproductive Laboratory P-536 - P-545 of Toronto, Toronto, ON, Canada, 3CFRH • ART Outcome Predictors - Laboratory P-546 - P-558 Mount Sinai Hospital, Toronto, ON, Canada, • Procedures and Techniques - P-559 - P-564 4Professor, University of Toronto, Toronto, ON, Laboratory: ART Canada, 5Medicine; Obstetrics & Gynecology, • ART - Clinical P-565 - P-610 LifeQuest Centre for Reproductive Medicine, 6 • Implantation P-611 - P-620 Toronto, ON, Canada, Division of Reproductive Endocrinology & Infertili, Women’s College • Early Pregnancy P-621 - P-627 Hospital, University of Toronto, Toronto, ON, • Procedures and Techniques - P-628 - P-635 Canada, 7Reproductive Endocrinology, Toronto, Clinical: ART ON, Canada, 8ONE Fertilty, Burlington, ON, • Reproductive Biology - Animal and P-636 - P-641 Canada, 9CReATe Fertility Centre, Toronto, ON, Experimental Models Canada, 10Obstetrics and Gynecology, Create • Reproductive Biology - Human Studies P-642 - P-646 Fertility Centre, Toronto, ON, Canada. • Embryo Biology P-647 - P-658 • Embryo Culture P-659 - P-682 P-360 PROTECTIVE EFFECT OF EVODIAE FRUCTUS • Stem Cells P-683 - P-685 EXTRACT AGAINST 4-VINYLCYCLOHEXENE • Health Disparities P-686 - P-696 DIEPOXIDE- INDUCED OVOTOXICITY IN CHO-K1 CELLS. S. Kim, J. Lee, S. KIM, D. Kim; Dongguk • Genetic Counsiling P-697 - P-712 university, Gyeonggi-do, Korea, Republic of.

nd 72 ASRM Scientific Congress & Expo 199 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-361 LEAN MASS IS A MODIFIABLE RISK Garcia,1 S. Kwon,1 K. Nguyen,1 N. Sung,1 L. Wu,1 FACTOR FOR VERTEBRAL FRACTURE A. M. Skariah,1 S. V. Dambaeva,2 A. Gilman- IN POSTMENOPAUSAL WOMEN. A. W. Sachs,2 K. Beaman,2 J. Kwak-Kim1; 1Obstetrics Tiegs,1 R. J. Meislin,2 N. M. Sachdev,3 M. J. and Gynecology, Rosalind Franklin University Nachtigall,4 L. E. Nachtigall5; 1OB/GYN, NYU of Medicine and Science, Vernon Hills, IL, Langone School of Medicine, New York, 2Microbiology and Immunology, Rosalind NY, 2NYU School of Medicine, New York, Franklin University of Medicine and Science, NY, 3Obstetrics and Gynecology, New York North Chicago, IL. University Fertility Center, New York, NY, 4Ob/Gyn, NYU Medical Center, New York, NY, 5 P-366 THE IMPACT OF SERUM VITAMIN D LEVEL Obstetrics and Gynecology, NYU School of ON IN VITRO FERTILIZATION OUTCOME: A Medicine, New York, NY. PROSPECTIVE OBSERVATIONAL STUDY. Z. Bu,1 L. Hu,1 Y. Sun2; 1Reproductive Medicine Center, First Affiliated Hos, Zhengzhou, China, 2Reproductive Medical Center, the First REPRODUCTIVE ENDOCRINOLOGY - CLINICAL Affiliated Hospital of Zhengzhou Univers, Zhengzhou, China. P-362 HIGHER 25-HYDROXYVITAMIN D (25(OH) D) IS ASSOCIATED WITH INCREASED P-367 IMPROVED LIVE BIRTH RATE FOLLOWING FECUNDABILITY. A. Z. Jukic,1 C. R. Weinberg,2 ANTIBIOTIC TREATMENT FOR CHRONIC A. Z. Steiner3; 1Yale School of Public Health, ENDOMETRITIS IN INFERTILE WOMEN WITH New Haven, CT, 2National Institute of A HISTORY OF REPEATED IMPLANTATION Environmental Health Sciences, Durham, NC, FAILURE. K. Kitaya,1 H. Matsubayashi,1 Y. 3University of North Carolina, Chapel Hill, NC. Takaya,1 K. Yamaguchi,2 R. Nishiyama,1 T. Ishikawa1; 1Reproduction Clinic Osaka, Osaka, 2 P-363 PATIENTS WITH UNEXPLAINED INFERTILITY Japan, Urology, Ishikawa Hospital, Himeji, DO NOT SHOW EVIDENCE OF DECREASED Japan. OVARIAN RESERVE COMPARED TO CONTROLS. H. Huddleston,1 N. Santoro,2 E. P-368 DIFFERENTIAL EFFECT OF OVARIAN Eisenberg,3 D. Haisenleder,4 M. P. Diamond,5 HYPERSTIMULATION ON THE SERUM M. Cedars6,7; 1University of California at San PROGESTERONE LEVEL , EMBRYO QUALITY Francisco School of Medicine, San Francisco, AND PREGNANCY RATES: AN ANALYSIS OF CO, 2Obstetrics and Gynecology, University 3,767 IVF CYCLES. O. Oktem,1,2 K. Yakin,1,2 A. of Colorado School of Medicine, Aurora, CO, Isiklar,2 B. Balaban,2 B. Urman1,2; 1Obstetrics 3NICHD, Bethesda, MD, 4University of Virginia, and Gynecology, Koc University School of Charlottesville, VA, 5Augusta University, Medicine, Istanbul, Turkey, 2Women’s Health Augusta, GA, 6Obstetrics, Gynecology Center Assisted Reproduction Unit, American and Reproductive Sciences, University of Hospital, Istanbul, Turkey. California, San Francisco, San Francisco, CA, 7for the Reproductive Medicine Network, P-369 FACTORS IMPACTING ENDOMETRIAL Bethesda, MD. THICKNESS (EMT) AND OUTCOMES IN LETROZOLE INTRAUTERINE INSEMINATION P-364 VALIDATION OF THE ACCESS AMH ASSAY (IUI) CYCLES. K. A. Green,1 M. Evans,2 & ITS COMPARISON WITH LABCORP I. Sasson,3 A. S. Vale,4 A. DeCherney,1 K. ULTRASENSITIVE ASSAY. A. Younis, K. C. Devine,5 E. A. Widra,5 M. J. Hill1; 1NIH- NICHD, Hawkins, W. J. Butler; Fertility Institute, Bethesda, MD, 2Oklahoma State University, Navicent Health & OBGYN Dept., Mercer Broken Arrow, OK, 3Shady Grove Fertility of University School of Medicine, Macon, GA. PA, Wayne, PA, 4Lankenau Medical Center, Wynnewood, PA, 5Shady Grove Fertility P-365 CO-PRESENCE OF INCREASED Center, Washington, DC. ANTRAL FOLLICLE COUNT AND HYPERANDROGENISM PREDICTS P-370 FERTILITY OUTCOMES IN WOMEN WITH THE MANIFESTATION OF IMMUNE HYPOPITUITARISM (HP) WHO UNDERGO INFLAMMATORY RESPONSES. M. D. Salazar ART TREATMENT. J. Rodriguez-Purata,1 L.

nd 72 ASRM Scientific Congress & Expo 200 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Sekhon,1,2 J. A. Lee,1 M. C. Whitehouse,1 A. B. P-376 CIRCULATING LEVELS OF VASCULAR Copperman,1,2 B. Sandler1,2; 1Reproductive ENDOTHELIAL GROWTH FACTOR AFTER Medicine Associates of New York, New York, EMBRYO TRANSFER ARE HIGHER NY, 2Obstetrics, Gynecology and Reproductive IN WOMEN WHOSE OOCYTES WERE Science, Icahn School of Medicine at Mount FERTILIZED BY INTRACYTOPLASMIC Sinai, New York, NY. SPERM INJECTION (ICSI). D. Nasioudis,1 T. Kanninen,1 G. Sisti,1 L. El Kabab,1 S. S. 1 2 1 P-371 FOLLICLE TRACKING UNDER ULTRASOUND Witkin, S. D. Spandorfer ; Department of Obstetrics and Gynecology, Weill REVEALED OVULATION DEFECTS IN 2 UNEXPLAINED INFERTILITY DURING Cornell Medicine, New York, NY, Ronald NATURAL CYCLE. F. Guo; Center of O. Perelman and Claudia Cohen Center for Reproductive Medicine, Nantong University Reproduction and Infertility, Weill Cornell Affiliated Hospital, Nantong, China. Medicine, New York, NY.

P-372 THE FREQUENCY OF A SLIGHTLY INCREASED SERUM PROGESTERONE (P) RANGE OF REPRODUCTIVE ENDOCRINOLOGY - RESEARCH 1.6 TO 1.9 NG/ML AT PEAK FOLLICULAR MATURATION PRIOR TO THE LUTEINIZING (LH) SURGE IN NATURAL CYCLES. J. H. P-377 INSULIN INDUCES OSCILLATING Check,1 J. R. Liss2; 1Dept. OB/GYN, Cooper EXPRESSION OF CIRCADIAN GENE PER2 Medical School of Rowan University, Melrose AND STEROIDAL ACUTE REGULATORY Park, PA, 2Cooper Institute for Reproductive PROTEIN GENE IN HUMAN GRANULOSA Hormonal Disorders, P.C., Mt. Laurel, NJ. CELLS. M. Chen,1 Y. Xu,1 B. Miao,1 H. Zhao,2 J. Gao,1 C. Zhou1; 1The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, P-373 PREVALENCE OF MACROPROLACTIN (MPRL) 2The Third Affiliated Hospital of Sun Yat-sen IN INFERTILE FEMALE PATIENTS: FREQUENT University, Guangzhou, China. MISDIAGNOSIS AND MISMANAGEMENT OF HYPERPROLACTINEMIA. K. M. Genesio Ceratto, M. M. Zitta, P. Avalos, M. H. Gomez, C. P-378 RASD1 REDUCTION IS ASSOCIATED WITH Avendano, C. Sanchez Sarmiento; Nascentis, REPEATED IMPLANTATION FAILURE. Y. Cordoba, Argentina. Choi,1 M. Park,2 K. Choi,3 E. Han,4 E. Kim,5 H. Kwon,6 D. Choi5; 1Biomedical Science, CHA University, Seoungnam-si, Korea, Republic P-374 ACADEMIC PRODUCTIVITY IN THE CLINICAL of, 2CHA Gangnam Fertility Center, Seoul, RESEARCH/REPRODUCTIVE ENDOCRINE Korea, Republic of, 3Fertility Center, CHA SCIENTIST TRAINING PROGRAM (CREST): bundang Medical Center. CHA University, A 10-YEAR APPRAISAL. N. Santoro,1 R. S. Seongnam-si, Gyeonggi-do, Korea, Republic Usadi,2 A. Christy,3 A. J. Polotsky,4 H. Zhang5; of, 4CHA University School of Medicine, 1Obstetrics and Gynecology, University of Seoul, Korea, Republic of, 5Fertility Colorado School of Medicine, Aurora, CO, Center, CHA Bundang Medical Center, CHA 2Reproductive Endocrinology and Infertility, University, Seongnam-si, Korea, Republic of, Carolinas Healthcare, Charlotte, NC, 6CHA Bundang Fertility Center, Seongnam-si, 3Contraception Discovery and Development Korea, Republic of. Branch, NIH, Rockville, MD, 4University of Colorado, Aurora, CO, 5Yale School of Public Health, New Haven, CT. P-379 SHOULD BLOOD SAMPLES BE COLLECTED UNDER FASTING CONDITIONS FOR MEASUREMENT OF ANTI-MULLERIAN P-375 VALIDATION OF THE ESTRADIOL ASSAY HORMONE (AMH) LEVELS. G. Lambert- BY USE OF MASS SPECTROMETRY AND Messerlian,1 J. A. Straseski,2 E. E. Eklund,3 G. FOLLICULAR VOLUME. M. Peavey,1 N. Akbas,2 E. Palomaki,3 J. E. Haddow3; 1Pathology and W. E. Gibbons,1 S. Devaraj,2 P. W. Zarutskie1; Laboratory Medicine and OB/GYN, Women 1Reproductive Endocrinology and Infertility, and Infants Hospital/ Alpert Medical School at Ob/Gyn, Baylor College of Medicine, Houston, Brown, Providence, RI, 2Pathology, University TX, 2Pathology and Immunology, Texas of Utah, Salt Lake City, UT, 3Pathology and Childrens Hospital, Houston, TX.

nd 72 ASRM Scientific Congress & Expo 201 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Laboratory Medicine, Women and Infants P-384 ANTI-MULLERIAN HORMONE (AMH) AS Hospital/ Alpert Medical School at Brown, A PREDICTOR OF POLYCYSTIC OVARY Providence, RI. SYNDROME (PCOS): AGE AND BODY MASS INDEX (BMI)-STRATIFIED THRESHOLDS FOR P-380 DO CHANGES IN STRICT KRUGER DISTINGUISHING PCOS FROM CONTROLS USING AN IDENTICAL ASSAY. M. Quinn,1 C. MORPHOLOGY AFTER SPERM PREPARATION 1 1 1 2 FOR INTRAUTERINE INSEMINATION Kao, A. K. Ahmad, M. Cedars, N. Santoro, E. Eisenberg,3 D. J. Haisenleder,4 R. S. Legro,5 CONTRIBUTE ANYTHING TO PREDICTING 1,6 1 CYCLE OUTCOME? C. F. Roman-Rodriguez,1 H. Huddleston ; Department of Obstetrics, N. Virji,2 N. Fahmy,2 B. Pacaud,2 M. Bray,3 L. Gynecology and Reproductive Sciences, Sung2; 1Obstetrics and Gynecology, Nassau University of California, San Francisco, San 2 University Medical Center, East Meadow, Francisco, CA, Obstetrics and Gynecology, NY, 2Reproductive Specialists of New York, University of Colorado School of Medicine, 3 4 Mineola, NY, 3Reproductive Specialists of New Aurora, CO, NICHD, Bethesda, MD, University 5 York, Brooklyn, NY. of Virginia, Charlottesville, VA, Penn State University College of Medicine, Hershey, PA, 6For the Reproductive Medicine Network, P-381 THE EFFECT OF IRON DEPOSITION ON THE Bethesda, MD. OVARY: IRON SUPPRESSES GRANULOSA CELL PROLIFERATION AND ARREST CELL CYCLE THROUGH REGULATING P38 MAPK/ P-385 PLATELET FACTOR 4 -- AN ANTIANGIOGENIC /P21 PATHWAY. M. Chen,1 C. Chou,1 J. CHEMOKINE THAT IS FIRST IDENTIFIED Yang,1 S. Chen,2 H. Ho,3 Y. Yang1; 1Obstetrics TO BE POSSIBLY ASSOCIATED WITH and Gynecology, National Taiwan University, THE ABERRANT FOLLICULOGENESIS IN Taipei, Taiwan, 2National Taiwan University POLYCYSTIC OVARIAN SYNDROME. C. 1 2 3 4 Hospital, Taipei, Taiwan, 3Obstetrics and Huang, C. Chou, M. Chen, S. Chen, H. 5 2 1 Gynecology, National Taiwan University Ho, Y. Yang ; Obstetrics and Gynecology Hospital, Taipei, Taiwan. Department, National Taiwan University Hospital, Taipei, Taiwan, 2Obstetrics and Gynecology, National Taiwan University, Taipei, Taiwan, 3National Taiwan University, 4 POLYCYSTIC OVARY SYNDROME Taipei, Taiwan, National Taiwan University Hospital, Taipei, Taiwan, 5Obstetrics and Gynecology, National Taiwan University P-382 WESTERN-STYLE DIET (WSD) IN THE Hospital, Taipei, Taiwan. PRESENCE AND ABSENCE OF ELEVATED CIRCULATING ANDROGEN ALTERS OVARIAN P-386 PREDICTORS OF PREGNANCY OUTCOMES STRUCTURE-FUNCTION IN YOUNG ADULT IN WOMEN WITH POLYCYSTIC OVARY RHESUS MONKEYS. C. V. Bishop,1 T. Reiter,1 SYNDROME WHO PERFORMED IN-VITRO R. L. Stouffer1,2; 1Division of Reproductive & MATURATION (IVM) OF OOCYTES. M. Dahan,1 Developmental Sciences, Oregon National E. Hatirnaz,2 S. Tan,1 B. Ata,3 A. Ozer,4 M. Primate Research Center, Beaverton, OR, Kanat-Pektas,5 S. Hatirnaz6; 1McGill University, 2Obstetrics & Gynecology, Oregon Health & Montreal, QC, Canada, 2IVF Center, Konak Science University, Portland, OR. Hastanesi, Izmit, Turkey, 3Koc University School of Medicine, Istanbul, Turkey, P-383 IMMUNOLOGICAL, STRUCTURAL AND 4Kahramanmaras Sutcu Imam University STEM CELL CHARACTERISTICS OF Hospital, Kahramanmaras, Turkey, 5Afyon SUBCUTANEOUS (SC) ABDOMINAL Kocatepe University Hospital, Afyonkarahisar, ADIPOSE IN LEAN POLYCYSTIC OVARY Turkey, 6Özel Konak Hastanesi, Kocaeli, Turkey. SYNDROME (PCOS) WOMEN VERSUS NORMOANDROGENIC OVULATORY (NL) P-387 IS ABBERANT HIPPO SIGNALING THE WOMEN. J. Phan,1 V. K. Madrigal,1 A. UNDERLYING ETIOLOGY OF POLYCYSTIC Guedikian,1 X. Li,2 D. A. Dumesic,1 G. D. OVARIAN SYNDROME? K. Maas,1,2 S. Chazenbalk1; 1OB/GYN, UCLA, Los Angeles, CA, Mirabal,3,4 A. Penzias,2,1 P. M. Sweetnam,5 K. 2UCLA, Los Angeles, CA. C. Eggan,6 D. Sakkas2; 1OB/GYN, REI Division,

nd 72 ASRM Scientific Congress & Expo 202 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Beth Israel Deaconess Medical Center / San Francisco, San Francisco,, CA, 5University of Harvard Medical School, Boston, MA, 2Boston California at San Francisco School of Medicine, IVF, Waltham, MA, 3CellBridge LLC, Salem, MA, San Francisco, CO. 4Nano Terra Inc, Cambridge, MA, 5CellBridge LLC, Bio-Medical Research, Salem, MA, IN VITRO 6 P-393 DOES MATURATION (IVM) HAVE AN HSCRB, Harvard University, Cambridge, MA. IMPACT ON MORPHOKINETIC PARAMETERS IN COMPARISON WITH IVF? H. Hattori,1 Y. Nakajo,1 P-388 COMPARISON OF PREGNANCY OUTCOMES N. Aono,2 H. Igarashi,1 K. Kyono1; 1Kyono ART BETWEEN OBESE AND NON-OBESE Clinic, Sendai, Miyagi, Japan, 2Kyono ART Cllinic POLYCYSTIC OVARY SYNDROME (PCOS) Takanawa, Minatoku, Tokyo, Japan. PATIENTS UNDERGOING IN VITRO FERTILIZATION (IVF) CYCLES. M. A. Clapp, P-394 WESTERN-STYLE DIET (WSD) IN THE H. E. Feil, E. Buyuk; Albert Einstein College of PRESENCE AND ABSENCE OF ELEVATED Medicine/Montefiore M, Bronx, NY. CIRCULATING ANDROGEN ALTERS HORMONE RESPONSIVENESS IN THE P-389 VITAMIN D DECREASES SERUM VEGF LEVELS RHESUS MACAQUE ENDOMETRIUM. O. CORRELATING WITH CLINICAL IMPROVEMENT D. Slayden, C. V. Bishop, E. Thompson, R. IN VITAMIN D-DEFICIENT WOMEN WITH PCOS: L. Stouffer; Division of Reprod. & Develop. A RANDOMIZED PLACEBO-CONTROLLED Sciences, Oregon National Primate Research TRIAL. M. Irani,1 D. Seifer,2 R. V. Grazi,3 S. Irani,4 Center (ONPRC), Oregon Health & Science R. Tal5; 1Weill Cornell Medicine, New York, University (OHSU), Beaverton, OR. NY, 2Dartmouth-Hitchcock Medical Center, 3 Lebanon, NH, Maimonides Medical Center, P-395 HYPERANDROGENIC ENVIRONMENT CAUSES Brooklyn, NY, 4SUNY Downstate Medical 5 IMPAIRED GLUT EXPRESSION AND GLUCOSE Center, Brooklyn, NY, Yale University School of METABOLISM IN HUMAN ENDOMERIUM. J. Medicine, New Haven, CT. Yoon,1 M. Lee,2 K. Choi,3 E. Kim,3 H. Song,4 D. Choi3; 1Fertility Center of CHA Gangnam Medical P-390 COGNITIVE BEHAVIORAL THERAPY IMPROVES Center, Seoul, Korea, Republic of, 2Obstetrics WEIGHT LOSS AND QUALITY OF LIFE IN and Gynecology, CHA Bundang Medical Center, WOMEN WITH POLYCYSTIC OVARY SYNDROME Seongnam-si, Gyeonggi-do, Korea, Republic of, (PCOS). L. Cooney,1 L. W. Milman,1 M. Sammel,2 3Fertility Center, CHA Bundang Medical Center, K. Allison,3 C. Epperson,3 A. Dokras1; 1Ob Gyn, CHA University, Seongnam-si, Gyeonggi-do, Univ of Pennsylvania, Philadelphia, PA, 2Univ Korea, Republic of, 4CHA Seoul Fertility Center, of Pennsylvania, Philadelphia, PA, 3Psychiatry, CHA University, Seoul, Korea, Republic of. Univ of Pennsylvania, Philadelphia, PA. P-396 THE ASSOCIATION BETWEEN BODY P-391 INTEGRATED OVARY-SPECIFIC DNA MASS INDEX AND ANDROGEN LEVELS IN METHYLATION PROFILING AND ADOLESCENT GIRLS WITH IRREGULAR TRANSCRIPTOME REVEALS NOVEL MENSES OR AMENORRHEA. C. N. Davis- REGULATORY FEATURES IN POLYCYSTIC Kankanamge,1 J. Strickland,1 M. Carnahan,2 OVARY SYNDROME. J. Jiao; China Medical J. Higgins,3 T. Dowlut-McElroy1; 1OB/GYN, University, Shenyang, China. University of Missouri-Kansas City, Kansas City, MO, 2University of Missouri-Kansas City, 3 P-392 EXPLORING OVARIAN CRITERIA FOR Kansas City, MO, CMH Gynecology, Children’s THE DIAGNOSIS OF POLYCYSTIC OVARY Mercy Hospital, Kansas City, MO. SYNDROME - SHOULD IT BE AGE-SPECIFIC? A. K. Ahmad,1 M. Quinn,2 C. Kao,3 N. Lenhart,1 P-397 COMPARISON OF CLOMIPHENE CITRATE M. Cedars,4 H. Huddleston5; 1Obstetrics, AND LETROZOLE FOR OVULATION Gynecology & Reproductive Sciences, University INDUCTION IN WOMEN WITH POLYCYSTIC of California San Francisco, San Francisco, OVARY SYNDROME: A PROSPECTIVE CA, 2UCSF, San Francisco, CA, 3University of RANDOMIZED TRIAL. W. Huang; Department California - San Francisco, OB/GYN R, San of Obstetrics & Gynecology, West China Francisco, CA, 4Obstetrics, Gynecology and Second University Hospital of Sichuan U, Reproductive Sciences, University of California, Chengdu, China.

nd 72 ASRM Scientific Congress & Expo 203 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-398 SEXUAL FUNCTION IN POLYCYSTIC OVARY P-402 THE DISTINCTIVE ROLE OF A DISINTEGRIN SYNDROME: A SYSTEMATIC REVIEW AND AND METALLOPROTEINASE WITH META-ANALYSIS. W. J. Walker,1 D. Lizneva,1 THROMBOSPONDIN MOTIFS19 (ADAMTS19) L. Gavrilova-Jordan,2 L. E. Blake,3 S. Brakta,4 I. IN POLYCYSTIC OVARY SYNDROME. E. Ersoy,1 Atabyekov,5 L. V. Suturina,6 M. P. Diamond,4 R. S. Ozler,1 E. Oztas,2 A. Ersoy,1 M. Ergin,3 N. Azziz7; 1Obstetrics and Gynecology, Augusta Yilmaz4; 1Obstetrics and Gynecology, Zekai University, Augusta, GA, 2OB&GYN, Georgia Tahir Burak Women’s Healthcare Training Regents University, Augusta, GA, 3Libraries, and Research Hospital, Ankara, Turkey, 2Zekai Augusta University, Augusta, GA, 4Augusta Tahir Burak Women’s Healthcare Training University, Augusta, GA, 5General Surgery, and Research Hospital, Ankara, Turkey, 325th Maykop, Russian Federation, 6Laboratory of December State Hospital, Gaziantep, Turkey, Gynecological Endocrinology, Scientific Center 4Reproductive Endocrinology Department, of Family Health and Human Reproduction, ZTB, Ankara, Turkey. Irkutsk, Russian Federation, 7Ob/GYn, and Medicine, Augusta University, Augusta, GA. P-403 Abstract withdrawn

P-399 PHENOTYPIC MARKERS OF POLYCYCSTIC P-404 PROTEIN PATHWAYS IN FOLLICULAR OVARY SYNDROME AND FECUNDITY. A. J. FLUID FROM POLYCYSTIC OVARIAN Gaskins,1 J. Rich-Edwards,2,3 S. Mahalingaiah,4 5,3 1 1 SYNDROME (PCOS) PATIENTS AND OVUM S. A. Missmer, J. E. Chavarro ; Department DONORS UNDERGOING IVF CYCLES. T. S. of Nutrition, Harvard T.H. Chan School of Domingues,1,2 T. C. Bonetti,3,4 C. Gomes,1 J. 2 Public Health, Boston, MA, Brigham and R. Alegretti,5 B. Barros,6 E. Motta5,2; 1Clinical, 3 Women’s Hospital, Boston, MA, Department Huntington Medicina Reprodutiva, Sao Paulo, of Epidemiology, Harvard T.H. Chan School Brazil, 2Gynecology, Universidade Federal de 4 of Public Health, Boston, MA, OB/GYN - REI, Sao Paulo, Sao Paulo, Brazil, 3Gynecology, Boston University School of Medicine, Boston, Federal University of Sao Paulo, Sao Paulo, 5 MA, Obstetrics, Gynecology and Reproductive Brazil, 4Scientific, Huntington Medicina Biology, Brigham and Women’s Hospital and Reprodutiva, Sao Paulo, Brazil, 5Huntington Harvard Medical School, Boston, MA. Medicina Reprodutiva, Sao Paulo, Brazil, 6Embryology, Huntington Medicina P-400 COMPARISON OF FRESH VERSUS Reprodutiva, Sào Paulo, Brazil. PREVIOUSLY FROZEN EMBRYO TRANSFER IN WOMEN WITH POLYCYSTIC OVARY 1 P-405 THE ASSOCIATION OF-429T>C AND -374T>A SYNDROME. O. S. Abdalmageed, T. RAGE 2 3 4 POLYMORPHISMS IN THE GENE WITH A. Farghaly, I. Elnashar, A. M. Ismail ; S. Song,1 1 POLYCYSTIC OVARY SYNDROME. Assiut University IVF Center, Assiut, Egypt, J. Park,2 L. Li,2 H. Jeong,3 B. Choi,3 K. Baek2; 2 Obstetrics and Gynecology, Assiut University 1Laboratory of Reproductive Medicine, 3 IVF Unit, Assiut, Egypt, Assiut University, Creation & Love Women’s Hospital, Gwangju, 4 Assiut, Egypt, Obstetrics and Gynecology, Korea, Republic of, 2Department of Biomedical Women’s Health Hospital, Assiut, Egypt. Science, CHA University, Pocheon, Korea, Republic of, 3Department of Obstetrics and P-401 COMPARATIVE STUDY OF THE THERAPEUTIC Gynecology, Center for EFFECTS OF DROSPIRENONE (DRSP, 3 MG) and Infertility, Creation & Love Women’s WITH ETHINYL ESTRADIOL (EE, 20 MCG) Hospital, Gwangju, Korea, Republic of. PILL WITH OR WITHOUT METFORMIN 500 MG IN POLYCYSTIC OVARY SYNDROME 1,2 3 P-406 OUTCOMES OF SINGLE VS DOUBLE EMBRYO (PCOS). S. M. Bhattacharya, B. Biswas, TRANSFER IN IN-VITRO MATURATION A. Basu4; 1Obstetrics and Gynecology, KPC 2 CYCLES DONE IN WOMEN WITH POLYCYSTIC Medical College, Kolkata, India, S.C.Das OVARY SYNDROME. s. hatirnaz,1 E. S. Memorial Medical and Research Center, Hatirnaz,1 S. L. Tan,2 B. Ata,3 m. kanat pektas,4 3 Kolkata, India, Obstetrics and Gynecology, a. ozer,5 M. Dahan6; 1ıvf center, Özel Konak SRI Aurobinda Seva Kendra, Kolkata, India, Hastanesi, Kocaeli, Turkey, 2obstetrics 4 Biochemistry, Postgraduate Institute of and gynecology, Mc Gill University School Medical Sciences, Haryana, India. of Medicine, Montreal, QC, Canada, 3Koc

nd 72 ASRM Scientific Congress & Expo 204 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

University School of Medicine, Istanbul, P-411 THE EFFECT OF METFORMIN ON PREGNANCY Turkey, 4obs & gyn, kocatepe university, OUTCOME, ENDOMETRIAL RECEPTIVITY & afyonkarahisar, Turkey, 5sutcu imam MIRNAS IN ENDOMETRIUM OF PATIENTS university, kahramanmaras, Turkey, 6McGill WITH PCOS UNDERGOING IVF/ICSI. D. University, Montreal, QC, Canada. Sun, G. Yao, L. Wu, J. Wang, Z. Zhao, J. Zhai; Reproductive Medicine, Zhengzhou, China. P-407 NON INVASIVE PREDICTION OF OVARIAN HYPER STIMULATION SYNDROME RISK IN P-412 INCREASED RISK OF EATING DISORDERS POLYCYSTIC OVARY SYNDROME (PCOS) IN WOMEN WITH POLYCYSTIC OVARY AND HYPER RESPONDERS BY FOLLICULAR SYNDROME. I. Lee,1 L. Cooney,1 S. Saini,1 M. FLUID METABOLOMICS. F. B. Cordeiro,1 E. Smith,1 K. C. Allison,2 A. Dokras1; 1Obstetrics T. R. Cataldi,2 L. d. Teixeira da Costa,3 A. B. and Gynecology, University of Pennsylvania, Victorino,1 A. P. Cedenho,1 E. G. Lo Turco3; Philadelphia, PA, 2Psychiatry, University of 1Department of Surgery, Division of Urology, Pennsylvania, Philadelphia, PA. Human Reproduction Section, Sao Paulo Federal University, Sao Paulo, Brazil, 2 P-413 EFFECTIVENESS OF A LETROZOLE Departament of Genetics, Escola Superior de ESCALATION PROTOCOL IN ACHIEVING Agricultura “Luiz de Queiroz”, Universidade 3 OVULATION IN PATIENTS WITH POLYCYSTIC de São Paulo, Piracicaba, Brazil, Department OVARY SYNDROME. T. L. Jones, C. C. Shenoy, of Surgery, Division of Urology, Human, Sao J. Jensen, E. A. Stewart, G. S. Daftary, C. Paulo Federal University, Sao Paulo, Brazil. Coddington; Reproductive Endocrinology and Infertility, Mayo Clinic, Rochester, MN. P-408 ASSESSING PATIENT AND PHYSICIAN COMPLIANCE WITH RECOMMENDED SLEEP P-414 SEXUAL FUNCTION AND POLYCYSTIC OVARY APNEA SCREENING IN PCOS PATIENTS. Y. SYNDROME: A SYSTEMATIC REVIEW AND Dondik, K. A. Ehlers, A. Gentry, K. Pagidas, H. META-ANALYSIS. D. Lizneva,1 W. J. Walker,1 Bohler; University of Louisville, Louisville, KY. L. Gavrilova-Jordan,1 M. P. Diamond,2 R. Azziz,1 L. Suturina,3 I. Atabyekov,3 S. Brakta2; P-409 EFFECT OF METFORMIN TREATMENT ON 1Obstetrics and Gynecology, Augusta INTRAFOLLICULAR CYTOKINES, OVARIAN University, Augusta, GA, 2Augusta University, RESPONSE TO GONADOTROPIN AND IN VITRO Augusta, GA, 3Reproductive Health Protection, FERTILIZATION OUTCOME IN PATIENTS WITH Scientific Center of Family Health and Human POLYCYSTIC OVARY SYNDROME. C. Kim,1 Y. Reproduction, Irkutsk, Russian Federation. Jeung,1 J. Moon,2 B. Kang1; 1Obstetrics and Gynecology, College of Medicine, University P-415 IMPACT OF METFORMIN ON IN VITRO of Ulsan, Asan Medical Center, Seoul, Korea, 2 FERTILIZATION OUTCOMES IN OVERWEIGHT Republic of, Endocrinology & Infertility, M AND OBESEPOLYCYSTIC OVARY SYNDROME Fertility Center, Seoul, Korea, Republic of. WOMEN: A PROSPECTIVE COHORT STUDY. O. S. Abdalmageed,1 T. A. Farghaly,2 A. M. P-410 PROGESTERONE SUPPLEMENTATION IN Ismail,3 W. W. Hurd4; 1Assiut University PCOS WOMEN UNDERGOING CLOMIPHENE IVF Center, Assiut, Egypt, 2Obstetrics and CITRATE STIMULATED IUI MAY IMPROVE Gynecology, Assiut University IVF Unit, Assiut, PREGNANCY BY INCREASING UTERINE Egypt, 3Obstetrics and Gynecology, Women’s BLOOD. G. Mukherjee,1 H. Konar,2 P. Mandve,3 Health Hospital, Assiut, Egypt, 4Obstetrics and S. Sharma,4 S. Ghosh,5 P. Chakraborty,6 B. Gynecology, Duke University, Durham, NC. Chakravarty7; 1Consultant, Kolkata, India, 2Professor, Obstetrics & Gynecology, Kolkata, India, 3MO, Kolkata, India, 4ART, Consultant, Kolkata, India, 5Assisted Reproduction, OBESITY AND METABOLISM Consultant, Kolkata, India, 6Infertility, Scientist, Kolkata, India, 7Reproductive Medicine, Director, Kolkata, India. P-416 ASSOCIATION OF INSULIN SENSITIVITY (IS) WITH AGE AT (AAM) IN GIRLS WITH (T1D): SEARCH

nd 72 ASRM Scientific Congress & Expo 205 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

FOR DIABETES IN YOUTH STUDY. H. Borg,1 Sapientiae - Centro de Estudos e Pesquisa W. Lang,2 R. D’Agostino,2 S. L. Young,1 J. em Reprodução Assistida, Sao Paulo, Brazil, Lawrence,3 C. Pihoker,4 G. Kim,4 P. Wadwa,5 3Disciplina de Urologia, Departamento de W. Tamborlane,6 E. Mayer-Davis1; 1University Cirurgia – UNIFESP, Sao Paulo, Brazil. of North Carolina, Chapel Hill, NC, 2Wake Forest School of Medicine, Winston-Salem, P-421 HIGH FAT DIET DOES NOT INCREASE NC, 3Kaiser Permanente, Pasadena, CA, 4 ENDOMETRIAL MACROPHAGE INFILTRATION University of Washington, Seattle, WA, S. Chang,1 5 6 IN SUPEROVULATED MICE. University of Colorado, Aurora, CO, Yale M. Charron,2 E. Buyuk1; 1Albert Einstein University, New Haven, CT. College of Medicine / Montefiore M, Bronx, NY, 2Biochemistry, Albert Einstein College of P-417 HIGH C-REACTIVE PROTEIN LEVELS IN Medicine, Bronx, NY. WOMEN UNDERGOING IVF ARE ASSOCIATED WITH LOW QUALITY EMBRYOS. E. Haikin P-422 OBESITY AND ART: DOES BMI AFFECT Herzberger, N. Miller, Y. Ghetler, R. Tamir EUPLOIDY RATES AND/OR PREGNANCY Yaniv, K. Amichay Keren, A. Shulman, A. OUTCOMES IN COUPLES UNDERGOING IVF Wiser; IVF Unit, Department of Obstetrics and WITH CCS? A. L. Ganza,1,2 M. C. Whitehouse,1 Gynecology, Meir Medical Center, Kfar-Saba, J. A. Lee,1 P. G. McGovern,3,2 M. Lederman,1,2 A. Israel. B. Copperman,1,3 D. E. Stein1,2; 1Reproductive Medicine Associates of New York, New York, P-418 DOSE OF HUMAN CHORIONIC NY, 2Obstetrics, Gynecology and Reproductive GONADOTROPIN TO TRIGGER FINAL Science, Icahn School of Medicine at Mount OOCYTE MATURATION. M. Irani,1 R. Setton,2 Sinai West-Mount Sinai St. Luke’s, New York, V. Gunnala,3 I. Kligman,4 D. E. Goldschlag,5 Z. NY, 3Obstetrics, Gynecology and Reproductive Rosenwaks6; 1Reproductive Endocrinology Science, Icahn School of Medicine at Mount and Infertility, Weill Cornell Medicine, New Sinai, New York, NY. York, NY, 2Department of Obstetrics and Gynecology, Weill Cornell Medical College, 3 P-423 EFFECT OF BODY MASS INDEX (BMI) IN OOCYTE New York, NY, OB/GYN, REI Fellow, New DONOR, RECIPIENT AND MALE PARTNER ON York, NY, 4Weill Cornell Medical College, 5 LABORATORY AND REPRODUCTIVE OUTCOMES New York, NY, Obstetrics, Gynecolology and IN CYCLES WITH DONOR OOCYTES. T. Freour,1,2 Reproductive Medicine, Weill Cornell Medical P. Massart,1,2 F. Bateh-Poisot,2 D. Garcia,3 P. 6 Center, Manhattan, NY, Weill Cornell Medicine Barriere,1 R. Vassena,2 V. Vernaeve2; 1University - Center for Reproductive Medicine, 1305 York Hospital of Nantes, Nantes, France, 2Clinica Eugin, Avenue, New York, NY. Barcelona, Spain, 3Fundacio Privada EUGIN, Barcelona, Spain. P-419 BMI IS NOT ASSOCIATED WITH ANEUPLOIDY IN PATIENTS UNDERGOING P-424 NATURAL ANTI-OXIDANT PREIMPLANTATION GENETIC SCREENING 1 2 SUPPLEMENTATION PRIOR TO INFERTILITY (PGS). L. A. Bishop, C. M. Owen, K. TREATMENT RESULTS IN EXCELLENT Koniares,3 M. J. Hill,4 K. S. Richter,5 K. Devine6; 1 CLINICAL OUTCOMES FOR INFERTILITY Shady Grove Fertility Reproductive Science L. A. 2 PATIENTS WITH PRIOR IVF FAILURES. Center, Rockville, MD, NIH/NICHD/PRAE, Munkwitz, W. B. Schoolcraft, M. Katz-Jaffe; 3 Bethesda, MD, Georgetown University Colorado Center for Reproductive Medicine, 4 SOM, Washington, DC, NIH, Bethesda, MD, Lone Tree, CO. 5Research, Shady Grove Fertility Reproductive Science Center, Rockville, MD, 6Shady Grove Fertility Center, Washington, DC. P-425 EFFECT OF BMI ON LIVE BIRTH RATES IN EUPLOID FROZEN SINGLE EMBRYO TRANSFERS. J. Kort,1 C. Riestenberg,2 M. P-420 ARTIFICIAL SWEETENERS - DO THEY Shah,1 A. Yeaton-Massey,1 A. A. Milki,1 R. Lathi1; 1 BEAR AN INFERTILITY RISK? G. Halpern, 1Stanford University, Palo Alto, CA, 2Kaiser 1,2,3 1,2 1 D. P. Braga, A. S. Setti, R. C. Figueira, Permanente Santa Clara, Santa Clara, CA. A. Iaconelli Jr.,1,2 E. Borges Jr.1,2; 1Fertility Medical Group, Sao Paulo, Brazil, 2Instituto

nd 72 ASRM Scientific Congress & Expo 206 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-426 THE EFFECT OF TELOMERES ON IN VITRO Co1; 1OB/GYN, SUNY Downstate Medical Center, FERTILIZATION RESULTS. N. Weeg,1 E. Brooklyn, NY, 2Ob/gyn, Kings County Hospital Haikin Herzberger,2 T. Biron-Shental,3 A. Center, Brooklyn, NY. Wiser4; 1Obstetrics and Gynecology, Meir Medical Center, Israel, Kfar Saba, Israel, 2 P-432 INCREMENTAL COSTS OF HEALTHCARE IVF Unit, Department of Obstetrics and AND WORK LOSS ATTRIBUTED TO Gynecology, Sackler Faculty of Medicine, Tel 3 ENDOMETRIOSIS IN A COHORT OF Aviv University, Tzur Yigal, Israel, Obstetrics COMMERCIALLY INSURED WOMEN. A. M. an Gynecology, Consultant of Maternal Fetal Soliman,1 E. Surrey,2 M. Bonafede,3 J. K. 4 Medicine, Kfar Saba, Israel, IVF Unit, Meir Nelson,3 J. Castelli-Haley,4 C. A. Winkel5; Medical Center, Kfar Sava, Israel. 1AbbVie Inc, North Chicago, IL, 2Colorado Center for Reproductive Medicine, Lone P-427 OBESITY INCREASES COENZYME Q10. Tree, CO, 3Truven Health Analytics, An IBM C. Boots, K. Moley; OB/GYN, Washington Company, Ann Arbor, MI, 4AbbVie, North University in St. Louis, St. Louis, MO. Chicago, IL, 5Obstetrics and Gynecology, Georgetown University, Shepherdstown, WV. P-428 THE ROLE OF TAC1 NEURONS IN THE METABOLIC AND REPRODUCTIVE ACTION P-433 GNRH ANALOG AND LETROZOLE OF LEPTIN. E. I. Lewis,1,2 C. A. Maguire,3,2 R. INHIBIT STEM CELL RECRUITMENT TO S. Carroll,3,2 U. B. Kaiser,3,2 V. M. Navarro3,2; ENDOMETRIOSIS. G. Sahin Ersoy, M. Majidi 1Department of OBGYN, Brigham and Zolbin, E. Cosar, H. S. Taylor; Yale School of Women’s, Boston, MA, 2Harvard Medical Medicine, New Haven, CT. School, Boston, MA, 3Department of Medicine, Division of Endocrinology, Brigham and P-434 USE OF ELAGOLIX FOR THE MANAGEMENT Women’s, Boston, MA. OF ENDOMETRIOSIS-ASSOCIATED PAIN: SECONDARY EFFICACY RESULTS FROM TWO P-429 OBESITY IS ASSOCIATED WITH AN INCREASE RANDOMIZED, PLACEBO-CONTROLLED IN SPONTANEOUS ABORTION RATE IN STUDIES. E. Surrey,1 L. C. Giudice,2 B. A. YOUNG WOMEN UNDERGOING IVF WITHOUT Lessey,3 H. S. Taylor,4 L. A. Williams,5 J. P. AFFECTING THE ANEUPLOIDY RATE. M. Rowan,5 K. Chwalisz,5 B. Schwefel,5 J. W. Irani,1 V. Gunnala,2 Z. Rosenwaks,3 S. D. Thomas,5 R. I. Jain5; 1Colorado Center for Spandorfer4; 1Reproductive Endocrinology Reproductive Medicine, Lone Tree, CO, and Infertility, Weill Cornell Medicine, New 2Obstetrics, Gynecology and Reproductive York, NY, 2OB/GYN, REI Fellow, New York, Sciences, University of California San NY, 3Weill Cornell Medicine - Center for Francisco, San Francisco, CA, 3Obstetrics and Reproductive Medicine, New York, NY, 4Cornell Gynecology, Reproductive Endocrinology University Medical Center, New York City, NY. and Infertility, Greenville Health System, Greenville, SC, 4Yale School of Medicine, New Haven, CT, 5AbbVie Inc., North Chicago, IL. ENDOMETRIOSIS P-435 PROLONGED ADMINISTRATION OF GNRH P-430 A NON-INVASIVE TEST FOR ENDOMETRIOSIS AGONIST (GNRHA) PRIOR TO EMBRYO BASED ON A PANEL OF PLASMA TRANSFER (ET) IN ENDOMETRIOSIS MICRORNAS. A. Vanhie, Y. El-Aalamat, D. O, (ENDO) AND (INT)NEGATIVE D. P. Peterse, C. Meuleman, A. Fassbender, T. PATIENTS: THE IMPACT OF FREEZE- D’Hooghe; Development and Regeneration, ALL CYCLES. E. Surrey, M. Katz-Jaffe, KU Leuven, Leuven, Belgium. L. A. Kondapalli, R. L. Gustofson, W. B. Schoolcraft; Colorado Center for Reproductive Medicine, Lone Tree, CO. P-431 EFFECT OF NORETHINDRONE VS LEUPROLIDE TREATMENT ON BREAKTHROUGH BLEEDING OF WOMEN WITH SYMPTOMATIC P-436 LOW PREVALENCE OF ENDOMETRIAL ENDOMETRIOSIS. O. Muneyyirci-Delale,1,2 C. BIOPSIES CONTAINING NERVE FIBERS Charles,1 M. Dalloul,1 V. Mniarji,1 J. Tolentino,1 S. IN WOMEN WITH AND WITHOUT ENDOMETRIOSIS. D. O,1 F. Manconi,2 R.

nd 72 ASRM Scientific Congress & Expo 207 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Markham,2 A. Fassbender,1 D. P. Peterse,1 Gynecology, Reproductive Endocrinology A. Vanhie,1 C. Meuleman,1 I. S. Fraser,3 T. and Infertility, Greenville Health System, D’Hooghe1; 1Department of Development & Greenville, SC, 4Sao Paulo University, Sao Regeneration, KU Leuven, Leuven, Belgium, Paulo, Brazil, 5Gynecological Oncology and 2University of Sydney, Sydney, Australia, Gynecology, Medical University, Lublin, 3Women’s and Children’s Health, University of Poland, 6AbbVie Inc., North Chicago, IL. New South Wales, Sydney, Australia. P-441 LIPOPOLYSACCHARIDE PROMOTES P-437 FERTILITY IN PATIENTS WITH UNTREATED THE DEVELOPMENT OF MURINE COLORECTAL ENDOMETRIOSIS. S. ENDOMETRIOSIS-LIKE LESIONS VIA Ferrero,1,2 U. Leone Roberti Maggiore,1,2 C. NUCLEAR FACTOR-KAPPA B PATHWAY. Scala,1 E. Tafi,1 P. Venturini,1 A. Racca1; 1Unit F. Taniguchi, Y. Azuma, N. Terakawa, T. of Obstetrics and Gynaecology, IRCCS AOU Harada; Ob/Gyn, Tottori University Faculty of San Martino – IST, DiNOGMI, University of Medicine, Yonago, Japan. Genova, Genova, Italy, 2Piazza della Vittoria 14 S.r.l., Genova, Italy. P-442 HISTONE DEACETYLASES IN EUTOPIC AND ECTOPIC ENDOMETRIAL TISSUE OF P-438 DIVERGENT FIBROTIC RESPONSES PATIENTS WITH ENDOMETRIOSIS. C. Kim, TO DIFFERENTIAL MALE AND FEMALE J. Park, Y. Jeung, J. Moon; Obstetrics and SEX STEROID REGULATION OF KLF11 Gynecology, College of Medicine, University CRITICALLY DETERMINES ABDOMINAL of Ulsan, Asan Medical Center, Seoul, Korea, SCARRING IN DISEASES SUCH AS Republic of. ENDOMETRIOSIS. C. C. Shenoy, Z. Khan, Y. Zheng, G. S. Daftary; Reproductive P-443 SYSTEMATIC LITERATURE REVIEW AND Endocrinology & Infertility, Mayo Clinic, META-ANALYSIS REVEALS THE BIOLOGICAL Rochester, MN. FUNCTIONS MOST FREQUENTLY ALTERED IN ENDOMETRIOSIS. D. Parfitt, R. Berro, P-439 THE REGULATORY ROLE OF T. Hu-Seliger, A. Oromendia, C. Clementi, K. ENDOMETRIOSIS DERIVED CIRCULATING Kalmbach, S. Arunajadai, P. Yurttas Beim; MICRORNAS 125B-5P AND LET-7B-5P IN Celmatix Inc, New York, NY. MACROPHAGE CYTOKINE PRODUCTION. T. S. Kadakia,1,2 S. E. Nematian,2 R. Mamillapalli,3 4 1 P-444 DOES MEDICAL THERAPY EFFECT H. S. Taylor ; OB/GYN, Mount Sinai Beth Israel E. Cosar,1 R. 2 CIRCULATING MIRNAS? Medical Center, New York, NY, Obstetrics, Mamillapalli,2 I. Moridi,3 A. Duleba,4 H. S. Gynecology and Reproductive Medicine, Taylor1; 1Yale School of Medicine, New Haven, 3 Yale University, New Haven, CT, Obstretics, CT, 2Obstretics, Gynecology and Reproductive Gynecology and Reproductive Sciences, Sciences, Research, New Haven, CT, 4 Research, New haven, CT, Yale School of 3Obstetrics and Gynecology, Infertility, New Medicine, New Haven, CT. Haven, CT, 4Reproductive Medicine, University of California, San Diego, La Jolla, CA. P-440 ELAGOLIX, AN ORAL GONADOTROPIN- RELEASING HORMONE ANTAGONIST, FOR P-445 EFFECTS OF SINGLE ORAL ADMINISTRATION THE MANAGEMENT OF ENDOMETRIOSIS- OF SKI2670, GONADOTROPIN-RELEASING ASSOCIATED PAIN: SAFETY AND EFFICACY HORMONE(GNRH) ANTAGONIST, IN HEALTHY RESULTS FROM TWO DOUBLE-BLIND, PRE-MENOPAUSAL WOMEN. S. Han,1 K. Lim,2 RANDOMIZED, PLACEBO-CONTROLLED S. Cho,3 J. Kim,4 S. Choe,5 J. Jung,6 J. Ghim,7 1 2 STUDIES. H. S. Taylor, L. C. Giudice, B. H. Jeong,8 T. Yoo,8 S. Kim,8 H. Lim,1 J. Shim,9 K. 3 4 5 A. Lessey, M. Abrao, J. Kotarski, L. A. Bae1; 1Department of Clinical Pharmacology 6 6 6 Williams, J. P. Rowan, K. Chwalisz, W. R. and Therapeutics, Asan Medical Center, 6 6 6 6 Duan, B. Schwefel, J. W. Thomas, R. I. Jain ; University of Ulsan, Seoul, Korea, Republic 1 Yale School of Medicine, New Haven, CT, of, 2Department of Clinical Pharmacology 2 Obstetrics, Gynecology and Reproductive and Therapeutics, CHA University School of Sciences, University of California San Medicine and CHA Bundang Medical Center, 3 Francisco, San Francisco, CA, Obstetrics and Seongnam, Korea, Republic of, 3Department

nd 72 ASRM Scientific Congress & Expo 208 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

of Clinical Pharmacology, Inha University DECAY ACCELERATING FACTOR IN Hospital, Inha University School of Medicine, RESPONSE TO EMBRYO SIGNAL HUMAN Incheon, Korea, Republic of, 4Clinical Trials CHORIONIC GONADOTROPIN IS IMPAIRED Center, Chungnam National University Hospital, IN ENDOMETRIA FROM WOMEN WITH Daejeon, Korea, Republic of, 5Department ENDOMETRIOSIS. W. A. Palomino,1 F. of Clinical Pharmacology and Therapeutics, Argandoîa,2 C. Aguirre,2 P. Kohen,1 L. Devoto1; Pusan National University Hospital, Busan, 1Obstetrics&Gynecology Institute for Maternal Korea, Republic of, 6Department of Clinical and Child Research, University of Chile, Pharmacology and Therapeutics, Inje University Santiago, Chile, 2Institute for Maternal and Busan Paik Hospital, Busan, Korea, Republic Child Research, University of Chile, Santiago of, 7Department of Clinical Pharmacology and Chile, Chile. Toxicology, Anam Hospital, Korea University College of Medicine, Seoul, Korea, Republic of, P-451 DYSREGULATED INFERTILITY-RELATED 8SK Chemicals, Seongnam, Korea, Republic of, 9 GENES IN WOMEN WITH ENDOMETRIOSIS. Department of Obstetrics and Gynecology, K. D. Nayar, M. Saxena, G. Kant, R. Ahuja, S. Asan Medical Center, University of Ulsan, Seoul, Chulet, A. Mohan; IVF, Akanksha IVF Centre, Korea, Republic of. New Delhi, India.

P-446 Abstract withdrawn P-452 DISCOVERY OF ENDOMETRIOSIS BIOMARKERS IN MENSTRUAL PLASMA P-447 DMARD USAGE DECREASES OPIOID USAGE SAMPLES USING A PROTEOMICS APPROACH. IN ENDOMETRIOSIS PATIENTS. A. Kotlyar,1 X. D. O,1 E. Waelkens,2 D. P. Peterse,1 A. Vanhie,1 Liu,2 T. Falcone3; 1Ob/Gyn and Women’s Health C. Meuleman,1 T. D’Hooghe,1 A. Fassbender1; Institute, The Cleveland Clinic Foundation, 1Department of Development & Regeneration, Cleveland, OH, 2Quantitative Health Sciences, KU Leuven, Leuven, Belgium, 2Department The Cleveland Clinic Foundation, Cleveland, of Cellular & , KU Leuven, OH, 3Ob Gyn, Cleveland Clinic, Cleveland, OH. Leuven, Belgium.

P-448 ELEVATED ANTIMULLERIAN HORMONE P-453 INCREASED EXPRESSION AND (AMH) DOES NOT FALSELY PREDICT CHEMOATRACTANT ACTIVITY OF CXCR4 OVARIAN RESPONSE IN PATIENTS WITH AND CXCL12 IN ENDOMETRIOTIC LESIONS. ADVANCED STAGE ENDOMETRIOSIS. C. I. Moridi,1 R. Mamillapalli,1 E. Cosar,2 G. R. Juneau, J. M. Franasiak, S. J. Morin, T. A. Sahin Ersoy,3 H. S. Taylor4; 1obstetrics and Molinaro, R. T. Scott Jr., M. Maguire; RMANJ, gynecology, infertility, NewHaven, CT, Basking Ridge, NJ. 2Canakkale 18 March University Medical Faculty, Canakkale, Turkey, 3Obstetrics and Gynecology, Dr. Lutfi Kirdar Education and P-449 DIFFERENTIAL EXPRESSION OF KISSPEPTIN 4 IN PATIENTS WITH AND WITHOUT Research Hospital, Istanbul, Turkey, Yale ENDOMETRIOSIS. A. O. Abdelkareem,1,2 A. S. School of Medicine, New haven, CT. Ait-Allah,1 S. M. Rasheed,1 Y. A. Helmy,3 P. Yong,4 M. A. Bedaiwy5; 1Obstetrics and Gynecology, P-454 COST VALUE OF LAPAROSCOPIC VS Faculty of Medicine, Sohag University, Sohag, ROBOTIC SURGERY FOR ENDOMETRIOSIS. Egypt, 2Obstetrics and Gynecology, REI Division, T. Luu,1 E. Soto,2 X. Liu,3 T. Falcone4; 1Cleveland University of British Columbia, Vancouver, Clinic Foundation, Cleveland, OH, 2South BC, Canada, 3Obstetrics and Gynecology, Florida Institute for Reproductive Medicine, Faculty of Medicine-Sohag University, Sohag, Hollywood, FL, 3Quantitative Health Sciences, Egypt, 4Obstetrics & Gynaecology, Assistant Cleveland Clinic, Cleveland, OH, 4ob gyn, Professor, Vancouver, BC, Canada, 5Department Cleveland Clinic, Cleveland, OH. of Obstetrics and Gynecology, BC Women’s Hospital, Vancouver, BC, Canada. P-455 THE EFFECT OF ELAGOLIX ON BONE MINERAL DENSITY: SAFETY RESULTS FROM TWO P-450 THE ENDOMETRIAL EXPRESSION RANDOMIZED, PLACEBO-CONTROLLED AND PARACRINE REGULATION OF STUDIES IN WOMEN WITH ENDOMETRIOSIS- COMPLEMENT REGULATORY PROTEIN ASSOCIATED PAIN. D. F. Archer,1 N. Watts,2 C.

nd 72 ASRM Scientific Congress & Expo 209 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Gallagher,3 J. Simon,4 W. R. Duan,5 J. P. Rowan,5 M. Anchan1; 1Dept of Obstetrics & Gynecology, K. Chwalisz,5 B. Schwefel,5 J. W. Thomas,5 R. I. Brigham & Women’s Hospital and Harvard Jain,5 L. A. Williams5; 1Department of Obstetrics Medical School, Boston, MA, 2Dept of & Gynecology, Eastern Virginia Medical School, Epidemiology, Harvard Chan School, Boston, MA. Norfolk, VA, 2Mercy Health Osteoporosis and 3 Bone Health Services, Cincinnati, OH, Creighton P-461 HIGHER PREDICTION RATES OF University School of Medicine, Omaha, NE, 4 ENDOMETRIOSIS BY RISK FACTOR ANALYSIS Women’s Health and Research Consultants and FROM CLINICAL SYMPTOMS AND SIGNS. S. George Washington University, Washington, DC, Tan,1,2 C. Chen,1 C. Hsieh,1 C. Chen,1 C. Tzeng1; 5 AbbVie Inc., North Chicago, IL. 1Center for Reproductive Medicine, Taipei Medical University Hospital, Taipei, Taiwan, P-456 INSULIN-LIKE GROWTH FACTOR-I 2Graduate Institute of Clinical Medicine, STIMULATES ESTROGEN RECEPTOR College of Medicine, Taipei Medical University, BETA AND AROMATASE EXPRESSION VIA Taipei, Taiwan. PI3K/AKT-MEDIATED TRANSCRIPTIONAL ACTIVATION IN ENDOMETRIOSIS. Q. Xue, P-462 RISK FACTOR SCORE OF SYMPTOMS IN Y. Zhou; Obstetrics and Gynecology, Peking PATIENT WITH ENDOMETRIOSIS. Y. Chen; University First Hospital, Beijing, China. Center for Reproductive Medicine and Science, Taipei Medical University, Taipei, Taiwan. P-457 INCIDENCE OF COMORBIDITIES AMONG WOMEN WITH ENDOMETRIOSIS: A P-463 DISCOVERY OF NOVEL CHEMOKINE AS A RETROSPECTIVE MATCHED COHORT STUDY. Y. 1 2 3 CLINICAL MARKER OF ENDOMETRIOSIS. A. M. Soliman, E. Surrey, S. J. Johnson, Chou,1,2 C. Tzeng2; 1Department of Obstetrics & 3 1 1 M. Davis, J. Castelli-Haley, M. C. Snabes ; Gynecology, Taipei Medical University, Center 1 2 AbbVie, North Chicago, IL, Colorado Center for Reproductive Medicine, Taipei Medical for Reproductive Medicine, Lone Tree, CO, University Hospital, Taipei, Taiwan, 2Taipei 3 Medicus Economics, Milton, MA. Medical University, Taipei, Taiwan.

P-458 UP-REGULATED HYALURONAN SYNTHASE 2 MEDIATES EPIDERMAL GROWTH FACTOR-INDUCED CELL MIGRATION AND LEIOMYOMA INVASION IN HUMAN ENDOMETRIOTIC STROMAL CELLS. B. Peng,1 H. Zhan,1,2 P. Yong,1 P. C. Leung,1 J. Lin,2 M. A. Bedaiwy1; P-464 SILIBININ INHIBITIS PROGESTERONE 1Department of Obstetrics & Gynaecology, INDUCED RANKL EXPRESSION IN HUMAN D. E. Ikhena, Child & Family Research Institute, University UTERINE LEIOMYOMA CELLS. S. Liu, S. Kujawa, S. Bulun, P. Yin; Obstetrics of British Columbia, Vancouver, BC, Canada, and Gynecology, Prentice Women’s Hospital, 2Department of Gynecology and Obstetrics, Northwestern University Feinberg School of Women’s Hospital, Zhejiang University Medicine, Chicago, IL. Medical College, Hangzhou, China.

P-465 A-KINASE ANCHORING PROTEIN-13 P-459 IMPACT OF LARGE ENDOMETRIOMAS ON (AKAP13) BINDS AND ACTIVATES THE RESPONSE TO HYPERSTIMULATION 1 1,2 PROGESTERONE RECEPTOR. F. S. Chuong, FOR IN VITRO FERTILIZATION. S. Ferrero, C. Washington,1 K. C. Cayton,1 P. Driggers,1 M. A. Racca,1 E. Tafi,1 C. Scala,1 P. Venturini,1 U. Malik,2 J. Segars1; 1Johns Hopkins University Leone Roberti Maggiore1,2; 1Unit of Obstetrics School of Medicine, Baltimore, MD, 2OBG, and Gynaecology, IRCCS AOU San Martino – IST, Uniformed Services University of the Health DiNOGMI, University of Genova, Genova, Italy, Science, Bethesda, MD. 2Piazza della Vittoria 14 S.r.l., Genova, Italy.

P-466 CYTOKINE REGULATION CENTRAL TO P-460 CHARACTERISTICS OF WOMEN EXPERIENCING ULIPRISTAL-MEDIATED LEIOMYOMA PERSISTENT ENDOMETRIOSIS PAIN AFTER TREATMENT. M. Malik,1 J. L. Britten,1 J. LAPAROSCOPY AND LNG-IUD PLACEMENT. Cox,2 X. Zhang,3 M. D. Wilkerson,3 L. K. C. R. Sacha,1 L. V. Farland,1,2 S. A. Missmer,1,2 R.

nd 72 ASRM Scientific Congress & Expo 210 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Nieman,4 W. H. Catherino1; 1Obstetrics and HIGH FREQUENCY. A. El Andaloussi,1 S. Habib,1 Gynecology, Uniformed Services University G. Soylemez,1 N. Ismail,2 A. Al-Hendy1; 1Dept of of the Health Sciences, Bethesda, MD, 2Fort Obstetrics & Gynecology, Augusta Univ, Augusta, Belvoir Community Hospital, Fort Belvoir, GA, 2Pathology Clinical Microbiology Division, VA, 3Collaborative Health Initiative Research University of Pittsburgh, Pittsburgh, PA. Program, USUHS, Bethesda, MD, 4NIDDK, Bethesda, MD. ENVIRONMENT AND TOXICOLOGY P-467 CINE MRI CAN BE AN EFFECTIVE TOOL TO DETERMINE SURGICAL INDICATION FOR P-472 KNOWLEDGE, ATTITUDES, AND BEHAVIORS UTERINE FIBROIDS IN INFERTILE WOMEN. RELATED TO ENVIRONMENTAL CHEMICAL C. Tabata, T. Fujiwara, O. Tsutsumi; Center EXPOSURE AMONG WOMEN SEEKING for Human Reproduction and Gynecologic FERTILITY CARE. A. Pilato,1 K. Hoeger,2 W. , Sanno Hospital, Tokyo, Japan. Vitek,2 E. S. Barrett3; 1OBGYN, University of Rochester, Rochester, NY, 2University of P-468 VERSICAN PROTEOLYSIS IN THE Rochester Medical Center, Rochester, NY, PATHOGENESIS OF UTERINE LEIOMYOMA. 3Obstetrics and Gynecology, University of N. Gueye,1 T. J. Mead,2 C. J. Biscotti,3 T. Rochester, Rochester, NY. Falcone,4 S. S. Apte5; 1Cleveland Clinic, 2 University Heights, OH, Department of P-473 EFFECT OF IN VITRO AND IN VIVO , Cleveland Clinic, ACRYLAMIDE EXPOSURE ON MOUSE 3 Cleveland, OH, Laboratory Medicine- OOCYTES. O. Cinar,1 D. Aras,2 Z. Cakar,1 S. Anatomic Pathology, Cleveland Clinic, Ozkavukcu,3 A. Can1; 1Department of Histology 4 University Heights, OH, ob gyn, Cleveland and Embryology, Ankara University School of 5 Clinic, Cleveland, OH, Department of Medicine, Ankara, Turkey, 2Ankara University, Biomedical Engineering, Cleveland Clinic Biotechnology Instıtute, Ankara, Turkey, Lerner Research Institute, Cleveland, OH. 3Center for Assisted Reproduction, Dep. of Obstetrics and Gynecology, Ankara University P-469 CHANGES IN ADENOMYOSIS AFTER School of Medicine, Ankara, Turkey. TREATMENT WITH ULIPRISTAL ACETATE. 1,2 1 1 1 S. Ferrero, C. Scala, A. Racca, E. Tafi, P. P-474 SILVER NANOPARTICLES(AGNPS) INDUCED 1 1,2 1 Venturini, U. Leone Roberti Maggiore ; Unit CHANGES OF REPRODUCTIVE PARAMETERS of Obstetrics and Gynaecology, IRCCS AOU AND GENE EXPRESSION WAS INVOLVED San Martino – IST, DiNOGMI, University of IN APOPTOSIS IN THE MURINE MALE 2 Genova, Genova, Italy, Piazza della Vittoria 14 TESTIS. E. Wang,1 Y. Huang,2 Q. Du,2 Y. Sun2; S.r.l., Genova, Italy. 1The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China, 2Reproductive P-470 EARLY-LIFE EXPOSURE TO ENDOCRINE- Medical Center, The First Affiliated Hospital of DISRUPTING CHEMICALS (EDCS) LEADS TO Zhengzhou University, Zhengzhou, China. THE DEVELOPMENT OFUTERINE FIBROIDS BY IMPAIRING DNA REPAIR CAPACITY IN P-475 ASSESSMENT OF THE EMBRYO TRANSFER 1 MYOMETRIAL STEM CELLS. L. Prusinski, CATHETER MICROBIOME AFTER EUPLOID 2 3 4 5 Q. Yang, A. Mas, M. P. Diamond, C. Walker, BLASTOCYST TRANSFER IS NOT PREDICTIVE 6 1 A. Al-Hendy ; Obstetrics and Gynecology, OF SUSTAINED IMPLANTATION. J. M. 2 Augusta University, Augusta, GA, OB/GYN, Franasiak,1 C. R. Juneau,1 S. J. Morin,1 X. 3 Augusta University, Augusta, GA, PhD, Paterna Tao,2 J. Rajchel,2 J. N. Landis,2 Y. Zhan,2 N. 4 (Valencia), Spain, Augusta University, Augusta, Treff,1 R. T. Scott Jr.1; 1Reproductive Medicine 5 GA, Texas A&M Institute of Biosciences Associates of New Jersey, Basking Ridge, NJ, 6 and Technology, Houston, TX, Obstetrics & 2FAEEC, Basking Ridge, NJ. Gynecology, Augusta University, Augusta, GA. P-476 HIGH THROUGHPUT SCREEN USING VIABLE P-471 AUTOPHAGY AND FIBROIDS: AUTOPHAGY FLUORESCENT ESC REPORTER OF STRESS RELATED PROTEINS ATG4 AND ATG10 ARE FORCED DIFFERENTIATION TO THE FIRST DEFECTED IN HUMAN UTERINE FIBROIDS WITH

nd 72 ASRM Scientific Congress & Expo 211 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

LINEAGE. E. E. Puscheck,1,2 E. D. Louden,3 Q. Johnson, L. Marriott, M. Reay, P. Parsons; SPD Li,4 Y. Yang,5 D. A. Rappolee3; 1Obstetrics and Development Company Ltd, Bedford, United Gynecology, Reproductive Endocrine and Kingdom. Infertility, Grosse Pointe Farms, MI, 2Wayne State University School of Medicine, Detroit, MI, 3Obstetrics and Gynecology, Wayne State University School of Medicine, Detroit, MI, OXIDATIVE STRESS 4Ob/Gyn, Wayne State University, Detroit, MI, 5Wayne State University, Detroit, MI. P-482 GASTRIC BYPASS SURGERY IS ASSOCIATED WITH REDUCTION IN OVARIAN ENDOPLASMIC P-477 TRIMESTER-SPECIFIC URINARY PARABEN RETICULUM STRESS. J. P. Alvarez,1,2 A. Frank,2 CONCENTRATIONS AND PREGNANCY D. Clegg2; 1Obstetrics and Gynecology, UCLA, Los GLUCOSE LEVELS AMONG WOMEN FROM Angeles, CA, 2Cedars Sinai, Los Angeles, CA. A FERTILITY CLINIC. Y. Chiu,1 L. Minguez- Alarcon,2 C. Messerlian,2 J. B. Ford,2 M. Keller,3 J. C. Petrozza,4 P. L. Williams,5 R. Hauser,6 P-483 OOCYTES ARE MORE RESISTENT TO L. T. James-Todd2; 1Nutrition, Harvard T.H. OXIDATIVE STRESS THAN EMBRYOS. Wang,1,2 F. Wang,1 L. G. Robinson,1 Y. G. Kramer,3 Chan School of Public Health, Boston, MA, M. L. Seth-Smith,1 N. M. Sachdev,3 D. L. Keefe1; 2Environmental Health, Harvard T.H. Chan 1Department of Obstetrics and Gynecology, School of Public Health, Boston, MA, 3Harvard NYU Langone Medical College, Laboratory T.H. Chan School of Public Health, Boston, MA, of Reproductive Medicine, New York, NY, 4Obstetrics and Gynecology, Massachusetts 2Reproductive Medicine Center, Tongji Hospital, General Hospital, Boston, MA, 5Biostatistics, Tongji Medical College of Huazhong University Harvard T.H. Chan School of Public Health, of Science and Technology, Wuhan, China, 3OBS- Boston, MA, 6Harvard Chan School of Public GYN, NYU Fertility Center, New York, NY. Health, Boston, MA.

P-484 THE ACTIONS OF SILDENAFIL ON P-478 Abstract withdrawn TROPHOBLAST SURVIVAL IS DEPENDENT ON HBEGF SIGNALING. A. Bolnick,1 C. Jain,1 B. P-479 CAN GLOBAL TEMPERATURE AFFECT IN Kilburn,1 P. Singhal,2 S. Svytka,1 J. Bolnick,1 C. 1 VITRO FERTILIZATION CYCLES? L. Cipriani, A. Barrak,1 R. Greige,1 D. Armant1; 1Obstetrics and 2 3 4 5 Bianchi, A. Bazzocchi, F. Fabbri, G. Damiano, Gynecology, Wayne State University, Detroit, MI, 5 1 5 6 P. Ciotti, L. Notarangelo, N. Calza, L. Orazi, 2Obstetrics and Gynecology/Oncology, Good 1 1 E. Porcu ; S. Orsola Hospital, Infertility and IVF Samaritan Hospital Medical Center, West Islip, NY. Center, Bologna, Italy, 2Sant’Orsola Hospital, Infertility and IVF Center, Bologna, Italy, 3Infertility and IVF Center, University of Bologna, P-485 EPIDIDYMAL SPERM ANALYSIS Bologna, Italy, 4S.Orsola Hospital, Infertility FOLLOWING TIME AND DOSE DEPENDENT and IVF Center, University of Bologna, Bologna, ADMINISTRATION OF MONOSODIUM D. Italy, 5S. Orsola Hospital, Human Reproductive GLUTAMATE IN PREADOLESCENT RATS. Kianifard; Department of Basic Sciences, Medicine Unit, Bologna, Italy, 6Carlo Poma Faculty of Veterinary Medicine, University of Hospital, Gynaecologic Unit, Mantova, Italy. Tabriz, Tabriz, Iran, Islamic Republic of.

P-480 DETERMINATION OF VOLATILE ORGANIC P-486 STANDARDIZATION OF THE TUNEL COMPOUNDS LEVEL IN INCUBATORS. X. Yang, T. Berwald, P. Marsh, W. Y. Lin, PROTOCOL FOR SPERM DNA R. Quinones, M. Rosen; Department of FRAGMENTATION BETWEEN TWO R. Sharma,1 S. Forte,2 S. Obstetrics, Gynecology & Reproductive LABORATORIES. Gupta,1 Z. Cakar,1 C. DeGeyter,3 A. Agarwal1; Sciences, University of California, San 1American Center for Reproductive Medicine, Francisco, San Francisco, CA. Department of Urology, Cleveland Clinic, Cleveland, OH, 2Gyn. Endokrinoliogie and P-481 VAGINAL LUBRICANT USE AMONG WOMEN Reproduktionsmedizin, Universitatsspital TRYING TO CONCEIVE: INSIGHTS FROM A Basel Frauenklinik, Basel, Switzerland, SURVEY OF OVER 1000 PARTICIPANTS. S.

nd 72 ASRM Scientific Congress & Expo 212 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

3Division of Gynaecological Endocrinolgy and Martins,4 R. Ferriani5; 1Human Reproduction Reproductive Medicine, University Women’s Department, Ribeirao Preto Medical School Hospital of Basel, Basel, Switzerland. ( FMRP ) - USP, Ribeirao Preto, Brazil, 2University of Sao Paulo, Ribeirao Preto, Brazil, 3Department of Obstetrics and Gynecology, P-487 IN HUMAN GERMINAL VESICLE OOCYTES 4 MITOCHONDRIAL STRESS DISRUPTS MEIOTIC Faculty o, Ribeirao Preto, Brazil, Ribeirao Preto Medical School, University of Sao P, Ribeirào SPINDLES WITHOUT AFFECTING MEAN 5 TELOMERE LENGTH. L. Wang,1,2 F. Wang,1 L. G. Preto, Brazil, Obstetrics and Gynecology, Robinson,1 Y. G. Kramer,3 M. L. Seth-Smith,1 N. M. University of Sao Paulo, Ribeirao Preto, Brazil. Sachdev,3 D. L. Keefe1; 1Department of Obstetrics and Gynecology, NYU Langone Medical College, P-492 LONGITUDINAL INTUSSUSCEPTION Laboratory of Reproductive Medicine, New York, VASOEPIDIDYMOSTOMY LEARNING NY, 2Reproductive Medicine Center, Tongji Hospital, CURVE. B. B. Najari,1 P. Bach,1 F. Neto,1 P. Tongji Medical College of Huazhong University of S. Li,1 M. Goldstein,2 A. J. Gottesdiener,3 A. Science and Technology, Wuhan, China, 3OBS-GYN, Ayangbesan1; 1Urology, Weill Cornell Medical NYU Fertility Center, New York, NY. College, New York, NY, 2Male Reproductive Medicine, and Urology, Weill Cornell Medical College, New York Presbyteri, New York, NY, P-488 EFFICACY OF ASCORBIC ACID IN 3 ALLEVIATING OXIDATIVE STRESS USING Weill Cornell Medical College, New York, NY. IN-VITRO HUMAN SPERM MODEL. G. Ahmad,1,2 R. Sharma,2 S. Roychoudhary,2 S. P-493 CFTR GENE POLYMORPHISM ARE Esteves,3 A. Agarwal2; 1Physiology, University ASSOCIATED WITH REDUCED SPERM of Health Sciences, Lahore, Lahore, Pakistan, PROGRESSIVE MOTILITY IN IDIOPATHIC 2American Center for Reproductive Medicine, INFERTILE MEN. E. Ventimiglia,1 P. Department of Urology, Cleveland Clinic, Capogrosso,1 P. Filippo,1 F. Montorsi,1 A. Cleveland, OH, 3ANDROFERT - Andrology & Salonia2; 1Division of Experimental Oncology/ Human Reproduction Clinic, Campinas, Brazil. Unit of Urology, Milan, Italy, 2IRCCS Ospedale San Raffaele, Milan, Italy.

P-494 EPIGENETIC DYSREGULATION OF MALE REPRODUCTION AND UROLOGY - CLINICAL MAEL GENE CONTRIBUTES TO ONE OF THE CAUSES OF NON- P-489 A THOROUGH CHROMOSOMAL OBSTRUCTIVE AZOOSPERMIA WITH ASSESSMENT BY NEXT GENERATION HYPOSPERMATOGENESIS. Y. Lin, Y. Cheng, C. SEQUENCING CARRIED OUT ON THE MALE Lu; Urology, National Cheng Kung University, GAMETE IN INFERTILE COUPLES. S. Cheung, College of Medicin, Tainan, Taiwan. T. Cozzubbo, S. Chow, Z. Rosenwaks, G. D. Palermo; Reproductive Medicine, Weill Cornell P-495 REPEAT MICROSURGICAL RECONSTRUCTION Medicine, New York, NY. AFTER FAILED INITIAL VASECTOMY REVERSAL. P. V. Bach,1 B. B. Najari,1 F. Neto,1 A. 1 1 2 P-490 DNA FRAGMENTATION IN RELATION TO Ayangbesan, A. V. Gottesdiener, M. Goldstein ; 1 SPERM SOURCE AND REPRODUCTIVE Urology, Weill Cornell Medical College, New 2 OUTCOME. T. Paniza,1 T. Cozzubbo,1 S. York, NY, Male Reproductive Medicine, and Cheung,1 A. Parrella,1 M. Goldstein,2 Z. Urology, Weill Cornell Medical College, New Rosenwaks,1 G. D. Palermo1; 1Reproductive York Presbyteri, New York, NY. Medicine, Weill Cornell Medicine, New York, NY, 2Urology, Weill Cornell Medicine, New York, NY. P-496 VARIABILITY OF MALE FERTILITY NUTRICEUTICALS: SUPPLEMENT ANALYSIS, 1 P-491 MAGNETIC ACTIVATED CELL SORTING COST AND QUALITY CONTROL. S. Pan, S. C. 2 1 PERFORMED BEFORE DOUBLE GRADIENT Honig ; Urology, Yale New Haven Hospital, 2 CENTRIFUGATION IMPROVE THE RECOVERY New Haven, CT, Urology, Yale University, New OF GOOD QUALITY SPERMATOZOA. T. S. Haven, CT. Bertelli,1 M. G. Da Broi,2 P. A. Navarro,3 W.

nd 72 ASRM Scientific Congress & Expo 213 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-497 OUTCOMES OF VARICOCELECTOMY IN P-502 DIETARY ZINC INTAKE AND REPRODUCTIVE MEN WITH HISTORY OF ORCHIOPEXY FOR FUNCTION IN YOUNG MEN. J. Gabrielsen,1 UNDESCENDED TESTES. F. Neto,1 P. V. Bach,2 B. G. J. Wood,2 A. J. Gaskins,3 S. H. Swan,4 J. B. Najari,1 A. Gottesdiener,1 A. Ayangbesan,1 P. S. Mendiola,5 N. Joergensen,6 J. E. Chavarro,3 Li,1 M. Goldstein3; 1Urology, Weill Cornell Medical C. Tanrikut1; 1Department of Urology, College, New York, NY, 2Weill Cornell Medical Massachusetts General Hospital, Boston, College, New York, NY, 3Male Reproductive MA, 2Division of Urology, Universidade de Medicine, and Urology, Weill Cornell Medical Sao Paulo, Sao Paulo, Brazil, 3Department College, New York Presbyteri, New York, NY. of Nutrition, Harvard School of Public Health, Boston, MA, 4Preventive Medicine, Icahn School of Medicine at Mount Sinai, P-498 THE EFFECT OF A 4-HOUR MODERATE 5 AND 1-HOUR INTENSE EXERCISE NewYork, NY, Preventive Medicine and Public Health, University of Murcia, SESSION VERSUS RESTING CONDITION 6 ON LUTEINIZING HORMONE (LH) LEVEL, Murcia, Spain, University Department of VARIATION, AND PULSATILITY IN SIX Growth and Reproduction, Rigshospitalet, HEALTHY MALE SUBJECTS. J. L. Chiang,1 Copenhagen, Denmark. M. P. Leondires,2 W. Y. Craig,3 F. L. Lucas,3 D. I. Spratt4; 1Obstetrics and Gynecology, Maine P-503 OXIDATION REDUCTION POTENTIAL Medical Center, Portland, ME, 2Reproductive - A NOVEL TEST FOR EVALUATING Endocrinology and Infertility, Reproductive MALE INFERTILITY. A. Agarwal,1 S. Medicine Associates of Connecticut, Roychoudhury,1 R. Sharma,1 S. Gupta,1 Norwalk, CT, 3Maine Medical Center Research Z. Cakar,1 M. M. Arafa,2 E. S. Sabanegh1; Institute, Scarborough, ME, 4Reproductive 1American Center for Reproductive Endocrinology and Infertility, Maine Medical Medicine, Department of Urology, Cleveland Center, Portland, ME. Clinic, Cleveland, OH, 2Urology, Hamad Medical Corporation, Doha, Qatar. P-499 OXIDATION REDUCTION POTENTIAL: A NOVEL MARKER OF VARICOCELE P-504 ROLE OF SPERM CELL SPECIFIC RNA PATHOPHYSIOLOGY. A. Agarwal,1 A. TO SCREEN FOR UNEXPLAINED MALE Majzoub,1 S. Roychoudhury,1 M. M. Arafa2; INFERTILITY. T. Cozzubbo, N. Pereira, S. 1American Center for Reproductive Medicine, Cheung, A. P. Clement, Z. Rosenwaks, G. D. Department of Urology, Cleveland Clinic, Palermo; Reproductive Medicine, Weill Cornell Cleveland, OH, 2Urology, Hamad Medical Medicine, New York, NY. Corporation, Doha, Qatar. P-505 TRIPEPTIDYL PEPTIDASE I (TPP1) IS P-500 CLINICAL CONSEQUENCES OF A POSITIVE OUTCOME MARKER FOR MICRODELETIONS OF Y CHROMOSOME IN VARICOCELECTOMY IN ADULTS. M. JAPANESE NON-OBSTRCTIVE AZOOSPERMIC Camargo,1 P. Intasqui,1 L. Berloffa Belardin,1 PATIENTS. T. Ishikawa, S. Mizuta, K. M. P. Antoniassi,1 K. Cardozo,2 V. Melechco Yamaguchi, Y. Takaya, R. Nishiyama, K. Kitaya, Carvalho,2 A. Cedenho,1 R. Bertolla3; 1Sao H. Matsubayashi; Reproduction Clinic Osaka, Paulo Federal University, Sao Paulo, Osaka, Japan. Brazil, 2Fleury Group, Sao Paulo, Brazil, 3Deparment of Surgery, Division of Urology, P-501 FEMALE PARTNER DEMOGRAPHICS OF MEN Human R, Sao Paulo Federal University, Sao SEEKING VASECTOMY REVERSAL. J. M. Paulo, Brazil. Rehmer,1 H. Sayles,2 A. Perkins,3 S. L. Gustin,1 S. H. Marks,3 C. M. Deibert4; 1Department of Obstetrics P-506 EXPERT PERSPECTIVES ON SEMEN and Gynecology, University of Nebraska Medical ANALYSIS PARAMETERS THAT ARE Center, Omaha, NE, 2Department of Biostatistics, IMPORTANT TO PATIENT COUNSELING. K. University of Nebraska Medical Center, Omaha, Ostrowski,1 J. Gore,1 M. Rogers,2 T. J. Walsh1; NE, 3International Center for Vasectomy Reversal, 1University of Washington, Department of Tucson, AZ, 4Division of Urologic Surgery, Urology, Seattle, WA, 2University of Pittsburgh, University of Nebraska Medical Center, Omaha, Department of Urology, Pittsburgh, PA. NE.

nd 72 ASRM Scientific Congress & Expo 214 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-507 DOES THE DEGREE OF SPERM DNA Seattle, WA, 2Virginia Center for Reproductive FRAGMENTATION AFFECT EMBRYO Medicine, Reston, VA, 3Pharmacy, University ANEUPLOIDY RATE. I. Gat,1 K. Tang,1 V. of Washington, Seattle, WA. Kuznyetsov,1 R. Abramov,1 R. Antes,1 S. Moskovtsev,1 M. Filice,1 C. L. Librach2; 1Create 2 P-513 SOURCES OF KNOWLEDGE AND EFFECT OF Fertility Centre, Toronto, ON, Canada, CReATe EDUCATION ON UROLOGISTS’ ATTITUDES Fertility Centre, Toronto, ON, Canada. TOWARDS PENILE TRANSPLANTATION. B. B. Najari,1 P. V. Bach,2 A. Bolyakov,1 R. Lischer,1 P-508 CORRELATION BETWEEN TWO SPERM D. Paduch3; 1Urology, Weill Cornell Medical DNA FRAGMENTATION TESTS (TUNEL AND College, New York, NY, 2Weill Cornell Medical SCSA) AND EVALUATION OF TUNEL ASSAY College, New York, NY, 3Dept of Urology, Weill INTER-LAB VARIABIALITY. C. LeSaint,1 L. Cornell Medical College, New York, NY. Vingataramin,1 S. Alix,1 S. Phillips,2 A. Zini,3 1 1 J. I. Kadoch ; Clinique OVO, Montreal, QC, P-514 PREGNANCY TRIALS USING THE DEVICE Canada, 2OVO Fertility, Montreal, QC, Canada, 3 FOR IMPROVED SEMEN IMPROVED SEMEN McGill University, Cote St-Luc, QC, Canada. COLLECTION. S. Prien,1 C. A. Dehn,2 K. K. Evenson,3 L. Penrose4; 1Ob/Gyn, Texas Tech P-509 MALE INFERTILITY AND MEDICAL University Health Sciences Center, Lubbock, COMORBIDITIES: INFERTILE MEN ARE NOT TX, 2Umbrella Corporation, San Antonio, LESS HEALTHY THAN FERTILE. F. Cheung,1 TX, 3Animal Science, Texas Tech University, E. Shreck,1 I. Kopysitsky,1 A. Chang,1 D. Lubbock, TX, 4Department of Obstetrics and Kenigsberg,2 D. Schulsinger,1 Y. Sheynkin1; Gynecology, Texas Tech University Health 1SUNY at Stony Brook, Stony Brook, NY, 2Long Sciences Center, Lubbock, TX. Island IVF, Melville, NY. P-515 THE PREDICT VALUE OF SEMINIFEROUS P-510 CLINICAL OUTCOMES OF MICRODISSECTION TUBULE HYALINIZATION FOR THE SPERM TESTICULAR SPERM EXTRACTION (MICRO RETRIEVAL RATE OF MICRO-DISSECTION TESE) AND INTRACYTOPLASMIC SPERM TESTICULAR SPERM EXTRACTION IN THE INJECTION (ICSI) IN PATIENTS WITH NON-OBSTRUCTIVE AZOOSPERMIA PATIENTS. KLINEFELTER SYNDROME. T. Ishikawa, S. G. Liu,1 J. Zhang,1 Z. Wang,2 X. Liang3; 1Andrology, Mizuta, K. Yamaguchi, Y. Takaya, R. Nishiyama, Reproductive Center, Sixth Affiliated Hospital K. Kitaya, H. Matsubayashi; Reproduction of Sun Yan-Sen University, Guangzhou, China, Clinic Osaka, Osaka, Japan. 2Urology, Sixth Affiliated Hospital of Sun Yan-Sen University, Guangzhou, China, 3Obstetrics & P-511 OLIGOASTENOSPERMIC MEN TREATED WITH Gynecology, Rreproductive Center, The Sixth PROXEED PLUS SHOWED CORRELATION Affiliated Hospital of Sun Yat-Sen University, BETWEEN SPERM MOTILITY AND SEMINAL Guangzhou, China. CARNITINE. S. Micic,1 N. Lalic,2 N. Bojanic,3 D. Djordjevic,3 A. Virmani,4 A. Agarwal5; P-516 EVALUATION OF INTRA- AND INTER- 1Urology, Uromedica Polyclinic, Belgrade, OBSERVER RELIABILITY OF THE ORP Serbia, 2Andrology Lab, Uromedica (OXIDATION-REDUCTION POTENTIAL) TEST Polyclinic, Belgrade, Serbia, 3Clinical Center FOR OS (OXIDATIVE STRESS) IN MALE FACTOR of Serbia, Urologic Clinic, Belgrade, Serbia, INFERTILITY. A. Agarwal,1 S. Roychoudhury,1 4Inovation,Research and Development, Sigma- R. Sharma,1 S. Gupta,1 A. Majzoub,1 K. tau Health Science, Utrecht, Netherlands, Bjugstad,2 E. S. Sabanegh1; 1American Center 5Andrology Center, American Center for for Reproductive Medicine, Department of Reproductive Medicine, Cleveland, OH. Urology, Cleveland Clinic, Cleveland, OH, 2Aytu BioScience, Englewood, CO. P-512 POTENTIAL IMPACT OF THE CAP-SCORE TEST™ ON CLINICAL PREGNANCY AND P-517 THE IMPACT OF EMBRYO MORPHOKINETICS MEDICAL COSTS IN COUPLES WITH ON ICSI OUTCOME: UNEXPALINED UNEXPLAINED INFERTILITY. J. B. INFERTILITY VS. MALE FACTOR INFERTILITY. Babigumira,1 F. Sharara,2 L. P. Garrison3; N. Adel,1 M. Elmahdy,2 A. A. Aboali,1 S. A. 1Global Health, University of Washington, Hebisha,2 A. Elmasdy,1 M. Galal1; 1Madina

nd 72 ASRM Scientific Congress & Expo 215 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Fertility Center, Alexandria, Egypt, 2Obs. Gyn., J. Travis,1 A. Simpson,2 M. A. Moody,2 C. Alexandria University - Faculty of Medicine, Cardona,2 G. C. Ostermeier2; 1Cornell Alexandria, Egypt. University, Ithaca, NY, 2Androvia LifeSciences, Mountainside, NJ. P-518 PRELIMINARY EXPERIENCE WITH THE NOVEL LAPAROENDOSCOPIC SINGLE- P-524 IDENTIFICATION OF COMMON UNDERLYING SITE EXTRAPERITONEAL (LESS-EP) PATHOLOGIES ASSOCIATED WITH MALE VARICOCELECTOMY. T. Rude, Y. Yamaguchi, INFERTILITY AND DIABETES USING DATA K. Khurana, G. J. Felder, L. Zhao, J. P. Alukal; MINING AND IN SILICO ANALYSES. N. Urology, NYU, New York, NY. Kothandaraman,1 A. Agarwal,1 L. Samanta,2,1 M. Assidi3; 1American Center for Reproductive Medicine, Department of Urology, Cleveland SPERM BIOLOGY Clinic, Cleveland, OH, 2Redox Biology Laboratory, School of Life Sciences, Ravenhaw University, Orissa, India, 3Centre P-519 DOES SPERM ORIGIN HAVE AN IMPACT ON for Excellence in Genomic Medicine Research, MORPHOKINETICS OF HUMAN ZYGOTES? Jeddah, Saudi Arabia. T. Takeuchi,1 N. Aono,1 N. Oka,1 R. Obata,1 N. Okuyama,1 M. Machida,1 K. Nagao,2 H. Igarashi,3 K. Kyono3; 1Kyono ART Clinic Takanawa, P-525 A COMPREHENSIVE STUDY INTO THE Minatoku, Tokyo, Japan, 2Urology, Toho EFFECTS OF ADVANCING MALE AGE ON University, Ota-ku, Tokyo, Japan, 3Kyono ART SEMEN PARAMETERS, SPERM GENETIC Clinic, Sendai, Miyagi, Japan. INTEGRITY AND THE OUTCOME OF ASSISTED REPRODUCTIVE TREATMENTS. A. Raberi,1,2 G. Rozis,3 S. Alfarawati,2 K. P-520 NON-CODING RNA PROFILING AS Glynn,3 L. Lansdowne,2 S. Batha,3 D. Wells2,1; AN INDICATOR OF MALE GAMETE 1The Nuffield Department of Obstetrics & T. Cozzubbo, REPRODUCTIVE POTENTIAL. Gynaecology, Institute of Reproductive N. Pereira, S. Cheung, A. P. Clement, Z. Sciences, Oxford, United Kingdom, Rosenwaks, G. D. Palermo; Reproductive 2Reprogenetics UK, Oxford, United Medicine, Weill Cornell Medicine, New York, NY. Kingdom, 3Lister Fertility Clinic, London, United Kingdom. P-521 HYDROGEN MOLECULE TREATMENT ENHANCES ATP PRODUCTION IN HUMAN P-526 THE POTENTIAL APPLICATION OF THE SPERMATOZOA. K. Nakata,1 K. Yoshida,2 INDUCED PLURIPOTENT STEM CELLS (IPS) M. Yoshida,3 N. Yamashita1; 1Reproductive INDUCED FROM URINE STEM CELLS IN Medicine Research Center, Yamashita Shonan MALE INFERTILITY. G. Liu,1 J. Zhang,1 Z. Yume Clinic, Kanagawa, Japan, 2Biomedical Wang,2 X. Liang3; 1Andrology, Reproductive Engineerring Center, Toin University of Center, Sixth Affiliated Hospital of Sun Yan- Yokohama, Kanagawa, Japan, 3Misaki Marine Sen University, Guangzhou, China, 2Urology, Biological Station Graduate School of Science, Sixth Affiliated Hospital of Sun Yan-Sen University of Tokyo, Kanagawa, Japan. University, Guangzhou, China, 3Obstetrics & Gynecology, Rreproductive Center, Sixth P-522 SEGMENTED HAIRPIN-LOOP ORGANIZATION Affiliated Hospital of Sun Yat-Sen University, OF CHROMOSOMES IN SPERM NUCLEI: Guangzhou, China. IMPLICATIONS FOR FERTILIZATION AND EMBRYOGENESIS. D. Ioannou,1 H. G. P-527 FIVE TIMES LOWER RISK OF DNA Tempest2; 1Human and Molecular Genetics, FRAGMENTATION IN SPERM WITH SLIGHTLY Assistant Professor, Miami, FL, 2Human and NARROW HEADS THAN THE NORMAL SIZED Molecular Genetics, Florida International HEADS. S. Watanabe,1 A. Fukui,2 A. Funamizu,3 University, Miami, FL. A. Tanaka4; 1Anatomical Science, Hirosaki University Graduate school of Medicine, P-523 CAPACITATION TIMING VARIES AMONG Hirosaki, Japan, 2Obstetrics and Gynecology, MEN, BUT IS CONSISTENT AMONG Hirosaki University, Graduate School of EJACULATES WITHIN INDIVIDUALS. A. Medicine, Hirosaki, Japan, 3Obstetrics and

nd 72 ASRM Scientific Congress & Expo 216 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Gynecology, Hirosaki University Graduate P-532 MICROSURGICAL TESTICULAR SPERM School of Medicine, Hirosaki, Japan, 4Saint EXTRACTION (MICROTESE) SPERM Mother Hospital, Kitakyusyu, Japan. RETRIEVAL RATE (SRR) POST TESTICULAR SPERM ASPIRATION (TESA). A. H. AlMalki,1 A. Zini2; 1Urology, McGill University, Montreal, QC, Canada, 2McGill University. SPERM PREPARATION P-533 A SIMPLE NEW METHOD FOR THE FREEZE- P-528 ADVANCED PROFILING OF IVF DRYING AND STORAGE OF HUMAN SPERM. 1 2 3 4 APPLICABILITY OF REVERSE P. Patrizio, Y. Natan, Y. Barak, P. Levi Setti, A. 5 1 PROGRESSIVE SPERMATOZOA SORTED Arav ; Obstetrics, Gynecology & Reproductive VIA HIGH THROUGHPUT DIFFUSE-TYPE Sciences, Yale Fertility Center & Fertility 2 MICROFLUIDIC BIOCHIP. P. Li-Chern,1 F. Hsu,2 Preservati, New Haven, CT, FertileSafe Ltd., 3 C. Wang3; 1College of Biomedical Engineering, Nes-Ziona, Israel, Clinical Embryologist, Rosh 4 Taipei Medical University, Taipei, Taiwan, 2The Haayin, Israel, Dept. Gynecology, Division Ph.D. Program for Translational Medicine, of Gynecology and Reproductive Medicine, College of Medical Science and Technology, Humanitas Fertility Center-Humanitas Taipei Medical University, Taipei, Taiwan, Research Hospital, Rozzano (Milano), Italy, 5 3Gynecology and Obstetrics, Taipei Medical Fertilesafe Ltd, Nes- Ziona, Israel. University Hospital, Taipei, Taiwan. P-534 EMBRYO QUALITY IS IMPROVED BY PICSI P-529 BIOMARKERS FOR SPERM QUALITY ARE SPERM SELECTION. A RANDOMIZED 1 2 ASSOCIATED WITH FERTILITY RATES AND CONTROLLED TRIAL. L. Alegre, N. Garrido, 3 4 5 EMBRYO VIABILITY. E. Lopez-Bayghen,1,2 J. Romero, A. E. Palma, J. Remohi Gimenez, 6 1 P. Tello-Mora,1 B. Quintanilla-Vega1; M. Meseguer ; Clinical Embryology, IVI 2 1Departmento de Toxicología, Cinvestav- Valencia, Valencia, Spain, Andrology IPN, Ciudad de Mexico, Mexico, 2Laboratorio Laboratory, Instituto Valenciano IVI Valencia, 3 de Investigación y Diagnóstico Molecular, Valencia, Spain, IVI Valencia, valencia, 4 Instituto Ingenes, Ciudad de Mexico, Mexico. Spain, IVF Laboratory, IVI Panama, Panama, Panama, 5IVI Valencia, Valencia, Spain, 6Clinical Embryology, Valencia, Spain. P-530 OPTIMAL TIMING FOR INTRAUTERINE INSEMINATION (IUI) AFTER ADMINISTERING HCG IN OVULATION INDUCTION IUI CYCLES. P-535 MORPHOKINETIC PARAMETERS IN SPERM B. S. Hurst,1 K. Merriam,2 P. Marshburn,3 M. SELECTION BY ANNEXIN-V SORTING Matthews,4 R. S. Usadi5; 1Ob/Gyn, Carolinas PRIOR TO ICSI IN OVUM DONATION HealthCare System, Charlotte, NC, 2Carolinas PROGRAM. RESULTS FROM A PROSPECTIVE 1 2 Medical Center, Charlotte, NC, 3Department RANDOMIZED TRIAL. L. Alegre, L. Romany, 3 4 1 of OB/GYN, Carolinas Healthcare System, N. Garrido, A. Tejera, J. Remohi Gimenez, 5 1 Charlotte, NC, 4Carolinas Healthcare System, M. Meseguer ; IVI Valencia, Valencia, Spain, 2 3 Charlotte, NC, 5Reproductive Endocrinology and Embryologist, Valencia, Spain, Andrology Infertility, Carolinas Healthcare, Charlotte, NC. Laboratory, Instituto Valenciano IVI Valencia, Valencia, Spain, 4In Vitro Fertilization Laboratory, IVI Company, Valencia, Spain, P-531 THE EFFECTIVENESS OF DIFFERENT 5Clinical Embryology, Valencia, Spain. MAGNETIC ACTIVATED CELL SORTING COLUMNS AND AUTOMATED SEPARATION PROGRAMS IN DEPLETING APOPTOTIC CLINICAL REPRODUCTIVE LABORATORY SPERM CELLS. N. Aziz,1 J. Novotny,2 J. Brezinova,3 I. Oborna2,3; 1Gynaecology, Consultant, Liverpool Women’s Hospital and P-536 CAN USE OF TIME-LAPSE MONITORING the University of Liverpool, Liverpool, United COMPARED TO CONVENTIONAL Kingdom, 2Faculty of Medicine and , MORPHOLOGIC ASSESSMENT IMPROVE Palacky University, Olomouc, Czech Republic, DAY 3 EMBRYO SELECTION AMONG 3SpermBank International Ltd., Olomouc, EXPERIENCED EMBRYOLOGISTS AND Czech Republic. INEXPERIENCED TRAINEES? A PILOT

nd 72 ASRM Scientific Congress & Expo 217 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

STUDY. I. Okeigwe, D. E. Ikhena, R. Confino, Science at Saint Barnabas, Livingston, NJ, M. Pavone, J. Robins, J. X. Zhang; Obstetrics 4Ob-Gyn, IRMS at Saint Barnabas, Livingston, & Gynecology, Division of Reproductive NJ, 5Aparent IVF Laboratory, Highland Park, Endocrinology & Infertility, Northwestern IL, 6FCI, Highland Park, IL, 7Molecular PGD, University, Chicago, IL. Reprogenetics, Livingston, NJ.

P-537 MATERNAL PREDICTORS OF MORPHOKINETIC P-542 ANALYSIS OF VEGF AND FGF IN HUMAN EMBRYO PARAMETERS USING TIME-LAPSE SERUM AND FOLLICULAR FLUID AS (TL) IMAGING. I. Souter,1 I. Dimitriadis,2 MARKERS OF IVF CYCLE RESPONSE. A. C. L. Bormann,3 R. Hauser,4 C. Messerlian5; Kotlyar,1 R. Baird,2 R. Flyckt3; 1Ob/Gyn and 1Obstetrics & Gynecology/REI Division, Harvard Women’s Health Institute, The Cleveland Medical School-Massachusetts General Clinic Foundation, Cleveland, OH, 2Ob/Gyn Hospital, Boston, MA, 2Tufts Medical Center, and Women’s Health Institute, Cleveland Boston, MA, 3Massachusetts General Hospital- Clinic Lerner College of Medicine, Cleveland, Harvard Medical School, Boston, MA, 4Harvard OH, 3Cleveland Clinic, Beachwood, OH. Chan School of Public Health, Boston, MA, 5 Environmental Health, Harvard T.H. Chan P-543 EMBRYO MORPHOKINETICS AND OVARIAN School of Public Health, Boston, MA. RESERVE. S. Akarsu, F. Gode, B. F. Tamer, A. Z. Isik; In Vitro Fertilization Centre, Izmir P-538 ANEUPLOIDY RATES OF EMBRYOS DERIVED University, Izmir, Turkey. FROM FRESH DONOR EGG CYCLES VS FROZEN DONOR EGG CYCLES. S. R. P-544 PARTHENOGENETIC ACTIVATION Kirkpatrick, G. Proctor, M. Wilson, H. Huffman, AND DEVELOPMENTAL POTENTIAL M. Bush, D. Ambler; Conceptions, Littleton, CO. OF MOUSE OOCYTES AFTER INTRACYTOPLASMIC INJECTION (ICSI) OF P-539 A SYSTEMATIC STUDY USING A LASER PVP (POLYVINYLPYRROLIDONE) AND HA REVEALS DIFFERENCES IN THE BLASTOCYST (HYALURONIC ACID). S. Roychoudhury,1 I. HATCHING RATE AND CLINICAL OUTCOMES Maldonado-Rosas,2 A. Agarwal,1 S. Esteves,3 BETWEEN TWO DIFFERENT METHODS: R. Sharma,1 S. Gupta,1 M. Assidi4; 1American CLASSIC ASSISTED HATCHING (AH) AND Center for Reproductive Medicine, Department ZONA THINNING (ZT). L. Herrero,1 N. of Urology, Cleveland Clinic, Cleveland, OH, Basile,2 J. Garcia Velasco,2 N. Costa Borges,3 2Citmer IVF Clinic, Miguel de Cervantes, Mexico G. Calderon3; 1IVF laboratory, IVI Madrid, City, Mexico, 3ANDROFERT, Andrology & Human madrid, Spain, 2IVI Madrid, Madrid, Spain, Reproduction Clinic, São Paulo, Brazil, 4Center 3Embryotools, Barcelona, Spain. of Excellence in Genomic Medicine Research, KFMRC, Jeddah, Saudi Arabia. P-540 ENDOMETRIAL CELL GROWTH ON TAILORED AMORPHOUS MULTI-POROUS SCAFFOLDS: P-545 UTILIZATION OF INTRACYTOPLASMIC A NOVEL PLATFORM FOR AUTOLOGOUS SPERM INJECTION (ICSI) AMONG FERTILITY ENDOMETRIAL COCULTURE. L. E. Eisman,1 L. CENTERS IN THE UNITED STATES 2000- I. Barmat,2 M. Falk,3 T. J. Kowal,3 H. Jain,4 S. G. 2013. T. A. Chang,1 E. S. Jacoby,1 Y. T. Su,2 J. F. Somkuti2; 1Ob/Gyn, Abington Jefferson Health, Knudtson,1 R. D. Robinson,1 R. S. Schenken1; Abington, PA, 2Reproductive Endocrinology, 1Obstetrics and Gynecology, University of Abington Reproductive Medicine, Abington, Texas Health Science Center, San Antonio, TX, PA, 3Biological Sciences, Lehigh University, 2Texas State University, San Marcos, TX. Bethlehem, PA, 4Materials Science and Engineering, Lehigh University, Bethlehem, PA. ART OUTCOME PREDICTORS - LABORATORY P-541 CENTER SPECIFIC VARIATIONS OF TRIPLOID 1 2 EMBRYOS. K. Bauckman, C. Welch, G. P-546 EEVA™ PREGNANCY PILOT STUDY: A 3 4 5 Garrisi, M. G. Garrisi, C. Wagner Coughlin, B. RANDOMIZED CONTROLLED TRIAL OF SINGLE 6 7 2 1 Kaplan, T. Lemma, S. Munne ; Reprogenetics, EMBRYO TRANSFER (SET) ON DAY 3 OR DAY 2 Highland Park, IL, Reprogenetics, Livingston, 5 WITH OR WITHOUT TIME-LAPSE IMAGING NJ, 3Institute for Reproductive Medicine and

nd 72 ASRM Scientific Congress & Expo 218 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

(TLI) SELECTION. D. J. Kaser,1 C. L. Bormann,1 and Gynecology, University of Texas Health S. A. Missmer,1,2 L. V. Farland,1,2 E. S. Ginsburg,1 Science Center, San Antonio, TX, 2Texas State C. Racowsky1; 1Obstetrics, Gynecology & University, San Marcos, TX. Reproductive Biology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, 2 P-551 SHOULD WE LEAVE THE PAST BEHIND Epidemiology, Harvard Chan School, Boston, MA. US? DETERMINING THE ROLE OF STATIC CLEAVAGE STAGE MORPHOLOGY IN P-547 METABOLOMIC PROFILE OF FOLLICULAR THE SELECTION OF BLASTOCYSTS FOR FLUID AS A PREDICTIVE TOOL FOR TRANSFER. A. Bartolucci,1 L. Engmann,2 PREGNANCY OUTCOMES. D. A. Montani,1 J. J. Nulsen,3 E. Neuber,3 C. A. Benadiva4; 1IVF, Camillo,1 A. Rodrigues-Oliveira,2 D. Oliveira- CARS, Farmington, CT, 2Obstetrics and Silva,2 E. G. Lo Turco,3 R. Fraietta3; 1Department Gynecology, Division of REI, University of of Surgery, Division of Urology, Human Connecticut Health Center, Farmington, Reproduction Sector, Sao Paulo Federal CT, 3Center for Advanced Reproductive University, Sao Paulo, Brazil, 2Sao Paulo Federal Services, Farmington, CT, 4REI, University of University, Diadema, Brazil, 3Department of Connecticut, Farmington, CT. Surgery, Division of Urology, Human, Sao Paulo Federal University, Sao Paulo, Brazil. P-552 FOLLICLE SIZE AND SYNCHRONICITY OF FOLLICULAR DEVELOPMENT INFLUENCE P-548 A TRINARY SCORING SYSTEM GENERATED BY MORPHOKINETIC VARIABLES IN HUMAN THE EEVATM TEST’S TIME-LAPSE MICROSCOPY EMBRYOS. S. Kahraman,1 C. Pirkevi (TLM) SOFTWARE DOES NOT PREDICT PLOIDY Cetinkaya,1 M. Cetinkaya,1 M. Montag2; AT THE BLASTOCYST STAGE OR DELIVERY 1Assisted Reproductive Technologies and OF EUPLOID EMBRYOS. M. D. Werner,1 J. Reproductive Genetics Center, Istanbul M. Franasiak,2 C. R. Juneau,3 S. Morin,4 E. J. Memorial Hospital, Istanbul, Turkey, Forman,5 K. H. Hong,1 K. M. Upham,5 R. T. Scott6; 2Ilabcomm GmbH, Sankt Augustin, Germany. 1REI, RMANJ, Rutgers-RWJ, Basking Ridge, NJ, 2RMANJ, NJ, NJ, 3RMANJ, Basking Ridge, 4 P-553 HIGHER PREGNANCY RATES WITH ZONA- NJ, Rutgers-Robert Wood Johnson Medical A. Hershlag, 5 6 FREE EUPLOID BLASTOCYSTS. School, Maplewood, NJ, RMA, NJ, NJ, REI, A. Laib, Y. Pan, A. Peyser, J. Moschella; Center RMANJ,Rutgers-RWJ, Basking Ridge, NJ. for Human Reproduction, Hofstra Northwell School of Medicine, Manhasset, NY. P-549 THE EFFECT OF BLASTOCYST MORPHOLOGY AND QUANTITATIVE PARAMETERS OF EMBRYO 1 P-554 CHANGES IN SERUM INHIBIN B LEVELS ON THE CLINICAL OUTCOMES. S. Saribal, G. THROUGHOUT CONTROLLED OVARIAN Kuspinar,2 Y. Yalim,3 G. Uncu,4 B. Ata,5 B. AVCI1; 1 HYPERSTIMULATION, RATHER THAN Department of Histology and Embryology, INITIAL CONCENTRATIONS, ARE BETTER Department of Gynecology and Obstetric IVF PREDICTORS OF OVARIAN RESPONSE. E. Center, Uludag University Medical Faculty, Haikin Herzberger,1 A. Hershko Klement,1 2 Bursa, Turkey, Department of Histology and S. Mazaki-Tovi,2 H. Kanety,3 R. Hemi,3 N. Embryology, Uludag University Medical Faculty, Zada,4 A. Shulman,1 A. Wiser1; 1IVF Unit, 3 Bursa, Turkey, Department of Gynecology Department of Obstetrics and Gynecology, and Obstetric IVF Center, Uludag University Meir Medical Center, Kfar-Saba, Israel, 2Sheba 4 Medical Faculty, Bursa, Turkey, Deparment of Medical Center, Ramat-Gan, Israel, 3Institute Gynecology and Obstetric IVF Center, Uludag of Endocrinology, Sheba Medical Center, University Medical Faculty, Bursa, Turkey, Tel Hashomer, Sackler School of Medicine, 5 Department of Gynecology and Obstetric, Koc Ramat-Gan, Israel, 4Institute of Endocrinology, University School of Medicine, Istanbul, Turkey. Sheba Medical Center, Tel Hashomer, Sackler School of Medicine, Ramat-Gan, Israel. P-550 EFFICACY OF ASSISTED HATCHING BASED ON EMBRYO QUALITY IN IVF CYCLES 1 P-555 FRAGMENT REMOVAL OF THE FRAGMENTED WITH FRESH TRANSFERS. T. A. Chang, HUMAN DAY2 EMBRYOS SIGNIFICANTLY E. S. Jacoby,1 Y. T. Su,2 J. F. Knudtson,1 R. 1 1 1 INCREASED SUBSEQUENT DEVELOPMENT D. Robinson, R. S. Schenken ; Obstetrics AND CLINICAL OUTCOMES. S. Kim,1 Y. Kim,1

nd 72 ASRM Scientific Congress & Expo 219 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

S. Kwak,1 J. Park,1 C. Yoo,1 H. Sun,2 J. Kim,2 K. P-560 NATIONAL SURVEY ON USE OF TIME- Lee,2 H. Chi1; 1Babydream Research Center, LAPSE IMAGING SYSTEMS (TLI-S) IN IVF Mamapapa&Baby Ob/Gy Clinic, Ulsan, Korea, LABORATORIES. A. V. Dolinko,1 L. V. Farland,1,2 Republic of, 2Mamapapa&Baby OB&GY clinic, D. J. Kaser,1 S. A. Missmer,1,2 C. Racowsky1; Ulsan, Korea, Republic of. 1Dept of Obstetrics & Gynecology, Brigham & Women’s Hospital and Harvard Medical School, 2 P-556 DIFFERENTIAL EXPRESSION OF TRP Boston, MA, Dept of Epidemiology, Harvard CHANNELS MODULATE ART OUTCOME. Chan School, Boston, MA. L. Samanta,1 N. Swain,2 S. Kar3; 1Zoology, Ravenshaw University, Cuttack, India, P-561 CLINICAL UTILITY OF VIRTUAL PROGENY 2Redox Biology Lab, Department of Zoology, ANALYTICS IN ASSESSING REPRODUCTIVE Ravenshaw University, Cuttack, India, DISEASE RISK. R. M. Lim,1 A. J. Silver,1 M. J. 3Consultant Gynaecologist, Kar Clinic & Silver,1 J. A. Lee,2 S. Yerkes,2 A. M. Morriss,1 L. M. Hospital Pvt. Ltd., Bhubaneswar, India. Silver,1 A. B. Copperman2,3; 1GenePeeks, Inc., New York, NY, 2Reproductive Medicine Associates of 3 P-557 CLINICAL PERFORMANCE OF DIAFERT® New York, New York, NY, Obstetrics, Gynecology TO DETERMINE GRANULOCYTE and Reproductive Science, Icahn School of COLONY-STIMULATING FACTOR (G-CSF) Medicine at Mount Sinai, New York, NY. CONCENTRATION IN FOLLICULAR FLUID (FF) AS A PREDICTOR OF IMPLANTATION DURING P-562 KINETICS OF THE EARLY IN VITRO IN VITRO FERTILIZATION (IVF). J. Foidart,1 DEVELOPMENT OF HUMAN HAPLOID H. Tournaye,2 T. D’Hooghe,3 G. Verheyen,2 K. ANDROGENOTES. L. Escrich,1 N. Grau,1 Y. Reape,4 F. Devreker,5 S. Perrier d’Hauterive,1 Galiana,1 M. F. Insua,1 J. Remohi Gimenez,2 M. F. Somers6; 1CPMA-Université de Liége, Escriba1,3; 1IVF Laboratory, University Institute IVI CHR Citadelle, Liége, Belgium, 2Universitair Valencia, Valencia, Spain, 2IVI Valencia, Valencia, Ziekenhuis Brussel, Brussels, Belgium, 3Leuven Spain, 3IVI- Fundation, Valencia, Spain. University Hospital (during study), Leuven, 4 Belgium, Allergan plc (during study), Jersey P-563 OPTIMIZATION OF ESTRADIOL ASSAY FOR City, NJ, 5Université Libre de Bruxelles, Brussels, 6 USE DURING OVARIAN STIMULATION FOR IN Belgium, Allergan plc, Jersey City, NJ. VITRO FERTILIZATION. M. Peavey,1 N. Akbas,2 W. E. Gibbons,1 S. Devaraj,2 P. W. Zarutskie1; P-558 ASSOCIATION BETWEEN PROGESTERONE 1Reproductive Endocrinology and Infertility, LEVELS ON DAY OF TRIGGER AND OOCYTE Department of Ob/Gyn, Baylor College of Medicine, MATURITY, EMBRYO QUALITY MEASURES, AND Houston, TX, 2Pathology and Immunology, Texas IVF CYCLE OUTCOME. N. M. Crawford,1 A. M. Childrens Hospital, Houston, TX. Young,2 C. F. Boylan,2 H. S. Hoff,1 J. E. Mersereau,1 D. Berger3; 1University of North Carolina, Chapel 2 3 P-564 ARTIFICIAL SHRINKAGE OF FRESH Hill, NC, UNC Fertility, Raleigh, NC, University BLASTOCYST: IMPACT ON SUCCES RATES IN of Pennsylvania, Philadelphia, PA. IVF/ICSI. S. Baillet,1 A. Gala,2 V. Loup,3 S. Bringer,4 T. Anahory,5 S. Hamamah3; 1ART-PGD Department, Montpellier 1 University, UFR of Medicine, Montpellier Cedex 5, France, 2CHU Montpellier, PROCEDURES AND TECHNIQUES - LABORATORY: ART Montpellier, France, 3ART/PGD Department, Montpellier, France, 4Medical Doctor, Montpellier, 5 P-559 CAN BLASTOCYST EXPANSION France, Gynæcologie Obstætrique, Mædecine de MORPHOKINETICS BE USEFUL IN SELECTING la Reproduction, Montpellier, France. A SINGLE EMBRYO? A RETROSPECTIVE STUDY OF DOUBLE BLASTOCYST TRANSFERS IN DONOR EGG BLASTOCYST RECIPIENTS. T. T. ART - CLINICAL Huang,1 T. Kosasa,1 H. J. Ahn,2 B. Kessel1; 1OB/ GYN, University of Hawaii School of Medicine, 2 P-565 : NATIONAL TRENDS Honolulu, HI, Office of Biostatistics and AND OUTCOMES, 2000-2013. J. F. Quantitative Health Science, University of Kawwass,1 S. Crawford,2 H. Hipp,3 S. Boulet,4 Hawaii School of Medicine, Honolulu, HI.

nd 72 ASRM Scientific Congress & Expo 220 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

D. M. Kissin,5 D. J. Jamieson2; 1Reproductive N. Banks,1 M. J. Hill,1 G. Patounakis,1 E. Endocrinology and Infertility, Emory Levens,2 K. Devine,2 A. DeCherney,1 B. W. University Reproductive Center (& CDC), Whitcomb3; 1PRAE, NIH, Bethesda, MD, Atlanta, GA, 2CDC, Atlanta, GA, 3Gynecology 2Shady Grove Fertility Reproductive Science and Obstetrics, Emory University School of Center, Rockville, MD, 3Biostatistics and Medicine, Atlanta, GA, 4Centers for Disease Epidemiology, University of Massachusetts Control and Prevention, Atlanta, GA, Amherst, Amherst, MA. 5Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA. P-571 SUBENDOMETRIAL VASCULARITY AND HIGH SENSITIVE C-REACTIVE P-566 INFECTIOUS DISEASE SCREENING OF PROTEIN IN PATIENTS WITH SEMEN FOR SURROGACY CASES. A. A. UNEXPLAINEDINFERTILITY UNDERGOING Kiessling; Bedford Research Foundation, ENDOMETRIAL SCRATCHING PRIOR Bedford, MA. TO INTRAUTERINE INSEMINATION. H. Hamza,1 M. Rezk,2 A. Saad3; 1Obstetrics and P-567 EMBRYO CRYOPRESERVATION WITH Gynecology, Faculty of Medicine - Menoufia University, Berket el Sabaa - Menofiya, WARMING INCREASES PREECLAMPSIA 2 COMPARED TO FRESH EMBRYO TRANSFER. Egypt, Obstetrics and Gynecology, Faculty M. Barsky,1 D. Wilson,2 D. Bernson,3 Y. of Medicine - Menoufia University, Menofiya, 3 Zhang,4 C. K. Sites1; 1Obstetrics and Egypt, Obstetrics and Gynecology, Faculty Gynecology, Baystate Medical Center, of Medicine - Menoufia University, Shebin el Springfield, MA, 2Baystate Health, Kom - Menofiya, Egypt. Springfield, MA, 3Massachusetts Department of Public Health, Boston, MA, 4Division of P-572 PLANNING FOR THE FUTURE: HOW MANY Reproductive Health, CDC, Mathematical EGGS DO PATIENTS NEED TO HARVEST Statistician, Chamblee, GA. TO ACHIEVE THEIR FERTILITY GOALS? A. Coates,1,2 E. Mounts,1 A. Kung,3 B. J. Bankowski,1 S. Munne4; 1Oregon Reproductive P-568 CONTRIBUTION OF CRYOPRESERVATION 2 CYCLES TO CUMULATIVE LIVE BIRTH Medicine, Portland, OR, School of OUTCOMES FOLLOWING OOCYTE Biosciences, University of Kent, Canterbury, United Kingdom, 3Reprogenetics, Portland, DONATION WITH PREIMPLANTATION 4 GENETIC SCREENING (PGS) IN THE UNITED OR, Reprogenetics, Livingston, NJ. STATES: 2005 TO 2013. D. H. Barad,1,2 S. Darmon,1 V. A. Kushnir,1,3 E. Lazzaroni-Tealdi,1 P-573 PATIENTS PREFER SUBCUTANEOUS Q. Wang,1 D. Albertini,1,4 N. Gleicher1,5; PROGESTERONE OVER VAGINAL 1Center for Human Reproduction, New York, ADMINISTRATION. UNEXPECTED RESULTS NY, 2Albert Einstein College of Medicine, OF A PROSPECTIVE TRIAL. A. Gosalvez- Bronx, NY, 3Wake Forest School of Medicine, Vega,1,2 E. Ninchritz,2 E. Fernandez-Sanchez1; Winston-Salem, NC, 4University of Kansas 1Unit of Reproductive Medicine, Hospital Medical Center, Kansas City, KS, 5Rockefeller Universitario Quirónsalud Madrid, Pozuelo de University, New York, NY. Alarcón. Madrid, Spain, 2Universidad Europea de Madrid, Villaviciosa de Odón, Spain. P-569 ARE BLASTOCYST ANEUPLOIDY RATES DIFFERENT BETWEEN FERTILE AND P-574 NONCOMPLIANCE WITH ASRM/SART INFERTILE POPULATIONS? J. Kort,1 R. C. GUIDELINES CONTINUES TO BE HIGH IN 2013 McCoy,2 Z. Demko,3 R. Lathi1; 1Reproductive COMPARED TO 2011-2012 IN DONOR OOCYTE Endocrinology and Infertility, Stanford CYCLES WITH BLASTOCYST TRANSFER. K. University, Stanford, CA, 2Genome Sciences, S. Acharya,1 S. Keyhan,2 C. R. Acharya,3 S. J. University of Washington, Seattle, WA, Li,4 S. J. Muasher5; 1Duke University Obstetrics 3Natera, Inc., San Carlos, CA. and Gynecology, Duke University Obstetrics and Gynecology, Durham, NC, 2Obstetrics and Gynecology, Reproductive Endocrinology P-570 EXAMINING PATERNAL AGE AS A RISK 3 FACTOR FOR POORER OUTCOMES IN and Infertility Fellow, Durham, NC, Dept. DONOR OOCYTE CYCLES. T. C. Plowden,1 Of Biostatistics and Bioinformatics, Duke

nd 72 ASRM Scientific Congress & Expo 221 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Computational Biology and Bioinformatics, MI, 2Henry Ford Health System, Detroit, MI, Durham, NC, 4Obstetrics and Gynecology - Duke 3Urology, Biostatistician, Detroit, MI, 4Wayne Fertility Center, Duke University Medical Center, State University School of Medicine, Detroit, Durham, NC, 5Duke University, Chapel Hill, NC. MI, 5Department of Urology, Henry Ford Health System, Detroit, MI. P-575 THE SUCCESS RATE OF INTRAUTERINE INSEMINATION AFTER FAILED OOCYTE P-580 ABDOMINAL ECTOPIC PREGNANCY CASES RETRIEVAL. M. Irani,1 V. Gunnala,2 I. Kligman,3 AFTER IN VITRO FERTILIZATION: A SYSTEMATIC Z. Rosenwaks4; 1Reproductive Endocrinology REVIEW OF A RARE COMPLICATION. N. Yoder, and Infertility, Weill Cornell Medicine, New R. Tal, J. Martin; Obstetrics, Gynecology & York, NY, 2OB/GYN, REI Fellow, New York, Reproductive Sciences, Yale University School of NY, 3Weill Cornell Medical College, New Medicine, New Haven, CT. York, NY, 4Weill Cornell Medicine - Center for Reproductive Medicine, New York, NY. P-581 EFFECT OF TIME TRENDS OF PREIMPLANTATION GENETIC SCREENING P-576 ELECTIVE SINGLE EMBRYO TRANSFER IN (PGS) UTILIZATION ON OOCYTE DONATION WOMEN UNDER AGE 38 REDUCES MULTIPLE CYCLE LIVE BIRTH RATES IN THE UNITED BIRTH RATES BUT NOT LIVE BIRTH RATES STATES: 2005 TO 2013. D. H. Barad,1,2 IN UNITED STATES FERTILITY CLINICS. A. S. Darmon,1 V. A. Kushnir,1,3 E. Lazzaroni- Mancuso,1 S. Boulet,2 E. Duran,1 E. M. Munch,1 Tealdi,1 Q. Wang,4 L. Zhang,1 D. Albertini,1,5 N. D. M. Kissin,2 B. J. Van Voorhis1; 1Obstetrics Gleicher1,6; 1Center for Human Reproduction, and Gynecology, University of Iowa Hospitals New York, NY, 2Albert Einstein College of and Clinics, Iowa City, IA, 2Division of Medicine, Bronx, NY, 3Wake Forest School of Reproductive Health, Centers for Disease Medicine, Winston-Salem, NC, 4The Center Control and Prevention, Atlanta, GA. for Human Reproduction, New York, NY, 5University of Kansas Medical Center, Kansas 6 P-577 PERINATAL OUTCOMES AFTER FRESH City, KS, Rockefeller University, New York, NY. VERSUS FROZEN EMBRYO TRANSFERS. S. Chan,1 Y. Greenstein,2 D. Dasig,3 L. Farah- P-582 PROGESTERONE SUPPLEMENTATION FOR Eways3; 1Obstetrics and Gynecology, Kaiser LUTEAL PHASE SUPPORT IN NON-ASSISTED Permanente Medical Center, Santa Clara, REPRODUCTIVE TECHNOLOGY TREATMENTS Santa Clara, CA, 2Obstetrics and Gynecology, - PREVALENCE OF USE AND PRACTICE Kaiser Permanente, Modesto, Modesto, CA, PATTERNS AMONG INFERTILITY SPECIALISTS. 3Reproductive Endocrinology and Infertility, E. Weedin,1 J. Kort,2 A. Quaas,3 V. L. Baker,4 Kaiser Permanente Center for Reproductive K. R. Hansen5; 1Obstetrics and Gynecology, Health, Fremont, CA. The University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2Stanford University, Menlo Park, CA, 3Oklahoma University Health P-578 SPINDLE POSITION AND SECOND POLAR BODY 4 ORIENTATION ENABLES THE PREDICTION OF Science Center, Oklahoma City, OK, Division of REI, Department of Obstetrics and Gyne, EMBRYONIC DEVELOPMENTAL POTENTIAL 5 AFTER ICSI. S. Kim, J. Eum, W. Y. Choi, S. Paek, Stanford University, Stanford, CA, Obstetrics S. Kwon, J. Kim, R. Kim, Y. Hur, T. K. Yoon, W. Lee, and Gynecology, University of Oklahoma Health D. Lee; Fertility Center, CHA Gangnam Medical Sciences Center, Oklahoma City, OK. Center, College of Medicine, CHA University, Seoul, Korea, Republic of. P-583 HYPERMETHYLATION SUPPRESSES EXPRESSION OF HUMAN SYNCYTIN 2 IN P-579 TRENDS IN EMBRYO TRANSFER RATE, PLACENTA OF PREECLAMPSIA. C. Feng; MULTIPLE BIRTH RATE, AND PREGNANCY The Second Affiliated Hospital, School of RATE IN RESPONSE TO THE AMERICAN Medicine, Zhejiang University, Hangzhou, SOCIETY OF REPRODUCTIVE MEDICINE’S China. RECOMMENDATION TO LIMIT EMBRYO TRANSFER. M. Bazzi,1 N. Abdullah,2 P. P-584 INITIATION OF PROGESTERONE Karabon,3 J. Chick,4 A. A. Dabaja5; 1Wayne SUPPLEMENTATION ONE DAY AFTER State University School of Medicine, dearborn, OOCYTE RETRIEVAL DID NOT DECREASE

nd 72 ASRM Scientific Congress & Expo 222 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

LIVE BIRTH RATE:A PROSPECTIVE P-589 A SIMPLE AND NON-INVASIVE METHOD RANDOMIZED CONTROLLED TRIAL. J. FOR EMBRYO SELECTION IN HUMAN IVF: Gao,1,2 F. Gu,1,2 C. Zhou,1,2 B. Miao,1,2 Y. Xu 1,2; SEQUENTIAL EMBRYO ASSESSMENT ON DAY 1Reproductive Center, First Affiliated Hospital, 2 AND DAY 3. J. Cha, J. Lee, S. Shin, Y. Kim, Sun Yat-sen University, Guangzhou, China, S. Lee, H. Cha, J. Kim, J. Ahn, H. Kim, K. Pak, 2Guangdong Provincial Key Laboratory of J. Yoon, S. Park; Agaon Fertility Clinic, Seoul, Reproductive Medicine, Guangzhou, China. Korea, Republic of.

P-585 DISPARATE UTILIZATION OF P-590 THE RELEVANCE OF PRECONCEPTIONAL INTRACYTOPLASMIC SPERM INJECTION CARRIER SCREENING (PCS) AND GENETIC (ICSI) WITHIN HUMAN SERVICES MATCHING OF DONATED OOCYTES (HHS) REGIONS AND METROPOLITAN AND SPERM ON LIVEBIRTH RATES. MEGAREGIONS IN THE U.S. P. Zagadailov, J. RETROSPECTIVE ANALYSIS OF 1934 E. Stern, A. L. Hsu; Obstetrics and Gynecology, CONSECUTIVE EMBRYO TRANSFERS. Dartmouth-Hitchcock, Lebanon, NH. R. Rivera Egea,1 E. Bosch,2 P. Alama,3 J. Martin,4 J. Remohi Gimenez,5 N. 6 1 P-586 NON-ART DELIVERIES FOR WOMEN Garrido ; Andrology Laboratory, Instituto Universitario IVI Valencia, Valencia, Spain, WITH AND WITHOUT ART LIVE BIRTH: 2 ANALYSIS OF SART CORS CYCLES LINKED Medical Director of IVI Valencia, Instituto Universitario IVI Valencia, Valencia, Spain, TO INPATIENT HOSPITAL DISCHARGES IN 3 MASSACHUSETTS. J. E. Stern,1 D. Gopal,2 H. Director of the Ovodonation Programme, Diop,3 B. Luke4; 1Obstetrics and Gynecology, Instituto Universitario IVI Valencia, 4 Dartmouth-Hitchcock, Lebanon, NH, Valencia, Spain, Lab Director CGT & PGD, 5 2Department of Community Health Sciences, Igenomix, Paterna (Valencia), Spain, IVI 6 BUSPH, Boston, MA, 3Mass Department of Valencia, Valencia, Spain, Andrology Public Health, Mass Department of Public Laboratory, Instituto Valenciano IVI Health, Boston, MA, 4Obstetrics, Gynecology, Valencia, Valencia, Spain. and Reproductive Biology, Michigan State University, East Lansing, MI. P-591 PREVALENCE AND EFFECT OF PREIMPLANTATION GENETIC SCREENING P-587 A STUDY ON THE TIMING OF THE INITIATION (PGS) ON OOCYTE DONATION CYCLES IN THE UNITED STATES: 2005 TO 2013. D. OF LUTEAL PHASE PROGESTERONE 1,2 1 1,3 SUPPLEMENTATION IN FROZEN EMBRYO H. Barad, S. Darmon, V. A. Kushnir, E. Lazzaroni-Tealdi,1 Q. Wang,1 L. Zhang,1 D. TRANSFERE CYCLE AFTER SPONTANEOUS 1,4 1,5 1 Y. Fukuda, A. Moriyama, M. Albertini, N. Gleicher ; Center for Human OVULATION. 2 Kitamura, Y. Katagiri, M. Morita; Obstetrics Reproduction, New York, NY, Albert Einstein 3 and Gynecology, Toho University Medical College of Medicine, Bronx, NY, Wake Center Omori Hospital, Tokyo, Japan. Forest School of Medicine, Winston-Salem, NC, 4University of Kansas Medical Center, Kansas City, KS, 5Rockefeller University, P-588 PREGNANCY RATE AFTER ENDOMETRIAL New York, NY. SCRATCHING IN COUPLES WITH UNEXPLAINED INFERTILITY IN OVULATION INDUCTION & IUI CYCLES - A RANDOMISED CONTROLLED TRIAL. P-592 COMBINING URINARY LUTEINIZING A. Kriplani,1 T. Goel,2 R. Mahey,3 K. Garima,4 J. B. HORMONE (LH) TESTING WITH Sharma,5 N. Bhatla6; 1Obstetrics & Gynaecology, ULTRASOUND MONITORING FOR TIMING All India Institute of Medical Sciences, New Delhi, INTRAUTERINE INSEMINATION CYCLES: A India, 2AIIMS,New Delhi, New Delhi, India, 3All RANDOMIZED CONTROLLED TRIAL. H. El 1 1 1 2 India Institute of Medical Sciences, New Delhi, Hachem, L. Lapensee, I. Kadoch, N. Dean, 1 1 New Delhi, India, 4Obstetrics and Gynaecology, R. Antaki ; Reproductive Endocrinology and All India Institute of Medical Sciences, New Infertility, OVO Clinic - CHUM University of 2 Delhi, India, 5Obstetrics & Gynaecology, All Montreal, Montreal, QC, Canada, Clinique India Institute of Medical Sciences, New Delhi, de Procreation Assistee CHUM, Montreal, New Delhi, India, 6Department of Obstetrics & QC, Canada. Gynaecology, New Delhi, India.

nd 72 ASRM Scientific Congress & Expo 223 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-593 DIFFERENT ESTROGEN ROUTE D. J. McLernon,1 A. J. Lee,1 S. Bhattacharya2; ADMINISTRATION DOES NOT INFLUENCE 1Institute of Applied Health Sciences, University CLINICAL PREGNANCY RATES IN FROZEN of Aberdeen, Aberdeen, United Kingdom, EMBRYO TRANSFER. M. Cavagnoli,1 C. 2Division of Applied Health Sciences, University Gomes,1 F. Torelli,1 T. C. Bonetti,2 P. C. of Aberdeen, Aberdeen, United Kingdom. Serafini,3 E. Motta4; 1Clinical, Huntington Medicina Reprodutiva, Sao Paulo, Brazil, P-599 BODY MASS INDEX AND NUMBER OF 2Gynecology, Federal University of Sao 3 MATURE EGGS RETRIEVED VERSUS Paulo, Sao Paulo, Brazil, Discipline of NUMBER EXPECTED: IS THERE A GREATER Ginecolgy, Hospital das Clinicas, Un, 4 DISCREPANCY IN OVERWEIGHT AND OBESE Sao Paulo, Brazil, Huntington Medicina PATIENTS? S. Kim, L. R. Goodman, R. Flyckt; Reprodutiva, Sao Paulo, Brazil. Cleveland Clinic, Beachwood, OH.

P-594 WHAT INFLUENCES ANTI-MULLERIAN P-600 UTILIZATION AND EFFECTS OF EMBRYO HORMONE LEVELS? ASSOCIATIONS WITH 1 BANKING ON ART OUTCOME REPORTING GENOTYPE COMBINATIONS. M. Gold, S. V. A. Kushnir,1,2 D. H. Barad,1,3 1 1 1 2 IN THE U.S. L. Bristow, R. Shraga, M. Berliss, J. Luk ; S. Darmon,1 D. Albertini,1,4 N. Gleicher1,5; 1 2 Recombine, New York, NY, Reproductive 1Center for Human Reproduction, New Endocrinology and Infertility, Neway Fertility York, NY, 2Wake Forest School of Medicine, Center, New York City, NY. Winston-Salem, NC, 3Albert Einstein College of Medicine, Bronx, NY, 4University of Kansas P-595 IS IMMUNOTHERAPY USEFUL IN Medical Center, Kansas City, KS, 5Rockefeller RECURRENT IMPLANTATION FAILURE University, Bronx, NY. PATIENTS; ESPECIALLY WITH HIGH NATURAL KILLER CELL? H. Sun,1 K. Lee,1 1 1 1 1 2 P-601 SHOULD MINORITY WOMEN HAVE ONLY I. Park, S. Kim, H. Chi, J. Kim, J. Cho ; C. 1 FROZEN-THAWED EMBRYOS TRANSFERS? Mamapapa & Baby OB&GY Clinic, Ulsan, Chatzicharalampous,1,2 M. Bray,3,1 J. Jackman,1 2 Korea, Republic of, Ellemedi Women’s M. Saketos,4 L. Sung,4 J. Stelling5; 1Obstetrics Hospital, Changwon, Korea, Republic of. and Gynecology, The Brooklyn Hospital Center, Brooklyn, NY, 2Genetics and Genomic Sciences, P-596 DOES ANTAGONIST ADMINISTRATION ON Icahn School of Medicine at Mount Sinai, New THE DAY OF HCG IN ICSI/IVF CYCLES WITH York, NY, 3Reproductive Specialists of New York, PREMATURE PROGESTERONE RISE (PPR)- Brooklyn, NY, 4Reproductive Specialists of New USING LONG AGONIST PROTOCOL- IMPROVES York, Mineola, NY, 5SUNY Stony Brook School of PREGNANCY OUTCOME? S. A. Hebisha,1 B. A. Medicine, Stony Brook, NY. Aboelazm,1 H. M. Adel,1 A. I. Ahmed2; 1Gynecology, Alexandria University - Faculty of Medicine, 2 P-602 OUTCOMES FOR IN VITRO FERTILIZATION IN Alexandria, Egypt, Obstetric and Gynecology, UTERINE ADENOMYOSIS: A RETROSPECTIVE MFM Division, Department of Medical Genetics, COHORT STUDY. D. O’Connor,1 M. A. Wayne State University, Detroit, MI. Bedaiwy,2 C. Dunne,3 B. Taylor,3 J. Havelock,4 C. Lawrence,5 B. Kuzeljevic6; 1Resident, University P-597 MONO-HP-HMG IN OVARIAN STIMULATION of British Columbia, Vancouver, BC, Canada, FOR ART IS ASSOCIATED WITH A 2Department of Obstetrics and Gynecology, SIGNIFICANTLY LOWER INCIDENCE OF BC Women’s Hospital, Vancouver, BC, Canada, PREMATURE PROGESTERONE RISE 3University of British Columbia, Vancouver, COMPARED TO MIXED FSH-HP-HMG: IS BC, Canada, 4Pacific Centre for Reproductive HCG-DERIVED LH ACTIVITY PROTECTIVE? F. Medicine, Vancouver, BC, Canada, 5Pacific Sharara,1,2 M. R. Goodwin1; 1Virginia Center for Centre for Reproductive Medicine, Burnaby, Reproductive Medicine, Reston, VA, 2Ob/gyn, BC, Canada, 6British Columbia Women’s George Washington University, Washington, DC. Hospital, Vancouver, BC, Canada.

P-598 PREDICTING THE CHANCES OF A LIVE BIRTH P-603 THE ASSESSMENT OF OPTIMAL TIMING PREGNANCY AT DIFFERENT POINTS IN TIME OF OOCYTE RETRIEVAL BASED ON LH IN COUPLES WITH UNEXPLAINED FERTILITY. SURGE IN NATURAL CYCLE IVF: A LARGE

nd 72 ASRM Scientific Congress & Expo 224 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

SCALE RETROSPECTIVE STUDY. M. Ito,1 Institutet, Stockholm, Sweden, 4Department A. Yabuuchi,2 K. Ezoe,2 D. Sato,1 A. Yuge,1 of Public Health and Caring Sciences, Uppsala H. Yamasaki,1 K. Shinohara,1 N. Yatabe,1 T. University, Uppsala, Sweden. Kobayashi,1 K. Kato1; 1Advanced Medical Research Institute of Fertility, Kato Ladies 2 P-608 DOES PRESENCE OF HUMAN Clinic, Shinjuku, Japan, Research Laboratory, PAPILLOMAVIRUS (HPV) INFECTION Kato Ladies Clinic, Shinjuku, Japan. INFLUENCE THE RESULTS OF IN VITRO FERTILIZATION (IVF) TREATMENT? I. P-604 SHORT INTERPREGNANCY INTERVAL (IPI) Oborna,1 H. Ondryasova,1 B. Zborilova,2 J. AND OBSTETRIC OUTCOMES IN ASSISTED Brezinova,3 J. Vrbkova1; 1Faculty of Medicine REPRODUCTION. M. Quinn, M. Cedars, and Dentistry, Palacky University, Olomouc, V. Y. Fujimoto; Department of Obstetrics, Czech Republic, 2Fertimed Ltd, Olomouc, Gynecology and Reproductive Sciences, Czech Republic, 3Arleta, Ltd, Kostelec nad University of California, San Francisco, San Orlicí, Czech Republic. Francisco, CA. P-609 THE CORRELATION OF THYROID FUNCTION P-605 IS ENDOMETRIAL PATTERN ASSOCIATED AND PRE-CONCEPTION TSH LEVELS WITH WITH SERUM PROGESTERONE AND LIVE ASSISTED REPRODUCTIVE TECHNOLOGY BIRTH DURING IVF? T. D. Lewis,1 P. Lindner,2 OUTCOMES. Y. Xu,1 G. Yao,2 J. He,3 Y. M. W. Healy,3 K. Devine,4 K. S. Richter,5 A. Sun4; 1Reproductive Medical Center, First DeCherney,6 M. Levy,7 M. J. Hill8; 1Reproductive Affiliated Hospital of Zhengzhou University, Endocrinology & Infertility, National Institutes Zhengzhou, China, 2Reproductive Medicine, of Health, Bethesda, MD, 2Uniformed Services First Affiliated Hospital, Zhengzhou, China, University of the Health Sciences, North 3Reproductive Medicine, Zhengzhou, China, Bethesda, MD, 3National Institutes of Health- 4Reproductive Medical Center, The First NICHD, Germantown, MD, 4Shady Grove Fertility Affiliated Hospital of Zhengzhou University, Center, Washington, DC, 5Research, Shady Grove Zhengzhou, China. Fertility Reproductive Science Center, Rockville, MD, 6Eunice Kennedy Shriver National Institute 7 P-610 PROGESTERONE LEVELS AND IVF of Child, bethesda, MD, Shady Grove Fertility, I. Rybkin,1 G. Bareh,2 K. Wei,1 8 PREGNANCY. Rockville, MD, NIH, Bethesda, MD. J. D. Jacobson,1 J. Corselli,1 P. J. Chan1; 1Gynecology and Obstetrics, Loma Linda P-606 RE-PUNCTURE TO PREVENT OOCYTE University School of Medicine, Loma Linda, DEGENERATION DOES NOT INGLUENCE CA, 2Loma Linda University, Yucaipa, CA. PIEZO-ICSI PREGNANCY RATES OR EMBRYO VIABILITY. R. Matsunaga,1 S. Watanabe,1 M. Miura,1 Y. Kobayashi,1 N. Yamanaka,1 M. IMPLANTATION Kamihata,1 A. Kuwahata,1 T. Horiuchi2; 1Ochi Yume Clinic, Nagoya, Japan, 2Department of Life Science, Prefectural University of P-611 1+ 1 > 2: A COST EFFECTIVENESS ANALYSIS Hiroshima, Shobara, Japan. OF SINGLE EMBRYO TRANSFER WITH PGS IN TWO SUCCESSIVE CYCLES VS A DOUBLE EMBRYOTRANSFER WITH PGS IN P-607 SYMPTOMS OF ANXIETY AND DEPRESSION ONE. J. Rodriguez-Purata,1 A. Santistevan,2 AMONG INFERTILE WOMEN, WOMEN L. Sekhon,1,3 J. A. Lee,1 K. Hunter Cohn,2 T. PREGNANT AFTER INFERTILITY TREATMENT Mukherjee,1 B. Sandler,1 P. Yurttas Beim,2 A. AND SPONTANEOUSLY PREGNANT WOMEN. B. Copperman4,3; 1Reproductive Medicine 1 2 3 L. S. Joelsson, A. Berglund, K. Wanggren, Associates of New York, New York, NY, 4 1 T. Tyden ; Department of Women’s and 2Celmatix Inc, New York, NY, 3Obstetrics, Children’s, Obstetrics and Gynecology, Gynecology and Reproductive Science, Icahn 2 Uppsala, Sweden, National Centre for School of Medicine at Mount Sinai, New York, Knowledge on Men’s Violence Against NY, 4Obstetrics and Gynecology, RMANY-Mount 3 Women, Uppsala, Sweden, Department of Sinai, New York, NY. Clinical Science, Intervention and Technology, Obstetrics and Gynecology, Karolinska

nd 72 ASRM Scientific Congress & Expo 225 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-612 THE PREDICTIVE VALUE OF THE P-617 DOES AN ENDOMETRIAL SCRATCH AFFECT FIRST SERUM HCG LEVEL FOLLOWING PREGNANCY RATES IN EGG-DONATION TRANSFER OF A SINGLE, EUPLOID, TREATMENT PATIENTS WITH OR WITHOUT FROZEN EMBRYO TRANSFER. L. Sekhon,1,2 PREVIOUS IMPLANTATION FAILURES? A. N. Herlihy,1,2 J. Rodriguez-Purata,1 J. A. Izquierdo,1 J. Rayward,1 M. Moschetta,2 M. Lee,1 M. C. Whitehouse,1 B. McAvey,1 L. Calomarde Rees,2 R. Gomez de Segura,2 L. Grunfeld,1,2 T. Mukherjee,1,2 B. Sandler,1,2 A. Lopez2; 1Reproductive Medicine, ProcreaTec, B. Copperman1,2; 1Reproductive Medicine Madrid, Spain, 2ProcreaTec, Madrid, Spain. Associates of New York, New York, NY, 2 Obstetrics, Gynecology & Reproductive P-618 PREGNANCY OUTCOME FOLLOWING Science, Icahn School of Medicine at Mount FRESH VS. FROZEN EMBRYO TRANSFER Sinai, New York, NY. ON EMBRYOS CREATED WITH THE SERUM PROGESTERONE >2 NG/ML ON THE DAY OF P-613 THE EFFECT OF INTRALIPID ON PREGNANCY THE HUMAN CHORIONIC GONADOTROPIN RATES IN IN VITRO (IVF). R. TRIGGER IN WOMEN WITH DECREASED EGG H. Shirlow,1 M. Healey,2,3,4 M. Volovsky,1 V. B. RESERVE. J. H. Check,1 R. Cohen,2 C. Wilson2; MacLachlan,4 B. J. Vollenhoven1,4,5; 1Monash 1Dept. OB/GYN, Cooper Medical School of University, Melbourne, Australia, 2University Rowan University, Melrose Park, PA, 2Cooper of Melbourne, Melbourne, Australia, 3Royal Institute for Reproductive and Hormonal Women’s Hospital, Melbourne, Australia, Disorders, P.C., Mt. Laurel, NJ. 4Monash IVF, Melbourne, Australia, 5Monash Health, Melbourne, Australia. P-619 ESTROGEN INDUCES C-KIT VIA EGR1- DEPENDENT TRANSCRIPTIONAL P-614 THE DEVELOPMENT RATE OF THE EUPLOID REGULATION FOR SUCCESSFUL EMBRYO HAS A MORE SIGNIFICANT IMPACT IMPLANTATION IN MOUSE UTERUS. M. ON IMPLANTATION THAN MORPHOLOGY. Park,1 K. Kang,2 H. Choi,2 M. Koong,2 I. Kang,2 X. Yang, A. Runge, T. Leung, M. Cedars, M. T. K. Yoon,2 H. Kim,1 H. Song1,2; 1Biomedical Rosen; Department of Obstetrics, Gynecology Science, CHA University, Seongnam, Korea, & Reproductive Sciences, University of Republic of, 2CHA Seoul Fertility Center, CHA California, San Francisco, San Francisco, CA. University, Seoul, Korea, Republic of.

P-615 EARLY GROWTH RESPONSE 1 (EGR1) IS P-620 USING A HISTOLOGICAL MARKER TO REQUIRED FOR PROPER EPITHELIAL-STROMAL DETERMINE ENDOMETRIAL RECEPTIVITY

CROSS-TALKS TO RESPOND TO E2 AND P4 NONINVASIVELY - PROOF OF PRINCIPLE. F. FOR SUCCESSFUL EMBRYO IMPLANTATION Meng,1 U. T. Meier2; 1OB/GYN and Women’s IN THE UTERUS. H. Kim,1 Y. Kim,1 K. Kang,2 H. Health, Montefiore Medical Center/Albert Choi,2 M. Koong,2 I. Kang,2 T. K. Yoon,2 H. Song1,2; Einstein College of Medicine, Hartsdale, NY, 1Biomedical Science, CHA University, Seongnam, 2Anatomy and Structural Biology, Albert Korea, Republic of, 2CHA Seoul Fertility Center, Einstein College of Medicine, Bronx, NY. CHA University, Seoul, Korea, Republic of.

P-616 IMPACT OF TRANSCRIPTOMIC BASIS EARLY PREGNANCY OF LOCAL ENDOMETRIAL INJURY ON IMPLANTATION RATE AMONG P-621 INTERACTION OF UTERINE NATURAL KILLER PREVIOUSLY FAILED IVF-ICSI CYCLES. N. CELL IMMUNOGLOBULIN RECEPTOR (KIR) 1 2 3 1 Singh, M. Bhat, D. Ghosh ; Department HAPLOTYPE AND TROPHOBLASTIC HLA-C of Obstetrics & Gynaecology & IVF, All India LIGAND INFLUENCES RISK OF PREGNANCY Institute Of Medical Sciences, Delhi, India, LOSS: A RETROSPECTIVE ANALYSIS OF 2 Senior Research Fellow, Department of DIRECT EMBRYO GENOTYPING DATA. S. Physiology, All India Institute Of Medical J. Morin,1 M. M. Han,2 J. M. Franasiak,3 C. R. 3 Sciences, Delhi, India, Department of Juneau,1 N. Treff,4 R. T. Scott Jr.1; 1Reproductive Physiology, All India Institute Of Medical Medicine Associates of New Jersey, Basking Sciences, Delhi, India. Ridge, NJ, 2The Foundation for Embryonic Competence, Basking Ridge, NJ, 3Reproductive

nd 72 ASRM Scientific Congress & Expo 226 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Medicine Associates of New Jersey, NJ, NJ, Centre, Vancouver, BC, Canada, 6Olive Fertility 4RMANJ, Rutgers-RWJ, Basking Ridge, NJ. Centre, Vancouver, BC, Canada, 7University of British Columbia, Vancouver, BC, Canada. P-622 ARE MATERNAL THYROID ANTIBODIES ASSOCIATED WITH EUPLOID MISCARRIAGE P-627 KARMAN CANNULA ASPIRATION: IN WOMEN WITH RECURRENT PREGNANCY AN ALTERNATIVE TO PRESUMPTIVE LOSS (RPL)? S. Cueva, D. McQueen, M. S. METHOTREXATE FOR PREGNANCY OF Barkoff, M. Stephenson; University of Illinois UNKNOWN LOCATION AFTER IVF. I. at Chicago, Chicago, IL. Insogna,1 S. A. Missmer,2 L. V. Farland,2 E. S. Ginsburg,1 P. Brady1; 1Dept of Obstetrics & P-623 INTERPRETING EARLY HCG DYNAMICS IN Gynecology, Brigham & Women’s Hospital and Harvard Medical School, Boston, MA, THE ERA OF THE THAWED EUPLOID SINGLE 2 EMBRYO TRANSFER: HOW IMPORTANT IS Dept of Epidemiology, Harvard Chan School, DOUBLING? L. Sekhon,1,2 J. Rodriguez-Purata,1 Boston, MA. D. Aharon,1,2 J. A. Lee,1 M. C. Whitehouse,1 J. Klein,1 M. Lederman,1 L. Grunfeld,1,2 T. Mukherjee,1,2 A. B. Copperman1,2; 1Reproductive Medicine Associates of New York, New York, NY, 2Obstetrics, PROCEDURES AND TECHNIQUES - CLINICAL: ART Gynecology & Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, NY. P-628 EVALUATING CHANGE IN GONADOTROPIN- RELEASING HORMONE ANALOG (GNRH) USE P-624 DOES INTRALIPID INFUSION IMPROVE IN A US REAL-WORLD DATABASE STUDY OF OUTCOMES IN RPL (RECURRENT 96,446 IN VITRO FERTILIZATION CYCLES PREGNANCY LOSS)/RIF (RECURRENT OVER 6.5 YEARS. G. L. Mottla,1 K. S. Richter,2 IMPLANTATION FAILURE) PATIENTS B. Kaplan,3 B. Hayward,4 M. C. Mahony4; UNDERGOING IVF? IS IT COST-EFFECTIVE? J. 1Research, Shady Grove Fertility Reproductive E. Hirshfeld-Cytron,1 A. Martini,2 S. Jasulaitis,1 Science Center, Annapolis, MD, 2Research, M. L. Uhler1; 1Fertility Centers of Illinois, Shady Grove Fertility Reproductive Science Chicago, IL, 2Rush University, Chicago, IL. Center, Rockville, MD, 3Fertility Centers of Illinois, Chicago, IL, 4EMD Serono, Inc., Rockland, MA. P-625 MEAN GESTATIONAL SAC DIAMETER TO CROWN-RUMP LENGTH DIFFERENCE AS A MARKER OF FIRST TRIMESTER PREGNANCY P-629 FASTER AND MORE ACCURATE IMPROVED LOSS AFTER IN VITRO FERTILIZATION. J. D. RESCUE ICSI BY OBSERVING CHANGING Kapfhamer,1 S. Palaniappan,1 K. M. Summers,1 SIZE AND POSITION OF CHROMOSOME A. Mancuso,1 G. Ryan,1 D. Shah2; 1Obstetrics AND SPINDLE USING POLARIZATION and Gynecology, University of Iowa Hospitals MICROSCOPE AND DIFFERENTIAL and Clinics, Iowa City, IA, 2Reproductive CONTRAST MICROSCOPE. A. Tanaka, M. Endocrinology and Infertility, University of Nagayoshi, I. Tanaka, T. Miki, T. Yamaguchi; Pennsylvania, Philadelphia, PA. Saint Mother Hospital, Kitakyusyu, Japan.

P-626 REPRODUCTIVE OUTCOMES OF COUPLES P-630 EFFECT OF ENDOMETRIAL BIOPSY ON IN WITH RECURRENT PREGNANCY LOSS VITRO FERTILIZATION CLINICAL PREGNANCY DUE TO PARENTAL CHROMOSOME RATES - A RANDOMIZED MULTICENTRE STUDY. REARRANGEMENT. M. A. Bedaiwy,1 S. I. J. L. Hilton,1 K. Liu,2 C. A. Laskin,3 J. Havelock4; Maithripala,2 U. S. Durland,3 J. Havelock,4 1Division of Reproductive Endocrinology S. Kashyap,5 J. Hitkari,6 S. Lisonkova7; and Infertility, Department of Obstetrics and 1Department of Obstetrics and Gynecology, Gynaecology, University of British Coumbia, University of British Columbia, Vancouver, BC, Vancouver, BC, Canada, 2Centre for Fertility & Canada, 2Department of Medical Genetics, Reproductive Health, Toronto, ON, Canada, University of British Columbia, Vancouver, 3Medicine; Obstetrics & Gynecology, LifeQuest BC, Canada, 3PCRM, Burnaby, BC, Canada, Centre for Reproductive Medicine, Toronto, 4Pacific Centre for Reproductive Medicine, ON, Canada, 4Pacific Centre for Reproductive Vancouver, BC, Canada, 5Genesis Fertility Medicine, Burnaby, BC, Canada.

nd 72 ASRM Scientific Congress & Expo 227 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-631 SPERM RETRIEVAL RATES (SRR) AT REDO Medical Center, Cincinnati, OH. TESTICULAR SPERM ASPIRATION (REDO- TESA). A. H. AlMalki,1 A. Zini2; 1Urology, McGill 2 P-637 EFFECTS OF RESVERATROL ON DIABETES- University, Montreal, QC, Canada, McGill INDUCED DNA DAMAGE AND MODULATION University. OF POLY (ADP-RIBOSE) POLYMERASE SIGNALING IN RAT TESTIS. N. Kilarkaje,1 P-632 THE EFFECT OF PROPOFOL DOSAGE A. Abdelali,2 M. Al-Bader3; 1Department of DURING OOCYTE RETRIEVAL ON IN VITRO Anatomy, Kuwait University, Kuwait, Kuwait, FERTILIZATION OUTCOMES. A. C. Petrini, 2Msc, Kuwait, Kuwait, 3Department of N. Pereira, S. D. Spandorfer; The Ronald Physiology, Kuwait University, Kuwait, Kuwait. O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell P-638 Abstract withdrawn Medicine, New York, NY.

P-639 ZP1 CONTRIBUTES TO THE PREVENTION OF P-633 EFFECTS OF DIFFERENT ENDOMETRIAL POLYSPERMY IN MICE. N. Banks,1 M. Avella,2 PREPARATIONS ON THE OUTCOMES OF B. Baibakov,2 K. Tokuhiro,2 J. Dean2; 1NICHD, FROZEN EMBRYO TRANSFER CYCLES OF IN Bethesda, MD, 2NIDDK, Bethesda, MD. VITRO FERTILIZATION/INTRACYTOPLASMIC SPERM INJECTION: A STUDY BASED ON MORE THAN 30,000 CYCLES. T. Du, Q. Chen, P-640 ACTIVATION OF MOUSE OOCYTES AFTER Q. Lyu, Y. Kuang; Department of Assisted INTRACYTOPLASMIC INJECTION OF HUMAN Reproduction, Shanghai Ninth People’s SPERM WITH LINEAR AND ROTATIONAL 1 Hospital, Shanghai, China. MOTION. S. Roychoudhury, I. Maldonado- Rosas,2 A. Agarwal,1 S. Esteves,3 R. Sharma,1 S. Gupta1; 1American Center for Reproductive P-634 COMPARISON OF CONVENTIONAL Medicine, Department of Urology, INTRACYTOPLASMIC SPERM INJECTION AND Cleveland Clinic, Cleveland, OH, 2Citmer PHYSIOLOGIC INTRACYTOPLASMIC SPERM IVF Clinic, Miguel de Cervantes, Mexico City, 1 INJECTION (PICSI) OUTCOMES. M. Javed, S. Mexico, 3ANDROFERT, Andrology & Human 1 2 3 3 Bengawi, L. Almahdi, A. Salih, H. Alsufayan ; Reproduction Clinic, São Paulo, Brazil. 1IVF Laboratory, Thuriah Medical Center, Riyadh, Saudi Arabia, 2Coordination, Thuriah Medical Center, Riyadh, Saudi Arabia, 3Thuriah P-641 OVARIAN EXPRESSION OF BMP15, GDF9 Medical Center, Riyadh, Saudi Arabia. AND C-KIT CAN BE A NEW PREDICTIVE MARKER FOR OVARIAN AGING IN THE MOUSE MODEL. B. Joo,1 M. Park,1 K. Lee,2 J. P-635 RANDOMIZED TRIAL ON THE EFFECT Lee,1 J. Choi,3 C. Kim1; 1Center for Anti-Aging OF PREWASHING THE INSEMINATION Industry, Pusan National Universtiy, Busan, CATHETER ON THE PREGNANCY OUTCOME. Korea, Republic of, 2Department of Obstetrics N. Alasmari; Reproductive Endocrinology & and Gynecology, Medical Research Institute, Infertility, McGill Reproductive Health Center, Busan, Korea, Republic of, 3Eroom Women’s Montreal, QC, Canada. Hospital, Busan, Korea, Republic of.

REPRODUCTIVE BIOLOGY - ANIMAL AND EXPERIMENTAL MODELS REPRODUCTIVE BIOLOGY - HUMAN STUDIES

P-636 SYNERGISTIC GENE ACTIVATION OF P-642 TROPHECTODERM (TE) CELL THE SEX CHROMOSOMES DURING TRANSPLANTATION: A FEASIBLE TECHNIQUE SPERMATOGENESIS: A MOUSE MODEL. S. O. 1 2 1 TO IMPROVE BLASTOCYST QUALITY. R. Adams, K. G. Alavattam, J. M. Sroga, M. Perez,1 H. Adriaanse,1 G. R. Navarrete,1 1 2 1 A. Thomas, S. H. Namekawa ; Obstetrics B. Tilley,1 A. Patel,1 R. Gada,2 K. L. Lee,2 L. and Gynecology, University of Cincinnati, Lawrence,2 M. R. Thomas,2 S. J. Chantilis2; 2 West Chester, OH, Division of Reproductive 1Dallas Fertility Center, Dallas, TX, 2Dallas-Fort Sciences, Cincinnati Children’s Hospital Worth Fertility Associates, Dallas, TX.

nd 72 ASRM Scientific Congress & Expo 228 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-643 DOES THE CYTOPLASMIC EXCHANGE COMPETENCE IN HUMAN OOCYTES. R. BETWEEN AGED OOCYTES AND YOUNG- Matsunaga,1 S. Watanabe,1 M. Miura,1 Y. HEALTHY OOCYTES RESCUE THE Kobayashi,1 N. Yamanaka,1 M. Kamihata,1 CHROMOSOMAL ABNORMALITIES CAUSED A. Kuwahata,1 M. Ochi,1 T. Horiuchi2; 1Ochi BY AGING? A. Tanaka, M. Nagayoshi, I. Yume Clinic Nagoya, Nagoya, Japan, Tanaka, T. Miki, T. Yamaguchi; Saint Mother 2Department of Life Science, Prefectural Hospital, Kitakyusyu, Japan. University of Hiroshima, Shobara, Japan.

P-644 ELEVATED BMI IN PATIENTS OF P-648 TIME-LAPSE OBSERVATION CAN HELP ADVANCED MATERNAL AGE DOES NOT IMPROVE WORKFLOW AND ENSURE THE AFFECT BLASTOCYST DEVELOPMENT OR CORRECT OBSERVATION OF FERTILIZED CHROMOSOMAL COMPLEMENT, BUT HAS EMBRYOS. R. Suzuki, H. Watanabe, H. NEGATIVE CONSEQUENCES FOR EMBRYO Hasegawa, K. Tsukamoto, M. Kobayashi, METABOLISM AND IMPLANTATION. K. T. Kyoya, S. Saito, J. Kobayashi; Kanagawa C. Barentsen,1 S. Lyons,2 J. M. Stevens,1 C. Ladies Clinic, Kanagawa-ken, Japan. Broeckling,2 J. Kirkwood,2 R. L. Krisher,1 1 1 W. B. Schoolcraft ; Colorado Center for P-649 TROPHECTODERM GRADE PREDICTS Reproductive Medicine, Lone Tree, CO, 2 PREGNANCY OUTCOMES IN SINGLE Colorado State University, Fort Collins, CO. BLASTOCYST TRANSFER CYCLES. M. Xia, L. Cai, Q. Zeng, J. Liu; The Clinical Center for P-645 WHAT IS THE BEST LEAD FOLLICLE SIZE Reproductive Medicine, The First Affiliated FOR OVULATION INDUCTION IN OLDER Hospital of Nanjing Medical University, WOMEN ≥43 YEARS TO AVOID PREMATURE Nanjing, China. LUTEINIZATION OF FOLLICLES? Y. Wu,1 V. A. Kushnir,1,2 S. Darmon,1 Q. 1 1 1,3 P-650 EARLIER DAY OF BLASTOCYST Wang, L. Zhang, D. Albertini, D. H. TROPHECTODERM BIOPSY IS PREDICTIVE Barad,1,4 N. Gleicher1,5; 1Center for Human 2 OF EMBRYONIC EUPLOIDY ACROSS ALL Reproduction, New York, NY, Wake Forest AGE GROUPS IN BOTH AUTOLOGOUS School of Medicine, Winston-Salem, NC, 3 AND DONOR CYCLES: ESSENTIAL DATA University of Kansas Medical Center, A. Kaing,1 L. 4 FOR COUNSELING PATIENTS. Kansas City, KS, Albert Einstein College of Kroener,1 R. Tassin,2 M. Li,2 L. Liu,3 R. Buyalos,2 5 Medicine, Bronx, NY, Rockefeller University, G. Hubert,2 M. Shamonki1,2; 1Obstetrics New York, NY. and Gynecology, University of California Los Angeles, Los Angeles, CA, 2Fertility and P-646 GENE EXPRESSION LEVELS OF MMP 2, MMP Surgical Associates of California, Thousand 9, TIMP 1 AND ADAMTS 1 IN Oaks, CA, 3PacGenomics, Agoura Hills, CA. OF IVF/ICSI PREGNANCIES. O. Gun- 1 2 3 4 Eryilmaz, B. Urman, Y. Yukselten, A. Boza, P-651 METABOLIC IMAGING AS A NON-INVASIVE A. Sunguroglu5; 1Zekai Tahir Burak Ankara, 2 TOOL FOR ASSESSING OOCYTE AND Ankara, Turkey, Department of OBGYN Koc EMBRYO MITOCHONDRIAL FUNCTION. University School of Medic, Istanbul, Turkey, T. Sanchez,1 D. Needleman2; 1Harvard, 3 Ankara University, School of Medicine, Cambridge, MA, 2Department of Molecular 4 Ankara, Turkey, American Hospital, Istanbul, and Cellular Biology, Harvard, Cambridge, MA. Turkey, 5Medical Biology, Ankara University Faculty of Medicine, Ankara, Turkey. P-652 ARE EARLY MORPHOKINECTIC PARAMETERS PREDICTIVE OF MONOZYGOTIC SPLITTING AFTER SINGLE EMBRYO TRANSFER? L. 1,2 1 1 EMBRYO BIOLOGY Sekhon, M. Kon, J. Rodriguez-Purata, J. A. Lee,1 B. McAvey,1 A. B. Copperman1; 1Reproductive Medicine Associates of New P-647 A NEW APPROACH TO EVALUATE York, New York, NY, 2Obstetrics, Gynecology THE INFLUENCE OF ADVANCING and Reproductive Science, Icahn School of MATERNAL AGE UPON MEIOTIC SPINDLE Medicine at Mount Sinai, New York, NY. MORPHOLOGY AND DEVELOPMENTAL

nd 72 ASRM Scientific Congress & Expo 229 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-653 BLASTOCYST METABOLISM, AS DETERMINED EMBRYO CULTURE BY A NOVEL QUANTITATIVE APPROACH, IS NOT IMPACTED BY CHROMOSOME P-659 AFFIXING LABELS ON CULTURE DISHES COMPLEMENT OR GENDER BUT IS ALTERED 1 DECREASE THE DEVELOPMENT RATE OF WITH MATERNAL AGE. T. Schlenker, A. H. Kawano,1 K. Nakata,1 Greene,1 S. Lyons,2 J. M. Stevens,1 J. Herrick,1 MOUSE EMBRYOS. M. Kamoshita,2 J. Ito,2 N. Kashiwazaki,2 N. J. Prenni,2 J. Kirkwood,2 C. Broeckling,2 W. B. Yamashita1; 1Yamashita Syonan Yume Clinic, Schoolcraft,1 R. L. Krisher1; 1Colorado Center Fujisawa, Japan, 2Laboratory of Animal for Reproductive Medicine, Lone Tree, CO, Reproduction Department of Animal Science 2Colorado State University, Fort Collins, CO. & Biotechnology School of Veterinary, Azabu University, Sagamihara, Japan. P-654 BLASTOCYST SCORING SYSTEMS PROVIDE EVIDENCE OF EUPLOID PREDICTABILITY. M. Katz-Jaffe,1 M. Schweitz,2 S. McReynolds,3 J. M. P-660 WASHING MINERAL OIL USED FOR Stevens,4 W. B. Schoolcraft1; 1Colorado Center MICRODROP OVERLAY DOES NOT IMPROVE J. E. for Reproductive Medicine, Lone Tree, CO, STABILITY OF MEDIA OSMOLALITY. Swain,1 A. E. Batcheller,2 W. B. Schoolcraft,3 2Genetics, Fertility Genetics Inc., Lone Tree, CO, N. Bossert2; 1CCRM IVF Network, Lone Tree, 3Fertility Genetics, Lone Tree, CO, 4Embryology, CO, 2CCRM Minneapolis, Edina, MN, 3Medical Fertility Labs of Colorado, Lone Tree, CO. Director, Colorado Center for Reproductive Medicine, Lone Tree, CO. P-655 BLASTOMERE EXTRUSION AND ABNORMAL CLEAVAGE BEHAVIOR IN HUMAN EMBRYOS P-661 UNSTABLE OSMOTIC PRESSURE IN UNDER TIME-LAPSE MONITORING: MICRODROPS CULTURED UNDER MINERAL POSSIBLE WAY OF EMBRYO “SELF- OIL IN NON-HUMIDIFIED INCUBATORS. K. CORRECTION”? N. Zaninovic, Q. Zhan, Iwata, K. Yumoto, Y. Mio; Reproductive Centre, C. Norberg, Z. Ye, R. Clarke, Z. Rosenwaks; Mio Fertility Clinic, Yonago, Japan. Center for Reproductive Medicine, Weill Cornell Medicine, New York, NY. P-662 BLASTOCYST FORMATION RATE CAN BE PREDICTED BY AN AUTOMATIC SYSTEM P-656 EARLY STAGE EMBRYOS THAT HAVE BEEN INDEPENDENTLY OF THE NUMBER ABNORMALLY CLEAVED STILL PRODUCE GOOD OF OOCYTES RETRIEVED AND THE IMPLANTATION OUTCOMES AND SUCCESSFUL MORPHOLOGY OF THE EMBRYOS ON DAY 3. PREGNANCIES, BUT ONLY IF THEY DEVELOP N. Basile,1 B. Aparicio-Ruiz,2 J. Garcia Velasco,1 INTO BLASTOCYSTS. Y. Kobayashi,1 R. M. de los Santos,3 J. Remohi Gimenez,2 M. Matsunaga,1 M. Miura,1 N. Yamanaka,1 M. Meseguer4; 1IVI Madrid, Madrid, Spain, 2IVI Kamihata,1 S. Watanabe,1 A. Kuwahata,1 M. Valencia, Valencia, Spain, 3IVF, Embryology, Ochi,1 T. Horiuchi2; 1Ochi Yume Clinic, Nagoya, Valencia, Spain, 4Clinical Embryology, Japan, 2Department of Life Science, Prefectural Valencia, Spain. University of Hiroshima, Shobara, Japan.

P-663 BLASTOCYST DEVELOPMENT USING P-657 EVALUATION OF EARLY CYTOKINETIC SEQUENTIAL MEDIA VERSUS ONE-STEP TIMEPOINTS BY TIMELAPSE MICROSCOPY. G. F. Celia, K. J. Fresa, T. F. Chi, D. J. Kotze, MEDIA IN EMBRYOSCOPE AND PLANER K. Kaskar,1 D. P. Hamilton,2 S. Bocca, S. Oehninger; Ob/Gyn, The INCUBATORS. K. Miller,2 P. W. Zarutskie,1 W. E. Gibbons1; Jones Institute for Reproductive Medicine, 1Department Ob/Gyn, Baylor College of Norfolk, VA. Medicine, Houston, TX, 2Family Fertility Center, Texas Children’s Hospital, Houston, TX. P-658 IS ICSI WITH CALCIUM IONOPHORE AFFECTING HUMAN EMBRYO DEVELOPMENT? J. A. Aguilar,1 M. Ojeda,1 E. Taboas,1 M. Perez,1 E. P-664 IS THE ADDITIONAL INFORMATION FROM Munoz2; 1IVF Laboratory, IVI Vigo, Vigo, Spain, TIME-LAPSE MONITORING USEFUL IN J. X. Zhang,1 M. 2Gyneacology, IVI Vigo, Vigo, Spain. EMBRYO ASSESSMENT. Pavone,1 A. K. Lawson,2 J. Robins3; 1Obstetrics and Gynecology, Northwestern University

nd 72 ASRM Scientific Congress & Expo 230 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Feinburg School of Medicine, Chicago, Tanaka, H. Otsubo, S. Mizumoto, T. Kuramoto; IL, 2Northwestern University, Chicago, IL, Kuramoto Women’s Clinic, Fukuoka, Japan. 3Northwestern University Feinberg School of Medicin, Chicago, IL. P-671 PRELIMINARY EVIDENCE THAT ILOPROST PREVENTS APOPTOSIS IN CULTURED P-665 EVALUATION OF PREIMPLANTATION EMBRYOS. B. Schniers,1 J. Huang,2 S. Prien3; HUMAN EMBRYO METABOLISM IN EMBRYOS 1Reproductive Physiology, Texas Tech EXPOSED TO L-CARNITINE DURING IN- University, Lubbock, TX, 2Obstetrics and VITRO DEVELOPMENT. C. K. Leary,1,2 R. G. Gynecology, Texas Tech University, Lubbock, Sturmey2; 1The Hull IVF Unit, Hull, United TX, 3Ob/Gyn, Texas Tech University Health Kingdom, 2Hull York Medical School, Hull, Sciences Center, Lubbock, TX. United Kingdom. P-672 CLINICAL UTILITY OF MONOPRONUCLEAR P-666 DOES VITRIFICATION DAY MATTER: EUPLOID ZYGOTES OBTAINED AFTER EMBRYOS WITH IDENTICAL DAY 5/6 INTRACYTOPLASMIC SPERM INJECTION(ICSI). MORPHOLOGY GRADE AND FROZEN EMBRYO H. Tsuji,1,2 M. Tokoro,1,3 N. Fukunaga,1,2,4,3 E. TRANSFER CYCLE OUTCOMES. R. Slifkin,1 J. Asano,1,2 S. Kounogi,1,4 Y. Asada1,2,4,3; 1Asada Rodriguez-Purata,1 L. Sekhon,1,2 J. A. Lee,1 M. C. Ladies Clinic Medical Corporation, Nagoya, Whitehouse,1 A. B. Copperman,3,2 B. Sandler,1,2 Japan, 2Asada Ladies Kachigawa Clinic, Nagoya, M. Duke1; 1Reproductive Medicine Associates Japan, 3Asada Institute for Reproductive of New York, New York, NY, 2Obstetrics, Medicine, Nagoya, Japan, 4Asada Ladies Nagoya Gynecology and Reproductive Science, Icahn Clinic, Nagoya, Japan. School of Medicine at Mount Sinai, New York, 3 NY, Obstetrics and Gynecology, RMANY-Mount P-673 THE IMPACT OF PREINCUBATION TIME Sinai, New York, NY. BETWEEN OOCYTES RETRIEVAL AND INTRACYTOPLASMIC SPERM INJECTION (ICSI) P-667 A NOVEL, HIGHLY SENSITIVE TANDEM ON FERTILIZATION AND EMBRYO QUALITY MASS SPECTROMETRY METABOLOMICS BY AGE. M. Kobayashi,1 H. Watanabe,1 H. APPROACH PREDICTS OUTCOME OF POOR Hasegawa,2 K. Tsukamoto,1 R. Suzuki,1 T. Kyoya,1 QUALITY DAY 5 BLASTOCYSTS. R. L. Krisher,1 S. Saito,1 J. Kobayashi1; 1Kanagawa Ladies Clinic, S. Lyons,2 A. Greene,1 J. M. Stevens,1 J. Herrick,1 Kanagawa-ken, Japan, 2Kanagawa Ladies Clinic, J. Kirkwood,2 J. Prenni,2 C. Broeckling,2 Kanagawa, Japan. W. B. Schoolcraft1; 1Colorado Center for Reproductive Medicine, Lone Tree, CO, 2 P-674 HATCH-ALL TECHNIQUE IMPROVES EMBRYO Colorado State University, Fort Collins, CO. DEVELOPMENT AND PREGNANCY OUTCOME. G. A. Abdo, M. Goodwin, A. G. Abdo, F. I. P-668 CAN THE LOCATION OF A TROPHECTODERM Sharara; Virginia Center for Reproductive BIOPSY CONTRIBUTE TO HUMAN Medcicne, Reston, VA. BLASTOCYST DEVELOPMENT ? T. Takano, M. Funabiki, S. Taguchi, F. Saji, N. Amano, L. P-675 SINGLE VERSUS SEQUENTIAL CULTURE Young, Y. Nakamura; Oak Clinic, Osaka, Japan. MEDIUM: WHAT IS THE BETTER CHOICE TO IMPROVE ONGOING PREGNANCY RATES? A P-669 ENMOTION: EMBRYO’S NATURAL MOTION. SYSTEMATIC REVIEW AND META-ANALYSIS. BLASTULATION IS NOT DIFFERENT F. Dieamant,1,2 C. G. Petersen,1,2 A. L. Mauri,1,2 L. BETWEEN STATIC AND DYNAMIC CULTURE D. Vagnini,2 A. Renzi,2 G. R. Oliveira-Pelegrin,2 SYSTEMS. C. R. Juneau, J. M. Franasiak, S. J. J. Ricci,1 M. Cavagna,1,2,3 J. A. Oliveira,1,2 R. L. Morin, M. D. Werner, K. M. Upham, R. T. Scott Baruffi,1,2 J. G. Franco Jr.1,2; 1Center for Human Jr.; RMANJ, Basking Ridge, NJ. Reproduction Prof. Franco Jr, Ribeirao Preto, Brazil, 2Paulista Center for Diagnosis Research 3 P-670 SUCCESSFUL PREGNANCIES AFTER and Training, Ribeirao Preto, Brazil, Women’s VITRIFIED EMBRYO TRANSFER OF HUMAN Health Reference Center Perola Byington EMBRYOS CULTURED IN RECOMBINANT Hospital, Sao Paulo, Brazil. ALBUMIN. M. Murakami, A. Egashira, K.

nd 72 ASRM Scientific Congress & Expo 231 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-676 REPLACEMENT OF SODIUM PYRUVATE N. Fukunaga,2,1,3 Y. Asada2,1,3; 1Asada Ladies WITH ETHYL PYRUVATE PROMOTES Kachigawa Clinic, Asada Ladies Clinic Medical ZYGOTIC CLEAVAGE AND INNER CELL MASS Corporation, Nagoya, Japan, 2Asada Ladies DEVELOPMENT DURING IN VITRO CULTURE Nagoya Clinic, Asada Ladies Clinic Medical OF EMBRYOS FROM FEMALES OF ADVANCED Corporation, Nagoya, Japan, 3Asada Institute MATERNAL AGE. E. Silva,1 J. Becker,1 J. Herrick,1 for Reproductive Medicine, Asada Ladies S. Lyons,2 C. Broeckling,2 J. Barfield,2 W. B. Clinic Medical Corporation, Nagoya, Japan. Schoolcraft,1 J. Swain,1 R. L. Krisher1; 1Colorado Center for Reproductive Medicine, LoneTree, CO, 2Colorado State University, Fort Collins, CO. STEM CELLS P-677 THE IMPACT OF M-PHASE ON BLASTOCYST DEVELOPMENT: A TIME-LAPSE STUDY. B. P-683 SPONTANEOUS SINGLE-COPY LOSS Huang, L. Jin; Reproductive Medical Center, OF TP53 IN HUMAN EMBRYONIC STEM Tongji Hospital, Wuhan, China. CELLS MARKEDLY INCREASES CELL PROLIFERATION AND SURVIVAL. H. Amir,1,2 P-678 GROWTH FACTORS IGF-I AND IGF-II IN K. Sabatini,2 D. Chhabra,2 R. Morey,2 L. C. HUMAN EMBRYO CO-CULTURE WITH Laurent2; 1Obstetric and Gynecology, The Tel AUTOLOGOUS GRANULOSA CELL CLUSTERS Aviv Sourasky Medical Center, Tel Aviv, Israel, COMPARED TO REGULAR EMBRYO CULTURE 2Department of Reproductive Medicine, UCSD, IN IVF. A. Vithoulkas,1 M. J. Levanduski,2 V. San Diego, CA. Goudas,3,1 K. Illmensee1; 1Genesis Fertility 2 Center, Patras, Greece, Embryology, P-684 PAID HUMAN SUBJECTS PROVIDING Westchester Fertility and Reproductive OOCYTES FOR STEM CELL RESEARCH: 3 Endocrinology, White Plains, NY, Advanced FAVORABLE OUTCOMES AND EIGHT YEAR Fertility Center of Texas, Houston, TX. EXPERIENCE. L. Z. Safier, A. Gumer, M. Kline, D. Egli, M. V. Sauer; Columbia University P-679 MEDIA OSMOLALITY CHANGES OVER 7 DAYS Medical Center, New York, NY. FOLLOWING CULTURE IN A NON-HUMIDIFIED 1 BENCHTOP INCUBATOR. J. E. Swain, W. B. P-685 DERIVATION OF INTEGRATION-FREE IPSCS 2 3 3 Schoolcraft, N. Bossert, A. E. Batcheller ; FROM HUMAN MURAL GRANULOSA CELLS. 1 CCRM IVF Lab Network, Lone Tree, CO, B. Cai, Y. Xu, C. Zhou; Reproductive Medical 2 Colorado Center for Reproductive Medicine, Center, The First Affiliated Hospital, Sun Yat- 3 Lone Tree, CO, CCRM Minneapolis, Edina, MN. sen University, Guangzhou, China.

P-680 EMBRYOKINETICS AND IMPLANTATION RATE BY TIME-LAPSE MICROSCOPY. L. Yang, M. Peavey, K. Kaskar, K. Miller, C. T. Valdes, T. HEALTH DISPARITIES L. Woodard, P. W. Zarutskie, W. E. Gibbons; Obstetrics and Gynecology, Baylor College of P-686 RACIAL DIFFERENCES IN RISK AND Medicine, Houston, TX. COMPONENTS OF METABOLIC SYNDROME IN WOMEN WITH PCOS: A MULTI-NATIONAL P-681 CYTOPLASMIC PITTING ASSOCIATED WITH STUDY. J. L. Chan,1 S. Kar,2 E. Vanky,3 E. SINGLE MEDIUM CULTURE AND ITS IMPACT Stener-Victorin,4 L. Morin-Papunen,5 G. Maciel,6 ON THE ICSI RESULTS. M. V. Paz, J. Cicaré, I. Sundstrom Poromaa,7 J. Mellembakken,8 F. Lo Menzo, L. Domenech, P. Perfumo, V. B. A. Dokras1; 1OBGYN, Univ of Pennsylvania, Ventura; Servicio Medicina Reproductiva. Philadelphia, PA, 2Kar Clinic, Nagar, India, Grupo Gamma, Rosario, Argentina. 3Children’s and Women’s Health, Trondheim, Norway, 4Karolinska Institutet, Stockholm, 5 P-682 WHAT IS THE OPTIMAL EMBRYO NUMBER Sweden, OBGYN, Univ of Oulu, Oulu, Finland, 6 FOR IMPROVING DEVELOPMENT Gynecology, Univ of Sao Paulo Medical School, 7 CONDITIONS IN WOW CULTURE DISHES? H. Sao Paulo, Brazil, Women and Children’s Watanabe,1 K. Nakayama,2 H. Tsuji,1 E. Asano,1 Health, Uppsala Univ, Uppsala, Sweden, 8OBGYN, Oslo Univ Hospital, Oslo, Norway.

nd 72 ASRM Scientific Congress & Expo 232 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-687 EFFECTS OF NEWLY INTRODUCED PRACTICES Endocrinology and Infertility, Fertility Centers OVER 10 YEARS (2004-2013) ON WORLDWIDE of Illinois, Warrenville, IL, 4Fertility Centers of TRENDS IN ASSISTED REPRODUCTIVE Illinois, Highland Park, IL. TECHNOLOGY. V. A. Kushnir,1,2 D. H. Barad,1,3 S. Darmon,1 D. Albertini,1,4 N. Gleicher1,5; 1Center 2 P-692 EFFECT OF RACE AND ETHNICITY ON LIVE for Human Reproduction, New York, NY, Wake BIRTH RATES IN THIRD-PARTY ART CYCLES Forest School of Medicine, Winston-Salem, NC, A. Shapiro,1,2 D. H. Barad,2,3 3 IN THE U.S. Albert Einstein College of Medicine, Bronx, NY, S. Darmon,2 D. Albertini,2,4 N. Gleicher,2,5 V. 4 University of Kansas Medical Center, Kansas A. Kushnir2,6; 1Rutgers New Jersey Medical 5 City, KS, Rockefeller University, New York, NY. School, West New York, NJ, 2Center for Human Reproduction, New York, NY, 3Albert Einstein P-688 FERTILITY TREATMENT IN THE TRANSGENDER College of Medicine, Bronx, NY, 4University COMMUNITY: A PUBLIC OPINION STUDY. R. of Kansas Medical Center, Kansas City, KS, H. Goldman,1 D. J. Kaser,1 S. A. Missmer,1,2 L. V. 5Rockefeller University, New York, NY, 6Wake Farland,1,2 S. Scout,3 R. K. Ashby,1 E. S. Ginsburg1; Forest School of Medicine, Winston-Salem, NC. 1Center for Infertility and Reproductive Surgery, Dept of Obstetrics and Gynecology, Brigham P-693 EFFECT OF RACE AND ETHNICITY ON FERTILITY and Women’s Hospital and Harvard Medical 2 RATES AND UTILIZATION OF ART IN THE USA. School, Boston, MA, Dept of Epidemiology, V. A. Kushnir,1,2 A. Shapiro,1,3 D. H. Barad,1,4 S. 3 Harvard Chan School, Boston, MA, Boston Darmon,1 D. Albertini,1,5 N. Gleicher1,6; 1Center University School of Public Health, Boston, MA. for Human Reproduction, New York, NY, 2Wake Forest School of Medicine, Winston-Salem, NC, P-689 RACIAL DISPARITIES IN ELECTIVE SINGLE 3Rutgers New Jersey Medical School, New Ark, EMBRYO TRANSFER (ESET) UTILIZATION IN NJ, 4Albert Einstein College of Medicine, Bronx, THE UNITED STATES: A NATIONAL STUDY. NY, 5University of Kansas Medical Center, Kansas T. C. Plowden,1 S. L. Mumford,1 K. Kim,1 V. L. City, KS, 6Rockefeller University, New York, NY. Baker,2 A. Christy,3 A. K. Styer4; 1NICHD, NIH, 2 Rockville, MD, Division of REI, Department P-694 LATINO COLLEGE STUDENTS ON INFERTILITY. of Obstetrics and Gyne, Stanford University, J. S. Place; Physiology and Health Science, Ball 3 Stanford, CA, Contraception Discovery and State University, Muncie, IN. Development Branch, NIH, Rockville, MD, 4Massachusetts General Hospital/Harvard Medical Sch, Boston, MA. P-695 RELIGIOUS ATTENDANCE AND ETHICAL VIEWS ON VARIOUS TREATMENTS FOR INFERTILITY AMONG REPRODUCTIVE- P-690 LESBIAN, GAY, BISEXUAL, TRANSGENDER AGED U.S. WOMEN. S. C. Collins,1 E. Chan2; (LGBT) CONTENT ON REPRODUCTIVE 1Department of Obstetrics, Gynecology, and ENDOCRINOLOGY AND INFERTILITY CLINIC Reproductive Sciences, Yale University School 1 2 3 WEBSITES. H. Y. Wu, B. C. Monseur, O. Yin, of Medicine, New Haven, CT, 2Department of 3 4 5 J. H. Selter, B. D. Lau, M. S. Christianson ; Sociology, Yale University, New Haven, CT. 1Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, 2Virginia Commonwealth University School P-696 ETHNIC DIFFERENCES IN OVARIAN of Medicine, Richmond, VA, 3Johns Hopkins RESERVE AND ASSISTED REPRODUCTIVE University School of Medicine, Baltimore, MD, TECHNOLOGY OUTCOMES. J. Jayakumaran, 4Surgery, Johns Hopkins University School C. Silva, B. K. Gangrade, S. Patel; Center for of Medicine, Baltimore, MD, 5Gynecology and Reproductive Medicine, Orlando, FL. Obstetrics, Johns Hopkins University School of Medicine, Lutherville, MD.

GENETIC COUNSELING P-691 IMPACT OF RACE ON OOCYTE DONATION. X. Zhou,1 D. McQueen,2 A. Schufreider,1 M. L. Uhler,3 E. C. Feinberg4; 1The University P-697 BECKWITH-WIEDEMANN SYNDROME of Chicago, Chicago, IL, 2University of IN IVF: NEED FOR IMPROVEMENT IN Illinois Chicago, Chicago, IL, 3Reproductive PRENATAL DIAGNOSIS. C. S. Sullivan-

nd 72 ASRM Scientific Congress & Expo 233 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

Pyke,1 K. A. Duffy,2 K. O’Neill,1 J. M. Kalish3; P-703 PREIMPLANTATION GENETIC SCREENING 1Obstetrics & Gynecology, University of (PGS) APPEARS UNABLE TO CORRECTLY Pennsylvania, Philadelphia, PA, 2Division of DETERMINE PLOIDY OF EMBRYOS FROM A Human Genetics, The Children’s Hospital of SINGLE TROPHECTODERM BIOPSY (TEB). Philadelphia, Philadelphia, PA, 3Department N. Gleicher,1,2 A. Vidali,1 V. A. Kushnir,1,3 D. H. of Pediatrics, The Perelman School of Barad,1,4 C. Hudson,5,1 Q. Wang,1 L. Zhang,1 D. Medicine, Philadelphia, PA. Albertini1,6; 1Center for Human Reproduction, New York, NY, 2Rockefeller University, New York, NY, 3Wake Forest School of Medicine, P-698 IS THE NUMBER OF CGG REPEATS <45 4 A. Winston-Salem, NC, Albert Einstein College PREDICTIVE OF FERTILITY POTENTIAL? 5 Peyser,1 A. Cohen,2 T. Singer,1 C. Mullin,1 A. of Medicine, Bronx, NY, Fertility Center of Las 6 Hershlag1; 1Center for Human Reproduction, Vegas, Las Vegas, NV, University of Kansas Hofstra Northwell School of Medicine, Medical Center, Kansas City, KS. Manhasset, NY, 2Faculty of Industrial Engineering and Management, Statistics Lab, Technion-Israel P-704 OVARIAN RESERVE AND EMBRYONIC Institute of Technology, Haifa, Israel. ANEUPLOIDY RATES IN BRCA 1 AND 2 CARRIERS. L. Sekhon,1,2 J. Rodriguez- Purata,1 J. A. Lee,1 M. C. Whitehouse,1 M. P-699 THE WEIGHT OF THE INTERCHROMOSOMAL 1 1,2 1 EFFECT IN RECIPROCAL TRANSLOCATION Lederman, A. B. Copperman ; Reproductive T. Escudero,1 L. Ribustello,1 E. Medicine Associates of New York, New York, CARRIERS. 2 M. Armenti,1 E. Liu,1 J. Grifo,2 J. Hitkari,3 R. NY, Obstetrics, Gynecology & Reproductive Schmidt,4 B. R. Witt,5 M. Doyle,6 A. Nasseri,7 Science, Icahn School of Medicine at Mount S. Munne1; 1Reprogenetics, Livingston, NJ, Sinai, New York, NY. 2NYU Fertility Center, New York, NY, 3Olive Fertility Centre, Vancouver, BC, BC, Canada, P-705 GENOME-WIDE DNA METHYLATION 4NOVA IVF, Mountain View, CA, 5Greenwich ANALYSIS OF SPERM DNA FROM SMOKING Fertility Center, Greenwich, CT, 6CT Fertility, MALES SUFFERING FROM IDIOPATHIC Bridgeport, CT, 7The Valley Hospital Fertility INFERTILITY. M. M. Laqqan,1 J. Walter,2 Y. Center, Paramus, NJ. A. Alkhaled,1 S. Tierling,2 M. E. Hammadeh1; 1Obstetrics & Gynecology, Saarland University, 2 P-700 COMPARISON OF GENETIC DISEASE Germany, Homburg, Germany, Genetik/ CARRIER FREQUENCIES BETWEEN GENERAL Epigenetik, Saarland University, Germany, FERTILITY PATIENTS AND GAMETE DONORS Saarbruecken, Germany. UNDERGOING EXPANDED CARRIER SCREENING. S. Rodriguez,1 R. Shraga,1 S. P-706 DUCHENNE/BECKER MUSCULAR Yarnall,1 N. Kumar,1 S. S. Chuan,2 F. Licciardi3; DYSTROPHY: ADVANCES IN REPRODUCTIVE 1Recombine, New York, NY, 2REI, San Diego TESTING OPTIONS. S. Mundy, J. Wallace, Fertility Center, San Diego, CA, 3OBGYN, New York M. Westemeyer, K. Merrion, J. Schmidt, J. University Langone Medical Center, New York, NY. Saucier; Natera, Inc., San Carlos, CA.

P-701 PREIMPLANTATION GENETIC DIAGNOSIS P-707 PATERNAL AGE DOES NOT IMPACT (PGD) GENETIC COUNSELING; BUT WHY? ANEUPLOIDY RATES AS DETERMINED THE PATIENT EXPERIENCE. D. Goldberg- BY COMPREHENSIVE CHROMOSOME Strassler, R. Cabey, E. M. Armenti, A. Jordan; SCREENING (CCS) IN DONOR OOCYTE Reprogenetics, Livingston, NJ. CYCLES. J. Horne,1 J. M. Franasiak,2 C. R. Juneau,2 S. J. Morin,2 E. J. Forman,2 N. R. Treff,3 2 1 FMR1 R. T. Scott Jr. ; Rutgers, Robert Wood Johnson, P-702 IMPACT OF PRE-MUTATION STATUS ON 2 BLASTOCYST DEVELOPMENT IN PATIENTS Basking Ridge, NJ, Reproductive Medicine Associates of New Jersey, Basking Ridge, NJ, UNDERGOING ICSI AND PRE-IMPLANTATION 3 GENETIC TESTING. A. P. Hutchinson, N. Pereira, RMANJ, Rutgers-RWJ, Basking Ridge, NJ. D. P. Lilienthal, S. Coveney, J. P. Lekovich, R. Elias, Z. Rosenwaks; The Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine, Weill Cornell Medicine, New York, NY.

nd 72 ASRM Scientific Congress & Expo 234 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS

NON- Poster Presentations and Abstracts CME CE ARS

P-708 CLINICAL UTILITY OF EXPANDED CARRIER SCREENING: REPRODUCTIVE BEHAVIORS OF AT-RISK COUPLES. K. K. Wong,1 K. Ready,1 C. Lieber,1 J. D. Goldberg,2 I. S. Haque,1 G. A. Lazarin,1 C. Ghiossi3; 1Counsyl, South San Francisco, CA, 2Counsyl, Inc., South San Francisco, CA, 3California State University, Long Beach, CA.

P-709 DO PATIENTS PURSUING PREIMPLANTATION GENETIC DIAGNOSIS (PGD) FOR MONOGENIC DISORDERS HAVE AN INCREASED RISK OF ANEUPLOIDY COMPARED TO AGE-MATCHED CONTROLS? S. M. Maxwell, J. Friedenthal, T. G. Nazem, A. K. Masbou, D. H. McCulloh, J. Grifo, K. N. Goldman; NYU Fertility Center, New York, NY.

P-710 EXCELLENT EMBRYO DEVELOPMENT AND IVF OUTCOMES FOR PATIENTS WITH GERMLINE BRCA1 OR BRCA2 MUTATIONS. A. King, K. L. Hornberger, D. O. Young, D. Klepacka, W. B. Schoolcraft, M. Katz-Jaffe; Colorado Center for Reproductive Medicine, Lone Tree, CO.

P-711 CHROMOSOMAL MICROARRAY ANALYSIS OF MISCARRIAGE PRODUCTS IN RECURRENT PREGNANCY LOSS. D. Bar-Avin Dayan,1 S. Rienstein,2 H. Yonath,2 E. Guetta,2 E. Pras,2 H. Carp,1 D. Seidman1; 1Department of Obstetrics and Gynecology, Sheba Medical Center, Ramat Gan, Israel, 2Institute of Genetics, Sheba Medical Center, Ramat Gan, Israel.

P-712 MATERNAL WHOLE EXOME SEQUENCING REVEALS CANDIDATE PATHWAYS FOR EMBRYONIC ANEUPLOIDY RISK. D. Marin,1 C. Bohrer,2 Y. Zhang,3 Y. Zhan,2 R. T. Scott Jr.,1 J. Xing,3 N. Treff1; 1RMANJ, Rutgers-RWJ, Basking Ridge, NJ, 2Foundation for Embryonic Competence, Basking Ridge, NJ, 3Department of Genetics, Rutgers, the State University of New Jersey, Piscataway, NJ.

nd 72 ASRM Scientific Congress & Expo 235 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Topic Index

ART In Vitro Fertilization O7, O8, O27, O52, O53, O67, O85, O86, O87, O88, O89, O90, O98, O101, O120, O131, O143, O144, O169, O170, O171, O175, O182, O184, O217, O218, O223, O224, O225, O242, O243, O244, O255, O256, O-267, O-269, P1, P2, P81, P82, P88, P89, P124, P129, P159, P160, P161, P163, P164, P165, P166, P167, P168, P169, P170, P172, P174, P176, P177, P180, P182, P183, P184, P188, P189, P191, P193, P196, P197, P198, P199, P200, P201, P203, P204, P206, P208, P237, P243, P244, P245, P317, P318, P323, P324, P326, P329, P334, P386, P407, P420, P448, P539, P541, P543, P544, P545, P546, P547, P549, P550, P551, P552, P553, P554, P555, P556, P557, P558, P559, P562, P564, P567, P568, P569, P570, P572, P574, P575, P576, P577, P578, P580, P581, P585, P586, P589, P591, P600, P601, P602, P603, P605, P606, P608, P609, P628, P629, P630, P634, P640, P643, P645, P646, P687, P689, P691

ART Other O54, O93, O100, O102, O119, O127, O128, O130, O132, O172, O173, O174, O186, O222, O226, P4, P5, P6, P75, P90, P93, P100, P112, P162, P173, P175, P178, P181, P186, P187, P190, P194, P195, P207, P538, P540, P542, P548, P560, P561, P565, P566, P571, P579, P583, P588, P590, P592, P596, P597, P598, P599, P604, P607, P632, P633, P635, P642, P644, P692, P693, P695

Cancer P7, P51, P52, P53, P54, P55, P56, P58, P60, P62, P63, P64, P66

Contraception/Family Planning O13, O15, O16, O17, O18, P15, P16, P17, P18, P19, P20, P694

Cryopreservation O176, O178, O180, P74, P76, P77, P80, P83, P85, P86, P87, P91, P92, P94, P96, P98, P101, P192, P202, P435

Early Pregnancy O49, O206, O254, O257, O258, P621, P622, P625, P627

Embryo Biology O55, O56, O57, O58, O59, O60, O96, O259, O260, O261, O262, P84, P99, P130, P155, P156, P647, P649, P650, P651, P652, P653, P654, P655, P656, P657, P658

Embryo Culture O6, O207, O263, O264, P659, P660, P661, P662, P663, P664, P665, P666, P667, P668, P669, P670, P671, P672, P673, P674, P675, P676, P677, P678, P679, P680, P681, P682

Embryo Transfer O61, O62, O63, O64, O65, O66, O115, O208, P252, P253, P254, P255, P256, P257, P258, P259, P260, P261, P262, P263, P264, P265, P266, P268, P269, P270, P271, P272, P273, P274, P275

Endometriosis O188, O209, O229, O230, O231, O234, P430, P431, P432, P433, P434, P436, P437, P438, P439, P440, P441, P442, P443, P444, P445, P446, P447, P449, P450, P451, P452, P453, P455, P456, P457, P458, P459, P460, P461, P462, P463

Endometrium O25, O28, O30, O179, O204, O205, O232, O233, O253, P95, P277, P278, P279, P280, P281, P282, P283, P284, P285, P286, P287, P288, P289, P290, P291, P292, P293, P294, P295, P296, P297, P298, P299, P310, P367

Environment and Toxicology O1, O21, O29, O68, O69, O70, O71, O219, P348, P472, P473, P475, P476, P477, P478, P479, P480, P481

Female Reproductive Endocrinology O118, O200, O201, P57, P171, P179, P185, P205, P246, P362, P363, P366, P368, P369, P370, P371, P374, P377, P378, P379, P380, P381, P610, P641

Female Reproductive Surgery O24, O31, O32, O33, O34, O35, O104, O105, O106, O107, O108, P300, P301, P302, P303, P304, P306, P307, P308, P311, P454, P467

Female Reproductive Tract O14, O36, P267, P276

nd 72 ASRM Scientific Congress & Expo 236 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Topic Index

Fertility Preservation O3, O5, O73, O74, O75, O76, O77, O78, O185, O-266, P24, P49, P50, P59, P61, P67, P68, P69, P70, P71, P72, P73, P97

Fertilization P78, P214, P216, P220, P639, P648

Genetic Counseling O12, O211, O212, O213, O214, O215, O216, O241, P697, P698, P699, P700, P701, P702, P703, P704, P705, P706, P707, P708, P709, P710, P711, P712

Imaging O4, O37, O38, O39, O40, O41, O42, P313, P314, P536, P537

Implantation O129, O220, O221, P595, P611, P612, P613, P614, P615, P616, P617, P618, P619, P620

Leiomyoma O2, O235, O236, O237, O238, O239, O240, O-268, P464, P465, P466, P468, P469, P471

Luteal Phase Support O142, O177, P372, P410, P573, P582, P584, P587, P593

Male Factor O19, O22, O157, O158, O159, O160, O161, O162, P8, P315, P316, P319, P320, P321, P322, P325, P327, P328, P330, P331, P332, P333, P335, P336, P341, P343, P346, P354, P489, P491, P493, P507, P508, P509, P512, P516, P517

Male Reproductive Endocrinology O20, O198, P337, P338, P345, P498

Male Reproductive Urology O103, O109, O110, O111, O112, O113, O114, O187, O193, O194, O195, O196, O197, P344, P349, P350, P351, P352, P353, P355, P490, P492, P495, P496, P497, P499, P500, P501, P502, P505, P506, P510, P511, P513, P515, P518

Menopause O94, O202, O203, P357, P358, P359, P360, P361

Mental Health O9, O97, O99, O151, O152, O153, O154, O155, O156, P21, P22, P23, P25, P26, P27, P28, P29

Nursing O50, O51, P9, P30, P31, P32, P33, P424

Obesity and Metabolism O247, O248, O249, O250, O251, O252, P382, P388, P394, P415, P416, P417, P418, P419, P421, P423, P425, P426, P427, P428, P429

Oocyte Biology O91, O133, O135, O137, O138, O190, P209, P210, P211, P212, P213, P215, P217, P218, P219

Oocyte Maturation O95, O134, O136, P221, P222, P223, P224, P225, P226, P227, P406

Ovarian Function O26, O121, O126, O168, P34, P35, P36, P37, P38, P39

Ovarian Reserve O117, O163, O164, O165, O166, O167, P40, P41, P42, P43, P44, P45, P46, P47, P48, P65, P696

Ovarian Stimulation O140, O141, P228, P229, P230, P231, P232, P233, P234, P235, P236, P238, P240, P241, P242, P247, P248, P249, P250, P251, P413

Oxidative Stress O210, P340, P347, P356, P482, P483, P484, P485, P486, P487, P488, P503

Polycystic Ovary Syndrome O79, O80, O81, O82, O83, O84, O92, O227, O245, O-265, P383, P384, P385, P387, P389, P390, P391, P392, P393, P395, P396, P397, P398, P399, P400, P401, P402, P403, P404, P405, P408, P409, P411, P412, P414, P686

Practice Management O10, O11, O181, P10, P11, P12, P13, P14, P239, P305, P312

nd 72 ASRM Scientific Congress & Expo 237 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Topic Index

Preimplantation Genetic Diagnosis O43, O44, O45, O46, O47, O48, O145, O146, O147, O148, O149, O150, O246, O-270, P79, P102, P103, P104, P105, P106, P107, P108, P109, P110, P111, P113, P114, P115, P116, P117, P118, P119, P120, P121, P122, P123, P125, P126, P127, P128, P131, P132, P133, P134, P135, P136, P137, P138, P139, P140, P141, P142, P143, P144, P145, P146, P147, P148, P149, P150, P151, P152, P153, P154, P157, P158, P422, P626

Reproductive Hormones O116, O122, O139, O189, O199, P364, P373, P375, P563, P594, P623

Reproductive Immunology P365, P376, P624

Sexuality P309, P688, P690

Sperm Biology O23, O72, P504, P519, P520, P521, P522, P523, P524, P525, P527, P636

Sperm Preparation O183, O228, P514, P528, P529, P530, P531, P533, P534, P535

Stem Cells O123, O124, O125, O191, O192, P470, P526, P683, P684, P685

Testis P474, P494, P532, P631, P637, P638

nd 72 ASRM Scientific Congress & Expo 238 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Abbas, A...... P303, P304, P305, P310 AlAnsari, A. A...... P341 Abbott, D. H...... O79 Alasmari, N...... P635 Abd Alnaby, A...... O105 Alavattam, K. G...... P636 Abdalbadie, A. S...... P235 AlBader, M...... P637 Abdallah, M...... P79 Albertini, D...... P4, P5, P272, P568, P581, P591, P600, P645, Abdalmageed, O. S...... P303, P304, P305, P310, P400, P415 ...... P687, P692, P693, P703 Abdelaleem, A. A...... P235, P304, P305, P310 Aldred, J...... P302 Abdelali, A...... P637 Alegre, L...... P87, P534, P535 Abdelhadi, O. A...... O80, O81, O83 Alegretti, J. R...... P404 Abdelkareem, A. O...... P449 Alfarawati, S...... O45, P139, P525 Abdelmagied, A. M...... P303, P304, P305, P310 Algergawy, A...... O105 Abdo, A. G...... P674 Alhalwagy, A...... O105 Abdo, G. A...... O246, P674 AlHendy, A...... O2, O236, O237, O268, P57, P470, P471 Abduljabbar, H...... P309 Ali, M. K...... P303, P304, P305, P310 Abdullah, N...... P579 Alix, S...... P508 Abern, M...... P351 Alkafy, S...... P309 Abhyankar, N...... P351, P355 Alkhader, H. A...... P253 Aboali, A. A...... P216, P517 Alkhaled, Y. A...... P322, P705 Aboelazm, B. A...... O220, P216, P596 Allison, K...... P390 Abramov, R...... P507 Allison, K. C...... P412 Abrao, M...... P440 Almahdi, L...... P634 AbuRafea, B...... P205 AlMalki, A. H...... P532, P631 Abusamaan, M. S...... O31 Almog, B...... P237 AbuSoud, H...... O135, O210 Alper, M. M...... O38, P230, P236 AbuSoud, H. M...... P52 AlRumaihi, k. R...... P340, P341 Acharya, C. R...... O131, P574 Alsahly, N...... P309 Acharya, K. S...... O131, P574 Alsaid, S. S...... P340, P341 Acton, A. J...... O80, O81, O83 Alserri, A...... P261 Adams, S. R...... P636 Alsufayan, H...... P634 AddaHerzog, E...... O85 Alukal, J. P...... P518 Adel, H. M...... O220, P216, P596 Alvarez Sedo, C...... P211, P333 Adel, N...... P517 Alvarez, G...... P333 Adriaanse, H...... P642 Alvarez, J. P...... P482 Agarwal, A...... O113, O114, P340, P347, P486, P488, P499, Alvero, R...... P45 ...... P503, P511, P516, P524, P544, P640 Alvi, F. A...... O107 Aghajanova, L...... O204 Alzaben, F...... P309 Aguilar, J. A...... P658 Amano, N...... P668 Aguirre, C...... P450 Amaro, E. A...... P332 Aharon, D...... O176, P623 AmatRoldan, I...... O39 Ahmad, A. K...... P384, P392 Ambler, D...... P538 Ahmad, G...... P488 Amichay Keren, K...... P417 Ahmady, A...... P103, P137 Amir, H...... P683 Ahmed, A. I...... O220, P216, P596 Amita, M...... P278 Ahn, H. J...... P559 Amrane, S...... O87 Ahn, J.H...... P199, P589 Anahory, T...... P564 Ahuja, R...... P248, P451 Anaya, Y...... O182 AitAllah, A. S...... P449 Anchan, R. M...... P460 Aizpurua, J...... P291 Anderson, A. R...... P109 Ajmani, K...... O7 Anderson, J...... O98 Akana, M. C...... P321 Anderson, K...... O36 Akarsu, S...... P543 Anderson, R. E...... P106, P168, P258 Akbas, N...... P375, P563 Anderson-Bialis, D...... O98 Akin, N...... O118, O201 Annaheim, S...... P19 Akopians, A. L...... O79 Antaki, R...... P592 Alama, P...... P590 Antes, R...... P507

nd 72 ASRM Scientific Congress & Expo 239 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Antoine, Y...... P288, P292, P296 Bach, P. V...... O103, O110, O193, P495, P497, P513 Antonazzo, P...... O157 Badeghiesh, A. M...... P190 Antoniassi, M. P...... P505 Badran, E...... P235, P304, P305, P310 Antonini, G...... O114 Bae, K.S...... P445 Aono, N...... O84, P393, P519 Baek, K.H...... P405 Aparicio-Ruiz, B...... O225, P662 Baibakov, B...... P16, P639 Apte, S. S...... P468 Baillet, S...... P564 Apter, D...... O15 Baird, D...... O163 Arafa, M. M...... P340, P341, P499, P503 Baird, R...... P542 Aras, D...... P473 Baker, V. L...... O242, O249, P164, P582, P689 Arav, A...... P88, P533 Balaban, B...... O201, P368 Archer, D. F...... P455 Balasch, S...... O196 Argandoîa, F...... P450 Balayan, S...... O204 Arian, S...... O32 Ball, G...... P80, P94 Arita, N...... P53 Ballesteros Boluda, A...... P86 Armagan, A...... P343 Balmir, F...... P219 Armant, D...... P484 Balthazar, U...... P109 Armenti, E. M...... P140, P699, P701 Bankowski, B. J...... O145, P572 Arnolds, K...... O104 Banks, N...... O90, P111, P170, P174, P570, P639 Arnolds, K. S...... O33, O106 Barad, D. H...... P4, P5, P272, P568, P581, P591, P600, Arrach, N...... P103, P137 ...... P645, P687, P692, P693, P703 Arredondo, F...... O27, O222, P109, P181 Barak, Y...... P533 Artusa, L...... P222 Barash, O...... O64, P129 Arun Muthuvel, V...... O177 BarAvin Dayan, D...... P711 Arunajadai, S...... O27, P443 Barbieri, E...... O145, O170, O213, P146 Asada, Y...... P672, P682 BarChama, N...... P320, P323 Asano, E...... P672, P682 Bareh, G...... P610 Ash, W...... P14 Barentsen, K. C...... P644 Ashby, R. K...... P688 Barfield, J...... P676 Assidi, M...... P524, P544 Bark, S...... P133 Aston, K. I...... P203, P338, P348 Barkoff, M. S...... P622 Ata, B...... O145, P386, P406, P549 Barmat, L. I...... P540 Atabekoglu, C. S...... P312 Barnard, E...... P276 Atabyekov, I...... P398, P414 Barnea, E. R...... O266 Avalos, P...... P373 Barnes, F. L...... P110 Avci, B...... P50, P549 Barnhart, K...... O206, O254, O257 Avella, M...... P16, P84, P639 BarOr, D...... P343 Avendano, C...... P373 Barr, C...... P79 Awonuga, A. O...... P90 Barrak, C...... P484 Ayangbesan, A...... P492, P495, P497 Barrera, S...... O115 Ayaz, A...... P343 Barrett, B...... P356 Ayerdi, F...... P274 Barrett, E. S...... O164, P472 Ayers, J. W...... P126 Barriere, P...... P188, P423 Ayoubi, J...... O85 Barritt, J...... P115 Azem, F...... P65 Barros, B...... P404 Aziz, N...... P531 Barsky, M...... P567 Azuma, Y...... P441 Bartasi, G...... O7 Azziz, R...... P398, P414 Bartels, C. B...... P270 Baba, T...... O121 Bartolomei, M. S...... P36 Babariya, D...... O45 Bartolucci, A...... O69, P270, P551 Babayev, E...... O133, O172 Barton, G...... O197 Babayev, S...... O65, P269 Baruffi, R. L...... P675 Babigumira, J. B...... P512 Basar, M...... P327 Baccarelli, A...... O247 Basar, M. M...... P325 Bach, P...... P492 Basile, N...... O225, P539, P662

nd 72 ASRM Scientific Congress & Expo 240 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Basu, A...... P401 Bhattacharya, S. M...... P401 Batcheller, A. E...... P97, P660, P679 Bianchi, A...... P479 BatehPoisot, F...... P423 Bianchi, E...... O24 Batha, S...... P525 Bildik, G...... O118, O201 Bauckman, K...... P108, P120, P541 Bilinski, M...... P211, P333 Bayer, S...... O38 Biricik, A...... P104 Bazzi, M...... P579 Biron-Shental, T...... P426 Bazzocchi, A...... P479 Biscotti, C. J...... P468 Beaman, K...... O253, P285, P365 Bishop, C. V...... O140, P382, P394 Becker, A...... P115 Bishop, L. A...... O244, P111, P419 Becker, J...... P676 Bisht, S...... P51 Bedaiwy, M. A...... P449, P458, P602, P626 Biswas, B...... P401 Bedient, C. E...... P12, P197 Bjugstad, K...... P516 Behbehani, S...... P47, P257 Bjugstad, K. B...... P340, P343 Behr, B...... O44, P164 Black, M...... P101 Behrens, A...... O215 Blake, L. E...... P398 Beliveau, L. N...... P205 Blakemore, J. K...... O216, P21 Belloc, S...... O85, O141 Blakesley, R...... O268 Benadiva, C. A...... O143, P138, P270, P551 Blanes Espi, J...... P266 Benard, J...... P68 Blazek, J...... O46, O53, P141 Bendikson, K...... O139, P103, P137 Blesson, C. S...... O91 Bendikson, K. A...... O150, O186 Bocca, S...... P657 Bengawi, S...... P634 Bodine, R...... O5 Benhaim, J.L...... P42 Boekelheide, K...... O24 BenHaroush, A...... P167 Bogale, B...... O6 BenMeir, A...... P252 Bohler, H...... P408 Benoit, A...... P68 Bohrer, C...... P712 Beran, B...... O104 Bojanic, N...... P511 Beran, B. D...... O33, O106 Bolnick, A...... P484 Berger, D...... P558 Bolnick, J...... P484 Berger, D. S...... P273 Bolumar, D...... O28 Bergh, C. M...... O120 Bolyakov, A...... O193, O198, O228, P326, P350, P352, P513 Bergh, P. A...... O51, O120, O217, P265 Bonafede, M...... O230, P432 Berglund, A...... P607 Bond, K. R...... O14 Berjeb, K...... P59 Bonetti, T. C...... P30, P231, P280, P404, P593 Berkeley, A. S...... O57, P140 Bonitz, R. P...... O20 Berker, B...... P312 Bono, S...... P104 Berkowitz, K...... O167 Boots, C...... P427 Berliss, M...... O200, P594 Borba, J...... P76 Berloffa Belardin, L...... P505 Borg, H...... P416 Bern, O...... P88 Borges Jr., E...... P420 Bernabeu, R...... P124, P149 Bormann, C. L...... P537, P546 Bernson, D...... P567 Borowiecki, A...... O8 Berro, R...... O27, P443 Bortoletto, P...... O184, P161, P311 Bertelli, T. S...... P491 Bosch, E...... P590 Bertolla, R...... P505 Bossert, N...... P660, P679 Bertrand, K. A...... P62 Boulet, S...... O255, P206, P565, P576 Berwald, T...... P480 Bournat, J...... P349 Besch-Williford, C...... O188 Bouyahia, M...... P59 Beyhan, Z...... P154 Boylan, C. F...... P558 Bhasin, D...... P29 Boza, A...... P646 Bhat, M...... P616 Bradford, A...... P26, P61 Bhatla, N...... P588 Bradley, L...... O235 Bhattacharya, R...... P204 Brady, P...... P627 Bhattacharya, S...... P598 Braga, D. P...... P420

nd 72 ASRM Scientific Congress & Expo 241 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Braham, M...... P59 Cameron, K...... O116, P58 Brake, A. J...... P110 Camillo, J...... P547 Brakta, S...... P57, P398, P414 Campos-Galindo, I...... O72 Brannigan, R. E...... O197, P20 Can, A...... P473 Brannstrom, M...... O266 Canteenwalla, U...... O12 Brassesco, M...... P89 Capogrosso, P...... O162, P493 Braun, J. M...... O1 Cardona, C...... P354, P523 Braverman, A...... P23 Cardozo, E. R...... P161 Bray, M...... P380, P601 Cardozo, K...... P505 Breton, B...... P122, P123, P148 Carlsson, I...... O12, P14 Brezina, P. R...... P130, P152 Carnahan, M...... P396 Brezinova, J...... P531, P608 Carp, H...... P711 Briley, S. M...... P218 Carr, S. C...... O11 Bringer, S...... P292, P564 Carrascosa, J. P...... P291 Bristow, S. L...... O200, P321, P594 Carrell, D. T...... O248, P203, P338, P348 BritonJones, C...... O60, O261, P29, P178, P191, P214 Carreras Collado, R...... P266 Britten, J. L...... O240, P466 Carroll, R. S...... P428 Broeckling, C...... P644, P653, P667, P676 Casper, R...... P83, P359 Broekmans, F. J...... O94 Casson, P. R...... P25 Broughton, D. E...... O36, O181 Castaneda, A. G...... P332 Brown, B. K...... O50 Castelli-Haley, J...... O229, O230, P432, P457 Brown, M. B...... O256, P193, P196 Castillon Cortes, G...... O115 Browne, A. S...... P109 Cataldi, T. R...... P407 Brunet, C...... P288 Cataldo, N. A...... O49 Bu, Z...... P366 Catenacci, M...... P172 Buckett, W. . .O76, P47, P82, P182, P245, P257, P261, P318, P319 Catherino, W. H...... O240, O268, P466 Bulun, S...... P464 Cavagna, M...... P675 Burkart Sadusky, A...... P16 Cavagnoli, M...... P593 Burns, J. S...... O21 Cavdar, S...... P201 Busetto, G...... O114 Cayton Vaught, K. C...... O236 Bush, M...... P538 Cayton, K. C...... O126, P465 Butler, P. R...... O19 Cedars, M...... O71, O164, O182, P44, P48, P54, P55, Butler, W. J...... P364 ...... P69, P363, P384, P392, P604, P614 Butts, S...... P36 Cedenho, A...... P505 Buyalos, R...... P650 Cedenho, A. P...... P407 Buyalos, R. P...... P336 Cedrin, I...... P260 Buyuk, E...... O86, P7, P165, P388, P421 Cekleniak, N...... O147, P151 Buzzi, J...... O119, O144 Celia, G. F...... P657 Caballero, T...... O144 Cengiz, C...... O19, P337 Cabanillas, S...... O28, O115 Cervantes, E...... P191, P262 Cabey, R...... O212, P146, P701 Cetin, I...... O157 Cabeza-Arvelaiz, Y...... P349 Cetinkaya, M...... P113, P552 Cai, B...... P685 Cha, H.J...... P199, P589 Cai, L...... P134, P649 Cha, J.H...... P199, P589 Cakar, Z...... P473, P486, P503 Chai, W...... P240 Cakmak, H...... O182, P44, P54, P55 Chakraborty, P...... P290, P410 Calafat, A...... O1 Chakravarty, B...... P290, P410 Calatayud Lliso, C...... P266 Chan, A...... O268 Calderon, G...... P539 Chan, E...... O99, P695 Calhoun, A. R...... O14 Chan, E...... P20 Calomarde Rees, M...... P617 Chan, J. L...... P686 Calza, N...... P479 Chan, P...... O153, P245, P318, P319 Camargo, M...... P505 Chan, P. J...... P610 Camarillo, D. B...... P164 Chan, S.W...... P577 Cameron, E...... O146 Chang, A...... P509

nd 72 ASRM Scientific Congress & Expo 242 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Chang, C.C...... P85 Choi, H...... P213, P615, P619 Chang, E...... P49, P209 Choi, J.R...... P641 Chang, S...... P421 Choi, K...... P378, P395 Chang, T. A...... P93, P545, P550 Choi, W. Y...... P578 Chang, W...... O46 Choi, Y...... P49, P209, P378 Chantilis, S. J...... P140, P642 Cholkeri-Singh, A...... O214, P301 Chapa, C...... P23 Chou, C.H...... P381, P385 Chapa, C. R...... P332 Chou, Y.C...... P463 Charles, C...... P431 Chow, S...... P489 Charron, M...... P421 Chow, V...... P344 Chason, R...... O90 Christ, J...... O82 Chattopadhyay, R...... P290 Christiansen, C. L...... O184 Chatzicharalampous, C...... P601 Christiansen, M...... P37 Chauhan, S...... O66 Christianson, M. S...... O249, P690 Chavarro, J. E...... O67, O247, P8, P13, P62, P399, P502 Christou, G...... P242 Chavez-Badiola, A...... O53, O267 Christy, A...... O242, P374, P689 Chawla, B...... P51 Chuan, S. S...... P700 Chazenbalk, G. D...... O79, P383 Chulet, S...... P248, P451 Cheah, M...... P72 Chung, J...... P261 Checa, M...... P266 Chung, K...... O139, O150, O186, O257, P103, P137 Check, J. H...... P192, P372, P618 Chung, M...... P133 Chen, C.H...... P461 Chung, P. H...... O41 Chen, C.W...... P461 Chuong, F. S...... O236, P465 Chen, J...... P43, P179 Chwalisz, K...... O229, O232, P434, P440, P455 Chen, M...... P377 Cicaré, J...... P681 Chen, M.J...... P381, P385 Cil, A. P...... P251 Chen, Q...... O62, O258, P633 Cinar, O...... P473 Chen, S...... P638 Ciotti, P...... P479 Chen, S. H...... P14, P138 Cipolla, K. M...... O181 Chen, S.U...... P381, P385 Cipolla, M. J...... O189 Chen, Y.A...... P462 Cipriani, L...... P479 Chen, Z...... P210 Clapp, M. A...... P7, P388 Chenette, D...... O3 Clarke, R...... P655 Cheng, X...... P282, P295 Clegg, D...... P482 Cheng, Y.S...... P494 Clement, A. P...... P504, P520 Chetkowski, R. J...... O130 Clementi, C...... O27, P443 Cheung, F...... P509 Clifton, J...... O154, P25 Cheung, S. . . .O112, O158, O194, P212, P489, P490, P504, P520 Clua, E...... P194 Chhabra, D...... P683 Coates, A...... O145, O147, O170, P102, P572 Chi, H...... P263, P317, P555, P595 Cobo, A...... P87 Chi, T.F. F...... P657 Coddington, C...... O37, P276, P413 Chia, G...... O125 Coello, A...... P87 Chiang, J. L...... P498 Cohen, A...... P237, P698 Chibber, S...... O238 Cohen, J...... O145 Chick, J...... P579 Cohen, L...... O238 Chiles, K. C...... P109 Cohen, M...... O212 Chin, W...... P228 Cohen, R...... P192, P618 Chiu, Y.H...... O67, P8, P477 Cohen, Y...... P237 Cho, J...... P595 Collazos, J...... O198 Cho, K...... O138 Collins, G...... P6, P176 Cho, S.H...... P445 Collins, S. C...... O78, O99, P695 Choe, S...... P445 Colls, P...... P108, P115, P120 Choi, A. W...... P20 Collura, B...... P29 Choi, B.C...... P405 Commander, S...... P116 Choi, D...... P378, P395 Confino, E...... P24

nd 72 ASRM Scientific Congress & Expo 243 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Confino, R...... P22, P64, P218, P536 Darmon, S...... P4, P5, P272, P568, P581, P591, P600, P645, Connell, M. T...... O88 ...... P687, P692, P693 Connolly, K...... P259 Darwish, E...... P81 Conrad, D...... O23 Dasig, D...... P577 Considine, R. V...... O80, O81, O83 Daumler, D. M...... O153 Cook-Andersen, H...... O138, P183 Davenport, E...... O139 Cooney, L...... O245, P300, P390, P412 Davila, A...... P1, P332 Cooper, A...... O9, O97 Davis, J. B...... O9, O97 Copperman, A. B. . . . O27, O60, O174, O176, O180, O219, O222, Davis, M...... P457 ...... O261, P29, P112, P171, P178, P181, P191, P214, P236, Davis-Kankanamge, C. N...... P396 ...... P241, P254, P256, P259, P262, P294, P320, P323, P370, Dayal, M...... P154 ...... P422, P561, P611, P612, P623, P652, P666, P704 De Berardinis, E...... O114 Cordeiro, F. B...... P407 de Carvalho, C. V...... P280 Coroleu, B...... P194 de Kat, A. C...... O94 Corselli, J...... P610 de los Santos, J...... P313 Corwin, J. B...... P2 de los Santos, M...... P662 Cosar, E...... P433, P444, P453 Dean, J...... P16, P639 Costa Borges, N...... P539 Dean, N...... P592 Costantini-Ferrando, M. F...... O151 Dearden, L...... P145 Cotroneo, E...... P104 DeCherney, A...... O88, O90, P111, P160, P170, P174, P208, Cottrell, H...... P279 ...... P369, P570, P605 Coutifaris, C...... O206, O260, P36 DeCherney, A. H...... O192 Covarrubias, L...... P26, P61 DeFranco, E...... P162 Coveney, S...... P702 Degelos, S...... O69 Cox, J...... P466 DeGeyter, C...... P486 Cozzubbo, T. . . . . O112, O158, O194, P212, P222, P489, P490, Dehn, C. A...... P514 ...... P504, P520 Deibert, C. M...... O111, P501 Craig, L. B...... O18, P17 Dela Cerna, C...... P108 Craig, W. Y...... P498 Dela Cruz, D. B...... P83 Crawford, N. M...... P27, P558 Delaroche, L...... P288 Crawford, S...... O52, P206, P565 Delgado-Gonzalo, R...... P19 Creux, H...... O76 Deli, K...... O214 Criniti, A. R...... P94 Demko, Z...... P143, P569 Crochet, J...... P131, P275 Denomme Tignanelli, M...... O59, O161 Csokmay, J...... O90 Desai, N...... O8, P105, P121, P315 Cuellar, R...... O13 Detti, L...... O168, P37 Cueva, S...... P622 Devaraj, S...... P375, P563 Cursio, E...... P104 Devine, K...... P111, P170, P174, P369, P419, P570, P605 Curtis, M. R...... O184 DeVita, J. M...... O40 D’Agostino, R...... P416 Devoto, L...... P450 D’Hooghe, T...... P430, P436, P452, P557 Devreker, F...... P557 Da Broi, M. G...... P491 Dia, F...... O167 Dabaja, A. A...... P579 Diamond, M. P...... O2, O31, O164, O232, P48, P363, P398, Dacharry, L...... P220 ...... P414, P470 Dada, R...... P51 Diao, Z...... P282, P295 Daftary, G. S...... P277, P413, P438 Diaz Bachiller, M...... P266 Dahan, M...... O137, O171, O218, P386, P406 Diaz, P...... P23 Dai, Q...... O262 Dieamant, F...... P675 Dambaeva, S. V...... O253, P285, P365 DiGiorgio, L...... O20 Damiano, G...... P479 Diken, Z...... P275 Daneshmand, S...... P12, P197 Dimitriadis, E...... P153 Daneyko, M...... P29 Dimitriadis, I...... P242, P537 Dang, V. Q...... O269 Ding, L...... P282, P295 Danzer, H...... P115 Diop, H...... P166, P169, P586 DiPaola, K...... O69

nd 72 ASRM Scientific Congress & Expo 244 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Djordjevic, D...... P511 Eisenberg, M...... O187, P331 Dodge, L. E...... O155, P189 Eisman, L. E...... P540 Dogan, S...... P126 Eklund, E. E...... P379 Dokras, A...... O245, P138, P390, P412, P686 El Andaloussi, A...... P471 Dolinko, A. V...... P560 El Hachem, H...... P68, P592 Domar, A. D...... O154, O155 El Kabab, L...... P376 Domenech, L...... P681 ElAalamat, Y...... P430 Domingues, T. S...... P30, P404 Elbardisi, H...... P340, P341 Dominguez, F...... O72 Elgindy, E. A...... P81 Dondik, Y...... P408 Elias, R...... O54, P222, P702 Dong, Y...... P32 Eliassen, A...... P62 Doody, K...... O65, P269 Ellakany, M...... P57 Doody, K. J...... P142 Elliott, T. A...... P85 Dorais, J...... P203 Elloumi, H...... P59 Dorfmann, A...... P144 Elmahdy, M...... P517 Douglas, N. C...... O183 Elmasdy, A...... P517 Dowlut-McElroy, T...... P396 Elmokhtar, M. A...... O209 Doyle, J...... P111 Elnashar, I...... P235, P304, P305, P310, P400 Doyle, K. M...... P138 ElNashar, S. A...... P277 Doyle, M...... P699 Elrefaiy, A. M...... O209 Drainoni, M.L...... O184 Elsenosy, E...... P235 Driggers, P...... O126, O236, P465 Eltsova, E...... P246 Drissennek, L...... P288, P292, P296 Enciso, M...... P291 Druckenmiller, S...... O152, P99, P107 EnginUstun, Y...... P200 Drum, J. A...... O102 Engmann, L...... O143, P551 Du, Q...... P474, P478 Entezami, F...... P288, P292, P296 Du, T...... O62, O258, P633 Epperson, C...... P390 Duan, W. R...... P440, P455 Ergin, M...... P402 Dubey, A. K...... P130, P131, P152 Ersoy, A...... P200, P402 Duffy, K. A...... P697 Ersoy, E...... P200, P402 Duke, M...... O261, P214, P323, P666 Esbert, M...... P86 Duleba, A...... O92, P183, P444 Escobar, P...... O33, O106 Dumdie, J...... O138 Escriba, M...... P562 Dumesic, D. A...... O79, P383 Escrich, L...... P562 Duncan, F. E...... P218 Escudero, T...... O147, P140, P699 Dunn, R. D...... O66 Esfandiari, N...... P83 Dunne, C...... P602 Esteves, S...... P488, P544, P640 Duran, E...... P576 Estofan, D. E...... P249 Duran, E. H...... O255 Estofan, P. M...... P249 Durland, U. S...... P626 Eum, J...... P578 Duthie, E. A...... O9, O97 Evans, M...... O154, P369 Dzhemlikhanova, L...... P75 Evenson, K. K...... P514 Dzidic, N...... P116 Ezoe, K...... P603 Eaton, J. L...... P159, P198 Fabbri, F...... P479 Ebinger, E. R...... P9 Fahmy, N...... P380 Eccles, J. M...... O215 Failor, C...... P93, P250 Edifor, R...... P8 Falco, L...... P19 Egashira, A...... P670 Falcone, T. . O32, O33, O82, O104, O106, P121, P447, P454, P468 Eggan, K. C...... P387 Falk, M...... P540 Egli, D...... O125, P684 Famuyide, A. O...... P277 Ehlers, K. A...... O227, P408 Fan, Y...... O62, P43, P179 Eid, M. E...... P271 Fanchin, R...... O85, P42 Eijkemans, R...... O94 Fang, C...... O30, P96, P185 Eisenberg, A. C...... O130 Fankhauser, D. M...... P2 Eisenberg, E...... O254, P363, P384 FarahEways, L...... P577

nd 72 ASRM Scientific Congress & Expo 245 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Farghaly, T. A...... P235, P303, P304, P305, P310, P400, P415 Fraietta, R...... P280, P547 Farland, L. V...... O6, O73, O101, O224, P62, P224, P460, Franasiak, J. M...... O47, O63, O166, O169, O223, O263, ...... P546, P560, P627, P688 ...... O270, P78, P225, P243, P287, P448, P475, Farooq, A...... O197 ...... P548, P621, P669, P707 Fassbender, A...... P430, P436, P452 Franco Jr., J. G...... P675 Faulkner, N...... P122, P123, P148 Frank, A...... P482 Faustmann, T. A...... O15 Frankel, A...... P265 Fedick, A...... O190 Fraser, A...... O203 Feichtinger, M...... O266 Fraser, I. S...... P436 Feil, H. E...... P388 Frattarelli, J. L...... O147 Feilding, B...... P31 Freeman, M. R...... P268 Feinberg, E. C...... O8, O149, O243, P691 French, B...... P236 Feinberg, R. F...... O11 Freour, T...... P423 Felder, G. J...... P518 Fresa, K. J...... P657 Feliciano, M...... O103, P350 Friason, F. K...... O14 Feng, C...... P583 Friedenthal, J...... P709 Feng, H. L...... P91, P98 Friedman, J. E...... P40 Feng, J...... P638 Fritz, M. A...... P273 Feng, Y...... P283 Fritz, R...... O86 Feoktistov, A...... P75 Fujii, D. T...... P175 Ferguson, K...... P344 Fujii, M. G...... P231 Fernandez, I...... O115 Fujimoto, V. Y...... P604 Fernandez, P...... O196 Fujiwara, T...... P467 Fernandez-Sanchez, E...... P573 Fukuda, Y...... P587 Ferrando, M...... O115, P274 Fukui, A...... P527 Ferrer Molina, P...... P266 Fukunaga, N...... P672, P682 Ferrero, S...... O239, P437, P459, P469 Fulco, F...... P333 Ferriani, R...... P491 Funabiki, M...... P668 Feskov, O...... P346 Funamizu, A...... P527 Fiameni, F...... O144 Furuhashi, K...... O42 Fields, R. A...... P155 Furuya, S...... P195 Figueira, R. C...... P420 Gabrielsen, J...... P502 Filippo, P...... O162, P493 Gada, R...... P642 Findley, B...... P335 Gala, A...... O141, O175, P296, P564 Fiorentino, F...... P104 Galache, P...... P332 Fisch, B...... P167 Galal, M...... P517 Fisch, S...... O79 Galan, A...... P87 Fisher, S. L...... P94 Galiana, Y...... P562 Fisher, T. E...... P94 Gallagher, C...... P455 Flanagan, J...... O213 Gamboa, L. A...... P76 Fletcher, N. M...... O31, O168, P37 Gangrade, B. K...... P177, P696 Flisser, E...... P256, P323 Ganza, A. L...... P320, P422 Florensa, M...... P86 Ganzer, L. M...... P249 Flyckt, R...... O32, P542, P599 Gao, J...... P377, P584 Flynn, K. E...... O9, O97 Garcia Velasco, J...... P539, P662 Foidart, J.M...... P557 Garcia, D...... P89, P423 Ford, J. B...... O1, P477 Garcia, R...... P308 Forehand, R...... O154 Garcia-Cerrudo, E...... O137 Forman, E. J...... P243, P548, P707 Garcia-Hernandez, E...... P149 Forte, S...... P486 Garima, K...... P588 Foster, S...... P14 Garner, F...... P12, P197 Fothergill, A...... P63, P66 Garor, R...... P167 Fox, C. W...... P299 Garrido, N...... O72, P534, P535, P590 Fox, J. H...... O73 Garrisi, G...... P108, P120, P541 Fragouli, E...... O45, O58, O170, O173, P139 Garrisi, M. G...... P541

nd 72 ASRM Scientific Congress & Expo 246 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Garrison, L. P...... P512 Goncalves, S. P...... P231 Garzo, V...... P183 Gonik, B...... O135 Gaskins, A. J...... O67, O247, P8, P13, P399, P502 Gonzalez, F...... O80, O81, O83 Gat, I...... P507 Goodall, N.N...... O170 Gavrilova-Jordan, L...... P398, P414 Goodman, L. R...... O35, P121, P599 Geber, S...... O179, P95 Goodrich, D...... O169, P127 Gelber, S. E...... O87 Goodwin, M...... O246, P674 Gelfond, J...... P93 Goodwin, M. R...... P207, P597 Gemzell-Danielsson, K...... O15 Gopal, D...... P166, P169, P586 Genesio Ceratto, K. M...... P373 Gordon, A. N...... P60 Gentile, V...... O114 Gordon, C...... P258 Gentry, A...... P408 Gordon, T. T...... O146 George, N. J...... P80 Gore, A...... P122, P123 Gerber, R. S...... P222 Gore, J...... P506 Germain, K...... P122 Gosalvez-Vega, A...... P573 Gerona, R. R...... O71 Gottesdiener, A...... P497 Ghadir, S...... O241, P102 Gottesdiener, A. J...... P492 Ghetler, Y...... P417 Gottesdiener, A. V...... P495 Ghim, J.L...... P445 Goudas, V...... P678 Ghiossi, C...... P708 Gouw, F...... O46 Ghosh, D...... P616 Gracia, C...... O116, P58 Ghosh, P...... O87 Graham, J...... O88, P160 Ghosh, S...... P290, P410 Grainger, D. A...... P206 Gibbons, W. E...... O91, P375, P563, P663, P680 Granger, S. W...... P236 Gibson-Helm, M...... O245 Grau, N...... P562 Gil Arribas, E. I...... O39, P180 Gray, J. E...... P273 Gilabert, R...... O39 Grazi, R. V...... P389 Giles, J...... O115 Greco, E...... P104 Gill, P. K...... P315 Green, K. A...... P160, P369 Gillman, M. W...... O67, O247 Green, L. J...... O123, P210 Gilman, A...... O171, O218, P245, P318 Greenblatt, E...... P359 Gilman-Sachs, A...... O253, P285, P365 Greene, A...... O207, P653, P667 Ginsburg, E. S...... O101, P546, P627, P688 Greenstein, Y...... P577 Giudice, L...... O204 Greige, R...... P484 Giudice, L. C...... P434, P440 Griffin, D...... O143 Gleicher, N...... P4, P5, P272, P568, P581, P591, P600, Grifo, J...... O3, O46, O58, O95, O173, O212, O216, O241, ...... P645, P687, P692, P693, P703 ...... O250, P21, P101, P107, P118, P136, P150, P157, Glynn, K...... P525 ...... P217, P264, P699, P709 Gode, F...... P543 Grill, E...... O151 Goel, T...... P588 Grindler, N. M...... O68, O70 Gold, M...... O200, P594 Grodstein, F...... P62 Goldberg, J. D...... P708 Groettrup-Wolfers, E...... O235 Goldberg, J. M...... O35, P121 Grogan, T...... O79 Goldberg-Strassler, D...... O212, P146, P701 Grossman, L. C...... O43, O125, O183 Goldfarb, J. M...... P6, P176 Grover, N. S...... O77 Goldman, K. N...... O3, O216, O250, P21, P99, P709 Grunert, G. M...... O46 Goldman, R. H...... O73, P688 Grunfeld, L...... P112, P241, P256, P294, P612, P623 Goldschlag, D. E...... P223, P418 Grynberg, M...... P68, P260 Goldstein, M...... O103, O110, O194, P490, P492, P495, P497 Gu, F...... P584 Goldstein-Tufaro, A...... P157 Guan, L...... P145 Gomes, A. P...... P231 Guarnaccia, M...... O43, O212, P146 Gomes, C...... P404, P593 Guedikian, A...... P383 Gomez de Segura, R...... P617 Guerrero, J...... P124 Gomez, M. H...... P373 Guetta, E...... P711 Gomez-Chavez, F...... P356 Gueye, N.A...... P468

nd 72 ASRM Scientific Congress & Expo 247 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Guimaraes, F...... O179, P95 Hashimoto, S...... O264 Gulerman, C...... P357 Hasson, Y...... P47, P82, P182, P257 Gumer, A...... P684 Hatch, E. E...... O195 Gun-Eryilmaz, O...... P646 Hatch, I...... P258 Gunnala, V. . . . . O34, O89, P100, P223, P326, P418, P429, P575 Hatirnaz, E...... P386 Guo, F...... P371 Hatirnaz, E. S...... P406 Guo, S.W...... O234 Hatirnaz, S...... P386, P406 Guo, W...... O257 Hattori, H...... P393 Gupta, A...... O153 Hauser, R...... O1, O21, O67, P8, P13, P477, P537 Gupta, S...... P486, P503, P516, P544, P640 Havelock, J...... P602, P626, P630 Gustin, S. L...... O111, P501 Hawkins, K. C...... P364 Gustofson, R. L...... P73, P255, P435 Hayes, L...... P9 Gutmann, J...... O27, O222, P181 Hayes, M. K...... O120 Gzgzyan, A...... P75 Haykal, R...... O79 Ha, D. T...... O269 Hayward, B...... O128, O132, P234, P628 Habib, D. M...... P303, P305, P310 He, J...... P609 Habib, S...... P471 He, Q...... P638 Hacker, M. R...... O155, P189 Healey, M...... O129, P613 Haddad, G...... O46 Healy, M. W...... O90, P111, P170, P174, P208, P605 Haddow, J. E...... P379 Heberlein, E. C...... O17 Haikin Herzberger, E...... P417, P426, P554 Hebisha, S. A...... O220, P216, P517, P596 Haisenleder, D...... P363 Hehemann, M. C...... O197 Haisenleder, D. J...... O254, P48, P384 Heitmann, R...... P175 Halicigil, C...... O69 Held, K. R...... P139 Hall, S. J...... O24 Hellmers, A...... P156 Hallam, S...... P148 Helmy, Y. A...... P449 Hallam, S. E...... P123 Hemi, R...... P554 Halpern, G...... P420 Hemmings, R...... P190 Halverson, R...... P80 Henderson, S...... O137 Hamamah, S...... O141, O175, P188, P288, P292, P296, P564 Henry, L. N...... O233 Hamilton, D. P...... P663 Herati, A. S...... O19, P337 Hammadeh, M. E...... P322, P705 Herbemont, C...... P260 Hammes, K...... O127 Herlihy, N...... O176, O180, P259, P612 Hammond, K. R...... O49 Hernandez, J...... P308 Hammoud, A...... P126 Hernandez, M...... P249 Hamza, H...... P571 Herndon, C. N...... O182 Han, E...... P378 Herrer Saura, R...... P180 Han, J...... O142 Herrero, B...... P319 Han, M...... O259 Herrero, L...... P539 Han, M. M...... P621 Herrick, J...... O207, P653, P667, P676 Han, S...... P445 Hershko Klement, A...... P82, P182, P554 Hancock, K...... O41, O54 Hershlag, A...... O212, P146, P553, P698 Hanna, C...... O13, P15, P18 Hesla, J. S...... O145, P102 Hannam, T...... P359 Hibray, C...... P80 Hansen, K. R...... P204, P582 Higgins, J...... P396 Haouzi, D...... P288, P292, P296 Hill, D. L...... P102 Haque, I. S...... O211, P708 Hill, G...... P268 Harada, T...... P441 Hill, L. K...... P353 Hariton, E...... P161 Hill, M. J...... O88, O90, P111, P160, P170, P174, P208, Harris, A...... O167 ...... P369, P419, P570, P605 Harris, E...... O75 Hilton, J. L...... P630 Hart, J...... P154 Hinckley, M...... O64, P129 Hartman, M. E...... P170 Hinds, M...... P268 Harton, G...... O7 Hipp, H...... O52, P206, P565 Hasegawa, H...... P648, P673 Hirshfeld-Cytron, J. E...... O8, P624

nd 72 ASRM Scientific Congress & Expo 248 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Hitkari, J...... P626, P699 Hughes, M...... O46, O96, P114, P141 Ho, H.N...... P381, P385 Hughes, M. R...... O146 Ho, J...... O186 Humaidan, P...... P228 Ho, J. R...... O150, O199, P103, P137 Humm, K. C...... P189 Ho, T. M...... O269 Humphries, L. A...... P189 Hodes-Wertz, B...... O152, O250 Hunter Cohn, K...... O222, P112, P181, P611 Hoeger, K...... O164, P472 Hur, J...... P213 Hoff, H. S...... O25, P27, P558 Hur, Y...... P49, P125, P209, P578 Hoffman, D. I...... O200 Hurd, W. W...... P415 Holden, A. E...... P330 Hurley, E. G...... P162 Hollett-Caines, J...... P205 Hurst, B. S...... O40, P530 Holt-Lunstad, J...... O248 HuSeliger, T...... P443 Hong, K. H...... P243, P548 Hussien, A...... P253 Honig, S. C...... P70, P496 Hutchinson, A. P...... P202, P702 Hopkins, M. R...... P277 Huynh, B. G...... O269 Horcajadas, J. A...... P291 Hwang, K...... O24, P345 Horiuchi, T...... P606, P647, P656 Hyman, J...... P252 Hornberger, K. L...... P710 Iaconelli Jr., A...... P420 Horne, J...... P707 Igarashi, H...... O84, P393, P519 Hotaling, J...... P203, P348 Igashira, C...... O42 Hotaling, J. M...... P338 Ikhena, D. E...... P22, P464, P536 Houghton, L...... O199 Iliodromiti, S...... O203 Houshdaran, S...... O204 Illions, E. H...... P7 Hovanes, K...... P116 Illmensee, K...... P678 Howard, J...... P268 Imudia, A. N...... O108 Howard, K. G...... P268 Inal, H. A...... P357 Howards, P. P...... P63, P66 Ingles, S...... P103 Hoyos, L. R...... P90 Ingles, S. A...... O139, P137 Hsieh, C.C...... P461 Innocenti, C...... P288 Hsu, A. L...... P585 Insogna, I...... P627 Hsu, F.C...... P528 Insua, M. F...... P562 Hsu, J. W...... O91 Intasqui, P...... P505 Hsu, J. Y...... O183 Ioannou, D...... P522 Hu, J. C...... O110 Irani, M. . . .O34, O89, P100, P223, P326, P389, P418, P429, P575 Hu, L...... P366 Irani, S...... P389 Hu, R...... P244 Iraurgui, L...... P274 Huang, A...... O46 Irwin, J...... O204 Huang, B...... P677 Isaac, J...... O213 Huang, C...... P79, P282, P295 Ishikawa, T...... P53, P232, P316, P367, P500, P510 Huang, C.C...... P385 Isik, A. Z...... P543 Huang, H.Y...... P298 Isiklar, A...... P368 Huang, J.C...... P671 Ismail, A. M...... P235, P400, P415 Huang, L...... P289 Ismail, N...... P471 Huang, R...... O30, P96, P185 Ito, J...... P659 Huang, T...... O53, O267 Ito, M...... P329, P603 Huang, T. T...... P559 Iturriaga, A...... O215 Huang, W...... P397 Ivani, K...... O64, P129 Huang, Y...... P474, P478 Iwata, K...... O208, P215, P661 Huang, Y.T...... P45 Izquierdo, A...... O115, P617 Hubbard, J...... P228 Jackman, J...... P601 Hubbard, J. A...... O49 Jackson-Bey, T...... P159, P198 Hubert, G...... P336, P650 Jacobson, J. D...... P610 Huddleston, H...... O204, P48, P363, P384, P392 Jacobson, M. H...... P66 Hudson, C...... P703 Jacoby, E. S...... P545, P550 Huffman, H...... P538 Jahoor, F...... O91

nd 72 ASRM Scientific Congress & Expo 249 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Jain, C...... P484 Kadoch, J. I...... P508 Jain, H...... P540 Kagawa, T...... P195 Jain, R. I...... O229, O232, P434, P440, P455 Kahraman, S...... P113, P251, P325, P327, P552 Jakiel, G...... P41 Kaing, A...... P650 Jalas, C...... O215 Kaiser, U. B...... P428 Jamal, W...... P190 Kalinchenko, S...... P246 James, D...... O5 Kalish, J. M...... P697 James-Todd, T...... P477 Kalmbach, K...... O27, P443 Jamieson, D. J...... O52, P206, P565 Kalra, B...... O199 Jang, H...... P49 Kamihata, M...... P606, P647, P656 Jang, J. M...... P92 Kamoshita, M...... P659 Janitz, A...... O18, P17 Kanat-Pektas, M...... P386, P406 Jansson, T...... O68, O70 Kandabarow, A. M...... O197 Jasensky, J...... P210 Kanety, H...... P554 Jasti, S...... P218 Kang, B.M...... P409 Jasulaitis, S...... P624 Kang, I...... P615, P619 Javadian, P...... P204 Kang, K...... P615, P619 Javed, M...... P634 Kannan, K...... O68, O70 Jayakumaran, J...... P177, P696 Kanninen, T...... P376 Jee, B...... P77 Kant, G...... P248, P451 Jeelani, R...... O210, P52 Kao, C.N...... P384, P392 Jenkins, T...... P338, P348 Kapfhamer, J. D...... P625 Jensen, J...... O13, O37, P15, P18, P413 Kaplan, B...... O128, O132, P234, P541, P628 Jeong, H...... P405, P445 Kar, S...... P556, P686 Jeong, H. J...... P133 Karabon, P...... P579 Jeong, J.W...... P299 Karatas, A...... P200, P201 Jeung, Y...... P409, P442 Karavany, G...... P252 Jiang, R...... P282, P295 Karmon, A...... P161 Jiao, J...... P391 Karnis, M. F...... P359 Jin, L...... P677 Kaser, D. J...... O6, O224, P224, P546, P560, P688 Jin, S...... O249 Kashanian, J...... O110, O197, P20 Jindal, S. K...... O86, P165 Kashiwazaki, N...... P659 Jinno, M...... P233 Kashyap, S...... P626 Joelsson, L. S...... P607 Kaskar, K...... P663, P680 Joergensen, N...... P502 Katada, Y...... O42 Johnson, J...... O166 Katagiri, Y...... P587 Johnson, S...... P481 Kathrins, M...... P351 Johnson, S. J...... P457 Kato, K...... P603 Johnstone, E. B...... O248, P203, P338 Katukurundage, D...... O253, P285 Jones, T. L...... O37, P276, P413 Katz, S. E...... O222, P181 Joo, B...... P641 Katz-Jaffe, M...... O48, O50, O59, O127, O161, O221, O233, Joo, J...... P35, P286, P293 ...... P97, P255, P335, P424, P435, P654, P710 Jordan, A...... P115, P146, P151, P701 Kaufmann, R...... P152 Joseph-Sohan, M...... O151 Kaufmann, R. A...... P130 Joshi, N. J...... P90 Kava, A...... P194 Juhani, A...... O31 Kawahara, T...... O4 Jukic, A. Z...... P362 Kawano, H...... P659 Juneau, C. R...... O47, O63, O166, O169, O223, O263, O270, Kawwass, J. F...... O52, P206, P565 ...... P78, P225, P243, P287, P448, P475, P-548, Kaye, L. A...... P270 ...... P621, P669, P707 Kearns, W. G...... P130, P131, P152 Jung, J...... P445 Keefe, D. L...... O3, O95, P39, P217, P483, P487 Jung, M. J...... P311 Keles, I...... O201 Jungheim, E...... O36, O181, P46 Kelk, D. A...... O96 Kadakia, T. S...... P439 Kelleher, C...... O117 Kadoch, I.J...... P592 Keller, L...... P144

nd 72 ASRM Scientific Congress & Expo 250 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Keller, M...... P477 Kishi, K...... O42 Kelly, M...... P84 Kissin, D. M...... O52, O255, P206, P565, P576 Kelsh, J. M...... P218 Kitamura, M...... P587 Kenigsberg, D...... P509 Kitaya, K...... P53, P232, P316, P367, P500, P510 Kennedy, E. B...... P189 Kitchen, J...... P114, P138 Kennedy, J...... O57 Klavanian, J...... O146 Keskintepe, L...... P154 Klein, J...... P256, P623 Keskintepe, M...... P154 Klein, N...... P94 Kesner, J. S...... O163 Kleinman, E...... O215 Kessel, B...... P559 Klenov, V...... P46 Ketch, C...... P204 Klepacka, D...... P710 Keyhan, S...... O131, P159, P198, P574 Kligman, I...... P202, P247, P418, P575 Khalafalla, K...... P340 Kline, M...... P684 Khan, I...... P126 Klock, S...... O185, P22 Khan, S...... O135, O210, P52 Kloss, G...... P41 Khan, Z...... O35, O37, P438 Knebel, S...... P139 Khrouf, M...... P59 Knudtson, J...... P93 Khudhari, A...... P190 Knudtson, J. F...... P250, P330, P545, P550 Khurana, K...... P518 Ko, J.J...... P221 Kianifard, D...... P485 Kobayashi, J...... P648, P673 Kiehl, M...... P142 Kobayashi, M...... O148, P648, P673 Kiessling, A. A...... P566 Kobayashi, T...... P603 Kijacic, D...... P142 Kobayashi, Y...... P606, P647, P656 Kilarkaje, N...... P637 Kobori, Y...... P342 Kilburn, B...... P484 Kofinas, J...... O95, P217 Kiltz, R...... P151 Kohan-Ghadr, H.R...... O135, P90 Kim, C...... P641 Kohen, P...... P450 Kim, C.H...... P409, P442 Kohn, T. P...... O226 Kim, D.I...... P360 Kokeguchi, S...... O42 Kim, E...... P395 Kolb, B. A...... P145 Kim, E.K...... P378 Kon, M...... P256, P652 Kim, E.Y...... P221 Konar, H...... P290, P410 Kim, G...... P416 Kondapalli, L. A...... P73, P255, P435 Kim, H. J...... P92 Koniares, K...... P111, P419 Kim, H. S...... P133 Konstantinidis, M...... O57, O212, O267, P138 Kim, H.R...... P615, P619 Koong, M...... P615, P619 Kim, H.Y...... P199, P589 Kopysitsky, I...... P509 Kim, J...... P125, P133, P209, P445, P578 Korrick, S...... O21 Kim, J.H...... P199, P589 Kort, J...... O44, P143, P425, P569, P582 Kim, J.W...... P263, P317, P555, P595 Kosasa, T...... P559 Kim, K...... P161, P689 Kostolias, A...... P95 Kim, K.H...... P221 Kostolias, A. F...... O179 Kim, M. H...... P133 Kotarski, J...... P440 Kim, R...... P578 Kothandaraman, N...... P347, P524 Kim, S...... O99, P35, P77, P263, P286, P293, P317, P360, Kotlyar, A...... P447, P542 ...... P445, P555, P578, P595, P599 Kotze, D. J...... P657 Kim, S...... O266 Koulianos, G. T...... O69 Kim, S.H...... P360 Kounogi, S...... P672 Kim, T...... P213 Kovacs, P...... P238 Kim, Y...... P213, P263, P317, P555, P615 Kovalevsky, G...... O11 Kim, Y.J...... P199, P589 Kowal, T. J...... P540 Kimati, C. T...... P30 Kramer, Y. G. . O95, O152, O156, O216, P21, P39, P217, P483, P487 King, A...... P710 Krichevsky, L...... P359 Kirkpatrick, S. R...... P538 Kriplani, A...... P588 Kirkwood, J...... P644, P653, P667 Krisher, R. L...... O207, P644, P653, P667, P676

nd 72 ASRM Scientific Congress & Expo 251 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Kroener, L...... P650 Lawlor, D...... O203 Kuang, Y...... O62, O258, P135, P226, P240, P633 Lawlor, D. A...... P229 Kubikova, N...... O45 Lawrence, C...... P602 Kubonoya, K...... P195 Lawrence, J...... P416 Kudesia, R...... P29 Lawrence, L...... P642 Kuebler, F...... P19 Lawson, A...... P24 Kujawa, S...... P464 Lawson, A. K...... O185, P21, P22, P64, P664 Kuliev, A...... P56, P117, P119, P132 Lazarin, G. A...... O211, P708 Kulkarni, A...... O52 Lazzaroni-Tealdi, E...... P272, P568, P581, P591 Kumar, A...... O199 Leader, B...... P356 Kumar, N...... O241, P14, P700 Leary, C. K...... P665 Kung, A...... O145, O170, P572 Lederhandler, S...... O16 Kuokkanen, S...... O205 Lederman, M...... P256, P422, P623, P704 Kuramoto, T...... P670 Lee, A. J...... P598 Kuroda, K...... P329 Lee, A. M...... O242 Kuru Pekcan, M...... P357 Lee, C.I...... P74 Kushnir, V. A...... P4, P5, P272, P568, P581, P591, P600, Lee, D...... P578 ...... P645, P687, P692, P693, P703 Lee, H...... P49, P77, P125 Kuspinar, G...... P50, P549 Lee, H.L...... P150, P157 Kuwahata, A...... P606, P647, P656 Lee, I...... P412 Kuzeljevic, B...... P602 Lee, J...... P77, P213, P641 Kuznyetsov, V...... P507 Lee, J. A. . . . . O60, O174, O176, O180, O219, O261, P29, P171, Kwak, S...... P263, P317, P555 ...... P178, P191, P214, P236, P241, P254, P256, P259, P262, KwakKim, J...... O253, P285, P365 ...... P294, P320, P323, P370, P422, P561, P611, P612, P623, Kwon, H...... P378 ...... P652, P666, P704 Kwon, S...... P365, P578 Lee, J.H...... P360 Kyono, K...... O84, P393, P519 Lee, J.W...... P199, P589 Kyoya, T...... P648, P673 Lee, K...... P35, P286, P293, P641 Laib, A...... P553 Lee, K. L...... P642 Laknaur, A...... O2, O237 Lee, K.A...... P221 Lakshmanan, G...... O22 Lee, K.H...... P263, P317, P555, P595 Lalic, N...... P511 Lee, M. M...... O21 Lalioti, M. D...... O122 Lee, M. S...... O101 Lam, J. S...... P187 Lee, M.H...... P395 Lamb, D. J...... O19, P337, P349 Lee, M.S...... P74 Lambert-Messerlian, G...... P379 Lee, S...... O156, P35, P213, P286, P293 Landis, J. N...... O56, P225, P475 Lee, S. S...... O156 Lang, W...... P416 Lee, S.K...... P199, P589 Lange, A...... P13 Lee, T.H...... P74 Lansdowne, L...... P525 Lee, W...... P49, P125, P209, P578 Lao, M...... P70 Lee, W. D...... P92 Laoreti, A...... O157 Leech, A. A...... O184 Lapensee, L...... P592 Leeners, B...... P19 Laqqan, M. M...... P322, P705 Legro, R. S...... O265, P48, P384 Large, M...... O46, P141 Lei, Z...... O227 Larman, M...... O7 Lekovich, J. P...... O41, O54, P202, P247, P702 LaRocque, K. A...... O127 Lemkaddem, A...... P19 Larreategui, Z...... P274 Lemma, T...... P541 Laskin, C. A...... P359, P630 Lenhart, N...... P392 Lathi, R...... O44, P143, P331, P425, P569 Leocata Nieto, F. A...... P220 Lattes, K...... P89 Leondires, M. P...... O222, P181, P498 Lau, B. D...... P690 Leone Roberti Maggiore, U...... O239, P437, P459, P469 Laue, H...... O247 LeSaint, C...... P508 Laurent, L. C...... P683 Lessey, B. A...... O25, O232, P299, P434, P440 Laven, J. S...... O26 Letourneau, J...... O75, P44, P54, P55, P69

nd 72 ASRM Scientific Congress & Expo 252 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Letterie, G...... P80 Liu, K...... P630 Leung, A...... P230 Liu, L...... P650 Leung, P. C...... P458 Liu, S...... P464 Leung, T...... P614 Liu, X...... O234, P447, P454 Levanduski, M. J...... P678 Liu, Y...... O124 Levens, E...... P170, P208, P570 Liu, Z...... O267 Levi Setti, P...... P533 Lizneva, D...... P398, P414 Levy, M...... O88, P160, P236, P605 Llacer, J...... P124, P149 Lewis, E. I...... P428 Lledo, B...... P124, P149 Lewis, T. D...... P605 Lo Menzo, F...... P681 Li, F...... P126 Lo Turco, E. G...... P407, P547 Li, J...... P185 Lo, J...... O96 Li, L...... P334, P405 Lo, K...... O153 Li, M...... P336, P650 Lonczak, A...... O56 Li, P. S...... O103, P492, P497 Londra, L. C...... P173 Li, S...... O187 Long, Q...... O234 Li, S. J...... O131, P574 Lopez, L...... P617 Li, S. W...... P334 Lopez Bayghen, E...... P529 Li, X...... O227, P96, P185, P267, P383 Lorenzi, D...... P211, P333 Li, Y...... P283 Lorenzo, F...... O74 Li, Y.J...... P159, P198 Loup, V...... P564 Liang, X...... O30, P96, P185 Lowther, K...... O122, O133, O136, O172 Liang, X.Y...... P43, P179, P515, P526 Lu, C.W...... P494 Libby, V...... O65, P269 Lu, R.P...... P244 Librach, C. L...... P359, P507 Lu, S...... P134, P147 Licciardi, F...... O156, P138, P700 Lu, Z...... O53 LiChern, P...... P528 Lubimkina, E...... P246 Lieber, C...... P708 Lucas, F. L...... P498 Liebermann, J...... O149 Lujan, S...... O196, P328 Lilienthal, D. P...... P702 Luk, J...... P594 Lim, H.S...... P445 Lukaszuk, A...... P41 Lim, J. H...... P92 Lukaszuk, K...... P41 Lim, K...... P445 Luke, B...... O256, P166, P169, P193, P196, P586 Lim, R. M...... P561 Luna, M...... P171, P191, P262 Lin, B...... O227 Luo, S...... O53, O267 Lin, J...... P135, P458 Lusignan, M.F...... P319 Lin, P. C...... O222, P181 Luu, T...... P454 Lin, W. Y...... P480 Lynch, A. M...... O251 Lin, Y.L...... P275 Lynch, M. E...... O116, P58 Lin, Y.M...... P494 Lyons, S...... P644, P653, P667, P676 Linas, B. P...... O184 Lyttle, B. M...... O77, P163 Lindheim, S. R...... P238 Lyu, Q...... O62, O258, P633 Lindner, P...... P605 Ma, L...... O199 Link, M...... P203 Ma, S...... P344 Linn, J...... P85 Maas, K...... P387 Lipshultz, L. I...... P349 Macanas, E...... P150 Lischer, R...... O193, P513 Maccari, V. M...... P249 Lischer, R. J...... O198 Machaj, A. S...... P117 Lisonkova, S...... P626 Machida, M...... P519 Liss, J. R...... P372 Maciel, G...... P686 Liu, E...... P118, P136, P140, P699 Mackens, S...... O115 Liu, G...... P515, P526 MacLachlan, V. B...... O129, P613 Liu, H...... O53, O267 Madrigal, V...... O79 Liu, J...... P135, P649 Madrigal, V. K...... P383 Liu, J. P...... O265 Maekawa, S...... O84

nd 72 ASRM Scientific Congress & Expo 253 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Maghraby, H...... P81 Mathews, J...... O149 Magnus, M...... O203 Mathur, A...... P61 Maguire, C. A...... P428 Matin, M...... P236 Maguire, M...... P448 Matsubayashi, H...... P53, P232, P316, P367, P500, P510 Mahalingaiah, S...... P399 Matsumoto, Y...... O42 Mahey, R...... P588 Matsunaga, R...... P606, P647, P656 Mahfoudh, A...... O137 Matsuura, M...... O42 Mahony, M. C...... O128, O132, P234, P628 Matthews, L. R...... O107 Mainigi, M. A...... O206, O252, O260 Matthews, M...... O40, P530 Maisenbacher, M. K...... P142 Mauner, A. L...... P73 Maithripala, S. I...... P117, P626 Mauri, A. L...... P675 Majidi Zolbin, M...... P433 Maxson, W...... O57 Majzoub, A...... O113, P340, P499, P516 Maxwell, R...... P238 Maldonado-Rosas, I...... P544, P640 Maxwell, S. M...... P118, P264, P709 Malik, M...... O236, O240, P465, P466 May, W...... P302 Malinowska, I...... P41 Mayer-Davis, E...... P416 Malizia, B. A...... O49 Mazaki-Tovi, S...... P554 Malpani, S...... P218 Mazmanian, K...... P145 Malysheva, M...... P246 Mazur, D. J...... O197, P20 Mamillapalli, R...... O124, P439, P444, P453 McAvey, B...... P612, P652 Man, L...... O5 McCaffrey, C...... O58, O173, P99, P150, P157 Manconi, F...... P436 McCallie, B. R...... O59, O161, O221, O233 Mancuso, A...... O255, P576, P625 McCann, C. R...... P80 Mandve, P...... P410 McClennen, E. L...... O244 Mangelson, G...... P10 McCormick, S...... O48, O127 Mankus, E. B...... P330 McCoy, R. C...... P143, P569 Manoharan, A...... P321 McCulloh, D. H...... O95, O156, O216, P99, P101, P107, Mansfield, M. R...... O50 ...... P118, P136, P150, P157, P217, P709 Mara, K...... P276 McEvoy, M...... P72 Marcos, J...... P180 McGee, E...... P25 Margolis, D...... O79 McGovern, P. G...... P320, P422 Mariani, B...... P144 Mckinnon, C...... O195 Marin, D...... O190, P712 McLernon, D. J...... P598 Maris, E...... O175 McQueen, D...... O149, O243, P622, P691 Markham, R...... P436 McReynolds, S...... O48, P654 Marks, S. H...... O111, P501 McWilliams, K...... P114 Marquis, K...... O192 McWilliams, T. K...... P114, P138 Marriott, L...... P481 Mead, T. J...... P468 Marsh, E. E...... O238, P24 Meadows, J. W...... O163 Marsh, P...... P480 Medina III, M...... O33 Marshburn, P...... O40, P530 Medrano, J. V...... O191 Martens, M...... P28 Meier, U. T...... P620 Martin, J...... O96, P580, P590 Meislin, R. J...... P361 Martinez, F...... P194 Meldrum, D. R...... P183 Martinez, J...... O196, P328 Melechco Carvalho, V...... P505 Martinez, P...... P291 Meligy, F. Y...... O209 Martini, A...... P624 Mellembakken, J...... P686 Martins, W...... P491 Melnick, A. P...... P202 Maruniak, K...... P335 Mendiola, J...... P502 Mas, A...... O2, P470 Mendola, R. J...... P120 Masbou, A. K...... P99, P101, P709 Mendoza, G...... O238, P24 Maslow, B.S. L...... O143, P270 Meng, F...... P620 Mason, J. B...... P358 Mensah, V...... P45 Massahi, N...... P131, P152 Merdassi, G...... P59 Massart, P...... P423 Merhi, Z...... O189

nd 72 ASRM Scientific Congress & Expo 254 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Merriam, K...... O40, P530 Monseur, B. C...... P690 Merrion, K...... P142, P706 Montag, M...... P552 Mersereau, J. E...... O77, P27, P163, P558 Montagnini, H. L...... P30 Mertens, A...... P63, P66 Montani, D. A...... P547 Merz, M...... O15 Monteleone, P. A...... P231 Meseguer, M...... O225, P87, P180, P313, P534, P535, P662 Montorsi, F...... O162, P493 Mesen, T. B...... O77 Moody, M. A...... P354, P523 Messerlian, C...... O1, P13, P477, P537 Moon, J...... O137 Meuleman, C...... P430, P436, P452 Moon, J.W...... P409, P442 Miao, B...... P377, P584 Moon, K...... O244 Micic, S...... P511 Moore, A. K...... O248, P203 Mielnik, A...... O198, O228, P350, P352 Morales, R...... P149 Miguens, M. B...... P211 Moravek, M. B...... P64 Miguez, J. M...... O191 Moreno, I...... O28, O191 Mikhail, E...... O108 Morey, R...... P683 Miki, T...... O160, P239, P306, P324, P629, P643 Moridi, I...... P444, P453 Milad, M. P...... O107, P311 Morimoto, Y...... O264 Miles, K. F...... O178 Kim Milki, A. A...... P425 Morin, S. J. . . . .O47, O63, O166, O223, O259, O263, O270, P78, Miller, B...... O27, O222, P181 ...... P225, P243, P287, P448, P475, P-548, P621, P669, P707 Miller, C. E...... O214, P301 Morin-Papunen, L...... P686 Miller, K...... P663, P680 Morita, M...... P587 Miller, N...... P417 Moriyama, A...... P587 Milligan, K...... O57 Morris, P. L...... P345 Mills, B. B...... O17 Morris, R...... O8, P52 Milman, L. W...... P390 Morrison, L...... O259 Minasi, M...... P104 Morrison, L. S...... O11 Miner, S. A...... O153 Morriss, A. M...... P561 Minguez-Alarcon, L...... O1, O21, O67, P8, P477 Moschella, J...... P553 Mio, Y...... O208, P215, P661 Moschetta, M...... P617 Miorin, J...... P231 Moschini, R. A...... O261 Mirabal, S...... P387 Moss, J...... P20 Mirisol, R...... P231 Mostafa, M. I...... P81 Missmer, S. A...... O101, O224, P62, P224, P399, P460, P546, Motan, T...... O142 ...... P560, P627, P688 Motta, E...... P30, P280, P404, P593 Mitchell, L...... P345 Mottla, G. L...... O128, O132, P234, P628 Mittal, S...... O228, P350, P352 Mounts, E...... O145, O170, O213, P115, P146, P572 Miura, M...... P606, P647, P656 Moy, F...... O134 Mizoguchi, C...... O208, P215 Mskhalaya, G...... P246 Mizumoto, S...... P670 Mu, L...... O78 Mizuta, S...... P53, P232, P316, P500, P510 Muasher, S. J...... O131, P574 Mniarji, V...... P431 Mukai, M...... O42 Modelski, M...... O11 Mukerji, B...... O167 Mohamed, N...... P253 Mukherjee, G...... P410 Mohamed, S. A...... P57 Mukherjee, T. . . O174, P171, P191, P256, P262, P611, P612, P623 Mohan, A...... P248, P451 Mukovtsev, S...... P507 MokLin, E...... O75, P69 Mullen, T...... P122 Mol, B. W...... O269 Mullet, T...... O175, P296 Molakatalla, S...... P72 Mullin, C...... P698 Moley, K...... O247, P281, P284, P427 Mumford, S. L...... O242, O251, P161, P173, P689 Molina, I...... O196, P328 Munch, E. M...... O255, P576 Molina, J...... P86 Mundy, S...... P706 Molinaro, T. A...... O51, O120, O217, O263, P78, P225, P265, Muneyyirci-Delale, O...... P431 ...... P287, P448 Munkwitz, L. A...... P424 Monnier, P...... O76

nd 72 ASRM Scientific Congress & Expo 255 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Munne, S. . . O46, O53, O57, O58, O73, O145, O147, O170, O173, Ninchritz, E...... P573 ...... O212, O267, P102, P108, P115, P118, P120, P136, Nishiyama, R...... P53, P232, P316, P367, P500, P510 ...... P146, P151, P291, P541, P572, P699 Nisson, H...... P115, P151 Munoz Garcia, M...... P266 Niu, Z...... P283 Munoz, E...... P658 Nodar, F...... P211 Murakami, M...... P670 Noel, M...... O182 Nabli, H...... O188 Nohales, M...... P87 Nachtigall, L. E...... P361 Nonez, H...... O261 Nachtigall, M. J...... P361 Noordam, M. J...... O23 Nagao, K...... P519 Norberg, C...... P655 Nagayoshi, M. . . . . O159, O160, P239, P306, P324, P629, P643 Norian, J. M...... P140, P145 Nagirnaja, L...... O23 Norman, R. J...... O269 Nagy, Z. P...... P85 Norton, E. L...... O178 Najari, B. B...... O103, O110, O193, P492, P495, P497, P513 Notarangelo, L...... P479 Nakajo, Y...... P393 Novotny, J...... P531 Nakamura, Y...... P668 Novotny, M...... O100 Nakaoka, Y...... O264 Noyes, N...... O152, P99, P101, P107 Nakata, K...... P521, P659 Nulsen, J...... O143, O222, P181, P270, P551 Nakayama, K...... P682 Nurudeen, S. K...... P79 Nal, E. E...... P325 Nyachieo, A...... O266 Namekawa, S. H...... P636 O, D...... P430, P436, P452 Nanassy, L...... P158 O’Brien, Y...... O117 Nasioudis, D...... P376 O’Connor, D...... P602 Nassan, F...... P8 O’Neill, K...... O252, P697 Nassar, J...... P42 Obata, R...... O84, P519 Nasseri, A...... P699 Obidniak, D...... P75 Nassr, A. A...... P303, P305 Oborna, I...... P531, P608 Natan, Y...... P88, P533 Ochi, M...... P647, P656 Navarrete, G. R...... P642 Oehninger, S...... P657 Navarro, P. A...... P491 Ojeda, M...... P658 Navarro, V. M...... P428 Oka, N...... O84, P519 Nayar, K. D...... P248, P451 Okada, K...... P345 Nazem, T. G...... P112, P709 Okamoto, N...... O4 Neal, S...... O47, O270 Okeigwe, I...... P536 Needleman, D...... O172, P651 Oktay, K. H...... O134, P67 Neggers, S. J...... O26 Oktem, O...... O118, O201, P368 Neitzel, D...... P148 Okuyama, N...... P519 Nelson, A...... O15 Olcha, M...... O259 Nelson, J...... P145 Olivares, R...... P157 Nelson, J. K...... O230, P432 Oliveira, J. A...... P675 Nelson, S. M...... O203, P229 Oliveira-Pelegrin, G. R...... P675 Nematian, S. E...... P439 Oliveira-Silva, D...... P547 Nervi, L...... O217 Omar, M. K...... O237 Neto, F...... O103, O110, P492, P495, P497 Omurtag, K...... O181 Neuber, E...... P551 Ondryasova, H...... P608 Newton, C...... P205 Oneta, M...... O157 Ng, E...... O265 Orazi, L...... P479 Nguyen, A...... O190 Ord, T...... O206, O260 Nguyen, E...... P204 Oromendia, A...... P443 Nguyen, J...... P155 Oromendia, C...... O110 Nguyen, K...... P365 Oron, G...... P167 Nguyen, L. K...... O269 Ortega, I...... O115 Nicolais, O. L...... O254 Ortiz Maffei, N...... P211 Niederberger, C...... P342, P351, P355 Ortiz, J...... P124 Nieman, L. K...... P466 Ortiz, J. A...... P149

nd 72 ASRM Scientific Congress & Expo 256 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Osianlis, T...... P153 Parrella, A...... O194, P490 Ostermeier, G. C...... P354, P523 Parry, J. P...... P302 Ostrowski, K...... P506 Parsons, P...... P481 Othman, E. R...... O209 Pastuszak, A. W...... P349 Otsubo, H...... P670 Patel, A...... P642 Otsuki, J...... O42 Patel, B...... P203, P338 Ouyang, Y...... P267 Patel, S...... P177, P696 Owen, C. M...... O90, O126, P111, P170, P174, P419 Patounakis, G...... P160, P170, P208, P570 Ozdemir, U...... P325 Patrizio, P...... P332, P533 Ozer, A...... P386, P406 Paulson, R...... O139, O150, O186, P103, P137 Ozerkan, K...... P50 Pavone, M...... O185, P218, P536, P664 Ozkavukcu, S...... P473 Pavone, M. E...... P64 Ozkok, B. A...... P201 Pavone, M. G...... P22 Ozler, S...... P402 Pawelczyk, L...... O92 Ozmen, B...... P312 Paz, M. V...... P681 Oztas, E...... P402 Peavey, M...... P375, P563, P680 Pacaud, B...... P380 Peck, J. D...... O18, P17 Pacheco, F. S...... P67 Pelczar, D. M...... P356 Paduch, D...... O193, O198, O228, P326, P350, P352, P513 Pell, J...... O203 Paek, S...... P578 Pellicer, A...... O115, O166, O196, P313, P328 Pagidas, K...... O227, P408 Peng, B...... P458 Pak, K.A...... P199, P589 Penrose, L...... O61, P514 Pakhalchuk, T...... P56, P119 Penzias, A...... O38, P387 Palaniappan, S...... P625 Penzias, A. S...... P230 Palatchi Cohen, C...... P23 Peregrino, P. F...... P231 Palermo, G. D...... O112, O158, O194, P212, P222, P489, Pereira, N...... O41, O54, O112, P202, P212, P222, P247, ...... P490, P504, P520 ...... P504, P520, P632, P702 Palma, A. E...... P534 Perez, M...... P658 Palmor, M...... P161 Perez, O...... P642 Palomaki, G. E...... P379 Perfumo, P...... P681 Palomino, W. A...... P299, P450 Perkins, A...... O111, P501 Palter, S...... O69 Perkins, N...... O251 Palter, S. F...... P313 Perloe, M...... O58 Palumbo, A...... P308 Perrier d’Hauterive, S...... P557 Pan, J.X...... P403 Perumal, V...... P314 Pan, S...... P496 Petersdorf, K...... O235 Pan, Y...... P553 Peterse, D. P...... P430, P436, P452 Paniza, T...... O194, P490 Petersen, C. G...... P675 Paolino, N. C...... O12 Petersen, P. G...... P231 Papier, S...... P211, P333 Peterson, C. M...... O248, P203 Papkov, G...... O178 Petrini, A. C...... P632 Paplomata, E...... P63 Petrozza, J. C...... P242, P477 Parent, J...... O154 Peyser, A...... P553, P698 Parfitt, D.E...... O27, P443 Pham, T. D...... O269 Park, H...... P213 Phan, J...... P383 Park, I...... P595 Phillips, S...... P190, P508 Park, J...... P263, P317, P555 Picklesimer, A. H...... O17 Park, J.H...... P221, P405 Picou, A...... P155, P156 Park, J.Y...... P442 Pierce, M. K...... O51 Park, K.S...... P221 Pihoker, C...... P416 Park, L...... O5 Pilato, A...... P472 Park, M...... P49, P378, P619, P641 Pimentel, R. N...... P39 Park, S...... O192 Pinkas, H...... P167 Park, S.Y...... P199, P589 Pirkevi Cetinkaya, C...... P113, P325, P327, P552 Parks, J. C...... O48, O59, O161, O221, O233 Pisarska, M. D...... P186

nd 72 ASRM Scientific Congress & Expo 257 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Place, J. S...... P11, P694 Ramirez, V...... P180 Plosker, S. M...... O108 Ramos, E. E...... O11 Plowden, T...... O242 Ransom, M. X...... O10 Plowden, T. C...... P570, P689 Rao, K...... P83 Pluchino, N...... O124 Rapelje, C...... P345 Pluijm, S. M...... O26 Rappolee, D. A...... P476 Polackwich, A. S...... O113 Rasheed, S. M...... P449 Pollard, J. W...... O205 Rasmussen, R...... O248 Polotsky, A. J...... O68, O70, O165, O249, P40, P374 Rassaby, L...... O12 Porcu, E...... P479 Rauch, E...... O151 Portela, S...... O115 Rausch, M...... O212 Portmann, M. P...... P84 Ravichandran, K...... O58, O170, O173 Pospisil, C. B...... O50 Rayward, J...... P617 Powell, T...... O68 Ready, K...... P708 Powell, T. L...... O70 Reape, K...... P557 Pras, E...... P711 Reay, M...... P481 Prates, R...... O212, P138, P146 Rebel, M...... P205 Prenni, J...... P653, P667 Rechitsky, S...... P56, P117, P119, P132 Presson, A...... P338 Reed, B. G...... O65, P269 Prewitt, M. M...... O116, P58 Rehmer, J. M...... O111, P501 Price, T. M...... O262 Reichman, D. E...... O87, P100, P326 Prien, S...... O61, P514, P671 Reis, F. M...... P71 Proctor, G...... P538 Reisz, J. A...... O221 Prokhorovich, M...... P56, P119 Reiter, T...... P382 Prosser, R...... O125 Rellini, A...... P25 Prough, S. G...... O147 Remohi Gimenez, J...... O225, P534, P535, P562, P590, P662 Provost, M. P...... O262 Ren, H...... P344 Prusinski, L...... P470 Ren, X...... O235 Przewlocki, M...... P9 Renzi, A...... P675 Puig, O...... P321 Resetkova, N...... O38, P230 Puscheck, E. E...... P90, P476 Revel, A...... P252 Qadri, F...... O135, P52 Revich, B. A...... O21 Qian, K...... P289 Rey Valzacchi, G...... P220 Qiao, J...... P147 Rezk, M...... P571 Qu, F...... P403 Ribustello, L. . . . O43, O46, O73, P102, P118, P136, P140, P699 Quaas, A...... P204, P582 Ricci, J...... P675 Quant, C...... P186 Rich, C...... O155 Quinn, M...... O71, P44, P54, P55, P69, P384, P392, P604 Richards, E. G...... P277 Quinones, R...... P480 Riche, D. M...... P302 Quintana, F...... P274 Rich-Edwards, J...... P399 QuintanillaVega, B...... P529 Richter, K. S...... O88, O128, O132, O244, P111, P170, P174, Raberi, A...... O45, P525 ...... P208, P234, P419, P605, P628 Raburn, D. J...... O262 Rienstein, S...... P711 Racca, A...... O239, P437, P459, P469 Riestenberg, C...... P425 Racowsky, C. . . . . O6, O57, O73, O224, P140, P224, P546, P560 Rinehart, L...... O8 Radin, R...... O251 Riqueros, M...... P86 Ragonesi, G...... O114 Rivas, K...... O33, O104, O106 Raj, R...... P25 Rivera Egea, R...... O72, P590 Rajakumar, A...... P279 Roberts, C. P...... P60 Rajchel, J...... O259, P475 Robertshaw, I...... O29 Rajendiran, K...... O68, O70 Robins, J...... P536, P664 Ramaiah, M...... O138 Robinson, K...... P123 Ramasamy, R...... O109, O226 Robinson, L...... P217 Rambhia, P...... P105 Robinson, L. G...... P39, P483, P487 Ramirez, E...... O79 Robinson, R. D...... P93, P250, P545, P550

nd 72 ASRM Scientific Congress & Expo 258 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Robles, A...... O34, P100 Sad Larcher, J. M...... P249 Rodrigues, F. P...... P280 Sadeghi, S...... O196 Rodrigues-Oliveira, A...... P547 Sadowy, S...... O43, O125 Rodriguez, A...... P275 Saed, G. M...... O31, O168, P37 Rodriguez, D...... P194 Safier, L. Z...... O183, P684 Rodriguez, I...... P194 Saha, I...... P290 Rodriguez, S...... O12, P700 Sahin Ersoy, G...... P433, P453 Rodriguez-Purata, J. . . . . O60, O174, O176, O180, O219, O261, Sahin, Y...... P251 ...... P171, P178, P191, P214, P241, P254, P259, P262, Sahoo, T...... P116 ...... P294, P323, P370, P611, P612, P623, P652, P666, P704 Saiki, K...... P25 Roeca, C. M...... O184 Saini, S...... O245, P412 Rogel, R...... O196 Saito, H...... P278 Rogers, M...... P506 Saito, S...... P648, P673 Roman-Rodriguez, C. F...... P380 Saji, F...... P668 Romany, L...... O225, P535 Sakakibara, K...... O148 Romero, J...... P313, P534 Saketos, M...... P601 RonEl, R...... P88 Sakkas, D. . . . .O38, O155, O172, P189, P230, P236, P356, P387 Rooney, K...... O155, P236 Salazar Garcia, M. D...... O253, P285, P365 Roque, M...... O179, P95 Salem, H...... O105 Rosales, J. C...... P23 Salem, W...... O150, O186, O199, P103, P137 Rosberger, Z...... O153 Salih, A...... P634 Rosen, A. M...... O58 Salonia, A...... O162, P493 Rosen, K. A...... O15 Samanta, L...... P347, P524, P556 Rosen, M...... O75, P44, P54, P55, P69, P480, P614 Sammel, M...... P390 Rosenbluth, E...... O64, P129 Sammel, M. D...... O116, O254, O257, P58, P300 Rosenfeld, J...... O170 Sampaio, M...... O179, P95 Rosenwaks, Z. . . . . O5, O34, O41, O54, O87, O89, O112, O158, San Ramon, G...... P56, P119, P132 ...... O194, P100, P202, P212, P222, P223, P247, P326, Sanchez Sarmiento, C...... P373 ...... P418, P429, P489, P490, P504, P520, P575, P655, P702 Sanchez, T...... O172, P651 Ross, R...... P130 Sandberg, J...... O248 Rothman, K. J...... O195 Sandler, B...... O174, O176, O180, O261, P171, P191, P214, Roudebush, W...... P353 ...... P256, P262, P323, P370, P611, P612, P666 Rouleau, J. P...... P308 Sandlow, J...... O9, O97 Rouzi, A. A...... P309 Sanjeeva Reddy, N...... O177 Rowan, J. P...... O229, O232, P434, P440, P455 Sano, K...... O148 Roychoudhary, S...... P488 Santamaria, X...... O231 Roychoudhury, S...... P499, P503, P516, P544, P640 Santistevan, A...... P181, P611 Royo, P...... O39 Santoro, N...... P48, P363, P374, P384 Rozis, G...... P525 Santos, R...... P23 Rubino, P...... P145 Sapir, O...... P167 Rubio, C...... O72 Sarasa, J...... P291 Rubio, J...... O196, P328 Sarda, V...... O6 Rude, T...... P518 Saribal, S...... P549 Rudolph, M. C...... O165 Sarma, M. K...... O79 Ruiz De Assin, R...... P145 Sasaki, K...... P301 Runge, A...... P614 Sasson, I...... O244, P84, P369 Ruthazer, R...... P230 Sato, D...... P603 Ryan, G...... P625 Sato, Y...... O4 Rybkin, I...... P610 Satoh, M...... O264 Ryu, M. J...... P133 Satriani, K...... O43 Saad, A...... P571 Sattar, N...... O203 Sabanegh, E. S...... O113, P503, P516 Saucier, J...... P706 Sabatini, K...... P683 Sauer, M. V...... O43, O125, O183, P684 Sacha, C. R...... P224, P460 Savasi, V...... O157 Sachdev, N. M...... P118, P136, P264, P361, P483, P487 Sawarkar, S. S...... P102

nd 72 ASRM Scientific Congress & Expo 259 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Saxena, M...... P248, P451 Seitz, C...... O235 Sayed, A. A...... O209 Sekhon, L. . . . O60, O174, O176, O180, O219, P112, P171, P178, Sayles, H...... O111, P501 ...... P191, P214, P241, P254, P256, P259, P262, P294, Scala, C...... O239, P437, P459, P469 ...... P323, P370, P611, P612, P623, P652, P666, P704 Scalici, E...... O141 Seli, E...... O122, O133, O136, O172 Schattman, G. L...... O5 Selter, J. H...... P690 Schembri Deguara, C...... P446 Senapati, S...... O206, O254, O257, P36 Schenken, R. S...... P93, P250, P330, P545, P550 Senra, J. C...... P71 Schertz, J...... P31 Seppan, P...... O22 Schickler, R...... O108 Serafini, P. C...... P30, P593 Schiewe, M. C...... P76, P106, P168, P258 Sergeyev, O...... O21 Schiffman, M. R...... O156 Sermondade, N...... P68, P260 Schindler, K...... O190 Serna, J...... O39, P180 Schirmer, D. A...... P60 SethSmith, M...... O95, P217 Schisterman, E...... O251 SethSmith, M. L...... P483, P487 Schlegel, P. N...... O103, O198, O228, P350, P352 Setti, A. S...... P420 Schlenker, T...... P653 Setton, R...... P418 Schmelter, T...... O15 Seval, M. M...... P312 Schmidt, J...... P706 Seyhan, A...... O118 Schmidt, R...... P699 Sha, H...... P283 Schneider, R. J...... O3 Shabtaie, S. A...... O226 Schneiderman, A...... P335 Shaeib, F...... O135, O210, P52 Schnell, V...... P131 Shah, D...... P117, P625 Schniers, B...... P671 Shah, D. K...... P300 Schnorr, J...... O222, P181 Shah, J...... O66, P61, P79 Schoolcraft, W. B. . . . .O48, O50, O59, O127, O161, O207, O221, Shah, M...... P331, P425 ...... O233, P73, P97, P255, P335, P424, P435, P644, Shah, N. J...... P22 ...... P653, P654, P660, P667, P676, P679, P710 Shaia, K...... P254, P256, P294 Schoolmeester, J. K...... P277 Shaikh, S...... O124 Schoyer, K. D...... O9, O97 Shalaby, S. M...... P57 Schufreider, A...... O149, O243, P691 Shamma, F. N...... P126 Schulsinger, D...... P509 Shamonki, M...... P336, P650 Schulte, M. M...... P281, P284 Shandley, L. M...... P63, P66 Schutt, A...... O91 Shapiro, A...... P5, P692, P693 Schwartz, D...... O68 Shapiro, B. S...... P12, P197 Schwartz, D. A...... O70 Shapiro, D...... P85, P140 Schwefel, B...... O229, O232, P434, P440, P455 Sharara, F...... O246, P207, P512, P597 Schweitz, M...... O48, P654 Sharara, F. I...... P674 Scott III, R. T...... O56, P128 Sharma, J. B...... P588 Scott, B...... P84 Sharma, N...... P248 Scott, K...... O270, P128 Sharma, P. A...... P359 Scott, R. T...... O47, O55, O63, O166, O169, O215, O223, Sharma, R...... O113, P340, P347, P486, P488, P503, P516, ...... O259, O263, O270, P78, P127, P128, P225, P243, ...... P544, P640 ...... P287, P448, P475, P548, P621, P669, P707, P712 Sharma, S...... P290, P410 Scout, S...... P688 SharpeTimms, K. L...... O188 Sdrigotti, A...... P220 Shaulov, T...... P261 Seaman, E...... P354 Shavit, T...... O171, O218, P82, P182 Seckin, B...... P357 Shazly, S. A...... P303, P304 Sedan, O...... P164 She, E...... O69 Seehuus, M...... O154, P25 Shefer, G...... P65 Segal, T...... P6 Shehata, A...... O105 Segars, J...... O126, O236, O268, P465 Shen, J...... P282, P295 Sehnert, S...... P14 Shenoy, C. C...... O37, P413, P438 Seidman, D...... P711 Shepherd, J. P...... P307 Seifer, D...... P389 Shepherd, K...... P187, P205

nd 72 ASRM Scientific Congress & Expo 260 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Sherbahn, R...... P172 Skaznik-Wikiel, M. E...... O165, P40 Sheynkin, Y...... P509 Skubisz, C. M...... P2 Shi, S...... O202 Slayden, O. D...... O14, P15, P18, P394 Shi, Y...... O30, P43, P179 Slifkin, R...... O261, P214, P256, P323, P666 Shikanov, A...... O123 Slutsky, E...... P126 Shim, J.Y...... P445 Smigulina, L...... O21 Shim, S...... P125 Smith, A...... P229 Shin, D...... O20 Smith, G. D...... P144, P210 Shin, J...... P213 Smith, K. N...... O185, P24, P64 Shin, S.H...... P199, P589 Smith, M...... O152 Shin, T...... P342 Smith, M. B...... O250 Shinohara, K...... P603 Smith, M. E...... P412 Shiotani, M...... O42 Snabes, M. C...... P457 Shirlow, R. H...... P613 Sniukiene, V...... O268 Shockley, M...... O104 Soderborg, T. K...... P40 Shockley, M. E...... O33, O106 Şœkœr, Y...... P312 Shoshany, O...... P351, P355 Soliman, A. M...... O229, O230, P432, P457 Shraga, R...... O200, O241, P321, P594, P700 Somers, F...... P557 Shreck, E...... P509 Somkuti, S. G...... P540 Shufaro, Y...... P167, P252 Son, W.Y...... O76, O137, O171, O218, P47, P82, P182, P245, Shulman, A...... P417, P554 ...... P257, P261, P318, P319 Shulman, L. P...... P56 Song, H...... P395, P615, P619 Shwayder, J. M...... P302 Song, S...... P405 Sibai, H...... P81 Sonigo, C...... P68 Sidell, N...... P279 Sonmezer, M...... P312 Siegel, C...... O36 Soong, Y.K...... P298 Sierra, S...... P359 Sorby, K...... P153 Sifer, C...... P260 Soriano, M...... O196 Sigman, M...... O24 Soto, E...... P454 Silva, C...... P177, P696 Souter, I...... P242, P537 Silva, E...... P676 Soylemez, G...... P471 Silver, A. J...... P561 Spaczynski, R. Z...... O92 Silver, L. M...... P561 Spades, C...... P186 Silver, M. J...... P561 Spandorfer, S. D...... O34, O89, O151, P376, P429, P632 Silver, R. M...... O251 Sparks, A. E...... O69 Silverberg, K...... P155, P156 Spath, K...... O45 Simmons, C. F...... P186 Spector, L. G...... O256 Simmons, R...... O252 Spencer, J...... P63, P66, P279 Simon, C...... O28, O72, O115, O191, P280 Spinella, F...... P104 Simon, J...... O232, O268, P455 Sprague, M. L...... O33, O104, O106 Simoni, M...... O78 Spratt, D. I...... P498 Simpson, A...... P354, P523 Sroga, J. M...... O29, P636 Simpson, S...... P238 Srouji, S...... P224 Singer, S. A...... P307 Stanczyk, F. Z...... O139, O163, O199 Singer, T...... O58, P698 Stein, D. E...... O176, O180, P256, P320, P422 Singh, N...... P314, P616 Stein, P...... P19 Singh, T...... O167 Stein, Q...... O213 Singhal, P...... P484 Steiner, A. Z...... O77, O163, O164, P163, P362 Sinha, N...... O75, P44 Steinkampf, M. P...... O49 Sisti, G...... P376 Steller, C...... P301 Sites, C. K...... P567 Stelling, J...... P601 Sjaarda, L...... O251 StenerVictorin, E...... O265, P686 Skarbrevik, D...... O138 Stentz, N. C...... P300 Skariah, A...... P285 Stephens, C. S...... P281, P284 Skariah, A. M...... O253, P365 Stephenson, M...... P622

nd 72 ASRM Scientific Congress & Expo 261 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Stern, H...... P144 Taieb, J...... P42 Stern, J. E...... O249, P166, P169, P585, P586 Takacs, P...... O257 Stevens, J. M. . . O50, O127, P255, P335, P644, P653, P654, P667 Takae, S...... O4 Stewart, E. A...... P413 Takahashi, C...... P232 Stimach, C...... P138 Takahashi, H...... P195 Stone, B...... O103 Takahashi, T...... P278 Stone, L...... P57 Takano, T...... P668 Stouffer, R. L...... O121, P34, P382, P394 Takaya, Y...... P53, P232, P316, P367, P500, P510 Straseski, J...... O248 Takemoto, Y...... O159 Straseski, J. A...... P379 Takeshita, S...... P233 Strawn, E. Y...... O9, O97 Takeuchi, M...... P233 Strecker, M. N...... P116 Takeuchi, T...... O84, P519 Strickland, J...... P396 Tal, R...... O124, P389, P580 Stuart, T...... O252 Talim, M. C...... P71 Sturmey, R. G...... P665 Tamborlane, W...... P416 Styer, A. K...... O242, O249, P161, P689 Tamer, B. F...... P543 Su, I...... O16, P183 Tamimi, R. M...... P62 Su, Y. T...... P545, P550 Tamir Yaniv, R...... P417 Sugino, N...... P297 Tamura, H...... P297 Sugishita, Y...... O134 Tan, L...... P359 Suh, C...... P77 Tan, S...... P386 Sullivan, M...... O184 Tan, S. L...... P406 Sullivan-Pyke, C. S...... O254, P697 Tan, S.J...... P461 Sumi, C...... O42 Tan, T...... P145 Sumimoto, T...... O42 Tanaka, A...... O159, O160, P215, P239, P306, P324, P329, Summers, K. M...... P625 ...... P527, P629, P643 Sun, D...... P411 Tanaka, I...... P239, P306, P324, P629, P643 Sun, H...... P263, P282, P295, P317, P555, P595 Tanaka, K...... P670 Sun, Y...... P366, P474, P478, P609 Tanaka, M...... O148 Sundheimer, L. W...... P186 Tanaka, T...... O264 Sundstrom Poromaa, I...... P686 Tang, K...... P507 Sung, L...... P380, P601 Taniguchi, F...... P441 Sung, N...... O253, P285, P365 Tannus, S...... O171, O218, P182, P245, P318 Sunguroglu, A...... P646 Tanrikut, C...... P8, P502 Suo, L...... P226 Tao, X...... O55, O56, O169, O223, O259, P127, P128, P475 Surdo, M...... P104 Tarasconi, B...... O85, P42 Surrey, E...... O229, P73, P255, P432, P434, P435, P457 Tassin, R...... P336, P650 Surrey, M...... P146, P151 Tavares, R. L...... P71 Suturina, L...... P414 Taylor, B...... P602 Suturina, L. V...... P398 Taylor, D...... P109 Suzuki, N...... O4, O134 Taylor, D. M...... O190 Suzuki, R...... P648, P673 Taylor, H. S. . . . . O122, O124, O136, O172, O229, O230, O232, Svytka, S...... P484 ...... P433, P434, P439, P440, P444, P453 Swain, J...... P676 Taylor, J...... P33 Swain, J. E...... P660, P679 Taylor, S...... O45 Swain, N...... P347, P556 Taylor, S. M...... P139 Swan, S. H...... P502 Taylor, T. H...... P116 Sweet, C. R...... O178 Teal, S...... O70 Sweetnam, P. M...... P387 Teede, H...... O245 Swindle, D. C...... O165, P40 Teglas, G...... P158 Tabata, C...... P467 Teixeira da Costa, L. d...... P407 Taboas, E...... P658 Tejera, A...... P535 Tadros, T...... O85, P42 Tekpetey, F...... P187, P205 Tafi, E...... O239, P437, P459, P469 TelloMora, P...... P529 Taguchi, S...... P668 Tempest, H. G...... P522

nd 72 ASRM Scientific Congress & Expo 262 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Ten, J...... P124, P149 Uncu, G...... P549 Terakawa, N...... P441 Upham, K. M...... O263, P548, P669 Terry, M...... O199 Urich, M...... P126 Thakore, S...... P6, P176 Uriondo, H...... P211, P333 Thakur, M...... O135, O210, P90 Urman, B...... O118, O201, P368, P646 Thomas, J. W...... O229, O232, P434, P440, P455 Urman, D...... O201 Thomas, M. A...... O29, O79, P636 Usadi, R. S...... O40, P374, P530 Thomas, M. R...... P642 Vagnini, L. D...... P675 Thompson, E...... P394 Valcarcel, A...... O144 Thompson, M. E...... P84 Valdes, C. T...... O91, P680 Tiegs, A. W...... P264, P361 Vale, A. S...... P369 Tierling, S...... P322, P705 Valero, P...... P180 Tilley, B...... P642 Valle, M...... O179, P95 Tilling, K...... P229 Vallve, J...... O231 Ting, A. Y...... O121, P34 Van Deman III, J...... O17 Tirado, E...... P356 van den HeuvelEibrink, M. M...... O26 Tiveron, M...... O74 van der Kooi, A.L. L...... O26 Tkachenko, O...... O121, P34 van der Schouw, Y. T...... O94 Tobiasz, A. M...... O168 van Dorp, W...... O26 Tobler, K...... P130 van Dulmenden Broeder, E...... O26 Tobler, K. J...... P131, P152 Van Voorhis, B. J...... O255, P576 Tokmak, A...... P201 Vanhie, A...... P430, P436, P452 Tokoro, M...... P672 Vanijgul, C...... O66 Tokuhiro, K...... P639 Vanky, E...... P686 Toledo, A. A...... P85 Vassena, R...... P89, P423 Toloubeydokhti, T...... O16 Vaughan, D. A...... P230 Tomasino, J. R...... O7 Vaughan, L. E...... P276 Torelli, F...... P593 Vega, M. G...... O86, P165 Tortoriello, D...... O147 Ventimiglia, E...... O162, P493 Toth, T. L...... O67, P13 Ventura, V. B...... P681 Tournaye, H...... P557 Venturini, P...... O239, P437, P459, P469 Tran, K...... P144 Vereczkey, A...... P158 Travis, A. J...... P354, P523 Verheyen, G...... P557 Treff, N. R...... O55, O56, O169, O190, O215, O259, O270, Verjus, C...... P19 ...... P127, P128, P243, P475, P621, P712, P707 VerMilyea, M...... P155, P156 Trevino, L...... O2 Vernaeve, V...... P89, P423 Truong, T...... P159, P198 Verschuren, M...... O94 Tsai, T...... P91, P98 Victor, A. R...... P110 Tse, J...... O197 Victorino, A. B...... P407 Tsuji, H...... P672, P682 Vidal, C...... O115 Tsuji, Y...... O42 Vidali, A...... P703 Tsukada, K...... O4 Vigil, A...... P79 Tsukamoto, K...... P648, P673 Vigo, F...... P280 Tsuneto, M...... O208, P215 Vilella, F...... O28, P280 Tsutsumi, O...... P467 Villamayor, M...... O74 Tucker, M. J...... O88, P84, P160 Viloria, T...... O225 Tulandi, T...... O76, P257 Vilos, A...... P187, P205 Turk, P...... P50 Vincens, C...... O141, P296 Tyden, T...... P607 Vingataramin, L...... P508 Tzakis, A...... O104 Viola, J...... O74 Tzakis, A. G...... O32, O33O106 Viotti, M...... P110 Tzeng, C.R...... P461, P463 Virji, N...... P380 Uhler, M. L...... O149, O243, P624, P691 Virmani, A...... P38, P511 Uhlmann, R. A...... O168, P37 Virmani, M. A...... O114 Umbarger, M. A...... P122 Vitek, W...... O164, O249, P472

nd 72 ASRM Scientific Congress & Expo 263 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Vithoulkas, A...... P678 Weinerman, R. S...... O260 Vladimirov, I. K...... O115 Welch, C...... P541 Vollenhoven, B. J...... O129, P613 Wells, D...... O45, O57, O58, O173, O267, P139, P525 Volovsky, M...... O129, P613 Werlin, L. B...... P115 Von Wald, T...... O213 Werner, M. D...... O166, O169, O263, P243, P548, P669 Vrbkova, J...... P608 Wesselink, A...... O195 Vresilovic, J...... O206 Wessels, C. E...... O61 Vuong, L. T...... O269 Westemeyer, M...... P706 Wachs, D...... O64, P129 Whang, H...... P213 Wadwa, P...... P416 Whitcomb, B. W...... P170, P208, P570 Waelkens, E...... P452 Whitehead, C...... P243 Waggoner, K...... P76, P168 Whitehouse, M. C. . . O174, O219, O261, P191, P214, P256, P262, Wagner Coughlin, C...... P115, P541 ...... P320, P323, P370, P422, P612, P623, P666, P704 Wald, K. A...... O75, P69 Whitney, J. B...... P106, P168, P258 Waler, N...... O109 Widra, E. A...... O222, P160, P181, P208, P236, P369 Walker, C...... P470 WiedmanKlayum, K. C...... O178 Walker, C. L...... O2 Wilcox, J...... P145 Walker, E...... O100 Wild, R. A...... P204 Walker, W. J...... P398, P414 Wilkerson, M. D...... P466 Wallace, J...... P706 Wilkinson, M...... O138 Walmsley, R. H...... P108, P120 Williams, L. A...... O229, O232, P434, P440, P455 Walsh, T. J...... P506 Williams, L. J...... O168, P37 Walter, J...... P322, P705 Williams, P...... O1, O21, O67, P8 WaltersSen, L...... P148 Williams, P. L...... P477 WaltersSen, L. C...... P122, P123 Williamson Dean, L...... O213 Wang, A. Y...... P184 Willman, S...... O64, P129 Wang, C.W...... P528 Wilson, C...... P192, P618 Wang, E...... P474, P478 Wilson, D...... P567 Wang, E. T...... P186 Wilson, M...... P538 Wang, F...... P39, P217, P483, P487 Wilson, S. E...... P302 Wang, F.F...... P403 Wingfield, M...... O117 Wang, F.M...... P244 Winkel, C. A...... O230, P432 Wang, H.S...... P298 Winter, K...... P247 Wang, J...... P411 Wise, L. A...... O195 Wang, L...... P289, P483, P487 Wiser, A...... P417, P426, P554 Wang, Q...... P272, P568, P581, P591, P645, P703 Wither, M. J...... O221 Wang, S...... O189, P45 Witkin, S. S...... P376 Wang, T...... O133, O172 Witt, B. R...... P699 Wang, Y...... O55 O190, P96 Wolfe, H...... O90 Wang, Z...... P515, P526 Wolff, E. F...... O192 Wanggren, K...... P607 Wong, E...... P344 Wantman, E...... P193, P196 Wong, J. M...... P311 Washington, C...... O236, P465 Wong, K. K...... O211, P708 Watanabe, A...... P233 Woo, I...... O139 Watanabe, H...... P648, P673, P682 Wood, G. J...... P502 Watanabe, S...... O160, P527, P606, P647, P656 Woodard, T. L...... P26, P61, P680 Watts, N...... P455 Worrall, G...... O154, P25 Weckstein, L...... O64, O222, P129, P181 Worton, H...... P31 Weedin, E...... P204, P582 Wu, H...... O222, P112 Weeg, N...... P426 Wu, H. Y...... P690 Wei, K...... P610 Wu, H.M...... P298 Wei, L...... P43, P179 Wu, L...... O253, P285, P365, P411 Weibel, H. S...... P82, P182 Wu, T. X...... O265 WeiHua, W...... P79 Wu, X...... P283, P638 Weinberg, C. R...... P362 Wu, X. K...... O265

nd 72 ASRM Scientific Congress & Expo 264 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Wu, Y...... P403 Yi, K...... P213 Wu, Y.G...... P645 Yi, Y...... P267 Wun, W.S. A...... O66 Yilmaz, N...... P200, P201, P402 Xia, M...... P649 Yin, O...... P690 Xie, X...... P134, P147 Yin, P...... P464 Xing, J...... O190, P712 Yoder, N...... P580 Xu, F...... O13 Yonath, H...... P711 Xu, J...... O121, P34 Yong, P...... P449, P458 Xu, Y...... P377, P584, P609, P685 Yoo, C...... P263, P317, P555 Xue, Q...... P456 Yoo, T...... P445 Yabuuchi, A...... P603 Yoon, H. J...... P92 Yadav, A...... P314 Yoon, J...... P395 Yakin, K...... P368 Yoon, J.S...... P199, P589 Yakistiran, B...... P312 Yoon, S...... P209 Yalcinkaya, T...... O69 Yoon, S. H...... P92 Yalim, Y...... P549 Yoon, T. K...... P49, P578, P615, P619 Yallampalli, C...... O91 Yoshida, A...... O148 Yamada, M...... P233 Yoshida, K...... P521 Yamaguchi, K...... P53, P232, P316, P367, P500, P510 Yoshida, M...... P521 Yamaguchi, T. . . . . P195, P239, P306, P324, P329, P629, P643 You, M. J...... P133 Yamaguchi, Y...... P518 Youm, J...... P77 Yamanaka, N...... P606, P647, P656 Younes, G...... O171, O218, P245, P318 Yamasaki, H...... P603 Young, A. M...... P558 Yamasaki, M...... P174 Young, D. O...... P710 Yamashita, N...... P521, P659 Young, E...... O74 Yan, G...... P282, P295 Young, J...... O69 Yan, Q...... P282, P295 Young, L...... P668 Yanez, L. Z...... P164 Young, S. L...... O25, P299, P416 Yang, C...... O122, O136 Younis, A...... P364 Yang, I...... O68, O70 Yu, B...... O93, P165 Yang, J.H...... P381 Yu, E...... P49, P209 Yang, L...... P680 Yuan, L...... O25 Yang, M...... O267 Yuge, A...... P603 Yang, Q...... O2, O237, P470 Yukselten, Y...... P646 Yang, S...... P213 Yumoto, K...... O208, P215, P661 Yang, X...... P480, P614, P638 Yurttas Beim, P...... O27, O222, P112, P181, P443, P611 Yang, Y...... P476 Zabielska, J...... P41 Yang, Y.S...... P381, P385 Zada, N...... P554 Yang, Z...... P135 Zagadailov, P...... P585 Yanowitz, J. L...... P219 Zaghi, S...... O86, P165 Yao, B...... P134 Zaki, H...... P253 Yao, G...... P411, P609 Zaletova, V...... P246 Yao, S...... O13, P15, P18 Zamfirova, I...... O214 Yarnall, S...... O12, O241, P14, P700 Zaninovic, N...... O5, P326, P655 Yatabe, N...... P603 Zarutskie, P. W...... P375, P563, P663, P680 Yauger, B...... O90 Zborilova, B...... P608 Ye, Y...... P227 Zelkowitz, P...... O153 Ye, Z...... P655 Zeng, Q...... P649 Yeaton-Massey, A...... P425 Zgodic, A...... P112 Yeboah, E...... O147, O170 Zhai, J...... P411 Yeh, J...... P13 Zhan, H...... P458 Yelian, F...... O46 Zhan, Q...... P326, P655 Yelke, H. K...... P325, P327 Zhan, Y...... O47, O169, O259, O270, P127, P128, P475, P712 Yeo, A...... P183 Zhang, C...... P338 Yerkes, S...... P561 Zhang, H...... P289, P374

nd 72 ASRM Scientific Congress & Expo 265 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Abstracts Author Index

Zhang, H...... O265 Zhang, J...... O53, O267, P102, P515, P526 Zhang, J. J...... P115, P151 Zhang, J. X...... P218, P536, P664 Zhang, L...... P581, P591, P645, P703 Zhang, S...... P135 Zhang, X...... P466 Zhang, Y...... P45, P334, P567, P638, P712 Zhao, H...... P377 Zhao, L...... P518 Zhao, Z...... P411 Zhen, X...... P282, P295 Zheng, M.X...... P244 Zheng, Y...... P438 Zhioua, A...... P59 Zhioua, F...... P59 Zhou, A...... O190 Zhou, C...... P377, P584, P685 Zhou, F...... P32 Zhou, H...... O123 Zhou, J...... P403 Zhou, L...... P240 Zhou, X...... O243, P691 Zhou, Y...... P226, P456 Zhu, M...... P123 Zhylkova, I...... P346 Zimberg, S...... O33, O104, O106 Zimmerman, R...... O215, O270 Zimmerman, R. S...... P128 Zini, A...... P508, P532, P631 Zitta, M. M...... P373 Zlatopolsky, Z...... P119, P132 Zohav, E...... P237 Zouves, C. G...... P110 Zozula, S...... P76 Zuccaro, M...... O125

nd 72 ASRM Scientific Congress & Expo 266 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Speaker Index

Aboulghar, Mohamed A...... 48 Cooper, Amber R...... 97 Adashi, Eli ...... 76 Covington, Laura S...... 126 Al-Hendy, Ayman ...... 127 Daley, George Q...... 82 Alukal, Joseph P...... 126 DeCherney, Alan H...... 48 Amato, Paula ...... 127 Deprest, Jan ...... 78 Appiah, Leslie A...... 103, 124 Desai, Nidhi ...... 32, 99 Applegarth, Linda D...... 112, 124 Dlugi, Alexander M...... 127 Armenti, Erin ...... 33 Dokras, Anuja ...... 35 Awwad, Johnny T...... 48 Domar, Alice D...... 40, 93 Bailey, Michael T ...... 86 Donnez, Jacques G...... 92 Bakos, Hassan W...... 97 Doody, Kevin J...... 32, 40, 106 Baldwin, Kara ...... 112 Dorfmann, Andrew D...... 39 Ball, G. David ...... 32 Dunaif, Andrea ...... 35 Barnes, Frank L...... 92 Dupree, James M...... 44 Barnhart, Kurt T...... 101 Duran, Lisa ...... 42, 90, 125 Barrionuevo, Marcelo ...... 85 Eaton, Jennifer L...... 127 Bartolomei, Marisa S...... 79, 88 Egli, Dieter ...... 89 Bashiri, Asher ...... 127 Eyvazzadeh, Aimee ...... 90 Bates, Jr., G. Wright ...... 37, 38, 49, 50, 82 Falcone, Tommaso ...... 108, 125 Bedaiwy, Mohamed A...... 129 Farquhar, Cynthia ...... 101 Bell, Ann V...... 102 Feng, Huai L...... 47, 124 Beltsos, Angeline N ...... 124 Forman, Deborah L...... 84 Bendikson, Kristin A...... 37, 38, 49, 50 Forman, Eric J...... 125 Berga, Sarah L...... PC 03 Frankfurter, David ...... 37, 38, 49, 50 Bhagavath, Bala ...... 110, 125 Friedman, Lawrence ...... 90 Bianchi, Diana W...... 76 Fujimoto, Victor Y...... 41 Bindeman, Julie ...... 128 Fukuda, Aisaku ...... 96 Black, Lauri ...... 108 Garcia, Monica ...... 86 Bocca, Silvina M...... 126 Gargiulo, Antonio R...... 110 Boi, Luca ...... 94 Gariepy, Aileen ...... 101 Boraas, Christy M...... 113 Garrido Puchalt, Nicolas ...... 36 Bormann, Charles L...... 125 Gavrilova-Jordan, Larisa ...... 128 Brannigan, Robert E...... 36 Gebhart, Marty B...... 128 Brisman, Melissa B...... 89, 124 Gilbert, Bruce R...... 98 Broadwell, Christina ...... 44 Gitlin, Susan A...... 128 Bruner-Tran, Kaylon L...... 41, 126 Giudice, Linda ...... 87 Bugge, Kathleen R...... 126 Goering, Matthew C...... 128 Bukulmez, Orhan ...... 127 Goldberg, Jeffrey M...... 35 Bulun, Serdar E...... 75, 87, 126 Goldstein, Marc ...... 129 Burgert, Tania S...... 105 Gonzalez, Frank ...... 127 Burney, Richard O...... 129 Gordon, Elaine R...... 111 Cabal, Ana Cobo ...... 92 Greely, Henry T...... 82 Caballero, Stephanie ...... 124 Green, Daniel Michael ...... 45 Cao, Yunxia ...... 87 Greil, Arthur L...... 102 Carmina, Enrico ...... 35 Grifo, Jamie A...... 92 Casson, Peter R...... 82 Haddad, Lisa ...... 113 Catherino, William H...... 92, 126 Hailstorks, Tiffany ...... 124 Chavarro, Jorge E...... 97 Hansen, Karl R...... 97 Checa, Miguel Angel ...... 85 Heard, Michael J...... 128 Chen, Melissa ...... 113 Hearns-Stewart, Rhonda M...... 86 Chen, Zi-Jiang ...... 87 Hill, George ...... 46 Chung, Karine ...... 124 Hill, Micah J...... 128 Coleman, Jenell ...... 83 Hirshfeld-Cytron, Jennifer E...... 128 Collins, Carolyn A...... 126 Holley, Sarah ...... 93 Collura, Barbara L...... 98 Honig, Stanton ...... 102

nd 72 ASRM Scientific Congress & Expo 267 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Speaker Index

Horton, Marcos ...... 85 Madlensky, Lisa ...... 45 Hotaling, James M...... 44, 128 Major, JoAnn ...... 127 Howards, Stuart S...... 51 Malhotra, Narendra ...... 91 Huang, Rui ...... 47 Marks, Sheldon H.F...... 98 Huddleston, Heather ...... 41, 124 Marsh, Erica E...... 126 Huffman, Carolyn S...... 128 McBain, Lindsey N...... 128 Hunsaker, Steve ...... 94 McCulloh, David H...... 39 Hwang, Kathleen ...... 128 McFarland, Richard ...... 86 Isaacson, Keith ...... 35 McLean, Mamie ...... 37, 38, 49, 50 Jackson, Maria M...... 90 Merhi, Zaher ...... 127 Jaffe, Janet ...... 83 Mersereau, Jennifer E...... 45, 125 Jahnukainen, Kirsi ...... 95 Miller, Charles E...... 110 Jamieson, Denise J...... 81 Mindes, Erica J...... 112 Janik, Grace M...... 108 Mol, Ben ...... 101 Jasulaitis, Sue ...... 32 Montville, Christopher P...... 37, 38, 49, 50 Jensen, Jeffrey ...... 77 Morbeck, Dean E...... 127 Jindal, Sangita K...... 99, 125 Morimoto, Yoshiharu ...... 96 Johnson, Julia ...... 97 Mounts, Emily ...... 108 Johnston-MacAnanny, Erika B...... 125 Muasher, Suheil J...... 91 Jordan, Amy ...... 43, 103 Munne, Santiago ...... 125 Joseph, Jamie M...... 126 Myatt, Leslie ...... 88 Josephs, Sheldon B...... 90 Nackley, Anna C...... 124 Judge, Anne ...... 93 Nagy, Zsolt Peter ...... 90 Jungheim, Emily S...... 127 Nangia, Ajay K...... 107 Kably Ambe, Alberto ...... 96 New, Maria I...... 78 Kaplan, Jay Ross ...... 77 Nezhat, Ceana H...... 35, 110 Keeyes, Michelle A...... 128 Nezhat, Farr R...... 100 Kelk, Dawn A...... 104 Niederberger, Craig ...... 36, 79 Kheriaty, Aaron ...... 82 O'Brien, Molly ...... 128 Kingsberg, Sheryl ...... 81 Ogawa, Takehiko ...... 88 Kirk, Emma ...... 46 Okada, Hidetaka ...... 96 Kissin, Dmitry ...... 91 Oktay, Kutluk ...... 125 Kolte, Astrid Marie ...... 46 Orwig, Kyle E...... 88, 128 Kottick, Judith ...... 99 Paduch, Darius A...... 124 Kovanci, Ertug ...... 75 Painter, Rebecca C...... 46 Krawetz, Stephen A...... 88 Pal, Lubna ...... 105 Krieg, Sacha ...... 43 Palter, Steven F...... 36, 110 Krisher, Rebecca L...... 125 Papier, Sergio ...... 85, 96 Ku, Lowell T...... 127 Parikh, Firuza R...... 91 Kumar, Neha ...... 128 Pascale, Claudia ...... 112 Kutteh, William H...... 126 Pasch, Lauri ...... 83 Kuwayama, Masashige ...... 92 Patrizio, Pasquale ...... 89, 127 Lamb, Julie D...... 37, 38, 49, 50 Pavone, Mary Ellen ...... I100, 127 Lanski, Ariadna Cymet ...... 112 Peipert, Jeffrey F...... 77 Lawson, Angela K...... 93 Pellicer, Antonio ...... 36 Layman, Lawrence C...... 33, 99 Penzias, Alan S...... 37, 38, 49, 50 Lazarin, Gabriel A...... 43 Petok, William D...... 107 Legro, Richard S...... 35 Petrozza, John C...... 126 Leonard, Jamie ...... 84 Pfeifer, Samantha M...... 35 Lessey, Bruce ...... 106 Piao, Yun-shang ...... 86 Liebermann, Juergen ...... 127 Pollack, Staci E...... 103 Lin, Paul C...... 42 Polotsky, Alex J...... 97 Lindheim, Steven R...... 36, 75, 110 Price, Thomas M...... 107 Loret de Mola, J. Ricardo ...... 96 Qiao, Jie ...... 47, 87, 125 Lujan, Marla ...... 105 Queenan, Jr., John T...... 46

nd 72 ASRM Scientific Congress & Expo 268 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Speaker Index

Quenby, Siobhan ...... 46 Surrey, Mark W...... 108, 125 Quinn, Colleen M...... 93 Swain, Jason E...... 125 Rackow, Beth W...... 46, 103 Swain, Margaret ...... 126 Racowsky, Catherine ...... 41 Tanrikut, Cigdem ...... 126 Raidoo, Shandhini ...... 113, 125 Taylor, Hugh S...... 87, 124 Ramasamy, Ranjith ...... 75, 126 Taylor, Robert N...... 34 Ranoux, Claude J...... 124 Tepper, Anne ...... 124 Ray, Keith ...... 37, 38, 49, 50 Thomas, Colin D...... 42, 94 Rebar, Robert W...... 48 Thomas, Robin L...... 125 Rechitsky, Svetlana ...... 126 Thompson, Ivana ...... 113 Reijo Pera, Renee A...... 89 Tobias, Tamara ...... 40 Riddle, Mary P...... 111 Tomasino, Jeanette Rodriguez ...... 84 Rinehart, Lisa A...... 84 Toner, James ...... 37, 38, 49, 50 Sakkas, Denny ...... 101 Toner, James P...... 100 Samplaski, Mary K...... 128 Toth, Thomas L...... 37, 38, 49, 50 Sandlow, Jay ...... 107, 126 Treff, Nathan R...... 33, 89, 128 Santoro, Nanette ...... 109 Trivedi, Prakash H...... 91 Schattman, Glenn L...... 99 Tulandi, Togas ...... 100 Schiffman, Mindy R...... 128 Turek, Paul J...... 125 Schlatt, Stefan ...... 75, 95 Usadi, Rebecca S...... 75, 82 Schlegel, Peter N...... 98, 127 Valerio, Emilio ...... 96 Schuman, Lisa ...... 124 Van Voorhis, Bradley J...... 91 Schust, Danny J...... 124 Vorzimer, Andrew W...... 126 Scoccia, Humberto ...... 107, 127 Weinberg, David ...... 88 Scott Jr., Richard T...... 39, 99 Wiemer, Klaus E...... 104 Segars, James ...... 37, 38, 49, 50 Wild, Robert A...... 101, 128 Seli, Emre ...... 34 Williams, Dan H...... 44 Senstra, Brad J.T...... 42, 84 Wise, Lauren A...... 128 Shah, Divya K...... 127 Woodruff, Teresa K...... 88 Shapiro, Bruce S...... 39 Wu, Diana H...... 101 Sharara, Fady I...... 124 Young, Steven L...... 106 Sharpe, Jacqueline A...... 127 Zhang, John J...... 129 Sharpe-Timms, Kathy L...... 128 Zhao, Yulian ...... 47, 127 Shin, David ...... 124 Shin, Paul R...... 124 Shiotani, Masahide ...... 96 Simmons, Katharine ...... 83 Simon, Carlos A...... 106, 125 Simon, Judy B...... 93 Simpson, Samantha ...... 110 Simpson, Tara H...... 89 Slaughter, Shelley R ...... 86 Smith, Coleen ...... 127 Smith, James F...... 45, 103 Snider, Alyssa C...... 108, 126 Soares, Michael J...... 80 Sparks, Amy E.T...... 100, 125 Spies, James B...... 92 Spitz, Aaron ...... 44 Stamper, Lora B...... 42, 84 Steiner, Anne Z...... 36 Stephenson, Mary ...... 43 Stevenson, Eleanor L...... 125 Su, Irene ...... 103 Sun, Yun ...... 87

nd 72 ASRM Scientific Congress & Expo 269 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Participant and Spouse/Partner Disclosure Index

All presenters and planners at the ASRM 2016 Scientific Congress and Pre-Congress Cources were required to disclose all commercial and financial relationships with entities producing, marketing, reselling, or distributing goods or services, consumed by, or used on patients. These disclosures were reviewed and potential conflicts of interest resolved by the Subcommittee on Standards of Commercial Support of the Continuing Medical Education Committee. Presenters and planners with anything to disclose are listed below along with any relationships their spouses/partners disclosed. Each presenter with anything to disclose is listed below along with any relationships their spouses/partners disclosed.

Aboulghar, Mohamed A. IBSA, Grant recipient; Ferring, Grant recipient; MSD, Honoraria Al-Hendy, Ayman Bayer, Paid consultant; Allergan, Paid consultant; National Institute of Health, Grant recipient Armenti, Erin M. Pfizer, Direct stockholder; GE, Direct stockholder; Vertex, Direct stockholder Baldwin, Kara California Cryobank, Full-time company employee Barnhart, Kurt Bayer, Paid consultant; SPD, Paid consultant Bedaiwy, Mohamed A. Allergan, Grant recipient Beltsos, Angeline N. Merck Pharmaceuticals, Speakers bureau; EMD Serono Pharmaceuticals, Speakers bureau; Ferring Pharmaceuticals, Speakers bureau; Diclegis, Speakers bureau; Good Start Genetics, Paid consultant; Optum, Paid consultant; Ovascience, Paid consultant; Progeny, Paid consultant Bendikson, Kristin Theralogix, Paid consultant Berga, Sarah L. Member, University of Virginia Medical Alumni Association/Medical School Foundation Board of Directors 2007 - 2016, Member, Board of Directors; Vermillion Pelvic Mass Registry Advisory Panel, May 2015, What's My Fertility Advisory Board Member, 2015 to Present, Paid consultant; ACOG, Editorial Committee, Guidelines for Women's Health Care, 2009-2016 (Gratis), American Journal of Obstetrics and Gynecology – 2003 to present (Gratis), International Society for Gynecological Endocrinology – Executive Committee Member 2004 to present, Menopause, Editorial Board, 1999-present (Gratis), Society for Women's Health Research, ISIS CVD Network Member – 2009 to 2015, The Endocrine Society, • Clinical Practice Guideline Task Force on Hypothalamic Amenorrhea – January 2011 – present (Gratis), • Editorial Board for Journal of Clinical Endocrinology and Metabolism– 2013-present (Gratis), • Special Programs Committee – 2013-2016, UpToDate Peer Review Board – 2005-present, Circuit Court of Mobile County, Alabama CV-2015-900766, Editor, committee member; Ferring Pharmaceuticals Inc.,Site PI, Clinical Trial "LutrePulse OmniPod Study 000070: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study Evaluating Three Doses of Subcutaneous Pulsatile GnRH Administered via OmniPod Pump for Ovulation Induction in Female Subjects with Primary Amenorrhea with Hypogonadotropic Hypogonadism", 2014 to present., NIH/NICHD Grant R01-HD-062618 (Cameron), "Role of Serotonin in Mediating Stress-Induced Infertility", Consultant, 07/10/10- 05/31/15, NIH/NICHD Grant K23-HD-064700 (Gesell), "Building Social Networks to Achieve Healthy Weight Gain during Pregnancy," Mentor, 09/01/11-06/30/16, NIH/NCI Grant 5R01-CA107408 (Bender), "Long Term Trajectory of Cognitive Function Related to Anastrozole Use in Women," Subcontract PI, 04/01/04-03/31/16, NIH/OD Grant T32 OD010957 (Cline-PD), "Laboratory Animal and Comparative Medicine Training," Faculty, 04/01/13-03/31/18, Grant recipient Bergh, Catherine M. MedSoftware, Company officer Bhagavath, Bala Hologic, Paid consultant; AbbVie, Paid consultant Bianchi, Diana W. Illumina, Grant recipient; Illumina, Honoraria Black, Lauri D. Illumina, Speakers bureau; Good Start Genetics Laboratory, Genetic Counseling Advisory Board; InformedDNA, Business Development Team Bocca, Silvina Merck-Organon, Speakers bureau Boraas, Christy M. Actavis, Speakers bureau; Merck, Speakers bureau Brannigan, Robert Edward AbbVie, Inc., A grant in support of Northwestern University’s Andrology fellowship was provided to Northwestern University, Feinberg School of Medicine. I am the Director of the Andrology Fellowship; The American Urological Association/The Journal of Urology, I am an Assistant Editor for The Journal of Urology

nd 72 ASRM Scientific Congress & Expo 270 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Participant and Spouse/Partner Disclosure Index

Briton-Jones, Christine Good Start Genetics, Member of Embryology Advisory Board Catherino, William H. AbbVie, Paid consultant; Actavis, Paid consultant; Medical College of Wisconsin, Honoraria; Recombine, Full-time company employee; Bayer, Grant recipient Centola, Grace M. New England Cryogenic Center/New England Cord Blood Bank/CryoGen Donor Egg Bank, Laboratory and Tissue Bank Director; Manhattan Cryobank, Tissue Bank Director; California Cryobank, Scientific Advisory Board; Fertility Center of California, Tissue Bank Director; Seattle /Phoenix Sperm Bank, Laboratory Director, Phoenix Sperm Bank; CryoBank Israel - US, Tissue Bank Director- US Christman, Gregory M. Abbvie Pharmaceuticals, Grant recipient; Abbvie Pharmaceuticals, Honoraria; Bayer Pharmaceuticals, Grant recipient; Bayer Pharmaceuticals, Paid consultant Cooper, Amber R. Celmatix, Inc, Scientific Advisory Board; Progenity, Speakers bureau; Progenity, Advisory Board, Key Unit Panel Daley, George Q. MPM Capital, Paid consultant; Epizyme, Verastem, True North, Solasia KK, RAZE, Ocata, 28- 7, Direct stockholder; Epizyme, Verastem, True North, Solasia KK, RAZE, Ocata, 28-7, Paid consultant; Athenahealth, Paid consultant Dlugi, Alexander M. Optum, UnitedHealth Group, Full-time company employee; Serono, Advisory Board; Ferring, Advisory Board Dokras, Anuja JDS Pharmaceuticals, Paid consultant Domar, Alice D. TriaDea, Company officer; FertiCalm, Company officer; Merck, Speakers bureau; Ferring, Paid consultant; Merck, Paid consultant; UptoDate, Paid consultant Donnez, Jacques G. Gedeon Richter and Preglem, Honoraria Doody, Kevin Merck Pharmaceutical, Paid consultant; Ferring Pharmaceutical, Paid consultant; Finox Pharmaceutical, Paid consultant; Serono Pharmaceutical, Speakers bureau; Good Start Genetics, Paid consultant Dunaif, Andrea AstraZeneca, Paid consultant; KinDex Pharmaceuticals, Inc, Paid consultant; JDS Therapuetics, LLC, Paid consultant; Tarsus Cardio, Inc, Honoraria; Ansh Labs, They performed AMH assays for several projects free-of-charge; GLG (Gerson Lehrman Group) Council, Paid consultant Dupree, James M. Blue Cross, Blue Shield of Michigan, Grant recipient Eisenberg, Michael Sandstone Diagnostics, Direct stockholder; Reprovantage, Direct stockholder; Glow, Advisor; EmbraceHer, Direct stockholder; Gilead, Paid consultant Farquhar, Cynthia Repromed Auckland, Family trust holds small shareholding in private fertility clinic, also a director Feinberg, Eve C. Abbvie, Paid consultant Forman, Deborah L. Janssen Biotech, Full-time company employee; Johnson & Johnson, Direct stockholder; Ingtercept Pharmaceuticals, Direct stockholder; Aduro BioTech Inc., Direct stockholder; TransEnterix, Inc., Direct stockholder Forman, Eric J. Ferring Pharmaceuticals, Speakers bureau Friedman, Lawrence IntegraMed America, Company officer Gargiulo, Antonio R. OmniGuide, Inc., Paid consultant; Kawasaki Robotics (USA), Inc., Paid consultant Gariepy, Aileen Merck- Etonogestrel implant trainer, Honoraria Gilbert, Bruce R. Sandstone Diagnostics, Inc, Clinical Trial Investigator; Novartis Pharma AG, Clinical Trial Investigator; NexMed, Clinical Trial Investigator; Mereo BioPharma 2 Ltd 2016, Clinical Trial Investigator Ginsburg, Elizabeth S. Serono, Grant recipient Giudice, Linda C. ASRM, Company officer; Merck, Pfizer, Direct stockholder; Abbvie Pharmaceutical, Paid consultant; NextGen Jane, Scientific Advisory Board member; Juniper Pharmaceuticals, Advisory Board Members Goering, Matthew C. CombiMatrix, Paid consultant Goldstein, Marc Therologix, Advisory board

nd 72 ASRM Scientific Congress & Expo 271 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Participant and Spouse/Partner Disclosure Index

Hansen, Karl R. Roche Diagnostics, Grant recipient; Ferring International Pharmascience Center US, Grant recipient Heard, Michael J. AbbVie Pharmaceuticals, Speakers bureau; VitaMed, Paid consultant; Dushenay Pharmaceuticals, Speakers bureau; Sigma Tau Pharmaceuticals, Paid consultant Hill, George United Healthcare Women’s Health Scientific Advisory Board, Paid consultant Hirshfeld-Cytron, Jennifer Erin Duchesnay, Speakers bureau Honig, Stanton C. AbbVie, Paid consultant; Lipocine, Paid consultant; Coloplast, Paid consultant; Endo, Paid consultant Horton, Marcos Merck, Speakers bureau Hotaling, James M. Nanonc. SpermDx, Andro360, StreamDx, Own equity in 4 early stage start up companies, none have any commerical products on the market at this time Howards, Stuart S. Sperm check, On board of directors Hullender Rubin, Lee Portland Acupuncture Studio LLC, Company officer Isaacson, Keith Karl Storz Endoscopy, Paid consultant Jasulaitis, Sue Merck Pharmaceuticals, Speakers bureau Jensen, Jeffrey Abbvie, Bayer Healthcare, HRA Pharma, Merck, ContraMed, MicroChips, Evofem, Paid consultant; Abbvie, Bayer, ContraMed,FHI 360, 360, Grant recipient Kingsberg, Sheryl A. Valeant, Acerus, Emotional Brain, Pfizer, Shionogi, Sermonix, NovoNordisk, Perrigo, Nuelle, Materna, Palatin, Paid consultant; Viveve, stock options Krawetz, Stephen A. Taylor and Francis, EIC of Systems Biology in Reproductive Medicine Krisher, Rebecca L. Merck Serono, Grant recipient Kumar, Neha Recombine, Full-time company employee Kuwayama, Masashige Repro-Support Medical Research Centre, Company officer Lazarin, Gabriel A. Counsyl, Full-time company employee Legro, Richard S. Millendo, Paid consultant; Bayer, Paid consultant; JDS Therapeutics, Paid consultant; Euroscreen, Paid consultant; Kindex, Paid consultant Lessey, Bruce A. Pfizer, Paid consultant; Pfizer, Grant recipient Liebermann, Juergen Sage/Origio, Paid consultant; Vivere, Paid consultant; Irvine Scientific, Speakers bureau Lin, Paul Chungyu Omniguide Surgical, Paid consultant; INVO Bioscience Inc., Direct stockholder Madlensky, Lisa Janssen, Full-time company employee McCulloh, David H. ReproART: Georgian American Center for Reproductive Medicine, Tbilisi, Georgia, Company officer; Biogenetics Corporation, Mountainside, New Jersey, USA, Company officer; NYU Fertility Center, New York, NY, USA, Full-time company employee Miller, Charles E. Abbvie, Actavis, Aegea Medical, Bayer Healthcare, Covidien, Espiner Medical, Ferring, Genesis Genetics. Gynesonics, Intuitive Surgical, Merck, Watson Pharmaceuticals, Grant/Research/Study; Abbvie, Covidien, Ethicon, Gynesonics, Halt Medical, Hologic Inc., Intuitive Surgical, Metalmark Capital, Pacira Pharmaceuticals, Smith & Nephew, Stryker Endoscopy, Paid consultant; Ethicon, Intuitive Surgical, Smith & Nephew, Speakers bureau; Thomas Medical/Catheter Reserach, Inc. (Miller Catheter), Royalties Mindes, Erica Vericel, Inc, Paid consultant; Cartiheal Inc, Paid consultant; Aesculap, Inc, Paid consultant; Orthospace, Inc, Direct stockholder Mol, Ben W. ObsEva, Geneva, Paid consultant Mounts, Emily Recombine, Paid consultant Munne, Santiago Reprogenetics, Company officer; Cooper Surgical, Company officer; Recombine, Direct stockholder Nagy, Zsolt Peter My Egg Bank, Direct stockholder; Cooper-Surgical/Origio, Paid consultant; Merck MSD, Speakers bureau

nd 72 ASRM Scientific Congress & Expo 272 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Participant and Spouse/Partner Disclosure Index

Nezhat, Ceana Karl Storz Endoscopy, Paid consultant; Plasma Surgical, Medical Advisor; SurgiQuest, Scientific Advisory Board Niederberger, Craig American Urological Association, Update series editor; Ferring, Grant recipient; Nexhand, Company officer Paduch, Darius A . AbbVie, Speakers bureau; Bayer, Paid consultant; AbbVie, Paid consultant Palter, Steven F. Lodestone Technology, Inc, Company officer Patrizio, Pasquale Counsyl, Scientific advisor; FertileSafe, Co-founder and scientific advisor Peipert, Jeffrey F. Merck, Grant recipient; Bayer, Grant recipient; Teva, Grant recipient; Teva - Advisory Board, Paid consultant; Perrigo - Advisory Board, Paid consultant Penzias, Alan S. OvaScience, Advisory board Member; ReproSource, Advisor Pera, Renee A. Auxogyn/Progyny, Direct stockholder Petrozza, John C. Smith & Nephew, Paid consultant Price, Thomas MedaCorp, Paid consultant; Guidepoint, Paid consultant; GLC, Paid consultant; Best Doctors, Paid consultant Price, Thomas M. MedaCorp, Paid consultant; Gerson Lehrman Group, Paid consultant; Guidepoint, Paid consultant; Best Doctors, Paid consultant Prien, Sam Reproductive Solutions Inc, Company officer Puchalt, Nicolas Garrido Merck Serono, Speakers bureau; MSD, Speakers bureau Quenby, Siobhan Ferring, Speakers bureau Racowsky, Catherine Life Global Group, Paid consultant; UpToDate, Honoraria; World Health Organization, Paid consultant Ranoux, Claude J. Chief Scientist and President as well as direct stock holder of INVO Bioscience, a medical device company, Company officer Ramasamy, Ranjith Lipocine, Paid consultant; Beckman, Paid consultant; Direx System, Grant recipient Ranoux, Claude J. Chief Scientist and President as well as direct stock holder of INVO Bioscience, a medical device company, Company officer Sakkas, Denny Ferring, Grant recipient; Origio, Scientific Advisory Board; Allergan, Trial Advisory Board; INVO Biosciences, Direct stockholder Salcedo, Jennifer Nexplanon Trainer, No-compensation agreement completed. No trainings completed.; Liletta Trainer, No trainings completed. No compensation received.; Merck - site co-investigator for a contraceptive vaginal ring study (no compensation yet received), Grant recipient; Gynuity - site co-investigator for a medical abortion telemedicine study (no compensation yet received), Grant recipient Santoro, Nanette Bayer Inc, Grant recipient; Menogenix Inc, Stock Options Schattman, Glenn L. Femasys, Medical advisor, clinical investigator; Theralogix, Paid consultant; Ferring, Speakers bureau Schlegel, Peter N. GNYUTES. Provider of SWL services, Company officer; Theralogix, Inc. Producer of Nutraceuticals, Paid consultant Scott, R.T. Foundation for Assessment & Enhancement of Embryonic Competence, Inc. Neither myself or my program get any personal benefit, Company officer; Ferring Pharmaceutical, Scientific Advisory Board Segars, James Biospecifics, Inc, as research site for possible new drug; American Board of Obstetrics and Gynecology, As board Director Sharara, Fady MAP Diagnostics, Company officer; Ferring Pharmaceuticals, Speakers bureau Shin, Paul R. Absorption pharmaceuticals, Direct stockholder Simon, Carlos Igenomix SL, Direct stockholder; Equipo IVI, Direct stockholder; Igenomix SL, Inventor patent: Gene expression profile as an endometrial receptivity marker (ERA) Smith, Yolanda R. UpToDate, Reviewer - receive royalty

nd 72 ASRM Scientific Congress & Expo 273 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS Participant and Spouse/Partner Disclosure Index

Snider, Alyssa Igenomix USA, Full-time company employee Spies, James B. Boston Scientific, Paid consultant Spitz, Aaron liposine, Paid consultant Swain, Jason Irvine Scientific, Royalties from Media Sales Tanrikut, Cigdem New England Cryogenic Center, Medical Director, Andrology Lab Tarlatzis, Basil Merck Sharp & Dohme, Merck Serono, Angelini, Grant recipient; Merck Sharp & Dohme, Merck Serono, IBSA, Ferring, Honoraria; Merck Sharp & Dohme, Merck Serono, IBSA, Speakers bureau; Ferring, IBSA, Travel Grants; OVASCIENCE, Ferring, Advisory Board Taylor, Hugh S. Pfizer, Grant recipient; OvaScience, Grant recipient; AbbVie, Honoraria; Bayer, Paid consultant; Euroscreen, Paid consultant Taylor, Robert N. AbbVie, ObsEva SA, Paid consultant; Actavis, Pfizer, Inc., Paid consultant; Bayer AG, Paid consultant; Pfizer, NIH, Bayer AG, Grant recipient Tobias, Tamara EMD Serono and nurse advisory board, Speakers bureau; Ferring, Speakers bureau Tomasino, Jeanette Rodriguez Progyny, Full-time company employee Turek, Paul J. Essential Beginnings, Inc, Company officer; BioQuiddity, Inc, Medical Advisory Board; Healthloop. com, Medical Advisory Board; MandalMed, Inc, Company officer; FertilityPlanit.com, Medical Advisory Board; Episona, Inc, Medical Advisory Board; Cellarity, Inc, Company officer Weinberg, David Merck and Co., Direct stockholder Wiemer, Klaus E. IVF Online, Paid consultant Young, Steven L. UNC School of Medicine, I am co-inventor on a currently unlicensed technology for testing for endometriosis and/or endometrial receptivity

nd 72 ASRM Scientific Congress & Expo 274 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS ASRM Abstract and Video Author and Spouse/ Partner Disclosure Index

All presenters and planners at the ASRM 2016 Scientific Congress and Pre-Congress Cources were required to disclose all commercial and financial relationships with entities producing, marketing, reselling, or distributing goods or services, consumed by, or used on patients. Each abstract or video author with anything to disclose is listed below along with any relationships their spouses/partners disclosed.

Abbott, D. H. Innocrin Pharmaceuticals, Paid consultant Abrao, M. S. Bayer, Paid consultant; Editor-in-Chief, Jpurnal of Endometriosis and Pelvic Pain Disorders Ajmani, K. Progyny, Inc., Company officer Albertini, D. Springer Publishing, Paid consultant; Serono, Honoraria Al-Hendy, A. NIH, Grant recipient; Bayer, Paid consultant; Allergan, Paid consultant; Repros, Grant recipient; Abb-vie, Grant recipient Alper, M. M. EMD Serono, Honoraria; Good Start Genetics, Advisory Board; Ferring, Honoraria; Reprosource, Advisor-Board; Finox, Grant recipient Anderson, R. E. Ovation Fertility, Direct stockholder Apter, D. Bayer, Grant recipient; Merck, Grant recipient; Exeltis, Grant recipient; Bayer, Merck and Exeltis, Speakers bureau; GSK, Grant recipient Archer, D. F. AbbVie, Paid consultant; AbbVie, Grant recipient; TherapeuticsMD, Paid consultant; TherapeuticsMD, Grant recipient; Bayer Healthcare, Paid consultant; Bayer Healthcare, Grant recipient; Agile Pharmaceuticals, Paid consultant; Exeltis/CHEMO France, Paid consultant; Endoceutics, Paid consultant; Endoceutics, Grant recipient; TEVA/HR Pharma, Paid consultant Armenti, E. M. Pfizer, Direct stockholder; GE, Direct stockholder; Vertex, Direct stockholder Arrach, N. Progenesis, Company officer Arunajadai, S. Celmatix Inc, Full-time company employee Azziz, R. GlobalPET, Direct stockholder; Kindex Pharmaceuticals, Paid consultant; JDS Therapeuticals, Honoraria Babigumira, J. B. Androvia Life Sciences, Paid consultant; Genentech Inc, Paid consultant Bae, K.-S. SK Chemicals Co., Ltd, Contracted researcher of SKI2670 Clinical Trial Barad, D. H. U.S. Patents, DHB is a co-inventor on a number of FMR1 gene-related U.S. patents and still pending patent applications, which claim diagnostic benefits from evaluations of the gene. One of these patents was licensed to Generation Medical Associates, PLLC; Generation Medical Associates, PLLC, Direct stockholder; U.S. Patents, DHB holds patents that claim therapeutic benefits from androgen supplementation in women with LFOR and hypoandrogenism and receives licensing fees for the patents from Fertility Nutraceuticals, LLC; U.S. Patents, DHB is a co-inventor on a number of patents that claim therapeutic benefits from AMH. Barnea, E. R. BioIncept, LLC, Company officer Barnhart, K. Bayer, Paid consultant; SPD, Paid consultant Barrett, C. B. Reprosource Fertility Diagnostics, Paid consultant Barriere, P. Genevrier France, Honoraria; Merck Serono France, Paid consultant; MSD France, Paid consultant; HRA Pharma, Paid consultant; Ferring France, Honoraria Bartasi, G. Progyny, Inc., Company officer Bedaiwy, M. A. Allergan, Grant recipient Behr, B. Auxogyn, Direct stockholder; Ivigen, Direct stockholder Bendikson, K. Theralogix, Paid consultant

nd 72 ASRM Scientific Congress & Expo 275 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS ASRM Abstract and Video Author and Spouse/ Partner Disclosure Index

Bergh, C. M. MedSoftware, Company officer Bergh, P. A. MedSoftware, Direct stockholder Berkeley, A. S. Merck, Direct stockholder; Pfizer, Direct stockholder; Glaxo, Direct stockholder; Becton, Dickenson, Full-time company employee; Bristol Myers, Direct stockholder Berliss, M. Recombine, Paid consultant Berro, R. Celmatix Inc, Full-time company employee Berwald, T. Illumina, Direct stockholder Bjugstad, K. B. Aytu BioScience, Full-time company employee Blakesley, R. E. Allergan, Full-time company employee Blazek, J. Genesis Genetics, Full-time company employee Bocca, S. Merck-Organon, Speakers bureau Boekelheide, K. Boehringer Ingelheim, Grant recipient; Boehringer Ingelheim, Paid consultant; Zafgen, Paid consultant; Semma Therapeutics, Direct stockholder; Serviers, Paid consultant Bonafede, M. Truven Health Analytics, An IBM Company, Full-time employee of Truven Health Analytics, An IBM Company which received a research contract to conduct this study with and on behalf of AbbVie, Inc. Bradford, A. UpToDate, Royalties Bradley, L. Bayer Pharma AG, Principal investigator; scientific advisor; Boston Scientific, Scientific advisory member; Smith Nephew, Speakers bureau; Smith Nephew, Scientific advisory panel; Gynesonics, Data safety and monitoring committee member Brannigan, R. E. Abbvie, Inc., A grant in support of Northwestern University's Andrology fellowship was provided to Northwestern University, Feinberg School of Medicine. I am the Director of the Andrology Fellowship; The American Urological Association/The Journal of Urology, I am an Assistant Editor for The Journal of Urology Breton, B. Good Start Genetics, Full-time company employee Bristow, S. L. Recombine, Full-time company employee; Recombine, Stock options Broekmans, F. J. Member of the external advisory board for Ferring BV, The Netherlands, Paid consultant; Member of the external advisory board for Merck Serono, The Netherlands, Paid consultant; Consultancy work for Gedeon Richter, Belgium, Paid consultant; Educational activities for Ferring BV, The Netherlands, Honoraria; Strategic cooperation with Roche on automated AMH assay development, Honoraria; Research cooperation with Ansh Labs, USA, Honoraria Burkart Sadusky, A. Omeros Corporation, Direct stockholder Bush, M. Natera, Direct stockholder; Natera, Paid consultant Cabey, R. E. Reprogenetics, Full-time company employee Cameron, E. Genesis Genetics, a Cooper Surgical company, Full-time company employee; Cooper Surgical, Direct stockholder Cardona, C. Androvia LifeSciences LLC, Full-time company employee; Androvia LifeSciences LLC, Direct stockholder Carlsson, I. B. Recombine, Full-time company employee; Recombine, Stock Options Carrell, D. T. Episona, Inc, Direct stockholder; Nanonc, Inc, Direct stockholder Casper, R. OvaScience, Insception-Lifebank, Circadian-Zirclight, TRIO Fertility, Direct stockholder; AbbVie, Allergan, Bayer, EMD-Serono, Ferring, Merck, OvaScience, Pfizer,, Paid consultant; TRIO Fertility, Circadian-Zirclight, Insception-Lifebank, Company officer; Up-to-Date, Teva, Royalties; Fertility and Sterility, Editorial editor Castelli-Haley, J. AbbVie, Full-time company employee; AbbVie, Direct stockholder

nd 72 ASRM Scientific Congress & Expo 276 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS ASRM Abstract and Video Author and Spouse/ Partner Disclosure Index

Cataldo, N. A. CenseoHealth, Independent contractor Catherino, W. H. Abbvie, Paid consultant; Actavis, Paid consultant; Medical College of Wisconsin, Honoraria; Recombine, Full- time company employee; Bayer, Grant recipient Cedars, M. Ferring Pharmaceutical, Research support - investigator - initiated Celia, G. F. Good Start Genetics, Paid consultant Chan, A. Allergan, Full-time company employee Chang, C.-C. MyEggBank, Direct stockholder; Reproductive Biology Associates, Full-time company employee Chason, R. Theralogix, Direct stockholder Chen, S. H. Ovascience, Paid consultant; Hologic, Speakers bureau; Optum, Paid consultant; Recombine, Paid consultant Chin, W. EMD Serono, Full-time company employee Cho, S.-H. SK Chemicals Co., Ltd., Contracted researcher of SKI2670 Clinical Trial Choe, S. SK Chemicals Co., Ltd., Contracted researcher of SKI2670 Clinical Trial Cholkeri-Singh, A. DySIS Medical, Speakers bureau; Hologic, Inc, Speakers Bureau, Advisory Board Member; Smith & Nephew, Paid consultant; Bayer, Speakers Bureau, Advisory Board Member Chwalisz, K. AbbVie Inc., Full-time company employee; AbbVie Inc., Direct stockholder Clementi, C. Celmatix Inc, Full-time company employee Coddington, C. PG, Merck, AbbVie, Stock; AbbVie Endometriosis Advisory Board, Advisory Board Cohen, J. Reprogenetics LLC, Paid consultant; Althea Science INC, Company officer; Life Global Inc., Grant recipient Cohen, L. Philips Ultrasound, Speakers bureau Commander, S. B. CombiMatrix, Full-time company employee Conrad, D. PierianDx, Grant recipient Considine, R. Eli Lilly Research Labs, Paid consultant; Merck Research Labs, Paid consultant Copperman, A. B. EMD Serono, Speakers bureau; Merck, Speakers bureau; Ferring, Speakers bureau D'Agostino, R. Sanofi, Paid consultant; GSK, Paid consultant; Edwards Lifesciences, Paid consultant; Sandoz, Paid consultant; Cardioxyl, Paid consultant Davis, M. R. AbbVie, Inc., Paid consultant; Takeda Pharmaceutical Company Ltd, Paid consultant; Alexion Pharmaceuticals Inc., Paid consultant; Sanofi S.A., Paid consultant; Astellas Pharma US, Inc., Paid consultant DeGeyter, C. Ferring, Grant recipient Demko, Z. Natera, Inc., Direct stockholder D'Hooghe, T. M. Merck Serono, Ferring, Roche, Grant recipient; Astellas, Actavis, Bayer, Proteomika, Cartagenia, Paid consultant; Zentech, Technical support; Merck Serono, I have joined Merck Serono as Vice-President Global Medical Affairs Fertility since October 1st 2015, but continue my academic work as Professor of Reproductive Medicine and Biology at KU Leuven (University of Leuven), involved in both teaching and research. D’Hooghe, T. M. Merck Serono, Ferring, Roche, Grant recipient; Astellas, Actavis, Bayer, Proteomika, Cartagenia, Paid consultant; Zentech, Technical support; Merck Serono, I have joined Merck Serono as Vice-President Global Medical Affairs Fertility since October 1st 2015, but continue my academic work as Professor of Reproductive Medicine and Biology at KU Leuven (University of Leuven), involved in both teaching and research. Diamond, M. P. NICHD, AbbVie, EMD Serono, Baxter, Grant recipient; Teijin Pharmaceuticals, Auxogyn, Paid consultant; Advanced Reproductive Care, Board of Directors and Stockholder Dokras, A. JDS Pharmaceuticals, Paid consultant

nd 72 ASRM Scientific Congress & Expo 277 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS ASRM Abstract and Video Author and Spouse/ Partner Disclosure Index

Domar, A. D. TriaDea, Company officer; FertiCalm, Company officer; Merck, Speakers bureau; Ferring, Paid consultant; Merck, Paid consultant; UptoDate, Paid consultant Doody, K. Merck Pharmaceutical, Paid consultant; Ferring Pharmaceutical, Paid consultant; Finox Pharmaceutical, Paid consultant; Serono Pharmaceutical, Speakers bureau; Good Start Genetics, Paid consultant Doyle, K. M. Genesis Genetics, Full-time company employee Driggers, P. Eisai, Inc., Speakers bureau; novo-nordisk, Speakers bureau; Eisai, Inc., Paid consultant; Eisai, Inc., Clinical Investigator; novo-nordisk, Clinical Investigator Drum, J. A. EMD Serono, Full-time company employee Duan, W. R. AbbVie, Full-time company employee Dubey, A. Advagenix, LLC, Direct stockholder Dunn, R. D. Finox, PI for one of many sites for Afolia ART Study Durland, U. S. Natera, The clinic where I work uses Natera's PGD and PGS services; Genesis Genetics, The clinic where I work uses Genesis Genetics' PGD and PGS services. Dzidic, N. Combimatrix, Full-time company employee Eggan, K. C. New York Stem Cell Foundation, Paid consultant; Q-State Biosciences, Company officer; Intellia Therapeutics, Full-time company employee Eisenberg, M. Sandstone Diagnostics, Direct stockholder; Reprovantage, Direct stockholder; Glow, Advisor; EmbraceHer, Direct stockholder; Gilead, Paid consultant Epperson, C. N. Shire Pharmaceuticals, Grant recipient; Forest Laboratories, Expert opinion; Johnson and Johnson, Pfizer, Abbott, Abbvie, Merck, Direct stockholder Falco, L. AVA AG, Full-time company employee Fankhauser, D. M. EMD Serono, EMD Serono has financially sponsored educational outreach for fertility patients/professionals, conducted by Fertility Within Reach; Boston IVF, Boston IVF is a sponsor of Fertility Within Reach; OvaScience, OvaScience is a sponsor of Fertility Within Reach; Reproductive Medicine Associated of Connecticut (RMACT), RMACT is a sponsor of Fertility Within Reach; Brigham and Women's Hospital, Brigham and Women's Hospital is a supporter of Fertility Within Reach via a charitable contribution; Village Fertility Pharmacy, Village Fertility Pharmacy is a supporter of Fertility Within Reach via a charitable contribution. Farland, L. V. Smith and Nephew, Full-time company employee Faulkner, N. Good Start Genetics, Full-time company employee Faustmann, T. A. Bayer Pharma AG, Full-time company employee Feinberg, E. C. Abbvie, Paid consultant Feinberg, R. F. Ferring, Medical Practice Participating in Clinical Trial; Finox, Medical Practice Participating in Clinical Trial Fields, R. A. Fairfax EggBank, Full-time company employee Foidart, J.-M. MITHRA Pharmaceuticals, Actavis (Women's Healthcare Division), Paid consultant; IMCYSE (Biotch specialized in immune diseases), Chariman SAB Forman, E. J. Ferring Pharmaceuticals, Speakers bureau Foster, S. Recombine, Full-time company employee; Recombine, Stock options Fraser, I. S. Bayer Pharmaceuticals, Speakers bureau; Merck/MSD, Speakers bureau; Vifor Pharma, Speakers bureau Fujiwara, T. Ferring Pharmaceutical, Grant recipient; Merck Serono Co., Ltd., Grant recipient; Mochida Pharmaceutical, Grant recipient Gallagher, C. abbievie, Paid consultant

nd 72 ASRM Scientific Congress & Expo 278 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS ASRM Abstract and Video Author and Spouse/ Partner Disclosure Index

Garrison, L. P. Androvia Life Sciences, Paid consultant Gemzell-Danielsson, K. Bayer AG, MSD/Merck, HRA Pharma, ExelGyn, Gedeon Richter, Actavis, Honoraria; Bayer, Grant recipient Ghim, J.-L. SK chemical Co., Ltd., Contracted research for SKI2670 clinical trial Ghiossi, C. Counsyl Inc., Paid consultant; Counsyl Inc., Stipend for 4-week student internship Ginsburg, E. S. Serono, Grant recipient Giudice, L. ASRM, Company officer; Merck, Pfizer, Direct stockholder; Abbvie Pharmaceutical, Paid consultant; NextGen Jane, Scientific Advisory Board member; Juniper Pharmaceuticals, Advisory Board Members Gleicher, N. Fertility Nutraceuticals, LLC, Direct stockholder; Generation Medical Associates, PLLC, Direct stockholder; Fertility Nutraceuticals, LLC, Receive patent licensing fees; Generation Medical Associates, PLLC, Patent licensed; U.S. Patents, NG holds patents that claim therapeutic benefits from androgen supplementation in women with LFOR and hypoandrogenism; U.S. Patents, NG is a co-inventor on a number of FMR1 gene-related U.S. patents and still pending patent applications, which claim diagnostic benefits; U.S. Patents, NG is a co- inventor on three pending AMH-related patent applications. Gold, M. Recombine, Full-time company employee; Recombine, I have stock options. Goldberg, J. D. Counsyl, Inc, Full-time company employee Goldberg-Strassler, D. Reprogenetics, Full-time company employee Goldfarb, J. M. Lumara Health -- no longer affiliated with teh company since 11/14, Direct stockholder; AdhereTech, Investor; Biomendics, Investor Goldstein, M. Therologix, advisory board Gore, A. Good Start Genetics, Full-time company employee; Singlera Genomics, Full-time company employee Grainger, D. A. Abbvie, Speakers bureau; Shionogi, Inc., Speakers bureau Granger, S. W. Salimetrics, Chief Scientific Officer Grill, E. McGill, Honoraria; Ethicon, Paid consultant; ASRM, Content Review Committee Groettrup-Wolfers, E. Bayer Pharma AG, Full-time company employee Grover, N. S. Sangamo Biosciences, Direct stockholder Gutmann, J. somalogic, Paid consultant Hall, S. J. Semma Therapeutics, Inc., Direct stockholder Hallam, S. E. Good Start Genetics, Full-time company employee Hamamah, S. Ferring, Grant recipient Hammond, K. CenseoHealth, Independent contractor Han, S. SK Chemicals Co., Ltd., Contracted researcher of SKI2670 Clinical Trial Hannam, T. EMD Serono, Our company sells pharmaceutical products to patients; Organon, Our company sells pharmaceutical products to patients; Ferring, Our company sells pharmaceutical products to patients Hansen, K. R. Roche Diagnostics, Grant recipient; Ferring International Pharmascience Center US, Grant recipient Haque, I. S. Counsyl, Full-time company employee; Counsyl, Direct stockholder Harada, T. Bayer, Honoraria; Nobel pharma Co., Paid consultant; Mochica Pharmaceutical Co., Honoraria; Takeda Pharmaceutical Co., Honoraria Harris, E. athenaHealth, Full-time company employee Harton, G. Progyny, Full-time company employee; Illumina, Paid consultant

nd 72 ASRM Scientific Congress & Expo 279 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS ASRM Abstract and Video Author and Spouse/ Partner Disclosure Index

Hasson, J. "Temp-drop LTD". This is a start-up company which manufactures a self monitoring device which continuously measures body temperature in sleep., Medical adviser. The position is unpaid. Hayward, B. EMD Serono, Inc., Full-time company employee Healey, M. Monash IVF, Direct stockholder Held, K. R. Reprogenetics Germany GmbH, Company officer; Reprogenetics GermanyGmbH, Direct stockholder Hill, G. United Healthcare Women's Health Scientific Advisory Board, Paid consultant Hirshfeld-Cytron, J. E. Duchesnay, Speakers bureau Honig, S. C. AbbVie, Paid consultant; Lipocine, Paid consultant; Coloplast, Paid consultant; Endo, Paid consultant Hotaling, J. StreamDx, Andro360, NanOnc, Direct stockholder Hovanes, K. CombiMatrix, Full-time company employee Hu, J. Intuitive Surgical, Speakers bureau; Genome Dx, Speakers bureau Hubbard, J. EMD Serono Research & Development Institute, Full-time company employee Humaidan, P. Merck, MSD and IBSA, Honoraria; Merck, MSD and Ferring, Grant recipient Hunter Cohn, K. Celmatix Inc, Full-time company employee Hurley, E. G. Theravance Biopharma (TBPH), Innoviva, Inc. (INVA), Direct stockholder Hu-Seliger, T. Celmatix Inc., Full-time company employee Iturriaga, A. Enlighten Health Genomics/Labcorp, Paid consultant Jain, R. I. Former employee of AbbVie Inc., Former employee of AbbVie Inc. Jang, J. Maria Fertility Hospital, Full-time company employee Jasulaitis, S. Merck Pharmaceuticals, Speakers bureau Jenkins, T. Nanonc, Direct stockholder Jensen, J. Abbvie, Bayer Healthcare, HRA Pharma, Merck, ContraMed, MicroChips, Evofem, Paid consultant; Abbvie, Bayer, ContraMed, FHI 360, Medicines 360, Grant recipient Jeong, H. SK chemicals, Company officer Joergensen, N. Ferring Pharmaceutical, Ferring sponsored an investigation at my department. The investigation was unrelated to the submitted work, and within another field of andrological research Johnson, J. Ovascience, Inc., Paid consultant Johnson, S. SPD Development Company Ltd, Full-time company employee Johnson, S. J. AbbVie, Paid consultant; Sanofi, Paid consultant; Alexion, Paid consultant; Astellas, Paid consultant; Takeda, Paid consultant Kadoch, I.-J. Clinique Ovo, Clinical director; Yad-Tech, Shares holder Kadoch, J. I. clinique ovo, Company officer Kalmbach, K. Celmatix Inc, Full-time company employee Kalra, B. Ansh Labs, Full-time company employee Kijacic, D. Natera, Full-time company employee; Natera, Direct stockholder Kim, H. J. Maria Fertility Hospital, Full-time company employee Kim, J. SK Chemicals Co., Ltd., Contracted researcher of SKI2670 Clinical Trial

nd 72 ASRM Scientific Congress & Expo 280 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS ASRM Abstract and Video Author and Spouse/ Partner Disclosure Index

Kim, S. M. SK Chemicals, Full-time company employee Kitchen, J. Genesis Genetics, Full-time company employee Klavanian, J. Genesis Genetics, a Cooper Surgical Company, Full-time company employee Klein, N. My Egg Bank, partner in SRM, a minority owner of My Egg Bank Knebel, S. Reprogenetics Germany, Full-time company employee Konstantinidis, M. Reprogenetics, CooperSurgical, Full-time company employee Kort, J. My Egg Bank, Direct stockholder Kovalevsky, G. Ferring, Clinical research trial investigator; Finox, Clinical research trial investigator Krisher, R. L. Merck Serono, Grant recipient Kuebler, F. Ava AG, Full-time company employee Kumar, A. AnshLabs, Full-time company employee Kumar, N. Recombine, Full-time company employee Kushnir, V. A. US Patents, Listed as a co-inventor on a pending AMH-related patent application. Lalioti, M. Biogen, Full-time company employee Lamb, D. J. Cellmatix, Scientific Advisory Board- Unpaid Lambert-Messerlian, G. Fujirebio, Grant recipient; Ansh Labs, Grant recipient; Natera Inc, Grant recipient Large, M. Genesis Genetics, a Copper Surgical Company, Full-time company employee Larman, M. Progyny, Full-time company employee Laskin, C. A. GlaxoSmithKline Pharma, Advisory panel for biological Benlysta. Laurent, L. Illumina, Inc., Full-time company employee Laven, J. S. Ferring B.V. The Netherlands, Grant recipient; Merck Diagnostics, Switserland, Paid consultant; Marckryl Pharma GMBH, Germany, Honoraria; Metagenics INC /RFB / Women's health, USA, Honoraria Lawlor, D. Roche Diagnostics, Grant recipient; Medtronic, Grant recipient; Ferring, Grant recipient Lazarin, G. A. Counsyl, Full-time company employee Leader, B. ReproSource, Full-time company employee Lee, W. D. Maria Fertility Hospital, Full-time company employee Leeners, B. Ava, Member of advisory board of Ava, Research grant together with other research groups and Ava Legro, R. S. Millendo, Paid consultant; Bayer, Paid consultant; JDS Therapeutics, Paid consultant; Euroscreen, Paid consultant; Kindex, Paid consultant Leone Roberti Maggiore, U. DEKA, Speakers bureau Lessey, B. A. Pfizer, Paid consultant; Pfizer, Grant recipient Levy, M. Donor Egg Bank, USA: President, Company officer Li, M. PacGenomics, Company officer Licciardi, F. Merck, Speakers bureau Lieber, C. Counsyl, Inc., Paid consultant Liebermann, J. Sage/Origio, Paid consultant; Vivere, Paid consultant; Irvine Scientific, Speakers bureau Lim, J. H. maria Fertility Hospital, Company officer

nd 72 ASRM Scientific Congress & Expo 281 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS ASRM Abstract and Video Author and Spouse/ Partner Disclosure Index

Lim, K. S. SK Chemicals Co., Ltd., Contracted researcher of SKI2670 Clinical Trial Lim, R. M. GenePeeks, Inc., Full-time company employee Lin, P. C. Omniguide Surgical, Paid consultant; INVO Bioscience Inc., Direct stockholder Lipshultz, L. I. Boston Scientific/American Medical Systems, Speaker, Consultant; Endo Pharmaceuticals, Consultant, Clinical Investigator; Repros Medical, Clinical Investigator, Speaker, Consultant; AbbVie, Consultant, Speaker; Lipocine, Paid consultant Liu, K. Ferring Canada, Grant recipient; Merck, Sponsorship to attend clinical observership program Lukaszuk, K. Ferring Pharmaceuticals, Honoraria; Roche Diagnostics, Honoraria; Merc, Honoraria Luke, B. Society for Assisted Reproductive Technology, Paid consultant MacLachlan, V. B. Monash IVF, Full-time company employee Mahony, M. C. EMD Serono, Inc., a business of Merck KGaA, Darmstadt, Germany, Full-time company employee Maisenbacher, M. K. Natera, Full-time company employee Malik, M. AB Sciex, Full-time company employee Manoharan, A. P. Recombine, Full-time company employee; Recombine, Stock options Marriott, L. SPD Development Company Ltd, Full-time company employee Maslow, B.-S. L. Natera - webinar 10/15., Honoraria Matin, M. Salimetrics, LLC, Full-time company employee Mauner, A. L. Fertility Laboratories of Colorado, Full-time company employee McCoy, R. C. Natera, Inc., RCM received conference travel funding from Natera, Inc.; Stanford University, RCM is a co- inventor on patent application USSN 14/938,842 filed by Stanford University. McCulloh, D. H. ReproART: Georgian American Center for Reproductive Medicine, Tbilisi, Georgia, Company officer; Biogenetics Corporation, Mountainside, New Jersey, USA, Company officer; NYU Fertility Center, New York, New York, USA, Full-time company employee McGovern, P. G. University Reproductive Associates, PC, Direct stockholder; Hasbrouck Heights Surgery Center, LLC, Direct stockholder McWilliams, K. Genesis Genetics, Full-time company employee McWilliams, T. K. Genesis Genetics, Full-time company employee Merrion, K. Natera, Inc., Full-time company employee; Natera, Inc., Option to hold stock in Natera, Inc. Merz, M. Bayer Pharma AG, Full-time company employee Miller, C. E. Abbvie, Actavis, Aegea Medical, Bayer Healthcare, Covidien, Espiner Medical, Ferring, Genesis Genetics, Gynesonics, Intuitive Surgical, Merck, Watson Pharmaceuticals, Grant/Research/Study; Abbvie, Covidien, Ethicon, Gynesonics, Halt Medical, Hologic Inc., Intuitive Surgical, Metalmark Capital, Pacira Pharmaceuticals, Smith & Nephew, Stryker Endoscopy, Paid consultant; Ethicon, Intuitive Surgical, Smith & Nephew, Speakers bureau; Thomas Medical/Catheter Reserach, Inc. (Miller Catheter), Royalties Milligan, K. Reprogenetics, Full-time company employee Missmer, S. A. Abbvie, Paid consultant Mol, B. W. ObsEva, Geneva, Paid consultant Moley, K. OvaScience, Scientific Advisory Board Member Molinaro, T. A. Merck, Paid consultant

nd 72 ASRM Scientific Congress & Expo 282 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS ASRM Abstract and Video Author and Spouse/ Partner Disclosure Index

Monseur, B. C. Medical Students for Choice, Board of Directors, Fundraising Chairperson Montag, M. Vitrolife, Paid consultant; Ferring, Speakers bureau; Merck, Paid consultant Moody, M. A. Androvia LifeSciences, Full-time company employee; Androvia LifeSciences, Direct stockholder Moreno, I. Igenomix S.L., Full-time company employee Morey, R. Synthetic Genomics, Full-time company employee Morriss, A. M. GenePeeks, Inc., Company officer Mottla, G. L. EMD Serono, Honoraria; EMD Seronio, Paid consultant Mounts, E. Recombine, Paid consultant Mullen, T. Good Start Genetics, Full-time company employee Mundy, S. Natera, Option to own stock at Natera Munne, S. Reprogenetics, Company officer; Cooper Surgical, Company officer; Recombine, Direct stockholder Nagy, Z. P. My Egg Bank, Direct stockholder; Cooper-Surgical/Origio, Paid consultant; Merck MSD, Speakers bureau Natan, Y. FertileSafe Ltd., Full-time company employee Needleman, D. Luminova, Company officer Neitzel, D. Good Start Genetics, Full-time company employee Nelson, A. Agile Pharmaceutical, ContraMed, Merck, Grant recipient; Allergan, Aspen Pharmaceutical, Bayer, Merck, Honoraria; Allergan, Agile Pharmaceutical, Bayer, ContraMed, The Female Health Company, Merck, MicroCHIPS Biotech, PharmaNest, Paid consultant Nelson, J. Nexgenomics, LLC, owner Nelson, J. K. Truven Health Analytics, An IBM Company, Full-time employee of Truven Health Analytics, An IBM Company which received a research contract to conduct this study with and on behalf of AbbVie, Inc. Nelson, S. M. Beckman Coulter, Ferring, Merck Serono, MSD, Roche, Speakers bureau; Roche Diagnostics, Grant recipient; Besins, Ferring, MSD, Merck Serono, Roche, Paid consultant Nervi, L. Actavis, Full-time company employee Niederberger, C. American Urological Association, Update series editor; Ferring, Grant recipient; Nexhand, Company officer Nieman, L. HRA Pharma, Grant recipient; UpToDate, royalties Novotny, M. Phillips Healthcare, Full-time company employee Omurtag, K. regular rate rhythm Software, Paid consultant Oromendia, A. Celmatix, Inc., Full-time company employee Ostermeier, G. C. Androvia LifeSciences, Full-time company employee; Androvia LifeSciences, Direct stockholder Paduch, D. Abbvie, Speakers bureau; Bayer, Paid consultant; Abbvie, Paid consultant Palermo, G. D. Irvine Scientific, Royalties Palomaki, G. Ansh Laboratories, Consulting contract between employer (Women & Infants Hospital) and Ansh Laboratories Palter, S. F. Lodestone Technology, Inc, Company officer Paolino, N. C. Recombine, Full-time company employee Paplomata, E. Novartis, funding of industry sponsored and investigator initiated clinical trials- funding given to the institution and not directly to the individual; Hoosier Research Network, funding of industry sponsored clinical trials- funding given to the institution and not directly to the individual; Genentech, funding of

nd 72 ASRM Scientific Congress & Expo 283 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS ASRM Abstract and Video Author and Spouse/ Partner Disclosure Index

industry sponsored clinical trials- funding given to the institution and not directly to the individual; Corcept pharmaceutical, funding of industry sponsored clinical trials- funding given to the institution and not directly to the individual Parfitt, D.-E. Celmatix Inc, Full-time company employee Parry, J. P. N/A, My wife and I recently have trademarked, have a provisional patent, and developed a website for the Parryscope surgical technique for which we are presenting data. Though we haven't submitted for the full patent, our understanding of patent law is that a surgical technique patent can't be used to prevent another doctor from performing a procedure (or charge licensing fees). (We're doing this to avoid potential headaches from patent trolls.) We have no affiliations with or funding from any manufacturers; ASRM-SRS, I am chair of the website committee for the Society of Reproductive Surgeons and coordinate literature reviews for SRS. Parsons, P. SPD Development Company Ltd., Full-time company employee Patrizio, P. Counsyl, scientific advisor; FertileSafe, co-founder and scientific advisor Penrose, L. Reproductive Solutions Inc., Company officer Penzias, A. S. OvaScience, Advisory board Member; ReproSource, Advisor Petersdorf, K. Bayer Pharma AG, Full-time company employee; Bayer Pharma AG, Direct stockholder Peterson, C. M. Clinical Innovations, Royalties Petrozza, J. C. Interlace Medical / Hologic, Scientific Advisory Committee; Smith and Nephew, Advisory Committee Price, T. M. MedaCorp, Paid consultant; Gerson Lehrman Group, Paid consultant; Guidepoint, Paid consultant; Best Doctors, Paid consultant Prien, S. Reproductive Solutions Inc, Company officer Puig, O. Roche, Full-time company employee Puscheck, E. E. Bayer Pharmaceuticals, Grant recipient; AbbVie Pharmaceutical Research and Development, Grant recipient; Ferring. International, Pharmascience Center U.S., Inc, Grant recipient; Gynesonics, Grant recipient Racowsky, C. Life Global Group, Paid consultant; UpToDate, Honoraria; World Health Organization, Paid consultant Ramasamy, R. Lipocine, Paid consultant; Beckman, Paid consultant; Direx System, Grant recipient Rasmussen, R. R. Health Management Resources, We own a clinic that uses their program and products. Rassaby, L. Recombine, Full-time company employee; Recombine, Stock options Ready, K. Counsyl, Full-time company employee Reape, K. Z. Allergan, Paid consultant; Spark Therapeutics, Inc., Full-time company employee Reay, M. SPD Development Company Ltd, Full-time company employee Reed, B. G. Sequenom, Direct stockholder Ren, X. Bayer HealthCare, Full-time company employee Riche, D. M. Merck, Novo Nordisk, Speakers bureau; Novo Nordisk, Advisory Board; Arbor Pharmaceuticals, Advisory Board Richter, K. S. EMD Serono, Paid consultant Robinson, K. Good Start Genetics, Inc., Full-time company employee Robinson, R. D. AbbVie, Grant recipient Rodriguez, S. Recombine, Full-time company employee; Recombine, Direct stockholder Rosberger, Z. Merck, Honoraria Rosen, K. A. Bayer Pharmaceuticals Inc., Full-time company employee

nd 72 ASRM Scientific Congress & Expo 284 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS ASRM Abstract and Video Author and Spouse/ Partner Disclosure Index

Ross, R. Advagenix, Company officer Rowan, J. P. AbbVie, Full-time company employee Ruthazer, R. Pfizer, Paid consultant Sakkas, D. Ferring, Grant recipient; Origio, Scientific Advisory Board; Allergan, Trial Advisory Board; INVO Biosciences, Direct stockholder Sammel, M. D. Swiss Precision Diagnostics, Paid consultant Sanchez, T. LuminOva, Inc., Direct stockholder Santistevan, A. Celmatix Inc, Full-time company employee Santoro, N. Bayer Inc, Grant recipient; Menogenix Inc, Stock Options Saucier, J. B. Natera, Inc, Full-time company employee; Natera, Inc, Direct stockholder; Natera, Inc, option to hold stock at Natera Schattman, G. L. Femasys, medical advisor, clinical investigator; Theralogix, Paid consultant; Ferring, Speakers bureau Schenken, R. S. Evestra, Consultant Schertz, J. EMD Serono Research and Development Institute, Billerica, MA, Full-time company employee Schlegel, P. N. GNYUTES, Provider of SWL services, Company officer; Theralogix, Inc, Producer of Nutraceuticals, Paid consultant Schmelter, T. Bayer Pharma AG, Full-time company employee; Bayer AG, Direct stockholder Schmidt, J. Natera, Inc., Paid consultant Schwefel, B. AbbVie, Inc, Full-time company employee; AbbVie, Inc, Direct stockholder Scott, R. T. Foundation for Assessment & Enhancement of Embryonic Competence, Inc. , Neither myself or my program get any personal benefit., Company officer; Ferring Pharmaceutical, Scientific Advisory Board Seaman, E. Androvia, Paid consultant Segars, J. Biospecifics, Inc, as research site for possible new drug; American Board of Obstetrics and Gynecology, As board Director Sehnert, S. Recombine, Full-time company employee; Recombine, Stock options Seifer, D. Rutgers Medical School/ MGH licensing agreement with Beckman-Coulter, Co-inventor of AMH as a method of determining ovarian reserve; Beckman-Coulter, Paid consultant; Women's Integrated Network, Paid consultant; What's my fertility?, Paid consultant Seitz, C. Bayer Pharma AG, Full-time company employee Sharara, F. MAP Diagnostics, Company officer; Ferring Pharmaceuticals, Speakers bureau Shim, J.-Y. SK chemicals Co., Ltd, Contracted researcher of SK12670 Clinical Trial Shraga, R. Recombine, Full-time company employee; Recombine, Stock Options Shulman, L. P. Merck, Sera, Sequenom, Vermillion, Bayer, Actavis, Mithra, Paid consultant; Actavis, Bayer, Sequenom, Mithra, Honoraria Shwayder, J. M. GE Ultrasound, Speakers bureau Silver, A. J. GenePeeks, Inc., Full-time company employee Silver, L. M. GenePeeks, Inc., Company officer Silver, M. J. GenePeeks, Inc., Full-time company employee Silverberg, K. Abbvie, Speakers bureau; Good Start Genetics, Paid consultant; Allergan, Paid consultant; Serono, Paid consultant; Illumina, Paid consultant; Myriad Genetics, Paid consultant; Finox, Grant recipient; Halt Medical, Grant recipient; Myriad Genetics, Grant recipient

nd 72 ASRM Scientific Congress & Expo 285 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS ASRM Abstract and Video Author and Spouse/ Partner Disclosure Index

Simon, C. Igenomix SL, Direct stockholder; Equipo IVI, Direct stockholder Simon, J. AbbVie, Inc. (North Chicago, IL), AMAG Pharmaceuticals, Inc. (Waltham, MA), Amgen Inc. (Thousand Oaks, CA), Apotex, Inc. (Toronto, Canada), Ascend Therapeutics (Herndon, VA), JDS Therapeutics, LLC (Purchase, NY), Merck & Co., Inc. (Whitehouse Station, NJ), Noven Pharmaceuticals, Inc. (New York, NY), Novo Nordisk (Bagsvrerd, Denmark), Nuelle, Inc. (Mountain View, CA), Perrigo Company, PLC (Dublin, Ireland), Radius Health, Inc. (Waltham, MA), Regeneron Pharmaceuticals, Inc. (Tarrytown, NY), Sanofi S.A. (Paris, France), Sermonix Pharmaceuticals, Inc. (Columbus, OH), Shionogi Inc. (Florham Park, NJ), Sprout Pharmaceuticals (Raleigh, NC), Symbiotec Pharmalab (Indore, India), TherapeuticsMD (Boca Raton, FL)., Dr. James A. Simon has served (within the last year) or is currently serving as a consultant to or on the advisory boards of those companies listed; AbbVie, Inc. (North Chicago, IL), Actavis, PLC. (Dublin, Ireland), Agile Therapeutics (Princeton, NJ), Bayer Healthcare LLC., (Tarrytown, NY), New England Research Institute, Inc. (Watertown, MA), Novo Nordisk (Bagsvrerd, Denmark), Palatin Technologies (Cranbury, NJ), Symbio Research, Inc. (Port Jefferson, NY), TherapeuticsMD (Boca Raton, FL)., Grant recipient; Amgen Inc. (Thousand Oaks, CA), Eisai, Inc. (Woodcliff Lake, NJ), Merck (Whitehouse Station, NJ), Noven Pharmaceuticals, Inc. (New York, NY), Novo Nordisk (Bagsvrerd, Denmark), Shionogi Inc. (Florham Park, NJ)., Speakers bureau; Sermonix Pharmaceuticals (Columbus, OH)., Direct stockholder Simpson, A. Androvia LifeSciences, Full-time company employee Slayden, O. D. Bayer Pharma AG, Berlin, Grant recipient Snabes, M. C. AbbVie, Full-time company employee Sniukiene, V. Allergan, Full-time company employee Soliman, A. M. AbbVie Inc., Full-time company employee; AbbVie Inc., Direct stockholder Somers, F. Allergan plc, Full-time company employee Spaczynski, R. Z. Polpharma Biuro Handlowe sp. z o.o., Warsaw, Poland, Speakers bureau; Ferring Pharmaceuticals Poland Sp. z o.o., Warsaw, Poland, Speakers bureau; Zentiva, A Sanofi Company, Warsaw, Poland, Speakers bureau Sprague, M. L. Covidien, Speakers bureau Stanczyk, F. Z. Merck & Co., Paid consultant; TherapeuticsMD, Paid consultant; Noven Pharmaceuticals, Paid consultant; Enteris Biopharma, Paid consultant; AbbVie, and, Agile Therapeutics, Paid consultant Stein, P. Ava AG, Full-time company employee Steinkampf, M. P. AbbVie Pharmaceuticals, Speakers bureau Stewart, E. A. AbbVie, Allergan, Astellas, Bayer, GlaxoSmithKline, Gynesonics, Welltwigs, Viteava, Paid consultant; UpToDate, Honoraria Stimach, C. Genesis Genetics, Full-time company employee Strecker, M. N. CombiMatrix, Full-time company employee Strickland, J. L. Merck Implanon trainer, Honoraria Sullivan, M. Gilead Sciences, Inc, Grant recipient Surrey, E. AbbVie Laboratories, Advisory board, speaker's bureau, grant recipient Suturina, L. V. Bayer, Paid consultant Swain, J. Irvine Scientific, Royalties from Media Sales Tabata, C. Ferring Pharmaceuticals Co., Ltd., Paid consultant; Merck Serono Co., Ltd., Speakers bureau; Mochida Pharmaceutical Co., Ltd., Speakers bureau Tanrikut, C. New England Cryogenic Center, Medical Director - Andrology Lab Taylor, H. S. Pfizer, Grant recipient; OvaScience, Grant recipient; Abbvie, Honoraria; Bayer, Paid consultant; Euroscreen, Paid consultant

nd 72 ASRM Scientific Congress & Expo 286 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS ASRM Abstract and Video Author and Spouse/ Partner Disclosure Index

Taylor, T. H. CombiMatrix, Full-time company employee Teal, S. B. Merck, Inc, Paid consultant; Actavis, Paid consultant Teede, H. J. Epworth sleep centre, Company officer Thomas, J. W. Abbvie, Full-time company employee Thomas, M. A. Medicines 360, Grant recipient; Agile, Grant recipient; Bayer, Grant recipient Tirado, E. ReproSource Inc, Full-time company employee Tomasino, J. R. Progyny, Full-time company employee Tournaye, H. Glaxo Smith Kline, Full-time company employee; Finox, Paid consultant Travis, A. J. Androvia LifeSciences, LLC, Paid consultant Treff, N. R. EMD Serono, Grant recipient; EMD Serono, Speakers bureau Umbarger, M. A. Good Start Genetics, Full-time company employee VerMilyea, M. Irvine Scientific, Paid consultant Virmani, M. A. Sigma Tau HealthScience, Full-time company employee Vollenhoven, B. J. Monash IVF, Direct stockholder Von Wald, T. CEGA LLC, Direct stockholder Wagner Coughlin, C. EMD Serono, Advisory Board; Good Start Genetics, Advisory Board Wallace, J. Natera, Inc., Full-time company employee Walsh, T. J. Boston Scientific, Paid consultant; Coloplast, Paid consultant; Counsyl Genetics, Paid consultant Walters-Sen, L. C. Good Start Genetics, Inc., Full-time company employee Wantman, E. SART and other infertility clinics., Paid consultant Watts, N. AbbVie, Paid consultant Weinberg, C. United Health Care, Direct stockholder; CVS, Direct stockholder Weinerman, R. S. Sermonix Pharmaceuticals, Direct stockholder Welch, C. Reprogenetics, Full-time company employee Wells, D. Reprogenetics UK, Direct stockholder; Illumina, Paid consultant; Recombine, Direct stockholder; Reprogenetics, Employee Westemeyer, M. Natera, Inc., Full-time company employee; Natera, Inc., Direct stockholder Widra, E. A. Counsyl, Paid consultant; Resolve, Board Member; Embryo Options, Direct stockholder; Capex MD, Direct stockholder; Capex MD, Board member Wilcox, J. G. Nexgenomics, LLC, Owner Williams, L. A. AbbVie, Inc, Full-time company employee Winkel, C. A. AbbVie, Paid consultant Witt, B. R. Ferring Pharmaceuticals, Honoraria Wolff, E. F. OvaScience, Grant recipient Wong, K. K. Counsyl, Full-time company employee Wu, H. Celmatix Inc., 14 Wall Street 16D, New York, NY 10005, Full-time company employee Xia, M. The people of Jiangsu Provence Hospital, Direct stockholder

nd 72 ASRM Scientific Congress & Expo 287 Salt Lake City, Utah ASRM 2O16 SCIENTIFIC CONGRESS ASRM Abstract and Video Author and Spouse/ Partner Disclosure Index

Yang, L. Bluebird Bio Inc., Direct stockholder; AbbVie Inc., Direct stockholder; Gilead Sciences, Direct stockholder; The Medicines Company, Direct stockholder; Trius Therapeutics, Direct stockholder; Durata Therapeutics, Direct stockholder Yang, Z. ZytoGen, Company officer Yarnall, S. Recombine, Full-time company employee; Recombine, Stock options Yoo, T. SK Chemicals, Full-time company employee Yoon, H. J. Maria Fertility Hospital, Full-time company employee Yoon, S. H. Maria Fertility Hospital, Full-time company employee Yurttas Beim, P. Celmatix Inc, Company officer Zgodic, A. Celmatix, Full-time company employee Zhan, Y. Thermo Fisher, Full-time company employee Zhang, H. BMS, Full-time company employee Zhao, L. Boston Scientific, Paid consultant Zimberg, S. Covidien, Paid consultant Zimmerman, R. Foundation for Embryonic Competence, Full-time company employee Zini, A. YAD-Tech Neutraceuticals, Direct stockholder

nd 72 ASRM Scientific Congress & Expo 288 Salt Lake City, Utah Ambassadors

Founder’s Club $1,000,000 Plus Kwang-Yul Cha, M.D., Ph.D.

Director’s Circle $500,000 to $999,999 Advanced Reproductive Care, Inc. and Rosemary and David Adamson

Visionary $100,000 to $499,999 EMD Serono, Inc. K.M. Kavoussi, M.D., Shahryar Kavoussi, M.D., Camran Nezhat, M.D. Parviz Kavoussi, M.D., and Cappy Rothman, M.D., Chuck Sims, M.D., Mehryar Kavoussi, J.D., Austin Fertility & California Cryobank Reproductive Medicine/Westlake IVF American Board of Obstetrics and Gynecology Masood Khatamee, M.D. Suheil Muasher, M.D. Manhattan Cryobank The TALOFA Foundation

Sustainer $50,000 to $99,999 G. David Adamson, M.D. Freeman Decorating Jennifer Thie, M.D. Services Inc.

Benefactor $10,000 to $49,999 Pira Amirsaleh David Hill Ph.D. and Marianne Steven Ory, M.D. Douglas Carrell, Ph.D. G. Hill, M.D. Robert Rebar, M.D. Sandra Carson, M.D. and Edward Karpman, M.D. David B. Seifer, M.D., FACOG Joe Leigh Simpson, M.D. William Keye, M.D. Richard V. Grazi, M.D., Christos Coutifaris, M.D., Ph.D. Saeed Khatamee FACOG, FACS Marian Damewood, M.D. Edward Kim, M.D. Peter Schlegel, M.D. Owen Davis, M.D. Kirk Cheng Lun Lo, M.D. Stephen Shaban, M.D. Harry Fisch, M.D. Roger Lobo, M.D. Mark Sigman, M.D. Marc Fritz, M.D. R. Dale McClure, M.D. Rebecca Sokol, M.D., M.P.H. William Gibbons, M.D. Craig Niederberger, M.D. Daniel Williams, M.D. Linda Giudice, M.D., Ph.D. Robert Oates, M.D. Richard Reindollar, M.D. and Ann Davis, M.D. Advocate $5,000 to $9,999 Robert Brannigan, M.D. Genetics & IVF Institute Dolores Lamb, Ph.D., H.C.L.D. Michael Soules, M.D. John Buster, M.D. Joseph Gianfortoni, M.D. Richard Legro, M.D. Aaron Spitz, M.D. Maria Bustillo, M.D. Elizabeth Ginsburg, M.D. Larry Lipshultz, M.D. Hugh Taylor, M.D. Bruce Carr, M.D. Marc Goldstein, M.D. New Morning Foundation Michael Thomas, M.D. Marcelle Cedars, M.D. Bruce Goldstein, J.D. Richard Paulson, M.D. James Toner, M.D., Ph.D. R. Jeffrey Chang, M.D. Jacqueline Gutmann, M.D. Nanette Santoro, M.D. Bradley Van Voorhis, M.D. Michael Coburn, M.D. Julia Johnson, M.D. William Schlaff, M.D. Drs. ZeRah – Taar – Pfeffer

Patron $1,000 to $4,999 Brian Acacio, M.D. James Goldfarb, M.D. Hung-ching Liu, Ph.D. Hossein Sadeghi-Nejad, M.D. Yalda Bahari Mary Hammond, M.D. J. Ricardo Loret de Mola, M.D. Marguerite Shepard, M.D. Banou, Inc. Deb Hanson Joel Marmar, M.D. Glenn Schattman, M.D. G. Wright Bates, Jr., M.D. John Harding, M.D. Aaron Milbank, M.D. Robert Schenken, M.D. Gordon Bates, M.D. George Hill, M.D. Edgar Mocanu, M.D. Isaac Schiff, M.D. Nancy Brackett, Ph.D. David Hoffman, M.D. Kenneth Moghadam, M.D. Gamal E. Serour, FRCS Jeffrey Buch, M.D. Stanton Honig, M.D. Kamran Moghissi, M.D. Lennie Siegel, B.B.A. Mark Bush, M.D. Mark Hornstein, M.D. Mary Molo, M.D. Yefim Sheynkin, M.D. Veasy Buttram, M.D. Stuart Howards, M.D. Lila Nachtigall, M.D. Joe Leigh Simpson, M.D. Sandra Carson, M.D. William Huang, M.D., Ph.D. Richard Nachtigall, M.D. Amy Sparks, Ph.D. Carol Chang Gabor Huszar, M.D. Steven Nakajima, M.D. Elizabeth Stewart, M.D. R. Jeffery Chang, M.D. Informa Healthcare Ajay Nangia, M.D. Cigdem Tanrikut, M.D. Janet Choi, M.D. Keith Isaacson, M.D. Genevieve Neal-Perry, M.D., Ph.D. The Department of Obstetrics Charles Coddington, M.D. Sangita Jindal, Ph.D. David Nudell, M.D. and Gynecology NYU School of Judith Daar, J.D. Emily Jungheim, M.D. Osvaldo Padron, M.D. Medicine Conceptions Reproductive Scott Kauma, M.D. Edwin Peterson, M.D. Andrew Toledo, M.D. Associates Roger Kempers, M.D. Angelia Pitman Chii-Ruey Tzeng, M.D., M.P.H. Cook Medical Mohit Khera, M.D. Thomas Price, M.D. Barry Verkauf, M.D., M.B.A. Erma Drobnis, Ph.D. Ali Khodadoust PSAV Presentation Services Robert Wah, M.D. Donald Evenson, Ph.D. Nancy Klein, M.D. Quest Diagnostics Edward Wallach, M.D. Ferring Pharmaceuticals, Inc. Lowell Ku, M.D. Catherine Racowsky, Ph.D. Russel Williams, M.D. Nancy Frankel, M.B.A. Andrew La Barbera, Ph.D., Rassetti Gynecology Benjamin Wong, M.D., M.B.A. Gary Frishman, M.D. H.C.L.D. Mohammad Rezaee, M.D. Mylene Yao, M.D. Genesis Fertility Andrew Levy and Neda Ginny Ryan, M.D. Kathryn Go, Ph.D. Khatamee Levy Friend $500 to $999 Mohamad Aboulghar, M.D. Alan Copperman, M.D. Keikhosrow Kavoussi Mary Schalkoff, Ph.D. Kevin Ake, B.S. David Cozzolino, M.D. David Keefe, M.D. Leah Schenk, M.D. Linda Applegarth, Ed.D. Eric Daiter, M.D. Rustom Khatib, M.D., Ph.D. Richard Scott, M.D. Auxogyn, Inc. Alan DeCherney, M.D. Robert Kiltz, M.D. James Seagers, M.D., FACOG Eric Avezzano, M.D. W. Paul Dmowski, M.D., Ph.D. Marian Lee David Seifer, M.D. William Baird, Ph.D. Carolyn Doherty, M.D. Michael Lee, M.S. Sheila Gold Foundation Andrea Boccelli, B.A. Mark Fallick, M.D. Christopher Lipari, M.D. Nathan Snyder, B.A., M.B.A. Chastity Bradley, Ph.D. David Fenig, M.D. Anthony Luciano, M.D. Andrea Stein, M.D. Peter Brinsden, M.D. Flemish Society for Obstetricians Charles Lynne, M.D. Judy Stern, Ph.D. William Butler, M.D. and Gynecologists Markus Margreiter Bo Suh, M.D. Richard Buyalos, M.D. Michael Fox, M.D. Henry Mateo-Sanez, M.D. Eric Surrey, M.D. Denise Cassidenti, M.D. Vickie Gamble Rachel McConnell, M.D. Erika Tabke, R.N. William Catherino, M.D., Ph.D. Sarah Girardi, M.D. Paul McDonough, M.D. Sean Tipton, M.A. Center for Reproductive Medicine Richard Grazi, M.D. Zsolt Nagy, M.D., Ph.D. Ilan Tur-Kaspa, M.D. Center for Surrogate Parenting Greater Boston Convention and Eleanor Nicoll, J.D. University Urology, PC Inc. & Egg Donation, Inc. Visitors Bureau Kosrow Nowroozi, M.D. Robert Visscher, M.D. Yoon-Seok Chang, M.D., Ph.D. David Hill, Ph.D. Progyny Christine Wilson, Ph.D., N.P. Samuel Chantillis, M.D. Scot Hutchison, M.D. Psychological Assessment Peng Cheang Wong, M.D. C. James Chuong, M.D., M.P.H. Igor Ilyin, M.D., Ph.D. Resources, Inc. Kangp Xu, Ph.D. ConceiveAbilities Francisco Irianni, M.D. Andrew Ruiz, M.Sc., M.S.T.S. Bill Yee, M.D. Edmond Confino, M.D. IVF Florida Reproductive Associates David Ryley, M.D. Armand Zini, M.D.